Dataset | *** REFERENCE GENES OMIM/GR/Bell

*** REFERENCE GENES OMIM/GR/Bell


A1BG	G:138670	.	.
A2LD1	G:613378	.	.
A2M	G:103950	.	{Alzheimer disease, susceptibility to}, 104300 (3)
A2ML1	G:610627	.	.
A4GALT	G:607922	.	[Blood group, P system], 111400 (3)
AAAS	G:605378	Bell>endocrine	Achalasia-addisonianism-alacrimia syndrome, 231550 (3)
AACS	G:614364	.	.
AADAC	G:600338	.	.
AADAT	G:611754	.	.
AAMP	G:603488	.	.
AANAT	G:600950	.	{Delayed sleep phase syndrome, susceptibility to}, 614163 (3)
AARS	G:601065	.	.
AARS2	G:612035	.	Combined oxidative phosphorylation deficiency 8, 614096 (3)
AARSD1	G:613212	.	.
AASDH	G:614365	.	.
AASDHPPT	G:607756	.	.
AASS	G:605113	.	Hyperlysinemia, 238700 (3)
AATF	G:608463	.	.
AATK	G:605276	.	.
AAVS1	P:102699	.	.
ABAT	G:137150	.	GABA-transaminase deficiency, 613163 (3)
ABCA1	GP:600046	.	HDL deficiency, type 2, 604091 (3)
ABCA1	GP:600046	.	Tangier disease, 205400 (3)
ABCA1	GP:600046	.	{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)
ABCA10	G:612508	.	.
ABCA12	G:607800	Bell>cutaneous	Ichthyosis, harlequin, 242500 (3)
ABCA12	G:607800	Bell>cutaneous	Ichthyosis, lamellar 2, 601277 (3)
ABCA13	G:607807	.	.
ABCA2	G:600047	.	.
ABCA3	G:601615	.	Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3)
ABCA4	G:601691	+GR-Bell	Cone-rod dystrophy 3, 604116 (3)
ABCA4	G:601691	+GR-Bell	Fundus flavimaculatus, 248200 (3)
ABCA4	G:601691	+GR-Bell	Macular degeneration, age-related, 2, 153800 (3)
ABCA4	G:601691	+GR-Bell	Retinal dystrophy, early-onset severe, 248200 (3)
ABCA4	G:601691	+GR-Bell	Retinitis pigmentosa 19, 601718 (3)
ABCA4	G:601691	+GR-Bell	Stargardt disease 1, 248200 (3)
ABCA5	G:612503	.	.
ABCA6	G:612504	.	.
ABCA7	G:605414	.	.
ABCA8	G:612505	.	.
ABCA9	G:612507	.	.
ABCB1	G:171050	.	{Inflammatory bowel disease 13}, 612244 (3)
ABCB10	G:605454	.	.
ABCB11	G:603201	Bell>metabolic	Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)
ABCB11	G:603201	Bell>metabolic	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
ABCB4	G:171060	.	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3)
ABCB4	G:171060	.	Cholestasis, progressive familial intrahepatic 3, 602347 (3)
ABCB4	G:171060	.	Gallbladder disease 1, 600803 (3)
ABCB5	G:611785	.	.
ABCB6	G:605452	.	Microphthalmia, isolated, with coloboma 7, 614497 (3)
ABCB6	G:605452	.	[Blood group, Langereis system], 111600 (3)
ABCB7	G:300135	+GR-Bell	Anemia, sideroblastic, with ataxia, 301310 (3)
ABCB8	G:605464	.	.
ABCB9	G:605453	.	.
ABCC1	G:158343	.	.
ABCC10	G:612509	.	.
ABCC11	G:607040	.	[Axillary odor, variation in], 117800 (3)
ABCC11	G:607040	.	[Colostrum secretion, variation in], 117800 (3)
ABCC11	G:607040	.	[Earwax, wet/dry], 117800 (3)
ABCC12	G:607041	.	.
ABCC13	G:608835	.	.
ABCC2	G:601107	.	Dubin-Johnson syndrome, 237500 (3)
ABCC3	G:604323	.	.
ABCC4	G:605250	.	.
ABCC5	G:605251	.	.
ABCC6	G:603234	+GR-Bell	Arterial calcification, generalized, of infancy, 2, 614473 (3)
ABCC6	G:603234	+GR-Bell	Pseudoxanthoma elasticum, 264800 (3)
ABCC6	G:603234	+GR-Bell	Pseudoxanthoma elasticum, forme fruste, 177850 (3)
ABCC8	G:600509	+GR-Bell	Diabetes mellitus, noninsulin-dependent, 125853 (3)
ABCC8	G:600509	+GR-Bell	Diabetes mellitus, permanent neonatal, 606176 (3)
ABCC8	G:600509	+GR-Bell	Diabetes mellitus, transient neonatal 2, 610374 (3)
ABCC8	G:600509	+GR-Bell	Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)
ABCC8	G:600509	+GR-Bell	Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
ABCC9	G:601439	+GR-Bell	Atrial fibrillation, familial, 12, 614050 (3)
ABCC9	G:601439	+GR-Bell	Cardiomyopathy, dilated, 1O, 608569 (3)
ABCD1	G:300371	Bell>neurological	Adrenoleukodystrophy, 300100 (3)
ABCD1	G:300371	Bell>neurological	Adrenomyeloneuropathy, 300100 (3)
ABCD2	G:601081	.	.
ABCD3	GP:170995	.	.
ABCD4	G:603214	.	.
ABCE1	G:601213	.	.
ABCF1	G:603429	.	.
ABCF2	G:612510	.	.
ABCG1	G:603076	.	.
ABCG2	G:603756	.	[Junior blood group system], 614490 (3)
ABCG2	G:603756	.	[Uric acid concentration, serum, QTL1], 138900 (3)
ABCG4	G:607784	.	.
ABCG5	G:605459	.	Sitosterolemia, 210250 (3)
ABCG8	G:605460	.	Gallbladder disease 4, 611465 (3)
ABCG8	G:605460	.	Sitosterolemia, 210250 (3)
ABHD1	G:612195	.	.
ABHD11-AS1	G:612545	.	.
ABHD12	G:613599	.	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, 612674 (3)
ABHD16A	G:142620	.	.
ABHD2	G:612196	.	.
ABHD3	G:612197	.	.
ABHD5	G:604780	.	Chanarin-Dorfman syndrome, 275630 (3)
ABI1	G:603050	.	.
ABI2	G:606442	.	.
ABI3	G:606363	.	.
ABI3BP	G:606279	.	.
ABL1	G:189980	.	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
ABL2	G:164690	.	.
ABLIM1	G:602330	.	.
ABLIM2	G:612544	.	.
ABLIM3	G:611305	.	.
ABO	GP:110300	.	[Blood group, ABO system] (3)
ABP1	G:104610	.	.
ABR	G:600365	.	.
ABRA	G:609747	.	.
ABTB1	G:608308	.	.
ACAA1	G:604054	.	.
ACAA2	G:604770	.	.
ACACA	G:200350	.	.
ACACB	G:601557	.	.
ACAD10	G:611181	.	.
ACAD11	G:614288	.	.
ACAD8	G:604773	.	Isobutyryl-CoA dehydrogenase deficiency, 611283 (3)
ACAD9	G:611103	Bell>metabolic	ACAD9 deficiency, 611126 (3)
ACADL	G:609576	.	.
ACADM	G:607008	Bell>metabolic	Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)
ACADS	G:606885	Bell>metabolic	Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)
ACADSB	G:600301	Bell>metabolic	2-methylbutyrylglycinuria, 610006 (3)
ACADVL	G:609575	Bell>metabolic	VLCAD deficiency, 201475 (3)
ACAN	G:155760	.	Osteochondritis dissecans, short stature, and early-onset osteoarthritis, 165800 (3)
ACAN	G:155760	.	Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3)
ACAN	G:155760	.	Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3)
ACAP1	G:607763	.	.
ACAP2	G:607766	.	.
ACAT1	G:607809	.	Alpha-methylacetoacetic aciduria, 203750 (3)
ACAT2	G:100678	.	.
ACBD3	G:606809	.	.
ACCS	G:608405	.	.
ACD	G:609377	.	.
ACE	GP:106180	Bell>renal	Renal tubular dysgenesis, 267430 (3)
ACE	GP:106180	Bell>renal	[Angiotensin I-converting enzyme, benign serum increase] (3)
ACE	GP:106180	Bell>renal	{Alzheimer disease, susceptibility to}, 104300 (3)
ACE	GP:106180	Bell>renal	{Microvascular complications of diabetes 3}, 612624 (3)
ACE	GP:106180	Bell>renal	{Myocardial infarction, susceptibility to} (3)
ACE	GP:106180	Bell>renal	{SARS, progression of} (3)
ACE	GP:106180	Bell>renal	{Stroke, hemorrhagic}, 614519 (3)
ACE2	G:300335	.	.
ACER1	G:613491	.	.
ACER2	G:613492	.	.
ACHE	G:100740	.	[Blood group, Yt system], 112100 (3)
ACIN1	G:604562	.	.
ACLS	P:200990	.	.
ACLY	G:108728	.	.
ACMSD	G:608889	.	.
ACO1	G:100880	.	.
ACO2	G:100850	.	Infantile cerebellar-retinal degeneration, 614559 (3)
ACOT1	G:614313	.	.
ACOT11	G:606803	.	.
ACOT12	G:614315	.	.
ACOT2	G:609972	.	.
ACOT4	G:614314	.	.
ACOT6	G:614267	.	.
ACOT7	G:602587	.	.
ACOT8	G:608123	.	.
ACOT9	G:300862	.	.
ACOX1	G:609751	Bell>metabolic	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
ACOX2	G:601641	.	.
ACOX3	G:603402	.	.
ACP1	G:171500	.	.
ACP2	G:171650	.	.
ACP5	G:171640	.	Spondyloenchondrodysplasia with immune dysregulation, 607944 (3)
ACP6	G:611471	.	.
ACPP	G:171790	.	.
ACPT	G:606362	.	.
ACR	G:102480	.	.
ACRBP	G:608352	.	.
ACRC	G:300369	.	.
ACRV1	G:102525	.	.
ACSBG1	G:614362	.	.
ACSBG2	G:614363	.	.
ACSF2	G:610465	.	.
ACSF3	G:614245	.	Combined malonic and methylmalonic aciduria, 614265 (3)
ACSL1	G:152425	.	.
ACSL3	G:602371	.	.
ACSL4	G:300157	.	Mental retardation, X-linked 63, 300387 (3)
ACSL5	G:605677	.	.
ACSL6	G:604443	.	Myelogenous leukemia, acute (3)
ACSM1	G:614357	.	.
ACSM2A	G:614358	.	.
ACSM2B	G:614359	.	.
ACSM3	G:145505	.	.
ACSM4	G:614360	.	.
ACSM5	G:614361	.	.
ACSS1	G:614355	.	.
ACSS2	G:605832	.	.
ACSS3	G:614356	.	.
ACTA1	G:102610	.	Myopathy, actin, congenital, with cores (3)
ACTA1	G:102610	.	Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3)
ACTA1	G:102610	.	Myopathy, congenital, with fiber-type disproportion 1, 255310 (3)
ACTA1	G:102610	.	Myopathy, nemaline, 3, 161800 (3)
ACTA2	G:102620	.	Aortic aneurysm, familial thoracic 6, 611788 (3)
ACTA2	G:102620	.	Moyamoya disease 5, 614042 (3)
ACTA2	G:102620	.	Multisystemic smooth muscle dysfunction syndrome, 613834 (3)
ACTB	G:102630	.	Dystonia, juvenile-onset, 607371 (3)
ACTC1	G:102540	.	Atrial septal defect 5, 612794 (3)
ACTC1	G:102540	.	Cardiomyopathy, dilated, 1R, 613424 (3)
ACTC1	G:102540	.	Cardiomyopathy, familial hypertrophic, 11, 612098 (3)
ACTC1	G:102540	.	Left ventricular noncompaction 4, 613424 (3)
ACTG1	G:102560	.	Deafness, autosomal dominant 20/26, 604717 (3)
ACTG2	G:102545	.	.
ACTL6A	G:604958	.	.
ACTL6B	G:612458	.	.
ACTL7A	G:604303	.	.
ACTL7B	G:604304	.	.
ACTN1	G:102575	.	.
ACTN2	G:102573	+GR-Bell	Cardiomyopathy, dilated, 1AA, 612158 (3)
ACTN3	GP:102574	.	.
ACTN4	G:604638	.	Glomerulosclerosis, focal segmental, 1, 603278 (3)
ACTR1A	G:605143	.	.
ACTR1B	G:605144	.	.
ACTR2	G:604221	.	.
ACTR3	G:604222	.	.
ACTRT1	G:300487	.	.
ACTRT2	G:608535	.	.
ACVR1	G:102576	.	Fibrodysplasia ossificans progressiva, 135100 (3)
ACVR1B	G:601300	.	Pancreatic cancer, somatic (3)
ACVR1C	G:608981	.	.
ACVR2A	G:102581	.	.
ACVR2B	G:602730	.	Heterotaxy, visceral, 4, autosomal, 613751 (3)
ACVRL1	G:601284	+GR-Bell	Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)
ACY1	G:104620	.	Aminoacylase 1 deficiency, 609924 (3)
ACY3	G:614413	.	.
ACYP1	G:600875	.	.
ACYP2	G:102595	.	.
AD5	P:602096	.	.
ADA	G:608958	Bell>immunodeficiency	Adenosine deaminase deficiency, partial, 102700 (3)
ADA	G:608958	Bell>immunodeficiency	Severe combined immunodeficiency due to ADA deficiency, 102700 (3)
ADAD1	G:614130	.	.
ADAM10	G:602192	.	.
ADAM11	G:155120	.	.
ADAM12	G:602714	.	.
ADAM15	G:605548	.	.
ADAM17	G:603639	.	Inflammatory skin and bowel disease, neonatal, 614328 (3)
ADAM19	G:603640	.	.
ADAM2	G:601533	.	.
ADAM20	G:603712	.	.
ADAM21	G:603713	.	.
ADAM22	G:603709	.	.
ADAM23	G:603710	.	.
ADAM28	G:606188	.	.
ADAM29	G:604778	.	.
ADAM30	G:604779	.	.
ADAM33	G:607114	.	.
ADAM7	G:607310	.	.
ADAM8	G:602267	.	.
ADAM9	G:602713	.	Cone-rod dystrophy 9, 612775 (3)
ADAMDEC1	G:606393	.	.
ADAMTS1	G:605174	.	.
ADAMTS10	G:608990	+GR-Bell	Weill-Marchesani syndrome 1, recessive, 277600 (3)
ADAMTS12	G:606184	.	.
ADAMTS13	G:604134	Bell>hematologic	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
ADAMTS14	G:607506	.	.
ADAMTS15	G:607509	.	.
ADAMTS16	G:607510	.	.
ADAMTS17	G:607511	.	Weill-Marchesani-like syndrome, 613195 (3)
ADAMTS18	G:607512	.	Knobloch syndrome 2, 608454 (3)
ADAMTS19	G:607513	.	.
ADAMTS2	G:604539	Bell>neurological	Ehlers-Danlos syndrome, type VIIC, 225410 (3)
ADAMTS20	G:611681	.	.
ADAMTS3	G:605011	.	.
ADAMTS4	G:603876	.	.
ADAMTS5	G:605007	.	.
ADAMTS6	G:605008	.	.
ADAMTS7	G:605009	.	.
ADAMTS8	G:605175	.	.
ADAMTS9	G:605421	.	.
ADAMTSL1	G:609198	.	.
ADAMTSL2	G:612277	Bell>skeletal	Geleophysic dysplasia 1, 231050 (3)
ADAMTSL3	G:609199	.	.
ADAMTSL4	G:610113	+GR-Bell	Ectopia lentis, isolated, autosomal recessive, 225100 (3)
ADAP1	G:608114	.	.
ADAP2	G:608635	.	.
ADAR	G:146920	.	Dyschromatosis symmetrica hereditaria, 127400 (3)
ADARB1	G:601218	.	.
ADARB2	G:602065	.	.
ADAT1	G:604230	.	.
ADC	G:608353	.	.
ADCK3	G:606980	.	Coenzyme Q10 deficiency, 607426 (3)
ADCK3	G:606980	.	Spinocerebellar ataxia, autosomal recessive 9, 612016 (3)
ADCY1	G:103072	.	.
ADCY10	G:605205	.	{Hypercalciuria, absorptive, susceptibility to}, 143870 (3)
ADCY2	G:103071	.	.
ADCY3	G:600291	.	.
ADCY4	G:600292	.	.
ADCY5	G:600293	.	.
ADCY6	G:600294	.	.
ADCY7	G:600385	.	.
ADCY8	G:103070	.	.
ADCY9	G:603302	.	.
ADCYAP1	G:102980	.	.
ADCYAP1R1	G:102981	.	.
ADD1	G:102680	.	{Hypertension, essential, salt-sensitive}, 145500 (3)
ADD2	G:102681	.	.
ADD3	G:601568	.	.
ADFN	P:300700	.	.
ADH1A	G:103700	.	.
ADH1B	GP:103720	.	{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)
ADH1B	GP:103720	.	{Alcohol dependence, protection against}, 103780 (3)
ADH1C	G:103730	.	{Alcohol dependence, protection against}, 103780 (3)
ADH1C	G:103730	.	{Parkinson disease, susceptibility to}, 168600 (3)
ADH4	G:103740	.	.
ADH5	G:103710	.	.
ADH6	G:103735	.	.
ADH7	G:600086	.	.
ADHFE1	G:611083	.	.
ADI1	G:613400	.	.
ADIG	G:611396	.	.
ADIPOQ	G:605441	.	Adiponectin deficiency, 612556 (3)
ADIPOR1	G:607945	.	.
ADIPOR2	G:607946	.	.
ADK	G:102750	.	Hypermethioninemia due to adenosine kinase deficiency, 614300 (3)
ADM	G:103275	.	.
ADM2	G:608682	.	.
ADNP	G:611386	.	.
ADO	G:611392	.	.
ADORA1	G:102775	.	.
ADORA2A	G:102776	.	.
ADORA2B	G:600446	.	.
ADORA3	G:600445	.	.
ADPGK	G:611861	.	.
ADPRH	G:603081	.	.
ADPRHL1	G:610620	.	.
ADPRHL2	G:610624	.	.
ADRA1A	G:104221	.	.
ADRA1B	G:104220	.	.
ADRA1D	G:104219	.	.
ADRA2A	G:104210	.	.
ADRA2B	G:104260	.	.
ADRA2C	GP:104250	.	{Congestive heart failure and beta-blocker response, modifier of} (3)
ADRB1	GP:109630	.	[Resting heart rate], 607276 (3)
ADRB1	GP:109630	.	{Congestive heart failure and beta-blocker response, modifier of} (3)
ADRB2	GP:109690	.	Beta-2-adrenoreceptor agonist, reduced response to (3)
ADRB2	GP:109690	.	{Asthma, nocturnal, susceptibility to}, 600807 (3)
ADRB2	GP:109690	.	{Obesity, susceptibility to}, 601665 (3)
ADRB3	G:109691	.	{Obesity, susceptibility to}, 601665 (3)
ADRBK1	G:109635	.	.
ADRBK2	G:109636	.	.
ADRM1	G:610650	.	.
ADSL	G:608222	.	Adenylosuccinase deficiency, 103050 (3)
ADSS	G:103060	.	.
ADSSL1	G:612498	.	.
ADTRP	G:614348	.	.
AEBP1	G:602981	.	.
AEN	G:610177	.	.
AES	G:600188	.	.
AF8T	P:116950	.	.
AFA	P:106250	.	.
AFAP1	G:608252	.	.
AFAP1L1	G:614410	.	.
AFAP1L2	G:612420	.	.
AFD1	P:154400	.	.
AFF1	G:159557	.	.
AFF2	G:300806	.	Mental retardation, X-linked, FRAXE type, 309548 (3)
AFF3	G:601464	.	.
AFF4	G:604417	.	.
AFG3L1P	G:603020	.	.
AFG3L2	G:604581	.	Ataxia, spastic, 5, autosomal recessive, 614487 (3)
AFG3L2	G:604581	.	Spinocerebellar ataxia 28, 610246 (3)
AFM	G:104145	.	.
AFP	GP:104150	.	.
AGA	G:613228	Bell>metabolic	Aspartylglucosaminuria, 208400 (3)
AGAP1	G:608651	.	.
AGAP2	G:605476	.	.
AGER	G:600214	.	.
AGFG1	G:600862	.	.
AGFG2	G:604019	.	.
AGGF1	G:608464	.	.
AGK	G:610345	.	Sengers syndrome, 212350 (3)
AGL	G:610860	Bell>metabolic	Glycogen storage disease IIIa, 232400 (3)
AGL	G:610860	Bell>metabolic	Glycogen storage disease IIIb, 232400 (3)
AGMO	G:613738	.	.
AGMX2	P:300310	.	.
AGPAT1	G:603099	.	.
AGPAT2	G:603100	+GR-Bell	Lipodystrophy, congenital generalized, type 1, 608594 (3)
AGPAT6	G:608143	.	.
AGPAT9	G:610958	.	.
AGPS	G:603051	Bell>metabolic	Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)
AGR2	G:606358	.	.
AGR3	G:609482	.	.
AGRN	G:103320	+GR-Bell	Myasthenia, limb-girdle, familial, 254300 (3)
AGRP	G:602311	.	{Leanness, inherited} (3)
AGRP	G:602311	.	{Obesity, late-onset}, 601665 (3)
AGT	GP:106150	Bell>renal	Renal tubular dysgenesis, 267430 (3)
AGT	GP:106150	Bell>renal	{Hypertension, essential, susceptibility to}, 145500 (3)
AGT	GP:106150	Bell>renal	{Preeclampsia, susceptibility to} (3)
AGTPBP1	G:606830	.	.
AGTR1	G:106165	Bell>renal	Hypertension, essential, 145500 (3)
AGTR1	G:106165	Bell>renal	Renal tubular dysgenesis, 267430 (3)
AGTR2	G:300034	.	Mental retardation, X-linked 88, 300852 (3)
AGTRAP	G:608729	.	.
AGXT	G:604285	Bell>metabolic	Hyperoxaluria, primary, type 1, 259900 (3)
AGXT2	G:612471	.	.
AHCTF1	G:610853	.	.
AHCY	G:180960	.	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 (3)
AHCYL1	G:607826	.	.
AHI1	G:608894	Bell>neurological	Joubert syndrome-3, 608629 (3)
AHNAK	G:103390	.	.
AHNAK2	G:608570	.	.
AHR	G:600253	.	.
AHRR	G:606517	.	.
AHSA1	G:608466	.	.
AHSG	G:138680	.	.
AHSP	G:605821	.	.
AIC	P:304050	.	.
AICDA	G:605257	.	Immunodeficiency with hyper-IgM, type 2, 605258 (3)
AIDA	G:612375	.	.
AIF1	G:601833	.	.
AIFM1	G:300169	.	Combined oxidative phosphorylation deficiency 6, 300816 (3)
AIFM2	G:605159	.	.
AIG1	G:608514	.	.
AIH3	P:301201	.	.
AIM1	G:601797	.	.
AIM2	G:604578	.	.
AIMP1	G:603605	.	Leukodystrophy, hypomyelinating, 3, 260600 (3)
AIMP2	G:600859	.	.
AIP	G:605555	.	Pituitary adenoma, ACTH-secreting, 219090 (3)
AIP	G:605555	.	Pituitary adenoma, growth hormone-secreting, 102200 (3)
AIP	G:605555	.	Pituitary adenoma, prolactin-secreting, 600634 (3)
AIPL1	G:604392	+GR-Bell	Leber congenital amaurosis 4, 604393 (3)
AIPL1	G:604392	+GR-Bell	Retinitis pigmentosa, juvenile (3)
AIRE	G:607358	Bell>immunodeficiency	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3)
AIRN	G:604893	.	.
AIS1	P:607836	.	.
AIS2	P:608391	.	.
AIS3	P:608392	.	.
AJAP1	G:610972	.	.
AJUBA	G:609066	.	.
AK1	G:103000	.	Hemolytic anemia due to adenylate kinase deficiency, 612631 (3)
AK2	G:103020	.	Reticular dysgenesis, 267500 (3)
AK3	G:609290	.	.
AK4	G:103030	.	.
AK5	G:608009	.	.
AKAP1	G:602449	.	.
AKAP10	G:604694	.	{Cardiac conduction defect, susceptibility to}, 115080 (3)
AKAP11	G:604696	.	.
AKAP12	G:604698	.	.
AKAP13	G:604686	.	.
AKAP14	G:300462	.	.
AKAP17A	G:312095	.	.
AKAP17A	G:465000	.	.
AKAP2	G:604582	.	.
AKAP3	G:604689	.	.
AKAP4	G:300185	.	.
AKAP5	G:604688	.	.
AKAP6	G:604691	.	.
AKAP7	G:604693	.	.
AKAP8	G:604692	.	.
AKAP8L	G:609475	.	.
AKAP9	G:604001	+GR-Bell	Long QT syndrome-11, 611820 (3)
AKIP1	G:609191	.	.
AKNA	G:605729	.	.
AKR1A1	G:103830	.	.
AKR1B1	G:103880	.	.
AKR1B10	G:604707	.	.
AKR1C1	G:600449	.	.
AKR1C2	G:600450	.	46XY sex reversal 8, 614279 (3)
AKR1C2	G:600450	.	Obesity, hyperphagia, and developmental delay (3)
AKR1C3	G:603966	.	.
AKR1C4	G:600451	.	{46XY sex reversal 8, modifier of}, 614279 (3)
AKR1D1	G:604741	.	Bile acid synthesis defect, congenital, 2, 235555 (3)
AKR7A2	G:603418	.	.
AKR7A3	G:608477	.	.
AKR7L	G:608478	.	.
AKT1	G:164730	.	Breast cancer, somatic, 114480 (3)
AKT1	G:164730	.	Colorectal cancer, somatic, 114500 (3)
AKT1	G:164730	.	Ovarian cancer, somatic, 167000 (3)
AKT1	G:164730	.	Proteus syndrome, somatic, 176920 (3)
AKT1S1	G:610221	.	.
AKT2	G:164731	.	Diabetes mellitus, type II, 125853 (3)
AKT2	G:164731	.	Hypoinsulinemic hypoglycemia with hemihypertrophy, 240900 (3)
AKT3	G:611223	.	.
AKTIP	G:608483	.	.
ALAD	G:125270	.	Porphyria, acute hepatic, 612740 (3)
ALAD	G:125270	.	{Lead poisoning, susceptibility to}, 612740 (3)
ALAS1	G:125290	.	.
ALAS2	G:301300	.	Anemia, sideroblastic, X-linked, 300751 (3)
ALAS2	G:301300	.	Protoporphyria, erythropoietic, X-linked, 300752 (3)
ALB	GP:103600	.	.
ALCAM	G:601662	.	.
ALDH16A1	G:613358	.	.
ALDH18A1	G:138250	.	Cutis laxa, autosomal recessive, type IIIA, 219150 (3)
ALDH1A1	G:100640	.	.
ALDH1A2	G:603687	.	.
ALDH1A3	G:600463	.	.
ALDH1B1	G:100670	.	.
ALDH1L1	G:600249	.	.
ALDH1L2	G:613584	.	.
ALDH2	GP:100650	.	Alcohol sensitivity, acute, 610251 (3)
ALDH2	GP:100650	.	{Esophageal cancer, alcohol-related, susceptibility to} (3)
ALDH2	GP:100650	.	{Hangover, susceptibility to}, 610251 (3)
ALDH2	GP:100650	.	{Sublingual nitroglycerin, susceptibility to poor response to} (3)
ALDH3A1	G:100660	.	.
ALDH3A2	G:609523	Bell>neurological	Sjogren-Larsson syndrome, 270200 (3)
ALDH3B1	G:600466	.	.
ALDH3B2	G:601917	.	.
ALDH4A1	G:606811	.	Hyperprolinemia, type II, 239510 (3)
ALDH5A1	G:610045	Bell>metabolic	Succinic semialdehyde dehydrogenase deficiency, 271980 (3)
ALDH6A1	G:603178	.	Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3)
ALDH7A1	G:107323	+GR-Bell	Epilepsy, pyridoxine-dependent, 266100 (3)
ALDH8A1	G:606467	.	.
ALDH9A1	G:602733	.	.
ALDOA	G:103850	.	Glycogen storage disease XII, 611881 (3)
ALDOB	G:612724	Bell>metabolic	Fructose intolerance, 229600 (3)
ALDOC	G:103870	.	.
ALG1	G:605907	Bell>metabolic	Congenital disorder of glycosylation, type Ik, 608540 (3)
ALG10	G:603313	.	{Acquired long QT syndrome, reduced susceptibility to}, 613688 (3)
ALG11	G:613666	.	Congenital disorder of glycosylation, type Ip, 613661 (3)
ALG12	G:607144	+GR-Bell	Congenital disorder of glycosylation, type Ig, 607143 (3)
ALG13	G:300776	.	.
ALG14	G:612866	.	.
ALG2	G:607905	+GR-Bell	Congenital disorder of glycosylation, type Ii, 607906 (3)
ALG3	G:608750	+GR-Bell	Congenital disorder of glycosylation, type Id, 601110 (3)
ALG5	G:604565	.	.
ALG6	G:604566	Bell>metabolic	Congenital disorder of glycosylation, type Ic, 603147 (3)
ALG8	G:608103	+GR-Bell	Congenital disorder of glycosylation, type Ih, 608104 (3)
ALG9	G:606941	.	Congenital disorder of glycosylation, type Il, 608776 (3)
ALK	G:105590	+GR-Bell	{Neuroblastoma, susceptibility to, 3}, 613014 (3)
ALKBH1	G:605345	.	.
ALKBH2	G:610602	.	.
ALKBH3	G:610603	.	.
ALKBH4	G:613302	.	.
ALKBH5	G:613303	.	.
ALKBH6	G:613304	.	.
ALKBH7	G:613305	.	.
ALKBH8	G:613306	.	.
ALLC	P:612396	.	.
ALMS1	G:606844	Bell>neurodegenerative	Alstrom syndrome, 203800 (3)
ALOX12	G:152391	.	.
ALOX12B	G:603741	+GR-Bell	Ichthyosiform erythroderma, congenital, nonbullous, 1, 242100 (3)
ALOX15	G:152392	.	.
ALOX15B	G:603697	.	.
ALOX5	G:152390	.	{Asthma, diminished response to antileukotriene treatment in}, 600807 (3)
ALOX5	G:152390	.	{Atherosclerosis, susceptibility to} (3)
ALOX5AP	G:603700	.	{Stroke, susceptibility to}, 601367 (3)
ALOXE3	G:607206	+GR-Bell	Ichthyosiform erythroderma, congenital, nonbullous, 1, 242100 (3)
ALPI	G:171740	.	.
ALPK1	G:607347	.	.
ALPL	G:171760	Bell>skeletal	Hypophosphatasia, adult, 146300 (3)
ALPL	G:171760	Bell>skeletal	Hypophosphatasia, childhood, 241510 (3)
ALPL	G:171760	Bell>skeletal	Hypophosphatasia, infantile, 241500 (3)
ALPL	G:171760	Bell>skeletal	Odontohypophosphatasia, 146300 (3)
ALPP	G:171800	.	.
ALPPL2	G:171810	.	.
ALS2	G:606352	Bell>neurological	Amyotrophic lateral sclerosis, juvenile, 205100 (3)
ALS2	G:606352	Bell>neurological	Amyotrophic lateral sclerosis, juvenile, 205100 (3)
ALS2	G:606352	Bell>neurological	Primary lateral sclerosis, juvenile, 606353 (3)
ALS2	G:606352	Bell>neurological	Primary lateral sclerosis, juvenile, 606353 (3)
ALS2	G:606352	Bell>neurological	Spastic paralysis, infantile onset ascending, 607225 (3)
ALS2	G:606352	Bell>neurological	Spastic paralysis, infantile onset ascending, 607225 (3)
ALS2CL	G:612402	.	.
ALS2CR8	G:607586	.	.
ALS3	P:606640	.	.
ALS5	P:602099	.	.
ALS7	P:608031	.	.
ALX1	G:601527	.	Frontonasal dysplasia 3, 613456 (3)
ALX3	G:606014	.	Frontonasal dysplasia 1, 136760 (3)
ALX4	G:605420	+GR-Bell	Frontonasal dysplasia 2, 613451 (3)
ALX4	G:605420	+GR-Bell	Parietal foramina 2, 609597 (3)
ALYREF	G:604171	.	.
AMACR	G:604489	Bell>metabolic	Alpha-methylacyl-CoA racemase deficiency, 614307 (3)
AMACR	G:604489	Bell>metabolic	Bile acid synthesis defect, congenital, 4, 214950 (3)
AMBN	G:601259	.	.
AMBP	G:176870	.	.
AMBRA1	G:611359	.	.
AMCN	P:208100	.	.
AMD1	G:180980	.	.
AMELX	G:300391	.	Amelogenesis imperfecta, hypoplastic/hypomaturation type 1E, 301200 (3)
AMELY	G:410000	.	.
AMFR	G:603243	.	.
AMH	G:600957	.	Persistent Mullerian duct syndrome, type I, 261550 (3)
AMHR2	G:600956	.	Persistent Mullerian duct syndrome, type II, 261550 (3)
AMICA1	G:609770	.	.
AMLCR2	P:602439	.	.
AMMECR1	G:300195	.	.
AMN	G:605799	.	Megaloblastic anemia-1, Norwegian type, 261100 (3)
AMOT	G:300410	.	.
AMPD1	GP:102770	.	.
AMPD2	G:102771	.	.
AMPD3	G:102772	.	[AMP deaminase deficiency, erythrocytic], 612874 (3)
AMPH	G:600418	.	.
AMT	G:238310	Bell>metabolic	Glycine encephalopathy, 605899 (3)
AMTN	G:610912	.	.
AMY1A	G:104700	.	.
AMY1B	G:104701	.	.
AMY1C	G:104702	.	.
AMY2A	G:104650	.	.
AMY2B	G:104660	.	.
ANAPC1	G:608473	.	.
ANAPC10	G:613745	.	.
ANAPC11	G:614534	.	.
ANAPC13	G:614484	.	.
ANAPC16	G:613427	.	.
ANAPC2	G:606946	.	.
ANAPC4	G:606947	.	.
ANAPC5	G:606948	.	.
ANAPC7	G:606949	.	.
ANCR	P:105830	.	.
ANG	G:105850	+GR-Bell	Amyotrophic lateral sclerosis 9, 611895 (3)
ANGPT1	G:601667	.	.
ANGPT2	G:601922	.	.
ANGPT4	G:603705	.	.
ANGPTL1	G:603874	.	.
ANGPTL2	G:605001	.	.
ANGPTL3	G:604774	.	Hypobetalipoproteinemia, familial, 2, 605019 (3)
ANGPTL4	GP:605910	.	{Reduced triglycerides, susceptibility to} (3)
ANGPTL5	G:607666	.	.
ANGPTL6	G:609336	.	.
ANIB1	P:105800	.	.
ANIB2	P:608542	.	.
ANIB3	P:609122	.	.
ANIB4	P:610213	.	.
ANK1	G:612641	.	Spherocytosis, type 1, 182900 (3)
ANK2	G:106410	.	Cardiac arrhythmia, ankyrin-B-related, 600919 (3)
ANK2	G:106410	.	Long QT syndrome-4, 600919 (3)
ANK3	G:600465	.	.
ANKAR	G:609803	.	.
ANKFY1	G:607927	.	.
ANKH	G:605145	+GR-Bell	Chondrocalcinosis 2, 118600 (3)
ANKH	G:605145	+GR-Bell	Craniometaphyseal dysplasia, 123000 (3)
ANKHD1	G:610500	.	.
ANKK1	GP:608774	.	Dopamine receptor D2, reduced brain density of (3)
ANKRA2	G:605787	.	.
ANKRD1	G:609599	.	.
ANKRD11	G:611192	.	KBG syndrome, 148050 (3)
ANKRD12	G:610616	.	.
ANKRD2	G:610734	.	.
ANKRD23	G:610736	.	.
ANKRD26	G:610855	.	Thrombocytopenia 2, 188000 (3)
ANKRD28	G:611122	.	.
ANKRD30A	G:610856	.	.
ANKRD54	G:613383	.	.
ANKRD6	G:610583	.	.
ANKRD7	G:610731	.	.
ANKS1A	G:608994	.	.
ANKS1B	G:607815	.	.
ANKS4B	G:609901	.	.
ANO1	G:610108	.	.
ANO10	G:613726	.	Spinocerebellar ataxia, autosomal recessive 10, 613728 (3)
ANO2	G:610109	.	.
ANO3	G:610110	.	.
ANO4	G:610111	.	.
ANO5	G:608662	.	Gnathodiaphyseal dysplasia, 166260 (3)
ANO5	G:608662	.	Miyoshi muscular dystrophy 3, 613319 (3)
ANO5	G:608662	.	Muscular dystrophy, limb-girdle, type 2L, 611307 (3)
ANO6	G:608663	.	Scott syndrome, 262890 (3)
ANO7	G:605096	.	.
ANO8	G:610216	.	.
ANOP1	P:301590	.	.
ANP32A	G:600832	.	.
ANP32C	G:606877	.	.
ANP32D	G:606878	.	.
ANP32E	G:609611	.	.
ANPEP	G:151530	.	.
ANTXR1	G:606410	.	{Hemangioma, capillary infantile, susceptibility to}, 602089 (3)
ANTXR2	G:608041	Bell>cutaneous	Fibromatosis, juvenile hyaline, 228600 (3)
ANTXR2	G:608041	Bell>cutaneous	Hyalinosis, infantile systemic, 236490 (3)
ANTXR2	G:608041	Bell>skeletal	Fibromatosis, juvenile hyaline, 228600 (3)
ANTXR2	G:608041	Bell>skeletal	Hyalinosis, infantile systemic, 236490 (3)
ANXA1	G:151690	.	.
ANXA10	G:608008	.	.
ANXA11	G:602572	.	.
ANXA13	G:602573	.	.
ANXA2	G:151740	.	.
ANXA2R	G:611296	.	.
ANXA3	G:106490	.	.
ANXA4	G:106491	.	.
ANXA5	G:131230	.	.
ANXA6	G:114070	.	.
ANXA7	G:186360	.	.
ANXA8	G:602396	.	.
ANXA9	G:603319	.	.
AOAH	G:102593	.	.
AOC2	G:602268	.	.
AOC3	G:603735	.	.
AOX1	G:602841	.	.
AP1AR	G:610851	.	.
AP1B1	G:600157	.	.
AP1G1	G:603533	.	.
AP1G2	G:603534	.	.
AP1M1	G:603535	.	.
AP1M2	G:607309	.	.
AP1S1	G:603531	.	.
AP1S2	G:300629	.	Mental retardation, X-linked syndromic, Fried type, 300630 (3)
AP2A1	G:601026	.	.
AP2A2	G:607242	.	.
AP2B1	G:601025	.	.
AP2M1	G:601024	.	.
AP2S1	G:602242	.	.
AP3B1	G:603401	+GR-Bell	Hermansky-Pudlak syndrome 2, 608233 (3)
AP3B2	G:602166	.	.
AP3D1	G:607246	.	.
AP3M1	G:610366	.	.
AP3M2	G:610469	.	.
AP3S1	G:601507	.	.
AP3S2	G:602416	.	.
AP4B1	G:607245	.	Cerebral palsy, spastic quadriplegic, 5, 614066 (3)
AP4E1	G:607244	.	Cerebral palsy, spastic quadriplegic, 4, 613744 (3)
AP4M1	G:602296	.	Cerebral palsy, spastic quadriplegic, 3, 612936 (3)
AP4S1	G:607243	.	Cerebral palsy, spastic quadriplegic, 6, 614067 (3)
AP5B1	G:614367	.	.
AP5M1	G:614368	.	.
AP5Z1	G:613653	.	Spastic paraplegia 48, autosomal recessive, 613647 (3)
APAF1	G:602233	.	.
APBA1	G:602414	.	.
APBA2	G:602712	.	.
APBA3	G:604262	.	.
APBB1	G:602709	.	.
APBB1IP	G:609036	.	.
APBB2	G:602710	.	{Alzheimer disease, late-onset}, 104300 (3)
APBB3	G:602711	.	.
APC	G:611731	+GR-Bell	Adenoma, periampullary, somatic (3)
APC	G:611731	+GR-Bell	Adenomatous polyposis coli, 175100 (3)
APC	G:611731	+GR-Bell	Colorectal cancer, somatic, 114500 (3)
APC	G:611731	+GR-Bell	Desmoid disease, hereditary, 135290 (3)
APC	G:611731	+GR-Bell	Gastric cancer, somatic, 613659 (3)
APC	G:611731	+GR-Bell	Hepatoblastoma, somatic, 114550 (3)
APC2	G:612034	.	.
APCDD1	G:607479	.	Hypotrichosis simplex, 605389 (3)
APCS	G:104770	.	.
APEH	G:102645	.	.
APEX1	G:107748	.	.
APEX2	G:300773	.	.
APH1A	G:607629	.	.
APH1B	G:607630	.	.
API5	G:609774	.	.
APIP	G:612491	.	.
APITD1	G:609130	.	.
APLF	G:611035	.	.
APLN	G:300297	.	.
APLNR	G:600052	.	.
APLP1	G:104775	.	.
APLP2	G:104776	.	.
APOA1	G:107680	.	Amyloidosis, 3 or more types, 105200 (3)
APOA1	G:107680	.	ApoA-I and apoC-III deficiency, combined (3)
APOA1	G:107680	.	Corneal clouding, autosomal recessive (3)
APOA1	G:107680	.	Hypoalphalipoproteinemia, 604091 (3)
APOA1BP	G:608862	.	.
APOA2	GP:107670	.	{Hypercholesterolemia, familial, modification of}, 143890 (3)
APOA4	G:107690	.	.
APOA5	G:606368	.	Hyperchylomicronemia, late-onset, 144650 (3)
APOA5	G:606368	.	{Hypertriglyceridemia, susceptibility to}, 145750 (3)
APOB	GP:107730	.	Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)
APOB	GP:107730	.	Hypobetalipoproteinemia, normotriglyceridemic (3)
APOBEC1	G:600130	.	.
APOBEC2	G:604797	.	.
APOBEC3A	G:607109	.	.
APOBEC3B	G:607110	.	.
APOBEC3C	G:607750	.	.
APOBEC3D	G:609900	.	.
APOBEC3F	G:608993	.	.
APOBEC3G	G:607113	.	.
APOBEC3H	G:610976	.	.
APOBEC4	G:609908	.	.
APOBR	G:605220	.	.
APOC1	G:107710	.	.
APOC2	G:608083	.	Hyperlipoproteinemia, type Ib, 207750 (3)
APOC3	G:107720	.	Hyperalphalipoproteinemia 2, 614028 (3)
APOC4	G:600745	.	.
APOD	G:107740	.	.
APOE	GP:107741	.	Alzheimer disease-2, 104310 (3)
APOE	GP:107741	.	Hyperlipoproteinemia, type III (3)
APOE	GP:107741	.	Lipoprotein glomerulopathy, 611771 (3)
APOE	GP:107741	.	Sea-blue histiocyte disease, 269600 (3)
APOE	GP:107741	.	{Macular degeneration, age-related}, 603075 (3)
APOF	P:107760	.	.
APOH	G:138700	.	.
APOL1	G:603743	.	{End-stage renal disease, nondiabetic, susceptibility to}, 612551 (3)
APOL1	G:603743	.	{Glomerulosclerosis, focal segmental, 4, susceptibility to}, 612551 (3)
APOL2	G:607252	.	.
APOL3	G:607253	.	.
APOL4	G:607254	.	.
APOL5	G:607255	.	.
APOL6	G:607256	.	.
APOLD1	G:612456	.	.
APOM	G:606907	.	.
APOO	G:300753	.	.
APP	GP:104760	+GR-Bell	Alzheimer disease 1, familial, 104300 (3)
APP	GP:104760	+GR-Bell	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3)
APP	GP:104760	+GR-Bell	Dementia, early-onset progressive, autosomal recessive (3)
APPBP2	G:605324	.	.
APPL1	G:604299	.	.
APPL2	G:606231	.	.
APRT	GP:102600	.	Urolithiasis, 2,8-dihydroxyadenine (3)
APTX	G:606350	Bell>neurological	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3)
APTX	G:606350	Bell>neurological	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3)
APTX	G:606350	Bell>neurological	Coenzyme Q10 deficiency, 607426 (3)
APTX	G:606350	Bell>neurological	Coenzyme Q10 deficiency, 607426 (3)
AQP1	G:107776	.	[Blood group, Colton], 110450 (3)
AQP10	G:606578	.	.
AQP11	G:609914	.	.
AQP12A	G:609789	.	.
AQP2	G:107777	+GR-Bell	Diabetes insipidus, nephrogenic, 125800 (3)
AQP3	G:600170	.	[Blood group GIL], 607457 (3)
AQP4	G:600308	.	.
AQP5	G:600442	.	.
AQP6	G:601383	.	.
AQP7	G:602974	.	[Glycerol quantitative trait locus], 614411 (3)
AQP8	G:603750	.	.
AQP9	G:602914	.	.
AQR	G:610548	.	.
ARAF	G:311010	.	.
ARAP1	G:606646	.	.
ARAP2	G:606645	.	.
ARAP3	G:606647	.	.
ARC	G:612461	.	.
ARCN1	G:600820	.	.
AREG	G:104640	.	.
ARF1	G:103180	.	.
ARF3	G:103190	.	.
ARF4	G:601177	.	.
ARF5	G:103188	.	.
ARF6	G:600464	.	.
ARFGAP1	G:608377	.	.
ARFGAP2	G:606908	.	.
ARFGAP3	G:612439	.	.
ARFGEF1	G:604141	.	.
ARFGEF2	G:605371	.	Periventricular heterotopia with microcephaly, 608097 (3)
ARFIP1	G:605928	.	.
ARFIP2	G:601638	.	.
ARFRP1	G:604699	.	.
ARG1	G:608313	+GR-Bell	Argininemia, 207800 (3)
ARG2	G:107830	.	.
ARGFX	G:611164	.	.
ARGLU1	G:614046	.	.
ARHGAP1	G:602732	.	.
ARHGAP10	G:609746	.	.
ARHGAP11A	G:610589	.	.
ARHGAP12	G:610577	.	.
ARHGAP15	G:610578	.	.
ARHGAP17	G:608293	.	.
ARHGAP18	G:613351	.	.
ARHGAP19	G:611587	.	.
ARHGAP20	G:609568	.	.
ARHGAP21	G:609870	.	.
ARHGAP22	G:610585	.	.
ARHGAP23	G:610590	.	.
ARHGAP24	G:610586	.	.
ARHGAP25	G:610587	.	.
ARHGAP26	G:605370	.	Leukemia, juvenile myelomonocytic, 607785 (3)
ARHGAP27	G:610591	.	.
ARHGAP28	G:610592	.	.
ARHGAP29	G:610496	.	.
ARHGAP30	G:614264	.	.
ARHGAP31	G:610911	.	.
ARHGAP32	G:608541	.	.
ARHGAP35	G:605277	.	.
ARHGAP4	G:300023	.	.
ARHGAP5	G:602680	.	.
ARHGAP6	G:300118	.	.
ARHGAP8	G:609405	.	.
ARHGAP9	GP:610576	.	{Coronary artery spasm 3, susceptibility to} (3)
ARHGDIA	G:601925	.	.
ARHGDIB	G:602843	.	.
ARHGDIG	G:602844	.	.
ARHGEF1	G:601855	.	.
ARHGEF10	G:608136	.	Slowed nerve conduction velocity, AD, 608236 (3)
ARHGEF10L	G:612494	.	.
ARHGEF11	G:605708	.	.
ARHGEF12	G:604763	.	Leukemia, acute myeloid, 601626 (3)
ARHGEF15	G:608504	.	.
ARHGEF19	G:612496	.	.
ARHGEF2	G:607560	.	.
ARHGEF25	G:610215	.	.
ARHGEF3	G:612115	.	.
ARHGEF4	G:605216	.	.
ARHGEF40	G:610018	.	.
ARHGEF5	G:600888	.	.
ARHGEF6	G:300267	.	Mental retardation, X-linked 46, 300436 (3)
ARHGEF7	G:605477	.	.
ARHGEF9	G:300429	+GR-Bell	Epileptic encephalopathy, early infantile, 8, 300607 (3)
ARID1A	G:603024	.	.
ARID1B	G:614556	.	Mental retardation, autosomal dominant 12, 614562 (3)
ARID2	G:609539	.	.
ARID3A	G:603265	.	.
ARID3B	G:612457	.	.
ARID4A	G:180201	.	.
ARID4B	G:609696	.	.
ARID5A	G:611583	.	.
ARID5B	G:608538	.	.
ARIH1	G:605624	.	.
ARIH2	G:605615	.	.
ARL1	G:603425	.	.
ARL11	G:609351	.	.
ARL13B	G:608922	+GR-Bell	Joubert syndrome 8, 612291 (3)
ARL14	G:614439	.	.
ARL2	G:601175	.	.
ARL3	G:604695	.	.
ARL4A	G:604786	.	.
ARL4C	G:604787	.	.
ARL4D	G:600732	.	.
ARL5A	G:608960	.	.
ARL5B	G:608909	.	.
ARL6	G:608845	+GR-Bell	Bardet-Biedl syndrome 3, 209900 (3)
ARL6	G:608845	+GR-Bell	Retinitis pigmentosa 55, 613575 (3)
ARL6	G:608845	+GR-Bell	{Bardet-Biedl syndrome 1, modifier of}, 209900 (3)
ARL6IP1	G:607669	.	.
ARL6IP4	G:607668	.	.
ARL6IP5	G:605709	.	.
ARL9	G:612405	.	.
ARMC10	G:611864	.	.
ARMC3	G:611226	.	.
ARMCX1	G:300362	.	.
ARMCX2	G:300363	.	.
ARMCX3	G:300364	.	.
ARMS2	G:611313	.	{Macular degeneration, age-related, 8}, 613778 (3)
ARNT	G:126110	.	Leukemia, acute myeloblastic (3)
ARNT2	G:606036	.	.
ARNTL	G:602550	.	.
ARNTL2	G:614517	.	.
ARPC1A	G:604220	.	.
ARPC1B	G:604223	.	.
ARPC2	G:604224	.	.
ARPC3	G:604225	.	.
ARPC4	G:604226	.	.
ARPC5	G:604227	.	.
ARPP19	G:605487	.	.
ARPP21	G:605488	.	.
ARR3	G:301770	.	.
ARRB1	G:107940	.	.
ARRB2	G:107941	.	.
ARRDC3	G:612464	.	.
ARSA	G:607574	Bell>neurological	Metachromatic leukodystrophy, 250100 (3)
ARSB	G:611542	Bell>metabolic	Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3)
ARSC2	G:301780	.	.
ARSD	G:300002	.	.
ARSE	G:300180	Bell>developmental	Chondrodysplasia punctata, X-linked recessive, 302950 (3)
ARSF	G:300003	.	.
ARSG	G:610008	.	.
ARSH	G:300586	.	.
ARSI	G:610009	.	.
ARSJ	G:610010	.	.
ARSK	G:610011	.	.
ART1	G:601625	.	.
ART3	G:603086	.	.
ART4	GP:110600	.	[Blood group, Dombrock] (3)
ART5	G:610625	.	.
ARTN	G:603886	.	.
ARV1	G:611647	.	.
ARVCF	G:602269	.	.
ARVD3	P:602086	.	.
ARVD4	P:602087	.	.
ARX	G:300382	Bell>developmental	Epileptic encephalopathy, early infantile, 1, 308350 (3)
ARX	G:300382	Bell>developmental	Hydranencephaly with abnormal genitalia, 300215 (3)
ARX	G:300382	Bell>developmental	Lissencephaly, X-linked 2, 300215 (3)
ARX	G:300382	Bell>developmental	Mental retardation, X-linked 29 and others, 300419 (3)
ARX	G:300382	Bell>developmental	Partington syndrome, 309510 (3)
ARX	G:300382	Bell>developmental	Proud syndrome, 300004 (3)
ARX	G:300382	Bell>neurological	Epileptic encephalopathy, early infantile, 1, 308350 (3)
ARX	G:300382	Bell>neurological	Epileptic encephalopathy, early infantile, 1, 308350 (3)
ARX	G:300382	Bell>neurological	Hydranencephaly with abnormal genitalia, 300215 (3)
ARX	G:300382	Bell>neurological	Hydranencephaly with abnormal genitalia, 300215 (3)
ARX	G:300382	Bell>neurological	Lissencephaly, X-linked 2, 300215 (3)
ARX	G:300382	Bell>neurological	Lissencephaly, X-linked 2, 300215 (3)
ARX	G:300382	Bell>neurological	Mental retardation, X-linked 29 and others, 300419 (3)
ARX	G:300382	Bell>neurological	Mental retardation, X-linked 29 and others, 300419 (3)
ARX	G:300382	Bell>neurological	Partington syndrome, 309510 (3)
ARX	G:300382	Bell>neurological	Partington syndrome, 309510 (3)
ARX	G:300382	Bell>neurological	Proud syndrome, 300004 (3)
ARX	G:300382	Bell>neurological	Proud syndrome, 300004 (3)
AS3MT	G:611806	.	.
ASAH1	G:613468	.	Farber lipogranulomatosis, 228000 (3)
ASAH2	G:611202	.	.
ASAH2B	G:610987	.	.
ASAP1	G:605953	.	.
ASAP2	G:603817	.	.
ASB1	G:605758	.	.
ASB11	G:300626	.	.
ASB2	G:605759	.	.
ASB3	G:605760	.	.
ASB4	G:605761	.	.
ASCC1	G:614215	.	Barrett esophagus/esophageal adenocarcinoma, 614266 (3)
ASCC2	G:614216	.	.
ASCC3	G:614217	.	.
ASCL1	G:100790	.	Central hypoventilation syndrome, congenital, 209880 (3)
ASCL1	G:100790	.	Haddad syndrome, 209880 (3)
ASCL2	G:601886	.	.
ASCL3	G:609154	.	.
ASCL4	G:609155	.	.
ASD1	P:108800	.	.
ASF1A	G:609189	.	.
ASF1B	G:609190	.	.
ASGR1	G:108360	.	.
ASGR2	G:108361	.	.
ASH1L	G:607999	.	.
ASH2L	G:604782	.	.
ASIC1	G:602866	.	.
ASIC2	G:601784	.	.
ASIC3	G:611741	.	.
ASIC4	G:606715	.	.
ASIP	G:600201	.	[Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3)
ASIP	G:600201	.	[Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3)
ASL	G:608310	Bell>metabolic	Argininosuccinic aciduria, 207900 (3)
ASMD	P:107250	.	.
ASMT	G:300015	.	.
ASMT	G:402500	.	.
ASMTL	G:300162	.	.
ASMTL	G:400011	.	.
ASNA1	G:601913	.	.
ASNS	G:108370	.	.
ASPA	G:608034	Bell>metabolic	Canavan disease, 271900 (3)
ASPH	G:600582	.	.
ASPM	G:605481	+GR-Bell	Microcephaly, primary autosomal recessive, 5, 608716 (3)
ASPN	G:608135	.	{Lumbar disc degeneration}, 603932 (3)
ASPN	G:608135	.	{Osteoarthritis susceptibility 3}, 607850 (3)
ASPRV1	G:611765	.	.
ASPSCR1	G:606236	.	Alveolar soft-part sarcoma, 606243 (3)
ASRGL1	G:609212	.	.
ASS1	G:603470	Bell>metabolic	Citrullinemia, 215700 (3)
ASTL	G:608860	.	.
ASTN1	G:600904	.	.
ASTN2	G:612856	.	.
ASXL1	G:612990	.	Bohring-Opitz syndrome, 605039 (3)
ASXL1	G:612990	.	Myelodysplastic syndrome, somatic, 614286 (3)
ASXL2	G:612991	.	.
ASZ1	G:605797	.	.
ATAD1	G:614452	.	.
ATAD2	G:611941	.	.
ATAD3A	G:612316	.	.
ATAD3B	G:612317	.	.
ATAD5	G:609534	.	.
ATCAY	G:608179	.	Ataxia, cerebellar, Cayman type, 601238 (3)
ATD	P:208500	.	.
ATE1	G:607103	.	.
ATF1	G:123803	.	.
ATF2	G:123811	.	.
ATF3	G:603148	.	.
ATF4	G:604064	.	.
ATF5	G:606398	.	.
ATF6	G:605537	.	.
ATF6B	G:600984	.	.
ATF7	G:606371	.	.
ATF7IP	G:613644	.	.
ATF7IP2	G:613645	.	.
ATG10	G:610800	.	.
ATG12	G:609608	.	.
ATG14	G:613515	.	.
ATG16L1	G:610767	.	{Inflammatory bowel disease 10}, 611081 (3)
ATG3	G:609606	.	.
ATG4A	G:300663	.	.
ATG4B	G:611338	.	.
ATG4C	G:611339	.	.
ATG4D	G:611340	.	.
ATG5	G:604261	.	.
ATG7	G:608760	.	.
ATG9A	G:612204	.	.
ATG9B	G:612205	.	.
ATHS	P:108725	.	.
ATIC	G:601731	Bell>metabolic	AICA-ribosiduria due to ATIC deficiency, 608688 (3)
ATL1	G:606439	+GR-Bell	Neuropathy, hereditary sensory, type ID, 613708 (3)
ATL1	G:606439	+GR-Bell	Spastic paraplegia-3A, 182600 (3)
ATL2	G:609368	.	.
ATL3	G:609369	.	.
ATM	G:607585	Bell>immunodeficiency	Ataxia-telangiectasia, 208900 (3)
ATM	G:607585	Bell>immunodeficiency	Lymphoma, B-cell non-Hodgkin, somatic (3)
ATM	G:607585	Bell>immunodeficiency	Lymphoma, mantle cell (3)
ATM	G:607585	Bell>immunodeficiency	T-cell prolymphocytic leukemia, sporadic (3)
ATM	G:607585	Bell>immunodeficiency	{Breast cancer, susceptibility to}, 114480 (3)
ATN1	G:607462	+GR-Bell	Dentatorubro-pallidoluysian atrophy, 125370 (3)
ATOH1	G:601461	.	.
ATOH7	G:609875	.	.
ATOX1	G:602270	.	.
ATP10A	G:605855	.	.
ATP11A	G:605868	.	.
ATP11B	G:605869	.	.
ATP11C	G:300516	.	.
ATP12A	G:182360	.	.
ATP13A2	G:610513	.	Parkinson disease 9, 606693 (3)
ATP13A3	G:610232	.	.
ATP13A4	G:609556	.	.
ATP1A1	G:182310	.	.
ATP1A2	G:182340	+GR-Bell	Alternating hemiplegia of childhood, 104290 (3)
ATP1A2	G:182340	+GR-Bell	Migraine, familial basilar, 602481 (3)
ATP1A2	G:182340	+GR-Bell	Migraine, familial hemiplegic, 2, 602481 (3)
ATP1A3	G:182350	+GR-Bell	Dystonia-12, 128235 (3)
ATP1A4	G:607321	.	.
ATP1B1	G:182330	.	.
ATP1B2	G:182331	.	.
ATP1B3	G:601867	.	.
ATP2A1	G:108730	.	Brody myopathy, 601003 (3)
ATP2A2	G:108740	.	Acrokeratosis verruciformis, 101900 (3)
ATP2A2	G:108740	.	Darier disease, 124200 (3)
ATP2A3	G:601929	.	.
ATP2B1	G:108731	.	.
ATP2B2	G:108733	.	{Deafness, autosomal recessive 12, modifier of}, 601386 (3)
ATP2B3	G:300014	.	.
ATP2B4	G:108732	.	.
ATP2C1	G:604384	.	Hailey-Hailey disease, 169600 (3)
ATP2C2	G:613082	.	.
ATP4A	G:137216	.	.
ATP4B	G:137217	.	.
ATP5A1	G:164360	.	.
ATP5B	G:102910	.	.
ATP5C1	G:108729	.	.
ATP5D	G:603150	.	.
ATP5E	G:606153	.	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, 614053 (3)
ATP5F1	G:603270	.	.
ATP5G1	G:603192	.	.
ATP5G2	G:603193	.	.
ATP5G3	G:602736	.	.
ATP5I	G:601519	.	.
ATP5J	G:603152	.	.
ATP5O	G:600828	.	.
ATP6AP1	G:300197	.	.
ATP6AP2	G:300556	.	Mental retardation, X-linked, with epilepsy, 300423 (3)
ATP6V0A1	G:192130	.	.
ATP6V0A2	G:611716	Bell>cutaneous	Cutis laxa, autosomal recessive, type IIA, 219200 (3)
ATP6V0A2	G:611716	Bell>cutaneous	Wrinkly skin syndrome, 278250 (3)
ATP6V0A4	G:605239	.	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
ATP6V0B	G:603717	.	.
ATP6V0C	G:108745	.	.
ATP6V0D1	G:607028	.	.
ATP6V0E1	G:603931	.	.
ATP6V0E2	G:611019	.	.
ATP6V1A	G:607027	.	.
ATP6V1B1	G:192132	.	Renal tubular acidosis with deafness, 267300 (3)
ATP6V1B2	G:606939	.	.
ATP6V1C1	G:603097	.	.
ATP6V1D	G:609398	.	.
ATP6V1E1	G:108746	.	.
ATP6V1F	G:607160	.	.
ATP6V1G1	G:607296	.	.
ATP6V1G2	G:606853	.	.
ATP6V1H	G:608861	.	.
ATP7A	G:300011	Bell>neurological	Menkes disease, 309400 (3)
ATP7A	G:300011	Bell>neurological	Occipital horn syndrome, 304150 (3)
ATP7A	G:300011	Bell>neurological	Spinal muscular atrophy, distal, X-linked 3, 300489 (3)
ATP7B	G:606882	Bell>metabolic	Wilson disease, 277900 (3)
ATP8A1	G:609542	.	.
ATP8A2	G:605870	.	.
ATP8B1	G:602397	Bell>metabolic	Cholestasis, benign recurrent intrahepatic, 243300 (3)
ATP8B1	G:602397	Bell>metabolic	Cholestasis, progressive familial intrahepatic 1, 211600 (3)
ATP8B2	G:605867	.	.
ATP8B3	G:605866	.	.
ATP8B4	G:609123	.	.
ATP9A	G:609126	.	.
ATP9B	G:614446	.	.
ATPAF1	G:608917	.	.
ATPAF2	G:608918	.	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, 604273 (3)
ATR	G:601215	Bell>skeletal	Seckel syndrome 1, 210600 (3)
ATRIP	G:606605	.	.
ATRN	G:603130	.	.
ATRNL1	G:612869	.	.
ATRX	G:300032	Bell>hematologic	Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3)
ATRX	G:300032	Bell>hematologic	Alpha-thalassemia/mental retardation syndrome, 301040 (3)
ATRX	G:300032	Bell>hematologic	Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)
ATXN1	G:601556	+GR-Bell	Spinocerebellar ataxia 1, 164400 (3)
ATXN10	G:611150	+GR-Bell	Spinocerebellar ataxia 10, 603516 (3)
ATXN1L	G:614301	.	.
ATXN2	G:601517	+GR-Bell	Spinocerebellar ataxia 2, 183090 (3)
ATXN2L	G:607931	.	.
ATXN3	G:607047	+GR-Bell	Machado-Joseph disease, 109150 (3)
ATXN7	G:607640	+GR-Bell	Spinocerebellar ataxia 7, 164500 (3)
ATXN8	G:613289	.	Spinocerebellar ataxia 8, 608768 (3)
ATXN8OS	G:603680	.	Spinocerebellar ataxia 8, 608768 (3)
AUH	G:600529	Bell>metabolic	3-methylglutaconic aciduria, type I, 250950 (3)
AUNX1	P:300614	.	.
AUP1	G:602434	.	.
AURKA	G:603072	.	{Colon cancer, susceptibility to}, 114500 (3)
AURKAIP1	G:609183	.	.
AURKB	G:604970	.	.
AURKC	G:603495	.	Spermatogenic failure 5, 243060 (3)
AUTS2	G:607270	.	.
AVEN	G:605265	.	.
AVIL	G:613397	.	.
AVL9	G:612927	.	.
AVP	G:192340	.	Diabetes insipidus, neurohypophyseal, 125700 (3)
AVPR1A	G:600821	.	.
AVPR1B	G:600264	.	.
AVPR2	G:300538	+GR-Bell	Diabetes insipidus, nephrogenic, 304800 (3)
AVPR2	G:300538	+GR-Bell	Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3)
AVSD1	P:606215	.	.
AXIN1	G:603816	.	Caudal duplication anomaly, 607864 (3)
AXIN1	G:603816	.	Hepatocellular carcinoma, somatic, 114550 (3)
AXIN2	G:604025	.	Colorectal cancer, 114500 (3)
AXIN2	G:604025	.	Oligodontia-colorectal cancer syndrome, 608615 (3)
AXL	G:109135	.	.
AZF1	P:415000	.	.
AZGP1	G:194460	.	.
AZI1	G:613479	.	.
AZI2	G:609916	.	.
AZIN1	G:607909	.	.
AZU1	G:162815	.	.
B2M	G:109700	.	Hypoproteinemia, hypercatabolic, 241600 (3)
B2MR	G:109710	.	.
B3GALNT1	G:603094	.	[Blood group, P system], 111400 (3)
B3GALNT2	G:610194	.	.
B3GALT1	G:603093	.	.
B3GALT2	G:603018	.	.
B3GALT4	G:603095	.	.
B3GALT5	G:604066	.	.
B3GALTL	G:610308	+GR-Bell	Peters-plus syndrome, 261540 (3)
B3GAT1	G:151290	.	.
B3GAT2	G:607497	.	.
B3GAT3	G:606374	.	Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects, 245600 (3)
B3GNT1	G:605517	.	.
B3GNT2	G:605581	.	.
B3GNT3	G:605863	.	.
B3GNT4	G:605864	.	.
B4GALNT1	G:601873	.	.
B4GALNT2	G:111730	.	.
B4GALNT3	G:612220	.	.
B4GALT1	G:137060	Bell>metabolic	Congenital disorder of glycosylation, type IId, 607091 (3)
B4GALT2	G:604013	.	.
B4GALT3	G:604014	.	.
B4GALT4	G:604015	.	.
B4GALT5	G:604016	.	.
B4GALT6	G:604017	.	.
B4GALT7	G:604327	.	Ehlers-Danlos syndrome, progeroid form, 130070 (3)
B9D1	G:614144	.	Meckel syndrome 9, 614209 (3)
B9D2	G:611951	.	Meckel syndrome 10, 614175 (3)
BAALC	G:606602	.	.
BAAT	G:602938	.	Hypercholanemia, familial, 607748 (3)
BABAM1	G:612766	.	.
BACE1	G:604252	.	.
BACE1-AS	G:614263	.	.
BACE2	G:605668	.	.
BACH1	G:602751	.	.
BACH2	G:605394	.	.
BAD	G:603167	.	.
BAG1	G:601497	.	.
BAG2	G:603882	.	.
BAG3	G:603883	+GR-Bell	Cardiomyopathy, dilated, 1HH, 613881 (3)
BAG3	G:603883	+GR-Bell	Myopathy, myofibrillar, BAG3-related, 612954 (3)
BAG4	G:603884	.	.
BAG5	G:603885	.	.
BAG6	G:142590	.	.
BAGE	G:605167	.	.
BAHD1	G:613880	.	.
BAI1	G:602682	.	.
BAI2	G:602683	.	.
BAI3	G:602684	.	.
BAIAP2	G:605475	.	.
BAIAP2L1	G:611877	.	.
BAIAP3	G:604009	.	.
BAK1	G:600516	.	.
BAMBI	G:604444	.	.
BANF1	G:603811	.	Nestor-Guillermo progeria syndrome, 614008 (3)
BANK1	G:610292	.	{Systemic lupus erythematosus, association with}, 152700 (3)
BANP	G:611564	.	.
BAP1	G:603089	.	Tumor predisposition syndrome, 614327 (3)
BARD1	G:601593	.	{Breast cancer, susceptibility to}, 114480 (3)
BARHL1	G:605211	.	.
BARHL2	G:605212	.	.
BARX1	G:603260	.	.
BARX2	G:604823	.	.
BASP1	G:605940	.	.
BATF	G:612476	.	.
BATF3	G:612470	.	.
BAX	G:600040	.	.
BAZ1A	G:605680	.	.
BAZ1B	G:605681	.	.
BAZ2A	G:605682	.	.
BAZ2B	G:605683	.	.
BBC3	G:605854	.	.
BBIP1	G:613605	.	.
BBOX1	G:603312	.	.
BBS1	G:209901	+GR-Bell	Bardet-Biedl syndrome 1, 209900 (3)
BBS10	G:610148	+GR-Bell	Bardet-Biedl syndrome 10, 209900 (3)
BBS12	G:610683	+GR-Bell	Bardet-Biedl syndrome 12, 209900 (3)
BBS2	G:606151	+GR-Bell	Bardet-Biedl syndrome 2, 209900 (3)
BBS4	G:600374	+GR-Bell	Bardet-Biedl syndrome 4, 209900 (3)
BBS5	G:603650	+GR-Bell	Bardet-Biedl syndrome 5, 209900 (3)
BBS7	G:607590	+GR-Bell	Bardet-Biedl syndrome 7, 209900 (3)
BBS9	G:607968	+GR-Bell	Bardet-Biedl syndrome 9, 209900 (3)
BCAM	G:612773	.	[Blood group, Auberger system], 111200 (3)
BCAM	G:612773	.	[Blood group, Lutheran null], 247420 (3)
BCAM	G:612773	.	[Blood group, Lutheran system], 111200 (3)
BCAN	P:600347	.	.
BCAP31	G:300398	.	.
BCAR1	G:602941	.	.
BCAR3	G:604704	.	.
BCAR4	G:613746	.	.
BCAS1	G:602968	.	.
BCAS2	G:605783	.	.
BCAS3	G:607470	.	.
BCAS4	G:607471	.	.
BCAT1	G:113520	.	.
BCAT2	G:113530	.	.
BCCIP	G:611883	.	.
BCHE	GP:177400	.	Apnea, postanesthetic (3)
BCKDHA	G:608348	Bell>metabolic	Maple syrup urine disease, type Ia, 248600 (3)
BCKDHB	G:248611	Bell>metabolic	Maple syrup urine disease, type Ib, 248600 (3)
BCL10	G:603517	.	Colon cancer, somatic, 114500 (3)
BCL10	G:603517	.	Lymphoma, MALT, somatic, 137245 (3)
BCL10	G:603517	.	{Lymphoma, follicular, somatic}, 613024 (3)
BCL10	G:603517	.	{Male germ cell tumor, somatic}, 273300, (3)
BCL10	G:603517	.	{Mesothelioma, somatic}, 156240 (3)
BCL10	G:603517	.	{Sezary syndrome, somatic}, (3)
BCL11A	G:606557	.	.
BCL11B	G:606558	.	.
BCL2	GP:151430	.	Leukemia/lymphoma, B-cell, 2 (3)
BCL2A1	G:601056	.	.
BCL2L1	G:600039	.	.
BCL2L10	G:606910	.	.
BCL2L11	G:603827	.	.
BCL2L12	G:610837	.	.
BCL2L14	G:606126	.	.
BCL2L2	G:601931	.	.
BCL3	G:109560	.	.
BCL5	G:151441	.	.
BCL6	G:109565	.	.
BCL6B	G:608992	.	.
BCL7A	G:601406	.	B-cell non-Hodgkin lymphoma, high-grade (3)
BCL7B	G:605846	.	.
BCL7C	G:605847	.	.
BCL9	G:602597	.	.
BCL9L	G:609004	.	.
BCLAF1	G:612588	.	.
BCMO1	G:605748	.	Hypercarotenemia and vitamin A deficiency, autosomal dominant, 115300 (3)
BCO2	G:611740	.	.
BCOR	G:300485	+GR-Bell	Microphthalmia, syndromic 2, 300166 (3)
BCORL1	G:300688	.	.
BCR	G:151410	.	Leukemia, acute lymphocytic, 613065 (3)
BCR	G:151410	.	Leukemia, chronic myeloid, 608232 (3)
BCRP2	G:113630	.	.
BCRP3	G:113640	.	.
BCRP4	G:113660	.	.
BCS1L	G:603647	Bell>metabolic	Bjornstad syndrome, 262000 (3)
BCS1L	G:603647	Bell>metabolic	Bjornstad syndrome, 262000 (3)
BCS1L	G:603647	Bell>metabolic	GRACILE syndrome, 603358 (3)
BCS1L	G:603647	Bell>metabolic	GRACILE syndrome, 603358 (3)
BCS1L	G:603647	Bell>metabolic	Leigh syndrome, 256000 (3)
BCS1L	G:603647	Bell>metabolic	Leigh syndrome, 256000 (3)
BCS1L	G:603647	Bell>metabolic	Mitochondrial complex III deficiency, 124000 (3)
BCS1L	G:603647	Bell>metabolic	Mitochondrial complex III deficiency, 124000 (3)
BCYRN1	G:606089	.	.
BDH1	G:603063	.	.
BDKRB1	G:600337	.	.
BDKRB2	G:113503	.	.
BDMR	P:600430	.	.
BDNF	G:113505	.	Central hypoventilation syndrome, congenital, 209880 (3)
BDNF	G:113505	.	{Anorexia nervosa, susceptibility to}, 606788 (3)
BDNF	G:113505	.	{Bulimia nervosa, age of onset of weight loss in}, 607499 (3)
BDNF	G:113505	.	{Memory impairment, susceptibility to} (3)
BDNF	G:113505	.	{Obsessive-compulsive disorder, protection against}, 164230 (3)
BDNF-AS1	G:611468	.	.
BDP1	G:607012	.	.
BEAN1	G:612051	.	Spinocerebellar ataxia 31, 117210 (3)
BECN1	G:604378	.	.
BEST1	G:607854	+GR-Bell	Best macular dystrophy, 153700 (3)
BEST1	G:607854	+GR-Bell	Bestrophinopathy, 611809 (3)
BEST1	G:607854	+GR-Bell	Maculopathy, bull's-eye (3)
BEST1	G:607854	+GR-Bell	Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma, 193220 (3)
BEST1	G:607854	+GR-Bell	Retinitis pigmentosa, concentric, 613194 (3)
BEST1	G:607854	+GR-Bell	Retinitis pigmentosa-50, 613194 (3)
BEST1	G:607854	+GR-Bell	Vitelliform macular dystrophy, adult-onset, 608161 (3)
BEST1	G:607854	+GR-Bell	Vitreoretinochoroidopathy, 193220 (3)
BEST2	G:607335	.	.
BEST3	G:607337	.	.
BEST4	G:607336	.	.
BET1	G:605456	.	.
BET3L	G:614137	.	.
BEX1	G:300690	.	.
BEX2	G:300691	.	.
BEX4	G:300692	.	.
BEX5	G:300693	.	.
BFSP1	G:603307	.	Cataract, cortical, juvenile-onset, 611391 (3)
BFSP2	G:603212	.	Cataract, autosomal dominant, multiple types 1, 611597 (3)
BFSP2	G:603212	.	Cataract, congenital, 604219 (3)
BFSP2	G:603212	.	Cataract, juvenile-onset, 604219 (3)
BGLAP	G:112260	.	.
BGN	G:301870	.	.
BHLHA15	G:608606	.	.
BHLHE22	G:613483	.	.
BHLHE23	G:609331	.	.
BHLHE40	G:604256	.	.
BHLHE41	G:606200	.	[Short sleeper], 612975 (3)
BHMT	G:602888	.	.
BHMT2	G:605932	.	.
BICC1	G:614295	.	{Renal dysplasia, cystic, susceptibility to}, 601331 (3)
BICD1	G:602204	.	.
BICD2	G:609797	.	.
BID	G:601997	.	.
BIK	G:603392	.	.
BIN1	G:601248	.	Myopathy, centronuclear, autosomal recessive, 255200 (3)
BIN2	G:605936	.	.
BIN3	G:606396	.	.
BIRC2	G:601712	.	.
BIRC3	G:601721	.	.
BIRC5	G:603352	.	.
BIRC6	G:605638	.	.
BIRC7	G:605737	.	.
BLACE	G:608450	.	.
BLCAP	G:613110	.	.
BLID	G:608853	.	.
BLK	G:191305	.	Maturity-onset diabetes of the young, type 11, 613375 (3)
BLM	G:604610	Bell>immunodeficiency	Bloom syndrome, 210900 (3)
BLMH	G:602403	.	{Alzheimer disease, susceptibility to}, 104300 (3)
BLNK	G:604515	.	Agammaglobulinemia 4, 613502 (3)
BLOC1S1	G:601444	.	.
BLOC1S2	G:609768	.	.
BLOC1S3	G:609762	+GR-Bell	Hermansky-Pudlak syndrome 8, 614077 (3)
BLVRA	G:109750	.	Hyperbiliverdinemia, 614156 (3)
BLVRB	G:600941	.	.
BLZF1	G:608692	.	.
BMF	G:606266	.	.
BMI1	G:164831	.	.
BMIQ1	P:606641	.	.
BMIQ2	P:606643	.	.
BMIQ3	P:607446	.	.
BMIQ4	P:607447	.	.
BMIQ5	P:608558	.	.
BMIQ6	P:608559	.	.
BMP1	G:112264	.	.
BMP10	G:608748	.	.
BMP15	G:300247	.	Ovarian dysgenesis 2, 300510 (3)
BMP15	G:300247	.	Premature ovarian failure 4, 300510 (3)
BMP2	G:112261	.	Brachydactyly, type A2, 112600 (3)
BMP2	G:112261	.	{HFE hemochromatosis, modifier of}, 235200 (3)
BMP3	G:112263	.	.
BMP4	G:112262	+GR-Bell	Microphthalmia, syndromic 6, 607932 (3)
BMP4	G:112262	+GR-Bell	Orofacial cleft 11, 600625 (3)
BMP5	G:112265	.	.
BMP6	G:112266	.	.
BMP7	G:112267	.	.
BMP8B	G:602284	.	.
BMPER	G:608699	.	Diaphanospondylodysostosis, 608022 (3)
BMPR1A	G:601299	+GR-Bell	Juvenile polyposis syndrome, infantile form, 174900 (3)
BMPR1A	G:601299	+GR-Bell	Polyposis syndrome, hereditary mixed, 2, 610069 (3)
BMPR1A	G:601299	+GR-Bell	Polyposis, juvenile intestinal, 174900 (3)
BMPR1B	G:603248	.	Brachydactyly, type A2, 112600 (3)
BMPR1B	G:603248	.	Chrondrodysplasia, acromesomelic, with genital anomalies, 609441 (3)
BMPR2	G:600799	Bell>respiratory	Pulmonary hypertension, familial primary, 178600 (3)
BMPR2	G:600799	Bell>respiratory	Pulmonary hypertension, primary, fenfluramine-associated, 178600 (3)
BMPR2	G:600799	Bell>respiratory	Pulmonary venoocclusive disease, 265450 (3)
BMS1	G:611448	.	.
BMX	G:300101	.	.
BNC1	G:601930	.	.
BNC2	G:608669	.	.
BNIP1	G:603291	.	.
BNIP2	G:603292	.	.
BNIP3	G:603293	.	.
BNIP3L	G:605368	.	.
BNIPL	G:611275	.	.
BOC	G:608708	.	.
BOK	G:605404	.	.
BOLA1	G:613181	.	.
BOLA2	G:613182	.	.
BOLA3	G:613183	.	Multiple mitochondrial dysfunctions syndrome 2, 614299 (3)
BOLL	G:606165	.	.
BOP1	G:610596	.	.
BORA	G:610510	.	.
BPGM	G:613896	.	Erythrocytosis due to bisphosphoglycerate mutase deficiency, 222800 (3)
BPHL	G:603156	.	.
BPI	G:109195	.	.
BPIFA1	G:607412	.	.
BPIFA4P	G:607627	.	.
BPIFB2	G:614108	.	.
BPIFB6	G:614110	.	.
BPIFC	G:614109	.	.
BPNT1	G:604053	.	.
BPTF	G:601819	.	.
BPY2	G:400013	.	.
BRAF	G:164757	.	Adenocarcinoma of lung, somatic, 211980 (3)
BRAF	G:164757	.	Cardiofaciocutaneous syndrome, 115150 (3)
BRAF	G:164757	.	Colorectal cancer, somatic (3)
BRAF	G:164757	.	LEOPARD syndrome 3, 613707 (3)
BRAF	G:164757	.	Melanoma, malignant, somatic (3)
BRAF	G:164757	.	Nonsmall cell lung cancer, somatic (3)
BRAF	G:164757	.	Noonan syndrome 7, 613706 (3)
BRAP	G:604986	.	.
BRAT1	G:614506	.	Rigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3)
BRCA1	G:113705	+GR-Bell	{Breast-ovarian cancer, familial, 1}, 604370 (3)
BRCA1	G:113705	+GR-Bell	{Pancreatic cancer, susceptibility to, 4}, 614320 (3)
BRCA2	G:600185	+GR-Bell	Fanconi anemia, complementation group D1, 605724 (3)
BRCA2	G:600185	+GR-Bell	Pancreatic cancer, 613347 (3)
BRCA2	G:600185	+GR-Bell	Prostate cancer, 176807 (3)
BRCA2	G:600185	+GR-Bell	Wilms tumor, 194070 (3)
BRCA2	G:600185	+GR-Bell	{Breast cancer, male, susceptibility to}, 114480 (3)
BRCA2	G:600185	+GR-Bell	{Breast-ovarian cancer, familial, 2}, 612555 (3)
BRCA2	G:600185	+GR-Bell	{Glioblastoma 3}, 613029 (3)
BRCA2	G:600185	+GR-Bell	{Medulloblastoma}, 155255 (3)
BRCA2	G:600185	+GR-Bell	{Pre-B-cell acute lymphoblastic leukemia}, (3)
BRCA3	P:605365	.	.
BRCC3	G:300617	.	.
BRD1	G:604589	.	.
BRD2	G:601540	.	.
BRD3	G:601541	.	.
BRD4	G:608749	.	.
BRD8	G:602848	.	.
BRDT	G:602144	.	.
BRE	G:610497	.	.
BRF1	G:604902	.	.
BRF2	G:607013	.	.
BRIP1	G:605882	+GR-Bell	Breast cancer, early-onset, 114480 (3)
BRIP1	G:605882	+GR-Bell	Fanconi anemia, complementation group J, 609054 (3)
BRK1	G:611183	.	.
BRMS1	G:606259	.	.
BRPF1	G:602410	.	.
BRS3	G:300107	.	.
BRSK1	G:609235	.	.
BRSK2	G:609236	.	.
BRWD3	G:300553	.	Mental retardation, X-linked 93, 300659 (3)
BSCL2	G:606158	+GR-Bell	Lipodystrophy, congenital generalized, type 2, 269700 (3)
BSCL2	G:606158	+GR-Bell	Neuropathy, distal hereditary motor, type V, 600794 (3)
BSCL2	G:606158	+GR-Bell	Silver spastic paraplegia syndrome, 270685 (3)
BSG	G:109480	.	[Blood group, OK], 111380 (3)
BSN	G:604020	.	.
BSND	G:606412	.	Bartter syndrome, type 4a, 602522 (3)
BSND	G:606412	.	Sensorineural deafness with mild renal dysfunction, 602522 (3)
BSPH1	G:612213	.	.
BST1	G:600387	.	.
BST2	G:600534	.	.
BSX	G:611074	.	.
BTAF1	G:605191	.	.
BTBD1	G:608530	.	.
BTBD2	G:608531	.	.
BTBD7	G:610386	.	.
BTBD9	G:611237	.	.
BTC	G:600345	.	.
BTD	G:609019	Bell>metabolic	Biotinidase deficiency, 253260 (3)
BTF3	G:602542	.	.
BTF3P11	G:602543	.	.
BTF3P12	G:603738	.	.
BTF3P13	G:603739	.	.
BTG1	G:109580	.	.
BTG2	G:601597	.	.
BTG3	G:605674	.	.
BTG4	G:605673	.	.
BTK	G:300300	Bell>immunodeficiency	Agammaglobulinemia and isolated hormone deficiency, 307200 (3)
BTK	G:300300	Bell>immunodeficiency	Agammaglobulinemia, X-linked 1, 300755 (3)
BTLA	G:607925	.	.
BTN1A1	G:601610	.	.
BTN2A1	G:613590	.	.
BTN2A2	G:613591	.	.
BTN2A3P	G:613592	.	.
BTN3A1	G:613593	.	.
BTN3A2	G:613594	.	.
BTN3A3	G:613595	.	.
BTNL2	G:606000	.	{Sarcoidosis, susceptibility to, 2}, 612387 (3)
BTNL3	G:606192	.	.
BTRC	G:603482	.	.
BUB1	G:602452	.	.
BUB1B	G:602860	.	Colorectal cancer, 114500 (3)
BUB1B	G:602860	.	Mosaic variegated aneuploidy syndrome, 257300 (3)
BUB1B	G:602860	.	[Premature chromatid separation trait], 176430 (3)
BUB3	G:603719	.	.
BUD31	G:603477	.	.
BVES	G:604577	.	.
BYSL	G:603871	.	.
BZRAP1	G:610764	.	.
C10orf10	G:611309	.	.
C10orf11	G:614537	.	.
C10orf2	G:606075	+GR-Bell	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)
C10orf2	G:606075	+GR-Bell	Progressive external ophthalmoplegia, autosomal dominant, 3, 609286 (3)
C10orf26	G:611129	.	.
C10orf27	G:612640	.	.
C11orf21	G:611033	.	.
C11orf24	G:610880	.	.
C11orf30	G:608574	.	.
C11orf31	G:607914	.	.
C11orf34	G:611904	.	.
C11orf41	G:612297	.	.
C11orf46	G:612295	.	.
C11orf75	G:609477	.	.
C11orf9	G:608329	.	.
C12orf10	G:611366	.	.
C12orf32	G:614085	.	.
C12orf5	G:610775	.	.
C12orf65	G:613541	.	Combined oxidative phosphorylation deficiency 7, 613559 (3)
C14orf1	G:604576	.	.
C14orf133	G:613401	.	Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)
C14orf166	G:610858	.	.
C14orf169	G:611919	.	.
C14orf2	G:604573	.	.
C14orf49	G:610861	.	.
C15orf2	G:610922	.	.
C15orf42	G:613298	.	.
C15orf48	G:608409	.	.
C15orf55	G:608963	.	.
C15orf63	G:612784	.	.
C16orf3	G:605179	.	.
C16orf5	G:610503	.	.
C16orf53	G:612033	.	.
C16orf57	G:613276	.	Poikiloderma with neutropenia, 604173 (3)
C17orf28	G:605752	.	.
C17orf70	G:611301	.	.
C18orf1	G:606571	.	.
C18orf54	G:613258	.	.
C19orf10	G:606746	.	.
C19orf12	G:614297	.	Neurodegeneration with brain iron accumulation 4, 614298 (3)
C19orf40	G:610884	.	.
C19orf59	G:609565	.	.
C19orf6	G:611011	.	.
C19orf63	G:614545	.	.
C1D	G:606997	.	.
C1GALT1	G:610555	.	.
C1GALT1C1	G:300611	.	Tn syndrome, 300622 (3)
C1orf116	G:611680	.	.
C1orf187	G:612682	.	.
C1orf27	G:609335	.	.
C1orf88	G:614234	.	.
C1QA	G:120550	.	C1q deficiency, 613652 (3)
C1QB	G:120570	.	C1q deficiency, 613652 (3)
C1QBP	G:601269	.	.
C1QC	G:120575	.	C1q deficiency, 613652 (3)
C1QL1	G:611586	.	.
C1QL2	G:614330	.	.
C1QTNF1	G:610365	.	.
C1QTNF3	G:612045	.	.
C1QTNF5	G:608752	.	Retinal degeneration, late-onset, autosomal dominant, 605670 (3)
C1QTNF8	G:614147	.	.
C1QTNF9	G:614285	.	.
C1QTNF9B	G:614148	.	.
C1R	G:613785	.	.
C1RL	G:608974	.	.
C1S	G:120580	.	C1s deficiency, 613783 (3)
C20orf11	G:611625	.	.
C20orf194	G:614146	.	.
C20orf20	G:611157	.	.
C20orf7	G:612360	.	Mitochondrial complex 1 deficiency, 252010 (3)
C21orf2	G:603191	.	.
C21orf33	G:601659	.	.
C21orf56	G:612412	.	.
C21orf7	G:611110	.	.
C22orf28	G:613901	.	.
C2CD4A	G:610343	.	.
C2CD4B	G:610344	.	.
C2CD4C	G:610336	.	.
C2orf40	G:611752	.	.
C2orf43	G:613570	.	.
C2orf71	G:613425	+GR-Bell	Retinitis pigmentosa 54, 613428 (3)
C3AR1	G:605246	.	.
C3orf15	G:609910	.	.
C3orf35	G:611429	.	.
C3orf52	G:611956	.	.
C3orf58	G:612200	.	.
C3orf77	G:614412	.	.
C4A	G:120810	.	C4a deficiency, 614380 (3)
C4A	G:120810	.	[Blood group, Rodgers], 614374 (3)
C4B	G:120820	.	C4B deficiency, 614379 (3)
C4BPA	G:120830	.	.
C4BPB	G:120831	.	.
C5AR1	G:113995	.	.
C5orf20	G:609710	.	.
C5orf38	G:610522	.	.
C5orf62	G:608324	.	.
C6orf1	G:611419	.	.
C6orf106	G:612217	.	.
C6orf130	G:614393	.	.
C6orf15	G:611401	.	.
C6orf221	G:611687	.	Hydatidiform mole, recurrent, 2, 614293 (3)
C6orf25	G:606520	.	.
C6orf48	G:605447	.	.
C7orf10	G:609187	.	[Glutaric aciduria III], 231690 (3)
C7orf13	G:610242	.	.
C8A	G:120950	.	C8 deficiency, type I, 613790 (3)
C8B	G:120960	.	C8 deficiency, type II, 613789 (3)
C8G	G:120930	.	.
C8orf37	G:614477	.	Cone-rod dystrophy 16, 614500 (3)
C8orf37	G:614477	.	Retinitis pigmentosa 64, 614500 (3)
C8orf38	G:612392	.	Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)
C8orf4	G:607702	.	.
C9orf116	G:614502	.	.
C9orf64	G:611342	.	.
C9orf72	G:614260	.	Amyotrophic lateral sclerosis with frontotemporal dementia, 105550 (3)
C9orf80	G:613273	.	.
C9orf86	G:610615	.	.
CA1	G:114800	.	.
CA10	G:604642	.	.
CA11	G:604644	.	.
CA12	G:603263	.	Hyperchlorhidrosis, isolated, 143860 (3)
CA13	G:611436	.	.
CA14	G:604832	.	.
CA2	G:611492	Bell>skeletal	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis, 259730 (3)
CA3	G:114750	.	.
CA4	G:114760	.	Retinitis pigmentosa 17, 600852 (3)
CA5A	G:114761	.	.
CA5B	G:300230	.	.
CA6	G:114780	.	.
CA7	G:114770	.	.
CA8	G:114815	.	Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3, 613227 (3)
CA9	G:603179	.	.
CAB39	G:612174	.	.
CAB39L	G:612175	.	.
CABIN1	G:604251	.	.
CABLES1	G:609194	.	.
CABP1	G:605563	.	.
CABP2	G:607314	.	.
CABP4	G:608965	.	Night blindness, congenital stationary, type 2B, 610427 (3)
CABP5	G:607315	.	.
CABYR	G:612135	.	.
CACD	P:215500	.	.
CACFD1	G:613104	.	.
CACNA1A	G:601011	+GR-Bell	Episodic ataxia, type 2, 108500 (3)
CACNA1A	G:601011	+GR-Bell	Migraine, familial hemiplegic, 1, 141500 (3)
CACNA1A	G:601011	+GR-Bell	Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3)
CACNA1A	G:601011	+GR-Bell	Spinocerebellar ataxia 6, 183086 (3)
CACNA1B	G:601012	.	.
CACNA1C	G:114205	+GR-Bell	Brugada syndrome 3, 611875 (3)
CACNA1C	G:114205	+GR-Bell	Timothy syndrome, 601005 (3)
CACNA1D	G:114206	.	.
CACNA1E	G:601013	.	.
CACNA1F	G:300110	+GR-Bell	Aland Island eye disease, 300600 (3)
CACNA1F	G:300110	+GR-Bell	Cone-rod dystrophy, X-linked, 3, 300476 (3)
CACNA1F	G:300110	+GR-Bell	Night blindness, congenital stationary, X-linked, type 2A, 300071 (3)
CACNA1G	G:604065	.	.
CACNA1H	G:607904	.	{Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3)
CACNA1H	G:607904	.	{Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3)
CACNA1I	G:608230	.	.
CACNA1S	G:114208	+GR-Bell	Hypokalemic periodic paralysis, type 1, 170400 (3)
CACNA1S	G:114208	+GR-Bell	{Malignant hyperthermia susceptibility 5}, 601887 (3)
CACNA1S	G:114208	+GR-Bell	{Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)
CACNA2D1	G:114204	.	.
CACNA2D2	G:607082	.	.
CACNA2D3	G:606399	.	.
CACNA2D4	G:608171	.	Retinal cone dystrophy 4, 610478 (3)
CACNB1	G:114207	.	.
CACNB2	G:600003	+GR-Bell	Brugada syndrome 4, 611876 (3)
CACNB3	G:601958	.	.
CACNB4	G:601949	.	Episodic ataxia, type 5, 613855 (3)
CACNB4	G:601949	.	{Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3)
CACNB4	G:601949	.	{Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3)
CACNG1	G:114209	.	.
CACNG2	G:602911	.	Mental retardation, autosomal dominant 10, 614256 (3)
CACNG3	G:606403	.	.
CACNG4	G:606404	.	.
CACNG5	G:606405	.	.
CACNG6	G:606898	.	.
CACNG7	G:606899	.	.
CACNG8	G:606900	.	.
CACYBP	G:606186	.	.
CAD	G:114010	.	.
CADM1	G:605686	.	.
CADM2	G:609938	.	.
CADM3	G:609743	.	.
CADM4	G:609744	.	.
CADPS	G:604667	.	.
CADPS2	G:609978	.	.
CAGE1	G:608304	.	.
CALB1	G:114050	.	.
CALB2	G:114051	.	.
CALCA	G:114130	.	.
CALCB	G:114160	.	.
CALCOCO2	G:604587	.	.
CALCR	G:114131	.	{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)
CALCRL	G:114190	.	.
CALD1	G:114213	.	.
CALHM1	G:612234	.	.
CALHM2	G:612235	.	.
CALM1	G:114180	.	.
CALM2	G:114182	.	.
CALM3	G:114183	.	.
CALML3	G:114184	.	.
CALML5	G:605183	.	.
CALML6	G:610171	.	.
CALN1	G:607176	.	.
CALR	G:109091	.	.
CALR3	G:611414	.	Cardiomyopathy, familial hypertrophic, 19, 613875 (3)
CALU	G:603420	.	.
CALY	G:604647	.	.
CAMK1	G:604998	.	.
CAMK1D	G:607957	.	.
CAMK2A	G:114078	.	.
CAMK2B	G:607707	.	.
CAMK2D	G:607708	.	.
CAMK2G	G:602123	.	.
CAMK2N2	G:608721	.	.
CAMK4	G:114080	.	.
CAMKK1	G:611411	.	.
CAMKMT	G:609559	.	.
CAMLG	G:601118	.	.
CAMP	G:600474	.	.
CAMSAP1	G:613774	.	.
CAMSAP2	G:613775	.	.
CAMSAP3	G:612685	.	.
CAMTA1	G:611501	.	.
CAMTA2	G:611508	.	.
CAND1	G:607727	.	.
CAND2	G:610403	.	.
CANDN1	P:607644	.	.
CANT1	G:613165	.	Desbuquois dysplasia, 251450 (3)
CANX	G:114217	.	.
CAPG	G:153615	.	.
CAPN1	G:114220	.	.
CAPN10	G:605286	.	{Diabetes mellitus, noninsulin-dependent 1}, 601283 (3)
CAPN11	G:604822	.	.
CAPN12	G:608839	.	.
CAPN13	G:610228	.	.
CAPN14	G:610229	.	.
CAPN2	G:114230	.	.
CAPN3	G:114240	+GR-Bell	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CAPN5	G:602537	.	.
CAPN6	G:300146	.	.
CAPN7	G:606400	.	.
CAPN9	G:606401	.	.
CAPNS1	G:114170	.	.
CAPRIN1	G:601178	.	.
CAPRIN2	G:610375	.	.
CAPS	G:114212	.	.
CAPS2	G:607724	.	.
CAPZA1	G:601580	.	.
CAPZA2	G:601571	.	.
CAPZA3	G:608722	.	.
CAPZB	G:601572	.	.
CARD10	G:607209	.	.
CARD11	G:607210	.	.
CARD14	G:607211	.	.
CARD17	G:609490	.	.
CARD18	G:605354	.	.
CARD6	G:609986	.	.
CARD8	G:609051	.	.
CARD9	G:607212	.	Candidiasis, familial, 2, autosomal recessive, 212050 (3) 212050 (3)
CARM1	G:603934	.	.
CARNS1	G:613368	.	.
CARS	G:123859	.	.
CARS2	G:612800	.	.
CARTPT	G:602606	.	{Obesity, susceptibility to}, 601665 (3)
CASC2	G:608598	.	.
CASC3	G:606504	.	.
CASC5	G:609173	.	.
CASD1	G:611686	.	.
CASK	G:300172	.	FG syndrome 4, 300422 (3)
CASK	G:300172	.	Mental retardation and microcephaly with pontine and cerebellar hypoplasia, 300749 (3)
CASK	G:300172	.	Mental retardation, with or without nystagmus, 300422 (3)
CASKIN1	G:612184	.	.
CASKIN2	G:612185	.	.
CASP1	G:147678	.	.
CASP10	G:601762	+GR-Bell	Autoimmune lymphoproliferative syndrome, type II, 603909 (3)
CASP10	G:601762	+GR-Bell	Gastric cancer, somatic, 137215 (3)
CASP10	G:601762	+GR-Bell	Non-Hodgkin lymphoma, somatic, 605027 (3)
CASP12	G:608633	.	{Sepsis, susceptibility to} (3)
CASP14	G:605848	.	.
CASP2	G:600639	.	.
CASP3	G:600636	.	.
CASP4	G:602664	.	.
CASP5	G:602665	.	.
CASP6	G:601532	.	.
CASP7	G:601761	.	.
CASP8	G:601763	.	Hepatocellular carcinoma, somatic, 114550 (3)
CASP8	G:601763	.	Immunodeficiency due to CASP8 deficiency, 607271 (3)
CASP8	G:601763	.	{Breast cancer, protection against}, 114480 (3)
CASP8	G:601763	.	{Lung cancer, protection against}, 211980 (3)
CASP8AP2	G:606880	.	.
CASP9	G:602234	.	.
CASQ1	G:114250	.	.
CASQ2	G:114251	+GR-Bell	Ventricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3)
CASR	GP:601199	.	Hyperparathyroidism, neonatal, 239200 (3)
CASR	GP:601199	.	Hypocalcemia, autosomal dominant, 146200 (3)
CASR	GP:601199	.	Hypocalcemia, autosomal dominant, with Bartter syndrome (3)
CASR	GP:601199	.	Hypocalciuric hypercalcemia, type I, 145980 (3)
CASR	GP:601199	.	{Epilepsy, idiopathic generalized, susceptibility to, 8}, 612899 (3)
CAST	G:114090	.	.
CASZ1	G:609895	.	.
CAT	G:115500	.	Acatalasemia, 614097 (3)
CATR1	G:600676	.	.
CATSPER1	G:606389	+GR-Bell	Spermatogenic failure 7, 612997 (3)
CATSPER2	G:607249	.	.
CATSPER3	G:609120	.	.
CATSPER4	G:609121	.	.
CATSPERB	G:611169	.	.
CATSPERG	G:613452	.	.
CAV1	G:601047	.	Lipodystrophy, congenital generalized, type 3, 612526 (3)
CAV2	G:601048	.	.
CAV3	G:601253	+GR-Bell	Cardiomyopathy, familial hypertrophic, 192600 (3)
CAV3	G:601253	+GR-Bell	Creatine phosphokinase, elevated serum, 123320 (3)
CAV3	G:601253	+GR-Bell	Long QT syndrome-9, 611818 (3)
CAV3	G:601253	+GR-Bell	Muscular dystrophy, limb-girdle, type IC, 607801 (3)
CAV3	G:601253	+GR-Bell	Myopathy, distal, Tateyama type, 614321 (3)
CAV3	G:601253	+GR-Bell	Rippling muscle disease, 606072 (3)
CBFA2T2	G:603672	.	.
CBFA2T3	G:603870	.	.
CBFB	G:121360	.	.
CBL	G:165360	.	Noonan syndrome-like disorder with or without juvenile meylomonocytic leukemia, 613563 (3)
CBLB	G:604491	.	.
CBLC	G:608453	.	.
CBLL1	G:606872	.	.
CBLN1	G:600432	.	.
CBLN2	G:600433	.	.
CBLN3	G:612978	.	.
CBR1	G:114830	.	.
CBR3	G:603608	.	.
CBS	G:613381	Bell>metabolic	Homocystinuria, B6-responsive and nonresponsive types, 236200 (3)
CBS	G:613381	Bell>metabolic	Thrombosis, hyperhomocysteinemic, 236200 (3)
CBWD1	G:611078	.	.
CBWD2	G:611079	.	.
CBWD3	G:611080	.	.
CBX1	G:604511	.	.
CBX2	G:602770	.	46XY sex reversal 5, 613080 (3)
CBX3	G:604477	.	.
CBX4	G:603079	.	.
CBX5	G:604478	.	.
CBX7	G:608457	.	.
CBY1	G:607757	.	.
CC2D1A	G:610055	.	Mental retardation, autosomal recessive 3, 608443 (3)
CC2D2A	G:612013	+GR-Bell	COACH syndrome, 216360 (3)
CC2D2A	G:612013	+GR-Bell	Joubert syndrome 9, 612285 (3)
CC2D2A	G:612013	+GR-Bell	Meckel syndrome, type 6, 612284 (3)
CCA1	P:115660	.	.
CCAL1	P:600668	.	.
CCAR1	G:612569	.	.
CCBE1	G:612753	.	Hennekam lymphangiectasia-lymphedema syndrome, 235510 (3)
CCBL1	G:600547	.	.
CCBL2	G:610656	.	.
CCBP2	G:602648	.	.
CCDC101	G:613374	.	.
CCDC106	G:613478	.	.
CCDC108	G:614270	.	.
CCDC110	G:609488	.	.
CCDC115	G:613734	.	.
CCDC122	G:613408	.	.
CCDC125	G:613781	.	.
CCDC136	G:611902	.	.
CCDC137	G:614271	.	.
CCDC19	G:605152	.	.
CCDC22	G:300859	.	.
CCDC26	G:613040	.	.
CCDC28B	G:610162	.	{Bardet-Biedl syndrome, modifier of}, 209900 (3)
CCDC34	G:612324	.	.
CCDC39	G:613798	+GR-Bell	Ciliary dyskinesia, primary, 14, 613807 (3)
CCDC40	G:613799	+GR-Bell	Ciliary dyskinesia, primary, 15, 613808 (3)
CCDC50	G:611051	.	Deafness, autosomal dominant 44, 607453 (3)
CCDC6	G:601985	.	.
CCDC62	G:613481	.	.
CCDC65	G:611088	.	.
CCDC73	G:612328	.	.
CCDC8	G:614145	+GR-Bell	Three M syndrome 3, 614205 (3)
CCDC80	G:608298	.	.
CCDC85B	G:605360	.	.
CCDC86	G:611293	.	.
CCDC88A	G:609736	.	.
CCDC88B	G:611205	.	.
CCDC88C	G:611204	.	.
CCHCR1	G:605310	.	.
CCIN	G:603960	.	.
CCK	G:118440	.	.
CCKAR	G:118444	.	.
CCKBR	G:118445	.	.
CCL1	G:182281	.	.
CCL11	G:601156	.	{Asthma, susceptibility to}, 600807 (3)
CCL11	G:601156	.	{HIV1, resistance to}, 609423 (3)
CCL13	G:601391	.	.
CCL14	G:601392	.	.
CCL15	G:601393	.	.
CCL16	G:601394	.	.
CCL17	G:601520	.	.
CCL18	G:603757	.	.
CCL19	G:602227	.	.
CCL2	GP:158105	.	{Coronary artery disease, modifier of} (3)
CCL2	GP:158105	.	{HIV-1, resistance to}, 609423 (3)
CCL2	GP:158105	.	{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)
CCL2	GP:158105	.	{Spina bifida, susceptibility to}, 182940 (3)
CCL20	G:601960	.	.
CCL21	G:602737	.	.
CCL22	G:602957	.	.
CCL23	G:602494	.	.
CCL24	G:602495	.	.
CCL25	G:602565	.	.
CCL26	G:604697	.	.
CCL27	G:604833	.	.
CCL28	G:605240	.	.
CCL3	G:182283	.	.
CCL3L1	G:601395	.	{HIV/AIDS, susceptibility to}, 609423 (3)
CCL3L3	G:609468	.	.
CCL3P1	G:609467	.	.
CCL4	G:182284	.	.
CCL4L1	G:603782	.	.
CCL4L2	G:610757	.	.
CCL5	G:187011	.	{HIV-1 disease, delayed progression of} (3)
CCL5	G:187011	.	{HIV-1 disease, rapid progression of} (3)
CCL7	G:158106	.	.
CCL8	G:602283	.	.
CCM2	G:607929	+GR-Bell	Cerebral cavernous malformations-2, 603284 (3)
CCNA1	G:604036	.	.
CCNA2	G:123835	.	.
CCNB1	G:123836	.	.
CCNB1IP1	G:608249	.	.
CCNB2	G:602755	.	.
CCNB3	G:300456	.	.
CCNC	G:123838	.	.
CCND1	G:168461	.	{Colorectal cancer, susceptibility to}, 114500 (3)
CCND1	G:168461	.	{von Hippel-Lindau disease, modification of}, 193300 (3)
CCND2	G:123833	.	.
CCND3	G:123834	.	.
CCNDBP1	G:607089	.	.
CCNE1	G:123837	.	.
CCNE2	G:603775	.	.
CCNF	G:600227	.	.
CCNG1	G:601578	.	.
CCNG2	G:603203	.	.
CCNH	G:601953	.	.
CCNK	G:603544	.	.
CCNL1	G:613384	.	.
CCNL2	G:613482	.	.
CCNO	G:607752	.	.
CCNT1	G:143055	.	.
CCNT2	G:603862	.	.
CCNY	G:612786	.	.
CCP110	G:609544	.	.
CCPG1	G:611326	.	.
CCR1	G:601159	.	.
CCR10	G:600240	.	.
CCR2	G:601267	.	{HIV infection, susceptibility/resistance to} (3)
CCR3	G:601268	.	.
CCR4	G:604836	.	.
CCR5	G:601373	.	{Diabetes mellitus, insulin-dependent, 22}, 612522 (3)
CCR5	G:601373	.	{HIV infection, susceptibility/resistance to} (3)
CCR5	G:601373	.	{Hepatitis C virus, resistance to}, 609532 (3)
CCR5	G:601373	.	{West nile virus, susceptibility to}, 610379 (3)
CCR6	G:601835	.	.
CCR7	G:600242	.	.
CCR8	G:601834	.	.
CCR9	G:604738	.	.
CCRL1	G:606065	.	.
CCRL2	G:608379	.	.
CCRN4L	G:608468	.	.
CCS	G:603864	.	.
CCT	P:302200	.	.
CCT2	G:605139	.	.
CCT3	G:600114	.	.
CCT4	G:605142	.	.
CCT5	G:610150	.	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CCT6A	G:104613	.	.
CCT6B	G:610730	.	.
CCT7	G:605140	.	.
CCV	P:115665	.	.
CD101	G:604516	.	.
CD109	G:608859	.	.
CD14	G:158120	.	.
CD151	G:602243	.	Nephropathy with pretibial epidermolysis bullosa and deafness, 609057 (3)
CD151	G:602243	.	[Blood group, Raph], 179620 (3)
CD160	G:604463	.	.
CD163	G:605545	.	.
CD163L1	G:606079	.	.
CD164	G:603356	.	.
CD177	G:162860	.	.
CD180	G:602226	.	.
CD19	G:107265	+GR-Bell	Immunodeficiency, common variable, 3, 613493 (3)
CD1A	G:188370	.	.
CD1B	G:188360	.	.
CD1C	G:188340	.	.
CD1D	G:188410	.	.
CD1E	G:188411	.	.
CD2	G:186990	.	.
CD200	G:155970	.	.
CD200R1	G:607546	.	.
CD207	G:604862	.	[Birbeck granule deficiency], 613393 (3)
CD209	G:604672	.	{Dengue fever, protection against}, 614371 (3)
CD209	G:604672	.	{HIV type 1, susceptibility to}, 609423 (3)
CD209	G:604672	.	{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)
CD22	G:107266	.	.
CD226	G:605397	.	.
CD24	G:600074	.	{Multiple sclerosis, susceptibility to}, 126200 (3)
CD244	G:605554	.	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CD247	G:186780	.	Immunodeficiency due to defect in CD3-zeta, 610163 (3)
CD248	G:606064	.	.
CD27	G:186711	.	.
CD274	G:605402	.	.
CD276	G:605715	.	.
CD28	G:186760	.	.
CD2AP	G:604241	.	Glomerulosclerosis, focal segmental, 3, 607832 (3)
CD2BP2	G:604470	.	.
CD300A	G:606790	.	.
CD300C	G:606786	.	.
CD300E	G:609801	.	.
CD300LB	G:610705	.	.
CD300LF	G:609807	.	.
CD300LG	G:610520	.	.
CD302	G:612246	.	.
CD320	G:606475	.	Methylmalonic aciduria due to transcobalamin receptor defect, 613646 (3)
CD33	G:159590	.	.
CD34	G:142230	.	.
CD36	G:173510	.	Platelet glycoprotein IV deficiency, 608404 (3)
CD36	G:173510	.	{Coronary heart disease, susceptibility to, 7}, 610938 (3)
CD36	G:173510	.	{Malaria, cerebral, reduced risk of}, 611162 (3)
CD36	G:173510	.	{Malaria, cerebral, susceptibility to}, 611162 (3)
CD37	G:151523	.	.
CD38	G:107270	.	.
CD3D	G:186790	.	Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)
CD3E	GP:186830	.	Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)
CD3EAP	G:107325	.	.
CD3G	GP:186740	.	.
CD4	G:186940	.	OKT4 epitope deficiency, 613949 (3)
CD40	G:109535	.	Immunodeficiency with hyper-IgM, type 3, 606843 (3)
CD40LG	G:300386	Bell>immunodeficiency	Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)
CD44	G:107269	.	[Blood group, Indian system] (3)
CD46	G:120920	+GR-Bell	{Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922 (3)
CD47	G:601028	.	.
CD48	G:109530	.	.
CD5	G:153340	.	.
CD52	G:114280	.	.
CD53	G:151525	.	.
CD55	G:125240	.	[Blood group Cromer], 613793 (3)
CD58	G:153420	.	.
CD59	G:107271	.	CD59 deficiency, 612300 (3)
CD5L	G:602592	.	.
CD6	G:186720	.	.
CD63	G:155740	.	.
CD68	G:153634	.	.
CD69	G:107273	.	.
CD7	G:186820	.	.
CD70	G:602840	.	.
CD72	G:107272	.	.
CD74	G:142790	.	.
CD79A	G:112205	.	Agammaglobulinemia 3, 613501 (3)
CD79B	G:147245	.	Agammaglobulinemia 6, 612692 (3)
CD80	G:112203	.	.
CD81	G:186845	.	Immunodeficiency, common variable, 6, 613496 (3)
CD82	G:600623	.	.
CD83	G:604534	.	.
CD84	G:604513	.	.
CD86	G:601020	.	.
CD8A	G:186910	.	CD8 deficiency, familial, 608957 (3)
CD8B	G:186730	.	.
CD9	G:143030	.	.
CD93	G:120577	.	.
CD96	G:606037	Bell>developmental	C syndrome, 211750 (3)
CD96	G:606037	Bell>developmental	C syndrome, 211750 (3)
CD97	G:601211	.	.
CD99	G:313470	.	.
CD99	G:450000	.	.
CD99L2	G:300846	.	.
CDA	G:123920	.	.
CDAN1	G:607465	+GR-Bell	Anemia, congenital dyserythropoietic, type I, 224120 (3)
CDAN3	P:105600	.	.
CDB2	P:602082	.	.
CDC14A	G:603504	.	.
CDC14B	G:603505	.	.
CDC16	G:603461	.	.
CDC20	G:603618	.	.
CDC23	G:603462	.	.
CDC25A	G:116947	.	.
CDC25B	G:116949	.	.
CDC25C	G:157680	.	.
CDC26	G:614533	.	.
CDC27	G:116946	.	.
CDC34	G:116948	.	.
CDC37	G:605065	.	.
CDC37L1	G:610346	.	.
CDC40	G:605585	.	.
CDC42	G:116952	.	.
CDC42BPA	G:603412	.	.
CDC42BPB	G:614062	.	.
CDC42BPG	G:613991	.	.
CDC42EP1	G:606084	.	.
CDC42EP2	G:606132	.	.
CDC42EP3	G:606133	.	.
CDC42EP4	G:605468	.	.
CDC42EP5	G:609171	.	.
CDC45	G:603465	.	.
CDC5L	G:602868	.	.
CDC6	G:602627	.	Meier-Gorlin syndrome 5, 613805 (3)
CDC7	G:603311	.	.
CDC73	G:607393	.	Hyperparathyroidism, familial primary, 145000 (3)
CDC73	G:607393	.	Hyperparathyroidism-jaw tumor syndrome, 145001 (3)
CDC73	G:607393	.	Parathyroid adenoma with cystic changes, 145001 (3)
CDC73	G:607393	.	Parathyroid carcinoma, 608266 (3)
CDCA3	G:607749	.	.
CDCA4	G:612270	.	.
CDCA5	G:609374	.	.
CDCA7	G:609937	.	.
CDCA7L	G:609685	.	.
CDCA8	G:609977	.	.
CDCP1	G:611735	.	.
CDCP2	G:612320	.	.
CDH1	G:192090	+GR-Bell	Endometrial carcinoma, somatic, 608089 (3)
CDH1	G:192090	+GR-Bell	Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3)
CDH1	G:192090	+GR-Bell	Ovarian carcinoma, somatic, 167000 (3)
CDH1	G:192090	+GR-Bell	{Breast cancer, lobular}, 114480 (3)
CDH1	G:192090	+GR-Bell	{Prostate cancer, susceptibility to}, 176807 (3)
CDH10	G:604555	.	.
CDH11	G:600023	.	.
CDH12	G:600562	.	.
CDH13	G:601364	.	.
CDH15	G:114019	.	Mental retardation, autosomal dominant 3, 612580 (3)
CDH16	G:603118	.	.
CDH17	G:603017	.	.
CDH18	G:603019	.	.
CDH19	G:603016	.	.
CDH2	G:114020	.	.
CDH20	G:605807	.	.
CDH22	G:609920	.	.
CDH23	G:605516	Bell>ocular	Deafness, autosomal recessive 12, 601386 (3)
CDH23	G:605516	Bell>ocular	Usher syndrome, type 1D, 601067 (3)
CDH23	G:605516	Bell>ocular	Usher syndrome, type 1D/F digenic, 601067 (3)
CDH3	G:114021	.	Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)
CDH3	G:114021	.	Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3)
CDH4	G:603006	.	.
CDH5	G:601120	.	.
CDH6	G:603007	.	.
CDH7	G:605806	.	.
CDH8	G:603008	.	.
CDH9	G:609974	.	.
CDHR1	G:609502	.	Cone-rod dystrophy 15, 613660 (3)
CDHR5	G:606839	.	.
CDIPT	G:605893	.	.
CDK1	G:116940	.	.
CDK10	G:603464	.	.
CDK11A	G:116951	.	.
CDK11B	G:176873	.	.
CDK13	G:603309	.	.
CDK14	G:610679	.	.
CDK16	G:311550	.	.
CDK17	G:603440	.	.
CDK18	G:169190	.	.
CDK2	G:116953	.	.
CDK20	G:610076	.	.
CDK2AP1	G:602198	.	.
CDK3	G:123828	.	.
CDK4	G:123829	.	{Melanoma, cutaneous malignant, 3}, 609048 (3)
CDK5	G:123831	.	.
CDK5R1	G:603460	.	.
CDK5R2	G:603764	.	.
CDK5RAP1	G:608200	.	.
CDK5RAP2	G:608201	+GR-Bell	Microcephaly, primary autosomal recessive, 3, 604804 (3)
CDK5RAP3	G:608202	.	.
CDK6	G:603368	.	.
CDK7	G:601955	.	.
CDK8	G:603184	.	.
CDK9	G:603251	.	.
CDKAL1	G:611259	.	{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)
CDKL1	G:603441	.	.
CDKL2	G:603442	.	.
CDKL3	G:608459	.	.
CDKL5	G:300203	Bell>neurological	Angelman syndrome-like, 105830 (3)
CDKL5	G:300203	Bell>neurological	Epileptic encephalopathy, early infantile, 2, 300672 (3)
CDKN1A	G:116899	.	.
CDKN1B	G:600778	.	Multiple endocrine neoplasia, type IV, 610755 (3)
CDKN1C	G:600856	+GR-Bell	Beckwith-Wiedemann syndrome, 130650 (3)
CDKN2A	G:600160	.	Li-Fraumeni syndrome, 151623 (3)
CDKN2A	G:600160	.	Melanoma and neural system tumor syndrome, 155755 (3)
CDKN2A	G:600160	.	Orolaryngeal cancer, multiple, (3)
CDKN2A	G:600160	.	Pancreatic cancer/melanoma syndrome, 606719 (3)
CDKN2A	G:600160	.	{Melanoma, cutaneous malignant, 2}, 155601 (3)
CDKN2B	G:600431	.	.
CDKN2B-AS1	G:613149	.	.
CDKN2C	G:603369	.	.
CDKN2D	G:600927	.	.
CDKN3	G:123832	.	.
CDNF	G:611233	.	.
CDO1	G:603943	.	.
CDON	G:608707	.	Holoprosencephaly 11, 614226 (3)
CDR1	G:302650	.	.
CDR2	G:117340	.	.
CDRT1	G:604596	.	.
CDS1	G:603548	.	.
CDS2	G:603549	.	.
CDSN	G:602593	.	Hypotrichosis simplex of scalp 1, 146520 (3)
CDSN	G:602593	.	Peeling skin syndrome, 270300 (3)
CDT1	G:605525	.	Meier-Gorlin syndrome 4, 613804 (3)
CDX1	G:600746	.	.
CDX2	G:600297	.	.
CDX4	G:300025	.	.
CDY1	G:400016	.	.
CDY2A	G:400018	.	.
CDYL	G:603778	.	.
CEACAM1	G:109770	.	.
CEACAM19	G:606691	.	.
CEACAM3	G:609142	.	.
CEACAM5	G:114890	.	.
CEACAM6	G:163980	.	.
CEBPA	G:116897	.	Leukemia, acute myeloid, 601626 (3)
CEBPB	G:189965	.	.
CEBPD	G:116898	.	.
CEBPE	G:600749	.	Specific granule deficiency, 245480 (3)
CEBPG	P:138972	.	.
CEBPZ	G:612828	.	.
CECR	P:115470	.	.
CECR1	G:607575	.	.
CECR2	G:607576	.	.
CEL	G:114840	.	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CELA1	G:130120	.	.
CELA2A	G:609443	.	.
CELA2B	G:609444	.	.
CELF1	G:601074	.	.
CELF2	G:602538	.	.
CELF3	G:612678	.	.
CELF4	G:612679	.	.
CELF5	G:612680	.	.
CELF6	G:612681	.	.
CELIAC2	P:609754	.	.
CELSR1	G:604523	.	.
CELSR2	G:604265	.	.
CELSR3	G:604264	.	.
CEMP1	G:611113	.	.
CEND1	G:608213	.	.
CENPA	G:117139	.	.
CENPB	G:117140	.	.
CENPC1	G:117141	.	.
CENPE	G:117143	.	.
CENPF	G:600236	.	.
CENPH	G:605607	.	.
CENPI	G:300065	.	.
CENPJ	G:609279	+GR-Bell	Microcephaly, primary autosomal recessive, 6, 608393 (3)
CENPJ	G:609279	+GR-Bell	Seckel syndrome 4, 613676 (3)
CENPK	G:611502	.	.
CENPL	G:611503	.	.
CENPM	G:610152	.	.
CENPN	G:611509	.	.
CENPO	G:611504	.	.
CENPP	G:611505	.	.
CENPQ	G:611506	.	.
CENPT	G:611510	.	.
CENPV	G:608139	.	.
CENPW	G:611264	.	.
CEP120	G:613446	.	.
CEP135	G:611423	.	.
CEP152	G:613529	+GR-Bell	Microcephaly, primary autosomal recessive, 4, 604321 (3)
CEP152	G:613529	+GR-Bell	Seckel syndrome 5, 613823 (3)
CEP170	G:613023	.	.
CEP250	G:609689	.	.
CEP290	G:610142	Bell>neurological	Bardet-Biedl syndrome 14, 209900 (3)
CEP290	G:610142	Bell>neurological	Joubert syndrome 5, 610188 (3)
CEP290	G:610142	Bell>neurological	Leber congenital amaurosis 10, 611755 (3)
CEP290	G:610142	Bell>neurological	Meckel syndrome type 4, 611134 (3)
CEP290	G:610142	Bell>neurological	Senior-Loken syndrome 6, 610189 (3)
CEP41	G:610523	.	Joubert syndrome 15, 614464 (3)
CEP55	G:610000	.	.
CEP57	G:607951	.	Mosaic variegated aneuploidy syndrome 2, 614114 (3)
CEP70	G:614310	.	.
CER1	G:603777	.	.
CERK	G:610307	.	.
CERKL	G:608381	+GR-Bell	Retinitis pigmentosa 26, 608380 (3)
CERS1	G:606919	.	.
CERS2	G:606920	.	.
CES1	GP:114835	.	.
CES2	G:605278	.	.
CES3	G:605279	.	.
CETN1	G:603187	.	.
CETN2	G:300006	.	.
CETN3	G:602907	.	.
CETP	G:118470	.	Hyperalphalipoproteinemia, 143470 (3)
CETP	G:118470	.	[High density lipoprotein cholesterol level QTL 10], 143470 (3)
CFB	GP:138470	+GR-Bell	{Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3)
CFB	GP:138470	+GR-Bell	{Macular degeneration, age-related, reduced risk of}, 603075 (3)
CFC1	G:605194	.	Double-outlet right ventricle, 217095 (3)
CFC1	G:605194	.	Heterotaxy, visceral, 2, autosomal, 605376 (3)
CFC1	G:605194	.	Transposition of the great arteries, dextro-looped 2, 613853 (3)
CFD	G:134350	.	Complement factor D deficiency, 613912 (3)
CFDP1	G:608108	.	.
CFH	G:134370	+GR-Bell	Basal laminar drusen, 126700 (3)
CFH	G:134370	+GR-Bell	Complement factor H deficiency, 609814 (3)
CFH	G:134370	+GR-Bell	{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3)
CFH	G:134370	+GR-Bell	{Macular degeneration, age-related, 4}, 610698 (3)
CFHR1	G:134371	+GR-Bell	{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)
CFHR1	G:134371	+GR-Bell	{Macular degeneration, age-related, reduced risk of}, 603075 (3)
CFHR2	G:600889	.	.
CFHR3	G:605336	+GR-Bell	{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)
CFHR3	G:605336	+GR-Bell	{Macular degeneration, age-related, reduced risk of}, 603075 (3)
CFHR4	G:605337	.	.
CFHR5	G:608593	.	.
CFI	G:217030	+GR-Bell	Complement factor I deficiency, 610984 (3)
CFI	G:217030	+GR-Bell	{Hemolytic uremic syndrome, atypical, susceptibility to, 3}, 612923 (3)
CFL1	G:601442	.	.
CFL2	G:601443	+GR-Bell	Nemaline myopathy 7, 610687 (3)
CFLAR	G:603599	.	.
CFM1	P:603855	.	.
CFP	G:300383	Bell>immunodeficiency	Properdin deficiency, X-linked, 312060 (3)
CFTR	G:602421	Bell>respiratory	Congenital bilateral absence of vas deferens, 277180 (3)
CFTR	G:602421	Bell>respiratory	Cystic fibrosis, 219700 (3)
CFTR	G:602421	Bell>respiratory	{Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3)
CFTR	G:602421	Bell>respiratory	{Hypertrypsinemia, neonatal} (3)
CFTR	G:602421	Bell>respiratory	{Pancreatitis, idiopathic}, 167800 (3)
CGA	G:118850	.	.
CGB	G:118860	.	.
CGB1	G:608823	.	.
CGB2	G:608824	.	.
CGB5	G:608825	.	.
CGB7	G:608826	.	.
CGB8	G:608827	.	.
CGF1	P:300082	.	.
CGGBP1	G:603363	.	.
CGN	G:609473	.	.
CGNL1	G:607856	.	.
CGREF1	G:606137	.	.
CGRRF1	G:606138	.	.
CH25H	G:604551	.	.
CHAD	G:602178	.	.
CHAF1A	G:601246	.	.
CHAF1B	G:601245	.	.
CHAT	G:118490	+GR-Bell	Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CHCHD1	G:608842	.	.
CHCHD3	G:613748	.	.
CHCHD4	G:611077	.	.
CHCHD7	G:611238	.	.
CHCHD8	G:608016	.	.
CHD1	G:602118	.	.
CHD1L	G:613039	.	.
CHD2	G:602119	.	.
CHD3	G:602120	.	.
CHD4	G:603277	.	.
CHD5	G:610771	.	.
CHD7	G:608892	+GR-Bell	CHARGE syndrome, 214800 (3)
CHD7	G:608892	+GR-Bell	Hypogonadotropic hypogonadism, 146110 (3)
CHD7	G:608892	+GR-Bell	Kallmann syndrome 5, 612370 (3)
CHD7	G:608892	+GR-Bell	{Scoliosis, idiopathic 3}, 608765 (3)
CHD8	G:610528	.	.
CHE2	G:177500	.	.
CHED1	P:121700	.	.
CHEK1	G:603078	.	.
CHEK2	GP:604373	.	Li-Fraumeni syndrome, 609265 (3)
CHEK2	GP:604373	.	Osteosarcoma, somatic, 259500 (3)
CHEK2	GP:604373	.	{Breast and colorectal cancer, susceptibility to} (3)
CHEK2	GP:604373	.	{Breast cancer, susceptibility to}, 114480 (3)
CHEK2	GP:604373	.	{Prostate cancer, familial, susceptibility to}, 176807 (3)
CHFR	G:605209	.	.
CHGA	G:118910	.	.
CHGB	G:118920	.	.
CHI3L1	G:601525	.	{Asthma-related traits, susceptibility to, 7}, 611960 (3)
CHI3L1	G:601525	.	{Schizophrenia, susceptibility to}, 181500 (3)
CHI3L2	G:601526	.	.
CHIA	G:606080	.	.
CHIC2	G:604332	.	{Leukemia, acute myeloid}, 601626 (3)
CHIT1	G:600031	.	[Chitotriosidase deficiency], 614122 (3)
CHKA	G:118491	.	.
CHKB	G:612395	.	Muscular dystrophy, congenital, megaconial type, 602541 (3)
CHL1	G:607416	.	.
CHM	G:300390	Bell>ocular	Choroideremia, 303100 (3)
CHML	G:118825	.	.
CHMP1A	G:164010	.	.
CHMP1B	G:606486	.	.
CHMP2A	G:610893	.	.
CHMP2B	GP:609512	+GR-Bell	Amyotrophic lateral sclerosis, CHMP2B-related (3)
CHMP2B	GP:609512	+GR-Bell	Dementia, familial, nonspecific, 600795 (3)
CHMP3	G:610052	.	.
CHMP4A	G:610051	.	.
CHMP4B	G:610897	.	Cataract, posterior polar, 3, 605387 (3)
CHMP4C	G:610899	.	.
CHMP5	G:610900	.	.
CHMP6	G:610901	.	.
CHMP7	G:611130	.	.
CHN1	G:118423	+GR-Bell	Duane retraction syndrome 2, 604356 (3)
CHN2	G:602857	.	.
CHODL	G:607247	.	.
CHORDC1	G:604353	.	.
CHPF	G:610405	.	.
CHPF2	G:608037	.	.
CHR	P:118840	.	.
CHRAC1	G:607268	.	.
CHRD	G:603475	.	.
CHRDL1	G:300350	.	.
CHRDL2	G:613127	.	.
CHRFAM7A	G:609756	.	.
CHRM1	G:118510	.	.
CHRM2	G:118493	.	.
CHRM3	G:118494	.	Eagle-Barrett syndrome, 100100 (3)
CHRM4	G:118495	.	.
CHRM5	G:118496	.	.
CHRNA1	G:100690	Bell>developmental	Multiple pterygium syndrome, lethal type, 253290 (3)
CHRNA1	G:100690	Bell>developmental	Myasthenic syndrome, fast-channel congenital, 608930 (3)
CHRNA1	G:100690	Bell>developmental	Myasthenic syndrome, slow-channel congenital, 601462 (3)
CHRNA10	G:606372	.	.
CHRNA2	G:118502	+GR-Bell	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)
CHRNA3	G:118503	.	{Lung cancer susceptibility 2}, 612052 (3)
CHRNA4	G:118504	+GR-Bell	Epilepsy, nocturnal frontal lobe, 1, 600513 (3)
CHRNA4	G:118504	+GR-Bell	{Nicotine addiction, susceptibility to}, 188890 (3)
CHRNA5	G:118505	.	{Lung cancer susceptibility 2}, 612052 (3)
CHRNA6	G:606888	.	.
CHRNA7	G:118511	.	.
CHRNA9	G:605116	.	.
CHRNB1	G:100710	.	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)
CHRNB1	G:100710	.	Myasthenic syndrome, slow-channel congenital, 601462 (3)
CHRNB2	G:118507	+GR-Bell	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
CHRNB3	G:118508	.	.
CHRNB4	G:118509	.	.
CHRND	G:100720	Bell>developmental	Multiple pterygium syndrome, lethal type, 253290 (3)
CHRND	G:100720	Bell>developmental	Myasthenic syndrome, fast-channel congenital, 608930 (3)
CHRND	G:100720	Bell>developmental	Myasthenic syndrome, slow-channel congenital, 601462 (3)
CHRNE	G:100725	.	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)
CHRNE	G:100725	.	Myasthenic syndrome, fast-channel congenital, 608930 (3)
CHRNE	G:100725	.	Myasthenic syndrome, slow-channel congenital, 601462 (3)
CHRNG	G:100730	Bell>developmental	Escobar syndrome, 265000 (3)
CHRNG	G:100730	Bell>developmental	Escobar syndrome, 265000 (3)
CHRNG	G:100730	Bell>developmental	Multiple pterygium syndrome, lethal type, 253290 (3)
CHRNG	G:100730	Bell>developmental	Multiple pterygium syndrome, lethal type, 253290 (3)
CHST1	G:603797	.	.
CHST10	G:606376	.	.
CHST11	G:610128	.	.
CHST12	G:610129	.	.
CHST13	G:610124	.	.
CHST14	G:608429	.	Ehlers-Danlos syndrome, musculocontractural type , 601776 (3)
CHST15	G:608277	.	.
CHST2	G:603798	.	.
CHST3	G:603799	+GR-Bell	Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3)
CHST5	G:604817	.	.
CHST6	G:605294	.	Macular corneal dystrophy, 217800 (3)
CHST7	G:300375	.	.
CHST8	G:610190	.	.
CHST9	G:610191	.	.
CHSY1	G:608183	.	Temtamy preaxial brachydactyly syndrome, 605282 (3)
CHSY3	G:609963	.	.
CHTF18	G:613201	.	.
CHTF8	G:613202	.	.
CHTOP	G:614206	.	.
CHUK	G:600664	.	Cocoon syndrome, 613630 (3)
CHURC1	G:608577	.	.
CIAO1	G:604333	.	.
CIAPIN1	G:608943	.	.
CIB1	G:602293	.	.
CIB2	G:605564	.	.
CIB3	G:610645	.	.
CIB4	G:610646	.	.
CIC	G:612082	.	.
CIDEA	G:604440	.	.
CIDEB	G:604441	.	.
CIDEC	G:612120	.	.
CIITA	G:600005	.	Bare lymphocyte syndrome, type II, complementation group A, 209920 (3)
CIITA	G:600005	.	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CILD2	P:606763	.	.
CILP	G:603489	.	{Lumbar disc disease, susceptibility to}, 603932 (3)
CILP2	G:612419	.	.
CINP	G:613362	.	.
CIR1	G:605228	.	.
CIRBP	G:602649	.	.
CIRH1A	G:607456	.	Cirrhosis, North American Indian childhood type, 604901 (3)
CISD1	G:611932	.	.
CISD2	G:611507	.	Wolfram syndrome 2, 604928 (3)
CISD3	G:611933	.	.
CISH	G:602441	.	{Bacteremia, susceptibility to}, 614383 (3)
CISH	G:602441	.	{Malaria, susceptibility to}, 611162 (3)
CISH	G:602441	.	{Tuberculosis, susceptibility to}, 607948 (3)
CIT	G:605629	.	.
CITED1	G:300149	.	.
CITED2	G:602937	.	Atrial septal defect 8, 614433 (3)
CITED2	G:602937	.	Ventricular septal defect 2, 614431 (3)
CITED4	G:606815	.	.
CIZ1	G:611420	.	.
CKAP2	G:611569	.	.
CKAP5	G:611142	.	.
CKB	G:123280	.	.
CKBE	P:123270	.	.
CKM	G:123310	.	.
CKMT1A	G:613415	.	.
CKMT1B	G:123290	.	.
CKMT2	G:123295	.	.
CKS1B	G:116900	.	.
CKS2	G:116901	.	.
CLA3	P:608029	.	.
CLAM	P:608027	.	.
CLASP1	G:605852	.	.
CLASP2	G:605853	.	.
CLC	G:153310	.	.
CLCA1	G:603906	.	.
CLCA2	G:604003	.	.
CLCA3P	G:604337	.	.
CLCF1	G:607672	+GR-Bell	Cold-induced sweating syndrome 1, 610313 (3)
CLCN1	G:118425	+GR-Bell	Myotonia congenita, dominant, 160800 (3)
CLCN1	G:118425	+GR-Bell	Myotonia congenita, recessive, 255700 (3)
CLCN1	G:118425	+GR-Bell	Myotonia levior, recessive (3)
CLCN2	G:600570	.	{Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3)
CLCN2	G:600570	.	{Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3)
CLCN2	G:600570	.	{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3)
CLCN3	G:600580	.	.
CLCN4	G:302910	.	.
CLCN5	G:300008	.	Dent disease, 300009 (3)
CLCN5	G:300008	.	Hypophosphatemic rickets, 300554 (3)
CLCN5	G:300008	.	Nephrolithiasis, type I, 310468 (3)
CLCN5	G:300008	.	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)
CLCN6	G:602726	.	.
CLCN7	G:602727	+GR-Bell	Osteopetrosis, autosomal dominant 2, 166600 (3)
CLCN7	G:602727	+GR-Bell	Osteopetrosis, autosomal recessive 4, 611490 (3)
CLCNKA	G:602024	.	Bartter syndrome, type 4b, digenic, 613090 (3)
CLCNKB	G:602023	.	Bartter syndrome, type 3, 607364 (3)
CLCNKB	G:602023	.	Bartter syndrome, type 4, digenic, 602522 (3)
CLDN1	G:603718	Bell>cutaneous	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3)
CLDN11	G:601326	.	.
CLDN12	G:611232	.	.
CLDN14	G:605608	.	Deafness, autosomal recessive 29, 614035 (3)
CLDN16	G:603959	.	Hypomagnesemia 3, renal, 248250 (3)
CLDN18	G:609210	.	.
CLDN19	G:610036	Bell>renal	Hypomagnesemia 5, renal, with ocular involvement, 248190 (3)
CLDN2	G:300520	.	.
CLDN23	G:609203	.	.
CLDN3	G:602910	.	.
CLDN4	G:602909	.	.
CLDN5	G:602101	.	.
CLDN7	G:609131	.	.
CLDN8	G:611231	.	.
CLEC10A	G:605999	.	.
CLEC11A	G:604713	.	.
CLEC12A	G:612088	.	.
CLEC16A	G:611303	.	.
CLEC1A	G:606782	.	.
CLEC1B	G:606783	.	.
CLEC2A	G:612087	.	.
CLEC2B	G:603242	.	.
CLEC2D	G:605659	.	.
CLEC3A	G:613588	.	.
CLEC3B	G:187520	.	.
CLEC4A	G:605306	.	.
CLEC4C	G:606677	.	.
CLEC4D	G:609964	.	.
CLEC4E	G:609962	.	.
CLEC4M	G:605872	.	.
CLEC5A	G:604987	.	.
CLEC6A	G:613579	.	.
CLEC7A	G:606264	.	Candidiasis, familial, 4, autosomal dominant, 613108 (3)
CLEC7A	G:606264	.	{Aspergillosis, susceptibility to}, 614079 (3)
CLEC9A	G:612252	.	.
CLECL1	G:607467	.	.
CLGN	G:601858	.	.
CLIC1	G:602872	.	.
CLIC2	G:300138	.	.
CLIC3	G:606533	.	.
CLIC4	G:606536	.	.
CLIC5	G:607293	.	.
CLINT1	G:607265	.	.
CLIP1	G:179838	.	.
CLIP2	G:603432	.	.
CLIP3	G:607382	.	.
CLK1	G:601951	.	.
CLK2	G:602989	.	.
CLK3	G:602990	.	.
CLK4	G:607969	.	.
CLMN	G:611121	.	.
CLMP	G:611693	.	.
CLN3	G:607042	Bell>neurological	Ceroid lipofuscinosis, neuronal, 3, 204200 (3)
CLN5	G:608102	Bell>neurological	Ceroid lipofuscinosis, neuronal, 5, 256731 (3)
CLN6	G:606725	Bell>neurological	Ceroid lipofuscinosis, neuronal, 6, 601780 (3)
CLN6	G:606725	Bell>neurological	Ceroid lipofuscinosis, neuronal, Kufs type, adult onset, 204300 (3)
CLN8	G:607837	Bell>neurological	Ceroid lipofuscinosis, neuronal, 8, 600143 (3)
CLN8	G:607837	Bell>neurological	Ceroid lipofuscinosis, neuronal, 8, 600143 (3)
CLN8	G:607837	Bell>neurological	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3)
CLN8	G:607837	Bell>neurological	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3)
CLN9	P:609055	.	.
CLNK	G:611434	.	.
CLNS1A	G:602158	.	.
CLOCK	G:601851	.	.
CLP1	G:608757	.	.
CLPP	G:601119	.	.
CLPS	G:120105	.	.
CLPTM1	G:604783	.	.
CLPTM1L	G:612585	.	.
CLRN1	G:606397	Bell>ocular	Retinitis pigmentosa 61, 614180 (3)
CLRN1	G:606397	Bell>ocular	Usher syndrome, type 3A, 276902 (3)
CLSPN	G:605434	.	.
CLSTN1	G:611321	.	.
CLSTN2	G:611323	.	.
CLSTN3	G:611324	.	.
CLTA	G:118960	.	.
CLTB	G:118970	.	.
CLTC	G:118955	.	.
CLTCL1	G:601273	.	.
CLU	G:185430	.	.
CLVS1	G:611292	.	.
CLYBL	G:609686	.	.
CMA1	G:118938	.	.
CMAHP	P:603209	.	.
CMAS	G:603316	.	.
CMBL	G:613379	.	.
CMD1B	P:600884	.	.
CMD1C	P:601493	.	.
CMD1H	P:604288	.	.
CMD1K	P:605582	.	.
CMD1Q	P:609915	.	.
CMIP	G:610112	.	.
CMKLR1	G:602351	.	.
CMM	P:155600	.	.
CMPK1	G:191710	.	.
CMPK2	G:611787	.	.
CMTM1	G:607884	.	.
CMTM2	G:607885	.	.
CMTM3	G:607886	.	.
CMTM4	G:607887	.	.
CMTM5	G:607888	.	.
CMTM6	G:607889	.	.
CMTM7	G:607890	.	.
CMTM8	G:607891	.	.
CMTX2	P:302801	.	.
CMTX3	P:302802	.	.
CMYA5	G:612193	.	.
CNA1	P:121400	.	.
CNBP	G:116955	.	Myotonic dystrophy 2, 602668 (3)
CNC	P:605244	.	.
CNDP1	G:609064	.	.
CNDP2	G:169800	.	.
CNFN	G:611764	.	.
CNGA1	G:123825	+GR-Bell	Retinitis pigmentosa 49, 613756 (3)
CNGA2	G:300338	.	.
CNGA3	G:600053	+GR-Bell	Achromatopsia-2, 216900 (3)
CNGA4	G:609472	.	.
CNGB1	G:600724	+GR-Bell	Retinitis pigmentosa 45, 613767 (3)
CNGB3	G:605080	Bell>ocular	Achromatopsia-3, 262300 (3)
CNGB3	G:605080	Bell>ocular	Macular degeneration, juvenile, 248200 (3)
CNIH	G:611287	.	.
CNIH2	G:611288	.	.
CNKSR1	G:603272	.	.
CNKSR2	G:300724	.	.
CNN1	G:600806	.	.
CNN2	G:602373	.	.
CNN3	G:602374	.	.
CNNM1	G:607802	.	.
CNNM2	G:607803	.	Hypomagnesemia 6, renal, 613882 (3)
CNNM3	G:607804	.	.
CNNM4	G:607805	.	Jalili syndrome, 217080 (3)
CNO	G:605695	.	.
CNOT1	G:604917	.	.
CNOT2	G:604909	.	.
CNOT3	G:604910	.	.
CNOT4	G:604911	.	.
CNOT6	G:608951	.	.
CNOT7	G:604913	.	.
CNOT8	G:603731	.	.
CNP	G:123830	.	.
CNPY1	G:612493	.	.
CNPY2	G:605861	.	.
CNPY3	G:610774	.	.
CNPY4	G:610047	.	.
CNR1	G:114610	.	.
CNR2	G:605051	.	.
CNST	G:613439	.	.
CNTF	G:118945	.	.
CNTFR	G:118946	.	.
CNTLN	G:611870	.	.
CNTN1	G:600016	.	Myopathy, congenital, Compton-North, 612540 (3)
CNTN2	G:190197	.	.
CNTN3	G:601325	.	.
CNTN4	G:607280	.	.
CNTN5	G:607219	.	.
CNTN6	G:607220	.	.
CNTNAP1	G:602346	.	.
CNTNAP2	G:604569	.	Cortical dysplasia-focal epilepsy syndrome, 610042 (3)
CNTNAP2	G:604569	.	Pitt-Hopkins like syndrome 1, 610042 (3)
CNTNAP2	G:604569	.	{Autism susceptibility 15}, 612100 (3)
CNTNAP3	G:610517	.	.
CNTNAP4	G:610518	.	.
CNTNAP5	G:610519	.	.
CNTRL	G:605496	.	.
CNTROB	G:611425	.	.
COA5	G:613920	.	Mitochondrial complex IV deficiency, 220110 (3)
COASY	G:609855	.	.
COBL	G:610317	.	.
COBLL1	G:610318	.	.
COBRA1	G:611180	.	.
COCH	G:603196	.	Deafness, autosomal dominant 9, 601369 (3)
COD2	P:300085	.	.
COG1	G:606973	+GR-Bell	Congenital disorder of glycosylation, type IIg, 611209 (3)
COG2	G:606974	.	.
COG3	G:606975	.	.
COG4	G:606976	+GR-Bell	Congenital disorder of glycosylation, type IIj, 613489 (3)
COG5	G:606821	+GR-Bell	Congenital disorder of glycosylation, type IIi, 613612 (3)
COG6	G:606977	.	.
COG7	G:606978	+GR-Bell	Congenital disorder of glycosylation, type IIe, 608779 (3)
COG8	G:606979	+GR-Bell	Congenital disorder of glycosylation, type IIh, 611182 (3)
COIL	G:600272	.	.
COL10A1	G:120110	.	Metaphyseal chondrodysplasia, Schmid type, 156500 (3)
COL11A1	G:120280	+GR-Bell	Fibrochondrogenesis, 228520 (3)
COL11A1	G:120280	+GR-Bell	Marshall syndrome, 154780 (3)
COL11A1	G:120280	+GR-Bell	Stickler syndrome, type II, 604841 (3)
COL11A1	G:120280	+GR-Bell	{Lumbar disc herniation, susceptibility to}, 603932 (3)
COL11A2	G:120290	Bell>skeletal	Deafness, autosomal dominant 13, 601868 (3)
COL11A2	G:120290	Bell>skeletal	Deafness, autosomal recessive 53, 609706 (3)
COL11A2	G:120290	Bell>skeletal	Fibrochondrogenesis 2, 614524 (3)
COL11A2	G:120290	Bell>skeletal	Otospondylomegaepiphyseal dysplasia, 215150 (3)
COL11A2	G:120290	Bell>skeletal	Stickler syndrome, type III, 184840 (3)
COL11A2	G:120290	Bell>skeletal	Weissenbacher-Zweymuller syndrome, 277610 (3)
COL12A1	G:120320	.	.
COL13A1	G:120350	.	.
COL14A1	G:120324	.	.
COL15A1	G:120325	.	.
COL16A1	G:120326	.	.
COL17A1	G:113811	Bell>cutaneous	Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)
COL18A1	G:120328	.	Knobloch syndrome, type 1, 267750 (3)
COL19A1	G:120165	.	.
COL1A1	GP:120150	+GR-Bell	Caffey disease, 114000 (3)
COL1A1	GP:120150	+GR-Bell	Ehlers-Danlos syndrome, type I, 130000 (3)
COL1A1	GP:120150	+GR-Bell	Ehlers-Danlos syndrome, type VIIA, 130060 (3)
COL1A1	GP:120150	+GR-Bell	OI type II, 166210 (3)
COL1A1	GP:120150	+GR-Bell	OI type III, 259420 (3)
COL1A1	GP:120150	+GR-Bell	OI type IV, 166220 (3)
COL1A1	GP:120150	+GR-Bell	Osteogenesis imperfecta, type I, 166200 (3)
COL1A1	GP:120150	+GR-Bell	{Osteoporosis}, 166710 (3)
COL1A2	G:120160	Bell>cutaneous	Ehlers-Danlos syndrome, cardiac valvular form, 225320 (3)
COL1A2	G:120160	Bell>cutaneous	Ehlers-Danlos syndrome, type VIIB, 130060 (3)
COL1A2	G:120160	Bell>cutaneous	Osteogenesis imperfecta, type II, 166210 (3)
COL1A2	G:120160	Bell>cutaneous	Osteogenesis imperfecta, type III, 259420 (3)
COL1A2	G:120160	Bell>cutaneous	Osteogenesis imperfecta, type IV, 166220 (3)
COL1A2	G:120160	Bell>cutaneous	{Osteoporosis, postmenopausal}, 166710 (3)
COL1AR	G:120340	.	.
COL21A1	G:610002	.	.
COL22A1	G:610026	.	.
COL23A1	G:610043	.	.
COL24A1	G:610025	.	.
COL25A1	G:610004	.	.
COL27A1	G:608461	.	.
COL28A1	G:609996	.	.
COL2A1	GP:120140	Bell>skeletal	Achondrogenesis, type II or hypochondrogenesis, 200610 (3)
COL2A1	GP:120140	Bell>skeletal	Avascular necrosis of the femoral head, 608805 (3)
COL2A1	GP:120140	Bell>skeletal	Epiphyseal dysplasia, multiple, with myopia and deafness, 132450 (3)
COL2A1	GP:120140	Bell>skeletal	Kniest dysplasia, 156550 (3)
COL2A1	GP:120140	Bell>skeletal	Legg-Calve-Perthes disease, 150600 (3)
COL2A1	GP:120140	Bell>skeletal	Osteoarthritis with mild chondrodysplasia, 604864 (3)
COL2A1	GP:120140	Bell>skeletal	Otospondylomegaepiphyseal dysplasia, 215150 (3)
COL2A1	GP:120140	Bell>skeletal	Platyspondylic skeletal dysplasia, Torrance type, 151210 (3)
COL2A1	GP:120140	Bell>skeletal	SED congenita, 183900 (3)
COL2A1	GP:120140	Bell>skeletal	SED, Namaqualand type (3)
COL2A1	GP:120140	Bell>skeletal	SMED Strudwick type, 184250 (3)
COL2A1	GP:120140	Bell>skeletal	Spondyloperipheral dysplasia, 271700 (3)
COL2A1	GP:120140	Bell>skeletal	Stickler sydrome, type I, nonsyndromic ocular, 609508 (3)
COL2A1	GP:120140	Bell>skeletal	Stickler syndrome, type I, 108300 (3)
COL3A1	G:120180	+GR-Bell	Ehlers-Danlos syndrome, type III, 130020 (3)
COL3A1	G:120180	+GR-Bell	Ehlers-Danlos syndrome, type IV, 130050 (3)
COL4A1	G:120130	+GR-Bell	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle, 611773 (3)
COL4A1	G:120130	+GR-Bell	Brain small vessel disease with Axenfeld-Rieger anomaly, 607595 (3)
COL4A1	G:120130	+GR-Bell	Brain small vessel disease with hemorrhage, 607595 (3)
COL4A1	G:120130	+GR-Bell	Porencephaly 1, 175780 (3)
COL4A2	G:120090	.	Porencephaly 2, 614483 (3)
COL4A2	G:120090	.	{Stroke, hemorrhagic}, 614519 (3)
COL4A3	G:120070	Bell>renal	Alport syndrome, autosomal recessive, 203780 (3)
COL4A3	G:120070	Bell>renal	Hematuria, benign familial, 141200 (3)
COL4A3BP	G:604677	.	.
COL4A4	G:120131	Bell>renal	Alport syndrome, autosomal recessive, 203780 (3)
COL4A4	G:120131	Bell>renal	Hematuria, familial benign (3)
COL4A5	G:303630	+GR-Bell	Alport syndrome, 301050 (3)
COL4A6	G:303631	.	.
COL5A1	G:120215	+GR-Bell	Ehlers-Danlos syndrome, type I, 130000 (3)
COL5A1	G:120215	+GR-Bell	Ehlers-Danlos syndrome, type II, 130010 (3)
COL5A2	G:120190	+GR-Bell	Ehlers-Danlos syndrome, type I, 130000 (3)
COL5A3	G:120216	.	.
COL6A1	G:120220	+GR-Bell	Bethlem myopathy, 158810 (3)
COL6A1	G:120220	+GR-Bell	Ullrich congenital muscular dystrophy, 254090 (3)
COL6A2	G:120240	+GR-Bell	Bethlem myopathy, 158810 (3)
COL6A2	G:120240	+GR-Bell	Myosclerosis, congenital, 255600 (3)
COL6A2	G:120240	+GR-Bell	Ullrich congenital muscular dystrophy, 254090 (3)
COL6A3	G:120250	+GR-Bell	Bethlem myopathy, 158810 (3)
COL6A3	G:120250	+GR-Bell	Ullrich congenital muscular dystrophy, 254090 (3)
COL6A4P1	G:612397	.	.
COL6A5	G:611916	.	.
COL7A1	G:120120	Bell>cutaneous	EBD inversa, 226600 (3)
COL7A1	G:120120	Bell>cutaneous	EBD, Bart type, 132000 (3)
COL7A1	G:120120	Bell>cutaneous	EBD, localisata variant (3)
COL7A1	G:120120	Bell>cutaneous	Epidermolysis bullosa dystrophica, AD, 131750 (3)
COL7A1	G:120120	Bell>cutaneous	Epidermolysis bullosa dystrophica, AR, 226600 (3)
COL7A1	G:120120	Bell>cutaneous	Epidermolysis bullosa pruriginosa, 604129 (3)
COL7A1	G:120120	Bell>cutaneous	Epidermolysis bullosa, pretibial, 131850 (3)
COL7A1	G:120120	Bell>cutaneous	Toenail dystrophy, isolated, 607523 (3)
COL7A1	G:120120	Bell>cutaneous	Transient bullous of the newborn, 131705 (3)
COL8A1	G:120251	.	.
COL8A2	G:120252	.	Corneal dystrophy polymorphous posterior, 2, 609140 (3)
COL8A2	G:120252	.	Corneal dystrophy, Fuchs endothelial, 1, 136800 (3)
COL9A1	G:120210	+GR-Bell	Epiphyseal dysplasia, multiple, 6, 614135 (3)
COL9A1	G:120210	+GR-Bell	Stickler syndrome, type IV, 614134 (3)
COL9A2	G:120260	+GR-Bell	Epiphyseal dysplasia, multiple, 2, 600204 (3)
COL9A2	G:120260	+GR-Bell	Stickler syndrome, type V, 614284 (3)
COL9A2	G:120260	+GR-Bell	{Intervertebral disc disease, susceptibility to}, 603932 (3)
COL9A3	G:120270	+GR-Bell	Epiphyseal dysplasia, multiple, 3, 600969 (3)
COL9A3	G:120270	+GR-Bell	Epiphyseal dysplasia, multiple, with myopathy (3)
COL9A3	G:120270	+GR-Bell	{Intervertebral disc disease, susceptibility to}, 603932 (3)
COLEC10	G:607620	.	.
COLEC11	G:612502	.	.
COLEC12	G:607621	.	.
COLQ	G:603033	+GR-Bell	Endplate acetylcholinesterase deficiency, 603034 (3)
COMMD1	G:607238	.	.
COMMD5	G:608216	.	.
COMMD6	G:612377	.	.
COMMD9	G:612299	.	.
COMP	G:600310	+GR-Bell	Epiphyseal dysplasia, multiple 1, 132400 (3)
COMP	G:600310	+GR-Bell	Pseudoachondroplasia, 177170 (3)
COMT	GP:116790	.	{Panic disorder, susceptibility to}, 167870 (3)
COMT	GP:116790	.	{Schizophrenia, susceptibility to}, 181500 (3)
COPA	G:601924	.	.
COPB1	G:600959	.	.
COPB2	G:606990	.	.
COPE	G:606942	.	.
COPG2	G:604355	.	.
COPG2IT1	G:610581	.	.
COPS2	G:604508	.	.
COPS3	G:604665	.	.
COPS5	G:604850	.	.
COQ2	G:609825	Bell>neurological	Coenzyme Q10 deficiency, 607426 (3)
COQ3	G:605196	.	.
COQ4	G:612898	.	.
COQ7	G:601683	.	.
COQ9	G:612837	.	Coenzyme Q10 deficiency, 607426 (3)
CORD1	P:600624	.	.
CORD8	P:605549	.	.
CORIN	G:605236	.	.
CORO1A	G:605000	.	.
CORO1B	G:609849	.	.
CORO1C	G:605269	.	.
CORO2A	G:602159	.	.
CORO2B	G:605002	.	.
CORO7	G:611668	.	.
CORT	G:602784	.	.
COTL1	G:606748	.	.
COX10	G:602125	.	Encephalopathy, progressive mitochondrial, with proximal renal tubulopathy due to cytochrome c oxidase deficiency (3)
COX11	G:603648	.	.
COX14	G:614478	.	Mitochondrial complex IV deficiency, 220110 (3)
COX15	G:603646	.	Cardiomyopathy, hypertrophic, early-onset fatal (3)
COX15	G:603646	.	Leigh syndrome due to cytochrome c oxidase deficiency, 256000 (3)
COX17	G:604813	.	.
COX18	G:610428	.	.
COX19	G:610429	.	.
COX4I1	G:123864	.	.
COX4I2	G:607976	.	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, 612714 (3)
COX4NB	G:604886	.	.
COX5A	G:603773	.	.
COX5B	G:123866	.	.
COX6A1	G:602072	.	.
COX6A2	G:602009	.	.
COX6B1	G:124089	.	Cytochrome c oxidase deficiency, 220110 (3)
COX6C	G:124090	.	.
COX7A1	G:123995	.	.
COX7A2	G:123996	.	.
COX7A2L	G:605771	.	.
COX7A2P2	G:123997	.	.
COX7B	G:603792	.	.
COX7B2	G:609811	.	.
COX7C	G:603774	.	.
COX8A	G:123870	.	.
CPA1	G:114850	.	.
CPA2	G:600688	.	.
CPA3	G:114851	.	.
CPA4	G:607635	.	.
CPA5	G:609561	.	.
CPA6	G:609562	.	Epilepsy, familial temporal lobe, 5, 614417 (3)
CPA6	G:609562	.	Febrile seizures, familial, 11, 614418 (3)
CPAMD8	G:608841	.	.
CPAT1	P:605388	.	.
CPB1	G:114852	.	.
CPB2	G:603101	.	.
CPD	G:603102	.	.
CPE	G:114855	.	.
CPEB1	G:607342	.	.
CPEB2	G:610605	.	.
CPEB3	G:610606	.	.
CPEB4	G:610607	.	.
CPLX1	G:605032	.	.
CPLX2	G:605033	.	.
CPLX3	G:609585	.	.
CPLX4	G:609586	.	.
CPM	G:114860	.	.
CPN1	G:603103	.	Carboxypeptidase N deficiency, 212070 (3)
CPN2	G:603104	.	.
CPNE1	G:604205	.	.
CPNE2	G:604206	.	.
CPNE3	G:604207	.	.
CPNE4	G:604208	.	.
CPNE5	G:604209	.	.
CPNE6	G:605688	.	.
CPNE7	G:605689	.	.
CPO	G:609563	.	.
CPOX	G:612732	.	Coproporphyria, 121300 (3)
CPOX	G:612732	.	Harderoporphyria, 121300 (3)
CPS1	GP:608307	Bell>metabolic	Carbamoylphosphate synthetase I deficiency, 237300 (3)
CPS1	GP:608307	Bell>metabolic	{Pulmonary hypertension, familial persistent, of the newborn}, 265380 (3)
CPS1	GP:608307	Bell>respiratory	Carbamoylphosphate synthetase I deficiency, 237300 (3)
CPS1	GP:608307	Bell>respiratory	{Pulmonary hypertension, familial persistent, of the newborn}, 265380 (3)
CPSF1	G:606027	.	.
CPSF2	G:606028	.	.
CPSF3	G:606029	.	.
CPSF3L	G:611354	.	.
CPSF4	G:603052	.	.
CPSF6	G:604979	.	.
CPT1A	G:600528	Bell>metabolic	CPT deficiency, hepatic, type IA, 255120 (3)
CPT1B	G:601987	.	.
CPT1C	G:608846	.	.
CPT2	G:600650	Bell>metabolic	CPT II deficiency, lethal neonatal, 608836 (3)
CPT2	G:600650	Bell>metabolic	CPT II deficiency, lethal neonatal, 608836 (3)
CPT2	G:600650	Bell>metabolic	CPT II deficiency, lethal neonatal, 608836 (3)
CPT2	G:600650	Bell>metabolic	CPT deficiency, hepatic, type II, 600649 (3)
CPT2	G:600650	Bell>metabolic	CPT deficiency, hepatic, type II, 600649 (3)
CPT2	G:600650	Bell>metabolic	CPT deficiency, hepatic, type II, 600649 (3)
CPT2	G:600650	Bell>metabolic	Myopathy due to CPT II deficiency, 255110 (3)
CPT2	G:600650	Bell>metabolic	Myopathy due to CPT II deficiency, 255110 (3)
CPT2	G:600650	Bell>metabolic	Myopathy due to CPT II deficiency, 255110 (3)
CPT2	G:600650	Bell>metabolic	{Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3)
CPT2	G:600650	Bell>metabolic	{Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3)
CPT2	G:600650	Bell>metabolic	{Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3)
CPVL	G:609780	.	.
CPXM1	G:609555	.	.
CPZ	G:603105	.	.
CR1	G:120620	.	[Blood group, Knops system], 607486 (3)
CR1	G:120620	.	{Malaria, severe, resistance to}, 611162 (3)
CR1L	G:605886	.	.
CR2	G:120650	.	{Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3)
CRABP1	G:180230	.	.
CRABP2	G:180231	.	.
CRAC1	P:601228	.	.
CRADD	G:603454	.	Mental retardation, autosomal recessive 34, 614499 (3)
CRAT	G:600184	.	.
CRB1	G:604210	+GR-Bell	Leber congenital amaurosis 8, 613835 (3)
CRB1	G:604210	+GR-Bell	Pigmented paravenous chorioretinal atrophy, 172870 (3)
CRB1	G:604210	+GR-Bell	Retinitis pigmentosa-12, autosomal recessive, 600105 (3)
CRB2	G:609720	.	.
CRB3	G:609737	.	.
CRBN	G:609262	.	Mental retardation, autosomal recessive 2, 607417 (3)
CRCP	G:606121	.	.
CREB1	G:123810	.	Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)
CREB3	G:606443	.	.
CREB3L2	G:608834	.	.
CREB3L3	G:611998	.	.
CREB3L4	G:607138	.	.
CREBBP	G:600140	+GR-Bell	Rubinstein-Taybi syndrome, 180849 (3)
CREBL2	G:603476	.	.
CREBZF	G:606444	.	.
CRELD1	G:607170	.	Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3)
CRELD1	G:607170	.	{Atrioventricular septal defect, susceptibility to, 2}, 606217 (3)
CRELD2	G:607171	.	.
CREM	G:123812	.	.
CRH	G:122560	.	.
CRHBP	G:122559	.	.
CRHR1	G:122561	.	.
CRHR2	G:602034	.	.
CRIM1	G:606189	.	.
CRIP1	G:123875	.	.
CRIP2	G:601183	.	.
CRIPAK	G:610203	.	.
CRIPT	G:604594	.	.
CRISP1	G:601193	.	.
CRISP2	G:187430	.	.
CRISPLD2	G:612434	.	.
CRK	G:164762	.	.
CRKL	G:602007	.	.
CRLF1	G:604237	Bell>developmental	Cold-induced sweating syndrome, 272430 (3)
CRLF1	G:604237	Bell>developmental	Crisponi syndrome, 601378 (3)
CRLF2	G:300357	.	.
CRLF2	G:400023	.	.
CRLS1	G:608188	.	.
CRMP1	G:602462	.	.
CRNKL1	G:610952	.	.
CRNN	G:611312	.	.
CROT	G:606090	.	.
CRP	G:123260	.	.
CRS	P:123100	.	.
CRTAC1	G:606276	.	.
CRTAM	G:612597	.	.
CRTAP	G:605497	Bell>skeletal	Osteogenesis imperfecta, type VII, 610682 (3)
CRTC1	G:607536	.	.
CRTC2	G:608972	.	.
CRTC3	G:608986	.	.
CRX	G:602225	+GR-Bell	Cone-rod retinal dystrophy-2, 120970 (3)
CRX	G:602225	+GR-Bell	Leber congenital amaurosis 7, 613829 (3)
CRY1	G:601933	.	.
CRY2	G:603732	.	.
CRYAA	GP:123580	.	Cataract, autosomal dominant nuclear (3)
CRYAA	GP:123580	.	Cataract, congenital, autosomal recessive (3)
CRYAA	GP:123580	.	Cataract, zonular central nuclear, autosomal dominant (3)
CRYAB	G:123590	+GR-Bell	Cataract, posterior polar 2, 613763 (3)
CRYAB	G:123590	+GR-Bell	Myopathy, myofibrillar, alpha-B crystallin-related, 608810 (3)
CRYAB	G:123590	+GR-Bell	Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related, 613869 (3)
CRYBA1	G:123610	.	Cataract, congenital zonular, with sutural opacities, 600881 (3)
CRYBA2	G:600836	.	.
CRYBA4	G:123631	.	Cataract, lamellar 2, 610425 (3)
CRYBA4	G:123631	.	Microphthalmia with cataract 4, 610426 (3)
CRYBB1	GP:600929	.	Cataract, congenital nuclear, autosomal recessive 3, 611544 (3)
CRYBB1	GP:600929	.	Cataract, pulverulent (3)
CRYBB2	GP:123620	.	Cataract, Coppock-like, 604307 (3)
CRYBB2	GP:123620	.	Cataract, cerulean, type 2, 601547 (3)
CRYBB2	GP:123620	.	Cataract, sutural, with punctate and cerulean opacities, 607133 (3)
CRYBB3	G:123630	.	Cataract, congenital nuclear, 2, 609741 (3)
CRYGA	G:123660	.	.
CRYGB	G:123670	.	.
CRYGC	GP:123680	.	Cataract, Coppock-like, 604307 (3)
CRYGC	GP:123680	.	Cataract, variable zonular pulverulent (3)
CRYGD	GP:123690	.	Cataract, congenital, cerulean type, 3, 608983 (3)
CRYGD	GP:123690	.	Cataract, crystalline aculeiform, 115700 (3)
CRYGD	GP:123690	.	Cataract, nonnuclear polymorphic congenital, 601286 (3)
CRYGD	GP:123690	.	Cataracts, punctate, progressive juvenile-onset (3)
CRYGN	G:609603	.	.
CRYGS	GP:123730	.	Cataract, progressive polymorphic cortical (3)
CRYL1	G:609877	.	.
CRYM	G:123740	.	Deafness, autosomal dominant 40 (3)
CRYZ	G:123691	.	.
CRYZL1	G:603920	.	.
CSDA	G:603437	.	.
CSDE1	G:191510	.	.
CSE	P:601042	.	.
CSE1L	G:601342	.	.
CSF1	G:120420	.	.
CSF1R	G:164770	.	Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3)
CSF2	G:138960	.	.
CSF2RA	G:306250	.	Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)
CSF2RA	G:425000	.	Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)
CSF2RB	G:138981	.	Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3)
CSF3	G:138970	.	.
CSF3R	G:138971	.	Neutrophilia, hereditary, 162830 (3)
CSH1	G:150200	.	.
CSH2	G:118820	.	.
CSHL1	G:603515	.	.
CSK	G:124095	.	.
CSMD1	G:608397	.	.
CSMD2	G:608398	.	.
CSMD3	G:608399	.	.
CSN1S1	G:115450	.	.
CSN2	G:115460	.	.
CSN3	G:601695	.	.
CSNK1A1	G:600505	.	.
CSNK1D	G:600864	.	.
CSNK1E	G:600863	.	.
CSNK1G1	G:606274	.	.
CSNK1G2	G:602214	.	.
CSNK1G3	G:604253	.	.
CSNK2A1	G:115440	.	.
CSNK2A2	G:115442	.	.
CSNK2B	G:115441	.	.
CSPG4	G:601172	.	.
CSPG4P1Y	G:400034	.	.
CSPG5	G:606775	.	.
CSPP1	G:611654	.	.
CSRNP1	G:606458	.	.
CSRP1	G:123876	.	.
CSRP2	G:601871	.	.
CSRP3	G:600824	+GR-Bell	Cardiomyopathy, dilated, 1M, 607482 (3)
CSRP3	G:600824	+GR-Bell	Cardiomyopathy, familial hypertrophic, 12, 612124 (3)
CST1	G:123855	.	.
CST11	G:609731	.	.
CST2	G:123856	.	.
CST3	G:604312	.	Cerebral amyloid angiopathy, 105150 (3)
CST3	G:604312	.	Macular degeneration, age-related, 11, 611953 (3)
CST4	G:123857	.	.
CST5	G:123858	.	.
CST6	G:601891	.	.
CST7	G:603253	.	.
CST8	G:608683	.	.
CSTA	G:184600	.	Exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of Siemens-like, 607936 (3)
CSTB	G:601145	Bell>neurological	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3)
CSTF1	G:600369	.	.
CSTF2	G:600368	.	.
CSTF2T	G:611968	.	.
CSTF3	G:600367	.	.
CT45A1	G:300648	.	.
CT45A2	G:300793	.	.
CT45A3	G:300794	.	.
CT45A4	G:300795	.	.
CT45A5	G:300796	.	.
CT45A6	G:300797	.	.
CT47A1	G:300780	.	.
CT47A10	P:300789	.	.
CT47A11	G:300592	.	.
CT47A2	G:300781	.	.
CT47A3	G:300782	.	.
CT47A4	G:300783	.	.
CT47A5	P:300784	.	.
CT47A6	G:300785	.	.
CT47A7	G:300786	.	.
CT47A8	G:300787	.	.
CT47A9	G:300788	.	.
CT47B1	G:300790	.	.
CTAA1	P:115650	.	.
CTAA2	P:601202	.	.
CTAG1A	G:300657	.	.
CTAG1B	G:300156	.	.
CTAG2	G:300396	.	.
CTAGE1	G:608856	.	.
CTAGE3P	G:608857	.	.
CTAGE4	G:608910	.	.
CTAGE5	G:602132	.	.
CTBP1	G:602618	.	.
CTBP2	G:602619	.	.
CTBS	G:600873	.	.
CTC1	G:613129	.	Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3)
CTCF	G:604167	.	.
CTCFL	G:607022	.	.
CTD	P:300216	.	.
CTDNEP1	G:610684	.	.
CTDP1	G:604927	+GR-Bell	Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)
CTDSP1	G:605323	.	.
CTDSP2	G:608711	.	.
CTDSPL	G:608592	.	.
CTF1	G:600435	.	.
CTGF	G:121009	.	.
CTH	G:607657	.	Cystathioninuria, 219500 (3)
CTH	G:607657	.	Homocysteine, total plasma, elevated (3)
CTHRC1	G:610635	.	Barrett esophagus/esophageal adenocarcinoma, 614266 (3)
CTIF	G:613178	.	.
CTLA4	GP:123890	.	{Celiac disease, susceptibility to, 3}, 609755 (3)
CTLA4	GP:123890	.	{Diabetes mellitus, insulin-dependent, susceptibility to}, 601388 (3)
CTLA4	GP:123890	.	{Graves disease, susceptibility to, 4} (3)
CTLA4	GP:123890	.	{Hypothyroidism, autoimmune}, 140300 (3)
CTNNA1	G:116805	.	.
CTNNA2	G:114025	.	.
CTNNA3	G:607667	.	.
CTNNAL1	G:604785	.	.
CTNNB1	G:116806	.	Hepatocellular carcinoma, 114550 (3)
CTNNB1	G:116806	.	Ovarian cancer, 167000 (3)
CTNNB1	G:116806	.	Pilomatricoma, 132600 (3)
CTNNBIP1	G:607758	.	.
CTNNBL1	G:611537	.	.
CTNND1	G:601045	.	.
CTNND2	G:604275	.	.
CTNS	G:606272	Bell>metabolic	Cystinosis, atypical nephropathic (3)
CTNS	G:606272	Bell>metabolic	Cystinosis, atypical nephropathic (3)
CTNS	G:606272	Bell>metabolic	Cystinosis, atypical nephropathic (3)
CTNS	G:606272	Bell>metabolic	Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3)
CTNS	G:606272	Bell>metabolic	Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3)
CTNS	G:606272	Bell>metabolic	Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3)
CTNS	G:606272	Bell>metabolic	Cystinosis, nephropathic, 219800 (3)
CTNS	G:606272	Bell>metabolic	Cystinosis, nephropathic, 219800 (3)
CTNS	G:606272	Bell>metabolic	Cystinosis, nephropathic, 219800 (3)
CTNS	G:606272	Bell>metabolic	Cystinosis, ocular nonnephropathic, 219750 (3)
CTNS	G:606272	Bell>metabolic	Cystinosis, ocular nonnephropathic, 219750 (3)
CTNS	G:606272	Bell>metabolic	Cystinosis, ocular nonnephropathic, 219750 (3)
CTPL1	P:605749	.	.
CTPS	G:123860	.	.
CTPS2	G:300380	.	.
CTR9	G:609366	.	.
CTRB1	G:118890	.	.
CTRC	G:601405	.	{Pancreatitis, chronic, susceptibility to}, 167800 (3)
CTRL	G:118888	.	.
CTSA	G:613111	.	Galactosialidosis, 256540 (3)
CTSB	G:116810	.	.
CTSC	G:602365	.	Haim-Munk syndrome, 245010 (3)
CTSC	G:602365	.	Papillon-Lefevre syndrome, 245000 (3)
CTSC	G:602365	.	Periodontitis, juvenile, 170650 (3)
CTSD	G:116840	Bell>neurological	Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
CTSE	G:116890	.	.
CTSF	G:603539	.	.
CTSG	G:116830	.	.
CTSH	G:116820	.	.
CTSK	G:601105	Bell>metabolic	Pycnodysostosis, 265800 (3)
CTSL1	G:116880	.	.
CTSL2	G:603308	.	.
CTSO	G:600550	.	.
CTSS	G:116845	.	.
CTSW	G:602364	.	.
CTSZ	G:603169	.	.
CTTN	G:164765	.	.
CTTNBP2	G:609772	.	.
CTU1	G:612694	.	.
CTXN1	G:600135	.	.
CUBN	G:602997	.	Megaloblastic anemia-1, Finnish type, 261100 (3)
CUEDC2	G:614142	.	.
CUL1	G:603134	.	.
CUL2	G:603135	.	.
CUL3	G:603136	.	Pseudohypoaldosteronism, type IIE, 614496 (3)
CUL4A	G:603137	.	.
CUL4B	G:300304	.	Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)
CUL5	G:601741	.	.
CUL7	G:609577	+GR-Bell	3-M syndrome 1, 273750 (3)
CUL9	G:607489	.	.
CUTC	G:610101	.	.
CUX1	G:116896	.	.
CUX2	G:610648	.	.
CX3CL1	G:601880	.	.
CX3CR1	G:601470	.	{Coronary artery disease, resistance to}, 607339 (3)
CX3CR1	G:601470	.	{Macular degeneration, age-related, 12}, 613784 (3)
CX3CR1	G:601470	.	{Rapid progression to AIDS from HIV1 infection}, 609423 (3)
CXADR	G:602621	.	.
CXB3S	P:120050	.	.
CXCL1	G:155730	.	.
CXCL10	G:147310	.	.
CXCL11	G:604852	.	.
CXCL12	G:600835	.	{AIDS, resistance to}, 609423 (3)
CXCL13	G:605149	.	.
CXCL14	G:604186	.	.
CXCL16	G:605398	.	.
CXCL17	G:611387	.	.
CXCL2	G:139110	.	.
CXCL3	G:139111	.	.
CXCL5	G:600324	.	.
CXCL6	G:138965	.	.
CXCL9	G:601704	.	.
CXCR1	G:146929	.	{AIDS, slow progression to}, 609423 (3)
CXCR2	G:146928	.	.
CXCR3	G:300574	.	.
CXCR4	G:162643	.	Myelokathexis, isolated (3)
CXCR4	G:162643	.	WHIM syndrome, 193670 (3)
CXCR5	G:601613	.	.
CXCR6	G:605163	.	.
CXCR7	G:610376	.	.
CXorf1	G:300565	.	.
CXorf61	G:300625	.	.
CXXC1	G:609150	.	.
CXXC4	G:611645	.	.
CXXC5	G:612752	.	.
CYB561	G:600019	.	.
CYB561D2	G:607068	.	.
CYB5A	G:613218	.	Methemoglobinemia, type IV, 250790 (3)
CYB5B	G:611964	.	.
CYB5R1	G:608341	.	.
CYB5R2	G:608342	.	.
CYB5R3	G:613213	.	Methemoglobinemia, type I, 250800 (3)
CYB5R3	G:613213	.	Methemoglobinemia, type II, 250800 (3)
CYB5R4	G:608343	.	.
CYBA	GP:608508	.	Chronic granulomatous disease, autosomal, due to deficiency of CYBA, 233690 (3)
CYBB	G:300481	.	Atypical mycobacteriosis, familial, X-linked 2, 300645 (3)
CYBB	G:300481	.	Chronic granulomatous disease, X-linked, 306400 (3)
CYBRD1	G:605745	.	.
CYC1	G:123980	.	.
CYCS	G:123970	.	Thrombocytopenia 4, 612004 (3)
CYFIP1	G:606322	.	.
CYFIP2	G:606323	.	.
CYGB	G:608759	.	.
CYLC1	G:300768	.	.
CYLC2	G:604035	.	.
CYLD	G:605018	.	Brooke-Spiegler syndrome, 605041 (3)
CYLD	G:605018	.	Cylindromatosis, familial, 132700 (3)
CYLD	G:605018	.	Trichoepithelioma, multiple familial, 1, 601606 (3)
CYMD	P:153880	.	.
CYMP	P:118943	.	.
CYP11A1	G:118485	Bell>endocrine	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3)
CYP11B1	G:610613	.	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3)
CYP11B1	G:610613	.	Aldosteronism, glucocorticoid-remediable, 103900 (3)
CYP11B2	G:124080	.	Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3)
CYP11B2	G:124080	.	Hypoaldosteronism, congenital, due to CMO II deficiency, 610600 (3)
CYP11B2	G:124080	.	{Low renin hypertension, susceptibility to} (3)
CYP17A1	G:609300	.	17,20-lyase deficiency, isolated, 202110 (3)
CYP17A1	G:609300	.	17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3)
CYP19A1	G:107910	.	Aromatase deficiency, 613546 (3)
CYP19A1	G:107910	.	Aromatase excess syndrome, 139300 (3)
CYP1A1	G:108330	.	.
CYP1A2	GP:124060	.	.
CYP1B1	G:601771	+GR-Bell	Glaucoma 3A, primary congenital, 231300 (3)
CYP1B1	G:601771	+GR-Bell	Glaucoma, early-onset, digenic (3)
CYP1B1	G:601771	+GR-Bell	Glaucoma, primary open angle, adult-onset, 137760 (3)
CYP1B1	G:601771	+GR-Bell	Glaucoma, primary open angle, juvenile-onset, 137750 (3)
CYP1B1	G:601771	+GR-Bell	Peters anomaly, 604229 (3)
CYP21A2	G:613815	Bell>endocrine	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3)
CYP21A2	G:613815	Bell>endocrine	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)
CYP24A1	G:126065	.	Hypercalcemia, infantile, 143880 (3)
CYP26A1	G:602239	.	.
CYP26B1	G:605207	.	.
CYP26C1	G:608428	.	.
CYP27A1	G:606530	Bell>metabolic	Cerebrotendinous xanthomatosis, 213700 (3)
CYP27B1	G:609506	Bell>endocrine	Vitamin D-dependent rickets, type I, 264700 (3)
CYP2A13	G:608055	.	.
CYP2A6	GP:122720	.	Coumarin resistance, 122700 (3)
CYP2A6	GP:122720	.	{Lung cancer, resistance to}, 211980 (3)
CYP2A6	GP:122720	.	{Nicotine addiction, protection from}, 188890 (3)
CYP2A7	G:608054	.	.
CYP2B6	G:123930	.	Efavirenz, poor metabolism of, 614546 (3)
CYP2B6	G:123930	.	{Efavirenz central nervous system toxicity, susceptibility to}, 614546 (3)
CYP2C18	G:601131	.	.
CYP2C19	G:124020	.	Clopidogrel, impaired responsiveness to, 609535 (3)
CYP2C19	G:124020	.	Mephenytoin poor metabolizer, 609535 (3)
CYP2C19	G:124020	.	Opremazole poor metabolizer, 609535 (3)
CYP2C19	G:124020	.	Proguanil poor metabolizer, 609535 (3)
CYP2C8	GP:601129	.	Rhabdomyolysis, cerivastatin-induced (3)
CYP2C9	G:601130	.	Warfarin sensitivity, 122700 (3)
CYP2D6	G:124030	.	{Codeine sensitivity}, 608902 (3)
CYP2D6	G:124030	.	{Debrisoquine sensitivity}, 608902 (3)
CYP2E1	G:124040	.	.
CYP2F1	G:124070	.	.
CYP2G1P	G:601133	.	.
CYP2J2	G:601258	.	.
CYP2R1	G:608713	.	Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3)
CYP2S1	G:611529	.	.
CYP2U1	G:610670	.	.
CYP39A1	G:605994	.	.
CYP3A4	G:124010	.	.
CYP3A43	G:606534	.	.
CYP3A5	G:605325	.	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CYP3A7	G:605340	.	.
CYP46A1	G:604087	.	.
CYP4A11	G:601310	.	.
CYP4B1	G:124075	.	.
CYP4F11	G:611517	.	.
CYP4F12	G:611485	.	.
CYP4F2	G:604426	.	.
CYP4F22	G:611495	+GR-Bell	Ichthyosis, lamellar, 3, 604777 (3)
CYP4F3	G:601270	.	.
CYP4F8	G:611545	.	.
CYP4V2	G:608614	.	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CYP51A1	G:601637	.	.
CYP7A1	G:118455	.	.
CYP7B1	G:603711	.	Bile acid synthesis defect, congenital, 3, 613812 (3)
CYP7B1	G:603711	.	Spastic paraplegia-5A, 270800 (3)
CYP8B1	G:602172	.	.
CYR61	G:602369	.	.
CYSLTR1	G:300201	.	.
CYSLTR2	G:605666	.	.
CYTH1	G:182115	.	.
CYTH2	G:602488	.	.
CYTH3	G:605081	.	.
CYTH4	G:606514	.	.
CYTIP	G:604448	.	.
CYTL1	G:607930	.	.
D2HGDH	G:609186	Bell>metabolic	D-2-hydroxyglutaric aciduria, 600721 (3)
DAAM1	G:606626	.	.
DAAM2	G:606627	.	.
DAB1	G:603448	.	.
DAB2	G:601236	.	.
DAB2IP	G:609205	.	.
DACH1	G:603803	.	.
DACH2	G:300608	.	.
DACT1	G:607861	.	.
DACT2	G:608966	.	.
DACT3	G:611112	.	.
DAD1	G:600243	.	.
DAD1P1	G:609860	.	.
DAG1	G:128239	.	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7, 613818 (3)
DAGLA	G:614015	.	.
DAGLB	G:614016	.	.
DAND5	G:609068	.	.
DAO	G:124050	.	.
DAOA	G:607408	.	.
DAOA-AS1	G:607415	.	.
DAP	G:600954	.	.
DAP3	G:602074	.	.
DAPK1	G:600831	.	.
DAPK3	G:603289	.	.
DAPP1	G:605768	.	.
DARC	G:613665	.	[Blood group, Duffy system], 110700 (3)
DARC	G:613665	.	[White blood cell count QTL], 611862 (3)
DARC	G:613665	.	{Malaria, vivax, protection against}, 611162 (3)
DARS	G:603084	.	.
DARS2	G:610956	+GR-Bell	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3)
DAXX	G:603186	.	.
DAZ1	G:400003	.	.
DAZ2	G:400026	.	.
DAZ3	G:400027	.	.
DAZAP1	G:607430	.	.
DAZAP2	G:607431	.	.
DAZL	G:601486	.	{Spermatogenic failure, susceptibility to} (3)
DBC1	G:602865	.	.
DBF4	G:604281	.	.
DBF4B	G:611661	.	.
DBH	G:609312	+GR-Bell	Dopamine beta-hydroxylase deficiency, 223360 (3)
DBH	G:609312	+GR-Bell	[Dopamine-beta-hydroxylase activity levels, plasma] (3)
DBI	G:125950	.	.
DBN1	G:126660	.	.
DBNDD2	G:611453	.	.
DBNL	G:610106	.	.
DBP	G:124097	.	.
DBR1	G:607024	.	.
DBT	G:248610	+GR-Bell	Maple syrup urine disease, type II, 248600 (3)
DCAF11	G:613317	.	.
DCAF17	G:612515	.	Woodhouse-Sakati syndrome, 241080 (3)
DCAF5	G:603812	.	.
DCAF6	G:610494	.	.
DCAF7	G:605973	.	.
DCBLD2	G:608698	.	.
DCC	G:120470	.	Mirror movements, congenital, 157600 (3)
DCD	G:606634	.	.
DCDC1	G:608062	.	.
DCDC2	G:605755	.	.
DCDC5	G:612321	.	.
DCHS1	G:603057	.	.
DCHS2	G:612486	.	.
DCK	G:125450	.	.
DCLK1	G:604742	.	.
DCLK2	G:613166	.	.
DCLK3	G:613167	.	.
DCLRE1A	G:609682	.	.
DCLRE1B	G:609683	.	.
DCLRE1C	G:605988	Bell>immunodeficiency	Omenn syndrome, 603554 (3)
DCLRE1C	G:605988	Bell>immunodeficiency	Severe combined immunodeficiency, Athabascan type, 602450 (3)
DCN	G:125255	+GR-Bell	Corneal dystrophy, congenital stromal, 610048 (3)
DCP1A	G:607010	.	.
DCP1B	G:609843	.	.
DCP2	G:609844	.	.
DCPS	G:610534	.	.
DCR	P:190685	.	.
DCSTAMP	G:605933	.	.
DCT	G:191275	.	.
DCTD	G:607638	.	.
DCTN1	G:601143	+GR-Bell	Neuropathy, distal hereditary motor, type VIIB, 607641 (3)
DCTN1	G:601143	+GR-Bell	Perry syndrome, 168605 (3)
DCTN1	G:601143	+GR-Bell	{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)
DCTN2	G:607376	.	.
DCTN3	G:607387	.	.
DCTN5	G:612962	.	.
DCTN6	G:612963	.	.
DCUN1D1	G:605905	.	.
DCUN1D4	G:612977	.	.
DCX	G:300121	Bell>neurological	Lissencephaly, X-linked, 300067 (3)
DCX	G:300121	Bell>neurological	Subcortical laminal heteropia, X-linked, 300067 (3)
DCXR	G:608347	.	.
DDAH1	G:604743	.	.
DDAH2	G:604744	.	.
DDB1	G:600045	.	.
DDB2	G:600811	Bell>cutaneous	Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3)
DDC	G:107930	Bell>metabolic	Aromatic L-amino acid decarboxylase deficiency, 608643 (3)
DDIT3	G:126337	.	.
DDIT4	G:607729	.	.
DDIT4L	G:607730	.	.
DDN	G:610588	.	.
DDO	G:124450	.	.
DDOST	G:602202	.	Congenital disorder of glycosylation, type Ir, 614507 (3)
DDR1	G:600408	.	.
DDR2	G:191311	.	Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3)
DDT	G:602750	.	.
DDU	P:125630	.	.
DDX1	G:601257	.	.
DDX10	G:601235	.	.
DDX11	G:601150	.	Warsaw breakage syndrome, 613398 (3)
DDX12P	G:601151	.	.
DDX17	G:608469	.	.
DDX18	G:606355	.	.
DDX19B	G:605812	.	.
DDX20	G:606168	.	.
DDX21	G:606357	.	.
DDX23	G:612172	.	.
DDX24	G:606181	.	.
DDX25	G:607663	.	.
DDX28	G:607618	.	.
DDX39B	G:142560	.	.
DDX3X	G:300160	.	.
DDX3Y	G:400010	.	.
DDX4	G:605281	.	.
DDX41	G:608170	.	.
DDX42	G:613369	.	.
DDX43	G:606286	.	.
DDX5	G:180630	.	.
DDX50	G:610373	.	.
DDX52	G:612500	.	.
DDX54	G:611665	.	.
DDX56	G:608023	.	.
DDX58	G:609631	.	.
DDX6	G:600326	.	.
DDX60	G:613974	.	.
DEAF1	G:602635	.	.
DEC1	G:604767	.	.
DECR1	GP:222745	.	.
DEDD	G:606841	.	.
DEF6	G:610094	.	.
DEFA1	G:125220	.	.
DEFA3	G:604522	.	.
DEFA4	G:601157	.	.
DEFA5	G:600472	.	.
DEFA6	G:600471	.	.
DEFB1	G:602056	.	.
DEFB103B	G:606611	.	.
DEFB118	G:607650	.	.
DEFB4A	G:602215	.	.
DEGS2	G:610862	.	.
DEK	G:125264	.	.
DENND1A	G:613633	.	.
DENND1B	G:613292	.	.
DENND1C	G:613634	.	.
DENND4A	G:600382	.	.
DENR	G:604550	.	.
DEPDC1	G:612002	.	.
DEPDC5	G:614191	.	.
DEPDC7	G:612294	.	.
DEPTOR	G:612974	.	.
DERL1	G:608813	.	.
DERL2	G:610304	.	.
DERL3	G:610305	.	.
DES	G:125660	+GR-Bell	Cardiomyopathy, dilated, 1I, 604765 (3)
DES	G:125660	+GR-Bell	Myopathy, desmin-related, cardioskeletal, 601419 (3)
DES	G:125660	+GR-Bell	Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)
DET1	G:608727	.	.
DFFA	G:601882	.	.
DFFB	G:601883	.	.
DFN4	P:300030	.	.
DFN6	P:300066	.	.
DFNA16	P:603964	.	.
DFNA18	P:606012	.	.
DFNA21	P:607017	.	.
DFNA24	P:606282	.	.
DFNA27	P:612431	.	.
DFNA30	P:606451	.	.
DFNA31	P:608645	.	.
DFNA33	P:614211	.	.
DFNA41	P:608224	.	.
DFNA43	P:608394	.	.
DFNA47	P:608652	.	.
DFNA49	P:608372	.	.
DFNA5	G:608798	.	Deafness, autosomal dominant 5, 600994 (3)
DFNA52	P:607683	.	.
DFNA53	P:609965	.	.
DFNA59	P:612642	.	.
DFNA7	P:601412	.	.
DFNB13	P:603098	.	.
DFNB14	P:603678	.	.
DFNB17	P:603010	.	.
DFNB20	P:604060	.	.
DFNB26	P:605428	.	.
DFNB27	P:605818	.	.
DFNB31	G:607928	+GR-Bell	Deafness, autosomal recessive 31, 607084 (3)
DFNB31	G:607928	+GR-Bell	Usher syndrome, type 2D, 611383 (3)
DFNB32	P:608653	.	.
DFNB33	P:607239	.	.
DFNB38	P:608219	.	.
DFNB40	P:608264	.	.
DFNB44	P:610154	.	.
DFNB45	P:612433	.	.
DFNB46	P:609647	.	.
DFNB47	P:609946	.	.
DFNB48	P:609439	.	.
DFNB5	P:600792	.	.
DFNB51	P:609941	.	.
DFNB55	P:609952	.	.
DFNB59	G:610219	.	Deafness, autosomal recessive 59, 610220 (3)
DFNB62	P:610143	.	.
DFNB65	P:610248	.	.
DFNB66	P:610212	.	.
DFNB68	P:610419	.	.
DFNB71	P:612789	.	.
DFNB81	P:614129	.	.
DFNB83	P:613685	.	.
DFNB85	P:613392	.	.
DFNB89	P:613916	.	.
DFNB96	P:614414	.	.
DFNM1	P:605429	.	.
DFNY1	P:400043	.	.
DGAT1	G:604900	.	.
DGAT2	G:606983	.	.
DGCR	P:188400	.	.
DGCR14	G:601755	.	.
DGCR2	G:600594	.	.
DGCR6	G:601279	.	.
DGCR6L	G:609459	.	.
DGCR8	G:609030	.	.
DGKA	G:125855	.	.
DGKB	G:604070	.	.
DGKD	G:601826	.	.
DGKE	G:601440	.	.
DGKG	G:601854	.	.
DGKH	G:604071	.	.
DGKI	G:604072	.	.
DGKK	G:300837	.	.
DGKQ	G:601207	.	.
DGKZ	G:601441	.	.
DGUOK	G:601465	Bell>neurological	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3)
DHCR24	G:606418	Bell>developmental	Desmosterolosis, 602398 (3)
DHCR7	G:602858	Bell>developmental	Smith-Lemli-Opitz syndrome, 270400 (3)
DHDDS	G:608172	+GR-Bell	Retinitis pigmentosa 59, 613861 (3)
DHDH	G:606377	.	.
DHFR	G:126060	.	Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3)
DHH	G:605423	+GR-Bell	46XY partial gonadal dysgenesis, with minifascicular neuropathy, 607080 (3)
DHH	G:605423	+GR-Bell	46XY sex reversal 7, 233420 (3)
DHODH	G:126064	.	Miller syndrome, 263750 (3)
DHPS	G:600944	.	.
DHRS1	G:610410	.	.
DHRS3	G:612830	.	.
DHRS4	G:611596	.	.
DHRS7	G:612833	.	.
DHRS9	G:612131	.	.
DHX15	G:603403	.	.
DHX16	G:603405	.	.
DHX29	G:612720	.	.
DHX32	G:607960	.	.
DHX33	G:614405	.	.
DHX36	G:612767	.	.
DHX38	G:605584	.	.
DHX40	G:607570	.	.
DHX58	G:608588	.	.
DHX8	G:600396	.	.
DHX9	G:603115	.	.
DIABLO	G:605219	.	Deafness, autosomal dominant 64, 614152 (3)
DIANPH	P:603933	.	.
DIAPH1	G:602121	.	Deafness, autosomal dominant 1, 124900 (3)
DIAPH2	G:300108	.	Premature ovarian failure, 300511 (3)
DICER1	G:606241	.	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3)
DICER1	G:606241	.	Pleuropulmonary blastoma, 601200 (3)
DIDO1	G:604140	.	.
DIH1	P:142340	.	.
DIMT1	G:612499	.	.
DIO1	GP:147892	.	.
DIO2	G:601413	.	.
DIO3	G:601038	.	.
DIO3OS	G:608523	.	.
DIP2A	G:607711	.	.
DIP2B	G:611379	.	Mental retardation, FRA12A type, 136630 (3)
DIP2C	G:611380	.	.
DIRAS1	G:607862	.	.
DIRAS2	G:607863	.	.
DIRAS3	G:605193	.	.
DIRC1	G:606423	.	.
DIRC2	G:602773	.	.
DIRC3	G:608262	.	.
DIS3	G:607533	.	.
DIS3L	G:614183	.	.
DIS3L2	G:614184	.	Perlman syndrome, 267000 (3)
DISC1	G:605210	.	{Schizoaffective disorder, susceptibility to}, 181500 (3)
DISC1	G:605210	.	{Schizophrenia, susceptibility to}, 604906 (3)
DISC2	G:606271	.	.
DISP1	G:607502	.	.
DISP2	G:607503	.	.
DIXDC1	G:610493	.	.
DKC1	G:300126	Bell>immunodeficiency	Dyskeratosis congenita, X-linked, 305000 (3)
DKC1	G:300126	Bell>immunodeficiency	Hoyeraal-Hreidarsson syndrome, 300240 (3)
DKK1	G:605189	.	.
DKK2	G:605415	.	.
DKK3	G:605416	.	.
DKK4	G:605417	.	.
DKKL1	G:605418	.	.
DLAT	G:608770	.	Pyruvate dehydrogenase E2 deficiency, 245348 (3)
DLC1	G:604258	.	Colorectal cancer, somatic (3)
DLD	G:238331	Bell>metabolic	Leigh syndrome, 256000 (3)
DLD	G:238331	Bell>metabolic	Maple syrup urine disease, type III, 248600 (3)
DLEC1	G:604050	.	.
DLEU1	G:605765	.	.
DLEU2	G:605766	.	.
DLG1	G:601014	.	.
DLG2	G:603583	.	.
DLG3	G:300189	.	Mental retardation, X-linked 90, 300850 (3)
DLG4	G:602887	.	.
DLG5	G:604090	.	.
DLGAP1	G:605445	.	.
DLGAP2	G:605438	.	.
DLGAP3	G:611413	.	.
DLK1	G:176290	.	.
DLL1	G:606582	.	.
DLL3	G:602768	Bell>skeletal	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
DLL4	G:605185	.	.
DLST	G:126063	.	.
DLX1	G:600029	.	.
DLX2	G:126255	.	.
DLX3	G:600525	.	Amelogenesis imperfecta, hypomaturation-hypoplastic type, with taurodontism, 104510 (3)
DLX3	G:600525	.	Trichodontoosseous syndrome, 190320 (3)
DLX4	G:601911	.	.
DLX5	G:600028	.	Split-hand/foot malformation 1 with sensorineural hearing loss, 220600 (3)
DLX6	G:600030	.	.
DMAP1	G:605077	.	.
DMBT1	G:601969	.	.
DMBX1	G:607410	.	.
DMC1	G:602721	.	.
DMD	G:300377	Bell>cardiac	Becker muscular dystrophy, 300376 (3)
DMD	G:300377	Bell>cardiac	Cardiomyopathy, dilated, 3B, 302045 (3)
DMD	G:300377	Bell>cardiac	Duchenne muscular dystrophy, 310200 (3)
DMD	G:300377	Bell>neurological	Becker muscular dystrophy, 300376 (3)
DMD	G:300377	Bell>neurological	Cardiomyopathy, dilated, 3B, 302045 (3)
DMD	G:300377	Bell>neurological	Duchenne muscular dystrophy, 310200 (3)
DMGDH	G:605849	.	Dimethylglycine dehydrogenase deficiency, 605850 (3)
DMP1	G:600980	Bell>skeletal	Hypophosphatemic rickets, AR, 241520 (3)
DMPK	G:605377	+GR-Bell	Myotonic dystrophy 1, 160900 (3)
DMRT1	G:602424	.	.
DMRT2	G:604935	.	.
DMTF1	G:608491	.	.
DMWD	G:609857	.	.
DMXL1	G:605671	.	.
DMXL2	G:612186	.	.
DNA2	G:601810	.	.
DNAAF1	G:613190	.	Ciliary dyskinesia, primary, 13, 613193 (3)
DNAAF2	G:612517	.	Ciliary dyskinesia, primary, 10, 612518 (3)
DNAH1	G:603332	.	.
DNAH10	G:605884	.	.
DNAH11	G:603339	+GR-Bell	Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3)
DNAH12	G:603340	.	.
DNAH14	G:603341	.	.
DNAH17	G:610063	.	.
DNAH2	G:603333	.	.
DNAH3	G:603334	.	.
DNAH5	G:603335	+GR-Bell	Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3)
DNAH6	G:603336	.	.
DNAH7	G:610061	.	.
DNAH8	G:603337	.	.
DNAH9	G:603330	.	.
DNAI1	G:604366	+GR-Bell	Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3)
DNAI2	G:605483	+GR-Bell	Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 (3)
DNAJA1	G:602837	.	.
DNAJA2	G:611322	.	.
DNAJA3	G:608382	.	.
DNAJB1	G:604572	.	.
DNAJB11	G:611341	.	.
DNAJB12	G:608376	.	.
DNAJB13	G:610263	.	.
DNAJB2	G:604139	.	.
DNAJB4	G:611327	.	.
DNAJB5	G:611328	.	.
DNAJB6	G:611332	.	.
DNAJB7	G:611336	.	.
DNAJB8	G:611337	.	.
DNAJB9	G:602634	.	.
DNAJC1	G:611207	.	.
DNAJC10	G:607987	.	.
DNAJC12	G:606060	.	.
DNAJC13	G:614334	.	.
DNAJC14	G:606092	.	.
DNAJC19	G:608977	Bell>metabolic	3-methylglutaconic aciduria, type V, 610198 (3)
DNAJC2	G:605502	.	.
DNAJC24	G:611072	.	.
DNAJC27	G:613527	.	.
DNAJC3	G:601184	.	.
DNAJC4	G:604189	.	.
DNAJC5	G:611203	.	Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)
DNAJC5B	G:613945	.	.
DNAJC5G	G:613946	.	.
DNAJC6	G:608375	.	.
DNAJC7	G:601964	.	.
DNAJC9	G:611206	.	.
DNAL1	G:610062	.	Ciliary dyskinesia, primary, 16, 614017 (3)
DNAL4	G:610565	.	.
DNALI1	G:602135	.	.
DNASE1	G:125505	.	{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
DNASE1L1	G:300081	.	.
DNASE1L2	G:602622	.	.
DNASE1L3	G:602244	.	Systemic lupus erythematosus 16, 614420 (3)
DNASE2	G:126350	.	.
DNASE2B	G:608057	.	.
DND1	G:609385	.	.
DNER	G:607299	.	.
DNM1	G:602377	.	.
DNM1L	G:603850	.	Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission, 614388 (3)
DNM2	G:602378	+GR-Bell	Charcot-Marie-Tooth disease, axonal, type 2M, 606482 (3)
DNM2	G:602378	+GR-Bell	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3)
DNM2	G:602378	+GR-Bell	Myopathy, centronuclear, 160150 (3)
DNM3	G:611445	.	.
DNMBP	G:611282	.	.
DNMT1	G:126375	+GR-Bell	Neuropathy, hereditary sensory, type IE, 614116 (3)
DNMT3A	G:602769	.	.
DNMT3B	G:602900	Bell>immunodeficiency	Immunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 (3)
DNMT3L	G:606588	.	.
DNPEP	G:611367	.	.
DNTT	G:187410	.	.
DNTTIP1	G:611388	.	.
DNTTIP2	G:611199	.	.
DOC2A	G:604567	.	.
DOC2B	G:604568	.	.
DOCK1	G:601403	.	.
DOCK10	G:611518	.	.
DOCK11	G:300681	.	.
DOCK2	G:603122	.	.
DOCK3	G:603123	.	.
DOCK4	G:607679	.	.
DOCK6	G:614194	.	Adams-Oliver syndrome 2, 614219 (3)
DOCK8	G:611432	.	Hyper-IgE recurrent infection syndrome, autosomal recessive, 243700 (3)
DOCK8	G:611432	.	Mental retardation, autosomal dominant 2, 614113 (3)
DOCK9	G:607325	.	.
DOHH	G:611262	.	.
DOK1	G:602919	.	.
DOK2	G:604997	.	.
DOK3	G:611435	.	.
DOK4	G:608333	.	.
DOK5	G:608334	.	.
DOK6	G:611402	.	.
DOK7	G:610285	+GR-Bell	Fetal akinesia deformation sequence, 208150 (3)
DOK7	G:610285	+GR-Bell	Myasthenia, limb-girdle, familial, 254300 (3)
DOLK	G:610746	Bell>metabolic	Congenital disorder of glycosylation, type Im, 610768 (3)
DOLPP1	P:614156	.	.
DOM3Z	G:605996	.	.
DONSON	G:611428	.	.
DOPEY2	G:604803	.	.
DOT1L	G:607375	.	.
DPAGT1	G:191350	Bell>metabolic	Congenital disorder of glycosylation, type Ij, 608093 (3)
DPCR1	G:613928	.	.
DPEP1	G:179780	.	.
DPEP2	G:609925	.	.
DPEP3	G:609926	.	.
DPF1	G:601670	.	.
DPF2	G:601671	.	.
DPF3	G:601672	.	.
DPH1	G:603527	.	.
DPH2	G:603456	.	.
DPH3	G:608959	.	.
DPH5	G:611075	.	.
DPM1	G:603503	Bell>metabolic	Congenital disorder of glycosylation, type Ie, 608799 (3)
DPM2	G:603564	.	.
DPM3	G:605951	.	Congenital disorder of glycosylation, type Io, 612937 (3)
DPP10	G:608209	.	.
DPP3	G:606818	.	.
DPP4	G:102720	.	.
DPP6	G:126141	.	Ventricular fibrillation, paroxysmal familial, 2, 612956 (3)
DPP7	G:610537	.	.
DPP8	G:606819	.	.
DPP9	G:608258	.	.
DPPA2	G:614445	.	.
DPPA3	G:608408	.	.
DPPA4	G:614125	.	.
DPPA5	G:611111	.	.
DPRX	G:611165	.	.
DPT	G:125597	.	.
DPY19L1	G:613892	.	.
DPY19L2	G:613893	.	Spermatogenic failure 9, 613958 (3)
DPY19L3	G:613894	.	.
DPY19L4	G:613895	.	.
DPY30	G:612032	.	.
DPYD	G:612779	Bell>metabolic	5-fluorouracil toxicity, 274270 (3)
DPYD	G:612779	Bell>metabolic	Dihydropyrimidine dehydrogenase deficiency, 274270 (3)
DPYS	G:613326	.	Dihydropyrimidinuria, 222748 (3)
DPYSL2	G:602463	.	.
DPYSL3	G:601168	.	.
DPYSL4	G:608407	.	.
DPYSL5	G:608383	.	.
DR1	G:601482	.	.
DRAM1	G:610776	.	.
DRAM2	G:613360	.	.
DRAP1	G:602289	.	.
DRD1	G:126449	.	.
DRD2	G:126450	.	Dystonia, myoclonic, 159900 (3)
DRD3	G:126451	.	{Essential tremor, susceptibility to}, 190300 (3)
DRD3	G:126451	.	{Schizophrenia, susceptibility to}, 181500 (3)
DRD4	G:126452	.	{Attention deficit-hyperactivity disorder}, 143465 (3)
DRD5	GP:126453	.	Dystonia, primary cervical (3)
DRD5	GP:126453	.	{Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3)
DRD5	GP:126453	.	{Blepharospasm, primary benign}, 606798 (3)
DRG1	G:603952	.	.
DRG2	G:602986	.	.
DRGX	G:606701	.	.
DROSHA	G:608828	.	.
DRP2	G:300052	.	.
DSC1	G:125643	.	.
DSC2	G:125645	+GR-Bell	Arrhythmogenic right ventricular dysplasia 11, 610476 (3)
DSC3	G:600271	.	Hypotrichosis and recurrent skin vesicles, 613102 (3)
DSCAM	G:602523	.	.
DSCAML1	G:611782	.	.
DSCC1	G:613203	.	.
DSCR3	G:605298	.	.
DSCR4	G:604829	.	.
DSCR6	G:609892	.	.
DSCR8	G:613396	.	.
DSE	G:605942	.	.
DSEL	G:611125	.	.
DSG1	G:125670	.	Keratosis palmoplantaris striata I, 148700 (3)
DSG2	G:125671	+GR-Bell	Arrhythmogenic right ventricular dysplasia 10, 610193 (3)
DSG2	G:125671	+GR-Bell	Cardiomyopathy, dilated, 1BB, 612877 (3)
DSG3	G:169615	.	.
DSG4	G:607892	.	Hypotrichosis, localized, autosomal recessive, 607903 (3)
DSN1	G:609175	.	.
DSP	G:125647	Bell>cutaneous	Arrhythmogenic right ventricular dysplasia 8, 607450 (3)
DSP	G:125647	Bell>cutaneous	Arrhythmogenic right ventricular dysplasia 8, 607450 (3)
DSP	G:125647	Bell>cutaneous	Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3)
DSP	G:125647	Bell>cutaneous	Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3)
DSP	G:125647	Bell>cutaneous	Epidermolysis bullosa, lethal acantholytic, 609638 (3)
DSP	G:125647	Bell>cutaneous	Epidermolysis bullosa, lethal acantholytic, 609638 (3)
DSP	G:125647	Bell>cutaneous	Keratosis palmoplantaris striata II, 612908 (3)
DSP	G:125647	Bell>cutaneous	Keratosis palmoplantaris striata II, 612908 (3)
DSP	G:125647	Bell>cutaneous	Skin fragility-woolly hair syndrome, 607655 (3)
DSP	G:125647	Bell>cutaneous	Skin fragility-woolly hair syndrome, 607655 (3)
DSPP	G:125485	.	Deafness, autosomal dominant 36, with dentinogenesis, 605594 (3)
DSPP	G:125485	.	Dentin dysplasia, type II, 125420 (3)
DSPP	G:125485	.	Dentinogenesis imperfecta, Shields type II, 125490 (3)
DSPP	G:125485	.	Dentinogenesis imperfecta, Shields type III, 125500 (3)
DST	G:113810	.	.
DSTN	G:609114	.	.
DSTYK	G:612666	.	.
DTD1	G:610996	.	.
DTL	G:610617	.	.
DTNA	G:601239	.	Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3)
DTNB	G:602415	.	.
DTNBP1	G:607145	+GR-Bell	Hermansky-Pudlak syndrome 7, 614076 (3)
DTX1	G:602582	.	.
DTX2	G:613141	.	.
DTX3	G:613142	.	.
DTX3L	G:613143	.	.
DTYMK	G:188345	.	.
DUOX1	G:606758	.	.
DUOX2	G:606759	.	Thryoid dyshormonogenesis 6, 607200 (3)
DUOXA1	G:612771	.	.
DUOXA2	G:612772	.	Thyroid dyshormonogenesis 5, 274900 (3)
DURS1	P:126800	.	.
DUS2L	G:609707	.	.
DUSP1	G:600714	.	.
DUSP10	G:608867	.	.
DUSP11	G:603092	.	.
DUSP12	G:604835	.	.
DUSP13	G:613191	.	.
DUSP14	G:606618	.	.
DUSP16	G:607175	.	.
DUSP18	G:611446	.	.
DUSP19	G:611437	.	.
DUSP2	G:603068	.	.
DUSP21	G:300678	.	.
DUSP3	G:600183	.	.
DUSP4	G:602747	.	.
DUSP5	G:603069	.	.
DUSP6	G:602748	.	.
DUSP7	G:602749	.	.
DUSP8	G:602038	.	.
DUSP9	G:300134	.	.
DUT	G:601266	.	.
DUX1	G:611441	.	.
DUX2	G:611442	.	.
DUX3	G:611443	.	.
DUX4	G:606009	.	.
DUX5	G:611444	.	.
DUXA	G:611168	.	.
DVL1	G:601365	.	.
DVL1L1	G:601225	.	.
DVL2	G:602151	.	.
DVL3	G:601368	.	.
DWS	P:220200	.	.
DYM	G:607461	.	Dyggve-Melchior-Clausen disease, 223800 (3)
DYM	G:607461	.	Smith-McCort dysplasia, 607326 (3)
DYNC1H1	G:600112	+GR-Bell	Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)
DYNC1I1	G:603772	.	.
DYNC1I2	G:603331	.	.
DYNC1LI2	G:611406	.	.
DYNC2H1	G:603297	.	Asphyxiating thoracic dystrophy 3, 613091 (3)
DYNC2H1	G:603297	.	Short rib-polydactyly syndrome, type II, digenic, 263520 (3)
DYNC2H1	G:603297	.	Short rib-polydactyly syndrome, type III, 263510 (3)
DYNLL1	G:601562	.	.
DYNLL2	G:608942	.	.
DYNLRB1	G:607167	.	.
DYNLRB2	G:607168	.	.
DYNLT1	G:601554	.	.
DYNLT3	G:300302	.	.
DYRK1A	G:600855	.	Mental retardation, autosomal dominant 7, 614104 (3)
DYRK1B	G:604556	.	.
DYRK2	G:603496	.	.
DYRK3	G:603497	.	.
DYRK4	G:609181	.	.
DYSF	G:603009	+GR-Bell	Miyoshi muscular dystrophy 1, 254130 (3)
DYSF	G:603009	+GR-Bell	Muscular dystrophy, limb-girdle, type 2B, 253601 (3)
DYSF	G:603009	+GR-Bell	Myopathy, distal, with anterior tibial onset, 606768 (3)
DYT10	P:128200	.	.
DYT13	P:607671	.	.
DYT15	P:607488	.	.
DYT17	P:612406	.	.
DYT2	P:224500	.	.
DYT4	P:128101	.	.
DYT7	P:602124	.	.
DYX1	P:127700	.	.
DYX1C1	G:608706	.	{Dyslexia, susceptibility to, 1}, 127700 (3)
DYX3	P:604254	.	.
DYX5	P:606896	.	.
DYX6	P:606616	.	.
DYX8	P:608995	.	.
DYX9	P:300509	.	.
DZIP1	G:608671	.	.
DZIP3	G:608672	.	.
E11S	P:129150	.	.
E2F1	G:189971	.	.
E2F2	G:600426	.	.
E2F3	G:600427	.	.
E2F4	G:600659	.	.
E2F5	G:600967	.	.
E2F6	G:602944	.	.
E2F7	G:612046	.	.
E2F8	G:612047	.	.
E4F1	G:603022	.	.
EAF1	G:608315	.	.
EAF2	G:607659	.	.
EAPP	G:609486	.	.
EARS2	G:612799	.	.
EBAG9	G:605772	.	.
EBF1	G:164343	.	.
EBF2	G:609934	.	.
EBF3	G:607407	.	.
EBF4	G:609935	.	.
EBI3	G:605816	.	.
EBLN1	G:613249	.	.
EBLN2	G:613250	.	.
EBM	P:302000	.	.
EBNA1BP2	G:614443	.	.
EBP	G:300205	+GR-Bell	Chondrodysplasia punctata, X-linked dominant, 302960 (3)
EBR3	P:226500	.	.
EBVS1	P:132850	.	.
ECA1	P:600131	.	.
ECE1	G:600423	+GR-Bell	Hirschsprung disease, cardiac defects, and autonomic dysfunction, 613870 (3)
ECE1	G:600423	+GR-Bell	{Hypertension, essential, susceptibility to}, 145500 (3)
ECE2	G:610145	.	.
ECEL1	G:605896	.	.
ECH1	G:600696	.	.
ECHDC1	G:612136	.	.
ECHS1	G:602292	.	.
ECI1	G:600305	.	.
ECI2	G:608024	.	.
ECM1	G:602201	.	Lipoid proteinosis, 247100 (3)
ECM2	G:603479	.	.
ECSIT	G:608388	.	.
ECT2	G:600586	.	.
EDA	G:300451	Bell>cutaneous	Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3)
EDA	G:300451	Bell>cutaneous	Tooth agenesis, selective, X-linked 1, 313500 (3)
EDA2R	G:300276	.	.
EDAR	G:604095	+GR-Bell	Ectodermal dysplasia, hypohidrotic, autosomal dominant, 129490 (3)
EDAR	G:604095	+GR-Bell	Ectodermal dysplasia, hypohidrotic, autosomal recessive, 224900 (3)
EDAR	G:604095	+GR-Bell	[Hair morphology 1, hair thickness], 612630 (3)
EDARADD	G:606603	+GR-Bell	Ectodermal dysplasia, anhidrotic, autosomal dominant, 129490 (3)
EDARADD	G:606603	+GR-Bell	Ectodermal dysplasia, anhidrotic, autosomal recessive, 224900 (3)
EDC3	G:609842	.	.
EDC4	G:606030	.	.
EDDM3A	G:611580	.	.
EDDM3B	G:611582	.	.
EDEM1	G:607673	.	.
EDEM2	G:610302	.	.
EDEM3	G:610214	.	.
EDF1	G:605107	.	.
EDIL3	G:606018	.	.
EDN1	GP:131240	.	.
EDN2	G:131241	.	.
EDN3	G:131242	Bell>cutaneous	Central hypoventilation syndrome, congenital, 209880 (3)
EDN3	G:131242	Bell>cutaneous	Waardenburg syndrome, type 4B, 613265 (3)
EDN3	G:131242	Bell>cutaneous	{Hirschsprung disease, susceptibility to, 4}, 613712 (3)
EDNRA	G:131243	.	Migraine, resistance to, 157300 (3)
EDNRB	G:131244	Bell>cutaneous	ABCD syndrome, 600501 (3)
EDNRB	G:131244	Bell>cutaneous	ABCD syndrome, 600501 (3)
EDNRB	G:131244	Bell>cutaneous	Waardenburg syndrome, type 4A, 277580 (3)
EDNRB	G:131244	Bell>cutaneous	Waardenburg syndrome, type 4A, 277580 (3)
EDNRB	G:131244	Bell>cutaneous	{Hirschsprung disease, susceptibility to, 2}, 600155 (3)
EDNRB	G:131244	Bell>cutaneous	{Hirschsprung disease, susceptibility to, 2}, 600155 (3)
EEA1	G:605070	.	.
EEC1	P:129900	.	.
EED	G:605984	.	.
EEF1A1	G:130590	.	.
EEF1A2	G:602959	.	.
EEF1B2	G:600655	.	.
EEF1B2P2	G:600656	.	.
EEF1B2P3	G:300140	.	.
EEF1D	G:130592	.	.
EEF1E1	G:609206	.	.
EEF1G	G:130593	.	.
EEF2	G:130610	.	.
EEF2K	G:606968	.	.
EEFSEC	G:607695	.	.
EEGV1	P:130180	.	.
EFCAB4A	G:614177	.	.
EFCAB4B	G:614178	.	.
EFEMP1	G:601548	.	Doyne honeycomb degeneration of retina, 126600 (3)
EFEMP2	G:604633	Bell>cutaneous	Cutis laxa, autosomal recessive, type IB, 614437 (3)
EFHA1	G:610632	.	.
EFHA2	G:610633	.	.
EFHC1	G:608815	.	{Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)
EFHC1	G:608815	.	{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3)
EFHC2	G:300817	.	.
EFHD1	G:611617	.	.
EFNA1	G:191164	.	.
EFNA2	G:602756	.	.
EFNA3	G:601381	.	.
EFNA4	G:601380	.	.
EFNA5	G:601535	.	.
EFNB1	G:300035	.	Craniofrontonasal dysplasia, 304110 (3)
EFNB2	G:600527	.	.
EFNB3	G:602297	.	.
EFR3A	G:611798	.	.
EFS	G:609906	.	.
EFTUD2	G:603892	.	Mandibulofacial dysostosis with microcephaly, 610536 (3)
EGF	G:131530	.	Hypomagnesemia 4, renal, 611718 (3)
EGFL6	G:300239	.	.
EGFL7	G:608582	.	.
EGFL8	G:609897	.	.
EGFR	G:131550	.	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3)
EGFR	G:131550	.	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3)
EGFR	G:131550	.	{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
EGI	P:600669	.	.
EGLN1	G:606425	.	Erythrocytosis, familial, 3, 609820 (3)
EGLN2	G:606424	.	.
EGLN3	G:606426	.	.
EGOT	G:611662	.	.
EGR1	G:128990	.	.
EGR2	G:129010	Bell>neurological	Charcot-Marie-Tooth disease, type 1D, 607678 (3)
EGR2	G:129010	Bell>neurological	Charcot-Marie-Tooth disease, type 1D, 607678 (3)
EGR2	G:129010	Bell>neurological	Dejerine-Sottas disease, 145900 (3)
EGR2	G:129010	Bell>neurological	Dejerine-Sottas disease, 145900 (3)
EGR2	G:129010	Bell>neurological	Neuropathy, congenital hypomyelinating, 1, 605253 (3)
EGR2	G:129010	Bell>neurological	Neuropathy, congenital hypomyelinating, 1, 605253 (3)
EGR3	G:602419	.	.
EGR4	G:128992	.	.
EHBP1	G:609922	.	{Prostate cancer, hereditary, 12}, 611868 (3)
EHD1	G:605888	.	.
EHD2	G:605890	.	.
EHD3	G:605891	.	.
EHD4	G:605892	.	.
EHF	G:605439	.	.
EHHADH	G:607037	.	.
EHMT1	G:607001	+GR-Bell	Kleefstra syndrome, 610253 (3)
EHMT2	G:604599	.	.
EI24	G:605170	.	.
EID1	G:605894	.	.
EID2	G:609773	.	.
EID3	G:612986	.	.
EIF1AX	G:300186	.	.
EIF1AY	G:400014	.	.
EIF2A	G:609234	.	.
EIF2AK1	G:613635	.	.
EIF2AK2	G:176871	.	.
EIF2AK3	G:604032	Bell>skeletal	Wolcott-Rallison syndrome, 226980 (3)
EIF2AK4	G:609280	.	.
EIF2B1	G:606686	+GR-Bell	Leukoencephalopathy with vanishing white matter, 603896 (3)
EIF2B2	G:606454	+GR-Bell	Leukoencephalopathy with vanishing white matter, 603896 (3)
EIF2B2	G:606454	+GR-Bell	Ovarioleukodystrophy, 603896 (3)
EIF2B3	G:606273	+GR-Bell	Leukoencephalopathy with vanishing white matter, 603896 (3)
EIF2B4	G:606687	+GR-Bell	Leukoencephaly with vanishing white matter, 603896 (3)
EIF2B4	G:606687	+GR-Bell	Ovarioleukodystrophy, 603896 (3)
EIF2B5	G:603945	+GR-Bell	Leukoencephalopathy with vanishing white matter, 603896 (3)
EIF2B5	G:603945	+GR-Bell	Ovarioleukodystrophy, 603896 (3)
EIF2C1	G:606228	.	.
EIF2C2	G:606229	.	.
EIF2C3	G:607355	.	.
EIF2C4	G:607356	.	.
EIF2D	G:613709	.	.
EIF2S1	G:603907	.	.
EIF2S2	G:603908	.	.
EIF2S3	G:300161	.	.
EIF3A	G:602039	.	.
EIF3B	G:603917	.	.
EIF3C	G:603916	.	.
EIF3D	G:603915	.	.
EIF3E	G:602210	.	.
EIF3F	G:603914	.	.
EIF3G	G:603913	.	.
EIF3H	G:603912	.	.
EIF3I	G:603911	.	.
EIF3J	G:603910	.	.
EIF3K	G:609596	.	.
EIF3M	G:609641	.	.
EIF4A1	G:602641	.	.
EIF4A2	G:601102	.	.
EIF4A3	G:608546	.	.
EIF4B	G:603928	.	.
EIF4E	G:133440	.	.
EIF4E2	G:605895	.	.
EIF4E3	G:609896	.	.
EIF4EBP1	G:602223	.	.
EIF4EBP2	G:602224	.	.
EIF4EBP3	G:603483	.	.
EIF4ENIF1	G:607445	.	.
EIF4G1	G:600495	.	Parkinson disease 18, 614251 (3)
EIF4G2	G:602325	.	.
EIF4G3	G:603929	.	.
EIF4H	G:603431	.	.
EIF5	G:601710	.	.
EIF5A	G:600187	.	.
EIF5A2	G:605782	.	.
EIF5B	G:606086	.	.
EIF6	G:602912	.	.
EJM2	P:604827	.	.
EKV3	P:609313	.	.
ELAC1	G:608079	.	.
ELAC2	G:605367	.	{Prostate cancer, susceptibility to}, 176807 (3)
ELANE	G:130130	+GR-Bell	Neutropenia, cyclic, 162800 (3)
ELANE	G:130130	+GR-Bell	Neutropenia, severe congenital 1, autosomal dominant, 202700 (3)
ELAVL1	G:603466	.	.
ELAVL2	G:601673	.	.
ELAVL3	G:603458	.	.
ELAVL4	G:168360	.	.
ELF1	G:189973	.	.
ELF3	G:602191	.	.
ELF4	G:300775	.	.
ELF5	G:605169	.	.
ELK1	G:311040	.	.
ELK3	G:600247	.	.
ELK4	G:600246	.	.
ELL	G:600284	.	.
ELL2	G:601874	.	.
ELL3	G:609885	.	.
ELMO1	G:606420	.	.
ELMO2	G:606421	.	.
ELMO3	G:606422	.	.
ELMOD2	G:610196	.	.
ELN	G:130160	+GR-Bell	Cutis laxa, AD, 123700 (3)
ELN	G:130160	+GR-Bell	Supravalvar aortic stenosis, 185500 (3)
ELOVL1	G:611813	.	.
ELOVL2	G:611814	.	.
ELOVL3	G:611815	.	.
ELOVL4	G:605512	.	Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3)
ELOVL4	G:605512	.	Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3)
ELOVL4	G:605512	.	Stargardt disease 3, 600110 (3)
ELOVL5	G:611805	.	.
ELOVL6	G:611546	.	.
ELOVL7	G:614451	.	.
ELP3	G:612722	.	.
ELP4	G:606985	.	.
ELSPBP1	G:607443	.	.
EMCN	G:608350	.	.
EMD	G:300384	+GR-Bell	Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)
EME1	G:610885	.	.
EME2	G:610886	.	.
EMG1	G:611531	.	Bowen-Conradi syndrome, 211180 (3)
EMID1	G:608926	.	.
EMID2	G:608927	.	.
EMILIN1	G:130660	.	.
EMILIN2	G:608928	.	.
EMILIN3	G:608929	.	.
EML1	G:602033	.	.
EML4	G:607442	.	.
EMP1	G:602333	.	.
EMP2	G:602334	.	.
EMP3	G:602335	.	.
EMR1	G:600493	.	.
EMR2	G:606100	.	.
EMR3	G:606101	.	.
EMR4P	G:612305	.	.
EMWX	P:300211	.	.
EMX1	G:600034	.	.
EMX2	G:600035	.	Schizencephaly, 269160 (3)
EMX2OS	G:607637	.	.
EN1	G:131290	.	.
EN2	G:131310	.	{Autism susceptibility 10}, 611016 (3)
ENAH	G:609061	.	.
ENAM	G:606585	.	Amelogenesis imperfecta, type IB, 104500 (3)
ENAM	G:606585	.	Amelogenesis imperfecta, type IC, 204650 (3)
ENC1	G:605173	.	.
ENDOG	G:600440	.	.
ENDOU	G:606720	.	.
ENG	G:131195	+GR-Bell	Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)
ENGASE	G:611898	.	.
ENKUR	G:611025	.	.
ENO1	G:172430	.	.
ENO2	G:131360	.	.
ENO3	G:131370	.	Glycogen storage disease XIII, 612932 (3)
ENOSF1	G:607427	.	.
ENOX1	G:610914	.	.
ENOX2	G:300282	.	.
ENPEP	G:138297	.	.
ENPP1	G:173335	Bell>cardiac	Arterial calcification, generalized, of infancy, 1, 208000 (3)
ENPP1	G:173335	Bell>cardiac	Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)
ENPP1	G:173335	Bell>cardiac	Ossification of posterior longitudinal ligament of spine, 602475 (3)
ENPP1	G:173335	Bell>cardiac	{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3)
ENPP1	G:173335	Bell>cardiac	{Obesity, susceptibility to}, 601665 (3)
ENPP2	G:601060	.	.
ENPP3	G:602182	.	.
ENSA	G:603061	.	.
ENTPD1	G:601752	.	.
ENTPD2	G:602012	.	.
ENTPD3	G:603161	.	.
ENTPD4	G:607577	.	.
ENTPD5	G:603162	.	.
ENTPD6	G:603160	.	.
ENUR1	P:600631	.	.
ENUR2	P:600808	.	.
EOMES	G:604615	.	.
EP300	G:602700	+GR-Bell	Colorectal cancer, 114500 (3)
EP300	G:602700	+GR-Bell	Rubinstein-Taybi syndrome 2, 613684 (3)
EP400	G:606265	.	.
EPAS1	G:603349	.	Erythrocytosis, familial, 4, 611783 (3)
EPB41	G:130500	.	Elliptocytosis-1, 611804 (3)
EPB41L1	G:602879	.	Mental retardation, autosomal dominant 11, 614257 (3)
EPB41L2	G:603237	.	.
EPB41L3	G:605331	.	.
EPB41L4A	G:612141	.	.
EPB41L4B	G:610340	.	.
EPB41L5	G:611730	.	.
EPB42	G:177070	.	Spherocytosis, hereditary, type 5, 612690 (3)
EPB49	G:125305	.	.
EPC1	G:610999	.	.
EPC2	G:611000	.	.
EPCAM	G:185535	+GR-Bell	Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)
EPCAM	G:185535	+GR-Bell	Diarrhea 5, with tufting enteropathy, congenital, 613217 (3)
EPHA1	G:179610	.	.
EPHA10	G:611123	.	.
EPHA2	G:176946	.	Cataract, age-related cortical, 2, 613020 (3)
EPHA2	G:176946	.	Cataract, posterior polar, 1, 116600 (3)
EPHA3	G:179611	.	.
EPHA4	G:602188	.	.
EPHA5	G:600004	.	.
EPHA6	G:600066	.	.
EPHA7	G:602190	.	.
EPHA8	G:176945	.	.
EPHB1	G:600600	.	.
EPHB2	G:600997	.	Prostate cancer, progression and metastasis of, 603688 (3)
EPHB3	G:601839	.	.
EPHB4	G:600011	.	.
EPHB6	G:602757	.	.
EPHX1	GP:132810	.	Hypercholanemia, familial, 607748 (3)
EPHX1	GP:132810	.	{Preeclampsia, susceptibility to}, 189800 (3)
EPHX2	G:132811	.	{Hypercholesterolemia, familial, due to LDLR defect, modifier of}, 143890 (3)
EPM2A	G:607566	Bell>neurological	Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3)
EPM2AIP1	G:607911	.	.
EPN1	G:607262	.	.
EPN2	G:607263	.	.
EPN3	G:607264	.	.
EPO	G:133170	.	{Microvascular complications of diabetes 2}, 612623 (3)
EPOR	G:133171	.	[Erythrocytosis, familial, 1], 133100 (3)
EPPK1	G:607553	.	.
EPRS	G:138295	.	.
EPS15	G:600051	.	.
EPS8	G:600206	.	.
EPSTI1	G:607441	.	.
EPT1	G:607915	.	.
EPX	G:131399	.	Eosinophil peroxidase deficiency, 261500 (3)
EPYC	G:601657	.	.
ERAL1	G:607435	.	.
ERAP1	G:606832	.	.
ERAP2	G:609497	.	.
ERAS	G:300437	.	.
ERBB2	G:164870	.	Adenocarcinoma of lung, somatic, 211980 (3)
ERBB2	G:164870	.	Gastric cancer, somatic, 137215 (3)
ERBB2	G:164870	.	Glioblastoma, somatic, 137800 (3)
ERBB2	G:164870	.	Ovarian cancer, somatic, (3)
ERBB2IP	G:606944	.	.
ERBB3	G:190151	Bell>developmental	Lethal congenital contractural syndrome 2, 607598 (3)
ERBB4	G:600543	.	.
ERC1	G:607127	.	.
ERCC1	G:126380	+GR-Bell	Cerebrooculofacioskeletal syndrome 4, 610758 (3)
ERCC2	G:126340	Bell>cutaneous	Cerebrooculofacioskeletal syndrome 2, 610756 (3)
ERCC2	G:126340	Bell>cutaneous	Cerebrooculofacioskeletal syndrome 2, 610756 (3)
ERCC2	G:126340	Bell>cutaneous	Trichothiodystrophy, 601675 (3)
ERCC2	G:126340	Bell>cutaneous	Trichothiodystrophy, 601675 (3)
ERCC2	G:126340	Bell>cutaneous	Xeroderma pigmentosum, group D, 278730 (3)
ERCC2	G:126340	Bell>cutaneous	Xeroderma pigmentosum, group D, 278730 (3)
ERCC3	G:133510	Bell>cutaneous	Trichothiodystrophy, 601675 (3)
ERCC3	G:133510	Bell>cutaneous	Trichothiodystrophy, 601675 (3)
ERCC3	G:133510	Bell>cutaneous	Xeroderma pigmentosum, group B, 610651 (3)
ERCC3	G:133510	Bell>cutaneous	Xeroderma pigmentosum, group B, 610651 (3)
ERCC4	G:133520	Bell>cutaneous	XFE progeroid syndrome, 610965 (3)
ERCC4	G:133520	Bell>cutaneous	Xeroderma pigmentosum, group F, 278760 (3)
ERCC5	G:133530	Bell>cutaneous	Xeroderma pigmentosum, group G, 278780 (3)
ERCC6	G:609413	Bell>cutaneous	Cerebrooculofacioskeletal syndrome 1, 214150 (3)
ERCC6	G:609413	Bell>cutaneous	Cockayne syndrome, type B, 133540 (3)
ERCC6	G:609413	Bell>cutaneous	De Sanctis-Cacchione syndrome, 278800 (3)
ERCC6	G:609413	Bell>cutaneous	UV-sensitive syndrome, 600630 (3)
ERCC6	G:609413	Bell>cutaneous	{Lung cancer, susceptibility to}, 211980 (3)
ERCC6	G:609413	Bell>cutaneous	{Macular degeneration, age-related, susceptibility to 5}, 613761 (3)
ERCC6	G:609413	Bell>developmental	Cerebrooculofacioskeletal syndrome 1, 214150 (3)
ERCC6	G:609413	Bell>developmental	Cockayne syndrome, type B, 133540 (3)
ERCC6	G:609413	Bell>developmental	De Sanctis-Cacchione syndrome, 278800 (3)
ERCC6	G:609413	Bell>developmental	UV-sensitive syndrome, 600630 (3)
ERCC6	G:609413	Bell>developmental	{Lung cancer, susceptibility to}, 211980 (3)
ERCC6	G:609413	Bell>developmental	{Macular degeneration, age-related, susceptibility to 5}, 613761 (3)
ERCC6	G:609413	Bell>neurological	Cerebrooculofacioskeletal syndrome 1, 214150 (3)
ERCC6	G:609413	Bell>neurological	Cockayne syndrome, type B, 133540 (3)
ERCC6	G:609413	Bell>neurological	De Sanctis-Cacchione syndrome, 278800 (3)
ERCC6	G:609413	Bell>neurological	UV-sensitive syndrome, 600630 (3)
ERCC6	G:609413	Bell>neurological	{Lung cancer, susceptibility to}, 211980 (3)
ERCC6	G:609413	Bell>neurological	{Macular degeneration, age-related, susceptibility to 5}, 613761 (3)
ERCC6L	G:300687	.	.
ERCC8	G:609412	Bell>neurological	Cockayne syndrome, type A, 216400 (3)
ERCM1	G:133535	.	.
ERDA1	G:603279	.	.
EREG	G:602061	.	.
ERF	G:611888	.	.
ERG	G:165080	.	.
ERGIC2	G:612236	.	.
ERH	G:601191	.	.
ERI1	G:608739	.	.
ERI3	G:609917	.	.
ERLEC1	G:611229	.	.
ERLIN1	G:611604	.	.
ERLIN2	G:611605	.	Spastic paraplegia-18, 611225 (3)
ERMAP	G:609017	.	[Blood group, Radin], 111620 (3)
ERMAP	G:609017	.	[Blood group, Scianna system], 111750 (3)
ERMN	G:610072	.	.
ERMP1	G:611156	.	.
ERN1	G:604033	.	.
ERN2	G:604034	.	.
ERP27	G:610642	.	.
ERP29	G:602287	.	.
ERP44	G:609170	.	.
ERPL1	G:131190	.	.
ERPL2	G:131180	.	.
ERRFI1	G:608069	.	.
ERV3-1	G:131170	.	.
ERVE-1	G:606601	.	.
ERVFRD-1	G:610524	.	.
ERVK-4	G:614011	.	.
ERVK-5	G:614012	.	.
ERVK-6	G:605626	.	.
ERVK-7	G:614013	.	.
ERVW-1	G:604659	.	.
ESA4	G:133220	.	.
ESAM	G:614281	.	.
ESAT	G:133250	.	.
ESB3	G:133290	.	.
ESCO1	G:609674	.	.
ESCO2	G:609353	Bell>developmental	Roberts syndrome, 268300 (3)
ESCO2	G:609353	Bell>developmental	SC phocomelia syndrome, 269000 (3)
ESD	G:133280	.	.
ESM1	G:601521	.	.
ESPL1	G:604143	.	.
ESPN	G:606351	.	Deafness, autosomal recessive 36, 609006 (3)
ESPN	G:606351	.	Deafness, neurosensory, without vestibular involvement, autosomal dominant (3)
ESR1	GP:133430	.	{Atherosclerosis, susceptibility to} (3)
ESR1	GP:133430	.	{HDL response to hormone replacement, augmented} (3)
ESR1	GP:133430	.	{Migraine, susceptibility to}, 157300 (3)
ESR1	GP:133430	.	{Myocardial infarction, susceptibility to}, 608446 (3)
ESR2	G:601663	.	.
ESRG	G:611473	.	.
ESRP1	G:612959	.	.
ESRP2	G:612960	.	.
ESRRA	G:601998	.	.
ESRRB	G:602167	.	Deafness, autosomal recessive 35, 608565 (3)
ESRRG	G:602969	.	.
ESX1	G:300154	.	.
ETAA1	G:613196	.	.
ETF1	G:600285	.	.
ETFA	G:608053	Bell>metabolic	Glutaric acidemia IIA, 231680 (3)
ETFB	G:130410	Bell>metabolic	Glutaric acidemia IIB, 231680 (3)
ETFDH	G:231675	Bell>metabolic	Glutaric acidemia IIC, 231680 (3)
ETHE1	G:608451	Bell>metabolic	Ethylmalonic encephalopathy, 602473 (3)
ETM2	P:602134	.	.
ETNK1	G:609858	.	.
ETNK2	G:609859	.	.
ETS1	G:164720	.	.
ETS2	G:164740	.	.
ETV1	G:600541	.	.
ETV2	G:609358	.	.
ETV3	G:164873	.	.
ETV4	G:600711	.	.
ETV5	G:601600	.	.
ETV6	G:600618	.	Leukemia, acute myeloid, somatic, 601626 (3)
ETV7	G:605255	.	.
EVC	G:604831	.	Ellis-van Creveld syndrome, 225500 (3)
EVC	G:604831	.	Weyers acrodental dysostosis, 193530 (3)
EVC2	G:607261	.	Ellis-van Creveld syndrome, 225500 (3)
EVI2A	G:158380	.	.
EVI2B	G:158381	.	.
EVI5	G:602942	.	.
EVPL	G:601590	.	.
EVR3	P:605750	.	.
EVX1	G:142996	.	.
EVX2	G:142991	.	.
EWSR1	G:133450	.	Ewing sarcoma, 612219 (3)
EWSR1	G:133450	.	Neuroepithelioma, 612219 (3)
EXO1	G:606063	.	.
EXOC1	G:607879	.	.
EXOC3	G:608186	.	.
EXOC3L1	G:614117	.	.
EXOC4	G:608185	.	.
EXOC5	G:604469	.	.
EXOC6	G:609672	.	.
EXOC6B	G:607880	.	.
EXOC7	G:608163	.	.
EXOG	G:604051	.	.
EXOSC1	G:606493	.	.
EXOSC10	G:605960	.	.
EXOSC2	G:602238	.	.
EXOSC3	G:606489	.	.
EXOSC4	G:606491	.	.
EXOSC5	G:606492	.	.
EXOSC6	G:606490	.	.
EXOSC7	G:606488	.	.
EXOSC8	G:606019	.	.
EXOSC9	G:606180	.	.
EXPH5	G:612878	.	.
EXT1	G:608177	.	Chondrosarcoma, 215300 (3)
EXT1	G:608177	.	Exostoses, multiple, type 1, 133700 (3)
EXT2	G:608210	+GR-Bell	Exostoses, multiple, type 2, 133701 (3)
EXT3	P:600209	.	.
EXTL1	G:601738	.	.
EXTL2	G:602411	.	.
EXTL3	G:605744	.	.
EYA1	G:601653	+GR-Bell	Branchiootorenal syndrome with cataract, 113650 (3)
EYA1	G:601653	+GR-Bell	Branchiootorenal syndrome, 113650 (3)
EYA1	G:601653	+GR-Bell	Otofaciocervical syndrome, 166780 (3)
EYA2	G:601654	.	.
EYA3	G:601655	.	.
EYA4	G:603550	+GR-Bell	Cardiomyopathy, dilated, 1J, 605362 (3)
EYA4	G:603550	+GR-Bell	Deafness, autosomal dominant 10, 601316 (3)
EYS	G:612424	+GR-Bell	Retinitis pigmentosa 25, 602772 (3)
EZH1	G:601674	.	.
EZH2	G:601573	.	Weaver syndrome 2, 614421 (3)
EZR	G:123900	.	.
F10	G:613872	.	Factor X deficiency, 227600 (3)
F11	G:264900	Bell>hematologic	Factor XI deficiency, autosomal dominant, 612416 (3)
F11	G:264900	Bell>hematologic	Factor XI deficiency, autosomal recessive, 612416 (3)
F11R	G:605721	.	.
F12	G:610619	.	Angioedema, hereditary, type III, 610618 (3)
F12	G:610619	.	Factor XII deficiency, 234000 (3)
F13A1	G:134570	.	Factor XIIIA deficiency, 613225 (3)
F13A1	G:134570	.	{Myocardial infarction, protection against}, 608446 (3)
F13A1	G:134570	.	{Venous thrombosis, protection against}, 188050 (3)
F13B	G:134580	.	Factor XIIIB deficiency, 613235 (3)
F2R	G:187930	.	.
F2RL1	G:600933	.	.
F2RL2	G:601919	.	.
F2RL3	G:602779	.	.
F7R	134450	.	.
F8A1	G:305423	.	.
FA2H	G:611026	+GR-Bell	Spastic paraplegia 35, autosomal recessive, 612319 (3)
FAAH	GP:602935	.	{Drug addiction, susceptibility to} (3)
FAAH2	G:300654	.	.
FABP1	G:134650	.	.
FABP2	G:134640	.	.
FABP3	G:134651	.	.
FABP4	G:600434	.	.
FABP5	G:605168	.	.
FABP6	G:600422	.	.
FABP7	G:602965	.	.
FADD	G:602457	.	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malforamtions, 613759 (3)
FADS1	G:606148	.	.
FADS2	G:606149	.	.
FADS3	G:606150	.	.
FAF1	G:604460	.	.
FAH	G:613871	Bell>metabolic	Tyrosinemia, type I, 276700 (3)
FAIM2	G:604306	.	.
FAIM3	G:606015	.	.
FAM102A	G:610891	.	.
FAM103A1	G:614547	.	.
FAM107A	G:608295	.	.
FAM109A	G:614239	.	.
FAM109B	G:614240	.	.
FAM110A	G:611393	.	.
FAM110B	G:611394	.	.
FAM110C	G:611395	.	.
FAM120A	G:612265	.	.
FAM120B	G:612266	.	.
FAM120C	G:300741	.	.
FAM123B	G:300647	.	Osteopathia striata with cranial sclerosis, 300373 (3)
FAM126A	G:610531	Bell>neurological	Leukodystrophy, hypomyelinating, 5, 610532 (3)
FAM127A	G:300213	.	.
FAM129B	G:614045	.	.
FAM129C	G:609967	.	.
FAM134B	G:613114	+GR-Bell	Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3)
FAM13A	G:613299	.	.
FAM13A-AS1	G:613300	.	.
FAM13B	G:609371	.	.
FAM161A	G:613596	+GR-Bell	Retinitis pigmentosa 28, 606068 (3)
FAM162A	G:608017	.	.
FAM163A	G:611727	.	.
FAM167A	G:610085	.	.
FAM175A	G:611143	.	.
FAM175B	G:611144	.	.
FAM178A	G:610348	.	.
FAM188A	G:611649	.	.
FAM189A2	G:607710	.	.
FAM20A	G:611062	.	Amelogenesis imperfecta and gingival fibromatosis syndrome, 614253 (3)
FAM20B	G:611063	.	.
FAM20C	G:611061	Bell>skeletal	Raine syndrome, 259775 (3)
FAM21C	G:613631	.	.
FAM32A	G:614554	.	.
FAM3A	G:300492	.	.
FAM3B	G:608617	.	.
FAM3C	G:608618	.	.
FAM3D	G:608619	.	.
FAM46A	G:611357	.	.
FAM46C	G:613952	.	.
FAM48A	G:613417	.	.
FAM50A	G:300453	.	.
FAM53C	G:609372	.	.
FAM57A	G:611627	.	.
FAM58A	G:300708	.	STAR syndrome, 300707 (3)
FAM65B	G:611410	.	.
FAM69A	G:614542	.	.
FAM69B	G:614543	.	.
FAM69C	G:614544	.	.
FAM82A1	G:611872	.	.
FAM82A2	G:611873	.	.
FAM82B	G:611871	.	.
FAM83H	G:611927	.	Amelogenesis imperfecta, type 3, 130900 (3)
FAM84A	G:611234	.	.
FAM84B	G:609483	.	.
FAM90A1	G:613041	.	.
FAM90A10P	G:613047	.	.
FAM90A12P	G:613048	.	.
FAM90A13P	G:613049	.	.
FAM90A14P	G:613050	.	.
FAM90A15P	G:613051	.	.
FAM90A18P	G:613052	.	.
FAM90A19P	G:613053	.	.
FAM90A20P	G:613054	.	.
FAM90A3P	G:613042	.	.
FAM90A5P	G:613043	.	.
FAM90A7P	G:613044	.	.
FAM90A8P	G:613045	.	.
FAM90A9P	G:613046	.	.
FAM9A	G:300477	.	.
FAM9B	G:300478	.	.
FAM9C	G:300479	.	.
FAN1	G:613534	.	.
FANCA	G:607139	+GR-Bell	Fanconi anemia, complementation group A, 227650 (3)
FANCB	G:300515	Bell>developmental	Fanconi anemia, complementation group B, 300514 (3)
FANCC	G:613899	+GR-Bell	Fanconi anemia, complementation group C, 227645 (3)
FANCD2	G:613984	+GR-Bell	Fanconi anemia, complementation group D2, 227646 (3)
FANCE	G:613976	+GR-Bell	Fanconi anemia, complementation group E, 600901 (3)
FANCF	G:613897	+GR-Bell	Fanconi anemia, complementation group F, 603467 (3)
FANCG	G:602956	+GR-Bell	Fanconi anemia, complementation group G, 614082 (3)
FANCI	G:611360	+GR-Bell	Fanconi anemia, complementation group I, 609053 (3)
FANCL	G:608111	+GR-Bell	Fanconi anemia, complementation group L, 614083 (3)
FANCM	G:609644	+GR-Bell	Fanconi anemia, complementation group M, 614087 (3)
FANK1	G:611640	.	.
FAP	G:600403	.	.
FARP1	G:602654	.	.
FARS2	G:611592	.	.
FARSA	G:602918	.	.
FARSB	G:609690	.	.
FAS	G:134637	+GR-Bell	Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)
FAS	G:134637	+GR-Bell	Squamous cell carcinoma, burn scar-related, somatic (3)
FAS	G:134637	+GR-Bell	{Autoimmune lymphoproliferative syndrome}, 601859 (3)
FASLG	G:134638	+GR-Bell	{Systemic lupus erythematosus, susceptibility}, 152700 (3)
FASN	G:600212	.	.
FASTK	G:606965	.	.
FASTKD2	G:612322	.	Mitochondrial complex IV deficiency, 220110 (3)
FASTKD5	G:614272	.	.
FAT1	G:600976	.	.
FAT2	G:604269	.	.
FAT3	G:612483	.	.
FAT4	G:612411	.	.
FATE1	G:300450	.	.
FAU	G:134690	.	.
FBL	G:134795	.	.
FBLIM1	G:607747	.	.
FBLN1	G:135820	.	Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses, 608180 (3)
FBLN2	G:135821	.	.
FBLN5	G:604580	Bell>cutaneous	Cutis laxa, autosomal dominant 2, 614434 (3)
FBLN5	G:604580	Bell>cutaneous	Cutis laxa, autosomal recessive, type IA, 219100 (3)
FBLN5	G:604580	Bell>cutaneous	Macular degeneration, age-related, 3, 608895 (3)
FBLN7	G:611551	.	.
FBN1	G:134797	+GR-Bell	Acromicric dysplasia, 102370 (3)
FBN1	G:134797	+GR-Bell	Aortic aneurysm, ascending, and dissection (3)
FBN1	G:134797	+GR-Bell	Ectopia lentis, familial, 129600 (3)
FBN1	G:134797	+GR-Bell	Geleophysic dysplasia 2, 614185 (3)
FBN1	G:134797	+GR-Bell	MASS syndrome, 604308 (3)
FBN1	G:134797	+GR-Bell	Marfan syndrome, 154700 (3)
FBN1	G:134797	+GR-Bell	Shprintzen-Goldberg syndrome, 182212 (3)
FBN1	G:134797	+GR-Bell	Stiff skin syndrome, 184900 (3)
FBN1	G:134797	+GR-Bell	Weill-Marchesani syndrome 2, dominant, 608328 (3)
FBN2	G:612570	+GR-Bell	Contractural arachnodactyly, congenital, 121050 (3)
FBN3	G:608529	.	.
FBP1	G:611570	.	Fructose-1,6-bidphosphatase deficiency, 229700 (3)
FBP2	G:603027	.	.
FBRS	G:608601	.	.
FBXL12	G:609079	.	.
FBXL13	G:609080	.	.
FBXL14	G:609081	.	.
FBXL15	G:610287	.	.
FBXL16	G:609082	.	.
FBXL17	G:609083	.	.
FBXL18	G:609084	.	.
FBXL19	G:609085	.	.
FBXL2	G:605652	.	.
FBXL20	G:609086	.	.
FBXL21	G:609087	.	.
FBXL22	G:609088	.	.
FBXL3	G:605653	.	.
FBXL4	G:605654	.	.
FBXL5	G:605655	.	.
FBXL6	G:609076	.	.
FBXL7	G:605656	.	.
FBXL8	G:609077	.	.
FBXO10	G:609092	.	.
FBXO11	G:607871	.	.
FBXO15	G:609093	.	.
FBXO16	G:608519	.	.
FBXO17	G:609094	.	.
FBXO18	G:607222	.	.
FBXO2	G:607112	.	.
FBXO21	G:609095	.	.
FBXO22	G:609096	.	.
FBXO24	G:609097	.	.
FBXO25	G:609098	.	.
FBXO27	G:609099	.	.
FBXO28	G:609100	.	.
FBXO3	G:609089	.	.
FBXO30	G:609101	.	.
FBXO31	G:609102	.	.
FBXO32	G:606604	.	.
FBXO33	G:609103	.	[Bone mineral density QTL 12], 612560 (3)
FBXO34	G:609104	.	.
FBXO36	G:609105	.	.
FBXO38	G:608533	.	.
FBXO39	G:609106	.	.
FBXO4	G:609090	.	.
FBXO40	G:609107	.	.
FBXO41	G:609108	.	.
FBXO42	G:609109	.	.
FBXO43	G:609110	.	.
FBXO44	G:609111	.	.
FBXO45	G:609112	.	.
FBXO46	G:609117	.	.
FBXO47	G:609498	.	.
FBXO5	G:606013	.	.
FBXO6	G:605647	.	.
FBXO7	G:605648	.	Parkinson disease 15, autosomal recessive, 260300 (3)
FBXO8	G:605649	.	.
FBXO9	G:609091	.	.
FBXW10	G:611679	.	.
FBXW11	G:605651	.	.
FBXW12	G:609075	.	.
FBXW2	G:609071	.	.
FBXW4	G:608071	.	.
FBXW5	G:609072	.	.
FBXW7	G:606278	.	.
FBXW8	G:609073	.	.
FBXW9	G:609074	.	.
FCAMR	G:605484	.	.
FCAR	G:147045	.	.
FCER1A	G:147140	.	.
FCER1G	G:147139	.	.
FCER2	G:151445	.	.
FCGR1A	G:146760	.	[IgG receptor I, phagocytic, familial deficiency of] (3)
FCGR1B	G:601502	.	.
FCGR1C	G:601503	.	.
FCGR2A	G:146790	.	{Lupus nephritis, susceptibility to} (3)
FCGR2B	G:604590	.	{Malaria, resistance to}, 611162 (3)
FCGR2B	G:604590	.	{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
FCGR2C	G:612169	.	.
FCGR3A	G:146740	.	Neutropenia, alloimmune neonatal (3)
FCGR3A	G:146740	.	{Viral infections, recurrent} (3)
FCGR3B	G:610665	.	.
FCGRT	G:601437	.	.
FCHO1	G:613437	.	.
FCHO2	G:613438	.	.
FCMTE1	P:601068	.	.
FCMTE2	P:607876	.	.
FCN1	G:601252	.	.
FCN2	G:601624	.	.
FCN3	G:604973	.	Immunodeficiency due to ficolin 3 deficiency, 613860 (3)
FCP1	P:305435	.	.
FCRL1	G:606508	.	.
FCRL2	G:606509	.	.
FCRL3	G:606510	.	.
FCRL4	G:605876	.	.
FCRL5	G:605877	.	.
FCRL6	G:613562	.	.
FCRLA	G:606891	.	.
FCRLB	G:609251	.	.
FDCSP	G:607241	.	.
FDFT1	G:184420	.	.
FDPS	G:134629	.	.
FDX1	G:103260	.	.
FDXR	G:103270	.	.
FEB1	P:121210	.	.
FEB2	P:602477	.	.
FEB5	P:609255	.	.
FEB6	P:609253	.	.
FEB7	P:611515	.	.
FECH	G:612386	.	Protoporphyria, erythropoietic, autosomal recessive, 177000 (3)
FEM1A	G:613538	.	.
FEM1B	G:613539	.	.
FEM1C	G:608767	.	.
FEN1	G:600393	.	.
FER	G:176942	.	.
FERMT1	G:607900	.	Kindler syndrome, 173650 (3)
FERMT2	G:607746	.	.
FERMT3	G:607901	.	Leukocyte adhesion deficiency, type III, 612840 (3)
FES	G:190030	.	.
FETUB	G:605954	.	.
FEV	G:607150	.	.
FEZ1	G:604825	.	.
FEZ2	G:604826	.	.
FEZF1	G:613301	.	.
FEZF2	G:607414	.	.
FFAR1	G:603820	.	.
FFAR2	G:603823	.	.
FFAR3	G:603821	.	.
FGA	GP:134820	Bell>hematologic	Afibrinogenemia, congenital, 202400 (3)
FGA	GP:134820	Bell>hematologic	Amyloidosis, hereditary renal, 105200 (3)
FGA	GP:134820	Bell>hematologic	Dysfibrinogenemia, alpha type, causing bleeding diathesis (3)
FGA	GP:134820	Bell>hematologic	Dysfibrinogenemia, alpha type, causing recurrent thrombosis (3)
FGB	G:134830	Bell>hematologic	Afibrinogenemia, congenital, 202400 (3)
FGB	G:134830	Bell>hematologic	Dysfibrinogenemia, beta type (3)
FGB	G:134830	Bell>hematologic	Thrombophilia, dysfibrinogenemic (3)
FGD1	G:300546	.	Aarskog-Scott syndrome, 305400 (3)
FGD1	G:300546	.	Mental retardation, X-linked syndromic 16, 305400 (3)
FGD2	G:605091	.	.
FGD4	G:611104	Bell>neurological	Charcot-Marie-Tooth disease, type 4H, 609311 (3)
FGD6	G:613520	.	.
FGF1	G:131220	.	.
FGF10	G:602115	.	Aplasia of lacrimal and salivary glands, 180920 (3)
FGF10	G:602115	.	LADD syndrome, 149730 (3)
FGF11	G:601514	.	.
FGF12	G:601513	.	.
FGF13	G:300070	.	.
FGF14	G:601515	.	Spinocerebellar ataxia 27, 609307 (3)
FGF16	G:300827	.	.
FGF17	G:603725	.	.
FGF18	G:603726	.	.
FGF19	G:603891	.	.
FGF2	G:134920	.	.
FGF20	G:605558	.	.
FGF21	G:609436	.	.
FGF22	G:605831	.	.
FGF23	G:605380	.	Hypophosphatemic rickets, autosomal dominant, 193100 (3)
FGF23	G:605380	.	Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
FGF3	G:164950	.	Deafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 (3)
FGF4	G:164980	.	.
FGF5	G:165190	.	.
FGF6	G:134921	.	.
FGF7	G:148180	.	.
FGF8	G:600483	.	Kallmann syndrome 6, 612702 (3)
FGF9	G:600921	.	Multiple synostoses syndrome 3, 612961 (3)
FGFBP1	G:607737	.	.
FGFBP2	G:607713	.	.
FGFR1	G:136350	+GR-Bell	Hypogonadotropic hypogonadism, 146110 (3)
FGFR1	G:136350	+GR-Bell	Jackson-Weiss syndrome, 123150 (3)
FGFR1	G:136350	+GR-Bell	Kallmann syndrome 2, 147950 (3)
FGFR1	G:136350	+GR-Bell	Osteoglophonic dysplasia, 166250 (3)
FGFR1	G:136350	+GR-Bell	Pfeiffer syndrome, 101600 (3)
FGFR1	G:136350	+GR-Bell	Trigonocephaly 1, 190440 (3)
FGFR1OP	G:605392	.	.
FGFR1OP2	G:608858	.	.
FGFR2	G:176943	Bell>skeletal	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3)
FGFR2	G:176943	Bell>skeletal	Apert syndrome, 101200 (3)
FGFR2	G:176943	Bell>skeletal	Beare-Stevenson cutis gyrata syndrome, 123790 (3)
FGFR2	G:176943	Bell>skeletal	Craniosynostosis, nonspecific (3)
FGFR2	G:176943	Bell>skeletal	Crouzon syndrome, 123500 (3)
FGFR2	G:176943	Bell>skeletal	Gastric cancer, somatic, 137215 (3)
FGFR2	G:176943	Bell>skeletal	Jackson-Weiss syndrome, 123150 (3)
FGFR2	G:176943	Bell>skeletal	LADD syndrome, 149730 (3)
FGFR2	G:176943	Bell>skeletal	Pfeiffer syndrome, 101600 (3)
FGFR2	G:176943	Bell>skeletal	Saethre-Chotzen syndrome, 101400 (3)
FGFR2	G:176943	Bell>skeletal	Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3)
FGFR3	G:134934	+GR-Bell	Achondroplasia, 100800 (3)
FGFR3	G:134934	+GR-Bell	Bladder cancer, somatic, 109800 (3)
FGFR3	G:134934	+GR-Bell	CATSHL syndrome, 610474 (3)
FGFR3	G:134934	+GR-Bell	Cervical cancer, somatic, 603956 (3)
FGFR3	G:134934	+GR-Bell	Colorectal cancer, somatic, 114500 (3)
FGFR3	G:134934	+GR-Bell	Crouzon syndrome with acanthosis nigricans, 612247 (3)
FGFR3	G:134934	+GR-Bell	Hypochondroplasia, 146000 (3)
FGFR3	G:134934	+GR-Bell	LADD syndrome, 149730 (3)
FGFR3	G:134934	+GR-Bell	Muenke syndrome, 602849 (3)
FGFR3	G:134934	+GR-Bell	Nevus, keratinocytic, nonepidermolytic, 162900 (3)
FGFR3	G:134934	+GR-Bell	Spermatocytic seminoma, somatic, 273300 (3)
FGFR3	G:134934	+GR-Bell	Thanatophoric dysplasia, type I, 187600 (3)
FGFR3	G:134934	+GR-Bell	Thanatophoric dysplasia, type II, 187601 (3)
FGFR4	G:134935	.	.
FGFRL1	G:605830	.	.
FGG	G:134850	Bell>hematologic	Dysfibrinogenemia, gamma type (3)
FGG	G:134850	Bell>hematologic	Hypofibrinogenemia, gamma type (3)
FGG	G:134850	Bell>hematologic	Thrombophilia, dysfibrinogenemic (3)
FGGY	G:611370	.	.
FGL1	G:605776	.	.
FGL2	G:605351	.	.
FGR	G:164940	.	.
FGS2	P:300321	.	.
FGS3	P:300406	.	.
FGS5	P:300581	.	.
FHIT	G:601153	.	.
FHL1	G:300163	+GR-Bell	Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)
FHL1	G:300163	+GR-Bell	Myopathy, X-linked, with postural muscle atrophy, 300696 (3)
FHL1	G:300163	+GR-Bell	Myopathy, reducing body, X-linked, childhood-onset, 300718 (3)
FHL1	G:300163	+GR-Bell	Myopathy, reducing body, X-linked, severe early-onset, 300717 (3)
FHL1	G:300163	+GR-Bell	Scapuloperoneal myopathy, X-linked dominant, 300695 (3)
FHL2	G:602633	.	.
FHL3	G:602790	.	.
FHL5	G:605126	.	.
FHOD1	G:606881	.	.
FHOD3	G:609691	.	.
FIBCD1	G:613357	.	.
FIBP	G:608296	.	.
FIG4	G:609390	+GR-Bell	Amyotrophic lateral sclerosis 11, 612577 (3)
FIG4	G:609390	+GR-Bell	Charcot-Marie-Tooth disease, type 4J, 611228 (3)
FIGF	G:300091	.	.
FIGLA	G:608697	.	Premature ovarian failure 6, 612310 (3)
FIGN	G:605295	.	.
FILIP1	G:607307	.	.
FILIP1L	G:612993	.	.
FIP1L1	G:607686	.	.
FIS1	G:609003	.	.
FITM1	G:612028	.	.
FITM2	G:612029	.	.
FIZ1	G:609133	.	.
FJX1	G:612206	.	.
FKBP10	G:607063	.	Osteogenesis imperfecta, type XI, 610968 (3)
FKBP11	G:610571	.	.
FKBP14	G:614505	.	Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss, 614557 (3)
FKBP1A	G:186945	.	.
FKBP1B	G:600620	.	.
FKBP2	G:186946	.	.
FKBP3	G:186947	.	.
FKBP4	G:600611	.	.
FKBP5	G:602623	.	{Major depressive disorder and accelerated response to antidepressant drug treatment}, 608516 (3)
FKBP6	G:604839	.	.
FKBP7	G:607062	.	.
FKBP8	G:604840	.	.
FKRP	G:606596	Bell>neurological	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3)
FKRP	G:606596	Bell>neurological	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3)
FKRP	G:606596	Bell>neurological	Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3)
FKRP	G:606596	Bell>neurological	Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3)
FKRP	G:606596	Bell>neurological	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)
FKRP	G:606596	Bell>neurological	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)
FKTN	G:607440	Bell>neurological	Cardiomyopathy, dilated, 1X, 611615 (3)
FKTN	G:607440	Bell>neurological	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3)
FKTN	G:607440	Bell>neurological	Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3)
FKTN	G:607440	Bell>neurological	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)
FLAD1	G:610595	.	.
FLCN	G:607273	+GR-Bell	Birt-Hogg-Dube syndrome, 135150 (3)
FLCN	G:607273	+GR-Bell	Colorectal cancer, somatic, 114500 (3)
FLCN	G:607273	+GR-Bell	Pneumothorax, primary spontaneous, 173600 (3)
FLCN	G:607273	+GR-Bell	Renal carcinoma, chromophobe, somatic, 144700 (3)
FLG	G:135940	.	Ichthyosis vulgaris, 146700 (3)
FLG	G:135940	.	{Dermatitis, atopic, susceptibility to, 2}, 605803 (3)
FLI1	G:193067	.	.
FLII	G:600362	.	.
FLNA	G:300017	Bell>gastroenterologic	Cardiac valvular dysplasia, X-linked, 314400 (3)
FLNA	G:300017	Bell>gastroenterologic	FG syndrome 2, 300321 (3)
FLNA	G:300017	Bell>gastroenterologic	Frontometaphyseal dysplasia, 305620 (3)
FLNA	G:300017	Bell>gastroenterologic	Heterotopia, periventricular, 300049 (3)
FLNA	G:300017	Bell>gastroenterologic	Heterotopia, periventricular, ED variant, 300537 (3)
FLNA	G:300017	Bell>gastroenterologic	Intestinal pseudoobstruction, neuronal, 300048 (3)
FLNA	G:300017	Bell>gastroenterologic	Melnick-Needles syndrome, 309350 (3)
FLNA	G:300017	Bell>gastroenterologic	Otopalatodigital syndrome, type I, 311300 (3)
FLNA	G:300017	Bell>gastroenterologic	Otopalatodigital syndrome, type II, 304120 (3)
FLNA	G:300017	Bell>gastroenterologic	Terminal osseous dysplasia, 300244 (3)
FLNB	G:603381	+GR-Bell	Atelosteogenesis, type I, 108720 (3)
FLNB	G:603381	+GR-Bell	Atelosteogenesis, type III, 108721 (3)
FLNB	G:603381	+GR-Bell	Boomerang dysplasia, 112310 (3)
FLNB	G:603381	+GR-Bell	Larsen syndrome, 150250 (3)
FLNB	G:603381	+GR-Bell	Spondylocarpotarsal synostosis syndrome, 272460 (3)
FLNC	G:102565	+GR-Bell	Myopathy, distal, 4, 614065 (3)
FLNC	G:102565	+GR-Bell	Myopathy, myofibrillar, 5, 609524 (3)
FLOT1	G:606998	.	.
FLOT2	G:131560	.	.
FLRT1	G:604806	.	.
FLRT2	G:604807	.	.
FLRT3	G:604808	.	.
FLT1	G:165070	.	.
FLT3	G:136351	.	Leukemia, acute lymphoblastic (3)
FLT3	G:136351	.	Leukemia, acute myeloid, 601626 (3)
FLT3	G:136351	.	Leukemia, acute myeloid, reduced survival in (3)
FLT3LG	G:600007	.	.
FLT4	G:136352	+GR-Bell	Hemangioma, capillary infantile, somatic, 602089 (3)
FLT4	G:136352	+GR-Bell	Lymphedema, hereditary I, 153100 (3)
FLVCR1	G:609144	.	Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)
FLVCR1-AS1	G:610864	.	.
FLVCR2	G:610865	.	Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome, 225790 (3)
FMN1	G:136535	.	.
FMN2	G:606373	.	.
FMNL1	G:604656	.	.
FMO1	G:136130	.	.
FMO2	G:603955	.	.
FMO3	G:136132	+GR-Bell	Trimethylaminuria, 602079 (3)
FMO4	G:136131	.	.
FMO5	G:603957	.	.
FMOD	G:600245	.	.
FMR1	G:309550	+GR-Bell	Fragile X syndrome, 300624 (3)
FMR1	G:309550	+GR-Bell	Fragile X tremor/ataxia syndrome, 300623 (3)
FMR1	G:309550	+GR-Bell	Premature ovarian failure 1, 311360 (3)
FMR1-AS1	G:300805	.	.
FN1	G:135600	.	Glomerulopathy with fibronectin deposits 2, 601894 (3)
FN3K	G:608425	.	.
FN3KRP	G:611683	.	.
FNBP1	G:606191	.	.
FNBP1L	G:608848	.	.
FNDC1	G:609991	.	.
FNDC3B	G:611909	.	.
FNDC4	G:611905	.	.
FNDC5	G:611906	.	.
FNIP1	G:610594	.	.
FNIP2	G:612768	.	.
FNTA	G:134635	.	.
FNTB	G:134636	.	.
FOLH1	G:600934	.	.
FOLH1B	G:609020	.	.
FOLR1	G:136430	.	Neurodegeneration due to cerebral folate transport deficiency, 613068 (3)
FOLR2	G:136425	.	.
FOLR3	G:602469	.	.
FOS	G:164810	.	.
FOSB	G:164772	.	.
FOSL1	G:136515	.	.
FOSL2	G:601575	.	.
FOXA1	G:602294	.	.
FOXA2	G:600288	.	.
FOXA3	G:602295	.	.
FOXC1	G:601090	.	Axenfeld-Rieger syndrome, type 3, 602482 (3)
FOXC1	G:601090	.	Iridogoniodysgenesis, type 1, 601631 (3)
FOXC1	G:601090	.	Iris hypoplasia and glaucoma, 601631 (3)
FOXC1	G:601090	.	Rieger or Axenfeld anomalies, 602482 (3)
FOXC2	G:602402	+GR-Bell	Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 (3)
FOXC2	G:602402	+GR-Bell	Lymphedema-distichiasis syndrome, 153400 (3)
FOXD1	G:601091	.	.
FOXD2	G:602211	.	.
FOXD3	G:611539	.	{Autoimmune disease, susceptibility to, 1}, 607836 (3)
FOXD4	G:601092	.	.
FOXD4L1	G:611084	.	.
FOXD4L2	G:611085	.	.
FOXD4L3	G:611086	.	.
FOXE1	G:602617	.	Bamforth-Lazarus syndrome, 241850 (3)
FOXE3	G:601094	.	Anterior segment mesenchymal dysgenesis, 107250 (3)
FOXE3	G:601094	.	Aphakia, congenital primary, 610256 (3)
FOXF1	G:601089	.	Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3)
FOXF2	G:603250	.	.
FOXG1	G:164874	.	Rett syndrome, congenital variant, 613454 (3)
FOXH1	G:603621	.	.
FOXI1	G:601093	+GR-Bell	Enlarged vestibular aqueduct, 600791 (3)
FOXI3	G:612351	.	.
FOXJ1	G:602291	.	.
FOXK2	G:147685	.	.
FOXL1	G:603252	.	.
FOXL2	G:605597	+GR-Bell	Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3)
FOXL2	G:605597	+GR-Bell	Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3)
FOXL2	G:605597	+GR-Bell	Premature ovarian failure 3, 608996 (3)
FOXM1	G:602341	.	.
FOXN1	G:600838	Bell>immunodeficiency	T-cell immunodeficiency, congenital alopecia, and nail dystrophy, 601705 (3)
FOXN2	G:143089	.	.
FOXN3	G:602628	.	.
FOXN4	G:609429	.	.
FOXO1	G:136533	.	Rhabdomyosarcoma, alveolar, 268220 (3)
FOXO3	G:602681	.	.
FOXO4	G:300033	.	.
FOXO6	G:611457	.	.
FOXP1	G:605515	.	Mental retardation with language impairment and autistic features, 613670 (3)
FOXP2	G:605317	.	Speech-language disorder-1, 602081 (3)
FOXP3	G:300292	Bell>immunodeficiency	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3)
FOXP3	G:300292	Bell>immunodeficiency	{Diabetes mellitus, type I, susceptibility to}, 222100 (3)
FOXP4	G:608924	.	.
FOXQ1	G:612788	.	.
FOXRED1	G:613622	.	Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)
FOXRED1	G:613622	.	Mitochondrial complex I deficiency, 252010 (3)
FOXRED2	G:613777	.	.
FOXS1	G:602939	.	.
FPGS	G:136510	.	.
FPGT	G:603609	.	.
FPR1	G:136537	.	.
FPR2	G:136538	.	.
FPR3	G:136539	.	.
FRA10A	P:136620	.	.
FRA10AC1	GP:608866	.	.
FRA11B	P:600651	.	.
FRA12A	P:136630	.	.
FRA16A	P:136570	.	.
FRA16B	P:136580	.	.
FRA17A	P:136660	.	.
FRA20A	P:136590	.	.
FRA2A	P:136610	.	.
FRA9B	P:136640	.	.
FRAS1	G:607830	Bell>developmental	Fraser syndrome, 219000 (3)
FRAT1	G:602503	.	.
FRAT2	G:605006	.	.
FRDA2	P:601992	.	.
FREM1	G:608944	.	Bifid nose with or without anorectal and renal anomalies, 608980 (3)
FREM1	G:608944	.	Manitoba oculotrichoanal syndrome, 248450 (3)
FREM1	G:608944	.	Trigonocephaly 2, 614485 (3)
FREM2	G:608945	Bell>developmental	Fraser syndrome, 219000 (3)
FREM3	G:608946	.	.
FRG1	G:601278	.	.
FRG2	G:609032	.	.
FRK	G:606573	.	.
FRMD3	G:607619	.	.
FRMD6	G:614555	.	.
FRMD7	G:300628	+GR-Bell	Nystagmus 1, congenital, X-linked, 310700 (3)
FRMD7	G:300628	+GR-Bell	Nystagmus, infantile periodic alternating, X-linked, 310700 (3)
FRMPD2	G:613323	.	.
FRMPD4	G:300838	.	.
FRRS1	G:611578	.	.
FRRS1L	G:604574	.	.
FRS2	G:607743	.	.
FRS3	G:607744	.	.
FRZB	G:605083	.	{Osteoarthritis susceptibility 1}, 165720 (3)
FSCB	G:611779	.	.
FSCN1	G:602689	.	.
FSCN2	G:607643	+GR-Bell	Retinitis pigmentosa 30, 607921 (3)
FSD1	G:609828	.	.
FSD1L	G:609829	.	.
FSHB	G:136530	.	Follicle-stimulating hormone deficiency, isolated, 229070 (3)
FSHMD1A	P:158900	.	.
FSHMD1B	P:158901	.	.
FSHR	G:136435	.	Ovarian dysgenesis 1, 233300 (3)
FSHR	G:136435	.	Ovarian hyperstimulation syndrome, 608115 (3)
FSHR	G:136435	.	Ovarian response to FSH stimulation, 276400 (3)
FST	G:136470	.	.
FSTL1	G:605547	.	.
FSTL3	G:605343	.	.
FTCD	G:606806	.	Glutamate formiminotransferase deficiency, 229100 (3)
FTH1	GP:134770	.	Iron overload, autosomal dominant (3)
FTHL17	G:300308	.	.
FTL	G:134790	.	Hyperferritinemia-cataract syndrome, 600886 (3)
FTL	G:134790	.	Neurodegeneration with brain iron accumulation 3, 606159 (3)
FTMT	G:608847	.	.
FTO	G:610966	.	Growth retardation, developmental delay, coarse facies, and early death, 612938 (3)
FTSJ1	G:300499	.	Mental retardation, X-linked 9, 309549 (3)
FTSJ2	G:606906	.	.
FUBP1	G:603444	.	.
FUBP3	G:603536	.	.
FUCA1	G:612280	Bell>metabolic	Fucosidosis, 230000 (3)
FUCA2	G:136820	.	.
FUK	G:608675	.	.
FURIN	G:136950	.	.
FUS	G:137070	+GR-Bell	Amyotrophic lateral sclerosis 6, autosomal recessive, with or without frontotemporal dementia, 608030 (3)
FUSE	P:174750	.	.
FUT1	GP:211100	.	.
FUT2	GP:182100	.	{Norwalk virus infection, resistance to} (3)
FUT2	GP:182100	.	{Vitamin B12 plasma level QTL1}, 612542 (3)
FUT3	GP:111100	.	[Blood group, Lewis] (3)
FUT4	G:104230	.	.
FUT5	G:136835	.	.
FUT6	G:136836	.	Fucosyltransferase 6 deficiency, 613852 (3)
FUT7	G:602030	.	.
FUT8	G:602589	.	.
FUT9	G:606865	.	.
FUZ	G:610622	.	.
FXC1	G:607388	.	.
FXN	G:606829	+GR-Bell	Friedreich ataxia with retained reflexes, 229300 (3)
FXN	G:606829	+GR-Bell	Friedreich ataxia, 229300 (3)
FXR1	G:600819	.	.
FXR2	G:605339	.	.
FXYD1	G:602359	.	.
FXYD2	G:601814	.	Hypomagnesemia-2, renal, 154020 (3)
FXYD3	G:604996	.	.
FXYD5	G:606669	.	.
FXYD6	G:606683	.	.
FXYD7	G:606684	.	.
FYB	G:602731	.	.
FYCO1	G:607182	.	Cataract, autosomal recessive congenital 2, 610019 (3)
FYN	G:137025	.	.
FZD1	G:603408	.	.
FZD10	G:606147	.	.
FZD2	G:600667	.	.
FZD3	G:606143	.	.
FZD4	G:604579	+GR-Bell	Exudative vitreoretinopathy, 133780 (3)
FZD4	G:604579	+GR-Bell	Retinopathy of prematurity, 133780 (3)
FZD5	G:601723	.	.
FZD6	G:603409	.	Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails), 614157 (3)
FZD7	G:603410	.	.
FZD8	G:606146	.	.
FZD9	G:601766	.	.
FZR1	G:603619	.	.
G0S2	G:614447	.	.
G2E3	G:611299	.	.
G3BP1	G:608431	.	.
G6PC	G:613742	+GR-Bell	Glycogen storage disease Ia, 232200 (3)
G6PC2	G:608058	.	.
G6PC3	G:611045	Bell>metabolic	Darsun syndrome, 612541 (3)
G6PC3	G:611045	Bell>metabolic	Neutropenia, severe congenital 4, autosomal recessive, 612541 (3)
G6PD	GP:305900	.	.
G6PDL	P:138110	.	.
G7P1	G:148750	.	.
GAA	G:606800	Bell>metabolic	Glycogen storage disease II, 232300 (3)
GAB1	G:604439	.	.
GAB2	G:606203	.	.
GAB3	G:300482	.	.
GABARAP	G:605125	.	.
GABARAPL1	G:607420	.	.
GABARAPL2	G:607452	.	.
GABBR1	G:603540	.	.
GABBR2	G:607340	.	{Nicotine dependence, protection against}, 188890 (3)
GABBR2	G:607340	.	{Nicotine dependence, susceptibility to}, 188890 (3)
GABPA	G:600609	.	.
GABPB1	G:600610	.	.
GABRA1	G:137160	.	{Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3)
GABRA1	G:137160	.	{Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3)
GABRA2	G:137140	.	{Alcohol dependence, susceptibility to}, 103780 (3)
GABRA3	G:305660	.	.
GABRA4	G:137141	.	.
GABRA5	G:137142	.	.
GABRA6	G:137143	.	.
GABRB1	G:137190	.	.
GABRB2	G:600232	.	.
GABRB3	GP:137192	.	{Epilepsy, childhood absence, susceptibility to, 5}, 612269 (3)
GABRD	G:137163	.	{Epilepsy, idiopathic generalized, 10}, 613060 (3)
GABRD	G:137163	.	{Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3)
GABRD	G:137163	.	{Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3)
GABRE	G:300093	.	.
GABRG1	G:137166	.	.
GABRG2	G:137164	.	Dravet syndrome, 607208 (3)
GABRG2	G:137164	.	Epilepsy, generalized, with febrile seizures plus, type 3, 611277 (3)
GABRG2	G:137164	.	Febrile seizures, familial, 8, 611277 (3)
GABRG2	G:137164	.	{Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3)
GABRG3	G:600233	.	.
GABRP	G:602729	.	.
GABRQ	G:300349	.	.
GABRR1	G:137161	.	.
GABRR2	G:137162	.	.
GAD1	G:605363	.	Cerebral palsy, spastic quadriplegic, 1, 603513 (3)
GAD2	G:138275	.	.
GADD45A	G:126335	.	.
GADD45B	G:604948	.	.
GADD45G	G:604949	.	.
GADD45GIP1	G:605162	.	.
GAGE1	G:300594	.	.
GAGE10	G:300737	.	.
GAGE12C	G:300727	.	.
GAGE12D	G:300728	.	.
GAGE12E	G:300729	.	.
GAGE12F	G:300730	.	.
GAGE12G	G:300731	.	.
GAGE12H	G:300732	.	.
GAGE12I	G:300637	.	.
GAGE12J	G:300733	.	.
GAGE13	G:300734	.	.
GAGE2A	G:300720	.	.
GAGE2B	G:300726	.	.
GAGE2C	G:300595	.	.
GAGE2D	G:300735	.	.
GAGE2E	G:300736	.	.
GAGE3	G:300596	.	.
GAGE4	G:300597	.	.
GAGE5	G:300598	.	.
GAGE6	G:300599	.	.
GAGE7	G:300601	.	.
GAGE8	G:300638	.	.
GAK	G:602052	.	.
GAL	G:137035	.	.
GAL3ST1	G:602300	.	.
GAL3ST2	G:608237	.	.
GAL3ST3	G:608234	.	.
GAL3ST4	G:608235	.	.
GALC	G:606890	Bell>metabolic	Krabbe disease, 245200 (3)
GALE	G:606953	+GR-Bell	Galactose epimerase deficiency, 230350 (3)
GALK1	G:604313	.	Galactokinase deficiency with cataracts, 230200 (3)
GALK2	G:137028	.	.
GALM	G:608883	.	.
GALNS	G:612222	.	Mucopolysaccharidosis IVA, 253000 (3)
GALNT1	G:602273	.	.
GALNT10	G:608043	.	.
GALNT12	G:610290	.	{Colorectal cancer, susceptibility to, 1}, 608812 (3)
GALNT13	G:608369	.	.
GALNT14	G:608225	.	.
GALNT2	G:602274	.	.
GALNT3	G:601756	.	Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
GALNT4	G:603565	.	.
GALNT6	G:605148	.	.
GALNT7	G:605005	.	.
GALNT8	G:606250	.	.
GALNT9	G:606251	.	.
GALP	G:611178	.	.
GALR1	G:600377	.	.
GALR2	G:603691	.	.
GALR3	G:603692	.	.
GALT	G:606999	Bell>metabolic	Galactosemia, 230400 (3)
GAMT	G:601240	+GR-Bell	GAMT deficiency, 612736 (3)
GAN	G:605379	+GR-Bell	Giant axonal neuropathy-1, 256850 (3)
GANAB	G:104160	.	.
GANC	G:104180	.	.
GAP43	G:162060	.	.
GAPDH	G:138400	.	.
GAPDHS	G:609169	.	.
GAPVD1	G:611714	.	.
GAR1	G:606468	.	.
GARS	G:600287	+GR-Bell	Charcot-Marie-Tooth disease, type 2D, 601472 (3)
GARS	G:600287	+GR-Bell	Neuropathy, distal hereditary motor, type V, 600794 (3)
GART	G:138440	.	.
GAS1	G:139185	.	.
GAS2	G:602835	.	.
GAS2L1	G:602128	.	.
GAS2L2	G:611398	.	.
GAS5	G:608280	.	.
GAS6	G:600441	.	.
GAS7	G:603127	.	.
GAS8	G:605178	.	.
GAST	G:137250	.	.
GATA1	G:305371	Bell>developmental	Anemia, X-linked, without thrombocytopenia, 300835 (3)
GATA1	G:305371	Bell>developmental	Dyserythropoietic anemia with thrombocytopenia, 300367 (3)
GATA1	G:305371	Bell>developmental	Leukemia, megakaryoblastic, of Down syndrome, 190685 (3)
GATA1	G:305371	Bell>developmental	Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3)
GATA1	G:305371	Bell>developmental	Macrothrombocytopenia, 300367 (3)
GATA1	G:305371	Bell>developmental	Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3)
GATA2	G:137295	.	Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency, 614172 (3)
GATA2	G:137295	.	Emberger syndrome, 614038 (3)
GATA2	G:137295	.	{Leukemia, acute myeloid, susceptibility to}, 601626 (3)
GATA2	G:137295	.	{Myelodysplastic syndrome, susceptibility to}, 614286 (3)
GATA3	G:131320	.	Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)
GATA4	G:600576	.	Atrial septal defect 2, 607941 (3)
GATA4	G:600576	.	Atrioventricular septal defect 4, 614430 (3)
GATA4	G:600576	.	Ventricular septal defect 1, 614429 (3)
GATA5	G:611496	.	.
GATA6	G:601656	.	Atrial septal defect 9, 614475 (3)
GATA6	G:601656	.	Atrioventricular septal defect 5, 614474 (3)
GATA6	G:601656	.	Pancreatic agenesis and congenital heart defects, 600001 (3)
GATA6	G:601656	.	Persistent truncus arteriosus, 217095 (3)
GATA6	G:601656	.	Tetralogy of Fallot, 187500 (3)
GATAD1	G:614518	.	.
GATM	G:602360	+GR-Bell	AGAT deficiency, 612718 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, perinatal lethal, 608013 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, perinatal lethal, 608013 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, perinatal lethal, 608013 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, perinatal lethal, 608013 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type I, 230800(3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type I, 230800(3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type I, 230800(3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type I, 230800(3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type II, 230900 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type II, 230900 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type II, 230900 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type II, 230900 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type III, 231000 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type III, 231000 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type III, 231000 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type III, 231000 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type IIIC, 231005 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type IIIC, 231005 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type IIIC, 231005 (3)
GBA	G:606463	Bell>metabolic	Gaucher disease, type IIIC, 231005 (3)
GBA	G:606463	Bell>metabolic	{Lewy body dementia, susceptibility to}, 127750 (3)
GBA	G:606463	Bell>metabolic	{Lewy body dementia, susceptibility to}, 127750 (3)
GBA	G:606463	Bell>metabolic	{Lewy body dementia, susceptibility to}, 127750 (3)
GBA	G:606463	Bell>metabolic	{Lewy body dementia, susceptibility to}, 127750 (3)
GBA	G:606463	Bell>metabolic	{Parkinson disease, late-onset, susceptibility to}, 168600 (3)
GBA	G:606463	Bell>metabolic	{Parkinson disease, late-onset, susceptibility to}, 168600 (3)
GBA	G:606463	Bell>metabolic	{Parkinson disease, late-onset, susceptibility to}, 168600 (3)
GBA	G:606463	Bell>metabolic	{Parkinson disease, late-onset, susceptibility to}, 168600 (3)
GBA2	G:609471	.	.
GBA3	G:606619	.	.
GBAS	G:603004	.	.
GBE1	G:607839	Bell>metabolic	Glycogen storage disease IV, 232500 (3)
GBF1	G:603698	.	.
GBGT1	G:606074	.	.
GBP1	G:600411	.	.
GBP2	G:600412	.	.
GBP3	G:600413	.	.
GBP4	G:612466	.	.
GBP5	G:611467	.	.
GBP6	G:612467	.	.
GBP7	G:612468	.	.
GBX1	G:603354	.	.
GBX2	G:601135	.	.
GCA	G:607030	.	.
GCAT	G:607422	.	.
GCC1	G:607418	.	.
GCC2	G:612711	.	.
GCDH	G:608801	Bell>metabolic	Glutaricaciduria, type I, 231670 (3)
GCET2	G:607792	.	.
GCFC2	G:189901	.	.
GCG	G:138030	.	.
GCGR	G:138033	.	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
GCH1	G:600225	+GR-Bell	Dystonia, DOPA-responsive, with or without hyperphenylalainemia, 128230 (3)
GCH1	G:600225	+GR-Bell	Hyperpehnylalaninemia, BH4-deficient, B, 233910 (3)
GCHFR	G:602437	.	.
GCK	G:138079	.	Diabetes mellitus, gestational, 125851 (3)
GCK	G:138079	.	Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3)
GCK	G:138079	.	Diabetes mellitus, permanent neonatal, 606176 (3)
GCK	G:138079	.	Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3)
GCK	G:138079	.	MODY, type II, 125851 (3)
GCKR	G:600842	.	[Fasting plasma glucose level QTL 5], 613463 (3)
GCLC	G:606857	.	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3)
GCLC	G:606857	.	{Myocardial infarction, susceptibility to}, 608446 (3)
GCLM	G:601176	.	{Myocardial infarction, susceptibility to}, 608446 (3)
GCM1	G:603715	.	.
GCM2	G:603716	.	Hypoparathyroidism, familial isolated, 146200 (3)
GCN1L1	G:605614	.	.
GCNT1	G:600391	.	.
GCNT2	G:600429	.	Adult i phenotype with congenital cataract, 110800 (3)
GCNT2	G:600429	.	Adult i phenotype without cataract, 110800 (3)
GCNT2	G:600429	.	[Blood group, Ii], 110800 (3)
GCNT3	G:606836	.	.
GCOM1	G:614071	.	.
GCOM2	G:608311	.	.
GCSH	G:238330	Bell>metabolic	Glycine encephalopathy, 605899 (3)
GCY	P:475000	.	.
GDA	G:139260	.	.
GDAP1	G:606598	+GR-Bell	Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3)
GDAP1	G:606598	+GR-Bell	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 (3)
GDAP1	G:606598	+GR-Bell	Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 (3)
GDAP1	G:606598	+GR-Bell	Charcot-Marie-Tooth disease, type 4A, 214400 (3)
GDE1	G:605943	.	.
GDF1	G:602880	.	Double-outlet right ventricle, 217095 (3)
GDF1	G:602880	.	Tetralogy of Fallot, 187500 (3)
GDF1	G:602880	.	Transposition of great arteries, dextro-looped 3, 613854 (3)
GDF10	G:601361	.	.
GDF11	G:603936	.	.
GDF15	G:605312	.	.
GDF2	G:605120	.	.
GDF3	G:606522	.	Klippel-Feil syndrome 3, autosomal dominant, 613702 (3)
GDF3	G:606522	.	Microphthalmia with coloboma 6, 613703 (3)
GDF3	G:606522	.	Microphthalmia, isolated 7, 613704 (3)
GDF5	G:601146	.	Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3)
GDF5	G:601146	.	Brachydactyly, type A2, 112600 (3)
GDF5	G:601146	.	Brachydactyly, type C, 113100 (3)
GDF5	G:601146	.	Chondrodysplasia, Grebe type, 200700 (3)
GDF5	G:601146	.	Fibular hypoplasia and complex brachydactyly, 228900 (3)
GDF5	G:601146	.	Multiple synostoses syndrome 2, 610017 (3)
GDF5	G:601146	.	Symphalangism, proximal, 185800 (3)
GDF5	G:601146	.	{Osteoarthritis}, 612400 (3)
GDF6	G:601147	.	Klippel-Feil syndrome 1, autosomal dominant, 118100 (3)
GDF6	G:601147	.	Microphthalmia with coloboma 6, digenic, 613703 (3)
GDF6	G:601147	.	Microphthalmia, isolated 4, 613094 (3)
GDF7	G:604651	.	.
GDF9	G:601918	.	.
GDI1	G:300104	.	Mental retardation, X-linked 41, 300849 (3)
GDI2	G:600767	.	.
GDNF	G:600837	+GR-Bell	Central hypoventilation syndrome, 209880 (3)
GDNF	G:600837	+GR-Bell	{Hirschsprung disease, susceptibility to, 3}, 613711 (3)
GDNF	G:600837	+GR-Bell	{Pheochromocytoma, modifier of}, 171300 (3)
GDPD5	G:609632	.	.
GEM	G:600164	.	.
GEMIN2	G:602595	.	.
GEMIN4	G:606969	.	.
GEMIN5	G:607005	.	.
GEMIN6	G:607006	.	.
GEMIN7	G:607419	.	.
GEN1	G:612449	.	.
GET4	G:612056	.	.
GFAP	G:137780	+GR-Bell	Alexander disease, 203450 (3)
GFER	G:600924	.	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay, 613076 (3)
GFI1	G:600871	.	Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3)
GFI1	G:600871	.	Neutropenia, severe congenital 2, autosomal dominant, 613107 (3)
GFI1B	G:604383	.	.
GFM1	G:606639	Bell>metabolic	Combined oxidative phosphorylation deficiency 1, 609060 (3)
GFM2	G:606544	.	.
GFPT1	G:138292	.	.
GFPT2	G:603865	.	.
GFRA1	G:601496	.	.
GFRA2	G:601956	.	.
GFRA3	G:605710	.	.
GGA1	G:606004	.	.
GGA2	G:606005	.	.
GGA3	G:606006	.	.
GGCT	G:137170	.	.
GGCX	G:137167	.	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 610842 (3)
GGCX	G:137167	.	Vitamin K-dependent coagulation defect, 277450 (3)
GGH	G:601509	.	.
GGN	G:609966	.	.
GGNBP1	G:609495	.	.
GGNBP2	G:612275	.	.
GGPS1	G:606982	.	.
GGT1	G:612346	.	.
GGT2	G:137181	.	.
GGT5	G:137168	.	.
GGT6	G:612341	.	.
GGT7	G:612342	.	.
GGTA1P	G:104175	.	.
GGTLC1	G:612338	.	.
GGTLC2	G:612339	.	.
GGTLC3	G:612340	.	.
GH1	G:139250	.	Growth hormone deficiency, isolated, type IA, 262400 (3)
GH1	G:139250	.	Growth hormone deficiency, isolated, type IB, 612781 (3)
GH1	G:139250	.	Growth hormone deficiency, isolated, type II, 173100 (3)
GH1	G:139250	.	Kowarski syndrome, 262650 (3)
GH2	G:139240	.	.
GHDC	G:608587	.	.
GHR	G:600946	.	Laron dwarfism, 262500 (3)
GHR	G:600946	.	Short stature, 604271 (3)
GHR	G:600946	.	{Hypercholesterolemia, familial, modification of}, 143890 (3)
GHRH	G:139190	.	.
GHRHR	G:139191	.	Growth hormone deficiency, isolated, type IB, 612781 (3)
GHRL	G:605353	.	{Obesity, susceptibility to}, 601665 (3)
GHSR	G:601898	.	Short stature, 604271 (3)
GIF	G:609342	.	Intrinsic factor deficiency, 261000 (3)
GIGYF1	G:612064	.	.
GIGYF2	G:612003	.	Parkinson disease 11, 607688 (3)
GIMAP1	G:608084	.	.
GIMAP2	G:608085	.	.
GIMAP4	G:608087	.	.
GIMAP5	G:608086	.	.
GINGF2	P:605544	.	.
GINGF4	P:611010	.	.
GINS1	G:610608	.	.
GINS2	G:610609	.	.
GINS3	G:610610	.	.
GINS4	G:610611	.	.
GIP	G:137240	.	.
GIPC1	G:605072	.	.
GIPC3	G:608792	.	Deafness, autosomal recessive 15, 601869 (3)
GIPR	GP:137241	.	.
GIT1	G:608434	.	.
GIT2	G:608564	.	.
GJA1	G:121014	Bell>cardiac	Atrioventricular septal defect 3, 600309 (3)
GJA1	G:121014	Bell>cardiac	Hallermann-Streiff syndrome, 234100 (3)
GJA1	G:121014	Bell>cardiac	Hypoplastic left heart syndrome 1, 241550 (3)
GJA1	G:121014	Bell>cardiac	Oculodentodigital dysplasia, 164200 (3)
GJA1	G:121014	Bell>cardiac	Oculodentodigital dysplasia, autosomal recessive, 257850 (3)
GJA1	G:121014	Bell>cardiac	Syndactyly, type III, 186100 (3)
GJA10	G:611924	.	.
GJA3	G:121015	.	Cataract, zonular pulverulent-3, 601885 (3)
GJA4	G:121012	.	.
GJA5	G:121013	.	Atrial fibrillation, familial, 11, 614049 (3)
GJA8	GP:600897	.	Cataract, nuclear progressive (3)
GJA8	GP:600897	.	Cataract, nuclear pulverulent (3)
GJA8	GP:600897	.	Cataract, zonular pulverulent-1, 116200 (3)
GJA8	GP:600897	.	Cataract-microcornea syndrome, 116150 (3)
GJA9	G:611923	.	.
GJB1	G:304040	+GR-Bell	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)
GJB2	G:121011	Bell>deafness	Bart-Pumphrey syndrome, 149200 (3)
GJB2	G:121011	Bell>deafness	Deafness, autosomal dominant 3A, 601544 (3)
GJB2	G:121011	Bell>deafness	Deafness, autosomal recessive 1A, 220290 (3)
GJB2	G:121011	Bell>deafness	Hystrix-like ichthyosis with deafness, 602540 (3)
GJB2	G:121011	Bell>deafness	Keratitis-ichthyosis-deafness syndrome, 148210 (3)
GJB2	G:121011	Bell>deafness	Keratoderma, palmoplantar, with deafness, 148350 (3)
GJB2	G:121011	Bell>deafness	Vohwinkel syndrome, 124500 (3)
GJB3	GP:603324	.	Deafness, autosomal dominant 2B, 612644 (3)
GJB3	GP:603324	.	Deafness, autosomal dominant, with peripheral neuropathy (3)
GJB3	GP:603324	.	Deafness, autosomal recessive (3)
GJB3	GP:603324	.	Deafness, digenic, GJB2/GJB3, 220290 (3)
GJB3	GP:603324	.	Erythrokeratodermia variabilis et progressiva, 133200 (3)
GJB4	G:605425	.	Erythrokeratodermia variabilis with erythema gyratum repens, 133200 (3)
GJB5	G:604493	.	.
GJB6	G:604418	+GR-Bell	Deafness, autosomal dominant 3B, 612643 (3)
GJB6	G:604418	+GR-Bell	Deafness, autosomal recessive 1B, 612645 (3)
GJB6	G:604418	+GR-Bell	Deafness, digenic GJB2/GJB6, 220290 (3)
GJB6	G:604418	+GR-Bell	Ectodermal dysplasia, hidrotic, 129500 (3)
GJB7	G:611921	.	.
GJC1	G:608655	.	.
GJC2	G:608803	Bell>neurological	Leukodystrophy, hypomyelinating, 2, 608804 (3)
GJC2	G:608803	Bell>neurological	Lymphedema, hereditary, IC, 613480 (3)
GJC2	G:608803	Bell>neurological	Spastic paraplegia, 44, 613206 (3)
GJC3	G:611925	.	.
GJD2	G:607058	.	.
GJD3	G:607425	.	.
GJD4	G:611922	.	.
GK2	P:600148	.	.
GK3P	P:600149	.	.
GKAP1	G:611356	.	.
GKN1	G:606402	.	.
GLA	G:300644	Bell>metabolic	Fabry disease, 301500 (3)
GLA	G:300644	Bell>metabolic	Fabry disease, cardiac variant, 301500 (3)
GLAT	G:137030	.	.
GLB1	G:611458	Bell>metabolic	GM1-gangliosidosis, type I, 230500 (3)
GLB1	G:611458	Bell>metabolic	GM1-gangliosidosis, type II, 230600 (3)
GLB1	G:611458	Bell>metabolic	GM1-gangliosidosis, type III, 230650 (3)
GLB1	G:611458	Bell>metabolic	Mucopolysaccharidosis type IVB (Morquio), 253010 (3)
GLB1	G:611458	Bell>neurological	GM1-gangliosidosis, type I, 230500 (3)
GLB1	G:611458	Bell>neurological	GM1-gangliosidosis, type II, 230600 (3)
GLB1	G:611458	Bell>neurological	GM1-gangliosidosis, type III, 230650 (3)
GLB1	G:611458	Bell>neurological	Mucopolysaccharidosis type IVB (Morquio), 253010 (3)
GLC1B	P:606689	.	.
GLC1C	P:601682	.	.
GLC1D	P:602429	.	.
GLC1F	P:603383	.	.
GLC1H	P:611276	.	.
GLC1I	P:609745	.	.
GLC1J	P:608695	.	.
GLC1K	P:608696	.	.
GLC1M	P:610535	.	.
GLC1N	P:611274	.	.
GLC3B	P:600975	.	.
GLC3C	P:613085	.	.
GLCCI1	G:614283	.	{Glucocorticoid therapy, response to}, 614400 (3)
GLCE	G:612134	.	.
GLDC	G:238300	Bell>metabolic	Glycine encephalopathy, 605899 (3)
GLDN	G:608603	.	.
GLE1	G:603371	Bell>developmental	Arthrogryposis, lethal, with anterior horn cell disease, 611890 (3)
GLE1	G:603371	Bell>developmental	Lethal congenital contracture syndrome 1, 253310 (3)
GLG1	G:600753	.	.
GLI1	G:165220	.	.
GLI2	G:165230	+GR-Bell	Holoprosencephaly-9, 610829 (3)
GLI3	G:165240	Bell>developmental	Greig cephalopolysyndactyly syndrome, 175700 (3)
GLI3	G:165240	Bell>developmental	Pallister-Hall syndrome, 146510 (3)
GLI3	G:165240	Bell>developmental	Polydactyly, postaxial, types A1 and B, 174200 (3)
GLI3	G:165240	Bell>developmental	Polydactyly, preaxial, type IV, 174700 (3)
GLI3	G:165240	Bell>developmental	{Hypothalamic hamartomas, somatic}, 241800 (3)
GLI4	G:165280	.	.
GLIPR1	G:602692	.	.
GLIPR1L1	G:610395	.	.
GLIPR1L2	G:610394	.	.
GLIPR2	G:607141	.	.
GLIS1	G:610378	.	.
GLIS2	G:608539	.	Nephronophthisis 7, 611498 (3)
GLIS3	G:610192	.	Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)
GLMN	G:601749	.	Glomuvenous malformations, 138000 (3)
GLO1	G:138750	.	.
GLP1R	G:138032	.	.
GLP2R	G:603659	.	.
GLRA1	G:138491	+GR-Bell	Startle disease, autosomal recessive (3)
GLRA1	G:138491	+GR-Bell	Startle disease/hyperekplexia, autosomal dominant, 149400 (3)
GLRA2	G:305990	.	.
GLRA3	G:600421	.	.
GLRB	G:138492	+GR-Bell	Hyperekplexia, autosomal recessive, 149400 (3)
GLRX	G:600443	.	.
GLRX2	G:606820	.	.
GLRX3	G:612754	.	.
GLRX5	G:609588	.	Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive, 205950 (3)
GLS	G:138280	.	.
GLS2	G:606365	.	.
GLT6D1	G:613699	.	.
GLTP	G:608949	.	.
GLTSCR1	G:605690	.	.
GLTSCR2	G:605691	.	.
GLUD1	G:138130	.	Hyperinsulinism-hyperammonemia syndrome, 606762 (3)
GLUD2	G:300144	.	.
GLUL	G:138290	.	Glutamine deficiency, congenital, 610015 (3)
GLYAT	G:607424	.	.
GLYB	G:138480	.	.
GLYCTK	G:610516	.	D-glyceric aciduria, 220120 (3)
GLYR1	G:610660	.	.
GLYS1	P:233100	.	.
GM2A	G:613109	.	GM2-gangliosidosis, AB variant, 272750 (3)
GMDS	G:602884	.	.
GMEB1	G:604409	.	.
GMEB2	G:607451	.	.
GMFB	G:601713	.	.
GMFG	G:604104	.	.
GMIP	G:609694	.	.
GML	G:602370	.	.
GMNC	G:614448	.	.
GMNN	G:602842	.	.
GMPR	G:139265	.	.
GMPR2	G:610781	.	.
GMPS	G:600358	.	Leukemia, acute myelogenous, 601626 (3)
GNA11	G:139313	.	.
GNA12	G:604394	.	.
GNA13	G:604406	.	.
GNA14	G:604397	.	.
GNA15	G:139314	.	.
GNAI1	G:139310	.	.
GNAI2	G:139360	.	Ventricular tachycardia, idiopathic, 192605 (3)
GNAI2P1	G:139180	.	.
GNAI3	G:139370	.	.
GNAL	G:139312	.	.
GNAO1	G:139311	.	.
GNAQ	G:600998	.	.
GNAS	GP:139320	.	Acromegaly, 102200 (3)
GNAS	GP:139320	.	McCune-Albright syndrome, 174800 (3)
GNAS	GP:139320	.	Osseous heteroplasia, progressive, 166350 (3)
GNAS	GP:139320	.	Prolonged bleeding time, brachydactyly and mental retardation (3)
GNAS	GP:139320	.	Pseudohypoparathyroidism Ia, 103580 (3)
GNAS	GP:139320	.	Pseudohypoparathyroidism Ib, 603233 (3)
GNAS	GP:139320	.	Pseudohypoparathyroidism Ic, 612462 (3)
GNAS	GP:139320	.	Pseudopseudohypoparathyroidism, 612463 (3)
GNAS-AS1	G:610540	.	Pseudohypoparathyroidism, type IB, 603233 (3)
GNAT1	G:139330	.	Night blindness, congenital stationary, autosomal dominant 3, 610444 (3)
GNAT2	G:139340	+GR-Bell	Achromatopsia-4, 613856 (3)
GNAT3	G:139395	.	.
GNAZ	G:139160	.	.
GNB1	G:139380	.	.
GNB1L	G:610778	.	.
GNB2	G:139390	.	.
GNB2L1	G:176981	.	.
GNB3	G:139130	.	{Hypertension, essential, susceptibility to}, 145500 (3)
GNB4	G:610863	.	.
GNB5	G:604447	.	.
GNE	G:603824	Bell>neurological	Inclusion body myopathy, autosomal recessive, 600737 (3)
GNE	G:603824	Bell>neurological	Nonaka myopathy, 605820 (3)
GNE	G:603824	Bell>neurological	Sialuria, 269921 (3)
GNG10	G:604389	.	.
GNG11	G:604390	.	.
GNG13	G:607298	.	.
GNG2	G:606981	.	.
GNG3	G:608941	.	.
GNG4	G:604388	.	.
GNG5	G:600874	.	.
GNG7	G:604430	.	.
GNGT1	G:189970	.	.
GNGT2	G:139391	.	.
GNL1	G:143024	.	.
GNL2	G:609365	.	.
GNL3	G:608011	.	.
GNLY	G:188855	.	.
GNMT	G:606628	.	Glycine N-methyltransferase deficiency, 606664 (3)
GNPAT	G:602744	.	Chondrodysplasia punctata, rhizomelic, type 2, 222765 (3)
GNPDA1	G:601798	.	.
GNPDA2	G:613222	.	.
GNPTAB	G:607840	Bell>metabolic	Mucolipidosis II alpha/beta, 252500 (3)
GNPTAB	G:607840	Bell>metabolic	Mucolipidosis II alpha/beta, 252500 (3)
GNPTAB	G:607840	Bell>metabolic	Mucolipidosis III alpha/beta, 252600 (3)
GNPTAB	G:607840	Bell>metabolic	Mucolipidosis III alpha/beta, 252600 (3)
GNPTG	G:607838	+GR-Bell	Mucolipidosis III gamma, 252605 (3)
GNRH1	G:152760	.	.
GNRH2	G:602352	.	.
GNRHR	G:138850	+GR-Bell	Fertile eunuch syndrome, 228300 (3)
GNRHR2	P:612875	.	.
GNS	G:607664	Bell>metabolic	Mucopolysaccharidosis type IIID, 252940 (3)
GOLGA1	G:602502	.	.
GOLGA2	G:602580	.	.
GOLGA2P2Y	G:400035	.	.
GOLGA3	G:602581	.	.
GOLGA4	G:602509	.	.
GOLGA5	G:606918	.	Thyroid carcinoma, papillary, 188550 (3)
GOLGA6A	G:610288	.	.
GOLGA7	G:609453	.	.
GOLGA7B	G:614189	.	.
GOLGA8B	G:609619	.	.
GOLGB1	G:602500	.	.
GOLIM4	G:606805	.	.
GOLM1	G:606804	.	.
GOLPH3	G:612207	.	.
GOLPH3L	G:612208	.	.
GON4L	G:610393	.	.
GOPC	G:606845	.	.
GORAB	G:607983	.	Geroderma osteodysplasticum, 231070 (3)
GORASP1	G:606867	.	.
GORASP2	G:608693	.	.
GOSR1	G:604026	.	.
GOSR2	G:604027	.	Epilepsy, progressive myoclonic 6, 614018 (3)
GOT1	G:138180	.	Aspartate aminotransferase, serum level of, QTL1, 614419 (3)
GOT2	G:138150	.	.
GP1BA	G:606672	.	Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)
GP1BA	G:606672	.	Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)
GP1BA	G:606672	.	von Willebrand disease, platelet-type, 177820 (3)
GP1BA	G:606672	.	{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)
GP1BB	G:138720	.	Bernard-Soulier syndrome, type B, 231200 (3)
GP1BB	G:138720	.	Giant platelet disorder, isolated, 231200 (3)
GP2	G:602977	.	.
GP5	G:173511	.	.
GP6	G:605546	.	Bleeding disorder, platelet-type, 11, 614201 (3)
GP9	G:173515	.	Bernard-Soulier syndrome, type C, 231200 (3)
GPA33	G:602171	.	.
GPAA1	G:603048	.	.
GPAM	G:602395	.	.
GPANK1	G:142610	.	.
GPATCH8	G:614396	.	.
GPBAR1	G:610147	.	.
GPBP1	G:608412	.	.
GPC1	G:600395	.	.
GPC3	G:300037	+GR-Bell	Simpson-Golabi-Behmel syndrome, type 1, 312870 (3)
GPC3	G:300037	+GR-Bell	Wilms tumor, somatic, 194070 (3)
GPC4	G:300168	.	.
GPC5	G:602446	.	.
GPC6	G:604404	.	Omodysplasia 1, 258315 (3)
GPCPD1	G:614124	.	.
GPD1	G:138420	.	Hypertriglyceridemia, transient infantile, 614480 (3)
GPD1L	G:611778	+GR-Bell	Brugada syndrome 2, 611777 (3)
GPD2	G:138430	.	{Diabetes, type 2, susceptibility to}, 125853 (3)
GPDS1	P:600510	.	.
GPER	G:601805	.	.
GPHA2	G:609651	.	.
GPHB5	G:609652	.	.
GPHN	G:603930	+GR-Bell	Hyperekplexia, 149400 (3)
GPHN	G:603930	+GR-Bell	Molybdenum cofactor deficiency, type C, 252150 (3)
GPI	G:172400	.	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency, 613470 (3)
GPIHBP1	G:612757	.	.
GPLD1	G:602515	.	.
GPM6A	G:601275	.	.
GPM6B	G:300051	.	.
GPN1	G:611479	.	.
GPNMB	G:604368	.	.
GPR1	G:600239	.	.
GPR101	G:300393	.	.
GPR115	G:614268	.	.
GPR119	G:300513	.	.
GPR12	G:600752	.	.
GPR123	G:612302	.	.
GPR124	G:606823	.	.
GPR125	G:612303	.	.
GPR126	G:612243	.	.
GPR128	G:612307	.	.
GPR132	G:606167	.	.
GPR133	G:613639	.	.
GPR135	G:607970	.	.
GPR137B	G:604658	.	.
GPR141	G:609045	.	.
GPR142	G:609046	.	.
GPR143	G:300808	+GR-Bell	Nystagmus 6, congenital, X-linked, 300814 (3)
GPR143	G:300808	+GR-Bell	Ocular albinism, type I, Nettleship-Falls type, 300500 (3)
GPR15	G:601166	.	.
GPR153	G:614269	.	.
GPR156	G:610464	.	.
GPR161	G:612250	.	.
GPR17	G:603071	.	.
GPR173	G:300253	.	.
GPR176	G:612183	.	.
GPR179	G:614515	.	.
GPR18	G:602042	.	.
GPR180	G:607787	.	.
GPR182	G:605307	.	.
GPR183	G:605741	.	.
GPR19	G:602927	.	.
GPR20	G:601908	.	.
GPR21	G:601909	.	.
GPR22	G:601910	.	.
GPR25	G:602174	.	.
GPR26	G:604847	.	.
GPR27	G:605187	.	.
GPR3	G:600241	.	.
GPR31	G:602043	.	.
GPR32	G:603195	.	.
GPR33	G:610118	.	.
GPR34	G:300241	.	.
GPR35	G:602646	.	.
GPR37	G:602583	.	.
GPR39	G:602886	.	.
GPR4	G:600551	.	.
GPR42	G:603822	.	.
GPR45	G:604838	.	.
GPR50	G:300207	.	.
GPR52	G:604106	.	.
GPR55	G:604107	.	.
GPR56	G:604110	+GR-Bell	Polymicrogyria, bilateral frontoparietal, 606854 (3)
GPR6	G:600553	.	.
GPR61	G:606916	.	.
GPR62	G:606917	.	.
GPR63	G:606915	.	.
GPR64	G:300572	.	.
GPR65	G:604620	.	.
GPR68	G:601404	.	.
GPR75	G:606704	.	.
GPR77	G:609949	.	.
GPR78	G:606921	.	.
GPR82	G:300748	.	.
GPR83	G:605569	.	.
GPR84	G:606383	.	.
GPR85	G:605188	.	.
GPR87	G:606379	.	.
GPR88	G:607468	.	.
GPR89A	G:612821	.	.
GPR89B	G:612806	.	.
GPR98	G:602851	Bell>ocular	Febrile seizures, familial, 4, 604352 (3)
GPR98	G:602851	Bell>ocular	Usher syndrome, type 2C, 605472 (3)
GPR98	G:602851	Bell>ocular	Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)
GPRASP1	G:300417	.	.
GPRC5A	G:604138	.	.
GPRC5B	G:605948	.	.
GPRC5C	G:605949	.	.
GPRC5D	G:607437	.	.
GPRC6A	G:613572	.	.
GPRIN1	G:611239	.	.
GPRIN2	G:611240	.	.
GPRIN3	G:611241	.	.
GPS1	G:601934	.	.
GPS2	G:601935	.	.
GPSM1	G:609491	.	.
GPSM2	G:609245	.	Deafness, autosomal recessive 82, 613557 (3)
GPT	G:138200	.	.
GPT2	G:138210	.	.
GPX1	G:138320	.	.
GPX2	G:138319	.	.
GPX3	G:138321	.	.
GPX4	G:138322	.	.
GPX5	G:603435	.	.
GPX6	G:607913	.	.
GRAMD4	G:613691	.	.
GRAP	G:604330	.	.
GRAP2	G:604518	.	.
GRASP	G:612027	.	.
GRB10	G:601523	.	.
GRB14	G:601524	.	.
GRB2	G:108355	.	.
GRB7	G:601522	.	.
GREB1	G:611736	.	.
GREM1	G:603054	.	.
GREM2	G:608832	.	.
GRHL1	G:609786	.	.
GRHL2	G:608576	.	Deafness, autosomal dominant 28, 608641 (3)
GRHL3	G:608317	.	.
GRHPR	G:604296	Bell>metabolic	Hyperoxaluria, primary, type II, 260000 (3)
GRIA1	G:138248	.	.
GRIA2	G:138247	.	.
GRIA3	G:305915	.	Mental retardation, X-linked 94, 300699 (3)
GRIA4	G:138246	.	.
GRID1	G:610659	.	.
GRID2	G:602368	.	.
GRID2IP	G:610639	.	.
GRIK1	G:138245	.	.
GRIK2	G:138244	.	Mental retardation, autosomal recessive, 6, 611092 (3)
GRIK3	G:138243	.	.
GRIK4	G:600282	.	.
GRIK5	G:600283	.	.
GRIN1	G:138249	.	Mental retardation, autosomal dominant 8, 614254 (3)
GRIN2A	G:138253	.	Epilepsy with neurodevelopmental defects, 613971 (3)
GRIN2B	G:138252	.	Mental retardation, autosomal dominant 6, 613970 (3)
GRIN2C	G:138254	.	.
GRIN2D	G:602717	.	.
GRIN3A	G:606650	.	.
GRIN3B	G:606651	.	.
GRINA	G:138251	.	.
GRIP1	G:604597	.	.
GRIPAP1	G:300408	.	.
GRK1	G:180381	.	Oguchi disease-2, 613411 (3)
GRK4	G:137026	.	.
GRK5	G:600870	.	.
GRK6	G:600869	.	.
GRK7	G:606987	.	.
GRM1	G:604473	.	.
GRM2	G:604099	.	.
GRM3	G:601115	.	.
GRM4	G:604100	.	.
GRM5	G:604102	.	.
GRM6	G:604096	.	Night blindness, congenital stationary, type 1B, 257270 (3)
GRM7	G:604101	.	.
GRM8	G:601116	.	.
GRN	G:138945	+GR-Bell	Frontotemporal lobar degeneration with ubiquitin-positive inclusions, 607485 (3)
GRP	G:137260	.	.
GRPEL1	G:606173	.	.
GRPR	G:305670	.	.
GRSF1	G:604851	.	.
GRWD1	G:610597	.	.
GRXCR1	G:613283	.	Deafness, autosomal recessive 25, 613285 (3)
GSC	G:138890	.	.
GSC2	G:601845	.	.
GSDMA	G:611218	.	.
GSDMB	G:611221	.	.
GSDMC	G:608384	.	.
GSG2	G:609240	.	.
GSK3A	G:606784	.	.
GSK3B	G:605004	.	.
GSM1	P:190100	.	.
GSN	G:137350	.	Amyloidosis, Finnish type, 105120 (3)
GSPT1	G:139259	.	.
GSPT2	G:300418	.	.
GSR	GP:138300	.	.
GSS	G:601002	Bell>hematologic	Glutathione synthetase deficiency, 266130 (3)
GSS	G:601002	Bell>hematologic	Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3)
GSTA1	G:138359	.	.
GSTA2	G:138360	.	.
GSTA3	G:605449	.	.
GSTA4	G:605450	.	.
GSTA5	G:607605	.	.
GSTK1	G:602321	.	.
GSTM1	G:138350	.	.
GSTM2	G:138380	.	.
GSTM3	G:138390	.	.
GSTM4	G:138333	.	.
GSTM5	G:138385	.	.
GSTO1	G:605482	.	.
GSTO2	G:612314	.	.
GSTP1	G:134660	.	.
GSTT1	G:600436	.	.
GSTT2	G:600437	.	.
GSTZ1	G:603758	.	.
GTDC1	G:610165	.	.
GTF2A1	G:600520	.	.
GTF2A1L	G:605358	.	.
GTF2A2	G:600519	.	.
GTF2B	G:189963	.	.
GTF2E1	G:189962	.	.
GTF2E2	G:189964	.	.
GTF2F1	G:189968	.	.
GTF2F2	G:189969	.	.
GTF2H1	G:189972	.	.
GTF2H2	G:601748	.	.
GTF2H3	G:601750	.	.
GTF2H4	G:601760	.	.
GTF2H5	G:608780	Bell>cutaneous	Trichothiodystrophy, complementation group A, 601675 (3)
GTF2I	G:601679	.	.
GTF2IRD1	G:604318	.	.
GTF2IRD2	G:608899	.	.
GTF2IRD2B	G:608900	.	.
GTF3A	G:600860	.	.
GTF3C1	G:603246	.	.
GTF3C2	G:604883	.	.
GTF3C3	G:604888	.	.
GTF3C4	G:604892	.	.
GTF3C5	G:604890	.	.
GTF3C6	G:611784	.	.
GTPBP1	G:602245	.	.
GTPBP10	G:610920	.	.
GTPBP2	G:607434	.	.
GTPBP3	G:608536	.	.
GTPBP5	G:610919	.	.
GTPBP6	G:300124	.	.
GTS	P:137580	.	.
GTSE1	G:607477	.	.
GUCA1A	G:600364	.	Cone dystrophy-3, 602093 (3)
GUCA1A	G:600364	.	Cone-rod dystrophy 14, 602093 (3)
GUCA1B	G:602275	+GR-Bell	Retinitis pigmentosa 48, 613827 (3)
GUCA1C	G:605128	.	.
GUCA2A	G:139392	.	.
GUCA2B	G:601271	.	.
GUCY1A2	G:601244	.	.
GUCY1A3	G:139396	.	.
GUCY1B2	G:603695	.	.
GUCY1B3	G:139397	.	.
GUCY2C	G:601330	.	.
GUCY2D	G:600179	.	Cone-rod dystrophy 6, 601777(3)
GUCY2D	G:600179	.	Leber congenital amaurosis 1, 204000 (3)
GUCY2E	P:601138	.	.
GUCY2F	G:300041	.	.
GUK1	G:139270	.	.
GUK2	P:139280	.	.
GULOP	P:240400	.	.
GULP1	G:608165	.	.
GUSB	G:611499	Bell>metabolic	Mucopolysaccharidosis VII, 253220 (3)
GXYLT1	G:613321	.	.
GXYLT2	G:613322	.	.
GYG1	G:603942	.	Glycogen storage disease XV, 613507 (3)
GYG2	G:300198	.	.
GYLTL1B	G:609709	.	.
GYPA	GP:111300	.	[Blood group, MN] (3)
GYPA	GP:111300	.	{Malaria, resistance to}, 611162 (3)
GYPB	GP:111740	.	[Blood group, Ss] (3)
GYPC	GP:110750	.	[Blood group, Gerbich] (3)
GYPC	GP:110750	.	{Malaria, resistance to}, 611162 (3)
GYPE	G:138590	.	.
GYS1	G:138570	.	Glycogen storage disease 0, muscle, 611556 (3)
GYS2	G:138571	.	Glycogen storage disease, type 0, 240600 (3)
GZF1	G:613842	.	.
GZMA	G:140050	.	.
GZMB	G:123910	.	.
GZMH	G:116831	.	.
GZMK	G:600784	.	.
GZMM	G:600311	.	.
H19	G:103280	.	Beckwith-Wiedemann syndrome, 130650 (3)
H19	G:103280	.	Silver-Russell syndrome, 180860 (3)
H19	G:103280	.	Wilms tumor 2, 194071 (3)
H1F0	G:142708	.	.
H1FX	G:602785	.	.
H2AFB3	G:300445	.	.
H2AFX	G:601772	.	.
H2AFY	G:610054	.	.
H2AFZ	G:142763	.	.
H2BFWT	G:300507	.	.
H3F3A	G:601128	.	.
H3F3B	G:601058	.	.
H6PD	G:138090	.	Cortisone reductase deficiency, 604931 (3)
HAAO	G:604521	.	.
HABP2	G:603924	.	{Carotid stenosis, susceptibility to} (3)
HABP2	G:603924	.	{Venous thromboembolism, susceptibility to}, 188050 (3)
HACE1	G:610876	.	.
HACL1	G:604300	.	.
HADH	G:601609	Bell>metabolic	3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3)
HADH	G:601609	Bell>metabolic	Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)
HADHA	G:600890	Bell>metabolic	Fatty liver, acute, of pregnancy, 609016 (3)
HADHA	G:600890	Bell>metabolic	Fatty liver, acute, of pregnancy, 609016 (3)
HADHA	G:600890	Bell>metabolic	HELLP syndrome, maternal, of pregnancy, 609016 (3)
HADHA	G:600890	Bell>metabolic	HELLP syndrome, maternal, of pregnancy, 609016 (3)
HADHA	G:600890	Bell>metabolic	LCHAD deficiency, 609016 (3)
HADHA	G:600890	Bell>metabolic	LCHAD deficiency, 609016 (3)
HADHA	G:600890	Bell>metabolic	Trifunctional protein deficiency, 609015 (3)
HADHA	G:600890	Bell>metabolic	Trifunctional protein deficiency, 609015 (3)
HADHB	G:143450	Bell>metabolic	Trifunctional protein deficiency, 609015 (3)
HAGH	G:138760	.	.
HAL	G:609457	.	[Histidinemia], 235800 (3)
HAMP	G:606464	Bell>hematologic	Hemochromatosis, type 2B, 613313 (3)
HAND1	G:602406	.	.
HAND2	G:602407	.	.
HAO1	G:605023	.	.
HAO2	G:605176	.	.
HAP1	G:600947	.	.
HAPLN1	G:115435	.	.
HAR1A	G:610556	.	.
HAR1B	G:610557	.	.
HARS	G:142810	.	Usher syndrome type 3B, 614504 (3)
HARS2	G:600783	.	.
HAS1	G:601463	.	.
HAS2	G:601636	.	.
HAS2-AS1	G:614353	.	.
HAS3	G:602428	.	.
HAT1	G:603053	.	.
HAUS1	G:608775	.	.
HAUS2	G:613429	.	.
HAUS3	G:613430	.	.
HAUS4	G:613431	.	.
HAUS5	G:613432	.	.
HAUS6	G:613433	.	.
HAUS7	G:300540	.	.
HAUS8	G:613434	.	.
HAVCR1	G:606518	.	{Atopy, resistance to}, 147050 (3)
HAVCR2	G:606652	.	.
HAX1	G:605998	.	Neutropenia, severe congenital 3, autosomal recessive, 610738 (3)
HBA1	GP:141800	Bell>hematologic	Erythremias, alpha- (3)
HBA1	GP:141800	Bell>hematologic	Heinz body anemias, alpha-, 140700 (3)
HBA1	GP:141800	Bell>hematologic	Hemoglobin H disease, nondeletional, 613978 (3)
HBA1	GP:141800	Bell>hematologic	Methemoglobinemias, alpha- (3)
HBA1	GP:141800	Bell>hematologic	Thalassemias, alpha-, 604131 (3)
HBA2	G:141850	+GR-Bell	Heinz body anemia, 140700 (3)
HBA2	G:141850	+GR-Bell	Hemoglobin H disease, nondeletional, 613978 (3)
HBA2	G:141850	+GR-Bell	Thalassemia, alpha-, 604131 (3)
HBB	GP:141900	Bell>hematologic	Delta-beta thalassemia, 141749 (3)
HBB	GP:141900	Bell>hematologic	Delta-beta thalassemia, 141749 (3)
HBB	GP:141900	Bell>hematologic	Erythremias, beta- (3)
HBB	GP:141900	Bell>hematologic	Erythremias, beta- (3)
HBB	GP:141900	Bell>hematologic	Heinz body anemias, beta-, 140700 (3)
HBB	GP:141900	Bell>hematologic	Heinz body anemias, beta-, 140700 (3)
HBB	GP:141900	Bell>hematologic	Hereditary persistence of fetal hemoglobin, 141749 (3)
HBB	GP:141900	Bell>hematologic	Hereditary persistence of fetal hemoglobin, 141749 (3)
HBB	GP:141900	Bell>hematologic	Methemoglobinemias, beta- (3)
HBB	GP:141900	Bell>hematologic	Methemoglobinemias, beta- (3)
HBB	GP:141900	Bell>hematologic	Sickle cell anemia, 603903 (3)
HBB	GP:141900	Bell>hematologic	Sickle cell anemia, 603903 (3)
HBB	GP:141900	Bell>hematologic	Thalassemia-beta, dominant inclusion-body, 603902 (3)
HBB	GP:141900	Bell>hematologic	Thalassemia-beta, dominant inclusion-body, 603902 (3)
HBB	GP:141900	Bell>hematologic	Thalassemias, beta-, 613985 (3)
HBB	GP:141900	Bell>hematologic	Thalassemias, beta-, 613985 (3)
HBD	G:142000	.	Thalassemia, delta- (3)
HBE1	G:142100	.	.
HBEGF	G:126150	.	.
HBG1	G:142200	.	Fetal hemoglobin quantitative trait locus 1, 141749 (3)
HBG2	G:142250	.	Cyanosis, transient neonatal, 613977 (3)
HBG2	G:142250	.	Fetal hemoglobin quantitative trait locus 1, 141749 (3)
HBM	G:609639	.	.
HBQ1	G:142240	.	.
HBS1L	G:612450	.	.
HBXIP	G:608521	.	.
HBZ	G:142310	.	.
HCAR1	G:606923	.	.
HCAR2	G:609163	.	.
HCAR3	G:606039	.	.
HCCS	G:300056	+GR-Bell	Microphthalmia, syndromic 7, 309801 (3)
HCFC1	G:300019	.	.
HCFC2	G:607926	.	.
HCG22	G:613918	.	.
HCK	G:142370	.	.
HCL2	P:266300	.	.
HCLS1	G:601306	.	.
HCN1	G:602780	.	.
HCN2	G:602781	.	.
HCN3	G:609973	.	.
HCN4	G:605206	+GR-Bell	Brugada syndrome 8, 613123 (3)
HCN4	G:605206	+GR-Bell	Sick sinus syndrome 2, 163800 (3)
HCP5	G:604676	.	.
HCRT	G:602358	.	Narcolepsy 1, 161400 (3)
HCRTR1	G:602392	.	.
HCRTR2	G:602393	.	.
HCST	G:604089	.	.
HCVS	P:122460	.	.
HDAC1	G:601241	.	.
HDAC10	G:608544	.	.
HDAC11	G:607226	.	.
HDAC2	G:605164	.	.
HDAC3	G:605166	.	.
HDAC4	G:605314	.	Brachydacytly-mental retardation syndrome, 600430 (3)
HDAC5	G:605315	.	.
HDAC6	G:300272	.	.
HDAC7	G:606542	.	.
HDAC8	G:300269	.	.
HDAC9	G:606543	.	.
HDC	G:142704	.	.
HDGF	G:600339	.	.
HDHD1	G:306480	.	.
HDLBP	G:142695	.	.
HDLCQ1	P:606613	.	.
HEBP1	G:605826	.	.
HEBP2	G:605825	.	.
HECA	G:607977	.	.
HECW1	G:610384	.	.
HEG1	G:614182	.	.
HELB	G:614539	.	.
HELLS	G:603946	.	.
HELQ	G:606769	.	.
HELZ	G:606699	.	.
HEMGN	G:610715	.	.
HENMT1	G:612178	.	.
HEPACAM	G:611642	+GR-Bell	Megalencephalic leukoencephalopathy with subcortical cysts 2A, 613925 (3)
HEPACAM	G:611642	+GR-Bell	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, 613926 (3)
HEPACAM2	G:614133	.	.
HEPH	G:300167	.	.
HEPN1	G:611641	.	.
HERC1	G:605109	.	.
HERC2	G:605837	.	[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)
HERC2	G:605837	.	[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)
HERC3	G:605200	.	.
HERC4	G:609248	.	.
HERC5	G:608242	.	.
HERC6	G:609249	.	.
HERPUD1	G:608070	.	.
HES1	G:139605	.	.
HES2	G:609970	.	.
HES3	G:609971	.	.
HES4	G:608060	.	.
HES5	G:607348	.	.
HES6	G:610331	.	.
HES7	G:608059	.	Spondylocostal dysostosis 4, autosomal recessive, 613686 (3)
HESX1	G:601802	Bell>endocrine	Growth hormone deficiency with pituitary anomalies, 182230 (3)
HESX1	G:601802	Bell>endocrine	Pituitary hormone deficiency, combined, 5, 182230 (3)
HESX1	G:601802	Bell>endocrine	Septooptic dysplasia, 182230 (3)
HEXA	G:606869	Bell>neurological	GM2-gangliosidosis, several forms, 272800 (3)
HEXA	G:606869	Bell>neurological	Tay-Sachs disease, 272800 (3)
HEXA	G:606869	Bell>neurological	[Hex A pseudodeficiency], 272800 (3)
HEXB	G:606873	Bell>neurological	Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3)
HEXIM1	G:607328	.	.
HEY1	G:602953	.	.
HEY2	G:604674	.	.
HEYL	G:609034	.	.
HFE	G:613609	Bell>metabolic	Hemochromatosis, 235200 (3)
HFE	G:613609	Bell>metabolic	[Transferrin serum level QTL2], 614193 (3)
HFE	G:613609	Bell>metabolic	{Alzheimer disease, susceptibility to}, 104300 (3)
HFE	G:613609	Bell>metabolic	{Microvascular complications of diabetes 7}, 612635 (3)
HFE	G:613609	Bell>metabolic	{Porphyria cutanea tarda, susceptibility to}, 176100 (3)
HFE	G:613609	Bell>metabolic	{Porphyria variegata, susceptibility to}, 176200 (3)
HFE2	G:608374	Bell>hematologic	Hemochromatosis, type 2A, 602390 (3)
HFE2	G:608374	Bell>metabolic	Hemochromatosis, type 2A, 602390 (3)
HGD	G:607474	Bell>metabolic	Alkaptonuria, 203500 (3)
HGF	G:142409	.	Deafness, autosomal recessive 39, 608265 (3)
HGFAC	G:604552	.	.
HGS	G:604375	.	.
HGSNAT	G:610453	Bell>metabolic	Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3)
HHAT	G:605743	.	.
HHATL	G:608116	.	.
HHC2	P:145981	.	.
HHC3	P:600740	.	.
HHEX	G:604420	.	.
HHIP	G:606178	.	.
HHLA1	G:604109	.	.
HHLA2	G:604371	.	.
HHLA3	G:604372	.	.
HIBADH	G:608475	.	.
HIBCH	G:610690	Bell>metabolic	3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)
HIC1	G:603825	.	.
HIC2	G:607712	.	.
HIF1A	G:603348	.	.
HIF1A-AS1	G:614528	.	.
HIF1A-AS2	G:614529	.	.
HIF1AN	G:606615	.	.
HIF3A	G:609976	.	.
HILS1	G:608101	.	.
HINFP	G:607099	.	.
HINT1	G:601314	.	.
HINT2	G:609997	.	.
HINT3	G:609998	.	.
HIP1	G:601767	.	.
HIP1R	G:605613	.	.
HIPK1	G:608003	.	.
HIPK2	G:606868	.	.
HIPK3	G:604424	.	.
HIPK4	G:611712	.	.
HIRA	G:600237	.	.
HIRIP3	G:603365	.	.
HIST1H1A	G:142709	.	.
HIST1H1B	G:142711	.	.
HIST1H1C	G:142710	.	.
HIST1H1D	G:142210	.	.
HIST1H1E	G:142220	.	.
HIST1H1T	G:142712	.	.
HIST1H2AA	G:613499	.	.
HIST1H2AB	G:602795	.	.
HIST1H2AC	G:602794	.	.
HIST1H2AD	G:602792	.	.
HIST1H2AE	G:602786	.	.
HIST1H2AI	G:602787	.	.
HIST1H2AJ	G:602791	.	.
HIST1H2AK	G:602788	.	.
HIST1H2AL	G:602793	.	.
HIST1H2AM	G:602796	.	.
HIST1H2BA	G:609904	.	.
HIST1H2BB	G:602803	.	.
HIST1H2BC	G:602847	.	.
HIST1H2BD	G:602799	.	.
HIST1H2BE	G:602805	.	.
HIST1H2BF	G:602804	.	.
HIST1H2BG	G:602798	.	.
HIST1H2BH	G:602806	.	.
HIST1H2BI	G:602807	.	.
HIST1H2BL	G:602800	.	.
HIST1H2BM	G:602802	.	.
HIST1H2BN	G:602801	.	.
HIST1H2BO	G:602808	.	.
HIST1H3A	G:602810	.	.
HIST1H3B	G:602819	.	.
HIST1H3C	G:602812	.	.
HIST1H3D	G:602811	.	.
HIST1H3E	G:602813	.	.
HIST1H3F	G:602816	.	.
HIST1H3G	G:602815	.	.
HIST1H3H	G:602818	.	.
HIST1H3I	G:602814	.	.
HIST1H3J	G:602817	.	.
HIST1H4A	G:602822	.	.
HIST1H4B	G:602829	.	.
HIST1H4C	G:602827	.	.
HIST1H4D	G:602823	.	.
HIST1H4E	G:602830	.	.
HIST1H4F	G:602824	.	.
HIST1H4G	G:602832	.	.
HIST1H4H	G:602828	.	.
HIST1H4I	G:602833	.	.
HIST1H4J	G:602826	.	.
HIST1H4K	G:602825	.	.
HIST1H4L	G:602831	.	.
HIST2H2AA3	G:142720	.	.
HIST2H2AC	G:602797	.	.
HIST2H2BE	G:601831	.	.
HIST2H3C	G:142780	.	.
HIST2H4A	G:142750	.	.
HIST3H3	G:602820	.	.
HIVEP1	G:194540	.	.
HIVEP2	G:143054	.	.
HIVEP3	G:606649	.	.
HJURP	G:612667	.	.
HK1	G:142600	.	Hemolytic anemia due to hexokinase deficiency, 235700 (3)
HK2	G:601125	.	.
HK3	G:142570	.	.
HKR1	G:165250	.	.
HLA-A	GP:142800	.	{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)
HLA-B	GP:142830	.	{Abacavir hypersensitivity, susceptibility to} (3)
HLA-B	GP:142830	.	{Spondyloarthropathy, susceptibility to, 1}, 106300 (3)
HLA-B	GP:142830	.	{Stevens-Johnson syndrome, susceptibility to}, 608579 (3)
HLA-B	GP:142830	.	{Synovitis, chronic, susceptibility to} (3)
HLA-B	GP:142830	.	{Toxic epidermal necrolysis, susceptibility to}, 608579 (3)
HLA-C	G:142840	.	{HIV-1 viremia, susceptibility to}, 609423 (3)
HLA-C	G:142840	.	{Psoriasis susceptibility 1}, 177900 (3)
HLA-DMA	G:142855	.	.
HLA-DMB	G:142856	.	.
HLA-DOA	G:142930	.	.
HLA-DOB	G:600629	.	.
HLA-DPA1	G:142880	.	.
HLA-DPB1	G:142858	.	{Beryllium disease, chronic, susceptibility to} (3)
HLA-DQA1	G:146880	+GR-Bell	{Celiac disease, susceptibility to}, 212750 (3)
HLA-DQA2	G:613503	.	.
HLA-DQB1	G:604305	+GR-Bell	{Celiac disease, susceptibility to}, 212750 (3)
HLA-DQB1	G:604305	+GR-Bell	{Creutzfeldt-Jakob disease, variant, resistance to}, 123400 (3)
HLA-DQB1	G:604305	+GR-Bell	{Multiple sclerosis, susceptibility to}, 126200 (3)
HLA-DRA	G:142860	.	.
HLA-DRB1	G:142857	.	{Multiple sclerosis, susceptibility to}, 126200 (3)
HLA-DRB1	G:142857	.	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
HLA-DRB1	G:142857	.	{Sarcoidosis, susceptibility l, 1}, 181000 (3)
HLA-DRB3	G:612735	.	.
HLA-DRB5	G:604776	.	.
HLA-E	G:143010	.	.
HLA-F	G:143110	.	.
HLA-G	G:142871	.	.
HLCS	G:609018	.	Holocarboxylase synthetase deficiency, 253270 (3)
HLF	G:142385	.	.
HLTF	G:603257	.	.
HLX	G:142995	.	.
HM13	G:607106	.	.
HMBS	G:609806	+GR-Bell	Porphyria, acute intermittent, 176000 (3)
HMBS	G:609806	+GR-Bell	Porphyria, acute intermittent, nonerythroid variant, 176000 (3)
HMCN1	G:608548	.	{Macular degeneration, age-related, 1}, 603075 (3)
HMG20A	G:605534	.	.
HMG20B	G:605535	.	.
HMGA1	G:600701	.	{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)
HMGA2	G:600698	.	.
HMGB1	G:163905	.	.
HMGB2	G:163906	.	.
HMGB3	G:300193	.	.
HMGCL	G:613898	Bell>metabolic	HMG-CoA lyase deficiency, 246450 (3)
HMGCR	GP:142910	.	[Statins, attenuated cholesterol lowering by] (3)
HMGCS1	G:142940	.	.
HMGCS2	G:600234	.	HMG-CoA synthase-2 deficiency, 605911 (3)
HMGN1	G:163920	.	.
HMGN2	G:163910	.	.
HMGN2P46	G:611314	.	.
HMGN3	G:604502	.	.
HMGN5	G:300385	.	.
HMGXB4	G:604702	.	.
HMHA1	G:601155	.	.
HMHB1	G:609961	.	.
HMI	P:300337	.	.
HMMR	G:600936	.	{Breast cancer, susceptibility to}, 114480 (3)
HMOX1	G:141250	.	Heme oxygenase-1 deficiency, 614034 (3)
HMOX1	G:141250	.	{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
HMOX2	G:141251	.	.
HMSD	G:612086	.	.
HMX1	G:142992	.	Oculoauricular syndrome, 612109 (3)
HMX2	G:600647	.	.
HMX3	G:613380	.	.
HNF1A	G:142410	.	Diabetes mellitus, insulin-dependent, 20, 612520 (3)
HNF1A	G:142410	.	Hepatic adenoma, somatic, 142330 (3)
HNF1A	G:142410	.	MODY, type III, 600496 (3)
HNF1A	G:142410	.	Renal cell carcinoma, 144700 (3)
HNF1A	G:142410	.	{Diabetes mellitus, insulin-dependent}, 222100 (3)
HNF1A	G:142410	.	{Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3)
HNF1B	G:189907	.	Diabetes mellitus, noninsulin-dependent, 125853 (3)
HNF1B	G:189907	.	Renal cysts and diabetes syndrome, 137920 (3)
HNF1B	G:189907	.	{Renal cell carcinoma}, 144700 (3)
HNF4A	G:600281	.	MODY, type I, 125850 (3)
HNF4A	G:600281	.	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
HNF4G	G:605966	.	.
HNMT	G:605238	.	{Asthma, susceptibility to}, 600807 (3)
HNRNPA0	G:609409	.	.
HNRNPA1	G:164017	.	.
HNRNPA2B1	G:600124	.	.
HNRNPA3	G:605372	.	.
HNRNPAB	G:602688	.	.
HNRNPC	G:164020	.	.
HNRNPD	G:601324	.	.
HNRNPF	G:601037	.	.
HNRNPH1	G:601035	.	.
HNRNPH2	G:300610	.	.
HNRNPH3	G:602324	.	.
HNRNPK	G:600712	.	.
HNRNPL	G:603083	.	.
HNRNPM	G:160994	.	.
HNRNPR	G:607201	.	.
HNRNPU	G:602869	.	.
HNRNPUL1	G:605800	.	.
HNRPDL	G:607137	.	.
HNRPLL	G:611208	.	.
HOGA1	G:613597	.	Hyperoxaluria, primary, type III, 613616 (3)
HOMER1	G:604798	.	.
HOMER2	G:604799	.	.
HOMER3	G:604800	.	.
HOMEZ	G:608119	.	.
HOOK1	G:607820	.	.
HOOK2	G:607824	.	.
HOOK3	G:607825	.	.
HOPX	G:607275	.	.
HORMAD1	G:609824	.	.
HOTAIR	G:611400	.	.
HOTTIP	G:614060	.	.
HOXA1	G:142955	.	Athabaskan brainstem dysgenesis syndrome, 601536 (3)
HOXA1	G:142955	.	Bosley-Salih-Alorainy syndrome, 601536 (3)
HOXA10	G:142957	.	.
HOXA11	G:142958	.	Radioulnar synostosis with amegakaryocytic thrombocytopenia, 605432 (3)
HOXA11-AS	G:607530	.	.
HOXA13	G:142959	.	Guttmacher syndrome, 176305 (3)
HOXA13	G:142959	.	Hand-foot-uterus syndrome, 140000 (3)
HOXA2	G:604685	.	Microtia, hearing impairment, and cleft palate, 612290 (3)
HOXA3	G:142954	.	.
HOXA4	G:142953	.	.
HOXA5	G:142952	.	.
HOXA6	G:142951	.	.
HOXA7	G:142950	.	.
HOXA9	G:142956	.	.
HOXB-AS5	G:610787	.	.
HOXB1	G:142968	.	.
HOXB13	G:604607	.	.
HOXB2	G:142967	.	.
HOXB3	G:142966	.	.
HOXB4	G:142965	.	.
HOXB5	G:142960	.	.
HOXB6	G:142961	.	.
HOXB7	G:142962	.	.
HOXB8	G:142963	.	.
HOXB9	G:142964	.	.
HOXC10	G:605560	.	.
HOXC11	G:605559	.	.
HOXC12	G:142975	.	.
HOXC13	G:142976	.	.
HOXC4	G:142974	.	.
HOXC5	G:142973	.	.
HOXC6	G:142972	.	.
HOXC8	G:142970	.	.
HOXC9	G:142971	.	.
HOXD1	G:142987	.	.
HOXD10	G:142984	.	Charcot-Marie-Tooth disease, foot deformity of, 192950 (3)
HOXD10	G:142984	.	Vertical talus, congenital, 192950 (3)
HOXD11	G:142986	.	.
HOXD12	G:142988	.	.
HOXD13	G:142989	.	Brachydactyly, type D, 113200 (3)
HOXD13	G:142989	.	Brachydactyly, type E, 113300 (3)
HOXD13	G:142989	.	Brachydactyly-syndactyly syndrome, 610713 (3)
HOXD13	G:142989	.	Syndactyly, type V, 186300 (3)
HOXD13	G:142989	.	Synpolydactyly with foot anomalies, 186000 (3)
HOXD13	G:142989	.	Synpolydactyly, type II, 186000 (3)
HOXD13	G:142989	.	VACTERL association, 192350 (3)
HOXD3	G:142980	.	.
HOXD4	GP:142981	.	{Leukemia, acute lymphoblastic, susceptibility to} (3)
HOXD8	G:142985	.	.
HOXD9	G:142982	.	.
HPCA	G:142622	.	.
HPCAL1	G:600207	.	.
HPCX	P:300147	.	.
HPD	G:609695	.	Hawkinsinuria, 140350 (3)
HPD	G:609695	.	Tyrosinemia, type III, 276710 (3)
HPE1	P:236100	.	.
HPFH2	P:142335	.	.
HPGD	G:601688	.	Cranioosteoarthropathy, 259100 (3)
HPGD	G:601688	.	Digital clubbing, isolated congenital, 119900 (3)
HPGD	G:601688	.	Hypertrophic osteoarthropathy, primary, autosomal recessive 1, 259100 (3)
HPGDS	G:602598	.	.
HPLH1	P:267700	.	.
HPN	G:142440	.	.
HPP1	P:145250	.	.
HPR	G:140210	.	.
HPRT1	G:308000	Bell>neurological	HPRT-related gout, 300323 (3)
HPRT1	G:308000	Bell>neurological	Lesch-Nyhan syndrome, 300322 (3)
HPS1	G:604982	+GR-Bell	Hermansky-Pudlak syndrome 1, 203300 (3)
HPS3	G:606118	+GR-Bell	Hermansky-Pudlak syndrome 3, 614072 (3)
HPS4	G:606682	+GR-Bell	Hermansky-Pudlak syndrome 4, 614073 (3)
HPS5	G:607521	+GR-Bell	Hermansky-Pudlak syndrome 5, 614074 (3)
HPS6	G:607522	+GR-Bell	Hermansky-Pudlak syndrome 6, 614075 (3)
HPSE	G:604724	.	.
HPSE2	G:613469	.	Urofacial syndrome, 236730 (3)
HPT	P:307700	.	.
HPV18I1	P:167959	.	.
HPV18I2	P:167960	.	.
HPV6AI1	G:604461	.	.
HPVC1	G:600762	.	.
HPX	G:142290	.	.
HRAS	G:190020	+GR-Bell	Costello syndrome, 218040 (3)
HRAS	G:190020	+GR-Bell	{Bladder cancer, somatic}, 109800 (3)
HRAS	G:190020	+GR-Bell	{Thyroid carcinoma, follicular, somatic}, 188470 (3)
HRASLS	G:606487	.	.
HRASLS2	G:613866	.	.
HRASLS5	G:611474	.	.
HRC	G:142705	.	.
HRES1	G:143025	.	.
HRG	G:142640	.	Thrombophilia due to HRG deficiency, 613116 (3)
HRH1	G:600167	.	.
HRH2	G:142703	.	.
HRH3	G:604525	.	.
HRH4	G:606792	.	.
HRK	G:603447	.	.
HRPT1	P:145000	.	.
HRSP12	G:602487	.	.
HS1BP3	G:609359	.	.
HS2ST1	G:604844	.	.
HS3ST1	G:603244	.	.
HS3ST2	G:604056	.	.
HS3ST3A1	G:604057	.	.
HS3ST3B1	G:604058	.	.
HS3ST4	G:604059	.	.
HS3ST5	G:609407	.	.
HS6ST1	G:604846	.	.
HS6ST2	G:300545	.	.
HS6ST3	G:609401	.	.
HSBP1	G:604553	.	.
HSCB	G:608142	.	.
HSD11B1	G:600713	.	Cortisone reductase deficiency, 604931 (3)
HSD11B2	G:614232	.	Apparent mineralocorticoid excess, 218030 (3)
HSD17B1	G:109684	.	.
HSD17B10	G:300256	Bell>neurological	17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3)
HSD17B10	G:300256	Bell>neurological	Mental retardation, X-linked 17/31, microduplication, 300705 (3)
HSD17B10	G:300256	Bell>neurological	Mental retardation, X-linked syndromic 10, 300220 (3)
HSD17B11	G:612831	.	.
HSD17B12	G:609574	.	.
HSD17B13	G:612127	.	.
HSD17B14	G:612832	.	.
HSD17B2	G:109685	.	.
HSD17B3	G:605573	.	Pseudohermaphroditism, male, with gynecomastia, 264300 (3)
HSD17B4	G:601860	Bell>metabolic	D-bifunctional protein deficiency, 261515 (3)
HSD17B4	G:601860	Bell>metabolic	Perrault syndrome, 233400 (3)
HSD17B6	G:606623	.	.
HSD17B7	G:606756	.	.
HSD17B8	G:601417	.	.
HSD3B1	G:109715	.	.
HSD3B2	G:613890	.	3-beta-hydroxysteroid dehydrogenase, type II, deficiency, 201810 (3)
HSD3B7	G:607764	.	Bile acid synthesis defect, congenital, 1, 607765 (3)
HSF1	G:140580	.	.
HSF2	G:140581	.	.
HSF2BP	G:604554	.	.
HSF4	G:602438	.	Cataract, Marner type, 116800 (3)
HSF4	G:602438	.	Cataract, lamellar, 116800 (3)
HSFY1	G:400029	.	.
HSH2D	G:608349	.	.
HSP90AA1	G:140571	.	.
HSP90AA2	G:140575	.	.
HSP90AB1	G:140572	.	.
HSP90B1	G:191175	.	.
HSPA12A	G:610701	.	.
HSPA12B	G:610702	.	.
HSPA13	G:601100	.	.
HSPA14	G:610369	.	.
HSPA1A	G:140550	.	.
HSPA1B	G:603012	.	.
HSPA1L	G:140559	.	.
HSPA2	G:140560	.	.
HSPA4	G:601113	.	.
HSPA5	G:138120	.	.
HSPA6	G:140555	.	.
HSPA7	G:140556	.	.
HSPA8	G:600816	.	.
HSPA9	G:600548	.	.
HSPB1	G:602195	+GR-Bell	Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)
HSPB1	G:602195	+GR-Bell	Neuropathy, distal hereditary motor, type IIB, 608634 (3)
HSPB2	G:602179	.	.
HSPB3	G:604624	.	Neuronopathy, distal hereditary motor, type IIC, 613376 (3)
HSPB6	G:610695	.	.
HSPB7	G:610692	.	.
HSPB8	G:608014	+GR-Bell	Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)
HSPB8	G:608014	+GR-Bell	Neuropathy, distal hereditary motor, type IIA, 158590 (3)
HSPB9	G:608344	.	.
HSPBAP1	G:608263	.	.
HSPBP1	G:612939	.	.
HSPD1	G:118190	.	Leukodystrophy, hypomyelinating, 4, 612233 (3)
HSPD1	G:118190	.	Spastic paraplegia-13, 605280 (3)
HSPE1	G:600141	.	.
HSPG2	G:142461	Bell>skeletal	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)
HSPG2	G:142461	Bell>skeletal	Schwartz-Jampel syndrome, type 1, 255800 (3)
HSPH1	G:610703	.	.
HTATIP2	G:605628	.	.
HTATSF1	G:300346	.	.
HTC1	P:145700	.	.
HTC2	P:307150	.	.
HTL	G:151310	.	.
HTLVR	G:143090	.	.
HTN1	G:142701	.	.
HTN3	G:142702	.	.
HTOR	P:143460	.	.
HTR1A	G:109760	.	.
HTR1B	G:182131	.	.
HTR1D	G:182133	.	.
HTR1E	G:182132	.	.
HTR1F	G:182134	.	.
HTR2A	G:182135	.	{Alcohol dependence, susceptibility to}, 103780 (3)
HTR2A	G:182135	.	{Anorexia nervosa, susceptibility to}, 606788 (3)
HTR2A	G:182135	.	{Major depressive disorder, response to citalopram therapy in}, 608516 (3)
HTR2A	G:182135	.	{Obsessive-compulsive disorder, susceptibility to}, 164230 (3)
HTR2A	G:182135	.	{Schizophrenia, susceptibility to}, 181500 (3)
HTR2A	G:182135	.	{Seasonal affective disorder, susceptibility to}, 608516 (3)
HTR2B	G:601122	.	.
HTR2C	G:312861	.	.
HTR3A	G:182139	.	.
HTR3B	G:604654	.	.
HTR3C	G:610121	.	.
HTR3D	G:610122	.	.
HTR3E	G:610123	.	.
HTR4	G:602164	.	.
HTR5A	G:601305	.	.
HTR6	G:601109	.	.
HTR7	G:182137	.	.
HTRA1	G:602194	+GR-Bell	{Macular degeneration, age-related, 7}, 610149 (3)
HTRA1	G:602194	+GR-Bell	{Macular degeneration, age-related, neovascular type}, 610149 (3)
HTRA2	G:606441	+GR-Bell	Parkinson disease 13, 610297 (3)
HTRA3	G:608785	.	.
HTRA4	G:610700	.	.
HTT	G:613004	+GR-Bell	Huntington disease, 143100 (3)
HULC	G:612210	.	.
HUNK	G:606532	.	.
HUS1	G:603760	.	.
HUS1B	G:609713	.	.
HUWE1	G:300697	.	Mental retardation, X-linked syndromic, Turner type, 300706 (3)
HVCN1	G:611227	.	.
HYAL1	G:607071	.	Mucopolysaccharidosis type IX, 601492 (3)
HYAL2	G:603551	.	.
HYAL3	G:604038	.	.
HYAL4	G:604510	.	.
HYD2	P:602639	.	.
HYDIN	G:610812	.	.
HYDIN2	G:610813	.	.
HYLS1	G:610693	Bell>developmental	Hydrolethalus syndrome, 236680 (3)
HYMAI	G:606546	.	.
HYOU1	G:601746	.	.
IAPP	G:147940	.	.
IARS	G:600709	.	.
IARS2	G:612801	.	.
IBD2	P:601458	.	.
IBD3	P:604519	.	.
IBD4	P:606675	.	.
IBD5	P:606348	.	.
IBD6	P:606674	.	.
IBD7	P:605225	.	.
IBD8	P:606668	.	.
IBD9	P:608448	.	.
IBGC1	P:213600	.	.
IBSP	G:147563	.	.
IBTK	G:606457	.	.
ICA1	G:147625	.	.
ICAM1	G:147840	.	{Malaria, cerebral, susceptibility to}, 611162 (3)
ICAM2	G:146630	.	.
ICAM3	G:146631	.	.
ICAM4	G:614088	.	[Blood group, Landsteiner-Wiener], 111250 (3)
ICAM5	G:601852	.	.
ICCA	P:602066	.	.
ICK	G:612325	.	Endocrine-cerebroosteodysplasia, 612651 (3)
ICMT	G:605851	.	.
ICOS	G:604558	+GR-Bell	Immunodeficiency, common variable, 1, 607594 (3)
ICOSLG	G:605717	.	.
ICT1	G:603000	.	.
ID1	G:600349	.	.
ID2	G:600386	.	.
ID3	G:600277	.	.
ID4	G:600581	.	.
IDDM10	P:601942	.	.
IDDM11	P:601208	.	.
IDDM13	P:601318	.	.
IDDM15	P:601666	.	.
IDDM17	P:603266	.	.
IDDM18	P:605598	.	.
IDDM2	P:125852	.	.
IDDM3	P:600318	.	.
IDDM4	P:600319	.	.
IDDM6	P:601941	.	.
IDDM7	P:600321	.	.
IDDM8	P:600883	.	.
IDE	G:146680	.	.
IDH1	G:147700	.	.
IDH2	G:147650	.	D-2-hydrosyglutaric aciduria 2, 613657 (3)
IDH3A	G:601149	.	.
IDH3B	G:604526	.	.
IDH3G	G:300089	.	.
IDI1	G:604055	.	.
IDNK	G:611343	.	.
IDO1	G:147435	.	.
IDO2	G:612129	.	.
IDS	G:300823	+GR-Bell	Mucopolysaccharidosis II, 309900 (3)
IDUA	G:252800	Bell>metabolic	Mucopolysaccharidosis Ih, 607014 (3)
IDUA	G:252800	Bell>metabolic	Mucopolysaccharidosis Ih/s, 607015 (3)
IDUA	G:252800	Bell>metabolic	Mucopolysaccharidosis Is, 607016 (3)
IER3	G:602996	.	.
IER3IP1	G:609382	.	Microcephaly, epilepsy, and diabetes syndrome, 614231 (3)
IER5	G:607177	.	.
IFFO1	G:610495	.	.
IFI16	G:147586	.	.
IFI27	G:600009	.	.
IFI27L1	G:611320	.	.
IFI27L2	G:611319	.	.
IFI30	G:604664	.	.
IFI35	G:600735	.	.
IFI44	G:610468	.	.
IFI44L	G:613975	.	.
IFI6	G:147572	.	.
IFIH1	G:606951	.	.
IFIT1	G:147690	.	.
IFIT2	G:147040	.	.
IFIT3	G:604650	.	.
IFITM1	G:604456	.	.
IFITM2	G:605578	.	.
IFITM3	G:605579	.	.
IFNA1	G:147660	.	.
IFNA10	G:147577	.	.
IFNA13	G:147578	.	.
IFNA14	G:147579	.	.
IFNA16	G:147580	.	.
IFNA17	G:147583	.	.
IFNA2	G:147562	.	.
IFNA21	G:147584	.	.
IFNA4	G:147564	.	.
IFNA5	G:147565	.	.
IFNA6	G:147566	.	.
IFNA7	G:147567	.	.
IFNA8	G:147568	.	.
IFNAR1	G:107450	.	.
IFNAR2	G:602376	.	{Hepatitis B virus, susceptibility to}, 610424 (3)
IFNB1	G:147640	.	.
IFNG	G:147570	.	{AIDS, rapid progression to}, 609423 (3)
IFNG	G:147570	.	{Aplastic anemia}, 609135 (3)
IFNG	G:147570	.	{Hepatitis C virus, response to therapy of}, 609532 (3)
IFNG	G:147570	.	{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3)
IFNG	G:147570	.	{Tuberculosis, protection against}, 607948 (3)
IFNGR1	G:107470	.	BCG infection, generalized familial, 209950 (3)
IFNGR1	G:107470	.	Mycobacterial infection, atypical, familial disseminated, 209950 (3)
IFNGR1	G:107470	.	{H. pylori infection, susceptibility to}, 600263 (3)
IFNGR1	G:107470	.	{Hepatitis B virus infection, susceptibility to}, 610424 (3)
IFNGR1	G:107470	.	{Mycobacterium tuberculosis infection, protection against}, 600263 (3)
IFNGR1	G:107470	.	{Tuberculosis, susceptibility to}, 607948 (3)
IFNGR2	G:147569	.	{Mycobacterial infection, atypical, familial disseminated}, 209950 (3)
IFNR	G:147573	.	.
IFNW1	G:147553	.	.
IFRD1	G:603502	.	.
IFRD2	G:602725	.	.
IFT122	G:606045	.	Cranioectodermal dysplasia, 218330 (3)
IFT172	G:607386	.	.
IFT20	G:614394	.	.
IFT43	G:614068	.	Cranioectodermal dysplasia 3, 614099 (3)
IFT57	G:606621	.	.
IFT74	G:608040	.	.
IFT80	G:611177	.	Asphyxiating thoracic dystrophy 2, 611263 (3)
IFT81	G:605489	.	.
IFT88	G:600595	.	.
IGAD1	P:137100	.	.
IGBP1	G:300139	Bell>developmental	Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia, 300472 (3)
IGDCC3	G:604184	.	.
IGES	P:147061	.	.
IGF1	G:147440	Bell>endocrine	Growth retardation with deafness and mental retardation due to IGF1 deficiency, 608747 (3)
IGF1R	G:147370	.	Insulin-like growth factor I, resistance to, 270450 (3)
IGF2	GP:147470	.	.
IGF2-AS	G:610146	.	.
IGF2BP1	G:608288	.	.
IGF2BP2	G:608289	.	{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)
IGF2BP3	G:608259	.	.
IGF2R	G:147280	.	.
IGFALS	GP:601489	.	Acid-labile subunit, deficiency of (3)
IGFBP1	G:146730	.	.
IGFBP2	G:146731	.	.
IGFBP3	G:146732	.	.
IGFBP4	G:146733	.	.
IGFBP5	G:146734	.	.
IGFBP6	G:146735	.	.
IGFBP7	G:602867	.	Retinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3)
IGFBPL1	G:610413	.	.
IGFL1	G:610544	.	.
IGFL2	G:610545	.	.
IGFL3	G:610546	.	.
IGFL4	G:610547	.	.
IGFLR1	G:614143	.	.
IGHA1	G:146900	.	.
IGHA2	G:147000	.	.
IGHD	G:147170	.	.
IGHD3-3	G:611937	.	.
IGHD@	G:146910	.	.
IGHE	G:147180	.	.
IGHG1	G:147100	.	.
IGHG2	G:147110	.	IgG2 deficiency, selective (3)
IGHG3	G:147120	.	.
IGHG4	G:147130	.	.
IGHJ@	G:147010	.	.
IGHM	G:147020	.	Agammaglobulinemia 1, 601495 (3)
IGHMBP2	G:600502	Bell>neurological	Neuronopathy, distal hereditary motor, type VI, 604320 (3)
IGHV3-23	G:611939	.	.
IGHV@	G:147070	.	.
IGJ	G:147790	.	.
IGKC	G:147200	.	[Kappa light chain deficiency], 614102 (3)
IGKDEL	G:146780	.	.
IGKJ@	G:146970	.	.
IGKV1OR2-108	G:147185	.	.
IGKV@	G:146980	.	.
IGLC1	G:147220	.	.
IGLJ@	G:147230	.	.
IGLL1	G:146770	.	Agammaglobulinemia 2, 613500 (3)
IGLP1	G:147080	.	.
IGLP2	G:147090	.	.
IGLV@	G:147240	.	.
IGSF1	G:300137	.	.
IGSF11	G:608351	.	.
IGSF3	G:603491	.	.
IGSF5	G:610638	.	.
IGSF6	G:606222	.	.
IGSF8	G:606644	.	.
IGSF9	G:609738	.	.
IGSF9B	G:613773	.	.
IHG1	P:308500	.	.
IHH	G:600726	.	Acrocapitofemoral dysplasia, 607778 (3)
IHH	G:600726	.	Brachydactyly, type A1, 112500 (3)
IKBIP	G:609861	.	.
IKBKAP	G:603722	Bell>neurological	Dysautonomia, familial, 223900 (3)
IKBKB	G:603258	.	.
IKBKE	G:605048	.	.
IKBKG	G:300248	Bell>immunodeficiency	Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3)
IKBKG	G:300248	Bell>immunodeficiency	Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3)
IKBKG	G:300248	Bell>immunodeficiency	Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3)
IKBKG	G:300248	Bell>immunodeficiency	Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3)
IKBKG	G:300248	Bell>immunodeficiency	Immunodeficiency, isolated, 300584 (3)
IKBKG	G:300248	Bell>immunodeficiency	Immunodeficiency, isolated, 300584 (3)
IKBKG	G:300248	Bell>immunodeficiency	Incontinentia pigmenti, type II, 308300 (3)
IKBKG	G:300248	Bell>immunodeficiency	Incontinentia pigmenti, type II, 308300 (3)
IKBKG	G:300248	Bell>immunodeficiency	Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)
IKBKG	G:300248	Bell>immunodeficiency	Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)
IKBKG	G:300248	Bell>immunodeficiency	{Atypical mycobacteriosis, familial}, 300636 (3)
IKBKG	G:300248	Bell>immunodeficiency	{Atypical mycobacteriosis, familial}, 300636 (3)
IKZF1	G:603023	.	Leukemia, acute lymphoblastic (3)
IKZF2	G:606234	.	.
IKZF3	G:606221	.	.
IKZF4	G:606239	.	.
IKZF5	G:606238	.	.
IL10	G:124092	.	{Graft-versus-host disease, protection against}, 614395 (3)
IL10	G:124092	.	{HIV-1, susceptibility to}, 609423 (3)
IL10	G:124092	.	{Rheumatoid arthritis, progression of}, 180300 (3)
IL10RA	G:146933	.	Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3)
IL10RB	G:123889	.	Inflammatory bowel disease 25, early onset, autosomal recessive, 612567 (3)
IL10RB	G:123889	.	{Hepatitis B virus, susceptibility to}, 610424 (3)
IL11	G:147681	.	.
IL11RA	G:600939	.	Craniosynostosis and dental anomalies, 614188 (3)
IL12A	G:161560	.	.
IL12B	G:161561	.	{Asthma, susceptibility to}, 600807 (3)
IL12RB1	G:601604	.	{Mycobacterial and salmonella infections, susceptibility to}, 209950 (3)
IL12RB2	G:601642	.	.
IL13	G:147683	.	{Allergic rhinitis, susceptibility to}, 607154 (3)
IL13	G:147683	.	{Asthma, susceptibility to}, 600807 (3)
IL13RA1	G:300119	.	.
IL13RA2	G:300130	.	.
IL15	G:600554	.	.
IL15RA	G:601070	.	.
IL16	G:603035	.	.
IL17A	G:603149	.	.
IL17B	G:604627	.	.
IL17C	G:604628	.	.
IL17D	G:607587	.	.
IL17F	G:606496	.	Candidiasis, familial, 6, autosomal dominant, 613956 (3)
IL17RA	G:605461	.	Candidiasis, familial, 5, autosomal recessive, 613953 (3)
IL17RB	G:605458	.	.
IL17RC	G:610925	.	.
IL17RD	G:606807	.	.
IL17REL	G:613414	.	.
IL18	G:600953	.	.
IL18BP	G:604113	.	.
IL18R1	G:604494	.	.
IL18RAP	G:604509	.	.
IL19	G:605687	.	.
IL1A	G:147760	.	.
IL1B	G:147720	.	{Gastric cancer risk after H. pylori infection}, 137215 (3)
IL1R1	G:147810	.	.
IL1R2	G:147811	.	.
IL1RAP	G:602626	.	.
IL1RAPL1	G:300206	.	Mental retardation, X-linked 21/34, 300143 (3)
IL1RAPL2	G:300277	.	.
IL1RL1	G:601203	.	.
IL1RL2	G:604512	.	.
IL1RN	G:147679	.	Interleukin 1 receptor antagonist deficiency, 612852 (3)
IL1RN	G:147679	.	{Gastric cancer risk after H. pylori infection}, 137215 (3)
IL1RN	G:147679	.	{Microvascular complications of diabetes 4}, 612628 (3)
IL2	G:147680	.	.
IL20	G:605619	.	.
IL20RA	G:605620	.	.
IL20RB	G:605621	.	.
IL21	G:605384	.	.
IL21R	G:605383	.	[IgE, elevated level of], 147050 (3)
IL22	G:605330	.	.
IL22RA1	G:605457	.	.
IL22RA2	G:606648	.	.
IL23A	G:605580	.	.
IL23R	G:607562	.	{Inflammatory bowel disease 17, protection against}, 612261 (3)
IL23R	G:607562	.	{Psoriasis, protection against}, 605606 (3)
IL24	G:604136	.	.
IL25	G:605658	.	.
IL26	G:605679	.	.
IL27	G:608273	.	.
IL27RA	G:605350	.	.
IL28A	G:607401	.	.
IL28B	G:607402	.	{Hepatitis C virus infection, response to therapy of}, 609532 (3)
IL28RA	G:607404	.	.
IL29	G:607403	.	.
IL2RA	G:147730	.	Interleukin-2 receptor, alpha chain, deficiency of, 606367 (3)
IL2RA	G:147730	.	{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)
IL2RB	G:146710	.	.
IL2RG	G:308380	Bell>immunodeficiency	Combined immunodeficiency, X-linked, moderate, 312863 (3)
IL2RG	G:308380	Bell>immunodeficiency	Combined immunodeficiency, X-linked, moderate, 312863 (3)
IL2RG	G:308380	Bell>immunodeficiency	Severe combined immunodeficiency, X-linked, 300400 (3)
IL2RG	G:308380	Bell>immunodeficiency	Severe combined immunodeficiency, X-linked, 300400 (3)
IL3	G:147740	.	.
IL31	G:609509	.	.
IL31RA	G:609510	.	Amyloidosis, primary localized cutaneous, 2, 613955 (3)
IL32	G:606001	.	.
IL33	G:608678	.	.
IL34	G:612081	.	.
IL36A	G:605509	.	.
IL36B	G:605508	.	.
IL36G	G:605542	.	.
IL36RN	G:605507	.	Psoriasis, generalized pustular, 614204 (3)
IL37	G:605510	.	.
IL3RA	G:308385	.	.
IL3RA	G:430000	.	.
IL4	G:147780	.	.
IL4I1	G:609742	.	.
IL4R	G:147781	.	{AIDS, slow progression to}, 609423 (3)
IL4R	G:147781	.	{Atopy, susceptibility to}, 147050 (3)
IL5	G:147850	.	.
IL5RA	G:147851	.	.
IL6	G:147620	.	{Crohn disease-associated growth failure}, 266600 (3)
IL6	G:147620	.	{Diabetes, susceptibility to}, 222100, 125853 (3)
IL6	G:147620	.	{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}, 108010 (3)
IL6	G:147620	.	{Kaposi sarcoma, susceptibility to}, 148000 (3)
IL6	G:147620	.	{Rheumatoid arthritis, systemic juvenile}, 604302 (3)
IL6R	G:147880	.	.
IL6ST	G:600694	.	.
IL7	G:146660	.	.
IL7R	G:146661	.	Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type, 608971 (3)
IL8	G:146930	.	.
IL9	G:146931	.	.
IL9R	G:300007	.	.
ILDR1	G:609739	.	Deafness, autosomal recessive 42, 609646 (3)
ILF2	G:603181	.	.
ILF3	G:603182	.	.
ILK	G:602366	.	.
ILVBL	G:605770	.	.
IMMP1L	G:612323	.	.
IMMP2L	G:605977	.	.
IMMT	G:600378	.	.
IMP3	G:612980	.	.
IMP4	G:612981	.	.
IMPA1	G:602064	.	.
IMPA2	G:605922	.	.
IMPAD1	G:614010	.	Chondrodysplasia with joint dislocations, GRAPP type, 614078 (3)
IMPDH1	G:146690	+GR-Bell	Leber congenital amaurosis 11, 613837 (3)
IMPDH1	G:146690	+GR-Bell	Retinitis pigmentosa 10, 180105 (3)
IMPDH2	GP:146691	.	[IMPDH2 enzyme activity, variation in] (3)
IMPG1	G:602870	.	.
IMPG2	G:607056	+GR-Bell	Maculopathy, IMPG2-related, 613581 (3)
IMPG2	G:607056	+GR-Bell	Retinitis pigmentosa 56, 613581 (3)
INA	G:605338	.	.
INADL	G:603199	.	.
INCENP	G:604411	.	.
INE1	G:300164	.	.
INE2	G:300165	.	.
INF2	G:610982	.	Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)
INF2	G:610982	.	Glomerulosclerosis, focal segmental, 5, 613237 (3)
ING1	G:601566	.	Squamous cell carcinoma, head and neck, somatic, 275355 (3)
ING2	G:604215	.	.
ING3	G:607493	.	.
ING4	G:608524	.	.
ING5	G:608525	.	.
INGX	G:300452	.	.
INHA	G:147380	.	.
INHBA	G:147290	.	.
INHBB	G:147390	.	.
INHBC	G:601233	.	.
INHBE	G:612031	.	.
INMT	G:604854	.	.
INO80	G:610169	.	.
INPP1	G:147263	.	.
INPP4A	G:600916	.	.
INPP4B	G:607494	.	.
INPP5A	G:600106	.	.
INPP5B	G:147264	.	.
INPP5D	G:601582	.	.
INPP5E	G:613037	+GR-Bell	Joubert syndrome 1, 213300 (3)
INPP5E	G:613037	+GR-Bell	Mental retardation, truncal obesity, retinal dystrophy, and micropenis, 610156 (3)
INPP5F	G:609389	.	.
INPP5J	G:606481	.	.
INPP5K	G:607875	.	.
INPPL1	G:600829	.	.
INS	GP:176730	.	Diabetes mellitus, insulin-dependent, 2, 125852 (3)
INS	GP:176730	.	Diabetes mellitus, permanent neonatal, 606176 (3)
INS	GP:176730	.	Diabetes mellitus, type 1, 125852 (3)
INS	GP:176730	.	Hyperproinsulinemia, familial, with or without diabetes (3)
INS	GP:176730	.	Maturity-onset diabetes of the young, type 10, 613370 (3)
INSC	G:610668	.	.
INSIG1	G:602055	.	.
INSIG2	G:608660	.	.
INSL3	G:146738	.	Cryptorchidism, idiopathic, 219050 (3)
INSL4	G:600910	.	.
INSL5	G:606413	.	.
INSL6	G:606414	.	.
INSM1	G:600010	.	.
INSM2	G:614027	.	.
INSR	G:147670	Bell>endocrine	Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3)
INSR	G:147670	Bell>endocrine	Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)
INSR	G:147670	Bell>endocrine	Leprechaunism, 246200 (3)
INSR	G:147670	Bell>endocrine	Rabson-Mendenhall syndrome, 262190 (3)
INSRR	G:147671	.	.
INTS1	G:611345	.	.
INTS10	G:611353	.	.
INTS12	G:611355	.	.
INTS2	G:611346	.	.
INTS3	G:611347	.	.
INTS4	G:611348	.	.
INTS5	G:611349	.	.
INTS6	G:604331	.	.
INTS7	G:611350	.	.
INTS8	G:611351	.	.
INTS9	G:611352	.	.
INTU	G:610621	.	.
INVS	G:243305	Bell>renal	Nephronophthisis 2, infantile, 602088 (3)
IP6K1	G:606991	.	.
IP6K2	G:606992	.	.
IP6K3	G:606993	.	.
IPMK	G:609851	.	.
IPO11	G:610889	.	.
IPO13	G:610411	.	.
IPO5	G:602008	.	.
IPO7	G:605586	.	.
IPO8	G:605600	.	.
IPP	G:147485	.	.
IPW	G:601491	.	.
IQCB1	G:609237	Bell>renal	Senior-Loken syndrome 5, 609254 (3)
IQCG	G:612477	.	.
IQCH	G:612523	.	.
IQCJ	G:611622	.	.
IQGAP1	G:603379	.	.
IQGAP2	G:605401	.	.
IQSEC1	G:610166	.	.
IQSEC2	G:300522	.	Mental retardation, X-linked 1, 309530 (3)
IQSEC3	G:612118	.	.
IRAK1	G:300283	.	.
IRAK2	G:603304	.	.
IRAK3	G:604459	.	{Asthma susceptibility 5}, 611064 (3)
IRAK4	G:606883	.	IRAK4 deficiency, 607676 (3)
IRAK4	G:606883	.	Invasive pneumococcal disease, recurrent isolated, 1, 610799 (3)
IREB2	G:147582	.	.
IRF1	G:147575	.	Gastric cancer, somatic, 137215 (3)
IRF1	G:147575	.	Myelodysplastic syndrome, preleukemic (3)
IRF1	G:147575	.	Myelogenous leukemia, acute (3)
IRF1	G:147575	.	Nonsmall cell lung cancer, somatic, 211980 (3)
IRF2	G:147576	.	.
IRF2BPL	G:611720	.	.
IRF3	G:603734	.	.
IRF4	G:601900	.	Multiple myeloma, 254500 (3)
IRF5	G:607218	.	{Inflammatory bowel disease 14}, 612245 (3)
IRF5	G:607218	.	{Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3)
IRF6	G:607199	+GR-Bell	Orofacial cleft 6, 608864 (3)
IRF6	G:607199	+GR-Bell	Popliteal pterygium syndrome, 119500 (3)
IRF6	G:607199	+GR-Bell	van der Woude syndrome, 119300 (3)
IRF7	G:605047	.	.
IRF8	G:601565	.	.
IRF9	G:147574	.	.
IRGM	G:608212	.	Inflammatory bowel disease 19, 612278 (3)
IRGM	G:608212	.	{Mycobacterium tuberculosis, protection against}, 607948 (3)
IRS1	GP:147545	.	{Coronary artery disease, susceptibility to} (3)
IRS1	GP:147545	.	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
IRS2	G:600797	.	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
IRS4	G:603510	.	.
IRX1	G:606197	.	.
IRX2	G:606198	.	.
IRX3	G:612985	.	.
IRX4	G:606199	.	.
IRX5	G:606195	.	.
IRX6	G:606196	.	.
ISCA1	G:611006	.	.
ISCU	G:611911	+GR-Bell	Myopathy with lactic acidosis, hereditary, 255125 (3)
ISG15	G:147571	.	.
ISG20	G:604533	.	.
ISG20L2	G:611930	.	.
ISL1	G:600366	.	.
ISL2	G:609481	.	.
ISLR	G:602059	.	.
ISLR2	G:614179	.	.
ISM2	G:612684	.	.
ISOC2	G:612928	.	.
ISX	G:612019	.	.
ISY1	G:612764	.	.
ISYNA1	G:611670	.	.
ITCH	G:606409	.	Autoimmune disease, syndromic multisystem, 613385 (3)
ITFG1	G:611803	.	.
ITGA1	G:192968	.	.
ITGA10	G:604042	.	.
ITGA11	G:604789	.	.
ITGA2	G:192974	.	.
ITGA2B	G:607759	.	Glanzmann thrombasthenia, 273800 (3)
ITGA2B	G:607759	.	Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)
ITGA3	G:605025	.	.
ITGA4	G:192975	.	.
ITGA5	G:135620	.	.
ITGA6	G:147556	Bell>cutaneous	Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)
ITGA7	G:600536	+GR-Bell	Muscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3)
ITGA8	G:604063	.	.
ITGA9	G:603963	.	.
ITGAD	G:602453	.	.
ITGAE	G:604682	.	.
ITGAL	G:153370	.	.
ITGAM	G:120980	.	{Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3)
ITGAV	G:193210	.	.
ITGAX	G:151510	.	.
ITGB1	G:135630	.	.
ITGB1BP1	G:607153	.	.
ITGB1BP2	G:300332	.	.
ITGB1BP3	G:608705	.	.
ITGB2	G:600065	.	Leukocyte adhesion deficiency, 116920 (3)
ITGB3	GP:173470	.	Glanzmann thrombasthenia, 273800 (3)
ITGB3	GP:173470	.	Purpura, posttransfusion (3)
ITGB3	GP:173470	.	Thrombocytopenia, neonatal alloimmune (3)
ITGB3	GP:173470	.	{Myocardial infarction, susceptibility to}, 608446 (3)
ITGB3BP	G:605494	.	.
ITGB4	G:147557	Bell>cutaneous	Epidermolysis bullosa of hands and feet, 131800 (3)
ITGB4	G:147557	Bell>cutaneous	Epidermolysis bullosa of hands and feet, 131800 (3)
ITGB4	G:147557	Bell>cutaneous	Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)
ITGB4	G:147557	Bell>cutaneous	Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)
ITGB4	G:147557	Bell>cutaneous	Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3)
ITGB4	G:147557	Bell>cutaneous	Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3)
ITGB5	G:147561	.	.
ITGB6	G:147558	.	.
ITGB7	G:147559	.	.
ITGB8	G:604160	.	.
ITGBL1	G:604234	.	.
ITIH1	G:147270	.	.
ITIH2	G:146640	.	.
ITIH3	G:146650	.	.
ITIH4	G:600564	.	{Hypercholesterolemia, susceptibility to}, 143890 (3)
ITIH5	G:609783	.	.
ITK	G:186973	.	Lymphoproliferative syndrome, EBV-associated, autosomal, 1, 613011 (3)
ITLN1	G:609873	.	.
ITLN2	G:609874	.	.
ITM2A	G:300222	.	.
ITM2B	G:603904	.	Dementia, familial British, 176500 (3)
ITM2B	G:603904	.	Dementia, familial Danish, 117300 (3)
ITM2C	G:609554	.	.
ITPA	G:147520	.	[Inosine triphosphatase deficiency], 613850 (3)
ITPK1	G:601838	.	.
ITPKA	G:147521	.	.
ITPKB	G:147522	.	.
ITPKC	G:606476	.	{Kawasaki disease, susceptibility to}, 611775 (3)
ITPR1	G:147265	+GR-Bell	Spinocerebellar ataxia 15, 606658 (3)
ITPR2	G:600144	.	.
ITPR3	G:147267	.	.
ITSN1	G:602442	.	.
ITSN2	G:604464	.	.
IVD	G:607036	Bell>metabolic	Isovaleric acidemia, 243500 (3)
IVL	G:147360	.	.
IVNS1ABP	G:609209	.	.
IYD	G:612025	.	Thyroid dyshormonogenesis 4, 274800 (3)
IZUMO1	G:609278	.	.
JAG1	GP:601920	+GR-Bell	Alagille syndrome, 118450 (3)
JAG1	GP:601920	+GR-Bell	Deafness, congenital heart defects, and posterior embryotoxon (3)
JAG1	GP:601920	+GR-Bell	Tetralogy of Fallot, 187500 (3)
JAG2	G:602570	.	.
JAK1	G:147795	.	.
JAK2	G:147796	.	Leukemia, acute myelogenous, 601626 (3)
JAK2	G:147796	.	Myelofibrosis, idiopathic, 254450 (3)
JAK2	G:147796	.	Polycythemia vera, 263300 (3)
JAK2	G:147796	.	Thrombocythemia 3, 614521 (3)
JAK2	G:147796	.	{Budd-Chiari syndrome}, 600880 (3)
JAK3	G:600173	Bell>immunodeficiency	SCID, autosomal recessive, T-negative/B-positive type (3)
JAKMIP1	G:611195	.	.
JAKMIP2	G:611197	.	.
JAKMIP3	G:611198	.	.
JAM2	G:606870	.	.
JAM3	G:606871	.	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3)
JARID2	G:601594	.	.
JAZF1	G:606246	.	.
JBS	P:147791	.	.
JDP2	G:608657	.	.
JKAMP	G:611176	.	.
JMJD1C	G:604503	.	.
JMJD6	G:604914	.	.
JMY	G:604279	.	.
JPH1	G:605266	.	.
JPH2	G:605267	.	Cardiomyopathy, familial hypertrophic 17, 613873 (3)
JPH3	G:605268	+GR-Bell	Huntington disease-like 2, 606438 (3)
JPX	G:300832	.	.
JRK	G:603210	.	.
JRKL	G:603211	.	.
JSRP1	G:608743	.	.
JTB	G:604671	.	.
JUN	G:165160	.	.
JUNB	G:165161	.	.
JUND	G:165162	.	.
JUP	G:173325	+GR-Bell	Arrhythmogenic right ventricular dysplasia 12, 611528 (3)
JUP	G:173325	+GR-Bell	Naxos disease, 601214 (3)
K12T	P:187310	.	.
KAAG1	G:608211	.	.
KAL1	G:300836	+GR-Bell	Kallmann syndrome, 308700 (3)
KALRN	G:604605	.	{Coronary heart disease, susceptibility to, 5}, 608901 (3)
KANK1	G:607704	.	Cerebral palsy, spastic quadriplegic, 2, 612900 (3)
KANSL1	G:612452	.	.
KANSL1L	G:613833	.	.
KARS	G:601421	.	Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3)
KAT2A	G:602301	.	.
KAT2B	G:602303	.	.
KAT5	G:601409	.	.
KAT6A	G:601408	.	.
KAT6B	G:605880	.	SBBYSS syndrome, 603736 (3)
KAT7	G:609880	.	.
KAT8	G:609912	.	.
KATNA1	G:606696	.	.
KATNB1	G:602703	.	.
KAZALD1	G:609208	.	.
KBTBD10	G:607701	.	.
KBTBD13	G:613727	.	Nemaline myopathy 6, 609273 (3)
KCNA1	G:176260	+GR-Bell	Episodic ataxia/myokymia syndrome, 160120 (3)
KCNA10	G:602420	.	.
KCNA2	G:176262	.	.
KCNA3	G:176263	.	.
KCNA4	G:176266	.	.
KCNA5	G:176267	.	Atrial fibrillation, familial, 7, 612240 (3)
KCNA6	G:176257	.	.
KCNA7	G:176268	.	.
KCNAB1	G:601141	.	.
KCNAB2	G:601142	.	.
KCNAB3	G:604111	.	.
KCNB1	G:600397	.	.
KCNB2	G:607738	.	.
KCNC1	G:176258	.	.
KCNC2	G:176256	.	.
KCNC3	G:176264	+GR-Bell	Spinocerebellar ataxia 13, 605259 (3)
KCNC4	G:176265	.	.
KCND1	G:300281	.	.
KCND2	G:605410	.	.
KCND3	G:605411	.	.
KCNE1	G:176261	+GR-Bell	Jervell and Lange-Nielsen syndrome 2, 612347 (3)
KCNE1	G:176261	+GR-Bell	Long QT syndrome-5, 613695 (3)
KCNE1L	G:300328	.	.
KCNE2	G:603796	+GR-Bell	Atrial fibrillation, familial, 4, 611493 (3)
KCNE2	G:603796	+GR-Bell	Long QT syndrome-6, 613693 (3)
KCNE3	G:604433	+GR-Bell	Brugada syndrome 6, 613119 (3)
KCNE4	G:607775	.	.
KCNF1	G:603787	.	.
KCNG1	G:603788	.	.
KCNG2	G:605696	.	.
KCNG3	G:606767	.	.
KCNG4	G:607603	.	.
KCNH1	G:603305	.	.
KCNH2	G:152427	+GR-Bell	Long QT syndrome-2, 613688 (3)
KCNH2	G:152427	+GR-Bell	Short QT syndrome-1, 609620 (3)
KCNH2	G:152427	+GR-Bell	{Long QT syndrome-2, acquired, susceptibility to}, 613688 (3)
KCNH3	G:604527	.	.
KCNH4	G:604528	.	.
KCNH5	G:605716	.	.
KCNH6	G:608168	.	.
KCNH7	G:608169	.	.
KCNH8	G:608260	.	.
KCNIP1	G:604660	.	.
KCNIP2	G:604661	.	.
KCNIP3	G:604662	.	.
KCNIP4	G:608182	.	.
KCNJ1	G:600359	Bell>renal	Bartter syndrome, type 2, 241200 (3)
KCNJ10	G:602208	+GR-Bell	Enlarged vestibular aqueduct, digenic, 600791 (3)
KCNJ10	G:602208	+GR-Bell	SESAME syndrome, 612780 (3)
KCNJ11	G:600937	+GR-Bell	Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3)
KCNJ11	G:600937	+GR-Bell	Diabetes mellitus, transient neonatal, 3, 610582 (3)
KCNJ11	G:600937	+GR-Bell	Diabetes, permanent neonatal, 606176 (3)
KCNJ11	G:600937	+GR-Bell	Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3)
KCNJ11	G:600937	+GR-Bell	{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)
KCNJ12	G:602323	.	.
KCNJ13	G:603208	+GR-Bell	Leber congenital amaurosis 16, 614186 (3)
KCNJ13	G:603208	+GR-Bell	Snowflake vitreoretinal degeneration, 193230 (3)
KCNJ14	G:603953	.	.
KCNJ15	G:602106	.	.
KCNJ16	G:605722	.	.
KCNJ18	G:613236	.	{Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3)
KCNJ2	G:600681	+GR-Bell	Atrial fibrillation, familial, 9, 613980 (3)
KCNJ2	G:600681	+GR-Bell	Long QT syndrome-7, 170390 (3)
KCNJ2	G:600681	+GR-Bell	Short QT syndrome-3, 609622 (3)
KCNJ3	G:601534	.	.
KCNJ4	G:600504	.	.
KCNJ5	G:600734	+GR-Bell	Hyperaldosteronism, familial, type III, 613677 (3)
KCNJ5	G:600734	+GR-Bell	Long QT syndrome 13, 613485 (3)
KCNJ6	G:600877	.	.
KCNJ8	G:600935	.	.
KCNJ9	G:600932	.	.
KCNK1	G:601745	.	.
KCNK10	G:605873	.	.
KCNK12	G:607366	.	.
KCNK13	G:607367	.	.
KCNK15	G:607368	.	.
KCNK16	G:607369	.	.
KCNK17	G:607370	.	.
KCNK18	G:613655	.	{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)
KCNK2	G:603219	.	.
KCNK3	G:603220	.	.
KCNK4	G:605720	.	.
KCNK5	G:603493	.	.
KCNK6	G:603939	.	.
KCNK7	G:603940	.	.
KCNK9	G:605874	.	Birk-Barel mental retardation dysmorphism syndrome, 612292 (3)
KCNMA1	G:600150	.	Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)
KCNMB1	G:603951	.	{Hypertension, diastolic, resistance to}, 608622 (3)
KCNMB2	G:605214	.	.
KCNMB3	G:605222	.	.
KCNMB4	G:605223	.	.
KCNN1	G:602982	.	.
KCNN2	G:605879	.	.
KCNN3	G:602983	.	.
KCNN4	G:602754	.	.
KCNQ1	G:607542	Bell>cardiac	Atrial fibrillation, familial, 3, 607554 (3)
KCNQ1	G:607542	Bell>cardiac	Jervell and Lange-Nielsen syndrome, 220400 (3)
KCNQ1	G:607542	Bell>cardiac	Long QT syndrome-1, 192500 (3)
KCNQ1	G:607542	Bell>cardiac	Short QT syndrome-2, 609621 (3)
KCNQ1	G:607542	Bell>cardiac	{Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)
KCNQ1DN	G:610980	.	.
KCNQ1OT1	G:604115	.	Beckwith-Wiedemann syndrome, 130650 (3)
KCNQ2	G:602235	+GR-Bell	Epileptic encephalopathy, early infantile, 7, 613720 (3)
KCNQ2	G:602235	+GR-Bell	Myokymia, 121200 (3)
KCNQ2	G:602235	+GR-Bell	Seizures, benign neonatal, 1, 121200 (3)
KCNQ3	G:602232	+GR-Bell	Seizures, benign neonatal, type 2, 121201 (3)
KCNQ4	G:603537	+GR-Bell	Deafness, autosomal dominant 2A, 600101 (3)
KCNQ5	G:607357	.	.
KCNRG	G:607947	.	.
KCNS1	G:602905	.	.
KCNS2	G:602906	.	.
KCNS3	G:603888	.	.
KCNT1	G:608167	.	.
KCNT2	G:610044	.	.
KCNV1	G:608164	.	.
KCNV2	G:607604	.	Retinal cone dystrophy 3B, 610356 (3)
KCP	G:609344	.	.
KCTD1	G:613420	.	.
KCTD10	G:613421	.	.
KCTD11	G:609848	.	.
KCTD12	G:610521	.	.
KCTD13	G:608947	.	.
KCTD16	G:613423	.	.
KCTD2	G:613422	.	.
KCTD3	G:613272	.	.
KCTD5	G:611285	.	.
KCTD7	G:611725	Bell>neurological	Epilepsy, progressive myoclonic 3, 611726 (3)
KDELC1	G:611613	.	.
KDELR1	G:131235	.	.
KDELR2	G:609024	.	.
KDM1A	G:609132	.	.
KDM1B	G:613081	.	.
KDM2A	G:605657	.	.
KDM2B	G:609078	.	.
KDM3A	G:611512	.	.
KDM3B	G:609373	.	.
KDM4A	G:609764	.	.
KDM4B	G:609765	.	.
KDM4C	G:605469	.	.
KDM4D	G:609766	.	.
KDM5A	G:180202	.	.
KDM5B	G:605393	.	.
KDM5C	G:314690	.	Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3)
KDM5D	G:426000	.	.
KDM6A	G:300128	.	Kabuki syndrome 2, 300867 (3)
KDM6B	G:611577	.	.
KDM8	G:611917	.	.
KDR	G:191306	.	Hemangioma, capillary infantile, somatic, 602089 (3)
KDR	G:191306	.	{Hemangioma, capillary infantile, susceptibility to}, 602089 (3)
KDSR	G:136440	.	.
KEAP1	G:606016	.	.
KEL	G:613883	.	[Blood group, Kell], 110900 (3)
KERA	G:603288	.	Cornea plana congenita, recessive, 217300 (3)
KHDC1	G:611688	.	.
KHDRBS1	G:602489	.	.
KHDRBS2	G:610487	.	.
KHDRBS3	G:610421	.	.
KHK	G:614058	.	[Fructosuria], 229800 (3)
KHSRP	G:603445	.	.
KIAA0020	G:609960	.	.
KIAA0100	G:610664	.	.
KIAA0101	G:610696	.	.
KIAA0196	G:610657	+GR-Bell	Spastic paraplegia-8, 603563 (3)
KIAA0226	G:613516	.	.
KIAA0319	G:609269	.	{Dyslexia, susceptibility to, 2}, 600202 (3)
KIAA0319L	G:613535	.	.
KIAA0391	G:609947	.	.
KIAA0513	G:611675	.	.
KIAA0586	G:610178	.	.
KIAA1009	G:610201	.	.
KIAA1109	G:611565	.	.
KIAA1199	G:608366	.	?Deafness, nonsyndromic (3)
KIAA1279	G:609367	.	Goldberg-Shprintzen megacolon syndrome, 609460 (3)
KIAA1324	G:611298	.	.
KIAA1324L	G:614048	.	.
KIAA1432	G:610354	.	.
KIAA1462	G:614398	.	.
KIAA1524	G:610643	.	.
KIAA1549	G:613344	.	.
KIAA1598	G:611171	.	.
KIAA1715	G:610236	.	.
KIAA1967	G:607359	.	.
KIAA2022	G:300524	.	.
KIF11	G:148760	.	.
KIF12	G:611278	.	.
KIF13A	G:605433	.	.
KIF13B	G:607350	.	.
KIF14	G:611279	.	.
KIF17	P:605037	.	.
KIF18A	G:611271	.	.
KIF1A	G:601255	+GR-Bell	Mental retardation, autosomal dominant 9, 614255 (3)
KIF1A	G:601255	+GR-Bell	Neuropathy, hereditary sensory, type IIC, 614213 (3)
KIF1A	G:601255	+GR-Bell	Spastic paraplegia 30, autosomal recessive, 610357 (3)
KIF1B	G:605995	+GR-Bell	Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
KIF1B	G:605995	+GR-Bell	Pheochromocytoma, 171300 (3)
KIF1B	G:605995	+GR-Bell	{Neuroblastoma, susceptibility to, 1}, 256700 (3)
KIF1C	G:603060	.	.
KIF20A	G:605664	.	.
KIF20B	G:605498	.	.
KIF21A	G:608283	+GR-Bell	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
KIF21A	G:608283	+GR-Bell	Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)
KIF21B	G:608322	.	.
KIF22	G:603213	.	Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3)
KIF23	G:605064	.	.
KIF24	G:613747	.	.
KIF25	G:603815	.	.
KIF26A	G:613231	.	.
KIF26B	G:614026	.	.
KIF27	G:611253	.	.
KIF2A	G:602591	.	.
KIF2C	G:604538	.	.
KIF3A	G:604683	.	.
KIF3B	G:603754	.	.
KIF3C	G:602845	.	.
KIF4A	G:300521	.	.
KIF4B	G:609184	.	.
KIF5A	G:602821	.	Spastic paraplegia 10, 604187 (3)
KIF5B	G:602809	.	.
KIF5C	G:604593	.	.
KIF6	G:613919	.	.
KIF7	G:611254	+GR-Bell	Acrocallosal syndrome, 200990 (3)
KIF7	G:611254	+GR-Bell	Hydrolethalus syndrome 2, 614120 (3)
KIF7	G:611254	+GR-Bell	Joubert syndrome 12, 200990 (3)
KIF9	G:607910	.	.
KIFAP3	G:601836	.	.
KIFC1	G:603763	.	.
KIFC3	G:604535	.	.
KIN	G:601720	.	.
KIR2DL1	G:604936	.	.
KIR2DL2	G:604937	.	.
KIR2DL3	G:604938	.	.
KIR2DL4	G:604945	.	.
KIR2DL5A	G:605305	.	.
KIR2DS1	G:604952	.	.
KIR2DS2	G:604953	.	.
KIR2DS3	G:604954	.	.
KIR2DS4	G:604955	.	.
KIR2DS5	G:604956	.	.
KIR3DL1	G:604946	.	{AIDS, delayed/rapid progression to}, 609423 (3)
KIR3DL2	G:604947	.	.
KIR3DL3	G:610095	.	.
KIR3DP1	G:610604	.	.
KIRREL	G:607428	.	.
KIRREL2	G:607762	.	.
KIRREL3	G:607761	.	Mental retardation, autosomal dominant 4, 612581 (3)
KISS1	G:603286	.	Hypogonadotropic hypogonadism, 146110 (3)
KISS1R	G:604161	.	Hypogonadotropic hypogonadism, 146110 (3)
KISS1R	G:604161	.	Precocious puberty, central, 176400 (3)
KIT	G:164920	.	Gastrointestinal stromal tumor, somatic, 606764 (3)
KIT	G:164920	.	Germ cell tumors, 273300 (3)
KIT	G:164920	.	Leukemia, acute myeloid, 601626 (3)
KITLG	G:184745	.	Hyperpigmentation, familial progressive, 2, 145250 (3)
KITLG	G:184745	.	[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3)
KLB	G:611135	.	.
KLC1	G:600025	.	.
KLC2	G:611729	.	.
KLC3	G:601334	.	.
KLF1	G:600599	.	Anemia, dyserythropoietic congenital, type IV, 613673 (3)
KLF1	G:600599	.	Blood group--Lutheran inhibitor, 111150 (3)
KLF1	G:600599	.	[Hereditary persistence of fetal hemoglobin], 613566 (3)
KLF10	G:601878	.	.
KLF11	G:603301	.	Maturity-onset diabetes of the young, type VII, 610508 (3)
KLF12	G:607531	.	.
KLF13	G:605328	.	.
KLF14	G:609393	.	.
KLF15	G:606465	.	.
KLF16	G:606139	.	.
KLF17	G:609602	.	.
KLF2	G:602016	.	.
KLF3	G:609392	.	.
KLF4	G:602253	.	.
KLF5	G:602903	.	.
KLF6	G:602053	.	Gastric cancer, somatic, 137215 (3)
KLF6	G:602053	.	Prostate cancer, somatic, 176807 (3)
KLF7	G:604865	.	.
KLF8	G:300286	.	.
KLF9	G:602902	.	.
KLHDC1	G:611281	.	.
KLHDC2	G:611280	.	.
KLHDC3	G:611248	.	.
KLHDC8A	G:614503	.	.
KLHDC8B	G:613169	.	Hodgkin lymphoma, 236000 (3)
KLHL1	G:605332	.	.
KLHL10	G:608778	.	.
KLHL12	G:614522	.	.
KLHL13	G:300655	.	.
KLHL14	G:613772	.	.
KLHL2	G:605774	.	.
KLHL24	G:611295	.	.
KLHL3	G:605775	.	Pseudohypoaldosteronism, type IID, 614495 (3)
KLHL31	G:610749	.	.
KLHL4	G:300348	.	.
KLHL5	G:608064	.	.
KLHL6	G:614214	.	.
KLHL7	G:611119	+GR-Bell	Retinitis pigmentosa 42, 612943 (3)
KLHL8	G:611967	.	.
KLHL9	G:611201	.	.
KLK1	GP:147910	.	[Kallikrein, decreased urinary activity of] (3)
KLK10	G:602673	.	.
KLK11	G:604434	.	.
KLK12	G:605539	.	.
KLK13	G:605505	.	.
KLK14	G:606135	.	.
KLK15	G:610601	.	.
KLK2	G:147960	.	.
KLK3	G:176820	.	.
KLK4	G:603767	.	Amelogenesis imperfecta, type IIA1, 204700 (3)
KLK5	G:605643	.	.
KLK6	G:602652	.	.
KLK7	G:604438	.	.
KLK8	G:605644	.	.
KLK9	G:605504	.	.
KLKB1	G:229000	.	Fletcher factor deficiency, 612423 (3)
KLLN	G:612105	.	.
KLRAP1	G:604274	.	.
KLRB1	G:602890	.	.
KLRC1	G:161555	.	.
KLRC2	G:602891	.	.
KLRC3	G:602892	.	.
KLRC4	G:602893	.	.
KLRD1	G:602894	.	.
KLRF1	G:605029	.	.
KLRG1	G:604874	.	.
KLRK1	G:611817	.	.
KMO	G:603538	.	.
KNCN	G:611455	.	.
KNG1	G:612358	.	[High molecular weight kininogen deficiency], 228960 (3)
KNG1	G:612358	.	[Kininogen deficiency], 228960 (3)
KNTC1	G:607363	.	.
KPNA1	G:600686	.	.
KPNA2	G:600685	.	.
KPNA3	G:601892	.	.
KPNA4	G:602970	.	.
KPNA5	G:604545	.	.
KPNA6	G:610563	.	.
KPNA7	G:614107	.	.
KPNB1	G:602738	.	.
KPRP	G:613260	.	.
KRAS	G:190070	.	Bladder cancer, 109800 (3)
KRAS	G:190070	.	Breast cancer, somatic, 114480 (3)
KRAS	G:190070	.	Cardiofaciocutaneous syndrome, 115150 (3)
KRAS	G:190070	.	Gastric cancer, 137215 (3)
KRAS	G:190070	.	Leukemia, acute myelogenous (3)
KRAS	G:190070	.	Lung cancer, 211980 (3)
KRAS	G:190070	.	Noonan syndrome 3, 609942 (3)
KRAS	G:190070	.	Pancreatic carcinoma, somatic, 260350 (3)
KREMEN1	G:609898	.	.
KREMEN2	G:609899	.	.
KRIT1	G:604214	+GR-Bell	Cavernous malformations of CNS and retina, 116860 (3)
KRIT1	G:604214	+GR-Bell	Cerebral cavernous malformations-1, 116860 (3)
KRIT1	G:604214	+GR-Bell	Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3)
KRR1	G:612817	.	.
KRT1	G:139350	.	Epidermolytic hyperkeratosis, 113800 (3)
KRT1	G:139350	.	Ichthyosis histrix, Curth-Macklin type, 146590 (3)
KRT1	G:139350	.	Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3)
KRT1	G:139350	.	Keratosis palmoplantaris striata III, 607654 (3)
KRT1	G:139350	.	Palmoplantar keratoderma, epidermolytic, 144200 (3)
KRT1	G:139350	.	Palmoplantar keratoderma, nonepidermolytic, 600962 (3)
KRT10	G:148080	.	Epidermolytic hyperkeratosis, 113800 (3)
KRT10	G:148080	.	Ichthyosis with confetti, 609165 (3)
KRT10	G:148080	.	Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3)
KRT12	G:601687	.	Meesmann corneal dystrophy, 122100 (3)
KRT13	G:148065	.	White sponge nevus, 193900 (3)
KRT14	G:148066	+GR-Bell	Dermatopathia pigmentosa reticularis, 125595 (3)
KRT14	G:148066	+GR-Bell	Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3)
KRT14	G:148066	+GR-Bell	Epidermolysis bullosa simplex, Koebner type, 131900 (3)
KRT14	G:148066	+GR-Bell	Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3)
KRT14	G:148066	+GR-Bell	Epidermolysis bullosa simplex, recessive, 601001 (3)
KRT14	G:148066	+GR-Bell	Naegeli-Franceschetti-Jadassohn syndrome, 161000 (3)
KRT15	G:148030	.	.
KRT16	G:148067	.	Pachyonychia congenita, Jadassohn-Lewandowsky type, 167200 (3)
KRT16	G:148067	.	Palmoplantar keratoderma, nonepidermolytic, 600962 (3)
KRT16	G:148067	.	Palmoplantar keratoderma, nonepidermolytic, focal, 613000 (3)
KRT16	G:148067	.	Palmoplantar verrucous nevus, unilateral, 144200 (3)
KRT17	G:148069	.	Pachyonychia congenita, Jackson-Lawler type, 167210 (3)
KRT17	G:148069	.	Steatocystoma multiplex, 184500 (3)
KRT18	G:148070	Bell>hepatic	Cirrhosis, cryptogenic (3)
KRT18	G:148070	Bell>hepatic	{Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3)
KRT19	G:148020	.	.
KRT2	G:600194	.	Ichthyosis bullosa of Siemens, 146800 (3)
KRT20	G:608218	.	.
KRT23	G:606194	.	.
KRT24	G:607742	.	.
KRT3	G:148043	.	Meesmann corneal dystrophy, 122100 (3)
KRT31	G:601077	.	.
KRT32	G:602760	.	.
KRT33A	G:602761	.	.
KRT33B	G:602762	.	.
KRT34	G:602763	.	.
KRT35	G:602764	.	.
KRT36	G:604540	.	.
KRT37	G:604541	.	.
KRT38	G:604542	.	.
KRT4	G:123940	.	White sponge nevus, 193900 (3)
KRT5	G:148040	+GR-Bell	Dowling-Degos disease, 179850 (3)
KRT5	G:148040	+GR-Bell	Epidermolysis bullosa simplex with migratory circinate erythema, 609352 (3)
KRT5	G:148040	+GR-Bell	Epidermolysis bullosa simplex with mottled pigmentation, 131960 (3)
KRT5	G:148040	+GR-Bell	Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3)
KRT5	G:148040	+GR-Bell	Epidermolysis bullosa simplex, Koebner type, 131900 (3)
KRT5	G:148040	+GR-Bell	Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3)
KRT6A	G:148041	+GR-Bell	Pachyonychia congenita, Jadassohn-Lewandowsky type, 167200 (3)
KRT6B	G:148042	+GR-Bell	Pachyonychia congenita, Jackson-Lawler type, 167210 (3)
KRT6C	G:612315	.	.
KRT7	G:148059	.	.
KRT71	G:608245	.	.
KRT72	G:608246	.	.
KRT73	G:608247	.	.
KRT74	G:608248	.	Hypotrichosis simplex of the scalp 2, 613981 (3)
KRT74	G:608248	.	Woolly hair, autosomal dominant, 194300 (3)
KRT75	G:609025	.	{Pseudofolliculitis barbae, susceptibility to}, 612318 (3)
KRT77	G:611158	.	.
KRT78	G:611159	.	.
KRT79	G:611160	.	.
KRT8	G:148060	Bell>hepatic	Cirrhosis, cryptogenic (3)
KRT8	G:148060	Bell>hepatic	{Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3)
KRT80	G:611161	.	.
KRT81	G:602153	.	Monilethrix, 158000 (3)
KRT82	G:601078	.	.
KRT83	G:602765	.	Monilethrix, 158000 (3)
KRT84	G:602766	.	.
KRT85	G:602767	.	Ectodermal dysplasia, 'pure' hair-nail type, 602032 (3)
KRT86	G:601928	.	Monilethrix, 158000 (3)
KRT9	G:607606	.	Epidermolytic palmoplantar keratoderma, 144200 (3)
KRTAP1-1	G:608819	.	.
KRTAP1-3	G:608820	.	.
KRTAP1-4	G:608821	.	.
KRTAP1-5	G:608822	.	.
KRTAP11-1	G:600064	.	.
KRTAP13-1	G:608718	.	.
KRTAP5-1	G:148022	.	.
KRTAP5-9	G:148021	.	.
KSR1	G:601132	.	.
KSR2	G:610737	.	.
KTN1	G:600381	.	.
KWE	P:148370	.	.
KYNU	G:605197	.	.
L1CAM	G:308840	Bell>neurological	CRASH syndrome, 303350 (3)
L1CAM	G:308840	Bell>neurological	CRASH syndrome, 303350 (3)
L1CAM	G:308840	Bell>neurological	CRASH syndrome, 303350 (3)
L1CAM	G:308840	Bell>neurological	Corpus callosum, partial agenesis of, 304100 (3)
L1CAM	G:308840	Bell>neurological	Corpus callosum, partial agenesis of, 304100 (3)
L1CAM	G:308840	Bell>neurological	Corpus callosum, partial agenesis of, 304100 (3)
L1CAM	G:308840	Bell>neurological	Hydrocephalus due to aqueductal stenosis, 307000 (3)
L1CAM	G:308840	Bell>neurological	Hydrocephalus due to aqueductal stenosis, 307000 (3)
L1CAM	G:308840	Bell>neurological	Hydrocephalus due to aqueductal stenosis, 307000 (3)
L1CAM	G:308840	Bell>neurological	Hydrocephalus with Hirschsprung disease, 307000 (3)
L1CAM	G:308840	Bell>neurological	Hydrocephalus with Hirschsprung disease, 307000 (3)
L1CAM	G:308840	Bell>neurological	Hydrocephalus with Hirschsprung disease, 307000 (3)
L1CAM	G:308840	Bell>neurological	Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)
L1CAM	G:308840	Bell>neurological	Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)
L1CAM	G:308840	Bell>neurological	Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)
L1CAM	G:308840	Bell>neurological	MASA syndrome, 303350 (3)
L1CAM	G:308840	Bell>neurological	MASA syndrome, 303350 (3)
L1CAM	G:308840	Bell>neurological	MASA syndrome, 303350 (3)
L1RE1	G:151626	.	.
L1RE2	G:151628	.	.
L2HGDH	G:609584	.	L-2-hydroxyglutaric aciduria, 236792 (3)
L3MBTL1	G:608802	.	.
L3MBTL2	G:611865	.	.
LACC1	G:613409	.	.
LACRT	G:607360	.	.
LACTB	G:608440	.	.
LAD1	G:602314	.	.
LAG3	G:153337	.	.
LAGE3	G:300060	.	.
LAIR1	G:602992	.	.
LAIR2	G:602993	.	.
LAKLG	G:153435	.	.
LALBA	G:149750	.	.
LAMA1	G:150320	.	.
LAMA2	G:156225	Bell>neurological	Muscular dystrophy, congenital merosin-deficient, 607855 (3)
LAMA2	G:156225	Bell>neurological	Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)
LAMA3	G:600805	Bell>cutaneous	Epidermolysis bullosa, generalized atrophic benign, 226650 (3)
LAMA3	G:600805	Bell>cutaneous	Epidermolysis bullosa, generalized atrophic benign, 226650 (3)
LAMA3	G:600805	Bell>cutaneous	Epidermolysis bullosa, generalized atrophic benign, 226650 (3)
LAMA3	G:600805	Bell>cutaneous	Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)
LAMA3	G:600805	Bell>cutaneous	Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)
LAMA3	G:600805	Bell>cutaneous	Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)
LAMA3	G:600805	Bell>cutaneous	Laryngoonychocutaneous syndrome, 245660 (3)
LAMA3	G:600805	Bell>cutaneous	Laryngoonychocutaneous syndrome, 245660 (3)
LAMA3	G:600805	Bell>cutaneous	Laryngoonychocutaneous syndrome, 245660 (3)
LAMA4	G:600133	.	.
LAMA5	G:601033	.	.
LAMB1	G:150240	.	.
LAMB2	G:150325	Bell>renal	Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3)
LAMB2	G:150325	Bell>renal	Pierson syndrome, 609049 (3)
LAMB3	G:150310	Bell>cutaneous	Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)
LAMB3	G:150310	Bell>cutaneous	Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)
LAMB3	G:150310	Bell>cutaneous	Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)
LAMB3	G:150310	Bell>cutaneous	Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)
LAMC1	G:150290	.	.
LAMC2	G:150292	Bell>cutaneous	Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)
LAMC2	G:150292	Bell>cutaneous	Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)
LAMC2	G:150292	Bell>cutaneous	Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)
LAMC2	G:150292	Bell>cutaneous	Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)
LAMC3	G:604349	.	Cortical malformations, occipital, 614115 (3)
LAMP1	G:153330	.	.
LAMP2	G:309060	.	Danon disease, 300257 (3)
LAMP3	G:605883	.	.
LAMTOR1	G:613510	.	.
LAMTOR2	G:610389	.	Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3)
LAMTOR3	G:603296	.	.
LANCL1	G:604155	.	.
LANCL2	G:612919	.	.
LAP3	G:170250	.	.
LAPTM4B	G:613296	.	.
LAPTM5	G:601476	.	.
LARGE	G:603590	Bell>neuromuscular	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3)
LARGE	G:603590	Bell>neuromuscular	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)
LARP1	G:612059	.	.
LARP6	G:611300	.	.
LARP7	G:612026	.	.
LARS	G:151350	.	.
LARS2	G:604544	.	.
LASP1	G:602920	.	.
LAT	G:602354	.	.
LAT2	G:605719	.	.
LATS1	G:603473	.	.
LATS2	G:604861	.	.
LBH	G:611763	.	.
LBP	G:151990	.	.
LBR	G:600024	Bell>skeletal	HEM skeletal dysplasia, 215140 (3)
LBR	G:600024	Bell>skeletal	Pelger-Huet anomaly, 169400 (3)
LBR	G:600024	Bell>skeletal	Reynolds syndrome, 613471 (3)
LBX1	G:604255	.	.
LBX2	G:607164	.	.
LCA5	G:611408	+GR-Bell	Leber congenital amaurosis 5, 604537 (3)
LCA9	P:608553	.	.
LCAT	G:606967	.	Fish-eye disease, 136120 (3)
LCAT	G:606967	.	Norum disease, 245900 (3)
LCE1A	G:612603	.	.
LCE1B	G:612604	.	.
LCE1C	G:612605	.	.
LCE1D	G:612606	.	.
LCE1E	G:612607	.	.
LCE1F	G:612608	.	.
LCE2A	G:612609	.	.
LCE2B	G:612610	.	.
LCE2C	G:612611	.	.
LCE2D	G:612612	.	.
LCE3A	G:612613	.	.
LCE3B	G:612614	.	.
LCE3C	G:612615	.	.
LCE3D	G:612616	.	.
LCE3E	G:612617	.	.
LCE4A	G:612618	.	.
LCE5A	G:612619	.	.
LCK	G:153390	.	.
LCLAT1	G:614241	.	.
LCMT1	G:610286	.	.
LCMT2	G:611246	.	.
LCN1	G:151675	.	.
LCN10	G:612904	.	.
LCN12	G:612905	.	.
LCN2	G:600181	.	.
LCN6	G:609379	.	.
LCN8	G:612902	.	.
LCN9	G:612903	.	.
LCO	G:165320	.	.
LCOR	G:607698	.	.
LCORL	G:611799	.	.
LCP1	G:153430	.	.
LCP2	G:601603	.	.
LCS1	P:214900	.	.
LCT	G:603202	.	Lactase deficiency, congenital, 223000 (3)
LDB1	G:603451	.	.
LDB2	G:603450	.	.
LDB3	G:605906	+GR-Bell	Cardiomyopathy, dilated 1C, 601493 (3)
LDB3	G:605906	+GR-Bell	Left ventricular noncompaction 3, with or without dilated cardiomyopathy, 601493 (3)
LDB3	G:605906	+GR-Bell	Myopathy, myofibrillar, ZASP-related, 609452 (3)
LDHA	G:150000	.	Glycogen storage disease XI, 612933 (3)
LDHB	G:150100	.	Lactate dehydrogenase-B deficiency, 614128 (3)
LDHC	G:150150	.	.
LDHD	G:607490	.	.
LDLR	G:606945	.	Hypercholesterolemia, familial, 143890 (3)
LDLR	G:606945	.	LDL cholesterol level QTL2, 143890 (3)
LDLRAP1	G:605747	.	Hypercholesterolemia, familial, autosomal recessive, 603813 (3)
LDOC1	G:300402	.	.
LEAP2	G:611373	.	.
LECT1	G:605147	.	.
LECT2	G:602882	.	.
LEF1	GP:153245	.	Sebaceous tumors, somatic (3)
LEFTY1	G:603037	.	.
LEFTY2	GP:601877	.	.
LEKR1	G:613536	.	.
LELP1	G:611042	.	.
LEMD1	G:610480	.	.
LEMD3	G:607844	.	Buschke-Ollendorff syndrome, 166700 (3)
LEMD3	G:607844	.	Melorheostosis with osteopoikilosis, 155950 (3)
LEMD3	G:607844	.	Osteopoikilosis, 166700 (3)
LENEP	G:607377	.	.
LEO1	G:610507	.	.
LEP	GP:164160	.	Obesity, morbid, with hypogonadism (3)
LEP	GP:164160	.	Obesity, severe, due to leptin deficiency (3)
LEPR	GP:601007	.	Obesity, morbid, with hypogonadism (3)
LEPRE1	G:610339	Bell>skeletal	Osteogenesis imperfecta, type VIII, 610915 (3)
LEPREL1	G:610341	.	Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3)
LEPREL2	G:610342	.	.
LEPROT	G:613461	.	.
LEPROTL1	G:607338	.	.
LETM1	G:604407	.	.
LFNG	G:602576	+GR-Bell	Spondylocostal dysostosis, autosomal recessive 3, 609813 (3)
LGALS1	G:150570	.	.
LGALS12	G:606096	.	.
LGALS13	G:608717	.	.
LGALS14	G:607260	.	.
LGALS2	G:150571	.	{Myocardial infarction, susceptibility to}, 608446 (3)
LGALS3	G:153619	.	.
LGALS3BP	G:600626	.	.
LGALS4	G:602518	.	.
LGALS7	G:600615	.	.
LGALS8	G:606099	.	.
LGALS9	G:601879	.	.
LGI1	G:604619	+GR-Bell	Epilepsy, familial temporal lobe, 1, 600512 (3)
LGI2	G:608301	.	.
LGI3	G:608302	.	.
LGI4	G:608303	.	.
LGMD1D	P:603511	.	.
LGMD1F	P:608423	.	.
LGMD1G	P:609115	.	.
LGMD1H	P:613530	.	.
LGMN	G:602620	.	.
LGR4	G:606666	.	{Schizophrenia, susceptibility to}, 181500 (3)
LGR5	G:606667	.	.
LGR6	G:606653	.	.
LGSN	G:611470	.	.
LGTN	G:151625	.	.
LHB	GP:152780	.	Hypogonadism, hypergonadotropic (3)
LHCGR	G:152790	.	Leydig cell adenoma, somatic, with precocious puberty, 176410 (3)
LHCGR	G:152790	.	Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3)
LHCGR	G:152790	.	Leydig cell hypoplasia with pseudohermaphroditism, 238320 (3)
LHCGR	G:152790	.	Luteinizing hormone resistance, female, 238320 (3)
LHCGR	G:152790	.	Precocious puberty, male, 176410 (3)
LHFP	G:606710	.	.
LHFPL1	G:300566	.	.
LHFPL2	G:609718	.	.
LHFPL3	G:609719	.	.
LHFPL4	G:610240	.	.
LHFPL5	G:609427	.	Deafness, autosomal recessive 67, 610265 (3)
LHX1	G:601999	.	.
LHX2	G:603759	.	.
LHX3	G:600577	Bell>endocrine	Pituitary hormone deficiency, combined, 3, 221750 (3)
LHX4	G:602146	.	Pituitary hormone deficiency, combined, 4, 262700 (3)
LHX5	G:605992	.	.
LHX6	G:608215	.	.
LHX8	G:604425	.	.
LHX9	G:606066	.	.
LIAS	G:607031	.	Pyruvate dehydrogenase lipoic acid synthetase deficiency, 614462 (3)
LIF	G:159540	.	.
LIFR	G:151443	Bell>skeletal	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)
LIG1	G:126391	.	.
LIG3	G:600940	.	.
LIG4	G:601837	.	LIG4 syndrome, 606593 (3)
LIG4	G:601837	.	Severe combined immunodeficiency with sensitivity to ionizing radiation, 602450 (3)
LIG4	G:601837	.	{Multiple myeloma, resistance to}, 254500 (3)
LILRA1	G:604810	.	.
LILRA2	G:604812	.	.
LILRA3	G:604818	.	.
LILRA4	G:607517	.	.
LILRA5	G:606047	.	.
LILRB1	G:604811	.	.
LILRB2	G:604815	.	.
LILRB3	G:604820	.	.
LILRB4	G:604821	.	.
LILRB5	G:604814	.	.
LIM2	GP:154045	.	Cataract, cortical pulverulent, late-onset (3)
LIMA1	G:608364	.	.
LIMD1	G:604543	.	.
LIME1	G:609809	.	.
LIMK1	G:601329	.	.
LIMK2	G:601988	.	.
LIMS1	G:602567	.	.
LIMS2	G:607908	.	.
LIN28A	G:611043	.	.
LIN28B	G:611044	.	.
LIN54	G:613367	.	.
LIN7A	G:603380	.	.
LIN7B	G:612331	.	.
LIN7C	G:612332	.	.
LIN9	G:609375	.	.
LINC00114	G:611723	.	.
LINC00163	G:610259	.	.
LINC00293	G:609543	.	.
LINC00294	G:612296	.	.
LINC00312	G:610485	.	.
LINGO1	G:609791	.	.
LINGO2	G:609793	.	.
LINGO3	G:609792	.	.
LINGO4	G:609794	.	.
LINS	G:610350	.	.
LIPA	G:613497	.	Cholesteryl ester storage disease, 278000 (3)
LIPA	G:613497	.	Wolman disease, 278000 (3)
LIPB	G:247980	.	.
LIPC	G:151670	.	Hepatic lipase deficiency, 614025 (3)
LIPC	G:151670	.	[High density lipoprotein cholesterol level QTL 12], 612797 (3)
LIPC	G:151670	.	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
LIPE	G:151750	.	.
LIPF	G:601980	.	.
LIPG	G:603684	.	.
LIPH	G:607365	.	Hypotrichosis, localized, autosomal recessive 2, 604379 (3)
LIPH	G:607365	.	Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3)
LIPI	G:609252	.	{Hypertriglyceridemia, susceptibility to}, 145750 (3)
LIPJ	G:613921	.	.
LIPK	G:613922	.	.
LIPM	G:613923	.	.
LIPN	G:613924	.	Ichthyosis, lamellar, 4, 613943 (3)
LIPT1	G:610284	.	.
LITAF	G:603795	+GR-Bell	Charcot-Marie-Tooth disease, type 1C, 601098 (3)
LIX1	G:610466	.	.
LLGL1	G:600966	.	.
LMAN1	G:601567	.	Combined factor V and VIII deficiency, 227300 (3)
LMAN1L	G:609548	.	.
LMAN2	G:609551	.	.
LMAN2L	G:609552	.	.
LMBR1	G:605522	.	Acheiropody, 200500 (3)
LMBR1	G:605522	.	Polydactyly, preaxial type II, 174500 (3)
LMBR1	G:605522	.	Syndactyly, type IV, 186200 (3)
LMBR1	G:605522	.	Triphalangeal thumb, type I, 174500 (3)
LMBR1	G:605522	.	Triphalangeal thumb-polysyndactyly syndrome, 174500 (3)
LMBR1L	G:610007	.	.
LMBRD1	G:612625	+GR-Bell	Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)
LMCD1	G:604859	.	.
LMF1	G:611761	.	Lipase deficiency, combined, 246650 (3)
LMLN	G:609380	.	.
LMNA	G:150330	Bell>cutaneous	Cardiomyopathy, dilated, 1A, 115200 (3)
LMNA	G:150330	Bell>cutaneous	Charcot-Marie-Tooth disease, type 2B1, 605588 (3)
LMNA	G:150330	Bell>cutaneous	Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3)
LMNA	G:150330	Bell>cutaneous	Emery-Dreifuss muscular dystrophy 3, AR, 181350 (3)
LMNA	G:150330	Bell>cutaneous	Heart-hand syndrome, Slovenian type, 610140 (3)
LMNA	G:150330	Bell>cutaneous	Hutchinson-Gilford progeria, 176670 (3)
LMNA	G:150330	Bell>cutaneous	Lipodystrophy, familial partial, 2, 151660 (3)
LMNA	G:150330	Bell>cutaneous	Malouf syndrome, 212112 (3)
LMNA	G:150330	Bell>cutaneous	Mandibuloacral dysplasia, 248370 (3)
LMNA	G:150330	Bell>cutaneous	Muscular dystrophy, congenital, 613205 (3)
LMNA	G:150330	Bell>cutaneous	Muscular dystrophy, limb-girdle, type 1B, 159001 (3)
LMNA	G:150330	Bell>cutaneous	Restrictive dermopathy, lethal, 275210 (3)
LMNB1	G:150340	.	Leukodystrophy, adult-onset, autosomal dominant, 169500 (3)
LMNB2	G:150341	.	{Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3)
LMO1	G:186921	.	.
LMO2	G:180385	.	.
LMO3	G:180386	.	.
LMO4	G:603129	.	.
LMO7	G:604362	.	.
LMOD1	G:602715	.	.
LMOD2	G:608006	.	.
LMTK2	G:610989	.	.
LMX1A	G:600298	.	.
LMX1B	G:602575	+GR-Bell	Nail-patella syndrome, 161200 (3)
LNPEP	G:151300	.	.
LNX1	G:609732	.	.
LNX2	G:609733	.	.
LONP1	G:605490	.	.
LOR	G:152445	.	Vohwinkel syndrome with ichthyosis, 604117 (3)
LOX	G:153455	.	.
LOXHD1	G:613072	.	Deafness, autosomal recessive 77, 613079 (3)
LOXL1	G:153456	.	{Exfoliation syndrome, susceptibility to}, 177650 (3)
LOXL2	G:606663	.	.
LOXL3	G:607163	.	.
LOXL4	G:607318	.	.
LPA	GP:152200	.	[LPA deficiency, congenital] (3)
LPAL2	G:611682	.	.
LPAR1	G:602282	.	.
LPAR2	G:605110	.	.
LPAR3	G:605106	.	.
LPAR4	G:300086	.	.
LPAR5	G:606926	.	.
LPAR6	G:609239	.	Hypotrichosis 8, 278150 (3)
LPAR6	G:609239	.	Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3)
LPCAT1	G:610472	.	.
LPCAT2	G:612040	.	.
LPCAT3	G:611950	.	.
LPCAT4	G:612039	.	.
LPGAT1	G:610473	.	.
LPHN2	G:607018	.	.
LPIN1	G:605518	.	Myoglobinuria, acute recurrent, autosomal recessive, 268200 (3)
LPIN2	G:605519	.	Majeed syndrome, 609628 (3)
LPIN3	G:605520	.	.
LPL	GP:609708	+GR-Bell	Combined hyperlipidemia, familial, 144250 (3)
LPL	GP:609708	+GR-Bell	Lipoprotein lipase deficiency, 238600 (3)
LPO	G:150205	.	.
LPP	G:600700	.	Leukemia, acute myeloid, 601626 (3)
LPXN	G:605390	.	.
LRAT	G:604863	+GR-Bell	Leber congenital amaurosis 14, 613341 (3)
LRAT	G:604863	+GR-Bell	Retinal dystrophy, early-onset severe, 613341 (3)
LRAT	G:604863	+GR-Bell	Retinitis pigmentosa, juvenile, 613341 (3)
LRBA	G:606453	.	.
LRCH1	G:610368	.	.
LRFN1	G:612807	.	.
LRFN2	G:612808	.	.
LRFN3	G:612809	.	.
LRFN4	G:612810	.	.
LRFN5	G:612811	.	.
LRG1	G:611289	.	.
LRIG1	G:608868	.	.
LRIG2	G:608869	.	.
LRIG3	G:608870	.	.
LRMP	G:602003	.	.
LRP1	G:107770	.	.
LRP10	G:609921	.	.
LRP1B	G:608766	.	.
LRP2	G:600073	Bell>developmental	Donnai-Barrow syndrome, 222448 (3)
LRP3	G:603159	.	.
LRP4	G:604270	.	Cenani-Lenz syndactyly syndrome, 212780 (3)
LRP4	G:604270	.	Sclerosteosis 2, 614305 (3)
LRP5	G:603506	Bell>skeletal	Exudative vitreoretinopathy 4, 601813 (3)
LRP5	G:603506	Bell>skeletal	Hyperostosis, endosteal, 144750 (3)
LRP5	G:603506	Bell>skeletal	Osteopetrosis, autosomal dominant 1, 607634 (3)
LRP5	G:603506	Bell>skeletal	Osteoporosis-pseudoglioma syndrome, 259770 (3)
LRP5	G:603506	Bell>skeletal	Osteosclerosis, 144750 (3)
LRP5	G:603506	Bell>skeletal	[Bone mineral density variability 1], 601884 (3)
LRP5	G:603506	Bell>skeletal	van Buchem disease, type 2, 607636 (3)
LRP5	G:603506	Bell>skeletal	{Osteoporosis}, 166710 (3)
LRP6	G:603507	.	{Coronary artery disease, autosomal dominant, 2}, 610947 (3)
LRP8	G:602600	.	{Myocardial infarction, susceptibility to}, 608446 (3)
LRPAP1	G:104225	.	.
LRPPRC	G:607544	Bell>metabolic	Leigh syndrome, French-Canadian type, 220111 (3)
LRR1	G:609193	.	.
LRRC1	G:608195	.	.
LRRC10	G:610846	.	.
LRRC16A	G:609593	.	.
LRRC2	G:607180	.	.
LRRC25	G:607518	.	.
LRRC26	G:613505	.	.
LRRC32	G:137207	.	.
LRRC4	G:610486	.	.
LRRC4C	G:608817	.	.
LRRC7	G:614453	.	.
LRRC8A	G:608360	.	Agammaglobulinemia 5, 613506 (3)
LRRC8B	G:612888	.	.
LRRC8C	G:612889	.	.
LRRC8D	G:612890	.	.
LRRC8E	G:612891	.	.
LRRFIP1	G:603256	.	.
LRRFIP2	G:614043	.	.
LRRK1	G:610986	.	.
LRRK2	G:609007	+GR-Bell	Parkinson disease-8, 607060 (3)
LRRN2	G:605492	.	.
LRRTM1	G:610867	.	.
LRRTM2	G:610868	.	.
LRRTM3	G:610869	.	.
LRRTM4	G:610870	.	.
LRSAM1	G:610933	+GR-Bell	Charcot-Marie-Toothe disease, axonal, type 2P, 614436 (3)
LRTOMT	G:612414	.	Deafness, autosomal recessive 63, 611451 (3)
LSAMP	G:603241	.	.
LSG1	G:610780	.	.
LSM1	G:607281	.	.
LSM12	G:611793	.	.
LSM14A	G:610677	.	.
LSM2	G:607282	.	.
LSM3	G:607283	.	.
LSM4	G:607284	.	.
LSM5	G:607285	.	.
LSM6	G:607286	.	.
LSM7	G:607287	.	.
LSP1	G:153432	.	.
LSS	G:600909	.	.
LST1	G:109170	.	.
LTA	G:153440	.	{Leprosy, susceptibility to, 4}, 610988 (3)
LTA	G:153440	.	{Myocardial infarction, susceptibility to}, 608446 (3)
LTA	G:153440	.	{Psoriatic arthritis, susceptibility to}, 607507 (3)
LTA4H	G:151570	.	.
LTB	G:600978	.	.
LTB4R	G:601531	.	.
LTB4R2	G:605773	.	.
LTBP1	G:150390	.	.
LTBP2	G:602091	+GR-Bell	Glaucoma 3, primary congenital, D, 613086 (3)
LTBP3	G:602090	.	Tooth agenesis, selective, 6, 613097 (3)
LTBP4	G:604710	.	Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities, 613177 (3)
LTBR	G:600979	.	.
LTC4S	G:246530	.	.
LTF	G:150210	.	.
LTK	G:151520	.	.
LTN1	G:613083	.	.
LUC7L	G:607782	.	.
LUC7L2	G:613056	.	.
LUC7L3	G:609434	.	.
LUM	G:600616	.	.
LUZP1	G:601422	.	.
LUZP2	G:608178	.	.
LUZP4	G:300616	.	.
LUZP6	G:611050	.	.
LXN	G:609305	.	.
LY6D	G:606204	.	.
LY6E	G:601384	.	.
LY6G5B	G:610433	.	.
LY6G5C	G:610434	.	.
LY6G6C	G:610435	.	.
LY6G6D	G:606038	.	.
LY6G6E	G:610437	.	.
LY6G6F	G:611404	.	.
LY6H	G:603625	.	.
LY75	G:604524	.	.
LY86	G:605241	.	.
LY9	G:600684	.	.
LY96	G:605243	.	.
LYL1	G:151440	.	.
LYN	G:165120	.	.
LYNX1	G:606110	.	.
LYPD1	G:610450	.	.
LYPD3	G:609484	.	.
LYPD6	G:613359	.	.
LYPLA1	G:605599	.	.
LYRM4	G:613311	.	.
LYST	G:606897	Bell>immunodeficiency	Chediak-Higashi syndrome, 214500 (3)
LYVE1	G:605702	.	.
LYZ	G:153450	.	Amyloidosis, renal, 105200 (3)
LYZL2	G:612748	.	.
LYZL4	G:612750	.	.
LYZL6	G:612751	.	.
LZIC	G:610458	.	.
LZTFL1	G:606568	.	.
LZTR1	G:600574	.	.
LZTS1	G:606551	.	Esophageal squamous cell carcinoma, 133239 (3)
LZTS2	G:610454	.	.
M6PR	G:154540	.	.
MAA	P:309800	.	.
MAB21L1	G:601280	.	.
MAB21L2	G:604357	.	.
MACC1	G:612646	.	.
MACF1	G:608271	.	.
MACOM	P:602499	.	.
MACROD1	G:610400	.	.
MACROD2	G:611567	.	.
MAD1L1	G:602686	.	Lymphoma, somatic (3)
MAD1L1	G:602686	.	Prostate cancer, somatic, 176807 (3)
MAD2L1	G:601467	.	.
MAD2L2	G:604094	.	.
MADCAM1	G:102670	.	.
MADD	G:603584	.	.
MAEA	G:606801	.	.
MAEL	G:611368	.	.
MAF	G:177075	.	Cataract, pulverulent or cerulean, with or without microcornea (3)
MAF1	G:610210	.	.
MAFA	G:610303	.	.
MAFB	G:608968	.	.
MAFD1	P:125480	.	.
MAFD2	P:309200	.	.
MAFF	G:604877	.	.
MAFG	G:602020	.	.
MAFK	G:600197	.	.
MAG	G:159460	.	.
MAGEA1	G:300016	.	.
MAGEA10	G:300343	.	.
MAGEA11	G:300344	.	.
MAGEA12	G:300177	.	.
MAGEA2	G:300173	.	.
MAGEA2B	G:300549	.	.
MAGEA3	G:300174	.	.
MAGEA4	G:300175	.	.
MAGEA5	G:300340	.	.
MAGEA6	G:300176	.	.
MAGEA8	G:300341	.	.
MAGEA9	G:300342	.	.
MAGEA9B	G:300764	.	.
MAGEB1	G:300097	.	.
MAGEB10	G:300761	.	.
MAGEB16	G:300762	.	.
MAGEB17	G:300763	.	.
MAGEB2	G:300098	.	.
MAGEB3	G:300152	.	.
MAGEB4	G:300153	.	.
MAGEB5	G:300466	.	.
MAGEB6	G:300467	.	.
MAGEC1	G:300223	.	.
MAGEC2	G:300468	.	.
MAGEC3	G:300469	.	.
MAGED1	G:300224	.	.
MAGED2	G:300470	.	.
MAGED4	G:300702	.	.
MAGED4B	G:300765	.	.
MAGEE1	G:300759	.	.
MAGEE2	G:300760	.	.
MAGEF1	G:609267	.	.
MAGEH1	G:300548	.	.
MAGEL2	G:605283	.	.
MAGI1	G:602625	.	.
MAGI2	G:606382	.	.
MAGI2-IT1	G:608950	.	.
MAGOH	G:602603	.	.
MAGT1	G:300715	+GR-Bell	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3)
MAGT1	G:300715	+GR-Bell	Mental retardation, X-linked 95, 300716 (3)
MAK	G:154235	+GR-Bell	REtinitis pigmentosa 62, 614181 (3)
MAL	G:188860	.	.
MAL2	G:609684	.	.
MALAT1	G:607924	.	.
MALL	G:602022	.	.
MALT1	G:604860	.	.
MAMDC2	G:612879	.	.
MAML1	G:605424	.	.
MAML2	G:607537	.	.
MAML3	G:608991	.	.
MAMLD1	G:300120	.	Hypospadias 2, X-linked, 300758 (3)
MAMSTR	G:610349	.	.
MAN1A1	G:604344	.	.
MAN1A2	G:604345	.	.
MAN1B1	G:604346	.	Mental retardation, autosomal recessive 15, 614202 (3)
MAN2A1	G:154582	.	.
MAN2A2	G:600988	.	.
MAN2B1	G:609458	Bell>metabolic	Mannosidosis, alpha-, types I and II, 248500 (3)
MAN2C1	G:154580	.	.
MANBA	G:609489	.	Mannosidosis, beta, 248510 (3)
MANEA	G:612327	.	.
MANF	G:601916	.	.
MAOA	GP:309850	.	Brunner syndrome, 300615 (3)
MAOB	G:309860	.	.
MAP1A	G:600178	.	.
MAP1B	G:157129	.	.
MAP1LC3A	G:601242	.	.
MAP1LC3B	G:609604	.	.
MAP1LC3C	G:609605	.	.
MAP1S	G:607573	.	.
MAP2	G:157130	.	.
MAP2K1	G:176872	.	Cardiofaciocutaneous syndrome, 115150 (3)
MAP2K2	G:601263	+GR-Bell	Cardiofaciocutaneous syndrome, 115150 (3)
MAP2K3	G:602315	.	.
MAP2K4	G:601335	.	.
MAP2K5	G:602520	.	.
MAP2K6	G:601254	.	.
MAP2K7	G:603014	.	.
MAP3K1	G:600982	.	46XY sex reversal 6, 613762 (3)
MAP3K10	G:600137	.	.
MAP3K11	G:600050	.	.
MAP3K12	G:600447	.	.
MAP3K13	G:604915	.	.
MAP3K14	G:604655	.	.
MAP3K15	G:300820	.	.
MAP3K2	G:609487	.	.
MAP3K3	G:602539	.	.
MAP3K4	G:602425	.	.
MAP3K5	G:602448	.	.
MAP3K6	G:604468	.	.
MAP3K7	G:602614	.	.
MAP3K8	G:191195	.	Lung cancer, somatic, 211980 (3)
MAP3K9	G:600136	.	.
MAP4	G:157132	.	.
MAP4K1	G:601983	.	.
MAP4K2	G:603166	.	.
MAP4K3	G:604921	.	.
MAP4K4	G:604666	.	.
MAP4K5	G:604923	.	.
MAP6	G:601783	.	.
MAP6D1	G:610593	.	.
MAP7	G:604108	.	.
MAP9	G:610070	.	.
MAPK1	G:176948	.	.
MAPK10	G:602897	Bell>neurological	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
MAPK11	G:602898	.	.
MAPK12	G:602399	.	.
MAPK13	G:602899	.	.
MAPK14	G:600289	.	.
MAPK3	G:601795	.	.
MAPK4	G:176949	.	.
MAPK6	G:602904	.	.
MAPK7	G:602521	.	.
MAPK8	G:601158	.	.
MAPK8IP1	G:604641	.	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
MAPK8IP2	G:607755	.	.
MAPK8IP3	G:605431	.	.
MAPK9	G:602896	.	.
MAPKAP1	G:610558	.	.
MAPKAPK2	G:602006	.	.
MAPKAPK3	G:602130	.	.
MAPKAPK5	G:606723	.	.
MAPRE1	G:603108	.	.
MAPRE2	G:605789	.	.
MAPRE3	G:605788	.	.
MAPT	G:157140	+GR-Bell	Dementia, frontotemporal, with or without parkinsonism, 600274 (3)
MAPT	G:157140	+GR-Bell	Pick disease, 172700 (3)
MAPT	G:157140	+GR-Bell	Supranuclear palsy, progressive atypical, 260540 (3)
MAPT	G:157140	+GR-Bell	Supranuclear palsy, progressive, 601104 (3)
MAPT	G:157140	+GR-Bell	{Parkinson disease, susceptibility to}, 168600 (3)
MARC1	G:614126	.	.
MARC2	G:614127	.	.
MARCH1	G:613331	.	.
MARCH10	G:613337	.	.
MARCH11	G:613338	.	.
MARCH2	G:613332	.	.
MARCH3	G:613333	.	.
MARCH4	G:608208	.	.
MARCH5	G:610637	.	.
MARCH6	G:613297	.	.
MARCH7	G:613334	.	.
MARCH8	G:613335	.	.
MARCH9	G:613336	.	.
MARCKS	G:177061	.	.
MARCKSL1	G:602940	.	.
MARCO	G:604870	.	.
MARK1	G:606511	.	.
MARK2	G:600526	.	.
MARK3	G:602678	.	.
MARK4	G:606495	.	.
MARS	G:156560	.	.
MARS2	G:609728	.	.
MARVELD2	G:610572	.	Deafness, autosomal recessive 49, 610153 (3)
MARVELD3	G:614094	.	.
MAS1	G:165180	.	.
MAS1L	G:607235	.	.
MASP1	G:600521	.	.
MASP2	G:605102	.	MASP2 deficiency, 613791 (3)
MAST1	G:612256	.	.
MAST2	G:612257	.	.
MAST3	G:612258	.	.
MASTL	G:608221	.	Thrombocytopenia-2, 188000 (3)
MAT1A	G:610550	.	Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency, 250850 (3)
MAT1A	G:610550	.	Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3)
MAT2A	G:601468	.	.
MAT2B	G:605527	.	.
MATK	G:600038	.	.
MATN1	G:115437	.	.
MATN2	G:602108	.	.
MATN3	G:602109	+GR-Bell	Epiphyseal dysplasia, multiple, 5, 607078 (3)
MATN3	G:602109	+GR-Bell	Spondyloepimetaphyseal dysplasia, 608728 (3)
MATN3	G:602109	+GR-Bell	{Osteoarthritis susceptibility 2}, 140600 (3)
MATN4	G:603897	.	.
MATR3	G:164015	.	Myopathy, distal 2, 606070 (3)
MAU2	G:614560	.	.
MAVS	G:609676	.	.
MAX	G:154950	.	{Pheochromocytoma, susceptibility to}, 171300 (3)
MAZ	G:600999	.	.
MB21D1	G:613973	.	.
MBD1	G:156535	.	.
MBD2	G:603547	.	.
MBD3	G:603573	.	.
MBD3L1	G:607963	.	.
MBD3L2	G:607964	.	.
MBD4	G:603574	.	.
MBD5	G:611472	.	Mental retardation, autosomal dominant 1, 156200 (3)
MBIP	G:609431	.	.
MBL2	G:154545	.	{Chronic infections, due to MBL deficiency}, 614372 (3)
MBNL1	G:606516	.	.
MBNL2	G:607327	.	.
MBNL3	G:300413	.	.
MBOAT1	G:611732	.	.
MBOAT2	G:611949	.	.
MBOAT4	G:611940	.	.
MBOAT7	G:606048	.	.
MBP	G:159430	.	.
MBS1	P:157900	.	.
MBS2	P:601471	.	.
MBS3	P:604185	.	.
MBTPS1	G:603355	.	.
MBTPS2	G:300294	.	IFAP syndrome with or without BRESHECK syndrome, 308205 (3)
MBTPS2	G:300294	.	Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)
MC1R	G:155555	.	[Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3)
MC1R	G:155555	.	[Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3)
MC1R	G:155555	.	[Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3)
MC1R	G:155555	.	{Melanoma, cutaneous malignant, 5}, 613099 (3)
MC1R	G:155555	.	{Oculocutaneous albinism, type II, modifier of}, 203200 (3)
MC1R	G:155555	.	{UV-induced skin damage}, 266300 (3)
MC2R	G:607397	.	Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3)
MC3R	G:155540	.	{Mycobacterium tuberculosis, protection against}, 607948 (3)
MC3R	G:155540	.	{Obesity, severe, susceptibility to, BMIQ9}, 602025 (3)
MC4R	G:155541	.	Obesity, autosomal dominant, 601665 (3)
MC5R	G:600042	.	.
MCAM	G:155735	.	.
MCAT	G:614479	.	.
MCC	G:159350	.	.
MCCC1	G:609010	.	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
MCCC2	G:609014	Bell>metabolic	3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)
MCCD1	G:609624	.	.
MCDR1	P:136550	.	.
MCDR3	P:608850	.	.
MCEE	G:608419	+GR-Bell	Methylmalonyl-CoA epimerase deficiency, 251120 (3)
MCF2	G:311030	.	.
MCF2L	G:609499	.	.
MCFD2	G:607788	.	Factor V and factor VIII, combined deficiency of, 613625 (3)
MCHR1	G:601751	.	.
MCHR2	G:606111	.	.
MCKD1	P:174000	.	.
MCL1	G:159552	.	.
MCM10	G:609357	.	.
MCM2	G:116945	.	.
MCM3	G:602693	.	.
MCM3AP	G:603294	.	.
MCM4	G:602638	.	.
MCM5	G:602696	.	.
MCM6	G:601806	.	Lactase persistance/nonpersistance, 223100 (3)
MCM7	G:600592	.	.
MCM8	G:608187	.	.
MCM9	G:610098	.	.
MCMBP	G:610909	.	.
MCOLN1	G:605248	Bell>metabolic	Mucolipidosis IV, 252650 (3)
MCOLN2	G:607399	.	.
MCOLN3	G:607400	.	.
MCPH1	G:607117	+GR-Bell	Microcephaly, primary autosomal recessive, 1, 251200 (3)
MCPH4	P:604321	.	.
MCRS1	G:609504	.	.
MCS	P:309605	.	.
MCTS1	G:300587	.	.
MCU	G:614197	.	.
MDC1	G:607593	.	.
MDFI	G:604971	.	.
MDFIC	G:614511	.	.
MDGA1	G:609626	.	.
MDGA2	G:611128	.	.
MDH1	G:154200	.	.
MDH2	G:154100	.	.
MDK	G:162096	.	.
MDM1	G:613813	.	.
MDM2	G:164785	.	{Accelerated tumor formation, susceptibility to}, 614401 (3)
MDM4	G:602704	.	.
MDRV	P:601846	.	.
MDS2	G:607305	.	.
ME1	G:154250	.	.
ME2	G:154270	.	{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
ME2	G:154270	.	{Opioid dependence, susceptibility to}, 610064 (3)
ME3	G:604626	.	.
MEA1	G:143170	.	.
MEAF6	G:611001	.	.
MECOM	G:165215	.	.
MECP2	G:300005	Bell>neurological	Angelman syndrome, 105830 (3)
MECP2	G:300005	Bell>neurological	Angelman syndrome, 105830 (3)
MECP2	G:300005	Bell>neurological	Angelman syndrome, 105830 (3)
MECP2	G:300005	Bell>neurological	Encephalopathy, neonatal severe, 300673 (3)
MECP2	G:300005	Bell>neurological	Encephalopathy, neonatal severe, 300673 (3)
MECP2	G:300005	Bell>neurological	Encephalopathy, neonatal severe, 300673 (3)
MECP2	G:300005	Bell>neurological	Mental retardation, X-linked syndromic, Lubs type, 300260 (3)
MECP2	G:300005	Bell>neurological	Mental retardation, X-linked syndromic, Lubs type, 300260 (3)
MECP2	G:300005	Bell>neurological	Mental retardation, X-linked syndromic, Lubs type, 300260 (3)
MECP2	G:300005	Bell>neurological	Mental retardation, X-linked, syndromic 13, 300055 (3)
MECP2	G:300005	Bell>neurological	Mental retardation, X-linked, syndromic 13, 300055 (3)
MECP2	G:300005	Bell>neurological	Mental retardation, X-linked, syndromic 13, 300055 (3)
MECP2	G:300005	Bell>neurological	Rett syndrome, 312750 (3)
MECP2	G:300005	Bell>neurological	Rett syndrome, 312750 (3)
MECP2	G:300005	Bell>neurological	Rett syndrome, 312750 (3)
MECP2	G:300005	Bell>neurological	Rett syndrome, preserved speech variant, 312750 (3)
MECP2	G:300005	Bell>neurological	Rett syndrome, preserved speech variant, 312750 (3)
MECP2	G:300005	Bell>neurological	Rett syndrome, preserved speech variant, 312750 (3)
MECP2	G:300005	Bell>neurological	{Autism susceptibility, X-linked 3}, 300496 (3)
MECP2	G:300005	Bell>neurological	{Autism susceptibility, X-linked 3}, 300496 (3)
MECP2	G:300005	Bell>neurological	{Autism susceptibility, X-linked 3}, 300496 (3)
MECR	G:608205	.	.
MED1	G:604311	.	.
MED10	G:612382	.	.
MED11	G:612383	.	.
MED12	G:300188	Bell>neurological	Lujan-Fryns syndrome, 309520 (3)
MED12	G:300188	Bell>neurological	Opitz-Kaveggia syndrome, 305450 (3)
MED12L	G:611318	.	.
MED13	G:603808	.	.
MED13L	G:608771	.	Transposition of the great arteries, dextro-looped 1, 608808 (3)
MED14	G:300182	.	.
MED15	G:607372	.	.
MED16	G:604062	.	.
MED17	G:603810	.	Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)
MED18	G:612384	.	.
MED19	G:612385	.	.
MED20	G:612915	.	.
MED21	G:603800	.	.
MED22	G:185641	.	.
MED23	G:605042	.	Mental retardation, autosomal recessive 18, 614249 (3)
MED24	G:607000	.	.
MED25	G:610197	+GR-Bell	Charcot-Marie-Tooth disease, type 2B2, 605589 (3)
MED26	G:605043	.	.
MED27	G:605044	.	.
MED28	G:610311	.	.
MED29	G:612914	.	.
MED30	G:610237	.	.
MED4	G:605718	.	.
MED6	G:602984	.	.
MED7	G:605045	.	.
MED8	G:607956	.	.
MED9	G:609878	.	.
MEF2A	G:600660	.	{Coronary artery disease, autosomal dominant, 1}, 608320 (3)
MEF2B	G:600661	.	.
MEF2C	G:600662	.	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations, 613443 (3)
MEF2D	G:600663	.	.
MEFV	G:608107	Bell>immunodeficiency	Familial Mediterranean fever, AD, 134610 (3)
MEFV	G:608107	Bell>immunodeficiency	Familial Mediterranean fever, AR, 249100 (3)
MEG3	G:605636	.	.
MEG8	G:613648	.	.
MEGF10	G:612453	.	Myopathy, early-onset, areflexia, respiratory distress, and dysphagia, 614399 (3)
MEGF11	G:612454	.	.
MEGF6	G:604266	.	.
MEGF8	G:604267	.	.
MEGF9	G:604268	.	.
MEHMO	P:300148	.	.
MEI1	G:608797	.	.
MEIG1	G:614174	.	.
MEIS1	G:601739	.	.
MEIS2	G:601740	.	.
MELK	G:607025	.	.
MEMO1	G:611786	.	.
MEN1	G:613733	+GR-Bell	Adrenal adenoma, somatic (3)
MEN1	G:613733	+GR-Bell	Angiofibroma, somatic (3)
MEN1	G:613733	+GR-Bell	Lipoma, somatic (3)
MEN1	G:613733	+GR-Bell	Multiple endocrine neoplasia 1, 131100 (3)
MEN1	G:613733	+GR-Bell	Parathyroid adenoma, somatic (3)
MEOX1	G:600147	.	.
MEOX2	G:600535	.	.
MEP1A	G:600388	.	.
MEP1B	G:600389	.	.
MEPCE	G:611478	.	.
MEPE	G:605912	.	.
MERTK	G:604705	+GR-Bell	Retinitis pigmentosa 38, 613862 (3)
MESDC2	G:607783	.	.
MESP1	G:608689	.	.
MESP2	G:605195	+GR-Bell	Spondylocostal dysostosis, autosomal recessive 2, 608681 (3)
MEST	G:601029	.	.
MESTIT1	G:607794	.	.
MET	G:164860	.	Hepatocellular carcinoma, childhood type, 114550 (3)
MET	G:164860	.	Renal cell carcinoma, papillary, familial and somatic, 605074 (3)
MET	G:164860	.	{Autism suseptibility 9}, 611015 (3)
METAP1	G:610151	.	.
METAP1D	G:610267	.	.
METAP2	G:601870	.	.
METRN	G:610998	.	.
METTL1	G:604466	.	.
METTL11A	G:613560	.	.
METTL19	G:614309	.	.
METTL2B	G:607846	.	.
METTL3	G:612472	.	.
METTL8	G:609525	.	.
METTL9	G:609388	.	.
MEX3A	G:611007	.	.
MEX3B	G:611008	.	.
MEX3C	G:611005	.	.
MEX3D	G:611009	.	.
MF4	P:309630	.	.
MFAP1	G:600215	.	.
MFAP2	G:156790	.	.
MFAP3	G:600491	.	.
MFAP4	G:600596	.	.
MFAP5	G:601103	.	.
MFGE8	G:602281	.	.
MFHAS1	G:605352	.	.
MFI2	G:155750	.	.
MFN1	G:608506	.	.
MFN2	G:608507	+GR-Bell	Charcot-Marie-Tooth disease, type 2A2, 609260 (3)
MFN2	G:608507	+GR-Bell	Hereditary motor and sensory neuropathy VI, 601152 (3)
MFNG	G:602577	.	.
MFRP	G:606227	.	Microphthalmia, isolated 5, 611040 (3)
MFSD10	G:610977	.	.
MFSD2A	G:614397	.	.
MFSD6	G:613476	.	.
MFSD8	G:611124	Bell>neurological	Ceroid lipofuscinosis, neuronal, 7, 610951 (3)
MGAM	G:154360	.	.
MGAT1	G:160995	.	.
MGAT2	G:602616	Bell>metabolic	Congenital disorder of glycosylation, type IIa, 212066 (3)
MGAT3	G:604621	.	.
MGAT4A	G:604623	.	.
MGAT4B	G:604561	.	.
MGAT4C	G:607385	.	.
MGAT5	G:601774	.	.
MGAT5B	G:612441	.	.
MGC1	P:309300	.	.
MGEA5	G:604039	.	.
MGLL	G:609699	.	.
MGMT	G:156569	.	.
MGP	G:154870	.	Keutel syndrome, 245150 (3)
MGRN1	G:607559	.	.
MGST1	G:138330	.	.
MGST2	G:601733	.	.
MGST3	G:604564	.	.
MHAC	P:605013	.	.
MHS2	P:154275	.	.
MHS4	P:600467	.	.
MHS6	P:601888	.	.
MIA	G:601340	.	.
MIA2	G:608001	.	.
MIA3	G:613455	.	.
MIAT	G:611082	.	{Myocardial infarction, susceptibility to}, 608446 (3)
MIB1	G:608677	.	.
MIB2	G:611141	.	.
MIC12	G:107254	.	.
MIC7	G:108990	.	.
MICA	G:600169	.	.
MICAL1	G:607129	.	.
MICAL2	G:608881	.	.
MICAL3	G:608882	.	.
MICALCL	G:612355	.	.
MICB	G:602436	.	.
MICU1	G:605084	.	.
MID1	G:300552	+GR-Bell	Opitz GBBB syndrome, type I, 300000 (3)
MID2	G:300204	.	.
MIDN	G:606700	.	.
MIEN1	G:611802	.	.
MIF	G:153620	.	{Rheumatoid arthritis, systemic juvenile, susceptibility to}, 604302 (3)
MIF4GD	G:612072	.	.
MIIP	G:608772	.	.
MINA	G:612049	.	.
MINK1	G:609426	.	.
MINPP1	G:605391	.	Thyroid carcinoma, follicular, 188470 (3)
MIOX	G:606774	.	.
MIP	GP:154050	.	Cataract, polymorphic and lamellar, 604219 (3)
MIPEP	G:602241	.	.
MIPOL1	G:606850	.	.
MIR1-1	G:609326	.	.
MIR1-2	G:610252	.	.
MIR100	G:613186	.	.
MIR101-1	G:612511	.	.
MIR101-2	G:612512	.	.
MIR103A1	G:613187	.	.
MIR103A2	G:613188	.	.
MIR105-1	G:300811	.	.
MIR105-2	G:300812	.	.
MIR106A	G:300792	.	.
MIR106B	G:612983	.	.
MIR107	G:613189	.	.
MIR10A	G:610173	.	.
MIR10B	G:611576	.	.
MIR122	G:609582	.	.
MIR1224	G:611620	.	.
MIR1225	G:611621	.	.
MIR124-1	G:609327	.	.
MIR1258	G:614488	.	.
MIR125A	G:611191	.	.
MIR125B1	G:610104	.	.
MIR125B2	G:610105	.	.
MIR126	G:611767	.	.
MIR127	G:611709	.	.
MIR128-1	G:611774	.	.
MIR128-2	G:611769	.	.
MIR1292	G:614155	.	.
MIR130A	G:610175	.	.
MIR130B	G:613682	.	.
MIR132	G:610016	.	.
MIR133A1	G:610254	.	.
MIR133A2	G:610255	.	.
MIR133B	G:610946	.	.
MIR134	G:610164	.	.
MIR136	G:611710	.	.
MIR137	G:614304	.	.
MIR138-1	G:613394	.	.
MIR138-2	G:613395	.	.
MIR140	G:611894	.	.
MIR141	G:612093	.	.
MIR143	G:612117	.	.
MIR144	G:612070	.	.
MIR145	G:611795	.	.
MIR146A	G:610566	.	.
MIR146B	G:610567	.	.
MIR148A	G:613786	.	.
MIR148B	G:613787	.	.
MIR150	G:611114	.	.
MIR152	G:613788	.	.
MIR155	G:609337	.	.
MIR15A	G:609703	.	.
MIR16-1	G:609704	.	.
MIR17	G:609416	.	.
MIR17HG	G:609415	.	Feingold syndrome 2, 614326 (3)
MIR181A1	G:612742	.	.
MIR181A2	G:612743	.	.
MIR181B1	G:612744	.	.
MIR181B2	G:612745	.	.
MIR181C	G:612746	.	.
MIR182	G:611607	.	.
MIR183	G:611608	.	.
MIR184	G:613146	.	Keratoconus with cataract, 614303 (3)
MIR187	G:612698	.	.
MIR18A	G:609417	.	.
MIR192	G:610939	.	.
MIR194-1	G:610940	.	.
MIR194-2	G:610941	.	.
MIR195	G:610718	.	.
MIR196A1	G:608632	.	.
MIR196A2	G:609687	.	.
MIR196B	G:609688	.	.
MIR197	G:611189	.	.
MIR199A1	G:610719	.	.
MIR199A2	G:610720	.	.
MIR19A	G:609418	.	.
MIR19B1	G:609419	.	.
MIR19B2	G:300722	.	.
MIR200A	G:612090	.	.
MIR200B	G:612091	.	.
MIR200C	G:612092	.	.
MIR203	G:611899	.	.
MIR204	G:610942	.	.
MIR205	G:613147	.	.
MIR206	G:611599	.	.
MIR208A	G:611116	.	.
MIR208B	G:613613	.	.
MIR20A	G:609420	.	.
MIR21	G:611020	.	.
MIR210	G:612982	.	.
MIR211	G:613753	.	.
MIR212	G:613487	.	.
MIR214	G:610721	.	.
MIR215	G:610943	.	.
MIR216A	G:610944	.	.
MIR219-1	G:611500	.	.
MIR22	G:612077	.	.
MIR221	G:300568	.	.
MIR222	G:300569	.	.
MIR223	G:300694	.	.
MIR224	G:300769	.	.
MIR23A	G:607962	.	.
MIR23B	G:610723	.	.
MIR24-1	G:609705	.	.
MIR24-2	G:610724	.	.
MIR25	G:612150	.	.
MIR26A1	G:612151	.	.
MIR26A2	G:613057	.	.
MIR26B	G:612152	.	.
MIR27A	G:612153	.	.
MIR27B	G:610636	.	.
MIR28	G:612154	.	.
MIR2861	G:613405	.	[Bone mineral density QTL 15], 613418 (3)
MIR296	G:610945	.	.
MIR29A	G:610782	.	.
MIR29B1	G:610783	.	.
MIR29C	G:610784	.	.
MIR30A	G:612329	.	.
MIR31	G:612155	.	.
MIR32	G:609355	.	.
MIR320A	G:614112	.	.
MIR326	G:613755	.	.
MIR328	G:613701	.	.
MIR335	G:611768	.	.
MIR338	G:614059	.	.
MIR33A	G:612156	.	.
MIR33B	G:613486	.	.
MIR346	G:611190	.	.
MIR34A	G:611172	.	.
MIR34B	G:611374	.	.
MIR34C	G:611375	.	.
MIR369	G:611794	.	.
MIR370	G:612553	.	.
MIR371A	G:612043	.	.
MIR372	G:612044	.	.
MIR373	G:611954	.	.
MIR375	G:611173	.	.
MIR376A1	G:610959	.	.
MIR376A2	G:610960	.	.
MIR376B	G:610961	.	.
MIR376C	G:610983	.	.
MIR378A	G:611957	.	.
MIR380	G:613654	.	.
MIR409	G:614057	.	.
MIR424	G:300682	.	.
MIR429	G:612094	.	.
MIR431	G:611708	.	.
MIR433	G:611711	.	.
MIR448	G:300686	.	.
MIR449A	G:613131	.	.
MIR449B	G:613132	.	.
MIR451A	G:612071	.	.
MIR489	G:614523	.	.
MIR492	G:614384	.	.
MIR499A	G:613614	.	.
MIR503	G:300865	.	.
MIR510	G:300866	.	.
MIR519D	G:614247	.	.
MIR570	G:614538	.	.
MIR610	G:612330	.	.
MIR616	G:614489	.	.
MIR659	G:613556	.	.
MIR661	G:613716	.	.
MIR877	G:611619	.	.
MIR9-1	G:611186	.	.
MIR9-2	G:611187	.	.
MIR9-3	G:611188	.	.
MIR92A1	G:609422	.	.
MIR93	G:612984	.	.
MIR95	G:613185	.	.
MIR96	G:611606	.	Deafness, autosomal dominant 50, 613074 (3)
MIR98	G:300810	.	.
MIR99A	G:614509	.	.
MIR99B	G:614510	.	.
MIRLET7A1	G:605386	.	.
MIRLET7A2	G:612142	.	.
MIRLET7A3	G:612143	.	.
MIRLET7B	G:611249	.	.
MIRLET7C	G:612144	.	.
MIRLET7D	G:612145	.	.
MIRLET7E	G:611250	.	.
MIRLET7F1	G:612146	.	.
MIRLET7F2	G:300721	.	.
MIRLET7G	G:612102	.	.
MIRLET7I	G:612148	.	.
MIS12	G:609178	.	.
MITF	G:156845	.	Tietz albinism-deafness syndrome, 103500 (3)
MITF	G:156845	.	Waardenburg syndrome, type 2A, 193510 (3)
MITF	G:156845	.	Waardenburg syndrome/ocular albinism, digenic, 103470 (3)
MIXL1	G:609852	.	.
MKI67	G:176741	.	.
MKI67IP	G:611970	.	.
MKKS	G:604896	+GR-Bell	Bardet-Biedl syndrome 6, 209900 (3)
MKKS	G:604896	+GR-Bell	McKusick-Kaufman syndrome, 236700 (3)
MKL1	G:606078	.	Megakaryoblastic leukemia, acute (3)
MKL2	G:609463	.	.
MKLN1	G:605623	.	.
MKNK1	G:606724	.	.
MKNK2	G:605069	.	.
MKRN1	G:607754	.	.
MKRN2	G:608426	.	.
MKRN3	G:603856	.	.
MKRN3-AS1	G:603857	.	.
MKS1	G:609883	Bell>developmental	Bardet-Biedl syndrome 13, 209900 (3)
MKS1	G:609883	Bell>developmental	Meckel syndrome, type 1, 249000 (3)
MKX	G:601332	.	.
MLANA	G:605513	.	.
MLC1	G:605908	Bell>neurological	Megalencephalic leukoencephalopathy with subcortical cysts, 604004 (3)
MLEC	G:613802	.	.
MLF1	G:601402	.	.
MLF1IP	G:611511	.	.
MLF2	G:601401	.	.
MLH1	G:120436	+GR-Bell	Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3)
MLH1	G:120436	+GR-Bell	Mismatch repair cancer syndrome, 276300 (3)
MLH1	G:120436	+GR-Bell	Muir-Torre syndrome, 158320 (3)
MLH3	G:604395	+GR-Bell	Colon cancer, hereditary nonpolyposis, type 7, 614385 (3)
MLH3	G:604395	+GR-Bell	Colorectal cancer, somatic, 114500 (3)
MLH3	G:604395	+GR-Bell	Endometrial cancer, 608089 (3)
MLIP	G:614106	.	.
MLL	GP:159555	.	.
MLL2	G:602113	.	Kabuki syndrome 1, 147920 (3)
MLL3	G:606833	.	.
MLL5	G:608444	.	.
MLLT1	G:159556	.	.
MLLT10	G:602409	.	Leukemia, acute T-cell lymphoblastic (3)
MLLT10	G:602409	.	Leukemia, acute myeloid, 601626 (3)
MLLT11	G:604684	.	Leukemia, acute myelomonocytic (3)
MLLT3	G:159558	.	.
MLLT4	G:159559	.	.
MLLT6	G:600328	.	.
MLN	G:158270	.	.
MLNR	G:602885	.	.
MLPH	G:606526	.	Griscelli syndrome, type 3, 609227 (3)
MLST8	G:612190	.	.
MLX	G:602976	.	.
MLXIP	G:608090	.	.
MLXIPL	G:605678	.	.
MLYCD	G:606761	.	Malonyl-CoA decarboxylase deficiency, 248360 (3)
MMAA	G:607481	+GR-Bell	Methylmalonic aciduria, vitamin B12-responsive, 251100 (3)
MMAB	G:607568	Bell>metabolic	Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type, 251110 (3)
MMACHC	G:609831	Bell>metabolic	Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3)
MMADHC	G:611935	+GR-Bell	Homocystinuria, cblD type, variant 1, 277410 (3)
MMADHC	G:611935	+GR-Bell	Methylmalonic aciduria and homocystinuria, cblD type, 277410 (3)
MMADHC	G:611935	+GR-Bell	Methylmalonic aciduria, cblD type, variant 2, 277410 (3)
MMD	G:604467	.	.
MME	G:120520	.	.
MMP1	G:120353	.	COPD, rate of decline of lung function in, 606963 (3)
MMP1	G:120353	.	{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)
MMP10	G:185260	.	.
MMP11	G:185261	.	.
MMP12	G:601046	.	.
MMP13	G:600108	.	Metaphyseal anadysplasia 1, 602111 (3)
MMP13	G:600108	.	Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3)
MMP14	G:600754	.	.
MMP15	G:602261	.	.
MMP16	G:602262	.	.
MMP17	G:602285	.	.
MMP19	G:601807	.	.
MMP2	G:120360	.	Torg-Winchester syndrome, 259600 (3)
MMP20	G:604629	.	Amelogenesis imperfecta, type IIA2, 612529 (3)
MMP21	G:608416	.	.
MMP23A	G:603320	.	.
MMP23B	G:603321	.	.
MMP24	G:604871	.	.
MMP25	G:608482	.	.
MMP26	G:605470	.	.
MMP28	G:608417	.	.
MMP3	G:185250	.	{Coronary heart disease, susceptibility to, 6}, 614466 (3)
MMP7	G:178990	.	.
MMP8	G:120355	.	.
MMP9	G:120361	.	Metaphyseal anadysplasia 2, 613073 (3)
MMRN1	G:601456	.	.
MMRN2	G:608925	.	.
MMVP1	P:157700	.	.
MMVP2	P:607829	.	.
MN1	G:156100	.	Meningioma, 607174 (3)
MNAT1	G:602659	.	.
MND1	G:611422	.	.
MNDA	G:159553	.	.
MNF1	G:614461	.	.
MNG1	P:138800	.	.
MNS1	G:610766	.	.
MNT	G:603039	.	.
MNX1	G:142994	.	Currarino syndrome, 176450 (3)
MOAP1	G:609485	.	.
MOB1A	G:609281	.	.
MOB1B	G:609282	.	.
MOB2	G:611969	.	.
MOB4	G:609361	.	.
MOBP	G:600948	.	.
MOCOS	G:613274	.	.
MOCS1	G:603707	Bell>neurological	Molybdenum cofactor deficiency, type A, 252150 (3)
MOCS2	G:603708	Bell>neurological	Molybdenum cofactor deficiency, type B, 252150 (3)
MOCS3	G:609277	.	.
MOG	G:159465	.	Narcolepsy 7, 614250 (3)
MOGAT1	G:610268	.	.
MOGAT2	G:610270	.	.
MOGAT3	G:610184	.	.
MOGS	G:601336	Bell>metabolic	Congenital disorder of glycosylation, type IIb, 606056 (3)
MOK	G:605762	.	.
MON1A	G:611464	.	.
MON1B	G:608954	.	.
MORC1	G:603205	.	.
MORC3	G:610078	.	.
MORF4	G:116960	.	.
MORF4L1	G:607303	.	.
MORF4L2	G:300409	.	.
MOS	G:190060	.	.
MOSPD1	G:300674	.	.
MOSPD3	G:609125	.	.
MOV10	G:610742	.	.
MOV10L1	G:605794	.	.
MOXD1	G:609000	.	.
MPDU1	G:604041	+GR-Bell	Congenital disorder of glycosylation, type If, 609180 (3)
MPDZ	G:603785	.	.
MPEG1	G:610390	.	.
MPG	G:156565	.	.
MPHOSPH10	G:605503	.	.
MPHOSPH6	G:605500	.	.
MPHOSPH8	G:611626	.	.
MPHOSPH9	G:605501	.	.
MPI	G:154550	Bell>metabolic	Congenital disorder of glycosylation, type Ib, 602579 (3)
MPL	G:159530	Bell>hematologic	Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)
MPL	G:159530	Bell>hematologic	Thrombocythemia 2, 601977 (3)
MPL	G:159530	Bell>hematologic	Thrombocytopenia, congenital amegakaryocytic, 604498 (3)
MPLKIP	G:609188	.	Trichothiodystrophy, nonphotosensitive 1, 234050 (3)
MPO	G:606989	.	Myeloperoxidase deficiency, 254600 (3)
MPO	G:606989	.	{Alzheimer disease, susceptibility to}, 104300 (3)
MPO	G:606989	.	{Lung cancer, protection against, in smokers} (3)
MPP1	G:305360	.	.
MPP2	G:600723	.	.
MPP3	G:601114	.	.
MPP4	G:606575	.	.
MPP5	G:606958	.	.
MPP6	G:606959	.	.
MPP7	G:610973	.	.
MPPE1	G:611900	.	.
MPPED1	G:602112	.	.
MPPED2	G:600911	.	.
MPRIP	G:612935	.	.
MPST	G:602496	.	.
MPV17	G:137960	Bell>neurological	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3)
MPV17	G:137960	Bell>neurological	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3)
MPZ	G:159440	Bell>neurological	Charcot-Marie-Tooth disease, dominant intermediate 3, 607791 (3)
MPZ	G:159440	Bell>neurological	Charcot-Marie-Tooth disease, dominant intermediate 3, 607791 (3)
MPZ	G:159440	Bell>neurological	Charcot-Marie-Tooth disease, type 1B, 118200 (3)
MPZ	G:159440	Bell>neurological	Charcot-Marie-Tooth disease, type 1B, 118200 (3)
MPZ	G:159440	Bell>neurological	Charcot-Marie-Tooth disease, type 2I, 607677 (3)
MPZ	G:159440	Bell>neurological	Charcot-Marie-Tooth disease, type 2I, 607677 (3)
MPZ	G:159440	Bell>neurological	Charcot-Marie-Tooth disease, type 2J, 607736 (3)
MPZ	G:159440	Bell>neurological	Charcot-Marie-Tooth disease, type 2J, 607736 (3)
MPZ	G:159440	Bell>neurological	Dejerine-Sottas disease, 145900 (3)
MPZ	G:159440	Bell>neurological	Dejerine-Sottas disease, 145900 (3)
MPZ	G:159440	Bell>neurological	Neuropathy, congenital hypomyelinating, 605253 (3)
MPZ	G:159440	Bell>neurological	Neuropathy, congenital hypomyelinating, 605253 (3)
MPZ	G:159440	Bell>neurological	Roussy-Levy syndrome, 180800 (3)
MPZ	G:159440	Bell>neurological	Roussy-Levy syndrome, 180800 (3)
MPZL1	G:604376	.	.
MPZL2	G:604873	.	.
MPZL3	G:611707	.	.
MR1	G:600764	.	.
MRAP	G:609196	.	Glucocorticoid deficiency 2, 607398 (3)
MRAS	G:608435	.	.
MRC1	G:153618	.	.
MRC2	G:612264	.	.
MRE11A	G:600814	.	Ataxia-telangiectasia-like disorder, 604391 (3)
MREG	G:609207	.	.
MRGPRD	G:607231	.	.
MRGPRE	G:607232	.	.
MRGPRF	G:607233	.	.
MRGPRG	G:607234	.	.
MRGPRX1	G:607227	.	.
MRGPRX2	G:607228	.	.
MRGPRX3	G:607229	.	.
MRGPRX4	G:607230	.	.
MRO	G:608080	.	.
MROS	P:155900	.	.
MRP63	G:611997	.	.
MRPL1	G:611821	.	.
MRPL10	G:611825	.	.
MRPL11	G:611826	.	.
MRPL12	G:602375	.	.
MRPL13	G:610200	.	.
MRPL14	G:611827	.	.
MRPL15	G:611828	.	.
MRPL16	G:611829	.	.
MRPL17	G:611830	.	.
MRPL18	G:611831	.	.
MRPL19	G:611832	.	.
MRPL2	G:611822	.	.
MRPL20	G:611833	.	.
MRPL21	G:611834	.	.
MRPL22	G:611835	.	.
MRPL23	G:600789	.	.
MRPL24	G:611836	.	.
MRPL27	G:611837	.	.
MRPL28	G:604853	.	.
MRPL3	G:607118	.	.
MRPL30	G:611838	.	.
MRPL32	G:611839	.	.
MRPL33	G:610059	.	.
MRPL34	G:611840	.	.
MRPL35	G:611841	.	.
MRPL36	G:611842	.	.
MRPL37	G:611843	.	.
MRPL38	G:611844	.	.
MRPL39	G:611845	.	.
MRPL4	G:611823	.	.
MRPL40	G:605089	.	.
MRPL41	G:611846	.	.
MRPL42	G:611847	.	.
MRPL43	G:611848	.	.
MRPL44	G:611849	.	.
MRPL45	G:611850	.	.
MRPL46	G:611851	.	.
MRPL47	G:611852	.	.
MRPL48	G:611853	.	.
MRPL49	G:606866	.	.
MRPL50	G:611854	.	.
MRPL51	G:611855	.	.
MRPL52	G:611856	.	.
MRPL53	G:611857	.	.
MRPL54	G:611858	.	.
MRPL55	G:611859	.	.
MRPL9	G:611824	.	.
MRPS10	G:611976	.	.
MRPS11	G:611977	.	.
MRPS12	G:603021	.	.
MRPS14	G:611978	.	.
MRPS15	G:611979	.	.
MRPS16	G:609204	Bell>metabolic	Combined oxidative phosphorylation deficiency 2, 610498 (3)
MRPS17	G:611980	.	.
MRPS18A	G:611981	.	.
MRPS18B	G:611982	.	.
MRPS18C	G:611983	.	.
MRPS2	G:611971	.	.
MRPS21	G:611984	.	.
MRPS22	G:605810	Bell>metabolic	Combined oxidative phosphorylation deficiency 5, 611719 (3)
MRPS23	G:611985	.	.
MRPS24	G:611986	.	.
MRPS25	G:611987	.	.
MRPS26	G:611988	.	.
MRPS27	G:611989	.	.
MRPS28	G:611990	.	.
MRPS30	G:611991	.	.
MRPS31	G:611992	.	.
MRPS33	G:611993	.	.
MRPS34	G:611994	.	.
MRPS35	G:611995	.	.
MRPS36	G:611996	.	.
MRPS5	G:611972	.	.
MRPS6	G:611973	.	.
MRPS7	G:611974	.	.
MRPS9	G:611975	.	.
MRRF	G:604602	.	.
MRSD	P:309620	.	.
MRT10	P:611096	.	.
MRT11	P:611097	.	.
MRT12	P:611090	.	.
MRT19	P:614343	.	.
MRT23	P:614344	.	.
MRT24	P:614345	.	.
MRT25	P:614346	.	.
MRT27	P:614340	.	.
MRT28	P:614347	.	.
MRT4	P:611107	.	.
MRT5	P:611091	.	.
MRT8	P:611094	.	.
MRT9	P:611095	.	Mental retardation, autosomal recessive, 9/26 (3)
MRVI1	G:604673	.	.
MRX1	P:309530	.	.
MRX14	P:300062	.	.
MRX2	P:300428	.	.
MRX20	P:300047	.	.
MRX23	P:300046	.	.
MRX42	P:300372	.	.
MRX49	P:300114	.	.
MRX50	P:300115	.	.
MRX52	P:300504	.	.
MRX53	P:300324	.	.
MRX72	P:300271	.	.
MRX73	P:300355	.	.
MRX77	P:300454	.	.
MRX78	P:300551	.	.
MRX81	P:300433	.	.
MRX82	P:300518	.	.
MRX84	P:300505	.	.
MRXS11	P:300238	.	.
MRXS5	P:304340	.	.
MRXS7	P:300218	.	.
MS4A1	G:112210	.	Immunodeficiency, common variable, 5, 613495 (3)
MS4A10	G:608403	.	.
MS4A12	G:606550	.	.
MS4A2	G:147138	.	{Atopy, susceptibility to}, 147050 (3)
MS4A3	G:606498	.	.
MS4A4A	G:606547	.	.
MS4A4E	G:608401	.	.
MS4A5	G:606499	.	.
MS4A6A	G:606548	.	.
MS4A6E	G:608402	.	.
MS4A7	G:606502	.	.
MS4A8B	G:606549	.	.
MSC	G:603628	.	.
MSD	P:311400	.	.
MSGN1	G:612209	.	.
MSH2	G:609309	+GR-Bell	Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3)
MSH2	G:609309	+GR-Bell	Mismatch repair cancer syndrome, 276300 (3)
MSH2	G:609309	+GR-Bell	Muir-Torre syndrome, 158320 (3)
MSH3	G:600887	.	.
MSH4	G:602105	.	.
MSH5	G:603382	.	.
MSH6	G:600678	+GR-Bell	Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3)
MSH6	G:600678	+GR-Bell	Endometrial cancer, familial, 608089 (3)
MSH6	G:600678	+GR-Bell	Mismatch repair cancer syndrome, 276300 (3)
MSI1	G:603328	.	.
MSI2	G:607897	.	.
MSL3	G:300609	.	.
MSLN	G:601051	.	.
MSMB	G:157145	.	{Prostate cancer, hereditary, 13}, 611928 (3)
MSMO1	G:607545	.	.
MSMP	G:612191	.	.
MSN	G:309845	.	.
MSR1	G:153622	.	Barrett esophagus/esophageal adenocarcinoma, 614266 (3)
MSR1	G:153622	.	Prostate cancer, hereditary, 176807 (3)
MSRA	G:601250	.	.
MSRB1	G:606216	.	.
MSRB2	G:613782	.	.
MSRB3	G:613719	.	Deafness, autosomal recessive 74, 613718 (3)
MSSE	P:132800	.	.
MST1	G:142408	.	.
MST1R	G:600168	.	.
MSTN	G:601788	+GR-Bell	Muscle hypertrophy, 614160 (3)
MSX1	G:142983	.	Orofacial cleft 5, 608874 (3)
MSX1	G:142983	.	Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3)
MSX1	G:142983	.	Witkop syndrome, 189500 (3)
MSX2	G:123101	+GR-Bell	Craniosynostosis, type 2, 604757 (3)
MSX2	G:123101	+GR-Bell	Parietal foramina 1, 168500 (3)
MSX2	G:123101	+GR-Bell	Parietal foramina with cleidocranial dysplasia, 168550 (3)
MT1A	G:156350	.	.
MT1B	G:156349	.	.
MT1E	G:156351	.	.
MT1F	G:156352	.	.
MT1G	G:156353	.	.
MT1H	G:156354	.	.
MT1IP	G:156355	.	.
MT1JP	G:156356	.	.
MT1L	G:156358	.	.
MT1M	G:156357	.	.
MT1X	G:156359	.	.
MT2A	G:156360	.	.
MT3	G:139255	.	.
MT4	G:606206	.	.
MTA1	G:603526	.	.
MTA2	G:603947	.	.
MTA3	G:609050	.	.
MTAP	G:156540	.	.
MTBP	G:605927	.	.
MTCH1	G:610449	.	.
MTCH2	G:613221	.	.
MTCP1	G:300116	.	.
MTDH	G:610323	.	.
MTERF	G:602318	.	.
MTF1	G:600172	.	.
MTF2	G:609882	.	.
MTFMT	G:611766	.	.
MTFP1	G:610235	.	.
MTHFD1	GP:172460	.	{Abruptio placentae, susceptibility to} (3)
MTHFD1	GP:172460	.	{Spina bifida, folate-sensitive, susceptibility to}, 601634 (3)
MTHFD1L	G:611427	.	.
MTHFD2	G:604887	.	.
MTHFD2L	G:614047	.	.
MTHFR	G:607093	Bell>metabolic	Homocystinuria due to MTHFR deficiency, 236250 (3)
MTHFR	G:607093	Bell>metabolic	{Neural tube defects, susceptibility to}, 601634 (3)
MTHFR	G:607093	Bell>metabolic	{Schizophrenia, susceptibility to}, 181500 (3)
MTHFR	G:607093	Bell>metabolic	{Thromboembolism, susceptibility to}, 188050 (3)
MTHFR	G:607093	Bell>metabolic	{Vascular disease, susceptibility to} (3)
MTHFS	G:604197	.	.
MTIF2	G:603766	.	.
MTL5	G:604374	.	.
MTM1	G:300415	Bell>neurological	Myotubular myopathy, X-linked, 310400 (3)
MTMR1	G:300171	.	.
MTMR12	G:606501	.	.
MTMR14	G:611089	.	{Centronuclear myopathy, autosomal, modifier of}, 160150 (3)
MTMR2	G:603557	+GR-Bell	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
MTMR3	G:603558	.	.
MTMR4	G:603559	.	.
MTMR6	G:603561	.	.
MTMR7	G:603562	.	.
MTMR9	G:606260	.	.
MTNR1A	G:600665	.	.
MTNR1B	G:600804	.	{Diabetes mellitus, type 2, susceptiblity to}, 125853 (3)
MTOR	G:601231	.	.
MTPAP	G:613669	.	Ataxia, spastic, 4, 613672 (3)
MTPN	G:606484	.	.
MTR	G:156570	+GR-Bell	Methylcobalamin deficiency, cblG type, 250940 (3)
MTR	G:156570	+GR-Bell	{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)
MTRF1	G:604601	.	.
MTRF1L	G:613542	.	.
MTRR	G:602568	+GR-Bell	Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3)
MTRR	G:602568	+GR-Bell	{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)
MTSS1	G:608486	.	.
MTTP	G:157147	Bell>metabolic	Abetalipoproteinemia, 200100 (3)
MTTP	G:157147	Bell>metabolic	{Metabolic syndrome, protection against}, 605552 (3)
MTUS1	G:609589	.	.
MTX1	G:600605	.	.
MTX2	G:608555	.	.
MUC1	G:158340	.	.
MUC12	G:604609	.	.
MUC13	G:612181	.	.
MUC15	G:608566	.	.
MUC16	G:606154	.	.
MUC17	G:608424	.	.
MUC19	G:612170	.	.
MUC2	G:158370	.	.
MUC20	G:610360	.	.
MUC22	G:613917	.	.
MUC3A	G:158371	.	.
MUC3B	G:605633	.	.
MUC4	G:158372	.	.
MUC5AC	G:158373	.	.
MUC5B	G:600770	.	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)
MUC6	G:158374	.	.
MUC7	G:158375	.	{Asthma, protection against}, 600807 (3)
MUC8	G:601932	.	.
MUCL1	G:610857	.	.
MUL1	G:612037	.	.
MUS81	G:606591	.	.
MUSK	G:601296	+GR-Bell	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)
MUT	G:609058	Bell>metabolic	Methylmalonic aciduria, mut(0) type, 251000 (3)
MUTED	G:607289	.	.
MUTYH	G:604933	Bell>gastroenterologic	Adenomas, multiple colorectal, 608456 (3)
MUTYH	G:604933	Bell>gastroenterologic	Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600 (3)
MUTYH	G:604933	Bell>gastroenterologic	Gastric cancer, somatic, 137215 (3)
MVD	G:603236	.	.
MVK	G:251170	Bell>metabolic	Hyper-IgD syndrome, 260920 (3)
MVK	G:251170	Bell>metabolic	Mevalonic aciduria, 610377 (3)
MVP	G:605088	.	.
MX1	G:147150	.	.
MX2	G:147890	.	.
MXD1	G:600021	.	.
MXD3	G:609450	.	.
MXI1	G:600020	.	{Prostate cancer, susceptibility to}, 176807 (3)
MYADM	G:609959	.	.
MYB	G:189990	.	.
MYBBP1A	G:604885	.	.
MYBL1	G:159405	.	.
MYBL2	G:601415	.	.
MYBPC1	G:160794	.	Arthrogryposis, distal, type 1B, 614335 (3)
MYBPC2	G:160793	.	.
MYBPC3	G:600958	+GR-Bell	?Cardiomyopathy, dilated, 115200 (3)
MYBPC3	G:600958	+GR-Bell	Cardiomyopathy, familial hypertrophic, 4, 115197 (3)
MYBPH	G:160795	.	.
MYC	G:190080	.	Burkitt lymphoma, 113970 (3)
MYCBP	G:606535	.	.
MYCBP2	G:610392	.	.
MYCBPAP	G:609835	.	.
MYCL1	G:164850	.	.
MYCL2	G:310310	.	.
MYCLK1	G:164865	.	.
MYCN	G:164840	+GR-Bell	Feingold syndrome, 164280 (3)
MYCNOS	G:605374	.	.
MYD88	G:602170	.	Pyogenic bacterial infections, recurrent, due to MYD88 deficiency, 612260 (3)
MYEOV	G:605625	.	.
MYF5	G:159990	.	.
MYF6	G:159991	.	Myopathy, centronuclear, 3, 614408 (3)
MYH1	G:160730	.	.
MYH10	G:160776	.	.
MYH11	G:160745	+GR-Bell	Aortic aneurysm, familial thoracic 4, 132900 (3)
MYH13	G:603487	.	.
MYH14	G:608568	.	Deafness, autosomal dominant 4, 600652 (3)
MYH14	G:608568	.	Peripheral neuropathy, myopathy, hoarseness, and hearing loss, 614369 (3)
MYH15	G:609929	.	.
MYH16	P:608580	.	.
MYH2	G:160740	.	Inclusion body myopathy-3, 605637 (3)
MYH3	G:160720	.	Arthrogryposis, distal, type 2A, 193700 (3)
MYH3	G:160720	.	Arthrogryposis, distal, type 2B, 601680 (3)
MYH4	G:160742	.	.
MYH6	G:160710	+GR-Bell	Atrial septal defect 3, 614089 (3)
MYH6	G:160710	+GR-Bell	Cardiomyopathy, dilated, 1EE, 613252 (3)
MYH6	G:160710	+GR-Bell	Cardiomyopathy, familial hypertrophic, 14, 613251 (3)
MYH6	G:160710	+GR-Bell	{Sick sinus syndrome 3}, 614090 (3)
MYH7	G:160760	+GR-Bell	Cardiomyopathy, dilated, 1S, 613426 (3)
MYH7	G:160760	+GR-Bell	Cardiomyopathy, familial hypertrophic, 1, 192600 (3)
MYH7	G:160760	+GR-Bell	Laing distal myopathy, 160500 (3)
MYH7	G:160760	+GR-Bell	Left ventricular noncompaction 5, 613426 (3)
MYH7	G:160760	+GR-Bell	Myopathy, myosin storage, 608358 (3)
MYH7	G:160760	+GR-Bell	Scapuloperoneal syndrome, myopathic type, 181430 (3)
MYH7B	G:609928	.	.
MYH8	G:160741	.	Carney complex variant, 608837 (3)
MYH8	G:160741	.	Trismus-pseudocamptodactyly syndrome, 158300 (3)
MYH9	G:160775	+GR-Bell	Deafness, autosomal dominant 17, 603622 (3)
MYH9	G:160775	+GR-Bell	Epstein syndrome, 153650 (3)
MYH9	G:160775	+GR-Bell	Fechtner syndrome, 153640 (3)
MYH9	G:160775	+GR-Bell	Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3)
MYH9	G:160775	+GR-Bell	May-Hegglin anomaly, 155100 (3)
MYH9	G:160775	+GR-Bell	Sebastian syndrome, 605249 (3)
MYL1	G:160780	.	.
MYL12B	G:609211	.	.
MYL2	G:160781	+GR-Bell	Cardiomyopathy, familial hypertrophic, 10, 608758 (3)
MYL3	G:160790	+GR-Bell	Cardiomyopathy, familial hypertrophic, 8, 608751 (3)
MYL4	G:160770	.	.
MYL5	G:160782	.	.
MYL6	G:609931	.	.
MYL6B	G:609930	.	.
MYL7	G:613993	.	.
MYL9	G:609905	.	.
MYLIP	G:610082	.	.
MYLK	G:600922	+GR-Bell	Aortic aneurysm, familial thoracic 7, 613780 (3)
MYLK2	G:606566	+GR-Bell	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
MYLK3	G:612147	.	.
MYMY1	P:252350	.	.
MYMY3	P:608796	.	.
MYNN	G:606042	.	.
MYO10	G:601481	.	.
MYO15A	G:602666	.	Deafness, autosomal recessive 3, 600316 (3)
MYO18A	G:610067	.	.
MYO18B	G:607295	.	.
MYO1A	G:601478	.	Deafness, autosomal dominant 48, 607841 (3)
MYO1B	G:606537	.	.
MYO1C	G:606538	.	.
MYO1D	G:606539	.	.
MYO1E	G:601479	.	Glomerulosclerosis, focal segmental, 6, 614131 (3)
MYO1F	G:601480	.	.
MYO1G	G:613445	.	.
MYO3A	G:606808	.	Deafness, autosomal recessive 30, 607101 (3)
MYO3B	G:610040	.	.
MYO5A	G:160777	Bell>neurological	Griscelli syndrome, type 1, 214450 (3)
MYO5A	G:160777	Bell>neurological	Griscelli syndrome, type 1, 214450 (3)
MYO5B	G:606540	.	Microvillus inclusion disease, 251850 (3)
MYO5C	G:610022	.	.
MYO6	G:600970	.	Deafness, autosomal dominant 22, 606346 (3)
MYO6	G:600970	.	Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3)
MYO6	G:600970	.	Deafness, autosomal recessive 37, 607821 (3)
MYO7A	G:276903	Bell>deafness	Deafness, autosomal dominant 11, 601317 (3)
MYO7A	G:276903	Bell>deafness	Deafness, autosomal recessive 2, 600060 (3)
MYO7A	G:276903	Bell>deafness	Usher syndrome, type 1B, 276900 (3)
MYO7A	G:276903	Bell>ocular	Deafness, autosomal dominant 11, 601317 (3)
MYO7A	G:276903	Bell>ocular	Deafness, autosomal recessive 2, 600060 (3)
MYO7A	G:276903	Bell>ocular	Usher syndrome, type 1B, 276900 (3)
MYO7B	G:606541	.	.
MYO9A	G:604875	.	.
MYO9B	G:602129	.	{Celiac disease, susceptibility to, 4}, 609753 (3)
MYOC	G:601652	.	Glaucoma 1A, primary open angle, juvenile-onset, 137750 (3)
MYOC	G:601652	.	Glaucoma 1A, primary open angle, recessive (3)
MYOC	G:601652	.	Glaucoma, early-onset, digenic (3)
MYOCD	G:606127	.	.
MYOD1	G:159970	.	.
MYOF	G:604603	.	.
MYOG	G:159980	.	.
MYOM1	G:603508	.	.
MYOM2	G:603509	.	.
MYOT	G:604103	+GR-Bell	Muscular dystrophy, limb-girdle, type 1A, 159000 (3)
MYOT	G:604103	+GR-Bell	Myopathy, spheroid body, 182920 (3)
MYOT	G:604103	+GR-Bell	Myotilinopathy, 609200 (3)
MYOZ1	G:605603	.	.
MYOZ2	G:605602	.	Cardiomyopathy, familial hypertrophic, 16, 613838 (3)
MYOZ3	G:610735	.	.
MYP1	P:310460	.	.
MYP10	P:609259	.	.
MYP11	P:609994	.	.
MYP12	P:609995	.	.
MYP13	P:300613	.	.
MYP14	P:610320	.	.
MYP15	P:612717	.	.
MYP16	P:612554	.	.
MYP17	P:608367	.	.
MYP18	P:255500	.	.
MYP2	P:160700	.	.
MYP3	P:603221	.	.
MYP5	P:608474	.	.
MYP6	P:608908	.	.
MYP7	P:609256	.	.
MYP8	P:609257	.	.
MYP9	P:609258	.	.
MYPN	G:608517	.	.
MYRIP	G:611790	.	.
MYSM1	G:612176	.	.
MYT1	G:600379	.	.
MYT1L	G:613084	.	.
MZF1	G:194550	.	.
MZT1	G:613448	.	.
MZT2A	G:613449	.	.
MZT2B	G:613450	.	.
N6AMT1	G:614553	.	.
NAA10	G:300013	.	N-terminal acetyltransferase deficiency, 300855 (3)
NAA15	G:608000	.	.
NAA20	G:610833	.	.
NAA25	G:612755	.	.
NAA38	G:607288	.	.
NAA50	G:610834	.	.
NAA60	G:614246	.	.
NAAA	G:607469	.	.
NAALAD2	G:611636	.	.
NAALADL1	G:602640	.	.
NAALADL2	G:608806	.	.
NAB1	G:600800	.	.
NAB2	G:602381	.	.
NACA	G:601234	.	.
NACA2	G:609274	.	.
NACC1	G:610672	.	.
NADK	G:611616	.	.
NADSYN1	G:608285	.	.
NAE1	G:603385	.	.
NAGA	G:104170	Bell>metabolic	Kanzaki disease, 609242 (3)
NAGA	G:104170	Bell>metabolic	Schindler disease, type I, 609241 (3)
NAGA	G:104170	Bell>metabolic	Schindler disease, type III, 609241 (3)
NAGK	G:606828	.	.
NAGLU	G:609701	.	Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3)
NAGPA	G:607985	.	.
NAGS	G:608300	Bell>metabolic	N-acetylglutamate synthase deficiency, 237310 (3)
NAIF1	G:610673	.	.
NAIP	G:600355	.	.
NALCN	G:611549	.	.
NAMPT	G:608764	.	.
NAMSD	P:310490	.	.
NANOG	G:607937	.	.
NANOS1	G:608226	.	.
NANOS2	G:608228	.	.
NANOS3	G:608229	.	.
NANP	G:610763	.	.
NANS	G:605202	.	.
NAP1L1	G:164060	.	.
NAP1L2	G:300026	.	.
NAP1L3	G:300117	.	.
NAP1L4	G:601651	.	.
NAP1L5	G:612203	.	.
NAPA	G:603215	.	.
NAPB	G:611270	.	.
NAPEPLD	G:612334	.	.
NAPG	G:603216	.	.
NAPRT1	G:611552	.	.
NAPSA	G:605631	.	.
NARF	G:605349	.	.
NARFL	G:611118	.	.
NARG2	G:610835	.	.
NARS	G:108410	.	.
NARS2	G:612803	.	.
NASP	G:603185	.	.
NAT1	G:108345	.	.
NAT10	G:609221	.	.
NAT2	G:612182	.	[Acetylation, slow], 243400 (3)
NAT6	G:607073	.	.
NAT8	G:606716	.	.
NAT8B	G:608190	.	.
NAT8L	G:610647	.	N-acetylaspartate deficiency, 614063 (3)
NAV1	G:611628	.	.
NAV2	G:607026	.	.
NAV3	G:611629	.	.
NBAS	G:608025	.	.
NBEA	G:604889	.	.
NBEAL1	G:609816	.	.
NBEAL2	G:614169	.	Gray platelet syndrome, 139090 (3)
NBEAP1	G:601889	.	Lymphoma, diffuse large cell (3)
NBL1	G:600613	.	.
NBN	G:602667	Bell>immunodeficiency	Leukemia, acute lymphoblastic (3)
NBN	G:602667	Bell>immunodeficiency	Nijmegen breakage syndrome, 251260 (3)
NBPF1	G:610501	.	.
NBPF10	G:614000	.	.
NBPF11	G:614001	.	.
NBPF12	G:608607	.	.
NBPF14	G:614003	.	.
NBPF15	G:610414	.	.
NBPF16	G:614005	.	.
NBPF19	G:614006	.	.
NBPF20	G:614007	.	.
NBPF23	G:612970	.	.
NBPF3	G:612992	.	.
NBPF4	G:613994	.	.
NBPF5	G:613995	.	.
NBPF6	G:613996	.	.
NBPF7	G:613997	.	.
NBPF8	G:613998	.	.
NBPF9	G:613999	.	.
NBR1	G:166945	.	.
NCALD	G:606722	.	.
NCAM1	G:116930	.	.
NCAM2	G:602040	.	.
NCAN	G:600826	.	.
NCAPD3	G:609276	.	.
NCAPG	G:606280	.	.
NCAPG2	G:608532	.	.
NCAPH	G:602332	.	.
NCAPH2	G:611230	.	.
NCBP1	G:600469	.	.
NCBP2	G:605133	.	.
NCDN	G:608458	.	.
NCEH1	G:613234	.	.
NCF1	G:608512	.	Chronic granulomatous disease due to deficiency of NCF-1, 233700 (3)
NCF2	G:608515	.	Chronic granulomatous disease due to deficiency of NCF-2, 233710 (3)
NCF4	G:601488	.	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III, 613960 (3)
NCK1	G:600508	.	.
NCK2	G:604930	.	.
NCKAP1	G:604891	.	.
NCKAP1L	G:141180	.	.
NCKAP5	G:608789	.	.
NCKIPSD	G:606671	.	.
NCL	G:164035	.	.
NCLN	G:609156	.	.
NCOA1	G:602691	.	.
NCOA2	G:601993	.	.
NCOA3	G:601937	.	.
NCOA4	G:601984	.	Thyroid carcinoma, papillary, 188550 (3)
NCOA6	G:605299	.	.
NCOA7	G:609752	.	.
NCOR1	G:600849	.	.
NCOR2	G:600848	.	.
NCR1	G:604530	.	.
NCR2	G:604531	.	.
NCR3	G:611550	.	{Malaria, mild, susceptibility to}, 609148 (3)
NCS1	G:603315	.	.
NCSTN	G:605254	.	Acne inversa, familial, 1, 142690 (3)
NDC80	G:607272	.	.
NDE1	G:609449	.	Lissencephaly 4 (with microcephaly), 614019 (3)
NDEL1	G:607538	.	.
NDFIP1	G:612050	.	.
NDFIP2	G:610041	.	.
NDN	G:602117	.	Prader-Willi syndrome, 176270 (3)
NDNL2	G:608243	.	.
NDOR1	G:606073	.	.
NDP	G:300658	Bell>developmental	Exudative vitreoretinopathy, X-linked, 305390 (3)
NDP	G:300658	Bell>developmental	Norrie disease, 310600 (3)
NDRG1	G:605262	+GR-Bell	Charcot-Marie-Tooth disease, type 4D, 601455 (3)
NDRG2	G:605272	.	.
NDRG3	G:605273	.	.
NDRG4	G:614463	.	.
NDST1	G:600853	.	.
NDST2	G:603268	.	.
NDST3	G:603950	.	.
NDUFA1	G:300078	.	Mitochondrial complex I deficiency, 252010 (3)
NDUFA10	G:603835	.	Leigh syndrome, 256000 (3)
NDUFA11	G:612638	.	Mitochondrial complex I deficiency, 252010 (3)
NDUFA12	G:614530	.	Leigh syndrome due to mitochondrial complex 1 deficiency, 256000 (3)
NDUFA13	G:609435	.	{Thyroid carcinoma, Hurthle cell}, 607464 (3)
NDUFA2	G:602137	.	Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)
NDUFA3	G:603832	.	.
NDUFA4	G:603833	.	.
NDUFA5	G:601677	.	.
NDUFA6	G:602138	.	.
NDUFA7	G:602139	.	.
NDUFA8	G:603359	.	.
NDUFA9	G:603834	.	Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)
NDUFAB1	G:603836	.	.
NDUFAF1	G:606934	.	Mitochondrial complex I deficiency, 252010 (3)
NDUFAF2	G:609653	.	Leigh syndrome, 256000 (3)
NDUFAF2	G:609653	.	Mitochondrial complex I deficiency, 252010 (3)
NDUFAF3	G:612911	.	Mitochondrial complex I deficiency, 252010 (3)
NDUFAF4	G:611776	.	Mitochondrial complex I deficiency, 252010 (3)
NDUFB1	G:603837	.	.
NDUFB10	G:603843	.	.
NDUFB11	G:300403	.	.
NDUFB2	G:603838	.	.
NDUFB3	G:603839	.	Mitochondrial complex I deficiency, 252010 (3)
NDUFB4	G:603840	.	.
NDUFB5	G:603841	.	.
NDUFB6	G:603322	.	.
NDUFB7	G:603842	.	.
NDUFB8	G:602140	.	.
NDUFB9	G:601445	.	.
NDUFC1	G:603844	.	.
NDUFC2	G:603845	.	.
NDUFS1	G:157655	.	Mitochondrial complex I deficiency, 252010 (3)
NDUFS2	G:602985	.	Mitochondrial complex I deficiency, 252010 (3)
NDUFS3	G:603846	.	Leigh syndrome, 256000 (3)
NDUFS4	G:602694	.	Leigh syndrome, 256000 (3)
NDUFS4	G:602694	.	Mitochondrial complex I deficiency, 252010 (3)
NDUFS5	G:603847	.	.
NDUFS6	G:603848	.	Complex I, mitochondrial respiratory chain, deficiency of, 252010 (3)
NDUFS7	G:601825	.	Leigh syndrome, 256000 (3)
NDUFS8	G:602141	.	Leigh syndrome, 256000 (3)
NDUFV1	G:161015	.	Mitochondrial complex I deficiency, 252010 (3)
NDUFV2	G:600532	.	Mitochondrial complex I deficiency, 252010 (3)
NDUFV3	G:602184	.	.
NEAT1	G:612769	.	.
NEB	G:161650	Bell>neurological	Nemaline myopathy 2, autosomal recessive, 256030 (3)
NEBL	G:605491	.	.
NECAB3	G:612478	.	.
NECAP1	G:611623	.	.
NECAP2	G:611624	.	.
NEDD1	G:600372	.	.
NEDD4	G:602278	.	.
NEDD4L	G:606384	.	.
NEDD8	G:603171	.	.
NEDD9	G:602265	.	.
NEFH	G:162230	.	{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)
NEFL	G:162280	+GR-Bell	Charcot-Marie-Tooth disease, type 1F, 607734 (3)
NEFL	G:162280	+GR-Bell	Charcot-Marie-Tooth disease, type 2E, 607684 (3)
NEFM	G:162250	.	.
NEGR1	G:613173	.	.
NEIL1	G:608844	.	.
NEIL2	G:608933	.	.
NEIL3	G:608934	.	.
NEK1	G:604588	.	Short rib-polydactyly syndorme, type II, 263520 (3)
NEK11	G:609779	.	.
NEK2	G:604043	.	.
NEK3	G:604044	.	.
NEK4	G:601959	.	.
NEK6	G:604884	.	.
NEK7	G:606848	.	.
NEK8	G:609799	.	Nephronophthisis 9, 613824 (3)
NEK9	G:609798	.	.
NELF	G:608137	.	Hypogonadotropic hypogonadism, 146110 (3)
NELL1	G:602319	.	.
NELL2	G:602320	.	.
NEMF	G:608378	.	.
NENF	G:611874	.	.
NEO1	G:601907	.	.
NES	G:600915	.	.
NET1	G:606450	.	.
NETO1	G:607973	.	.
NETO2	G:607974	.	.
NEU1	G:608272	Bell>metabolic	Sialidosis, type I, 256550 (3)
NEU1	G:608272	Bell>metabolic	Sialidosis, type II, 256550 (3)
NEU2	G:605528	.	.
NEU3	G:604617	.	.
NEU4	G:608527	.	.
NEURL	G:603804	.	.
NEURL2	G:608597	.	.
NEUROD1	G:601724	.	Maturity-onset diabetes of the young 6, 606394 (3)
NEUROD1	G:601724	.	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
NEUROD2	G:601725	.	.
NEUROD4	G:611635	.	.
NEUROD6	G:611513	.	.
NEUROG1	G:601726	.	.
NEUROG2	G:606624	.	.
NEUROG3	G:604882	Bell>gastroenterologic	Diarrhea 4, malabsorptive, congenital, 610370 (3)
NEXN	G:613121	+GR-Bell	Cardiomyopathy, dilated, 1CC, 613122 (3)
NEXN	G:613121	+GR-Bell	Cardiomyopathy, familial hypertrophic, 20, 613876 (3)
NF1	G:613113	+GR-Bell	Leukemia, juvenile myelomonocytic, 607785 (3)
NF1	G:613113	+GR-Bell	Neurofibromatosis, familial spinal, 162210 (3)
NF1	G:613113	+GR-Bell	Neurofibromatosis, type 1, 162200 (3)
NF1	G:613113	+GR-Bell	Neurofibromatosis-Noonan syndrome, 601321 (3)
NF1	G:613113	+GR-Bell	Watson syndrome, 193520 (3)
NF2	G:607379	+GR-Bell	Meningioma, NF2-related, somatic, 607174 (3)
NF2	G:607379	+GR-Bell	Neurofibromatosis, type 2, 101000 (3)
NF2	G:607379	+GR-Bell	Schwannomatosis, 162091 (3)
NFAM1	G:608740	.	.
NFASC	G:609145	.	.
NFAT5	G:604708	.	.
NFATC1	G:600489	.	.
NFATC2	G:600490	.	.
NFATC2IP	G:614525	.	.
NFATC3	G:602698	.	.
NFATC4	G:602699	.	.
NFE2	G:601490	.	.
NFE2L1	G:163260	.	.
NFE2L2	G:600492	.	.
NFE2L3	G:604135	.	.
NFIA	G:600727	.	.
NFIB	G:600728	.	.
NFIC	G:600729	.	.
NFIL3	G:605327	.	.
NFIX	G:164005	.	.
NFKB1	G:164011	.	.
NFKB2	G:164012	.	.
NFKBIA	G:164008	.	Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, 612132 (3)
NFKBIB	G:604495	.	.
NFKBIE	G:604548	.	.
NFKBIL1	G:601022	.	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
NFKBIZ	G:608004	.	.
NFRKB	G:164013	.	.
NFS1	G:603485	.	.
NFU1	G:608100	.	Multiple mitochondrial dysfunctions syndrome 1, 605711 (3)
NFX1	G:603255	.	.
NFYA	G:189903	.	.
NFYB	G:189904	.	.
NFYC	G:605344	.	.
NGB	G:605304	.	.
NGDN	G:610777	.	.
NGEF	G:605991	.	.
NGF	G:162030	.	Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)
NGFR	G:162010	.	.
NGFRAP1	G:300361	.	.
NGLY1	G:610661	.	.
NHCP1	G:118870	.	.
NHEJ1	G:611290	.	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, 611291 (3)
NHLH1	G:162360	.	.
NHLH2	G:162361	.	.
NHLRC1	G:608072	Bell>neurological	Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)
NHP2	G:606470	+GR-Bell	Dyskeratosis congenita, autosomal recessive 2, 613987 (3)
NHP2L1	G:601304	.	.
NHS	G:300457	.	Cataract, congenital, X-linked, 302200 (3)
NHS	G:300457	.	Nance-Horan syndrome, 302350 (3)
NICN1	G:611516	.	.
NID1	G:131390	.	.
NID2	G:605399	.	.
NIDDM1	P:601283	.	.
NIDDM2	P:601407	.	.
NIF3L1	G:605778	.	.
NIN	G:608684	.	.
NINJ1	G:602062	.	.
NINJ2	G:607297	.	.
NINL	G:609580	.	.
NIPA1	G:608145	.	Spastic paraplegia-6, 600363 (3)
NIPA2	G:608146	.	.
NIPAL4	G:609383	+GR-Bell	Ichthyosis, congenital, autosomal recessive, 612281 (3)
NIPBL	G:608667	+GR-Bell	Cornelia de Lange syndrome 1, 122470 (3)
NIPSNAP1	G:603249	.	.
NIPSNAP3A	G:608871	.	.
NIPSNAP3B	G:608872	.	.
NIT1	G:604618	.	.
NKAIN1	G:612871	.	.
NKAIN2	G:609758	.	.
NKAIN3	G:612872	.	.
NKAIN4	G:612873	.	.
NKAP	G:300766	.	.
NKD1	G:607851	.	.
NKD2	G:607852	.	.
NKG7	G:606008	.	.
NKIRAS1	G:604496	.	.
NKIRAS2	G:604497	.	.
NKRF	G:300440	.	.
NKS1	P:272370	.	.
NKTR	G:161565	.	.
NKX2-1	G:600635	.	Chorea, hereditary benign, 118700 (3)
NKX2-1	G:600635	.	Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)
NKX2-2	G:604612	.	.
NKX2-3	G:606727	.	.
NKX2-4	G:607808	.	.
NKX2-5	G:600584	.	Atrial septal defect 7, with or without AV conduction defects, 108900 (3)
NKX2-5	G:600584	.	Atrioventricular block, second-degree (3)
NKX2-5	G:600584	.	Conotruncal heart malformations, variable, 217095 (3)
NKX2-5	G:600584	.	Hypoplastic left heart syndrome 2, 614435 (3)
NKX2-5	G:600584	.	Hypothyroidism, congenital nongoitrous, 5, 225250 (3)
NKX2-5	G:600584	.	Tetrology of Fallot, 187500 (3)
NKX2-5	G:600584	.	Ventricular septal defect 3, 614432 (3)
NKX2-6	G:611770	.	Persistent truncus arteriosus, 217095 (3)
NKX2-8	G:603245	.	.
NKX3-1	G:602041	.	.
NKX3-2	G:602183	.	Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3)
NKX6-1	G:602563	.	.
NKX6-2	G:605955	.	.
NKX6-3	G:610772	.	.
NLGN1	G:600568	.	.
NLGN2	G:606479	.	.
NLGN3	G:300336	.	{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)
NLGN3	G:300336	.	{Autism susceptibility, X-linked 1}, 300425 (3)
NLGN4X	G:300427	+GR-Bell	Mental retardation, X-linked, 300495 (3)
NLGN4X	G:300427	+GR-Bell	{Asperger syndrome susceptibility, X-linked 2}, 300497 (3)
NLGN4X	G:300427	+GR-Bell	{Autism susceptibility, X-linked 2}, 300495 (3)
NLGN4Y	G:400028	.	.
NLK	G:609476	.	.
NLN	G:611530	.	.
NLRC4	G:606831	.	.
NLRC5	G:613537	.	.
NLRP1	G:606636	.	{Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3)
NLRP10	G:609662	.	.
NLRP11	G:609664	.	.
NLRP12	G:609648	.	Familial cold autoinflammatory syndrome 2, 611762 (3)
NLRP13	G:609660	.	.
NLRP14	G:609665	.	.
NLRP2	G:609364	.	.
NLRP3	G:606416	.	CINCA syndrome, 607115 (3)
NLRP3	G:606416	.	Cold-induced autoinflammatory syndrome, familial, 120100 (3)
NLRP3	G:606416	.	Muckle-Wells syndrome, 191900 (3)
NLRP4	G:609645	.	.
NLRP5	G:609658	.	.
NLRP6	G:609650	.	.
NLRP7	G:609661	.	Hydatidiform mole, 231090 (3)
NLRP8	G:609659	.	.
NLRP9	G:609663	.	.
NLRX1	G:611947	.	.
NMB	G:162340	.	.
NMBR	G:162341	.	.
NMD3	G:611021	.	.
NME1	G:156490	.	Neuroblastoma, 256700 (3)
NME2	G:156491	.	.
NME3	G:601817	.	.
NME4	G:601818	.	.
NME5	G:603575	.	.
NME6	G:608294	.	.
NME7	G:613465	.	.
NMI	G:603525	.	.
NMNAT1	G:608700	.	.
NMNAT2	G:608701	.	.
NMNAT3	G:608702	.	.
NMRK1	G:608704	.	.
NMT1	G:160993	.	.
NMT2	G:603801	.	.
NMU	G:605103	.	.
NMUR1	G:604153	.	.
NMUR2	G:605108	.	.
NNAT	G:603106	.	.
NNMT	G:600008	.	.
NNO1	P:600165	.	.
NNT	G:607878	.	.
NOB1	G:613586	.	.
NOBOX	G:610934	.	Premature ovarian failure 5, 611548 (3)
NOC2L	G:610770	.	.
NOC3L	G:610769	.	.
NOC4L	G:612819	.	.
NOD1	G:605980	.	.
NOD2	G:605956	.	Blau syndrome, 186580 (3)
NOD2	G:605956	.	Sarcoidosis, early-onset, 609464 (3)
NOD2	G:605956	.	{Inflammatory bowel disease 1}, 266600 (3)
NOD2	G:605956	.	{Psoriatic arthritis, susceptibility to}, 607507 (3)
NODAL	G:601265	+GR-Bell	Heterotaxy, visceral, 5, 270100 (3)
NOG	G:602991	.	Brachydactyly, type B2, 611377 (3)
NOG	G:602991	.	Multiple synostosis syndrome 1, 186500 (3)
NOG	G:602991	.	Stapes ankylosis with broad thumb and toes, 184460 (3)
NOG	G:602991	.	Symphalangism, proximal, 185800 (3)
NOG	G:602991	.	Tarsal-carpal coalition syndrome, 186570 (3)
NOL3	G:605235	.	.
NOL4	G:603577	.	.
NOL6	G:611532	.	.
NOL7	G:611533	.	.
NOL8	G:611534	.	.
NOLC1	G:602394	.	.
NOM1	G:611269	.	.
NOMO1	G:609157	.	.
NOMO2	G:609158	.	.
NOMO3	G:609159	.	.
NONO	G:300084	.	.
NOP10	G:606471	+GR-Bell	Dyskeratosis congenita, autosomal recessive 1, 224230 (3)
NOP14	G:611526	.	.
NOP16	G:612861	.	.
NOP2	G:164031	.	.
NOP56	G:614154	.	Spinocerebellar ataxia 36, 614153 (3)
NOS1	G:163731	.	.
NOS1AP	G:605551	.	.
NOS2	G:163730	.	{Malaria, resistance to}, 611162 (3)
NOS2P1	G:600720	.	.
NOS2P2	G:600719	.	.
NOS3	GP:163729	.	{Alzheimer disease, late-onset, susceptibility to}, 104300 (3)
NOS3	GP:163729	.	{Coronary artery spasm 1, susceptibility to} (3)
NOS3	GP:163729	.	{Hypertension, pregnancy-induced}, 189800 (3)
NOS3	GP:163729	.	{Hypertension, susceptibility to}, 145500 (3)
NOS3	GP:163729	.	{Ischemic stroke, susceptibility to}, 601367 (3)
NOSTRIN	G:607496	.	.
NOTCH1	G:190198	.	Aortic valve disease, 109730 (3)
NOTCH2	G:600275	+GR-Bell	Alagille syndrome 2, 610205 (3)
NOTCH2	G:600275	+GR-Bell	Hajdu-Cheney syndrome, 102500 (3)
NOTCH3	G:600276	+GR-Bell	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
NOTCH4	G:164951	.	.
NOTUM	G:609847	.	.
NOV	G:164958	.	.
NOVA1	G:602157	.	.
NOVA2	G:601991	.	.
NOX1	G:300225	.	.
NOX3	G:607105	.	.
NOX4	G:605261	.	.
NOX5	G:606572	.	.
NOXA1	G:611255	.	.
NOXO1	G:611256	.	.
NPAS1	G:603346	.	.
NPAS2	G:603347	.	.
NPAS3	G:609430	.	.
NPAS4	G:608554	.	.
NPAT	G:601448	.	.
NPB	G:607996	.	.
NPBWR1	G:600730	.	.
NPBWR2	G:600731	.	.
NPC1	G:607623	Bell>metabolic	Niemann-Pick disease, type C1, 257220 (3)
NPC1	G:607623	Bell>metabolic	Niemann-Pick disease, type D, 257220 (3)
NPC1L1	GP:608010	.	[Ezetimibe, nonresponse to] (3)
NPC2	G:601015	Bell>metabolic	Niemann-pick disease, type C2, 607625 (3)
NPDC1	G:605798	.	.
NPEPPS	G:606793	.	.
NPFF	G:604643	.	.
NPFFR1	G:607448	.	.
NPFFR2	G:607449	.	.
NPHP1	G:607100	Bell>neurological	Joubert syndrome 4, 609583 (3)
NPHP1	G:607100	Bell>neurological	Nephronophthisis 1, juvenile, 256100 (3)
NPHP1	G:607100	Bell>neurological	Senior-Loken syndrome-1, 266900 (3)
NPHP1	G:607100	Bell>renal	Joubert syndrome 4, 609583 (3)
NPHP1	G:607100	Bell>renal	Joubert syndrome 4, 609583 (3)
NPHP1	G:607100	Bell>renal	Nephronophthisis 1, juvenile, 256100 (3)
NPHP1	G:607100	Bell>renal	Nephronophthisis 1, juvenile, 256100 (3)
NPHP1	G:607100	Bell>renal	Senior-Loken syndrome-1, 266900 (3)
NPHP1	G:607100	Bell>renal	Senior-Loken syndrome-1, 266900 (3)
NPHP3	G:608002	Bell>renal	Meckel syndrome 7, 267010 (3)
NPHP3	G:608002	Bell>renal	Nephronophthisis 3, 604387 (3)
NPHP3	G:608002	Bell>renal	Renal-hepatic-pancreatic dysplasia, 208540 (3)
NPHP4	G:607215	Bell>renal	Nephronophthisis 4, 606966 (3)
NPHP4	G:607215	Bell>renal	Senior-Loken syndrome 4, 606996 (3)
NPHS1	G:602716	Bell>renal	Nephrotic syndrome, type 1, 256300 (3)
NPHS2	G:604766	.	Nephrotic syndrome, type 2, 600995 (3)
NPIP	G:606406	.	.
NPL	G:611412	.	.
NPLOC4	G:606590	.	.
NPM1	G:164040	.	Leukemia, acute myeloid, 601626 (3)
NPM1	G:164040	.	Leukemia, acute promyelocytic, NPM/RARA type (3)
NPM2	G:608073	.	.
NPM3	G:606456	.	.
NPNT	G:610306	.	.
NPPA	G:108780	.	Atrial fibrillation, familial, 6, 612201 (3)
NPPB	G:600295	.	.
NPPC	G:600296	.	.
NPR1	G:108960	.	.
NPR2	G:108961	.	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
NPR3	G:108962	.	.
NPRL2	G:607072	.	.
NPRL3	G:600928	.	.
NPS	G:609513	.	.
NPSR1	G:608595	.	{Asthma, susceptibility to, 2}, 608584 (3)
NPSR1-AS1	G:608596	.	.
NPTN	G:612820	.	.
NPTX1	G:602367	.	.
NPTX2	G:600750	.	.
NPTXR	G:609474	.	.
NPW	G:607997	.	.
NPY	G:162640	.	.
NPY1R	G:162641	.	.
NPY2R	G:162642	.	.
NPY5R	G:602001	.	.
NPY6R	G:601770	.	.
NQO1	GP:125860	.	{Benzene toxicity, susceptibility to} (3)
NQO1	GP:125860	.	{Breast cancer, poor survival after chemotherapy for} (3)
NQO1	GP:125860	.	{Leukemia, post-chemotherapy, susceptibility to} (3)
NQO2	G:160998	.	.
NR0B1	G:300473	Bell>developmental	46XY sex reversal 2, dosage-sensitive, 300018 (3)
NR0B1	G:300473	Bell>developmental	Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism, 300200 (3)
NR0B2	G:604630	.	Obesity, mild, early-onset, 601665 (3)
NR1D1	G:602408	.	.
NR1D2	G:602304	.	.
NR1H2	G:600380	.	.
NR1H3	G:602423	.	.
NR1H4	G:603826	.	.
NR1I2	G:603065	.	.
NR1I3	G:603881	.	.
NR2C1	G:601529	.	.
NR2C2	G:601426	.	.
NR2C2AP	G:608719	.	.
NR2E1	G:603849	.	.
NR2E3	G:604485	+GR-Bell	Enhanced S-cone syndrome, 268100 (3)
NR2E3	G:604485	+GR-Bell	Retinitis pigmentosa 37, 611131 (3)
NR2F1	G:132890	.	.
NR2F2	G:107773	.	.
NR2F6	G:132880	.	.
NR3C1	GP:138040	.	.
NR3C1P1	P:138060	.	.
NR3C2	G:600983	.	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)
NR3C2	G:600983	.	Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3)
NR4A1	G:139139	.	.
NR4A2	G:601828	.	.
NR4A3	G:600542	.	Chondrosarcoma, extraskeletal myxoid, 612237 (3)
NR5A1	GP:184757	+GR-Bell	46XY sex reversal 3, 612965 (3)
NR5A1	GP:184757	+GR-Bell	Premature ovarian failure 7, 612964 (3)
NR5A1	GP:184757	+GR-Bell	Spermatogenic failure 8, 613957 (3)
NR5A2	G:604453	.	.
NR6A1	G:602778	.	.
NRAP	G:602873	.	.
NRAS	G:164790	.	Autoimmune lymphoproliferative syndrome type IV, 614470 (3)
NRAS	G:164790	.	Colorectal cancer, 114500 (3)
NRAS	G:164790	.	Noonan syndrome 6, 613224 (3)
NRAS	G:164790	.	Thyroid carcinoma, follicular, 188470 (3)
NRBP1	G:606010	.	.
NRCAM	G:601581	.	.
NRD1	G:602651	.	.
NREP	G:607332	.	.
NRF1	G:600879	.	.
NRG1	G:142445	.	.
NRG2	G:603818	.	.
NRG3	G:605533	.	.
NRG4	G:610894	.	.
NRGN	G:602350	.	.
NRIP1	G:602490	.	.
NRIP3	G:613125	.	.
NRK	G:300791	.	.
NRL	GP:162080	+GR-Bell	Retinal degeneration, autosomal recessive, clumped pigment type (3)
NRL	GP:162080	+GR-Bell	Retinitis pigmentosa 27, 613750 (3)
NRN1	G:607409	.	.
NRON	G:609618	.	.
NRP1	G:602069	.	.
NRP2	G:602070	.	.
NRSN2	G:610666	.	.
NRTN	G:602018	.	.
NRXN1	G:600565	.	Pitt-Hopkins-like syndrome 2, 614325 (3)
NRXN1	G:600565	.	{Schizophrenia, susceptibility to, 17}, 614332 (3)
NRXN2	G:600566	.	.
NRXN3	G:600567	.	.
NSA2	G:612497	.	.
NSD1	G:606681	+GR-Bell	Beckwith-Wiedemann syndrome, 130650 (3)
NSD1	G:606681	+GR-Bell	Sotos syndrome, 117550 (3)
NSD1	G:606681	+GR-Bell	Weaver syndrome, 277590 (3)
NSDHL	G:300275	+GR-Bell	CHILD syndrome, 308050 (3)
NSDHL	G:300275	+GR-Bell	CK syndrome, 300831 (3)
NSF	G:601633	.	.
NSFL1C	G:606610	.	.
NSL1	G:609174	.	.
NSMAF	G:603043	.	.
NSMCE4A	G:612987	.	.
NSUN2	G:610916	.	.
NSX	P:310465	.	.
NT5C	G:191720	.	.
NT5C1A	G:610525	.	.
NT5C1B	G:610526	.	.
NT5C2	G:600417	.	.
NT5C3	G:606224	.	Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)
NT5DC3	G:611076	.	.
NT5E	G:129190	.	Calcification of joints and arteries, 211800 (3)
NT5M	G:605292	.	.
NTF3	G:162660	.	.
NTF4	G:162662	.	Glaucoma 1, open angle, 1O, 613100 (3)
NTHL1	G:602656	.	.
NTM	G:607938	.	.
NTN1	G:601614	.	.
NTN3	G:602349	.	.
NTN4	G:610401	.	.
NTNG1	G:608818	.	.
NTRK1	G:191315	Bell>neurological	Insensitivity to pain, congenital, with anhidrosis, 256800 (3)
NTRK1	G:191315	Bell>neurological	Medullary thyroid carcinoma, familial, 155240 (3)
NTRK2	G:600456	.	Obesity, hyperphagia, and developmental delay, 613886 (3)
NTRK3	G:191316	.	.
NTS	G:162650	.	.
NTSR1	G:162651	.	.
NTSR2	G:605538	.	.
NUAK1	G:608130	.	.
NUAK2	G:608131	.	.
NUB1	G:607981	.	.
NUBP1	G:600280	.	.
NUBP2	G:610779	.	.
NUBPL	G:613621	.	Mitochondrial complex I deficiency, 252010 (3)
NUCB1	G:601323	.	.
NUCB2	G:608020	.	.
NUCKS1	G:611912	.	.
NUDC	G:610325	.	.
NUDCD1	G:606109	.	.
NUDCD3	G:610296	.	.
NUDT1	G:600312	.	.
NUDT10	G:300527	.	.
NUDT11	G:300528	.	.
NUDT12	G:609232	.	.
NUDT13	G:609233	.	.
NUDT14	G:609219	.	.
NUDT2	G:602852	.	.
NUDT21	G:604978	.	.
NUDT3	G:609228	.	.
NUDT4	G:609229	.	.
NUDT5	G:609230	.	.
NUDT6	G:606261	.	.
NUDT7	G:609231	.	.
NUDT9	G:606022	.	.
NUF2	G:611772	.	.
NUFIP1	G:604354	.	.
NUFIP2	G:609356	.	.
NUMA1	G:164009	.	Leukemia, acute promyelocytic, NUMA/RARA type (3)
NUMB	G:603728	.	.
NUMBL	G:604018	.	.
NUP107	G:607617	.	.
NUP133	G:607613	.	.
NUP153	G:603948	.	.
NUP155	G:606694	.	.
NUP160	G:607614	.	.
NUP205	G:614352	.	.
NUP210	G:607703	.	.
NUP214	G:114350	.	Leukemia, T-cell acute lymphoblastic (3)
NUP214	G:114350	.	Leukemia, acute myeloid, 601626 (3)
NUP35	G:608140	.	.
NUP37	G:609264	.	.
NUP43	G:608141	.	.
NUP50	G:604646	.	.
NUP54	G:607607	.	.
NUP62	G:605815	Bell>neurological	Striatonigral degeneration, infantile, 271930 (3)
NUP85	G:170285	.	.
NUP88	G:602552	.	.
NUP93	G:614351	.	.
NUP98	G:601021	.	.
NUPL1	G:607615	.	.
NUS1	G:610463	.	.
NUSAP1	G:612818	.	.
NUTF2	G:605813	.	.
NVL	G:602426	.	.
NXF1	G:602647	.	.
NXF2	G:300315	.	.
NXF3	G:300316	.	.
NXF4	G:300318	.	.
NXF5	G:300319	.	.
NXN	G:612895	.	.
NXNL1	G:608791	.	.
NXPH1	G:604639	.	.
NXPH2	G:604635	.	.
NXPH3	G:604636	.	.
NXPH4	G:604637	.	.
NXT1	G:605811	.	.
NXT2	G:300320	.	.
NYS2	P:164100	.	.
NYS3	P:608345	.	.
NYS4	P:193003	.	.
NYX	G:300278	.	Night blindness, congenital stationary, type 1A, 310500 (3)
O3FAR1	G:609044	.	.
OAS1	GP:164350	.	{Diabetes mellitus, type 1, susceptibility to}, 222100 (3)
OAS1	GP:164350	.	{Viral infection, susceptibility to} (3)
OAS2	G:603350	.	.
OAS3	G:603351	.	.
OASD	P:300650	.	.
OASL	G:603281	.	.
OAT	G:613349	.	Gyrate atrophy of choroid and retina with or without ornithinemia, 258870 (3)
OAZ1	G:601579	.	.
OAZ2	G:604152	.	.
OAZ3	G:605138	.	.
OBFC1	G:613128	.	.
OBFC2A	G:612103	.	.
OBFC2B	G:612104	.	.
OBP2A	G:164320	.	.
OBP2B	G:604606	.	.
OBSCN	G:608616	.	.
OBSL1	G:610991	+GR-Bell	3-M syndrome 2, 612921 (3)
OC90	G:601658	.	.
OCA2	G:611409	+GR-Bell	Albinism, brown oculocutaneous, 203200 (3)
OCA2	G:611409	+GR-Bell	Albinism, oculocutaneous, type II, 203200 (3)
OCA2	G:611409	+GR-Bell	[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)
OCA2	G:611409	+GR-Bell	[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)
OCLM	G:604301	.	.
OCLN	G:602876	.	Band-like calcification with simplified gyration and polymicrogyria, 251290 (3)
OCM	G:164795	.	.
OCRL	G:300535	Bell>developmental	Dent disease 2, 300555 (3)
OCRL	G:300535	Bell>developmental	Lowe syndrome, 309000 (3)
ODC1	G:165640	.	{Colonic adenoma recurrence, reduced risk of}, 114500 (3)
ODF1	G:182878	.	.
ODF2	G:602015	.	.
ODF3	G:608356	.	.
ODF4	G:610097	.	.
ODZ1	G:300588	.	.
ODZ2	G:610119	.	.
ODZ3	G:610083	.	.
ODZ4	G:610084	.	.
OFC1	P:119530	.	.
OFC2	P:602966	.	.
OFC3	P:600757	.	.
OFCC1	G:614287	.	.
OFD1	G:300170	Bell>developmental	Joubert syndrome 10, 300804 (3)
OFD1	G:300170	Bell>developmental	Oral-facial-digital syndrome 1, 311200 (3)
OFD1	G:300170	Bell>developmental	Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)
OGDH	G:613022	.	.
OGFR	G:606459	.	.
OGG1	G:601982	.	Renal cell carcinoma, clear cell, somatic, 144700 (3)
OGN	G:602383	.	.
OGT	G:300255	.	.
OIP5	G:606020	.	.
OIT3	G:609330	.	.
OLA1	G:611175	.	.
OLFM1	G:605366	.	.
OLFM3	G:607567	.	.
OLFM4	G:614061	.	.
OLFML3	G:610088	.	.
OLIG1	G:606385	.	.
OLIG2	G:606386	.	.
OLIG3	G:609323	.	.
OLR1	G:602601	.	{Myocardial infarction, susceptibility to}, 608446 (3)
OMG	G:164345	.	.
OMP	G:164340	.	.
ONECUT1	G:604164	.	.
ONECUT2	G:604894	.	.
ONECUT3	G:611294	.	.
OOEP	G:611689	.	.
OPA1	G:605290	+GR-Bell	Optic atrophy 1, 165500 (3)
OPA1	G:605290	+GR-Bell	Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy, 125250 (3)
OPA1	G:605290	+GR-Bell	{Glaucoma, normal tension, susceptibility to}, 606657 (3)
OPA2	P:311050	.	.
OPA3	G:606580	Bell>metabolic	3-methylglutaconic aciduria, type III, 258501 (3)
OPA3	G:606580	Bell>metabolic	Optic atrophy 3 with cataract, 165300 (3)
OPA4	P:605293	.	.
OPA5	P:610708	.	.
OPA6	P:258500	.	.
OPCML	G:600632	.	{Ovarian cancer, somatic}, 167000 (3)
OPEM	P:311000	.	.
OPHN1	G:300127	.	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance, 300486 (3)
OPLAH	G:614243	.	5-oxoprolinase deficiency, 260005 (3)
OPN1LW	G:300822	+GR-Bell	Blue cone monochromacy, 303700 (3)
OPN1LW	G:300822	+GR-Bell	Colorblindness, protan, 303900 (3)
OPN1MW	G:300821	.	Blue cone monochromacy, 303700 (3)
OPN1MW	G:300821	.	Colorblindness, deutan, 303800 (3)
OPN1SW	G:613522	.	Colorblindness, tritan, 190900 (3)
OPN3	G:606695	.	.
OPN4	G:606665	.	.
OPN5	G:609042	.	.
OPRD1	G:165195	.	.
OPRK1	G:165196	.	.
OPRL1	G:602548	.	.
OPRM1	G:600018	.	.
OPTC	G:605127	.	.
OPTN	G:602432	+GR-Bell	Amyotrophic lateral sclerosis 12, 613435 (3)
OPTN	G:602432	+GR-Bell	Glaucoma 1, open angle, E, 137760 (3)
OPTN	G:602432	+GR-Bell	{Glaucoma, normal tension, susceptibility to}, 606657 (3)
OR10A5	G:608493	.	.
OR13G1	G:611677	.	.
OR1D2	G:164342	.	.
OR1F1	G:603232	.	.
OR2D2	G:608494	.	.
OR2F1	G:608497	.	.
OR2H2	G:600578	.	.
OR4C46	G:614273	.	.
OR51E1	G:611267	.	.
OR51E2	G:611268	.	.
OR5F1	G:608492	.	.
OR5I1	G:608496	.	.
OR6A2	G:608495	.	.
OR7D4	G:611538	.	.
ORAI1	G:610277	.	Immune dysfunction with T-cell inactivation due to calcium entry defect 1, 612782 (3)
ORAI2	G:610929	.	.
ORAI3	G:610930	.	.
ORAOV1	G:607224	.	.
ORC1	G:601902	.	Meier-Gorlin syndrome 1, 224690 (3)
ORC2	G:601182	.	.
ORC3	G:604972	.	.
ORC4	G:603056	.	Meier-Gorlin syndrome 2, 613800 (3)
ORC5	G:602331	.	.
ORC6	G:607213	.	Meier-Gorlin syndrome 3, 613803 (3)
ORM1	G:138600	.	.
ORM2	G:138610	.	.
ORMDL1	G:610073	.	.
ORMDL2	G:610074	.	.
ORMDL3	G:610075	.	.
OS9	G:609677	.	.
OSBP	G:167040	.	.
OSBP2	G:606729	.	.
OSBPL10	G:606738	.	.
OSBPL11	G:606739	.	.
OSBPL1A	G:606730	.	.
OSBPL2	G:606731	.	.
OSBPL3	G:606732	.	.
OSBPL5	G:606733	.	.
OSBPL6	G:606734	.	.
OSBPL7	G:606735	.	.
OSBPL8	G:606736	.	.
OSBPL9	G:606737	.	.
OSCAR	G:606862	.	.
OSCP1	G:608854	.	.
OSGEP	G:610107	.	.
OSGIN1	G:607975	.	.
OSGIN2	G:604598	.	.
OSM	G:165095	.	.
OSMR	G:601743	.	Amyloidosis, primary localized cutaneous, 1, 105250 (3)
OSR1	G:608891	.	.
OSR2	G:611297	.	.
OSTF1	G:610180	.	.
OSTM1	G:607649	Bell>skeletal	Osteopetrosis, autosomal recessive 5, 259720 (3)
OSTN	G:610280	.	.
OTC	G:300461	Bell>metabolic	Ornithine transcarbamylase deficiency, 311250 (3)
OTOA	G:607038	.	Deafness, autosomal recessive 22, 607039 (3)
OTOF	G:603681	+GR-Bell	Auditory neuropathy, autosomal recessive, 1, 601071 (3)
OTOF	G:603681	+GR-Bell	Deafness, autosomal recessive 9, 601071 (3)
OTOG	G:604487	.	.
OTOP1	G:607806	.	.
OTOP2	G:607827	.	.
OTOP3	G:607828	.	.
OTOR	G:606067	.	.
OTOS	G:607877	.	.
OTP	G:604529	.	.
OTSC1	P:166800	.	.
OTSC2	P:605727	.	.
OTSC3	P:608244	.	.
OTSC4	P:611571	.	.
OTSC5	P:608787	.	.
OTSC7	P:611572	.	.
OTSC8	P:612096	.	.
OTUB1	G:608337	.	.
OTUB2	G:608338	.	.
OTUD1	G:612022	.	.
OTUD3	G:611758	.	.
OTUD4	G:611744	.	.
OTUD5	G:300713	.	.
OTUD6A	G:300714	.	.
OTUD6B	G:612021	.	.
OTUD7A	G:612024	.	.
OTUD7B	G:611748	.	.
OTX1	G:600036	.	.
OTX2	G:600037	+GR-Bell	Microphthalmia, syndromic 5, 610125 (3)
OTX2	G:600037	+GR-Bell	Pituitary hormone deficiency, combined, 6, 613986 (3)
OTX2	G:600037	+GR-Bell	Retinal dystrophy, early-onset, and pituitary dysfunction, 610125 (3)
OVCA2	G:607896	.	.
OVGP1	G:603578	.	.
OVOL1	G:602313	.	.
OXA1L	G:601066	.	.
OXCT1	G:601424	.	Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)
OXCT2	G:610289	.	.
OXGR1	G:606922	.	.
OXR1	G:605609	.	.
OXSM	G:610324	.	.
OXSR1	G:604046	.	.
OXT	G:167050	.	.
OXTR	G:167055	.	.
P2RX1	G:600845	.	.
P2RX2	G:600844	.	.
P2RX3	G:600843	.	.
P2RX4	G:600846	.	.
P2RX5	G:602836	.	.
P2RX6	G:608077	.	.
P2RX7	G:602566	.	.
P2RY1	G:601167	.	.
P2RY10	G:300529	.	.
P2RY11	G:602697	.	.
P2RY12	G:600515	.	Bleeding disorder, platelet-type, 8, 609821 (3)
P2RY13	G:606380	.	.
P2RY14	G:610116	.	.
P2RY2	G:600041	.	.
P2RY4	G:300038	.	.
P2RY6	G:602451	.	.
P2RY8	G:300525	.	.
P4HA1	G:176710	.	.
P4HA2	G:600608	.	.
P4HA3	G:608987	.	.
P4HB	G:176790	.	.
PA2G4	G:602145	.	.
PABPC1	G:604679	.	.
PABPC1P10	G:173865	.	.
PABPC1P4	G:604681	.	.
PABPC3	G:604680	.	.
PABPC4	G:603407	.	.
PABPC5	G:300407	.	.
PABPN1	G:602279	.	Oculopharyngeal muscular dystrophy, 164300 (3)
PACRG	G:608427	.	.
PACS1	G:607492	.	.
PACS2	G:610423	.	.
PACSIN1	G:606512	.	.
PACSIN2	G:604960	.	.
PACSIN3	G:606513	.	.
PADI1	G:607934	.	.
PADI2	G:607935	.	.
PADI3	G:606755	.	.
PADI4	G:605347	.	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
PADI6	G:610363	.	.
PAEP	G:173310	.	.
PAF1	G:610506	.	.
PAFAH1B1	G:601545	+GR-Bell	Lissencephaly 1, 607432 (3)
PAFAH1B1	G:601545	+GR-Bell	Subcortical laminar heterotopia, 607432 (3)
PAFAH1B2	G:602508	.	.
PAFAH1B3	G:603074	.	.
PAFAH2	G:602344	.	.
PAG1	G:605767	.	.
PAGE1	G:300288	.	.
PAGE2	G:300738	.	.
PAGE3	G:300739	.	.
PAGE4	G:300287	.	.
PAH	G:612349	Bell>metabolic	Phenylketonuria, 261600 (3)
PAH	G:612349	Bell>metabolic	[Hyperphenylalaninemia, non-PKU mild], 261600 (3)
PAICS	G:172439	.	.
PAIP1	G:605184	.	.
PAIP2	G:605604	.	.
PAIP2B	G:611018	.	.
PAK1	G:602590	.	.
PAK1IP1	G:607811	.	.
PAK2	G:605022	.	.
PAK3	G:300142	.	Mental retardation, X-linked 30/47, 300558 (3)
PAK4	G:605451	.	.
PAK6	G:608110	.	.
PAK7	G:608038	.	.
PALB2	G:610355	+GR-Bell	Fanconi anemia, complementation group N, 610832 (3)
PALB2	G:610355	+GR-Bell	{Breast cancer, susceptibility to}, 114480 (3)
PALB2	G:610355	+GR-Bell	{Pancreatic cancer, susceptibility to, 3}, 613348 (3)
PALLD	G:608092	.	{Pancreatic cancer, susceptibility to, 1}, 606856 (3)
PALM	G:608134	.	.
PALMD	G:610182	.	.
PAM	G:170270	.	.
PAM16	G:614336	.	.
PANK1	G:606160	.	.
PANK2	G:606157	+GR-Bell	HARP syndrome, 607236 (3)
PANK2	G:606157	+GR-Bell	Neurodegeneration with brain iron accumulation 1, 234200 (3)
PANK3	G:606161	.	.
PANK4	G:606162	.	.
PANX1	G:608420	.	.
PANX2	G:608421	.	.
PANX3	G:608422	.	.
PAPD4	G:614121	.	.
PAPD5	G:605540	.	.
PAPD7	G:605198	.	.
PAPOLA	G:605553	.	.
PAPOLB	G:607436	.	.
PAPPA	G:176385	.	.
PAPPA-AS1	G:610689	.	.
PAPSS1	G:603262	.	.
PAPSS2	G:603005	.	SEMD, Pakistani type, 612847 (3)
PAQR5	G:607781	.	.
PAQR7	G:607779	.	.
PAQR8	G:607780	.	.
PARD3	G:606745	.	.
PARD6A	G:607484	.	.
PARD6B	G:608975	.	.
PARD6G	G:608976	.	.
PARG	G:603501	.	.
PARK10	P:606852	.	.
PARK12	P:300557	.	.
PARK16	P:613164	.	.
PARK2	G:602544	+GR-Bell	Adenocarcinoma of lung, somatic, 211980 (3)
PARK2	G:602544	+GR-Bell	Adenocarcinoma, ovarian, somatic, 167000 (3)
PARK2	G:602544	+GR-Bell	Parkinson disease, juvenile, type 2, 600116 (3)
PARK2	G:602544	+GR-Bell	{Leprosy, susceptibility to}, 607572 (3)
PARK3	P:602404	.	.
PARK4	P:605543	.	.
PARK7	G:602533	+GR-Bell	Parkinson disease 7, autosomal recessive early-onset, 606324 (3)
PARL	G:607858	.	.
PARN	G:604212	.	.
PARP1	G:173870	.	.
PARP10	G:609564	.	.
PARP12	G:612481	.	.
PARP14	G:610028	.	.
PARP15	G:612066	.	.
PARP2	G:607725	.	.
PARP3	G:607726	.	.
PARP4	G:607519	.	.
PARP9	G:612065	.	.
PARPBP	G:613687	.	.
PARS2	G:612036	.	.
PART1	G:604991	.	.
PARVA	G:608120	.	.
PARVB	G:608121	.	.
PARVG	G:608122	.	.
PASK	G:607505	.	.
PATE1	G:606861	.	.
PATZ1	G:605165	.	.
PAWR	G:601936	.	.
PAX1	G:167411	.	.
PAX2	G:167409	+GR-Bell	Optic nerve coloboma with renal disease, 120330 (3)
PAX2	G:167409	+GR-Bell	Renal hypoplasia, isolated (3)
PAX3	G:606597	+GR-Bell	Craniofacial-deafness-hand syndrome, 122880 (3)
PAX3	G:606597	+GR-Bell	Rhabdomyosarcoma 2, alveolar, 268220 (3)
PAX3	G:606597	+GR-Bell	Waardenburg syndrome, type 1, 193500 (3)
PAX3	G:606597	+GR-Bell	Waardenburg syndrome, type 3, 148820 (3)
PAX4	G:167413	.	Diabetes mellitus, ketosis-prone, 612227 (3)
PAX4	G:167413	.	Diabetes mellitus, type 2, 125853 (3)
PAX4	G:167413	.	Maturity-onset diabetes of the young, type IX, 612225 (3)
PAX5	G:167414	.	.
PAX6	G:607108	Bell>neurological	Aniridia, 106210 (3)
PAX6	G:607108	Bell>neurological	Cataract with late-onset corneal dystrophy, 604219 (3)
PAX6	G:607108	Bell>neurological	Coloboma of optic nerve, 120430 (3)
PAX6	G:607108	Bell>neurological	Coloboma, ocular, 120200 (3)
PAX6	G:607108	Bell>neurological	Foveal hyperplasia, 136520 (3)
PAX6	G:607108	Bell>neurological	Gillespie syndrome, 206700 (3)
PAX6	G:607108	Bell>neurological	Keratitis, 148190 (3)
PAX6	G:607108	Bell>neurological	Morning glory disc anomaly, 120430 (3)
PAX6	G:607108	Bell>neurological	Optic nerve hypoplasia, 165550 (3)
PAX6	G:607108	Bell>neurological	Peters anomaly, 604229 (3)
PAX7	G:167410	.	Rhabdomyosarcoma 2, alveolar, 268220 (3)
PAX8	G:167415	.	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
PAX9	G:167416	.	Tooth agenesis, selective, 3, 604625 (3)
PAXIP1	G:608254	.	{Alzheimer disease, susceptibility to}, 104300 (3)
PBCRA1	P:600790	.	.
PBK	G:611210	.	.
PBLD	G:612189	.	.
PBOV1	G:605669	.	.
PBRM1	G:606083	.	.
PBX1	G:176310	.	.
PBX2	G:176311	.	.
PBX3	G:176312	.	.
PBX4	G:608127	.	.
PCA3	G:604845	.	.
PCAP	P:602759	.	.
PCBD1	G:126090	.	Hyperphenylalaninemia, BH4-deficient, D, 264070 (3)
PCBD2	G:609836	.	.
PCBP1	G:601209	.	.
PCBP2	G:601210	.	.
PCBP3	G:608502	.	.
PCBP4	G:608503	.	.
PCCA	G:232000	.	Propionicacidemia, 606054 (3)
PCCB	G:232050	.	Propionicacidemia, 606054 (3)
PCDH1	G:603626	.	.
PCDH10	G:608286	.	.
PCDH11X	G:300246	.	.
PCDH11Y	G:400022	.	.
PCDH12	G:605622	.	.
PCDH15	G:605514	Bell>ocular	Deafness, autosomal recessive 23, 609533 (3)
PCDH15	G:605514	Bell>ocular	Usher syndrome, type 1D/F digenic, 601067 (3)
PCDH15	G:605514	Bell>ocular	Usher syndrome, type 1F, 602083 (3)
PCDH17	G:611760	.	.
PCDH18	G:608287	.	.
PCDH19	G:300460	.	Epileptic encephalopathy, early infantile, 9, 300088 (3)
PCDH20	G:614449	.	.
PCDH7	G:602988	.	.
PCDH8	G:603580	.	.
PCDH9	G:603581	.	.
PCDHA1	G:606307	.	.
PCDHA10	G:606316	.	.
PCDHA11	G:606317	.	.
PCDHA12	G:606318	.	.
PCDHA13	G:606319	.	.
PCDHA2	G:606308	.	.
PCDHA3	G:606309	.	.
PCDHA4	G:606310	.	.
PCDHA5	G:606311	.	.
PCDHA6	G:606312	.	.
PCDHA7	G:606313	.	.
PCDHA8	G:606314	.	.
PCDHA9	G:606315	.	.
PCDHA@	P:604966	.	.
PCDHAC1	G:606320	.	.
PCDHAC2	G:606321	.	.
PCDHB1	G:606327	.	.
PCDHB10	G:606336	.	.
PCDHB11	G:606337	.	.
PCDHB12	G:606338	.	.
PCDHB13	G:606339	.	.
PCDHB14	G:606340	.	.
PCDHB15	G:606341	.	.
PCDHB16	G:606345	.	.
PCDHB2	G:606328	.	.
PCDHB3	G:606329	.	.
PCDHB4	G:606330	.	.
PCDHB5	G:606331	.	.
PCDHB6	G:606332	.	.
PCDHB7	G:606333	.	.
PCDHB8	G:606334	.	.
PCDHB9	G:606335	.	.
PCDHB@	P:604967	.	.
PCDHG@	P:604968	.	.
PCDHGA1	G:606288	.	.
PCDHGA10	G:606297	.	.
PCDHGA11	G:606298	.	.
PCDHGA12	G:603059	.	.
PCDHGA2	G:606289	.	.
PCDHGA3	G:606290	.	.
PCDHGA4	G:606291	.	.
PCDHGA5	G:606292	.	.
PCDHGA6	G:606293	.	.
PCDHGA7	G:606294	.	.
PCDHGA8	G:606295	.	.
PCDHGA9	G:606296	.	.
PCDHGB1	G:606299	.	.
PCDHGB2	G:606300	.	.
PCDHGB3	G:606301	.	.
PCDHGB4	G:603058	.	.
PCDHGB5	G:606302	.	.
PCDHGB6	G:606303	.	.
PCDHGB7	G:606304	.	.
PCDHGC3	G:603627	.	.
PCDHGC4	G:606305	.	.
PCDHGC5	G:606306	.	.
PCF11	G:608876	.	.
PCGEM1	G:605443	.	.
PCGF1	G:610231	.	.
PCGF2	G:600346	.	.
PCGF6	G:607816	.	.
PCID2	G:613713	.	.
PCK1	G:614168	.	.
PCK2	G:614095	.	.
PCLO	G:604918	.	.
PCM1	G:600299	.	Thyroid carcinoma, papillary, 188550 (3)
PCMT1	G:176851	.	.
PCNA	G:176740	.	.
PCNT	G:605925	.	Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)
PCOLCE	G:600270	.	.
PCOLCE2	G:607064	.	.
PCOS1	P:184700	.	.
PCP4	G:601629	.	.
PCSK1	G:162150	.	Obesity with impaired prohormone processing, 600955 (3)
PCSK1	G:162150	.	{Obesity, susceptibility to, BMIQ12}, 612362 (3)
PCSK1N	G:300399	.	.
PCSK2	G:162151	.	.
PCSK4	G:600487	.	.
PCSK5	G:600488	.	.
PCSK6	G:167405	.	.
PCSK7	G:604872	.	.
PCSK9	G:607786	.	Hypercholesterolemia, familial, 3, 603776 (3)
PCSK9	G:607786	.	{Low density lipoprotein cholesterol level QTL 1}, 603776 (3)
PCTP	G:606055	.	.
PCYOX1	G:610995	.	.
PCYT1A	G:123695	.	.
PCYT1B	G:604926	.	.
PCYT2	G:602679	.	.
PDAP1	G:607075	.	.
PDB1	P:167250	.	.
PDB4	P:606263	.	.
PDC	G:171490	.	.
PDCD1	G:600244	.	{Multiple sclerosis, disease progression, modifier of}, 126200 (3)
PDCD1	G:600244	.	{Systemic lupus erythematosus, susceptibility to, 2}, 605218 (3)
PDCD10	G:609118	.	Cerebral cavernous malformations 3, 603285 (3)
PDCD11	G:612333	.	.
PDCD1LG2	G:605723	.	.
PDCD2	G:600866	.	.
PDCD4	G:608610	.	.
PDCD5	G:604583	.	.
PDCD6	G:601057	.	.
PDCD6IP	G:608074	.	.
PDCD7	G:608138	.	.
PDCL	G:604421	.	.
PDCL2	G:611676	.	.
PDCL3	G:611678	.	.
PDE10A	G:610652	.	.
PDE11A	G:604961	.	Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)
PDE1A	G:171890	.	.
PDE1B	G:171891	.	.
PDE1C	G:602987	.	.
PDE2A	G:602658	.	.
PDE3A	G:123805	.	.
PDE3B	G:602047	.	.
PDE4A	G:600126	.	.
PDE4B	G:600127	.	.
PDE4C	G:600128	.	.
PDE4D	G:600129	.	{Stroke, susceptibility to, 1}, 606799 (3)
PDE4DIP	G:608117	.	.
PDE5A	G:603310	.	.
PDE6A	G:180071	+GR-Bell	Retinitis pigmentosa 43, 613810 (3)
PDE6B	G:180072	+GR-Bell	Night blindness, congenital stationary, autosomal dominant 2, 163500 (3)
PDE6B	G:180072	+GR-Bell	Retinitis pigmentosa-40, 613801 (3)
PDE6C	G:600827	+GR-Bell	Cone dystrophy 4, 613093 (3)
PDE6D	G:602676	.	.
PDE6G	G:180073	+GR-Bell	Retinitis pigmentosa 57, 613582 (3)
PDE6H	G:601190	.	Retinal cone dystrophy 3, 610024 (3)
PDE7A	G:171885	.	.
PDE7B	G:604645	.	.
PDE8A	G:602972	.	.
PDE8B	G:603390	.	Pigmented nodular adrenocortical disease, primary, 3, 614190 (3)
PDE8B	G:603390	.	Striatal degeneration, autosomal dominant, 609161 (3)
PDE9A	G:602973	.	.
PDGFA	G:173430	.	.
PDGFB	G:190040	.	Meningioma, SIS-related (3)
PDGFC	G:608452	.	.
PDGFD	G:609673	.	.
PDGFRA	G:173490	.	Gastrointestinal stromal tumor, somatic, 606764 (3)
PDGFRA	G:173490	.	Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
PDGFRB	G:173410	.	Myelomonocytic leukemia, chronic (3)
PDGFRB	G:173410	.	Myeloproliferative disorder with eosinophilia, 131440 (3)
PDGFRL	G:604584	.	Colorectal cancer, 114500 (3)
PDGFRL	G:604584	.	Hepatocellular cancer, 114550 (3)
PDHA1	G:300502	Bell>neurological	Leigh syndrome, X-linked, 308930 (3)
PDHA1	G:300502	Bell>neurological	Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3)
PDHA2	G:179061	.	.
PDHB	G:179060	.	Pyruvate dehydrogenase E1-beta deficiency, 614111 (3)
PDHX	G:608769	Bell>metabolic	Lacticacidemia due to PDX1 deficiency, 245349 (3)
PDIA2	G:608012	.	.
PDIA3	G:602046	.	.
PDIA6	G:611099	.	.
PDIK1L	G:610785	.	.
PDK1	G:602524	.	.
PDK2	G:602525	.	.
PDK3	G:602526	.	.
PDK4	G:602527	.	.
PDLIM1	G:605900	.	.
PDLIM2	G:609722	.	.
PDLIM3	G:605889	.	.
PDLIM4	G:603422	.	{Osteoporosis, susceptibility to}, 166710 (3)
PDLIM5	G:605904	.	.
PDLIM7	G:605903	.	.
PDP1	G:605993	Bell>metabolic	Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)
PDPK1	G:605213	.	.
PDPN	G:608863	.	.
PDR	P:301220	.	.
PDRG1	G:610789	.	.
PDS5A	G:613200	.	.
PDS5B	G:605333	.	.
PDSS1	G:607429	Bell>neurological	Coenzyme Q10 deficiency, 607426 (3)
PDSS2	G:610564	Bell>neurological	Coenzyme Q10 deficiency, 607426 (3)
PDX1	G:600733	+GR-Bell	MODY, type IV, 606392 (3)
PDX1	G:600733	+GR-Bell	Pancreatic agenesis, 260370 (3)
PDX1	G:600733	+GR-Bell	{Diabetes mellitus, type II, susceptibility to}, 125853 (3)
PDXDC1	G:614244	.	.
PDXK	G:179020	.	.
PDXP	G:609246	.	.
PDYN	G:131340	.	Spinocerebellar ataxia 23, 610245 (3)
PDZD11	G:300632	.	.
PDZD2	G:610697	.	.
PDZD3	G:607146	.	.
PDZD4	G:300634	.	.
PDZD7	G:612971	.	Usher syndrome, type IIC, GPR98/PDZD7 digenic, 605472 (3)
PDZD7	G:612971	.	{Retinal disease in Usher syndrome type IIA, modifier of}, 276901 (3)
PDZD8	G:614235	.	.
PDZK1	G:603831	.	.
PDZK1IP1	G:607178	.	.
PDZRN3	G:609729	.	.
PDZRN4	G:609730	.	.
PEA15	G:603434	.	.
PEAR1	G:610278	.	.
PEBP1	G:604591	.	.
PEBP4	G:612473	.	.
PECAM1	G:173445	.	.
PECR	G:605843	.	.
PEE1	P:189800	.	.
PEF1	G:610033	.	.
PEG10	G:609810	.	.
PEG3	G:601483	.	.
PELI3	G:609827	.	.
PELO	G:605757	.	.
PELP1	G:609455	.	.
PEMT	G:602391	.	.
PENK	G:131330	.	.
PEPB	G:169900	.	.
PEPC	G:170000	.	.
PEPD	G:613230	.	Prolidase deficiency, 170100 (3)
PEPE	G:170200	.	.
PER1	G:602260	.	.
PER2	G:603426	.	Advanced sleep phase syndrome, familial, 604348 (3)
PER3	G:603427	.	.
PERP	G:609301	.	.
PES1	G:605819	.	.
PET112	G:603645	.	.
PEX1	GP:602136	+GR-Bell	Adrenoleukodystrophy, neonatal, 202370 (3)
PEX1	GP:602136	+GR-Bell	Refsum disease, infantile, 266510 (3)
PEX1	GP:602136	+GR-Bell	Zellweger syndrome-1, 214100 (3)
PEX10	GP:602859	+GR-Bell	Adrenoleukodystrophy, neonatal, 202370 (3)
PEX10	GP:602859	+GR-Bell	Zellweger syndrome, 214100 (3)
PEX11A	G:603866	.	.
PEX11B	G:603867	.	.
PEX11G	G:607583	.	.
PEX12	GP:601758	.	.
PEX13	GP:601789	+GR-Bell	Adrenoleukodystrophy, neonatal, 202370 (3)
PEX13	GP:601789	+GR-Bell	Zellweger syndrome, 214100 (3)
PEX14	GP:601791	+GR-Bell	Zellweger syndrome, 214100 (3)
PEX16	GP:603360	+GR-Bell	Zellweger syndrome, complementation group 9 (3)
PEX19	GP:600279	+GR-Bell	Zellweger syndrome, 214100 (3)
PEX2	GP:170993	.	Refsum disease, infantile, 266510 (3)
PEX26	GP:608666	+GR-Bell	Adrenoleukodystrophy, neonatal, 202370 (3)
PEX26	GP:608666	+GR-Bell	Refsum disease, infantile, 266510 (3)
PEX26	GP:608666	+GR-Bell	Zellweger syndrome, 214100 (3)
PEX3	GP:603164	+GR-Bell	Zellweger syndrome, complementation group G, 214100 (3)
PEX5	G:600414	+GR-Bell	Adrenoleukodystrophy, neonatal, 202370 (3)
PEX5	G:600414	+GR-Bell	Zellweger syndrome, 214100 (3)
PEX5L	G:611058	.	.
PEX6	GP:601498	+GR-Bell	Peroxisomal biogenesis disorder, complementation group 4 (3)
PEX6	GP:601498	+GR-Bell	Peroxisomal biogenesis disorder, complementation group 6 (3)
PEX7	GP:601757	Bell>developmental	Refsum disease, 266500 (3)
PEX7	GP:601757	Bell>developmental	Rhizomelic chondrodysplasia punctata, type 1, 215100 (3)
PF4	G:173460	.	.
PF4V1	G:173461	.	.
PFAS	G:602133	.	.
PFDN1	G:604897	.	.
PFDN2	G:613466	.	.
PFDN4	G:604898	.	.
PFDN5	G:604899	.	.
PFDN6	G:605660	.	.
PFKFB1	G:311790	.	.
PFKFB2	G:171835	.	.
PFKFB3	G:605319	.	.
PFKFB4	G:605320	.	.
PFKL	G:171860	.	.
PFKM	G:610681	.	Glycogen storage disease VII, 232800 (3)
PFKP	G:171840	.	.
PFM3	P:609566	.	.
PFN1	G:176610	.	.
PFN1P2	G:608609	.	.
PFN2	G:176590	.	.
PFN3	G:612812	.	.
PGA3	G:169710	.	.
PGA4	G:169720	.	.
PGA5	G:169730	.	.
PGAM1	G:172250	.	.
PGAM2	G:612931	.	Glycogen storage disease X, 261670 (3)
PGAM4	G:300567	.	.
PGAP1	G:611655	.	.
PGAP3	G:611801	.	.
PGC	G:169740	.	.
PGD	G:172200	.	.
PGF	G:601121	.	.
PGGT1B	G:602031	.	.
PGK1	G:311800	.	Phosphoglycerate kinase 1 deficiency, 300653 (3)
PGK2	G:172270	.	.
PGLS	G:604951	.	.
PGLYRP1	G:604963	.	.
PGLYRP2	G:608199	.	.
PGLYRP3	G:608197	.	.
PGLYRP4	G:608198	.	.
PGM1	G:171900	.	Glycogen storage disease XIV, 612934 (3)
PGM2	G:172000	.	.
PGM2L1	G:611610	.	.
PGM3	G:172100	.	.
PGM5	G:600981	.	.
PGP	G:172280	.	.
PGPEP1	G:610694	.	.
PGR	G:607311	.	.
PGRMC1	G:300435	.	.
PGRMC2	G:607735	.	.
PHACTR1	G:608723	.	.
PHACTR2	G:608724	.	.
PHACTR3	G:608725	.	.
PHACTR4	G:608726	.	.
PHAX	G:604924	.	.
PHB	G:176705	.	{Breast cancer, susceptibility to}, 114480 (3)
PHB2	G:610704	.	.
PHC1	G:602978	.	.
PHC2	G:602979	.	.
PHEX	G:300550	+GR-Bell	Hypophosphatemic rickets, X-linked dominant, 307800 (3)
PHF1	G:602881	.	.
PHF10	G:613069	.	.
PHF11	G:607796	.	[IgE levels QTL], 147050 (3)
PHF11	G:607796	.	{Asthma}, 600807 (3)
PHF15	G:610515	.	.
PHF16	G:300618	.	.
PHF17	G:610514	.	.
PHF19	G:609740	.	.
PHF2	G:604351	.	.
PHF20	G:610335	.	.
PHF21A	G:608325	.	.
PHF23	G:612910	.	.
PHF3	G:607789	.	.
PHF6	G:300414	.	Borjeson-Forssman-Lehmann syndrome, 301900 (3)
PHF8	G:300560	.	Mental retardation syndrome, X-linked, Siderius type, 300263 (3)
PHGDH	G:606879	.	Phosphoglycerate dehydrogenase deficiency, 601815 (3)
PHIP	G:612870	.	.
PHKA1	G:311870	+GR-Bell	Muscle glycogenosis, 300559 (3)
PHKA2	G:300798	+GR-Bell	Glycogen storage disease, type IXa1, 306000 (3)
PHKA2	G:300798	+GR-Bell	Glycogen storage disease, type IXa2, 306000 (3)
PHKB	G:172490	+GR-Bell	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)
PHKG1	G:172470	.	.
PHKG2	G:172471	+GR-Bell	Glycogen storage disease IXc, 613027 (3)
PHLDA1	G:605335	.	.
PHLDA2	G:602131	.	.
PHLDA3	G:607054	.	.
PHLDB1	G:612834	.	.
PHLDB2	G:610298	.	.
PHLPP1	G:609396	.	.
PHLPP2	G:611066	.	.
PHOX2A	G:602753	.	Fibrosis of extraocular muscles, congenital, 2, 602078 (3)
PHOX2B	G:603851	.	Central hypoventilation syndrome, congenital, with or without Hirschsprung disease, 209880 (3)
PHOX2B	G:603851	.	Neuroblastoma with Hirschsprung disease, 613013 (3)
PHOX2B	G:603851	.	{Neuroblastoma, susceptibility to, 2}, 613013 (3)
PHPT1	G:610167	.	.
PHRF1	G:611780	.	.
PHTF1	G:604950	.	.
PHYH	G:602026	+GR-Bell	Refsum disease, 266500 (3)
PHYHIP	G:608511	.	.
PI15	G:607076	.	.
PI3	G:182257	.	.
PI4K2A	G:609763	.	.
PI4K2B	G:612101	.	.
PI4KA	G:600286	.	.
PI4KB	G:602758	.	.
PIAS1	G:603566	.	.
PIAS2	G:603567	.	.
PIAS3	G:605987	.	.
PIAS4	G:605989	.	.
PIBF1	G:607532	.	.
PICALM	G:603025	.	Leukemia, acute T-cell lymphoblastic (3)
PICALM	G:603025	.	Leukemia, acute myeloid, 601626 (3)
PICK1	G:605926	.	.
PID1	G:612930	.	.
PIDD	G:605247	.	.
PIEZO1	G:611184	.	.
PIEZO2	G:613629	.	.
PIF1	G:610953	.	.
PIGA	G:311770	.	Multiple congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3)
PIGA	G:311770	.	Paroxysmal nocturnal hemoglobinuria, somatic, 300818 (3)
PIGB	G:604122	.	.
PIGC	G:601730	.	.
PIGF	G:600153	.	.
PIGH	G:600154	.	.
PIGK	G:605087	.	.
PIGL	G:605947	.	.
PIGM	G:610273	.	Glycosylphosphatidylinositol deficiency, 610293 (3)
PIGN	G:606097	.	Multiple congenital anomalies-hypotonia-seizures syndrome 1, 614080 (3)
PIGP	G:605938	.	.
PIGQ	G:605754	.	.
PIGR	G:173880	.	.
PIGS	G:610271	.	.
PIGT	G:610272	.	.
PIGU	G:608528	.	.
PIGV	G:610274	.	Mabry syndrome, 239300 (3)
PIGW	G:610275	.	.
PIGX	G:610276	.	.
PIGY	G:610662	.	.
PIGZ	G:611671	.	.
PIH1D1	G:611480	.	.
PIK3AP1	G:607942	.	.
PIK3C2A	G:603601	.	.
PIK3C2B	G:602838	.	.
PIK3C2G	G:609001	.	.
PIK3C3	G:602609	.	.
PIK3CA	G:171834	.	Breast cancer, somatic, 114480 (3)
PIK3CA	G:171834	.	Colorectal cancer, somatic, 114500 (3)
PIK3CA	G:171834	.	Gastric cancer, somatic, 137215 (3)
PIK3CA	G:171834	.	Hepatocellular carcinoma, somatic, 114550 (3)
PIK3CA	G:171834	.	Keratosis, seborrheic, somatic, 182000 (3)
PIK3CA	G:171834	.	Nevus, epidermal, 162900 (3)
PIK3CA	G:171834	.	Nonsmall cell lung cancer, somatic, 211980 (3)
PIK3CA	G:171834	.	Ovarian cancer, somatic, 167000 (3)
PIK3CB	G:602925	.	.
PIK3CD	G:602839	.	.
PIK3CG	G:601232	.	.
PIK3R1	G:171833	.	.
PIK3R2	G:603157	.	.
PIK3R3	G:606076	.	.
PIK3R4	G:602610	.	.
PIK3R5	G:611317	.	.
PIK3R6	G:611462	.	.
PIKFYVE	G:609414	.	Corneal fleck dystrophy, 121850 (3)
PILRA	G:605341	.	.
PILRB	G:605342	.	.
PIM1	G:164960	.	.
PIM2	G:300295	.	.
PIM3	G:610580	.	.
PIN1	G:601052	.	.
PIN1P1	G:602051	.	.
PIN4	G:300252	.	.
PINK1	G:608309	+GR-Bell	Parkinson disease 6, early onset, 605909 (3)
PINX1	G:606505	.	.
PION	G:613552	.	.
PIP	G:176720	.	.
PIP4K2A	G:603140	.	.
PIP4K2B	G:603261	.	.
PIP5K1A	G:603275	.	.
PIP5K1B	G:602745	.	.
PIP5K1C	G:606102	.	Lethal congenital contractural syndrome 3, 611369 (3)
PIP5KL1	G:612865	.	.
PIR	G:603329	.	.
PIRT	G:612068	.	.
PISD	G:612770	.	.
PITPNA	G:600174	.	.
PITPNB	G:606876	.	.
PITPNC1	G:605134	.	.
PITPNM1	G:608794	.	.
PITPNM2	G:608920	.	.
PITPNM3	G:608921	.	Cone-rod dystrophy 5, 600977 (3)
PITX1	G:602149	.	Clubfoot, congenital, 119800 (3)
PITX2	G:601542	+GR-Bell	Axenfeld-Rieger syndrome, type 1, 180500 (3)
PITX2	G:601542	+GR-Bell	Iridogoniodysgenesis, type 2, 137600 (3)
PITX2	G:601542	+GR-Bell	Peters anomaly, 604229 (3)
PITX2	G:601542	+GR-Bell	Ring dermoid of cornea, 180550 (3)
PITX3	GP:602669	.	Anterior segment mesenchymal dysgenesis, 107250 (3)
PITX3	GP:602669	.	Cataract, congenital (3)
PITX3	GP:602669	.	Cataract, posterior polar, 4, 610623 (3)
PITX3	GP:602669	.	Cataract, posterior polar, 4, syndromic, 610623 (3)
PIWIL1	G:605571	.	.
PIWIL2	G:610312	.	.
PIWIL3	G:610314	.	.
PIWIL4	G:610315	.	.
PJA1	G:300420	.	.
PKD1	G:601313	+GR-Bell	Polycystic kidney disease, adult type I, 173900 (3)
PKD1L1	G:609721	.	.
PKD1L2	G:607894	.	.
PKD1L3	G:607895	.	.
PKD2	G:173910	+GR-Bell	Polycystic kidney disease 2, 613095 (3)
PKD2L1	G:604532	.	.
PKD2L2	G:604669	.	.
PKD3	P:600666	.	.
PKDCC	G:614150	.	.
PKDREJ	G:604670	.	.
PKHD1	G:606702	Bell>renal	Polycystic kidney and hepatic disease, 263200 (3)
PKHD1L1	G:607843	.	.
PKIA	G:606059	.	.
PKIB	G:606914	.	.
PKIG	G:604932	.	.
PKLR	G:609712	Bell>hematologic	Adenosine triphosphate, elevated, of erythrocytes, 102900 (3)
PKLR	G:609712	Bell>hematologic	Pyruvate kinase deficiency, 266200 (3)
PKM2	G:179050	.	.
PKMYT1	G:602474	.	.
PKN1	G:601032	.	.
PKN2	G:602549	.	.
PKN3	G:610714	.	.
PKNOX1	G:602100	.	.
PKNOX2	G:613066	.	.
PKP1	G:601975	.	Ectodermal dysplasia/skin fragility syndrome, 604536 (3)
PKP2	G:602861	+GR-Bell	Arrhythmogenic right ventricular dysplasia 9, 609040 (3)
PKP3	G:605561	.	.
PKP4	G:604276	.	.
PLA1A	G:607460	.	.
PLA2G10	G:603603	.	.
PLA2G12A	G:611652	.	.
PLA2G12B	G:611653	.	.
PLA2G15	G:609362	.	.
PLA2G16	G:613867	.	.
PLA2G1B	G:172410	.	.
PLA2G2A	G:172411	.	{Colorectal cancer}, 114500 (3)
PLA2G2D	G:605630	.	.
PLA2G3	G:611651	.	.
PLA2G4A	GP:600522	.	Phospholipase A2, group IV A, deficiency of (3)
PLA2G4B	G:606088	.	.
PLA2G4C	G:603602	.	.
PLA2G4D	G:612864	.	.
PLA2G5	G:601192	.	Fleck retina, familial benign, 228980 (3)
PLA2G6	G:603604	Bell>neurological	Infantile neuroaxonal dystrophy 1, 256600 (3)
PLA2G6	G:603604	Bell>neurological	Karak syndrome, 610217 (3)
PLA2G6	G:603604	Bell>neurological	Neurodegeneration with brain iron accumulation 2B, 610217 (3)
PLA2G6	G:603604	Bell>neurological	Parkinson disease 14, 612953 (3)
PLA2G7	G:601690	.	Platelet-activating factor acetylhydrolase deficiency, 614278 (3)
PLA2G7	G:601690	.	{Asthma, susceptibility to}, 600807 (3)
PLA2G7	G:601690	.	{Atopy, susceptibility to}, 147050 (3)
PLA2R1	G:604939	.	.
PLAA	G:603873	.	.
PLAC1	G:300296	.	.
PLAC4	G:613770	.	.
PLAC8	G:607515	.	.
PLAC9	G:612857	.	.
PLAG1	G:603026	.	Adenomas, salivary gland pleomorphic, 181030 (3)
PLAGL1	G:603044	.	.
PLAGL2	G:604866	.	.
PLAT	G:173370	.	.
PLAU	G:191840	.	Quebec platelet disorder, 601709 (3)
PLAU	G:191840	.	{Alzheimer disease, late-onset, susceptibility to}, 104300 (3)
PLAUR	G:173391	.	.
PLB1	G:610179	.	.
PLCB1	G:607120	.	Epileptic encephalopathy, early infantile, 12, 613722 (3)
PLCB2	G:604114	.	.
PLCB3	G:600230	.	.
PLCB4	G:600810	.	.
PLCD1	G:602142	.	Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3)
PLCD3	G:608795	.	.
PLCD4	G:605939	.	.
PLCE1	G:608414	Bell>renal	Nephrotic syndrome, type 3, 610725 (3)
PLCG1	G:172420	.	.
PLCG2	G:600220	.	Familial cold autoinflammatory syndrome 3, 614468 (3)
PLCH1	G:612835	.	.
PLCH2	G:612836	.	.
PLCL1	G:600597	.	.
PLCL2	G:614276	.	.
PLCZ1	G:608075	.	.
PLD1	G:602382	.	.
PLD2	G:602384	.	.
PLDN	G:604310	.	Hermansky-pudlak syndrome 9, 614171 (3)
PLEC	G:601282	.	Epidermolysis bullosa simplex with pyloric atresia, 612138 (3)
PLEC	G:601282	.	Epidermolysis bullosa simplex, Ogna type, 131950 (3)
PLEC	G:601282	.	Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
PLEC	G:601282	.	Muscular dystrophy, limb-girdle, type 2Q, 613723 (3)
PLEK	G:173570	.	.
PLEK2	G:608007	.	.
PLEKHA1	G:607772	.	.
PLEKHA2	G:607773	.	.
PLEKHA3	G:607774	.	.
PLEKHA4	G:607769	.	.
PLEKHA5	G:607770	.	.
PLEKHA6	G:607771	.	.
PLEKHA7	G:612686	.	.
PLEKHA8	G:608639	.	.
PLEKHB1	G:607651	.	.
PLEKHG2	G:611893	.	.
PLEKHG4	G:609526	.	.
PLEKHG5	G:611101	Bell>neurological	Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3)
PLEKHG6	G:611743	.	.
PLEKHH2	G:612723	.	.
PLEKHM1	G:611466	.	Osteopetrosis, autosomal recessive 6, 611497 (3)
PLEKHM2	G:609613	.	.
PLEKHO1	G:608335	.	.
PLG	G:173350	Bell>hematologic	Conjunctivitis, ligneous, 217090 (3)
PLGLA	G:612212	.	.
PLGLB1	G:173340	.	.
PLIN1	G:170290	.	Lipodystrophy, familial partial, type 4, 613877 (3)
PLIN2	G:103195	.	.
PLIN3	G:602702	.	.
PLIN4	G:613247	.	.
PLIN5	G:613248	.	.
PLK1	G:602098	.	.
PLK2	G:607023	.	.
PLK3	G:602913	.	.
PLK4	G:605031	.	.
PLLP	G:600340	.	.
PLN	G:172405	.	Cardiomyopathy, dilated, 1P, 609909 (3)
PLN	G:172405	.	Cardiomyopathy, familial hypertrophic, 18, 613874 (3)
PLOD1	G:153454	Bell>developmental	Ehlers-Danlos syndrome, type VI, 225400 (3)
PLOD1	G:153454	Bell>developmental	Nevo syndrome, 601451 (3)
PLOD2	G:601865	.	Bruck syndrome 2, 609220 (3)
PLOD3	G:603066	.	Lysyl hydroxylase 3 deficiency, 612394 (3)
PLP1	G:300401	Bell>neurological	Pelizaeus-Merzbacher disease, 312080 (3)
PLP1	G:300401	Bell>neurological	Pelizaeus-Merzbacher disease, 312080 (3)
PLP1	G:300401	Bell>neurological	Spastic paraplegia-2, 312920 (3)
PLP1	G:300401	Bell>neurological	Spastic paraplegia-2, 312920 (3)
PLP2	G:300112	.	.
PLRG1	G:605961	.	.
PLS1	G:602734	.	.
PLS3	G:300131	.	.
PLSCR1	G:604170	.	.
PLSCR2	G:607610	.	.
PLSCR3	G:607611	.	.
PLSCR4	G:607612	.	.
PLTP	GP:172425	.	.
PLVAP	G:607647	.	.
PLXDC1	G:606826	.	.
PLXDC2	G:606827	.	.
PLXNA1	G:601055	.	.
PLXNA2	G:601054	.	.
PLXNA3	G:300022	.	.
PLXNA4	G:604280	.	.
PLXNB1	G:601053	.	.
PLXNB2	G:604293	.	.
PLXNB3	G:300214	.	.
PLXNC1	G:604259	.	.
PLXND1	G:604282	.	.
PMAIP1	G:604959	.	.
PMCH	G:176795	.	.
PMCHL1	G:176793	.	.
PMCHL2	G:176794	.	.
PMEL	G:155550	.	.
PMEPA1	G:606564	.	.
PMF1	G:609176	.	.
PML	G:102578	.	Leukemia, acute promyelocytic, PML/RARA type (3)
PMM1	G:601786	.	.
PMM2	G:601785	Bell>metabolic	Congenital disorder of glycosylation, type Ia, 212065 (3)
PMP2	G:170715	.	.
PMP22	G:601097	Bell>neurological	Charcot-Marie-Tooth disease, type 1A, 118220 (3)
PMP22	G:601097	Bell>neurological	Charcot-Marie-Tooth disease, type 1E, 118300 (3)
PMP22	G:601097	Bell>neurological	Dejerine-Sottas disease, 145900 (3)
PMP22	G:601097	Bell>neurological	Neuropathy, recurrent, with pressure palsies, 162500 (3)
PMP22	G:601097	Bell>neurological	Roussy-Levy syndrome, 180800 (3)
PMPCA	G:613036	.	.
PMPCB	G:603131	.	.
PMS1	G:600258	.	.
PMS2	G:600259	+GR-Bell	Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3)
PMS2	G:600259	+GR-Bell	Mismatch repair cancer syndrome, 276300 (3)
PMS2P1	G:605038	.	.
PMVK	G:607622	.	.
PNCK	G:300680	.	.
PNKD	G:609023	+GR-Bell	Paroxysmal nonkinesigenic dyskinesia, 118800 (3)
PNKP	G:605610	.	Epileptic encephalopathy, early infantile, 10, 613402 (3)
PNLIP	G:246600	.	.
PNLIPRP1	G:604422	.	.
PNLIPRP2	G:604423	.	.
PNMA1	G:604010	.	.
PNMA2	G:603970	.	.
PNMA3	G:300675	.	.
PNMT	G:171190	.	.
PNN	G:603154	.	.
PNOC	G:601459	.	.
PNP	G:164050	.	Immunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 (3)
PNPLA1	G:612121	.	.
PNPLA2	G:609059	.	Neutral lipid storage disease with myopathy, 610717 (3)
PNPLA3	G:609567	.	.
PNPLA4	G:300102	.	.
PNPLA5	G:611589	.	.
PNPLA6	G:603197	.	Spastic paraplegia 39, 612020 (3)
PNPLA7	G:612122	.	.
PNPLA8	G:612123	.	.
PNPO	G:603287	Bell>metabolic	Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3)
PNPT1	G:610316	.	.
PNRC1	G:606714	.	.
PNRC2	G:611882	.	.
PODN	G:608661	.	.
PODXL	G:602632	.	.
POF1B	G:300603	.	Premature ovarian failure 2B, 300604 (3)
POFUT1	G:607491	.	.
POFUT2	G:610249	.	.
POLA1	G:312040	.	.
POLB	G:174760	.	.
POLD1	G:174761	.	.
POLD2	G:600815	.	.
POLD3	G:611415	.	.
POLD4	G:611525	.	.
POLDIP2	G:611519	.	.
POLDIP3	G:611520	.	.
POLE	G:174762	.	.
POLE2	G:602670	.	.
POLE3	G:607267	.	.
POLE4	G:607269	.	.
POLG	G:174763	Bell>neurological	Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3)
POLG	G:174763	Bell>neurological	Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3)
POLG	G:174763	Bell>neurological	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)
POLG	G:174763	Bell>neurological	Progressive external ophthalmoplegia, autosomal dominant, 157640 (3)
POLG	G:174763	Bell>neurological	Progressive external ophthalmoplegia, autosomal recessive, 258450 (3)
POLG2	G:604983	.	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3)
POLH	G:603968	+GR-Bell	Xeroderma pigmentosum, variant type, 278750 (3)
POLI	G:605252	.	.
POLK	G:605650	.	.
POLL	G:606343	.	.
POLM	G:606344	.	.
POLN	G:610887	.	.
POLQ	G:604419	.	.
POLR1B	G:602000	.	.
POLR1C	G:610060	+GR-Bell	Treacher Collins syndrome 3, 248390 (3)
POLR1D	G:613715	+GR-Bell	Treacher Collins syndrome 2, 613717 (3)
POLR2A	GP:180660	.	.
POLR2B	G:180661	.	.
POLR2C	G:180663	.	.
POLR2D	G:606017	.	.
POLR2E	G:180664	.	.
POLR2F	G:604414	.	.
POLR2G	G:602013	.	.
POLR2H	G:606023	.	.
POLR2I	G:180662	.	.
POLR2J	G:604150	.	.
POLR2J2	G:609881	.	.
POLR2K	G:606033	.	.
POLR2L	G:601189	.	.
POLR2M	G:606485	.	.
POLR3A	G:614258	.	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3)
POLR3B	G:614366	.	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3)
POLR3D	P:187280	.	.
POLR3K	G:606007	.	.
POLRMT	G:601778	.	.
POMC	G:176830	.	Obesity, adrenal insufficiency, and red hair due to POMC deficiency, 609734 (3)
POMC	G:176830	.	{Obesity, early-onset, susceptibility to}, 601665 (3)
POMGNT1	G:606822	Bell>neurological	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3)
POMGNT1	G:606822	Bell>neurological	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3)
POMGNT1	G:606822	Bell>neurological	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)
POMP	G:613386	.	Keratosis linearis with ichthyosis congenita and sclerosing keratoderma, 601952 (3)
POMT1	G:607423	Bell>neurological	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3)
POMT1	G:607423	Bell>neurological	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3)
POMT1	G:607423	Bell>neurological	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)
POMT2	G:607439	Bell>neurological	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3)
POMT2	G:607439	Bell>neurological	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3)
POMT2	G:607439	Bell>neurological	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)
POMZP3	G:600587	.	.
PON1	GP:168820	.	{Coronary artery disease, susceptibility to} (3)
PON1	GP:168820	.	{Coronary artery spasm 2, susceptibility to (3)
PON1	GP:168820	.	{Microvascular complications of diabetes 5}, 612633 (3)
PON1	GP:168820	.	{Organophosphate poisoning, sensitivity to} (3)
PON2	G:602447	.	{Coronary artery disease, susceptibility to} (3)
PON3	G:602720	.	.
POP1	G:602486	.	.
POP4	G:606114	.	.
POP5	G:609992	.	.
POP7	G:606113	.	.
POPDC2	G:605823	.	.
POPDC3	G:605824	.	.
POR	G:124015	+GR-Bell	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, 201750 (3)
POR	G:124015	+GR-Bell	Disordered steroidogenesis due to cytochrome P450 oxidoreductase, 613571 (3)
PORCN	G:300651	+GR-Bell	Focal dermal hypoplasia, 305600 (3)
POSTN	G:608777	.	.
POT1	G:606478	.	.
POTEA	G:608915	.	.
POTEB	G:608912	.	.
POTED	G:607549	.	.
POTEE	G:608914	.	.
POTEG	G:608916	.	.
POTEH	G:608913	.	.
POTEKP	G:611266	.	.
POU1F1	G:173110	Bell>endocrine	Pituitary hormone deficiency, combined, 1, 613038 (3)
POU2AF1	G:601206	.	.
POU2F1	G:164175	.	.
POU2F2	G:164176	.	.
POU2F3	G:607394	.	.
POU3F1	G:602479	.	.
POU3F2	G:600494	.	.
POU3F3	G:602480	.	.
POU3F4	G:300039	.	Deafness, X-linked 2, 304400 (3)
POU4F1	G:601632	.	.
POU4F2	G:113725	.	.
POU4F3	G:602460	.	Deafness, autosomal dominant 15, 602459 (3)
POU5F1	G:164177	.	.
POU6F2	G:609062	.	{Wilms tumor susceptibility-5}, 601583 (3)
PPA1	G:179030	.	.
PPA2	G:609988	.	.
PPAN	G:607793	.	.
PPAP2A	G:607124	.	.
PPAP2B	G:607125	.	.
PPAP2C	G:607126	.	.
PPAPDC1B	G:610626	.	.
PPAPDC2	G:611666	.	.
PPARA	GP:170998	.	{Hyperapobetalipoproteinemia, susceptibility to} (3)
PPARD	G:600409	.	.
PPARG	G:601487	.	Carotid intimal medial thickness 1, 609338 (3)
PPARG	G:601487	.	Insulin resistance, severe, digenic, 604367 (3)
PPARG	G:601487	.	Lipodystrophy, familial partial, type 3, 604367 (3)
PPARG	G:601487	.	Obesity, severe, 601665 (3)
PPARG	G:601487	.	[Obesity, resistance to] (3)
PPARG	G:601487	.	{Diabetes, type 2}, 125853 (3)
PPARG	G:601487	.	{Glioblastoma, susceptibility to}, 137800 (3)
PPARGC1A	G:604517	.	.
PPARGC1B	G:608886	.	{Obesity, variation in}, 601665 (3)
PPAT	G:172450	.	.
PPBP	G:121010	.	.
PPBPL1	G:188035	.	.
PPBPL2	G:611591	.	.
PPCDC	G:609854	.	.
PPCS	G:609853	.	.
PPEF1	G:300109	.	.
PPEF2	G:602256	.	.
PPFIA1	G:611054	.	.
PPFIA2	G:603143	.	.
PPFIA3	G:603144	.	.
PPFIA4	G:603145	.	.
PPFIBP1	G:603141	.	.
PPFIBP2	G:603142	.	.
PPHLN1	G:608150	.	.
PPIA	G:123840	.	.
PPIAL4E	G:608608	.	.
PPIB	G:123841	.	Osteogenesis imperfecta, type IX, 259440 (3)
PPIC	G:123842	.	.
PPID	G:601753	.	.
PPIE	G:602435	.	.
PPIF	G:604486	.	.
PPIG	G:606093	.	.
PPIH	G:606095	.	.
PPIL1	G:601301	.	.
PPIL2	G:607588	.	.
PPIL4	G:607609	.	.
PPIP5K1	G:610979	.	.
PPIP5K2	G:611648	.	.
PPL	G:602871	.	.
PPM1A	G:606108	.	.
PPM1B	G:603770	.	.
PPM1D	G:605100	.	Breast cancer, 114480 (3)
PPM1G	G:605119	.	.
PPM1J	G:609957	.	.
PPM1K	G:611065	.	.
PPM1L	G:611931	.	.
PPM1M	G:608979	.	.
PPME1	G:611117	.	.
PPOX	G:600923	.	Porphyria variegata, 176200 (3)
PPP1CA	G:176875	.	.
PPP1CB	G:600590	.	.
PPP1CC	G:176914	.	.
PPP1R10	G:603771	.	.
PPP1R11	G:606670	.	.
PPP1R12A	G:602021	.	.
PPP1R12B	G:603768	.	.
PPP1R12C	G:613245	.	.
PPP1R13B	G:606455	.	.
PPP1R13L	G:607463	.	.
PPP1R14A	G:608153	.	.
PPP1R14B	G:601140	.	.
PPP1R14C	G:613242	.	.
PPP1R14D	G:613256	.	.
PPP1R15A	G:611048	.	.
PPP1R15B	G:613257	.	.
PPP1R16A	G:609172	.	.
PPP1R16B	G:613275	.	.
PPP1R17	G:604088	.	{Hypercholesterolemia, susceptibility to}, 143890 (3)
PPP1R18	G:610990	.	.
PPP1R1A	G:613246	.	.
PPP1R1B	G:604399	.	.
PPP1R1C	G:613240	.	.
PPP1R2	G:601792	.	.
PPP1R26	G:614056	.	.
PPP1R3A	G:600917	.	Insulin resistance, severe, digenic, 604367 (3)
PPP1R3B	G:610541	.	.
PPP1R3C	G:602999	.	.
PPP1R3D	G:603326	.	.
PPP1R7	G:602877	.	.
PPP1R8	G:602636	.	.
PPP1R9A	G:602468	.	.
PPP1R9B	G:603325	.	.
PPP2CA	G:176915	.	.
PPP2CB	G:176916	.	.
PPP2R1A	G:605983	.	.
PPP2R1B	G:603113	.	Lung cancer, 211980 (3)
PPP2R2A	G:604941	.	.
PPP2R2B	G:604325	+GR-Bell	Spinocerebellar ataxia 12, 604326 (3)
PPP2R2C	G:605997	.	.
PPP2R2D	G:613992	.	.
PPP2R3A	G:604944	.	.
PPP2R3B	G:300339	.	.
PPP2R4	G:600756	.	.
PPP2R5A	G:601643	.	.
PPP2R5B	G:601644	.	.
PPP2R5C	G:601645	.	.
PPP2R5D	G:601646	.	.
PPP2R5E	G:601647	.	.
PPP3CA	G:114105	.	.
PPP3CB	G:114106	.	.
PPP3CC	G:114107	.	.
PPP3R1	G:601302	.	.
PPP3R2	G:613821	.	.
PPP4C	G:602035	.	.
PPP4R1	G:604908	.	.
PPP4R2	G:613822	.	.
PPP5C	G:600658	.	.
PPP6C	G:612725	.	.
PPP6R1	G:610875	.	.
PPP6R2	G:610877	.	.
PPP6R3	G:610879	.	.
PPT1	G:600722	Bell>neurological	Ceroid lipofuscinosis, neuronal, 1, 256730 (3)
PPT2	G:603298	.	.
PPTC7	G:609668	.	.
PPY	G:167780	.	.
PPY2	G:606638	.	.
PPYR1	G:601790	.	.
PQBP1	G:300463	Bell>developmental	Renpenning syndrome, 309500 (3)
PRAC	G:609819	.	.
PRAF2	G:300840	.	.
PRAM1	G:606466	.	.
PRAME	G:606021	.	.
PRAP1	G:609776	.	.
PRB1	G:180989	.	.
PRB2	G:168810	.	.
PRB3	G:168840	.	.
PRB4	G:180990	.	.
PRC1	G:603484	.	.
PRCC	G:179755	.	Renal cell carcinoma, papillary, 605074 (3)
PRCD	G:610598	+GR-Bell	Retinitis pigmentosa 36, 610599 (3)
PRCP	G:176785	.	.
PRD	P:312550	.	.
PRDM1	G:603423	.	.
PRDM14	G:611781	.	.
PRDM16	G:605557	.	.
PRDM2	G:601196	.	.
PRDM4	G:605780	.	.
PRDM5	G:614161	.	Brittle cornea syndrome 2, 614170 (3)
PRDM7	G:609759	.	.
PRDM9	G:609760	.	.
PRDX1	G:176763	.	.
PRDX2	G:600538	.	.
PRDX3	G:604769	.	.
PRDX4	G:606506	.	.
PRDX5	G:606583	.	.
PRDX6	G:602316	.	.
PREB	G:606395	.	.
PRELID1	G:605733	.	.
PRELP	G:601914	.	.
PREP	G:600400	.	.
PREPL	G:609557	.	.
PREX1	G:606905	.	.
PREX2	G:612139	.	.
PRF1	G:170280	+GR-Bell	Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3)
PRF1	G:170280	+GR-Bell	Lymphoma, non-Hodgkin, 605027 (3)
PRG2	G:605601	.	.
PRG3	G:606814	.	.
PRG4	G:604283	.	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)
PRH1	G:168730	.	.
PRH2	G:168790	.	.
PRICKLE1	G:608500	+GR-Bell	Epilepsy, progressive myoclonic 1B, 612437 (3)
PRICKLE2	G:608501	.	Epilepsy, progressive myoclonic 5, 613832 (3)
PRICKLE3	G:300111	.	.
PRICKLE4	G:611389	.	.
PRIM1	G:176635	.	.
PRIM2	G:176636	.	.
PRIMA1	G:613851	.	.
PRKAA1	G:602739	.	.
PRKAA2	G:600497	.	.
PRKAB1	G:602740	.	.
PRKAB2	G:602741	.	.
PRKACA	G:601639	.	.
PRKACB	G:176892	.	.
PRKACG	G:176893	.	.
PRKAG1	G:602742	.	.
PRKAG2	G:602743	Bell>metabolic	Cardiomyopathy, familial hypertrophic 6, 600858 (3)
PRKAG2	G:602743	Bell>metabolic	Glycogen storage disease of heart, lethal congenital, 261740 (3)
PRKAG2	G:602743	Bell>metabolic	Wolff-Parkinson-White syndrome, 194200 (3)
PRKAG3	GP:604976	.	.
PRKAR1A	G:188830	Bell>cardiac	Acrodysostosis with hormone resistance, 101800 (3)
PRKAR1A	G:188830	Bell>cardiac	Adrenocortical tumor, somatic, (3)
PRKAR1A	G:188830	Bell>cardiac	Carney complex, type 1, 160980 (3)
PRKAR1A	G:188830	Bell>cardiac	Myxoma, intracardiac, 255960 (3)
PRKAR1A	G:188830	Bell>cardiac	Pigmented nodular adrenocortical disease, primary, 1, 610489 (3)
PRKAR1A	G:188830	Bell>cardiac	Thyroid carcinoma, papillary, somatic, 188550 (3)
PRKAR1B	G:176911	.	.
PRKAR2A	G:176910	.	.
PRKAR2B	G:176912	.	.
PRKCA	G:176960	.	Pituitary tumor, invasive (3)
PRKCB	G:176970	.	.
PRKCD	G:176977	.	.
PRKCE	G:176975	.	.
PRKCG	G:176980	+GR-Bell	Spinocerebellar ataxia 14, 605361 (3)
PRKCH	G:605437	.	{Cerebral infarction, susceptibility to}, 601367 (3)
PRKCI	G:600539	.	.
PRKCQ	G:600448	.	.
PRKCSH	G:177060	.	Polycystic liver disease, 174050 (3)
PRKCZ	G:176982	.	.
PRKD1	G:605435	.	.
PRKD2	G:607074	.	.
PRKD3	G:607077	.	.
PRKDC	G:600899	.	.
PRKG1	G:176894	.	.
PRKG2	G:601591	.	.
PRKRA	G:603424	.	Dystonia 16, 612067 (3)
PRKRIR	G:607374	.	.
PRKX	G:300083	.	.
PRKY	G:400008	.	.
PRL	G:176760	.	.
PRLH	G:602663	.	.
PRLHR	G:600895	.	.
PRLR	G:176761	.	.
PRM1	G:182880	.	.
PRM2	G:182890	.	.
PRMT1	G:602950	.	.
PRMT2	G:601961	.	.
PRMT3	G:603190	.	.
PRMT5	G:604045	.	.
PRMT6	G:608274	.	.
PRMT7	G:610087	.	.
PRMT8	G:610086	.	.
PRND	G:604263	.	.
PRNP	G:176640	+GR-Bell	Creutzfeldt-Jakob disease, 123400 (3)
PRNP	G:176640	+GR-Bell	Gerstmann-Straussler disease, 137440 (3)
PRNP	G:176640	+GR-Bell	Huntington disease-like 1, 603218 (3)
PRNP	G:176640	+GR-Bell	Insomnia, fatal familial, 600072 (3)
PRNP	G:176640	+GR-Bell	Prion disease with protracted course, 606688 (3)
PROC	G:612283	Bell>hematologic	Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3)
PROC	G:612283	Bell>hematologic	Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)
PROCR	G:600646	.	.
PRODH	G:606810	.	Hyperprolinemia, type I, 239500 (3)
PRODH	G:606810	.	{Schizophrenia, susceptibility to, 4}, 600850 (3)
PROK1	G:606233	.	.
PROK2	G:607002	+GR-Bell	Hypogonadism, hypogonadotropic, 146110 (3)
PROK2	G:607002	+GR-Bell	Kallmann syndrome 4, 610628 (3)
PROKR1	G:607122	.	.
PROKR2	G:607123	+GR-Bell	Kallmann syndrome 3, 244200 (3)
PROL1	G:608936	.	.
PROM1	G:604365	+GR-Bell	Cone-rod dystrophy 12, 612657 (3)
PROM1	G:604365	+GR-Bell	Macular dystrophy, retinal, 2, 608051 (3)
PROM1	G:604365	+GR-Bell	Retinitis pigmentosa 41, 612095 (3)
PROM1	G:604365	+GR-Bell	Stargardt disease 4, 603786 (3)
PROP1	G:601538	Bell>endocrine	Pituitary hormone deficiency, combined, 2, 262600 (3)
PROS1	G:176880	.	Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3)
PROS1	G:176880	.	Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)
PROSC	G:604436	.	.
PROX1	G:601546	.	.
PROZ	G:176895	.	.
PRPF18	G:604993	.	.
PRPF19	G:608330	.	.
PRPF3	G:607301	.	Retinitis pigmentosa 18, 601414 (3)
PRPF31	G:606419	+GR-Bell	Retinitis pigmentosa 11, 600138 (3)
PRPF4	G:607795	.	.
PRPF40A	G:612941	.	.
PRPF4B	G:602338	.	.
PRPF6	G:613979	+GR-Bell	Retinitis pigmentosa 60, 613983 (3)
PRPF8	G:607300	.	Retinitis pigmentosa 13, 600059 (3)
PRPH	G:170710	.	{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)
PRPH2	G:179605	+GR-Bell	Choriodal dystrophy, central areolar 2, 613105 (3)
PRPH2	G:179605	+GR-Bell	Foveomacular dystrophy, adult-onset, with choroidal neovascularization, 608161 (3)
PRPH2	G:179605	+GR-Bell	Macular dystrophy, patterned, 169150 (3)
PRPH2	G:179605	+GR-Bell	Macular dystrophy, vitelliform, 608161 (3)
PRPH2	G:179605	+GR-Bell	Retinitis pigmentosa 7, 608133 (3)
PRPH2	G:179605	+GR-Bell	Retinitis pigmentosa, digenic, 608133 (3)
PRPH2	G:179605	+GR-Bell	Retinitis punctata albescens, 136880 (3)
PRPS1	G:311850	Bell>neurological	Arts syndrome, 301835 (3)
PRPS1	G:311850	Bell>neurological	Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3)
PRPS1	G:311850	Bell>neurological	Deafness, X-linked 1, 304500 (3)
PRPS1	G:311850	Bell>neurological	Gout, PRPS-related, 300661 (3)
PRPS1	G:311850	Bell>neurological	Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3)
PRPS1	P:304500	Bell>neurological	Arts syndrome, 301835 (3)
PRPS1	P:304500	Bell>neurological	Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3)
PRPS1	P:304500	Bell>neurological	Deafness, X-linked 1, 304500 (3)
PRPS1	P:304500	Bell>neurological	Gout, PRPS-related, 300661 (3)
PRPS1	P:304500	Bell>neurological	Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3)
PRPS1L1	G:611566	.	.
PRPS2	G:311860	.	.
PRPSAP1	G:601249	.	.
PRPSAP2	G:603762	.	.
PRR13	G:610459	.	.
PRR4	G:605359	.	.
PRR5	G:609406	.	.
PRR5L	G:611728	.	.
PRRC2A	G:142580	.	.
PRRG1	G:604428	.	.
PRRG2	G:604429	.	.
PRRG3	G:300685	.	.
PRRG4	G:611690	.	.
PRRT2	G:614386	+GR-Bell	Episodic kinesigenic dyskinesia 1, 128200 (3)
PRRX1	G:167420	.	Agnathia-otocephaly complex, 202650 (3)
PRRX2	G:604675	.	.
PRS	P:309610	.	.
PRSS1	G:276000	.	Pancreatitis, hereditary, 167800 (3)
PRSS12	G:606709	.	Mental retardation, autosomal recessive 1, 249500 (3)
PRSS16	G:607169	.	.
PRSS2	G:601564	.	{Pancreatitis, chronic, protection against}, 167800 (3)
PRSS21	G:608159	.	.
PRSS22	G:609343	.	.
PRSS27	G:608018	.	.
PRSS3	G:613578	.	.
PRSS33	G:613797	.	.
PRSS36	G:610560	.	.
PRSS50	G:607950	.	.
PRSS53	G:610561	.	.
PRSS56	G:613858	.	Microphthalmia, isolated 6, 613517 (3)
PRSS8	G:600823	.	.
PRTFDC1	G:610751	.	.
PRTG	G:613261	.	.
PRTN3	G:177020	.	.
PRUNE2	G:610691	.	.
PRX	G:605725	Bell>neurological	Charcot-Marie-Tooth disease, type 4F, 145900 (3)
PRX	G:605725	Bell>neurological	Dejerine-Sottas disease, autosomal recessive, 145900 (3)
PRY	G:400019	.	.
PRY2	G:400041	.	.
PSAP	G:176801	Bell>metabolic	Combined SAP deficiency, 611721 (3)
PSAP	G:176801	Bell>metabolic	Gaucher disease, atypical, 610539 (3)
PSAP	G:176801	Bell>metabolic	Krabbe disease, atypical, 611722 (3)
PSAP	G:176801	Bell>metabolic	Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3)
PSAP	G:176801	Bell>neurological	Combined SAP deficiency, 611721 (3)
PSAP	G:176801	Bell>neurological	Combined SAP deficiency, 611721 (3)
PSAP	G:176801	Bell>neurological	Gaucher disease, atypical, 610539 (3)
PSAP	G:176801	Bell>neurological	Gaucher disease, atypical, 610539 (3)
PSAP	G:176801	Bell>neurological	Krabbe disease, atypical, 611722 (3)
PSAP	G:176801	Bell>neurological	Krabbe disease, atypical, 611722 (3)
PSAP	G:176801	Bell>neurological	Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3)
PSAP	G:176801	Bell>neurological	Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3)
PSAT1	G:610936	Bell>metabolic	Phosphoserine aminotransferase deficiency, 610992 (3)
PSCA	G:602470	.	.
PSD	G:602327	.	.
PSD3	G:614440	.	.
PSD4	G:614442	.	.
PSEN1	G:104311	+GR-Bell	Acne inversa, familial, 3, 613737 (3)
PSEN1	G:104311	+GR-Bell	Alzheimer disease, type 3, 607822 (3)
PSEN1	G:104311	+GR-Bell	Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3)
PSEN1	G:104311	+GR-Bell	Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3)
PSEN1	G:104311	+GR-Bell	Cardiomyopathy, dilated, 1U, 613694 (3)
PSEN1	G:104311	+GR-Bell	Dementia, frontotemporal, 600274 (3)
PSEN1	G:104311	+GR-Bell	Pick disease, 172700 (3)
PSEN2	G:600759	+GR-Bell	Alzheimer disease-4, 606889 (3)
PSEN2	G:600759	+GR-Bell	Cardiomyopathy, dilated, 1V, 613697 (3)
PSENEN	G:607632	.	Acne inversa, familial, 2, 613736 (3)
PSG1	G:176390	.	.
PSG10P	G:176399	.	.
PSG11	G:176401	.	.
PSG2	G:176391	.	.
PSG3	G:176392	.	.
PSG4	G:176393	.	.
PSG5	G:176394	.	.
PSG6	G:176395	.	.
PSG7	G:176396	.	.
PSG8	G:176397	.	.
PSG9	G:176398	.	.
PSIP1	G:603620	.	.
PSKH1	G:177015	.	.
PSMA1	G:602854	.	.
PSMA2	G:176842	.	.
PSMA3	G:176843	.	.
PSMA4	G:176846	.	.
PSMA5	G:176844	.	.
PSMA6	G:602855	.	{Myocardial infarcation, susceptibility to}, 608446 (3)
PSMA7	G:606607	.	.
PSMB1	G:602017	.	.
PSMB10	G:176847	.	.
PSMB11	G:611137	.	.
PSMB2	G:602175	.	.
PSMB3	G:602176	.	.
PSMB4	G:602177	.	.
PSMB5	G:600306	.	.
PSMB6	G:600307	.	.
PSMB7	G:604030	.	.
PSMB8	G:177046	.	Nakajo syndrome, 256040 (3)
PSMB9	G:177045	.	.
PSMC1	G:602706	.	.
PSMC2	G:154365	.	.
PSMC3	G:186852	.	.
PSMC3IP	G:608665	.	Ovarian dysgenesis 3, 614324 (3)
PSMC4	G:602707	.	.
PSMC5	G:601681	.	.
PSMC6	G:602708	.	.
PSMD10	G:603480	.	.
PSMD11	G:604449	.	.
PSMD12	G:604450	.	.
PSMD13	G:603481	.	.
PSMD14	G:607173	.	.
PSMD2	G:606223	.	.
PSMD4	G:601648	.	.
PSMD5	G:604452	.	.
PSMD7	G:157970	.	.
PSMD9	G:603146	.	.
PSME1	G:600654	.	.
PSME2	G:602161	.	.
PSME3	G:605129	.	.
PSME4	G:607705	.	.
PSMG1	G:605296	.	.
PSMG2	G:609702	.	.
PSORS10	P:612410	.	.
PSORS1C1	G:613525	.	.
PSORS1C2	G:613526	.	.
PSORS2	P:602723	.	.
PSORS3	P:601454	.	.
PSORS4	P:603935	.	.
PSORS5	P:604316	.	.
PSORS6	P:605364	.	.
PSORS7	P:605606	.	.
PSORS8	P:610707	.	.
PSORS9	P:607857	.	.
PSPC1	G:612408	.	.
PSPH	G:172480	.	Phosphoserine phosphatase deficiency, 614023 (3)
PSPHP1	G:604239	.	.
PSPN	G:602921	.	.
PSRC1	G:613126	.	.
PSTK	G:611310	.	.
PSTPIP1	G:606347	.	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3)
PTAFR	G:173393	.	.
PTBP1	G:600693	.	.
PTBP2	G:608449	.	.
PTBP3	G:607527	.	.
PTCH1	G:601309	+GR-Bell	Basal cell carcinoma, somatic, 605462 (3)
PTCH1	G:601309	+GR-Bell	Basal cell nevus syndrome, 109400 (3)
PTCH1	G:601309	+GR-Bell	Holoprosencephaly-7, 610828 (3)
PTCH2	G:603673	.	Basal cell carcinoma, somatic, 605462 (3)
PTCH2	G:603673	.	Medulloblastoma, 155255 (3)
PTCHD1	G:300828	.	.
PTCHD2	G:611251	.	.
PTCHD3	G:611791	.	.
PTCRA	G:606817	.	.
PTDSS1	G:612792	.	.
PTDSS2	G:612793	.	.
PTEN	GP:601728	.	Bannayan-Riley-Ruvalcaba syndrome, 153480 (3)
PTEN	GP:601728	.	Cowden disease, 158350 (3)
PTEN	GP:601728	.	Endometrial carcinoma, somatic, 608089 (3)
PTEN	GP:601728	.	Lhermitte-Duclos syndrome, 158350 (3)
PTEN	GP:601728	.	Macrocephaly/autism syndrome, 605309 (3)
PTEN	GP:601728	.	Malignant melanoma, somatic, 155600 (3)
PTEN	GP:601728	.	Squamous cell carcinoma, head and neck, somatic, 275355 (3)
PTEN	GP:601728	.	Thyroid carcinoma, follicular, somatic, 188470 (3)
PTEN	GP:601728	.	VATER association with macrocephaly and ventriculomegaly, 276950 (3)
PTEN	GP:601728	.	{Glioma susceptibility 2}, 613028 (3)
PTEN	GP:601728	.	{Meningioma}, 607174 (3)
PTEN	GP:601728	.	{Prostate cancer, somatic}, 176807 (3)
PTENP1	G:613531	.	.
PTER	G:604446	.	.
PTF1A	G:607194	.	Diabetes mellitus, permanent neonatal, with cerebellar agenesis, 609069 (3)
PTGDR	G:604687	.	{Asthma, susceptibility to, 1}, 607277 (3)
PTGDR2	G:604837	.	.
PTGDS	G:176803	.	.
PTGER1	G:176802	.	.
PTGER2	G:176804	.	{Asthma, aspirin-induced, susceptibility to}, 208550 (3)
PTGER3	G:176806	.	.
PTGER4	G:601586	.	.
PTGES	G:605172	.	.
PTGES2	G:608152	.	.
PTGES3	G:607061	.	.
PTGFR	G:600563	.	.
PTGFRN	G:601204	.	.
PTGIR	G:600022	.	.
PTGIS	G:601699	.	Hypertension, essential, 145500 (3)
PTGR1	G:601274	.	.
PTGR2	G:608642	.	.
PTGS1	G:176805	.	.
PTGS2	G:600262	.	.
PTH	G:168450	.	Hypoparathyroidism, autosomal dominant, 146200 (3)
PTH	G:168450	.	Hypoparathyroidism, autosomal recessive, 146200 (3)
PTH1R	G:168468	Bell>skeletal	Chondrodysplasia, Blomstrand type, 215045 (3)
PTH1R	G:168468	Bell>skeletal	Eiken syndrome, 600002 (3)
PTH1R	G:168468	Bell>skeletal	Failure of tooth eruption, primary, 125350 (3)
PTH1R	G:168468	Bell>skeletal	Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3)
PTH2	G:608386	.	.
PTH2R	G:601469	.	.
PTHLH	GP:168470	.	Brachydactyly, type E2, 613382 (3)
PTK2	G:600758	.	.
PTK2B	G:601212	.	.
PTK6	G:602004	.	.
PTK7	G:601890	.	.
PTLAH	P:168860	.	.
PTMA	G:188390	.	.
PTMS	G:168440	.	.
PTN	G:162095	.	.
PTOS1	P:178300	.	.
PTOV1	G:610195	.	.
PTP4A1	G:601585	.	.
PTP4A2	G:601584	.	.
PTP4A3	G:606449	.	.
PTPLA	G:610467	.	.
PTPMT1	G:609538	.	.
PTPN1	G:176885	.	{Insulin resistance, susceptibility to}, 125853 (3)
PTPN11	G:176876	+GR-Bell	LEOPARD syndrome 1, 151100 (3)
PTPN11	G:176876	+GR-Bell	Leukemia, juvenile myelomonocytic, 607785 (3)
PTPN11	G:176876	+GR-Bell	Metachondromatosis, 156250 (3)
PTPN11	G:176876	+GR-Bell	Noonan syndrome 1, 163950 (3)
PTPN12	G:600079	.	.
PTPN13	G:600267	.	.
PTPN14	G:603155	.	Choanal atresia and lymphedema, 613611 (3)
PTPN18	G:606587	.	.
PTPN2	G:176887	.	.
PTPN20A	G:610630	.	.
PTPN20B	G:610631	.	.
PTPN21	G:603271	.	.
PTPN22	G:600716	.	{Diabetes, type 1, susceptibility to}, 222100 (3)
PTPN22	G:600716	.	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
PTPN22	G:600716	.	{Systemic lupus erythematosus susceptibility to}, 152700 (3)
PTPN23	G:606584	.	.
PTPN3	G:176877	.	.
PTPN4	G:176878	.	.
PTPN5	G:176879	.	.
PTPN6	G:176883	.	.
PTPN7	G:176889	.	.
PTPN9	G:600768	.	.
PTPRA	G:176884	.	.
PTPRB	G:176882	.	.
PTPRC	G:151460	.	Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)
PTPRC	G:151460	.	{Hepatitic C virus, susceptibility to}, 609532 (3)
PTPRCAP	G:601577	.	.
PTPRD	G:601598	.	.
PTPRE	G:600926	.	.
PTPRF	G:179590	.	.
PTPRG	G:176886	.	.
PTPRH	G:602510	.	.
PTPRJ	G:600925	.	Colon cancer, somatic, 114500 (3)
PTPRK	G:602545	.	.
PTPRM	G:176888	.	.
PTPRN	G:601773	.	.
PTPRN2	G:601698	.	.
PTPRO	G:600579	.	Nephrotic syndrome, type 6, 614196 (3)
PTPRQ	G:603317	.	Deafness, autosomal recessive 84, 613391 (3)
PTPRR	G:602853	.	.
PTPRS	G:601576	.	.
PTPRT	G:608712	.	.
PTPRU	G:602454	.	.
PTPRZ1	G:176891	.	.
PTPRZ2	G:604008	.	.
PTRF	G:603198	.	Lipodystrophy, congenital generalized, type 4, 613327 (3)
PTRH2	G:608625	.	.
PTS	G:612719	.	Hyperphenylalaninemia, BH4-deficient, A, 261640 (3)
PTTG1	G:604147	.	.
PTTG1IP	G:603784	.	.
PTTG2	G:604231	.	.
PTX3	G:602492	.	.
PTX4	G:613442	.	.
PUF60	G:604819	.	.
PUM1	G:607204	.	.
PUM2	G:607205	.	.
PURA	G:600473	.	.
PURB	G:608887	.	.
PUS1	G:608109	.	Mitochondrial myopathy and sideroblastic anemia 1, 600462 (3)
PUS10	G:612787	.	.
PVALB	G:168890	.	.
PVR	G:173850	.	.
PVRL1	G:600644	.	Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3)
PVRL1	G:600644	.	Orofacial cleft 7, 225060 (3)
PVRL2	G:600798	.	.
PVRL3	G:607147	.	.
PVRL4	G:609607	.	Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3)
PVT1	G:165140	.	.
PWP2	G:601475	.	.
PWRN1	G:611215	.	.
PWRN2	G:611217	.	.
PXDN	G:605158	.	.
PXK	G:611450	.	.
PXN	G:602505	.	.
PYCARD	G:606838	.	.
PYCR1	G:179035	.	Cutis laxa, autosomal recessive, type IIB, 612940 (3)
PYCR1	G:179035	.	Cutis laxa, autosomal recessive, type IIIB, 614438 (3)
PYGB	G:138550	.	.
PYGL	G:613741	+GR-Bell	Glycogen storage disease VI, 232700 (3)
PYGM	G:608455	+GR-Bell	McArdle disease, 232600 (3)
PYGO1	G:606902	.	.
PYGO2	G:606903	.	.
PYHIN1	G:612677	.	.
PYY	GP:600781	.	{Obesity}, 601665 (3)
PYY2	G:606637	.	.
PZP	G:176420	.	.
QARS	G:603727	.	.
QDPR	G:612676	.	Hyperphenylalaninemia, BH4-deficient, C, 261630 (3)
QKI	G:609590	.	.
QPCT	G:607065	.	.
QPRT	G:606248	.	.
QRFP	G:609795	.	.
QRFPR	G:606925	.	.
QSOX1	G:603120	.	.
QSOX2	G:612860	.	.
QTRT1	G:609615	.	.
RAB10	G:612672	.	.
RAB11A	G:605570	.	.
RAB11B	G:604198	.	.
RAB11FIP1	G:608737	.	.
RAB11FIP2	G:608599	.	.
RAB11FIP3	G:608738	.	.
RAB11FIP4	G:611999	.	.
RAB11FIP5	G:605536	.	.
RAB13	G:602672	.	.
RAB14	G:612673	.	.
RAB17	G:602206	.	.
RAB18	G:602207	.	Warburg micro syndrome 3, 614222 (3)
RAB1A	G:179508	.	.
RAB1B	G:612565	.	.
RAB21	G:612398	.	.
RAB22A	G:612966	.	.
RAB23	G:606144	Bell>developmental	Carpenter syndrome, 201000 (3)
RAB24	G:612415	.	.
RAB25	G:612942	.	.
RAB26	G:605455	.	.
RAB27A	G:603868	Bell>immunodeficiency	Griscelli syndrome, type 2, 607624 (3)
RAB27B	G:603869	.	.
RAB28	G:612994	.	.
RAB2A	G:179509	.	.
RAB2B	G:607466	.	.
RAB30	G:605693	.	.
RAB31	G:605694	.	.
RAB32	G:612906	.	.
RAB33A	G:300333	.	.
RAB33B	G:605950	.	.
RAB34	G:610917	.	.
RAB35	G:604199	.	.
RAB36	G:605662	.	.
RAB37	G:609956	.	.
RAB38	G:606281	.	.
RAB39B	G:300774	.	Mental retardation, X-linked 72, 300271 (3)
RAB3A	G:179490	.	.
RAB3B	G:179510	.	.
RAB3C	G:612829	.	.
RAB3D	G:604350	.	.
RAB3GAP1	G:602536	Bell>developmental	Warburg micro syndrome 1, 600118 (3)
RAB3GAP2	G:609275	Bell>neurological	Martsolf syndrome, 212720 (3)
RAB3GAP2	G:609275	Bell>neurological	Warburg micro syndrome 2, 614225 (3)
RAB3IP	G:608686	.	.
RAB40AL	G:300405	.	.
RAB4A	G:179511	.	.
RAB4B	G:612945	.	.
RAB5A	G:179512	.	.
RAB5B	G:179514	.	.
RAB5C	G:604037	.	.
RAB6A	G:179513	.	.
RAB6C	G:612909	.	.
RAB7A	G:602298	+GR-Bell	Charcot-Marie-Tooth disease, type 2B, 600882 (3)
RAB7L1	G:603949	.	.
RAB8A	G:165040	.	.
RAB8B	G:613532	.	.
RAB9A	G:300284	.	.
RAB9B	G:300285	.	.
RABAC1	G:604925	.	.
RABEP1	G:603616	.	.
RABEP2	G:611869	.	.
RABEPK	G:605962	.	.
RABGAP1L	G:609238	.	.
RABGEF1	G:609700	.	.
RABGGTA	G:601905	.	.
RABGGTB	G:179080	.	.
RABIF	G:603417	.	.
RABL2A	G:605412	.	.
RABL2B	G:605413	.	.
RAC1	G:602048	.	.
RAC2	G:602049	.	Neutrophil immunodeficiency syndrome, 608203 (3)
RAC3	G:602050	.	.
RACGAP1	G:604980	.	.
RAD1	G:603153	.	.
RAD17	G:603139	.	.
RAD18	G:605256	.	.
RAD21	G:606462	.	.
RAD23A	G:600061	.	.
RAD23B	G:600062	.	.
RAD50	G:604040	.	Nijmegen breakage syndrome-like disorder, 613078 (3)
RAD51	G:179617	.	Mirror movements 2, 614508 (3)
RAD51	G:179617	.	{Breast cancer, susceptibility to}, 114480 (3)
RAD51AP1	G:603070	.	.
RAD51B	G:602948	.	.
RAD51C	G:602774	+GR-Bell	Fanconi anemia, complementation group 0, 613390 (3)
RAD51C	G:602774	+GR-Bell	{Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3)
RAD51D	G:602954	.	{Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)
RAD52	G:600392	.	.
RAD54B	G:604289	.	Lymphoma, non-Hodgkin (3)
RAD54L	G:603615	.	Adenocarcinoma, colonic, somatic (3)
RAD54L	G:603615	.	Lymphoma, non-Hodgkin, somatic, 605027 (3)
RAD54L	G:603615	.	{Breast cancer, invasive ductal}, 114480 (3)
RAD9A	G:603761	.	.
RAD9B	G:608368	.	.
RADIL	G:611491	.	.
RAE1	G:603343	.	.
RAET1E	G:609243	.	.
RAET1G	G:609244	.	.
RAET1L	G:611047	.	.
RAF1	G:164760	+GR-Bell	LEOPARD syndrome 2, 611554 (3)
RAF1	G:164760	+GR-Bell	Noonan syndrome 5, 611553 (3)
RAG1	G:179615	Bell>immunodeficiency	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 (3)
RAG1	G:179615	Bell>immunodeficiency	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 (3)
RAG1	G:179615	Bell>immunodeficiency	Combined cellular and humoral immune defects with granulomas, 233650 (3)
RAG1	G:179615	Bell>immunodeficiency	Combined cellular and humoral immune defects with granulomas, 233650 (3)
RAG1	G:179615	Bell>immunodeficiency	Omenn syndrome, 603554 (3)
RAG1	G:179615	Bell>immunodeficiency	Omenn syndrome, 603554 (3)
RAG1	G:179615	Bell>immunodeficiency	Severe combined immunodeficiency, B cell-negative, 601457 (3)
RAG1	G:179615	Bell>immunodeficiency	Severe combined immunodeficiency, B cell-negative, 601457 (3)
RAG2	G:179616	Bell>immunodeficiency	Combined cellular and humoral immune defects with granulomas, 233650 (3)
RAG2	G:179616	Bell>immunodeficiency	Combined cellular and humoral immune defects with granulomas, 233650 (3)
RAG2	G:179616	Bell>immunodeficiency	Omenn syndrome, 603554 (3)
RAG2	G:179616	Bell>immunodeficiency	Omenn syndrome, 603554 (3)
RAG2	G:179616	Bell>immunodeficiency	Severe combined immunodeficiency, B cell-negative, 601457 (3)
RAG2	G:179616	Bell>immunodeficiency	Severe combined immunodeficiency, B cell-negative, 601457 (3)
RAI1	G:607642	+GR-Bell	Smith-Magenis syndrome, 182290 (3)
RAI14	G:606586	.	.
RAI2	G:300217	.	.
RALA	G:179550	.	.
RALB	G:179551	.	.
RALBP1	G:605801	.	.
RALGAPA1	G:608884	.	.
RALGDS	G:601619	.	.
RALGPS1	G:614444	.	.
RAMP1	G:605153	.	.
RAMP2	G:605154	.	.
RAMP3	G:605155	.	.
RAN	G:601179	.	.
RANBP1	G:601180	.	.
RANBP10	G:614031	.	.
RANBP17	G:606141	.	.
RANBP2	G:601181	.	{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)
RANBP3	G:603327	.	.
RANBP9	G:603854	.	.
RANGAP1	G:602362	.	.
RANGRF	G:607954	.	.
RAP1A	G:179520	.	.
RAP1B	G:179530	.	.
RAP1GAP	G:600278	.	.
RAP1GDS1	G:179502	.	Lymphocytic leukemia, acute T-cell (3)
RAP2A	G:179540	.	.
RAP2B	G:179541	.	.
RAPGEF1	G:600303	.	.
RAPGEF2	G:609530	.	.
RAPGEF3	G:606057	.	.
RAPGEF4	G:606058	.	.
RAPGEF5	G:609527	.	.
RAPGEF6	G:610499	.	.
RAPH1	G:609035	.	.
RAPSN	G:601592	Bell>developmental	Fetal akinesia deformation sequence, 208150 (3)
RAPSN	G:601592	Bell>developmental	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)
RAPSN	G:601592	Bell>developmental	Myasthenic syndrome, congenital, associated with facial dysmorphism and acetylcholine receptor deficiency, 608931 (3)
RARA	G:180240	.	.
RARB	G:180220	.	.
RARG	G:180190	.	.
RARRES1	G:605090	.	.
RARRES2	G:601973	.	.
RARRES3	G:605092	.	.
RARS	G:107820	.	.
RARS2	G:611524	.	Pontocerebellar hypoplasia, type 6, 611523 (3)
RASA1	G:139150	+GR-Bell	Basal cell carcinoma, somatic, 605462 (3)
RASA1	G:139150	+GR-Bell	Capillary malformation-arteriovenous malformation, 608354 (3)
RASA1	G:139150	+GR-Bell	Parkes Weber slndrome, 608355 (3)
RASA2	G:601589	.	.
RASA3	G:605182	.	.
RASA4	G:607943	.	.
RASAL1	G:604118	.	.
RASAL2	G:606136	.	.
RASD1	G:605550	.	.
RASD2	G:612842	.	.
RASEF	G:611344	.	.
RASGEF1A	G:614531	.	.
RASGEF1B	G:614532	.	.
RASGRF1	G:606600	.	.
RASGRF2	G:606614	.	.
RASGRP1	G:603962	.	.
RASGRP2	G:605577	.	.
RASGRP3	G:609531	.	.
RASGRP4	G:607320	.	.
RASIP1	G:609623	.	.
RASL10A	G:602220	.	.
RASL10B	G:612128	.	.
RASL11A	G:612403	.	.
RASL11B	G:612404	.	.
RASSF1	G:605082	.	.
RASSF2	G:609492	.	.
RASSF3	G:607019	.	.
RASSF4	G:610559	.	.
RASSF5	G:607020	.	.
RASSF6	G:612620	.	.
RASSF7	G:143023	.	.
RASSF8	G:608231	.	.
RASSF9	G:610383	.	.
RAVER1	G:609950	.	.
RAVER2	G:609953	.	.
RAX	G:601881	+GR-Bell	Microphthalmia, isolated 3, 611038 (3)
RAX2	G:610362	.	Cone-rod dystrophy 11, 610381 (3)
RAX2	G:610362	.	Macular degeneration, age-related, 6, 613757 (3)
RB1	G:614041	+GR-Bell	Bladder cancer, somatic, 109800 (3)
RB1	G:614041	+GR-Bell	Osteosarcoma, somatic, 259500 (3)
RB1	G:614041	+GR-Bell	Retinoblastoma, 180200 (3)
RB1	G:614041	+GR-Bell	Retinoblastoma, trilateral, 180200 (3)
RB1	G:614041	+GR-Bell	Small cell cancer of the lung, somatic, 182280 (3)
RB1CC1	G:606837	.	Breast cancer, somatic, 114480 (3)
RBAK	G:608191	.	.
RBBP4	G:602923	.	.
RBBP5	G:600697	.	.
RBBP6	G:600938	.	.
RBBP7	G:300825	.	.
RBBP8	G:604124	.	Jawad syndrome, 251255 (3)
RBBP8	G:604124	.	Pancreatic carcinoma, somatic (3)
RBBP8	G:604124	.	Seckel syndrome 2, 606744 (3)
RBBP9	G:602908	.	.
RBCK1	G:610924	.	.
RBFOX1	G:605104	.	.
RBFOX2	G:612149	.	.
RBKS	G:611132	.	.
RBL1	G:116957	.	.
RBL2	G:180203	.	.
RBM10	G:300080	.	TARP syndrome, 311900 (3)
RBM12	G:607179	.	.
RBM14	G:612409	.	.
RBM15	G:606077	.	.
RBM15B	G:612602	.	.
RBM17	G:606935	.	.
RBM20	G:613171	+GR-Bell	Cardiomyopathy, dilated, 1DD, 613172 (3)
RBM22	G:612430	.	.
RBM25	G:612427	.	.
RBM28	G:612074	.	Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3)
RBM3	G:300027	.	.
RBM38	G:612428	.	.
RBM39	G:604739	.	.
RBM4	G:602571	.	.
RBM42	G:613232	.	.
RBM45	G:608888	.	.
RBM5	G:606884	.	.
RBM6	G:606886	.	.
RBM7	G:612413	.	.
RBM8A	G:605313	.	.
RBMS1	G:602310	.	.
RBMS2	G:602387	.	.
RBMS3	G:605786	.	.
RBMX	G:300199	.	.
RBMXL2	G:605444	.	.
RBMY1A1	G:400006	.	.
RBP1	G:180260	.	.
RBP2	G:180280	.	.
RBP3	G:180290	.	.
RBP4	GP:180250	.	Retinol binding protein, deficiency of (3)
RBP5	G:611866	.	.
RBP7	G:608604	.	.
RBPJ	G:147183	.	.
RBPMS	G:601558	.	.
RBX1	G:603814	.	.
RC3H1	G:609424	.	.
RCAN1	G:602917	.	.
RCAN2	G:604876	.	.
RCAN3	G:605860	.	.
RCBTB1	G:607867	.	{Alcohol dependence, susceptibility to}, 103780 (3)
RCBTB2	G:603524	.	.
RCC1	G:179710	.	.
RCC2	G:609587	.	.
RCD1	P:180020	.	.
RCE1	G:605385	.	.
RCHY1	G:607680	.	.
RCL1	G:611405	.	.
RCN1	G:602735	.	.
RCN2	G:602584	.	.
RCOR1	G:607675	.	.
RCSD1	G:610579	.	.
RCVRN	G:179618	.	.
RD3	G:180040	+GR-Bell	Leber congenital amaurosis 12, 610612 (3)
RDBP	G:154040	.	.
RDH10	G:607599	.	.
RDH11	G:607849	.	.
RDH12	G:608830	+GR-Bell	Leber congenital amaurosis 13, 612712 (3)
RDH5	G:601617	.	Fundus albipunctatus, 136880 (3)
RDH8	G:608575	.	.
RDM1	G:612896	.	.
RDX	G:179410	.	Deafness, autosomal recessive 24, 611022 (3)
REC8	G:608193	.	.
RECK	G:605227	.	.
RECQL	G:600537	.	.
RECQL4	G:603780	+GR-Bell	Baller-Gerold syndrome, 218600 (3)
RECQL4	G:603780	+GR-Bell	RAPADILINO syndrome, 266280 (3)
RECQL4	G:603780	+GR-Bell	Rothmund-Thomson syndrome, 268400 (3)
RECQL5	G:603781	.	.
REEP1	G:609139	.	Spastic paraplegia 31, 610250 (3)
REEP2	G:609347	.	.
REEP3	G:609348	.	.
REEP4	G:609349	.	.
REEP5	G:125265	.	.
REEP6	G:609346	.	.
REG1A	G:167770	.	.
REG1B	G:167771	.	.
REG3A	G:167805	.	.
REG3G	G:609933	.	.
REG4	G:609846	.	.
REL	G:164910	.	.
RELA	G:164014	.	.
RELB	G:604758	.	.
RELL1	G:611212	.	.
RELL2	G:611213	.	.
RELN	G:600514	Bell>developmental	Lissencephaly 2 (Norman-Roberts type), 257320 (3)
RELT	G:611211	.	.
REM1	G:610388	.	.
REN	G:179820	Bell>renal	Hyperuricemic nephropathy, familial juvenile 2, 613092 (3)
REN	G:179820	Bell>renal	Renal tubular dysgenesis, 267430 (3)
RENBP	G:312420	.	.
REP15	G:610848	.	.
REPS2	G:300317	.	.
RERE	G:605226	.	.
RERG	G:612664	.	.
RESP18	G:612721	.	.
REST	G:600571	.	.
RET	GP:164761	+GR-Bell	Central hypoventilation syndrome, congenital, 209880 (3)
RET	GP:164761	+GR-Bell	Medullary thyroid carcinoma, 155240 (3)
RET	GP:164761	+GR-Bell	Multiple endocrine neoplasia IIA, 171400 (3)
RET	GP:164761	+GR-Bell	Multiple endocrine neoplasia IIB, 162300 (3)
RET	GP:164761	+GR-Bell	Pheochromocytoma, 171300 (3)
RET	GP:164761	+GR-Bell	Renal agenesis, 191830 (3)
RET	GP:164761	+GR-Bell	{Hirschsprung disease, susceptibility to, 1}, 142623 (3)
RETN	G:605565	.	{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)
RETN	G:605565	.	{Hypertension, insulin resistance-related, susceptibility to}, 125853 (3)
RETNLB	G:605645	.	.
REV1	G:606134	.	.
REV3L	G:602776	.	.
REXO1	G:609614	.	.
REXO2	G:607149	.	.
REXO4	G:602930	.	.
RFC1	G:102579	.	.
RFC2	G:600404	.	.
RFC3	G:600405	.	.
RFC4	G:102577	.	.
RFC5	G:600407	.	.
RFFL	G:609735	.	.
RFK	G:613010	.	.
RFNG	G:602578	.	.
RFPL1	G:605968	.	.
RFPL1-AS1	G:605972	.	.
RFPL2	G:605969	.	.
RFPL3	G:605970	.	.
RFPL3-AS1	G:605971	.	.
RFPL4A	G:612601	.	.
RFT1	G:611908	+GR-Bell	Congenital disorder of glycosylation, type In, 612015 (3)
RFWD2	G:608067	.	.
RFWD3	G:614151	.	.
RFX1	G:600006	.	.
RFX2	G:142765	.	.
RFX3	G:601337	.	.
RFX4	G:603958	.	.
RFX5	G:601863	.	Bare lymphocyte syndrome, type II, complementation group C, 209920 (3)
RFX5	G:601863	.	Bare lymphocyte syndrome, type II, complementation group E, 209920 (3)
RFX6	G:612659	.	.
RFX7	G:612660	.	.
RFXANK	G:603200	.	MHC class II deficiency, complementation group B, 209920 (3)
RFXAP	G:601861	.	Bare lymphocyte syndrome, type II, complementation group D, 209920 (3)
RGCC	G:610077	.	.
RGL1	G:605667	.	.
RGL2	G:602306	.	.
RGL4	G:612214	.	.
RGMA	G:607362	.	.
RGMB	G:612687	.	.
RGN	G:300212	.	.
RGPD1	G:612704	.	.
RGPD2	G:612705	.	.
RGPD3	G:612706	.	.
RGPD4	G:612707	.	.
RGPD5	G:612708	.	.
RGPD6	G:612709	.	.
RGPD8	G:602752	.	.
RGR	G:600342	+GR-Bell	Retinitis pigmentosa 44, 613769 (3)
RGS1	G:600323	.	.
RGS10	G:602856	.	.
RGS11	G:603895	.	.
RGS12	G:602512	.	.
RGS13	G:607190	.	.
RGS14	G:602513	.	.
RGS16	G:602514	.	.
RGS17	G:607191	.	.
RGS18	G:607192	.	.
RGS19	G:605071	.	.
RGS2	G:600861	.	.
RGS20	G:607193	.	.
RGS21	G:612407	.	.
RGS3	G:602189	.	.
RGS4	G:602516	.	.
RGS5	G:603276	.	.
RGS6	G:603894	.	.
RGS7	G:602517	.	.
RGS7BP	G:610890	.	.
RGS8	G:607189	.	.
RGS9	G:604067	.	Bradyopsia, 608415 (3)
RGS9BP	G:607814	.	Bradyopsia, 608415 (3)
RGSL1	G:611012	.	.
RHAG	G:180297	.	Anemia, hemolytic, Rh-null, regulator type, 268150 (3)
RHBDF1	G:614403	.	.
RHBDF2	G:614404	.	.
RHBDL1	G:603264	.	.
RHBDL2	G:608962	.	.
RHBG	G:607079	.	.
RHCE	GP:111700	.	Rh-null disease, amorph type (3)
RHCE	GP:111700	.	[Blood group, Rhesus] (3)
RHCG	G:605381	.	.
RHD	G:111680	.	.
RHEB	G:601293	.	.
RHO	G:180380	+GR-Bell	Night blindness, congenital stationery, autosomal dominant 1, 610445 (3)
RHO	G:180380	+GR-Bell	Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3)
RHO	G:180380	+GR-Bell	Retinitis punctata albescens, 136880 (3)
RHOA	G:165390	.	.
RHOB	G:165370	.	.
RHOBTB1	G:607351	.	.
RHOBTB2	G:607352	.	.
RHOBTB3	G:607353	.	.
RHOC	G:165380	.	.
RHOD	G:605781	.	.
RHOG	G:179505	.	.
RHOH	G:602037	.	.
RHOJ	G:607653	.	.
RHOQ	G:605857	.	.
RHOT1	G:613888	.	.
RHOT2	G:613889	.	.
RHOU	G:606366	.	.
RHOXF1	G:300446	.	.
RHOXF2	G:300447	.	.
RHPN1	G:601031	.	.
RIC3	G:610509	.	.
RIC8A	G:609146	.	.
RIC8B	G:609147	.	.
RICTOR	G:609022	.	.
RIEG2	P:601499	.	.
RIF1	G:608952	.	.
RILP	G:607848	.	.
RILPL1	G:614092	.	.
RILPL2	G:614093	.	.
RIMBP2	G:611602	.	.
RIMBP3	G:612699	.	.
RIMBP3B	G:612700	.	.
RIMBP3C	G:612701	.	.
RIMKLB	G:614054	.	.
RIMS1	G:606629	.	Cone-rod dystrophy 7, 603649 (3)
RIMS2	G:606630	.	.
RIMS3	G:611600	.	.
RIMS4	G:611601	.	.
RIN1	G:605965	.	.
RIN2	G:610222	.	Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3)
RIN3	G:610223	.	.
RING1	G:602045	.	.
RINT1	G:610089	.	.
RIOK3	G:603579	.	.
RIPK1	G:603453	.	.
RIPK2	G:603455	.	.
RIPK3	G:605817	.	.
RIPK4	G:605706	.	Popliteal pterygium syndrome, lethal type, 263650 (3)
RIPPLY1	G:300575	.	.
RIPPLY2	G:609891	.	.
RIT1	G:609591	.	.
RIT2	G:609592	.	.
RLBP1	G:180090	+GR-Bell	Bothnia retinal dystrophy, 607475 (3)
RLBP1	G:180090	+GR-Bell	Fundus albipunctatus, 136880 (3)
RLBP1	G:180090	+GR-Bell	Newfoundland rod-cone dystrophy, 607476 (3)
RLBP1	G:180090	+GR-Bell	Retinitis punctata albescens, 136880 (3)
RLF	G:180610	.	.
RLIM	G:300379	.	.
RLN1	G:179730	.	.
RLN2	G:179740	.	.
RLN3	G:606855	.	.
RLTPR	G:610859	.	.
RMD1	P:600332	.	.
RMI1	G:610404	.	.
RMI2	G:612426	.	.
RMRP	G:157660	Bell>immunodeficiency	Anauxetic dysplasia, 607095 (3)
RMRP	G:157660	Bell>immunodeficiency	Cartilage-hair hypoplasia, 250250 (3)
RMRP	G:157660	Bell>immunodeficiency	Metaphyseal dysplasia without hypotrichosis, 250460 (3)
RMRP	G:157660	Bell>skeletal	Anauxetic dysplasia, 607095 (3)
RMRP	G:157660	Bell>skeletal	Cartilage-hair hypoplasia, 250250 (3)
RMRP	G:157660	Bell>skeletal	Metaphyseal dysplasia without hypotrichosis, 250460 (3)
RMST	G:607045	.	.
RN5S1@	G:180420	.	.
RN7SK	G:606515	.	.
RN7SL1	G:612177	.	.
RN7SL2	G:612179	.	.
RN7SL3	G:612180	.	.
RNASE1	G:180440	.	.
RNASE2	G:131410	.	.
RNASE3	G:131398	.	.
RNASE4	G:601030	.	.
RNASE6	G:601981	.	.
RNASE7	G:612484	.	.
RNASE8	G:612485	.	.
RNASE9	G:614014	.	.
RNASEH1	G:604123	.	.
RNASEH2A	G:606034	+GR-Bell	Aicardi-Goutieres syndrome 4, 610333 (3)
RNASEH2B	G:610326	+GR-Bell	Aicardi-Goutieres syndrome 2, 610181 (3)
RNASEH2C	G:610330	.	Aicardi-Goutieres syndrome 3, 610329 (3)
RNASEL	G:180435	.	Prostate cancer 1, 176807, 601518 (3)
RNASET2	G:612944	.	Leukoencephalopathy, cystic, without megalencephaly, 612951 (3)
RND1	G:609038	.	.
RND2	G:601555	.	.
RND3	G:602924	.	.
RNF103	G:602507	.	.
RNF11	G:612598	.	.
RNF111	G:605840	.	.
RNF112	G:601237	.	.
RNF114	G:612451	.	.
RNF123	G:614472	.	.
RNF125	G:610432	.	.
RNF128	G:300439	.	.
RNF13	G:609247	.	.
RNF135	G:611358	.	Macrocephaly, macrosomia, facial dysmorphism syndrome, 614192 (3)
RNF139	G:603046	.	Renal cell carcinoma, 144700 (3)
RNF14	G:605675	.	.
RNF146	G:612137	.	.
RNF167	G:610431	.	.
RNF168	G:612688	.	RIDDLE syndrome, 611943 (3)
RNF17	G:605793	.	.
RNF181	G:612490	.	.
RNF187	G:613754	.	.
RNF19A	G:607119	.	.
RNF19B	G:610872	.	.
RNF2	G:608985	.	.
RNF20	G:607699	.	.
RNF212	G:612041	.	Recombination rate QTL 1, 612042 (3)
RNF213	G:613768	.	{Moyamoya disease 2, susceptibility to}, 607151 (3)
RNF216	G:609948	.	.
RNF24	G:612489	.	.
RNF26	G:606130	.	.
RNF31	G:612487	.	.
RNF32	G:610241	.	.
RNF34	G:608299	.	.
RNF38	G:612488	.	.
RNF39	G:607524	.	.
RNF4	G:602850	.	.
RNF40	G:607700	.	.
RNF43	G:612482	.	.
RNF5	G:602677	.	.
RNF6	G:604242	.	Esophageal carcinoma, somatic, 133239 (3)
RNF7	G:603863	.	.
RNF8	G:611685	.	.
RNGTT	G:603512	.	.
RNH1	G:173320	.	.
RNLS	G:609360	.	.
RNMT	G:603514	.	.
RNMTL1	G:612600	.	.
RNPEP	G:602675	.	.
RNPEPL1	G:605287	.	.
RNPS1	G:606447	.	.
RNR1	G:180450	.	.
RNR2	G:180451	.	.
RNR3	G:180452	.	.
RNR4	G:180453	.	.
RNR5	G:180454	.	.
RNU1-4	G:180680	.	.
RNU2-1	G:180690	.	.
RNU4ATAC	G:601428	.	Microcephalic osteodysplastic primordial dwarfism, type I, 210710 (3)
RNU5A-1	G:180691	.	.
RNU6-1	G:180692	.	.
RNU6ATAC	G:601429	.	.
RNY1	G:601821	.	.
RNY3	G:601822	.	.
RNY4	G:601823	.	.
RNY5	G:601824	.	.
ROBO1	G:602430	.	.
ROBO2	G:602431	.	Vesicoureteral reflux 2, 610878 (3)
ROBO3	G:608630	.	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
ROBO4	G:607528	.	.
ROCK1	G:601702	.	.
ROCK2	G:604002	.	.
ROM1	G:180721	+GR-Bell	Retinitis pigmentosa 7, digenic (3)
ROPN1	G:611757	.	.
ROPN1L	G:611756	.	.
ROR1	G:602336	.	.
ROR2	G:602337	+GR-Bell	Brachydactyly, type B1, 113000 (3)
ROR2	G:602337	+GR-Bell	Robinow syndrome, autosomal recessive, 268310 (3)
RORA	G:600825	.	.
RORB	G:601972	.	.
RORC	G:602943	.	.
ROS1	G:165020	.	.
RP1	G:603937	+GR-Bell	Retinitis pigmentosa 1, 180100 (3)
RP1	G:603937	+GR-Bell	{Hypertriglyceridemia, susceptibility to}, 145750 (3)
RP1L1	G:608581	.	Occult macular dystrophy, 613587 (3)
RP2	G:300757	+GR-Bell	Retinitis pigmentosa 2, 312600 (3)
RP22	P:602594	.	.
RP23	P:300424	.	.
RP24	P:300155	.	.
RP29	P:612165	.	.
RP32	P:609913	.	.
RP34	P:300605	.	.
RP6	P:312612	.	.
RP9	G:607331	+GR-Bell	Retinitis pigmentosa 9, 180104 (3)
RPA1	G:179835	.	.
RPA2	G:179836	.	.
RPA3	G:179837	.	.
RPA4	G:300767	.	.
RPAP1	G:611475	.	.
RPAP2	G:611476	.	.
RPAP3	G:611477	.	.
RPE	G:180480	.	.
RPE65	G:180069	+GR-Bell	Leber congenital amaurosis 2, 204100 (3)
RPE65	G:180069	+GR-Bell	Retinitis pigmentosa 20, 613794 (3)
RPGR	G:312610	+GR-Bell	Cone-rod dystrophy-1, 304020 (3)
RPGR	G:312610	+GR-Bell	Macular degeneration, X-linked atrophic, 300834 (3)
RPGR	G:312610	+GR-Bell	Retinitis pigmentosa 3, 300029 (3)
RPGR	G:312610	+GR-Bell	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3)
RPGRIP1	G:605446	+GR-Bell	Cone-rod dystrophy 13, 608194 (3)
RPGRIP1	G:605446	+GR-Bell	Leber congenital amaurosis 6, 613826 (3)
RPGRIP1L	G:610937	Bell>developmental	COACH syndrome, 216360 (3)
RPGRIP1L	G:610937	Bell>developmental	Joubert syndrome 7, 611560 (3)
RPGRIP1L	G:610937	Bell>developmental	Meckel syndrome, type 5, 611561 (3)
RPH3A	G:612159	.	.
RPH3AL	G:604881	.	.
RPIA	G:180430	.	Ribose 5-phosphate isomerase deficiency, 608611 (3)
RPL10	G:312173	.	{Autism, susceptibility to, X-linked 5}, 300847 (3)
RPL11	G:604175	.	Diamond-Blackfan anemia 7, 612562 (3)
RPL12	G:180475	.	.
RPL13	G:113703	.	.
RPL15	G:604174	.	.
RPL17	G:603661	.	.
RPL18	G:604179	.	.
RPL18A	G:604178	.	.
RPL19	G:180466	.	.
RPL21	G:603636	.	.
RPL22	G:180474	.	.
RPL23	G:603662	.	.
RPL23A	G:602326	.	.
RPL24	G:604180	.	.
RPL26	G:603704	.	.
RPL27	G:607526	.	.
RPL27A	G:603637	.	.
RPL28	G:603638	.	.
RPL29	G:601832	.	.
RPL3	G:604163	.	.
RPL30	G:180467	.	.
RPL35A	G:180468	.	Diamond-Blackfan anemia 5, 612528 (3)
RPL36AL	G:180469	.	.
RPL37	G:604181	.	.
RPL37A	G:613314	.	.
RPL38	G:604182	.	.
RPL39	G:601904	.	.
RPL39L	G:607547	.	.
RPL4	G:180479	.	.
RPL41	G:613315	.	.
RPL5	G:603634	.	Diamond-Blackfan anemia 6, 612561 (3)
RPL6	G:603703	.	.
RPL7	G:604166	.	.
RPL7A	G:185640	.	.
RPL8	G:604177	.	.
RPL9	G:603686	.	.
RPLP0	G:180510	.	.
RPLP1	G:180520	.	.
RPLP2	G:180530	.	.
RPN1	G:180470	.	.
RPN2	G:180490	.	.
RPP14	G:606112	.	.
RPP21	G:612524	.	.
RPP30	G:606115	.	.
RPP38	G:606116	.	.
RPP40	G:606117	.	.
RPPH1	G:608513	.	.
RPRD1A	G:610347	.	.
RPRM	G:612171	.	.
RPS10	G:603632	+GR-Bell	Diamond-Blackfan anemia 9, 613308 (3)
RPS11	G:180471	.	.
RPS12	G:603660	.	.
RPS13	G:180476	.	.
RPS14	G:130620	.	Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550 (3)
RPS15	G:180535	.	.
RPS15A	G:603674	.	.
RPS16	G:603675	.	.
RPS17	G:180472	.	Diamond-Blackfan anemia 4, 612527 (3)
RPS18	G:180473	.	.
RPS19	G:603474	.	Diamond-Blackfan anemia 1, 105650 (3)
RPS19BP1	G:610225	.	.
RPS2	G:603624	.	.
RPS20	G:603682	.	.
RPS20P3	G:180463	.	.
RPS20P4	G:180464	.	.
RPS21	G:180477	.	.
RPS23	G:603683	.	.
RPS24	G:602412	+GR-Bell	Diamond-blackfan anemia 3, 610629 (3)
RPS25	G:180465	.	.
RPS26	G:603701	.	Diamond-Blackfan anemia 10, 613309 (3)
RPS27	G:603702	.	.
RPS27A	G:191343	.	.
RPS27L	G:612055	.	.
RPS28	G:603685	.	.
RPS29	G:603633	.	.
RPS3	G:600454	.	.
RPS3A	G:180478	.	.
RPS4X	G:312760	.	.
RPS4Y1	G:470000	.	.
RPS4Y2	G:400030	.	.
RPS5	G:603630	.	.
RPS6	G:180460	.	.
RPS6KA1	G:601684	.	.
RPS6KA2	G:601685	.	.
RPS6KA3	G:300075	+GR-Bell	Coffin-Lowry syndrome, 303600 (3)
RPS6KA3	G:300075	+GR-Bell	Mental retardation, X-linked 19, 300844 (3)
RPS6KA4	G:603606	.	.
RPS6KA5	G:603607	.	.
RPS6KA6	G:300303	.	.
RPS6KB1	G:608938	.	.
RPS6KB2	G:608939	.	.
RPS7	G:603658	.	Diamond-Blackfan anemia 8, 612563 (3)
RPS8	G:600357	.	.
RPS9	G:603631	.	.
RPSA	G:150370	.	.
RPTN	G:613259	.	.
RPTOR	G:607130	.	.
RQCD1	G:612054	.	.
RRAD	G:179503	.	.
RRAGA	G:612194	.	.
RRAGB	G:300725	.	.
RRAGC	G:608267	.	.
RRAGD	G:608268	.	.
RRAS	G:165090	.	.
RRAS2	G:600098	.	.
RRBP1	G:601418	.	.
RREB1	G:602209	.	.
RRH	G:605224	.	.
RRM1	G:180410	.	.
RRM2	G:180390	.	.
RRM2B	G:604712	.	Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3)
RRM2B	G:604712	.	Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3)
RRM2B	G:604712	.	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5, 613077 (3)
RRN3	G:605121	.	.
RRP1	G:610653	.	.
RRP15	G:611193	.	.
RRP1B	G:610654	.	.
RRP36	G:613475	.	.
RS1	G:300839	Bell>ocular	Retinoschisis, 312700 (3)
RSAD2	G:607810	.	.
RSC1A1	G:601966	.	.
RSF1	G:608522	.	.
RSL24D1	G:613262	.	.
RSPH1	G:609314	.	.
RSPH4A	G:612647	.	Ciliary dyskinesia, primary, 11, 612649 (3)
RSPH6A	G:607548	.	.
RSPH9	G:612648	+GR-Bell	Ciliary dyskinesia, primary, 12, 612650 (3)
RSPO1	G:609595	.	Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3)
RSPO1	G:609595	.	Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal, 610644 (3)
RSPO2	G:610575	.	.
RSPO3	G:610574	.	.
RSPO4	G:610573	.	Anonychia congenita, 206800 (3)
RSRC1	G:613352	.	.
RSS	P:180860	.	.
RSU1	G:179555	.	.
RTBDN	G:609553	.	.
RTCA	G:611286	.	.
RTDR1	G:605663	.	.
RTEL1	G:608833	.	.
RTF1	G:611633	.	.
RTKN	G:602288	.	.
RTL1	G:611896	.	.
RTN1	G:600865	.	.
RTN2	G:603183	.	Spastic paraplegia 12, autosomal dominant, 604805 (3)
RTN3	G:604249	.	.
RTN4	G:604475	.	.
RTN4IP1	G:610502	.	.
RTN4R	G:605566	.	{Schizophrenia, susceptibility to}, 181500 (3)
RTN4RL1	G:610461	.	.
RTN4RL2	G:610462	.	.
RTP1	G:609137	.	.
RTP2	G:609138	.	.
RTP3	G:607181	.	.
RTP4	G:609350	.	.
RTTN	G:610436	.	.
RUFY1	G:610327	.	.
RUFY2	G:610328	.	.
RUFY3	G:611194	.	.
RUNDC3A	G:605448	.	.
RUNX1	G:151385	.	Leukemia, acute myeloid, 601626 (3)
RUNX1	G:151385	.	Platelet disorder, familial, with associated myeloid malignancy, 601399 (3)
RUNX1T1	G:133435	.	.
RUNX2	G:600211	+GR-Bell	Cleidocranial dysplasia, 119600 (3)
RUNX2	G:600211	+GR-Bell	Dental anomalies, isolated (3)
RUNX3	G:600210	.	.
RUSC2	G:611053	.	.
RUVBL1	G:603449	.	.
RUVBL2	G:604788	.	.
RXFP1	G:606654	.	.
RXFP2	G:606655	.	Cryptorchidism, bilateral, 219050 (3)
RXFP3	G:609445	.	.
RXFP4	G:609043	.	.
RXRA	G:180245	.	.
RXRB	G:180246	.	.
RXRG	G:180247	.	.
RYBP	G:607535	.	.
RYK	G:600524	.	.
RYR1	G:180901	+GR-Bell	Central core disease, 117000 (3)
RYR1	G:180901	+GR-Bell	Minicore myopathy with external ophthalmoplegia, 255320 (3)
RYR1	G:180901	+GR-Bell	Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 (3)
RYR1	G:180901	+GR-Bell	{Malignant hyperthermia susceptibility 1}, 145600 (3)
RYR2	G:180902	+GR-Bell	Arrhythmogenic right ventricular dysplasia 2, 600996 (3)
RYR2	G:180902	+GR-Bell	Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3)
RYR3	G:180903	.	.
S100A1	G:176940	.	.
S100A10	G:114085	.	.
S100A11	G:603114	.	.
S100A12	G:603112	.	.
S100A13	G:601989	.	.
S100A14	G:607986	.	.
S100A2	G:176993	.	.
S100A3	G:176992	.	.
S100A4	G:114210	.	.
S100A5	G:176991	.	.
S100A6	G:114110	.	.
S100A7	G:600353	.	.
S100A8	G:123885	.	.
S100A9	G:123886	.	.
S100B	G:176990	.	.
S100G	G:302020	.	.
S100P	G:600614	.	.
S100PBP	G:611889	.	.
S100Z	G:610103	.	.
S1PR1	G:601974	.	.
S1PR2	G:605111	.	.
S1PR3	G:601965	.	.
S1PR4	G:603751	.	.
S1PR5	G:605146	.	.
SAA1	G:104750	.	.
SAA2	G:104751	.	.
SAA4	G:104752	.	.
SACM1L	G:606569	.	.
SACS	G:604490	Bell>neurological	Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)
SAE1	G:613294	.	.
SAFB	G:602895	.	.
SAFB2	G:608066	.	.
SAG	G:181031	+GR-Bell	Oguchi disease-1, 258100 (3)
SAG	G:181031	+GR-Bell	Retinitis pigmentosa 47, 613758 (3)
SAGE1	G:300359	.	.
SAI1	G:154280	.	.
SALL1	G:602218	+GR-Bell	Townes-Brocks branchiootorenal-like syndrome, 107480 (3)
SALL1	G:602218	+GR-Bell	Townes-Brocks syndrome, 107480 (3)
SALL2	G:602219	.	.
SALL3	G:605079	.	.
SALL4	G:607343	+GR-Bell	Duane-radial ray syndrome, 607323 (3)
SALL4	G:607343	+GR-Bell	IVIC syndrome, 147750 (3)
SAMD4A	G:610747	.	.
SAMD8	G:611575	.	.
SAMD9	G:610456	.	Tumoral calcinosis, familial, normophosphatemic, 610455 (3)
SAMD9L	G:611170	.	.
SAMHD1	G:606754	+GR-Bell	Aicardi-Goutieres syndrome 5, 612952 (3)
SAMHD1	G:606754	+GR-Bell	Chilblain lupus 2, 614415 (3)
SAMM50	G:612058	.	.
SAMSN1	G:607978	.	.
SAP130	G:609697	.	.
SAP18	G:602949	.	.
SAP30	G:603378	.	.
SAP30BP	G:610218	.	.
SAP30L	G:610398	.	.
SAPCD2	G:612057	.	.
SAR1A	G:607691	.	.
SAR1B	G:607690	.	Chylomicron retention disease, 246700 (3)
SARDH	G:604455	.	.
SARM1	G:607732	.	.
SARNP	G:610049	.	.
SARS	G:607529	.	.
SARS2	G:612804	.	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis, 613845 (3)
SART1	G:605941	.	.
SART3	G:611684	.	Porokeratosis, disseminated superficial actinic, 1, 175900 (3)
SASH1	G:607955	.	.
SASH3	G:300441	.	.
SASS6	G:609321	.	.
SAT1	G:313020	.	Keratosis follicularis spinulosa decalvans, 308800 (3)
SAT2	G:611463	.	.
SATB1	G:602075	.	.
SATB2	G:608148	.	Cleft palate and mental retardation, 119540 (3)
SAV1	G:607203	.	.
SAX1	P:108600	.	.
SAX2	P:611302	.	.
SBDS	G:607444	Bell>hematologic	Shwachman-Bodian-Diamond syndrome, 260400 (3)
SBF1	G:603560	.	.
SBF2	G:607697	+GR-Bell	Charcot-Marie-Tooth disease, type 4B2, 604563 (3)
SBNO1	G:614274	.	.
SBSN	G:609969	.	.
SC5DL	G:602286	Bell>metabolic	Lathosterolosis, 607330 (3)
SCA18	P:607458	.	.
SCA19	P:607346	.	.
SCA20	P:608687	.	.
SCA21	P:607454	.	.
SCA25	P:608703	.	.
SCA26	P:609306	.	.
SCA29	P:117360	.	.
SCA30	P:613371	.	.
SCA31	P:117210	.	.
SCA32	P:613909	.	.
SCA34	P:133190	.	.
SCA9	P:612876	.	.
SCAANT1	G:614481	.	.
SCAF11	G:603668	.	.
SCAMP1	G:606911	.	.
SCAMP2	G:606912	.	.
SCAMP3	G:606913	.	.
SCAMP4	G:613764	.	.
SCAMP5	G:613766	.	.
SCAND1	G:610416	.	.
SCAND2	G:610417	.	.
SCAP	G:601510	.	.
SCAPER	G:611611	.	.
SCAR2	P:213200	.	.
SCAR3	P:271250	.	.
SCAR7	P:609270	.	.
SCARA3	G:602728	.	.
SCARA5	G:611306	.	.
SCARB1	G:601040	.	[High density lipoprotien cholesterol level QTL6], 610762 (3)
SCARB2	G:602257	.	Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3)
SCARF1	G:607873	.	.
SCARF2	G:613619	.	Van den Ende-Gupta syndrome, 600920 (3)
SCARNA15	G:612675	.	.
SCARNA18	G:611329	.	.
SCASI	P:607317	.	.
SCAX1	P:302500	.	.
SCAX2	P:302600	.	.
SCAX3	P:301790	.	.
SCAX4	P:301840	.	.
SCD	G:604031	.	.
SCD5	G:608370	.	.
SCEL	G:604112	.	.
SCG2	G:118930	.	.
SCG3	G:611796	.	.
SCG5	G:173120	.	.
SCGB1A1	G:192020	.	{Asthma, susceptibility to}, 600807 (3)
SCGB1C1	G:610176	.	.
SCGB2A1	G:604398	.	.
SCGB2A2	G:605562	.	.
SCGB3A1	G:606500	.	.
SCGB3A2	G:606531	.	{Asthma, susceptibility to}, 600807 (3)
SCGN	G:609202	.	.
SCIMP	G:614406	.	.
SCIN	G:613416	.	.
SCKL2	P:606744	.	.
SCKL3	P:608664	.	.
SCLT1	G:611399	.	.
SCLY	G:611056	.	.
SCML1	G:300227	.	.
SCML2	G:300208	.	.
SCN10A	G:604427	.	.
SCN11A	G:604385	.	.
SCN1A	G:182389	+GR-Bell	Dravet syndrome, 607208 (3)
SCN1A	G:182389	+GR-Bell	Epilepsy, generalized, with febrile seizures plus, type 2, 604403 (3)
SCN1A	G:182389	+GR-Bell	Febrile seizures, familial, 3A, 604403 (3)
SCN1A	G:182389	+GR-Bell	Migraine, familial hemiplegic, 3, 609634 (3)
SCN1B	G:600235	+GR-Bell	Brugada syndrome 5, 612838 (3)
SCN1B	G:600235	+GR-Bell	Cardiac conduction defect, nonspecific, 612838 (3)
SCN1B	G:600235	+GR-Bell	Generalized epilepsy with febrile seizures plus, type 1, 604233 (3)
SCN2A	G:182390	.	Epileptic encephalopathy, early infantile, 11, 613721 (3)
SCN2A	G:182390	.	Seizures, benign familial infantile, 3, 607745 (3)
SCN2B	G:601327	.	.
SCN3A	G:182391	.	.
SCN3B	G:608214	+GR-Bell	Brugada syndrome 7, 613120 (3)
SCN4A	G:603967	+GR-Bell	Hyperkalemic periodic paralysis, type 2, 613345 (3)
SCN4A	G:603967	+GR-Bell	Myasthenic syndrome, acetazolamide-responsive, 614198 (3)
SCN4A	G:603967	+GR-Bell	Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3)
SCN4A	G:603967	+GR-Bell	Paramyotonia congenita, 168300 (3)
SCN4B	G:608256	+GR-Bell	Long QT syndrome-10, 611819 (3)
SCN5A	G:600163	+GR-Bell	Atrial fibrillation, familial, 10, 614022 (3)
SCN5A	G:600163	+GR-Bell	Brugada syndrome 1, 601144 (3)
SCN5A	G:600163	+GR-Bell	Cardiomyopathy, dilated, 1E, 601154 (3)
SCN5A	G:600163	+GR-Bell	Heart block, nonprogressive, 113900 (3)
SCN5A	G:600163	+GR-Bell	Heart block, progressive, type IA, 113900 (3)
SCN5A	G:600163	+GR-Bell	Long QT syndrome-3, 603830 (3)
SCN5A	G:600163	+GR-Bell	Sick sinus syndrome 1, 608567 (3)
SCN5A	G:600163	+GR-Bell	Ventricular fibrillation, familial, 1, 603829 (3)
SCN5A	G:600163	+GR-Bell	{Sudden infant death syndrome, susceptibility to}, 272120 (3)
SCN7A	G:182392	.	.
SCN8A	G:600702	.	Cognitive impairment with or without cerebellar ataxia, 614306 (3)
SCN8A	G:600702	.	Epileptic encephalopathy, early infantile, 13, 614558 (3)
SCN9A	G:603415	+GR-Bell	Dravet syndrome, 607208 (3)
SCN9A	G:603415	+GR-Bell	Epilepsy, generalized, with febrile seizures plus, type 7, 613863 (3)
SCN9A	G:603415	+GR-Bell	Erythermalgia, primary, 133020 (3)
SCN9A	G:603415	+GR-Bell	Febrile seizures, familial, 3B, 613863 (3)
SCN9A	G:603415	+GR-Bell	Insensitivity to pain, channelopathy-associated, 243000 (3)
SCN9A	G:603415	+GR-Bell	Paroxysmal extreme pain disorder, 167400 (3)
SCN9A	G:603415	+GR-Bell	Small fiber neuropathy, 133020 (3)
SCNM1	G:608095	.	.
SCNN1A	G:600228	Bell>renal	Bronchiectasis with or without elevated sweat chloride 2, 613021 (3)
SCNN1A	G:600228	Bell>renal	Pseudohypoaldosteronism, type I, 264350 (3)
SCNN1B	G:600760	Bell>renal	Bronchiectasis with or without elevated sweat chloride 1, 211400 (3)
SCNN1B	G:600760	Bell>renal	Liddle syndrome, 177200 (3)
SCNN1B	G:600760	Bell>renal	Pseudohypoaldosteronism, type I, 264350 (3)
SCNN1D	G:601328	.	.
SCNN1G	G:600761	Bell>renal	Bronchiectasis with or without elevated sweat chloride 3, 613071 (3)
SCNN1G	G:600761	Bell>renal	Liddle syndrome, 177200 (3)
SCNN1G	G:600761	Bell>renal	Pseudohypoaldosteronism, type I, 264350 (3)
SCO1	G:603644	.	Hepatic failure, early onset, and neurologic disorder (3)
SCO2	G:604272	Bell>metabolic	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency, 604377 (3)
SCP2	G:184755	.	Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3)
SCRG1	G:603163	.	.
SCRIB	G:607733	.	.
SCRT1	G:605858	.	.
SCT	G:182099	.	.
SCTR	G:182098	.	.
SCUBE1	G:611746	.	.
SCUBE2	G:611747	.	.
SCXA	G:609067	.	.
SCYL1	G:607982	.	.
SCYL3	G:608192	.	.
SCZD1	P:181510	.	.
SCZD10	P:605419	.	.
SCZD2	P:603342	.	.
SCZD3	P:600511	.	.
SCZD6	P:603013	.	.
SCZD7	P:603176	.	.
SCZD8	P:603206	.	.
SDC1	G:186355	.	.
SDC2	G:142460	.	.
SDC3	G:186357	.	{Obesity, association with}, 601665 (3)
SDC4	G:600017	.	.
SDCBP	G:602217	.	.
SDCCAG8	G:613524	.	.
SDF2	G:602934	.	.
SDF2L1	G:607551	.	.
SDF4	G:614282	.	.
SDHA	G:600857	.	Cardiomyopathy, dilated, 1GG, 613642 (3)
SDHA	G:600857	.	Leigh syndrome, 256000 (3)
SDHA	G:600857	.	Mitochondrial respiratory chain complex II deficiency, 252011 (3)
SDHA	G:600857	.	Paragangliomas 5, 614165 (3)
SDHAF1	G:612848	.	Mitochondrial complex II deficiency, 252011 (3)
SDHAF2	G:613019	.	Paragangliomas 2, 601650 (3)
SDHB	G:185470	+GR-Bell	Cowden-like syndrome, 612359 (3)
SDHB	G:185470	+GR-Bell	Gastrointestinal stromal tumor, 606764 (3)
SDHB	G:185470	+GR-Bell	Paraganglioma and gastric stromal sarcoma, 606864 (3)
SDHB	G:185470	+GR-Bell	Paragangliomas 4, 115310 (3)
SDHB	G:185470	+GR-Bell	Pheochromocytoma, 171300 (3)
SDHC	G:602413	+GR-Bell	Gastrointestinal stromal tumor, 606764 (3)
SDHC	G:602413	+GR-Bell	Paraganglioma and gastric stromal sarcoma, 606864 (3)
SDHC	G:602413	+GR-Bell	Paragangliomas 3, 605373 (3)
SDHD	G:602690	+GR-Bell	Carcinoid tumors, intestinal, 114900 (3)
SDHD	G:602690	+GR-Bell	Cowden-like syndrome, 612359 (3)
SDHD	G:602690	+GR-Bell	Merkel cell carcinoma, somatic (3)
SDHD	G:602690	+GR-Bell	Paraganglioma and gastric stromal sarcoma, 606864 (3)
SDHD	G:602690	+GR-Bell	Paragangliomas 1, with or without deafness, 168000 (3)
SDHD	G:602690	+GR-Bell	Pheochromocytoma, 171300 (3)
SDK1	G:607216	.	.
SDK2	G:607217	.	.
SDPR	G:606728	.	.
SDR16C5	G:608989	.	.
SDR9C7	G:609769	.	.
SDS	G:182128	.	.
SEA	G:165110	.	.
SEBOX	G:610975	.	.
SEC13	G:600152	.	.
SEC14L1	G:601504	.	.
SEC14L2	G:607558	.	.
SEC14L3	G:612824	.	.
SEC14L4	G:612825	.	.
SEC16A	G:612854	.	.
SEC16B	G:612855	.	.
SEC22A	G:612442	.	.
SEC22B	G:604029	.	.
SEC22C	G:604028	.	.
SEC23A	G:610511	.	Craniolenticulosutural dysplasia, 607812 (3)
SEC23B	G:610512	.	Anemia, dyserythropoietic congenital, type II, 224100 (3)
SEC24A	G:607183	.	.
SEC24B	G:607184	.	.
SEC24C	G:607185	.	.
SEC24D	G:607186	.	.
SEC31A	G:610257	.	.
SEC31B	G:610258	.	.
SEC61A1	G:609213	.	.
SEC61B	G:609214	.	.
SEC61G	G:609215	.	.
SEC62	G:602173	.	.
SEC63	G:608648	.	Polycystic liver disease, 174050 (3)
SECISBP2	G:607693	.	Thyroid hormone metabolism, abnormal, 609698 (3)
SECTM1	G:602602	.	.
SEH1L	G:609263	.	.
SEL1L	G:602329	.	.
SEL1L2	G:614289	.	.
SELE	G:131210	.	.
SELENBP1	G:604188	.	.
SELL	G:153240	.	.
SELP	GP:173610	.	{Atopy, susceptibility to}, 147050 (3)
SELPLG	G:600738	.	.
SEMA3A	G:603961	.	.
SEMA3B	G:601281	.	.
SEMA3C	G:602645	.	.
SEMA3D	G:609907	.	.
SEMA3E	G:608166	.	CHARGE syndrome, 214800 (3)
SEMA3F	G:601124	.	.
SEMA4A	G:607292	+GR-Bell	Cone-rod dystrophy 10, 610283 (3)
SEMA4A	G:607292	+GR-Bell	Retinitis pigmentosa 35, 610282 (3)
SEMA4C	P:604462	.	.
SEMA4D	G:601866	.	.
SEMA4F	G:603706	.	.
SEMA5A	G:609297	.	.
SEMA5B	G:609298	.	.
SEMA6A	G:605885	.	.
SEMA6B	G:608873	.	.
SEMA6C	G:609294	.	.
SEMA6D	G:609295	.	.
SEMA7A	GP:607961	.	[Blood group, John-Milton-Hagen] (3)
SEMG1	G:182140	.	.
SEMG2	G:182141	.	.
SENP1	G:612157	.	.
SENP2	G:608261	.	.
SENP3	G:612844	.	.
SENP5	G:612845	.	.
SENP6	G:605003	.	.
SENP7	G:612846	.	.
SENP8	G:608659	.	.
SEPHS1	G:600902	.	.
SEPHS2	G:606218	.	.
SEPN1	G:606210	Bell>neurological	Muscular dystrophy, rigid spine, 1, 602771 (3)
SEPN1	G:606210	Bell>neurological	Myopathy, congenital, with fiber-type disproportion, 255310 (3)
SEPP1	G:601484	.	.
SEPSECS	G:613009	.	Pontocerebellar hypoplasia type 2D, 613811 (3)
SEPT1	G:612897	.	.
SEPT10	G:611737	.	.
SEPT11	G:612887	.	.
SEPT12	G:611562	.	.
SEPT14	G:612140	.	.
SEPT2	G:601506	.	.
SEPT3	G:608314	.	.
SEPT4	G:603696	.	.
SEPT5	G:602724	.	.
SEPT6	G:300683	.	.
SEPT7	G:603151	.	.
SEPT7P2	G:611563	.	.
SEPT8	G:608418	.	.
SEPT9	G:604061	.	Amyotrophy, hereditary neuralgic, 162100 (3)
SEPW1	G:603235	.	.
SERBP1	G:607378	.	.
SERF1A	G:603011	.	.
SERF2	G:605054	.	.
SERGEF	G:606051	.	.
SERHL	G:607979	.	.
SERINC1	G:614548	.	.
SERINC2	G:614549	.	.
SERINC3	G:607165	.	.
SERINC4	G:614550	.	.
SERINC5	G:614551	.	.
SERPINA1	G:107400	Bell>hepatic	Emphysema due to AAT deficiency, 613490 (3)
SERPINA1	G:107400	Bell>hepatic	Emphysema-cirrhosis, due to AAT deficiency, 613490 (3)
SERPINA1	G:107400	Bell>hepatic	Hemorrhagic diathesis due to \'antithrombin\' Pittsburgh, 613490 (3)
SERPINA10	G:605271	.	{Venous thrombosis, susceptibility to} (3)
SERPINA2	P:107410	.	.
SERPINA3	G:107280	.	Cerebrovascular disease, occlusive (3)
SERPINA4	G:147935	.	.
SERPINA5	G:601841	.	.
SERPINA6	G:122500	.	Corticosteroid-binding globulin deficiency, 611489 (3)
SERPINA7	GP:314200	.	.
SERPINB1	G:130135	.	.
SERPINB10	G:602058	.	.
SERPINB13	G:604445	.	.
SERPINB2	G:173390	.	.
SERPINB3	G:600517	.	.
SERPINB4	G:600518	.	.
SERPINB5	G:154790	.	.
SERPINB6	G:173321	.	Deafness, autosomal recessive 91, 613453 (3)
SERPINB7	G:603357	.	.
SERPINB8	G:601697	.	.
SERPINB9	G:601799	.	.
SERPINC1	G:107300	.	Thrombophilia due to antithrombin III deficiency, 613118 (3)
SERPIND1	G:142360	.	Thrombophilia due to heparin cofactor II deficiency, 612356 (3)
SERPINE1	G:173360	.	Plasminogen activator inhibitor-1 deficiency, 613329 (3)
SERPINE1	G:173360	.	{Transcription of plasminogen activator inhibitor, modulator of} (3)
SERPINE2	G:177010	.	.
SERPINF1	G:172860	.	Osteogenesis imperfecta, type VI, 613982 (3)
SERPINF2	G:613168	.	Alpha-2-plasmin inhibitor deficiency, 262850 (3)
SERPING1	G:606860	.	Angioedema, hereditary, types I and II, 106100 (3)
SERPING1	G:606860	.	Complement component 4, partial deficiency of, 120790 (3)
SERPINH1	G:600943	.	Osteogenesis imperfecta, type X, 613848 (3)
SERPINH1	G:600943	.	{Preterm premature rupture of the membranes, susceptibility to}, 610504 (3)
SERPINI1	G:602445	.	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)
SERPINI2	G:605587	.	.
SERTAD3	G:612125	.	.
SESN1	G:606103	.	.
SESN2	G:607767	.	.
SESN3	G:607768	.	.
SET	G:600960	.	.
SETBP1	G:611060	.	Schinzel-Giedion midface retraction syndrome, 269150 (3)
SETD1A	G:611052	.	.
SETD1B	G:611055	.	.
SETD2	G:612778	.	.
SETD7	G:606594	.	.
SETD8	G:607240	.	.
SETDB1	G:604396	.	.
SETDB2	G:607865	.	.
SETMAR	G:609834	.	.
SETX	G:608465	+GR-Bell	Amyotrophic lateral sclerosis 4, juvenile, 602433 (3)
SETX	G:608465	+GR-Bell	Ataxia-ocular apraxia-2, 606002 (3)
SEZ6L	G:607021	.	.
SF1	G:601516	.	.
SF3A1	G:605595	.	.
SF3A2	G:600796	.	.
SF3A3	G:605596	.	.
SF3B1	G:605590	.	Myelodysplastic syndrome, somatic, 614286 (3)
SF3B2	G:605591	.	.
SF3B3	G:605592	.	.
SF3B4	G:605593	.	.
SFI1	G:612765	.	.
SFMBT1	G:607319	.	.
SFN	G:601290	.	.
SFPQ	G:605199	.	.
SFRP1	G:604156	.	.
SFRP2	G:604157	.	.
SFRP4	G:606570	.	.
SFRP5	G:604158	.	.
SFSWAP	G:601945	.	.
SFTPA1	G:178630	Bell>respiratory	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)
SFTPA2	G:178642	.	Pulmonary fibrosis, idiopathic, 178500 (3)
SFTPB	G:178640	Bell>metabolic	Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)
SFTPB	G:178640	Bell>respiratory	Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)
SFTPC	G:178620	Bell>respiratory	Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3)
SFTPD	G:178635	.	.
SGCA	G:600119	Bell>neurological	Muscular dystrophy, limb-girdle, type 2D, 608099 (3)
SGCB	G:600900	.	Muscular dystrophy, limb-girdle, type 2E, 604286 (3)
SGCD	G:601411	+GR-Bell	Cardiomyopathy, dilated, 1L, 606685 (3)
SGCD	G:601411	+GR-Bell	Muscular dystrophy, limb-girdle, type 2F, 601287 (3)
SGCE	G:604149	+GR-Bell	Dystonia-11, myoclonic, 159900 (3)
SGCG	G:608896	.	Muscular dystrophy, limb-girdle, type 2C, 253700 (3)
SGCZ	G:608113	.	.
SGIP1	G:611540	.	.
SGK1	G:602958	.	.
SGK2	G:607589	.	.
SGK3	G:607591	.	.
SGMS1	G:611573	.	.
SGMS2	G:611574	.	.
SGOL1	G:609168	.	.
SGOL2	G:612425	.	.
SGPL1	G:603729	.	.
SGPP1	G:612826	.	.
SGPP2	G:612827	.	.
SGSH	G:605270	Bell>metabolic	Mucopolysaccharidisis type IIIA (Sanfilippo A), 252900 (3)
SGSM1	G:611417	.	.
SGSM2	G:611418	.	.
SGSM3	G:610440	.	.
SGTA	G:603419	.	.
SH2B1	G:608937	.	.
SH2B2	G:605300	.	.
SH2B3	G:605093	.	Erythrocytosis, somatic, 133100 (3)
SH2B3	G:605093	.	Myelofibrosis, somatic, 254450 (3)
SH2B3	G:605093	.	Thrombocythemia, somatic, 187950 (3)
SH2D1A	G:300490	Bell>immunodeficiency	Lymphoproliferative syndrome, X-linked, 308240 (3)
SH2D1B	G:608510	.	.
SH2D2A	G:604514	.	.
SH2D3A	G:604721	.	.
SH2D3C	G:604722	.	.
SH3BGR	G:602230	.	.
SH3BGRL	G:300190	.	.
SH3BP2	G:602104	+GR-Bell	Cherubism, 118400 (3)
SH3BP4	G:605611	.	.
SH3BP5	G:605612	.	.
SH3D19	G:608674	.	.
SH3GL1	G:601768	.	.
SH3GL2	G:604465	.	.
SH3GL3	G:603362	.	.
SH3GLB1	G:609287	.	.
SH3GLB2	G:609288	.	.
SH3KBP1	G:300374	.	.
SH3PXD2B	G:613293	.	Frank-ter Haar syndrome, 249420 (3)
SH3RF2	G:613377	.	.
SH3TC2	G:608206	+GR-Bell	Charcot-Marie-Tooth disease, type 4C, 601596 (3)
SH3TC2	G:608206	+GR-Bell	Mononeuropathy of the median nerve, mild, 613353 (3)
SHANK1	G:604999	.	.
SHANK2	G:603290	.	{Autism susceptibility 17}, 613436 (3)
SHANK3	G:606230	+GR-Bell	Phelan-McDermid syndrome, 606232 (3)
SHANK3	G:606230	+GR-Bell	{Schizophrenia 15}, 613950 (3)
SHARPIN	G:611885	.	.
SHB	G:600314	.	.
SHBG	G:182205	.	.
SHC1	G:600560	.	.
SHC1P2	G:600739	.	.
SHC2	G:605217	.	.
SHC3	G:605263	.	.
SHCBP1	G:611027	.	.
SHD	G:610481	.	.
SHE	G:610482	.	.
SHFM1	P:183600	.	.
SHFM2	P:313350	.	.
SHFM5	P:606708	.	.
SHH	G:600725	.	Holoprosencephaly-3, 142945 (3)
SHH	G:600725	.	Microphthalmia with coloboma 5, 611638 (3)
SHH	G:600725	.	Schizencephaly, 269160 (3)
SHH	G:600725	.	Single median maxillary central incisor, 147250 (3)
SHISA5	G:607290	.	.
SHISA9	G:613346	.	.
SHMT1	G:182144	.	.
SHMT2	G:138450	.	.
SHOC2	G:602775	.	Noonan-like syndrome with loose anagen hair, 607721 (3)
SHOX	G:312865	+GR-Bell	Langer mesomelic dysplasia, 249700 (3)
SHOX	G:312865	+GR-Bell	Langer mesomelic dysplasia, 249700 (3)
SHOX	G:312865	+GR-Bell	Leri-Weill dyschondrosteosis, 127300 (3)
SHOX	G:312865	+GR-Bell	Leri-Weill dyschondrosteosis, 127300 (3)
SHOX	G:312865	+GR-Bell	Short stature, idiopathic familial, 300582 (3)
SHOX	G:312865	+GR-Bell	Short stature, idiopathic familial, 300582 (3)
SHOX	G:400020	+GR-Bell	Langer mesomelic dysplasia, 249700 (3)
SHOX	G:400020	+GR-Bell	Langer mesomelic dysplasia, 249700 (3)
SHOX	G:400020	+GR-Bell	Leri-Weill dyschondrosteosis, 127300 (3)
SHOX	G:400020	+GR-Bell	Leri-Weill dyschondrosteosis, 127300 (3)
SHOX	G:400020	+GR-Bell	Short stature, idiopathic familial, 300582 (3)
SHOX	G:400020	+GR-Bell	Short stature, idiopathic familial, 300582 (3)
SHOX2	G:602504	.	.
SHPK	G:605060	.	.
SHPRH	G:608048	.	.
SHQ1	G:613663	.	.
SHROOM1	G:611179	.	.
SHROOM2	G:300103	.	.
SHROOM3	G:604570	.	.
SHROOM4	G:300579	.	Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)
SIAE	G:610079	.	{Autoimmune disease, susceptibility to, 6}, 613551 (3)
SIAH1	G:602212	.	.
SIAH2	G:602213	.	.
SIDT1	G:606816	.	.
SIGIRR	G:605478	.	.
SIGLEC1	G:600751	.	.
SIGLEC10	G:606091	.	.
SIGLEC11	G:607157	.	.
SIGLEC12	G:606094	.	.
SIGLEC5	G:604200	.	.
SIGLEC6	G:604405	.	.
SIGLEC7	G:604410	.	.
SIGLEC8	G:605639	.	.
SIGLEC9	G:605640	.	.
SIGMAR1	G:601978	.	Amyotrophic lateral sclerosis 16, juvenile, 614373 (3)
SIK1	G:605705	.	.
SIK2	G:608973	.	.
SIKE1	G:611656	.	.
SIL1	G:608005	Bell>neurological	Marinesco-Sjogren syndrome, 248800 (3)
SIM1	G:603128	.	Obesity, severe, 601665 (3)
SIM2	G:600892	.	.
SIN3A	G:607776	.	.
SIN3B	G:607777	.	.
SIPA1	G:602180	.	.
SIPA1L2	G:611609	.	.
SIRPA	G:602461	.	.
SIRPB1	G:603889	.	.
SIRPG	G:605466	.	.
SIRT1	G:604479	.	.
SIRT2	G:604480	.	.
SIRT3	G:604481	.	.
SIRT4	G:604482	.	.
SIRT5	G:604483	.	.
SIRT6	G:606211	.	.
SIRT7	G:606212	.	.
SIT1	G:604964	.	.
SIVA1	G:605567	.	.
SIX1	G:601205	.	Brachiootic syndrome 3, 608389 (3)
SIX1	G:601205	.	Deafness, autosomal dominant 23, 605192 (3)
SIX2	G:604994	.	.
SIX3	G:603714	+GR-Bell	Holoprosencephaly-2, 157170 (3)
SIX3	G:603714	+GR-Bell	Schizensephaly, 269160 (3)
SIX4	G:606342	.	.
SIX5	G:600963	+GR-Bell	Branchiootorenal syndrome 2, 610896 (3)
SIX6	G:606326	+GR-Bell	Microphthalmia with cataract 2, 212550 (3)
SKAP1	G:604969	.	.
SKAP2	G:605215	.	.
SKI	G:164780	.	.
SKIL	G:165340	.	.
SKIV2L	G:600478	.	.
SKOR1	G:611273	.	.
SKP1	G:601434	.	.
SKP1P2	G:601435	.	.
SKP2	G:601436	.	.
SLA	G:601099	.	.
SLA2	G:606577	.	.
SLAIN1	G:610491	.	.
SLAIN2	G:610492	.	.
SLAMF1	G:603492	.	.
SLAMF6	G:606446	.	.
SLAMF7	G:606625	.	.
SLAMF8	G:606620	.	.
SLAMF9	G:608589	.	.
SLBP	G:602422	.	.
SLC10A1	G:182396	.	.
SLC10A2	G:601295	.	Bile acid malabsorption, primary, 613291 (3)
SLC10A3	G:312090	.	.
SLC10A6	G:613366	.	.
SLC10A7	G:611459	.	.
SLC11A1	G:600266	.	{Buruli ulcer, susceptibility to}, 610446 (3)
SLC11A1	G:600266	.	{Mycobacterium tuberculosis, susceptibility to infection by}, 607948 (3)
SLC11A2	G:600523	.	Anemia, hypochromic microcytic, 206100 (3)
SLC12A1	G:600839	Bell>renal	Bartter syndrome, type 1, 601678 (3)
SLC12A2	G:600840	.	.
SLC12A3	G:600968	.	Gitelman syndrome, 263800 (3)
SLC12A4	G:604119	.	.
SLC12A5	G:606726	.	.
SLC12A6	G:604878	Bell>neurological	Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)
SLC12A7	G:604879	.	.
SLC12A8	G:611316	.	.
SLC13A1	G:606193	.	.
SLC13A2	G:604148	.	.
SLC13A3	G:606411	.	.
SLC13A4	G:604309	.	.
SLC13A5	G:608305	.	.
SLC14A1	G:613868	.	[Blood group, Kidd], 111000 (3)
SLC14A2	G:601611	.	.
SLC15A1	G:600544	.	.
SLC15A2	G:602339	.	.
SLC15A3	G:610408	.	.
SLC16A1	G:600682	.	Erythrocyte lactate transporter defect, 245340 (3)
SLC16A1	G:600682	.	Hyperinsulinemic hypoglycemia, familial, 7, 610021 (3)
SLC16A10	G:607550	.	.
SLC16A12	G:611910	.	Cataract, juvenile, with microcornea and glucosuria, 612018 (3)
SLC16A2	G:300095	Bell>neurological	Allan-Herndon-Dudley syndrome, 300523 (3)
SLC16A3	G:603877	.	.
SLC16A4	G:603878	.	.
SLC16A5	G:603879	.	.
SLC16A6	G:603880	.	.
SLC16A7	G:603654	.	.
SLC16A8	G:610409	.	.
SLC16A9	G:614242	.	.
SLC17A1	G:182308	.	.
SLC17A2	G:611049	.	.
SLC17A3	G:611034	.	?Glycogen storage disease Ic, 232240 (3)
SLC17A4	G:604216	.	.
SLC17A5	G:604322	Bell>metabolic	Salla disease, 604369 (3)
SLC17A5	G:604322	Bell>metabolic	Salla disease, 604369 (3)
SLC17A5	G:604322	Bell>metabolic	Sialic acid storage disorder, infantile, 269920 (3)
SLC17A5	G:604322	Bell>metabolic	Sialic acid storage disorder, infantile, 269920 (3)
SLC17A6	G:607563	.	.
SLC17A7	G:605208	.	.
SLC17A8	G:607557	.	Deafness, autosomal dominant 25, 605583 (3)
SLC17A9	G:612107	.	.
SLC18A1	G:193002	.	.
SLC18A2	G:193001	.	.
SLC18A3	G:600336	.	.
SLC18B1	G:613361	.	.
SLC19A1	G:600424	.	.
SLC19A2	G:603941	+GR-Bell	Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)
SLC19A3	G:606152	.	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2), 607483 (3)
SLC1A1	G:133550	.	.
SLC1A2	G:600300	.	.
SLC1A3	G:600111	.	Episodic ataxia, type 6, 612656 (3)
SLC1A4	G:600229	.	.
SLC1A5	G:109190	.	.
SLC1A6	G:600637	.	.
SLC1A7	G:604471	.	.
SLC20A1	G:137570	.	.
SLC20A2	G:158378	.	Basal ganglia cancification, idiopathic, 3, 614540 (3)
SLC22A1	G:602607	.	.
SLC22A10	G:607580	.	.
SLC22A11	G:607097	.	.
SLC22A12	G:607096	.	Hypouricemia, renal, 220150 (3)
SLC22A13	G:604047	.	.
SLC22A14	G:604048	.	.
SLC22A15	G:608275	.	.
SLC22A16	G:608276	.	.
SLC22A17	G:611461	.	.
SLC22A18	G:602631	.	Breast cancer, somatic, 114480 (3)
SLC22A18	G:602631	.	Lung cancer, somatic, 211980 (3)
SLC22A18	G:602631	.	Rhabdomyosarcoma, somatic, 268210 (3)
SLC22A18AS	G:603240	.	.
SLC22A2	G:602608	.	.
SLC22A20	G:611696	.	.
SLC22A23	G:611697	.	.
SLC22A24	G:611698	.	.
SLC22A25	G:610792	.	.
SLC22A3	G:604842	.	.
SLC22A4	G:604190	.	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
SLC22A5	G:603377	.	Carnitine deficiency, systemic primary, 212140 (3)
SLC22A6	G:607582	.	.
SLC22A7	G:604995	.	.
SLC22A8	G:607581	.	.
SLC22A9	G:607579	.	.
SLC23A1	G:603790	.	.
SLC23A2	G:603791	.	.
SLC24A1	G:603617	.	Night blindness, congenital stationary, type 1D, 613830 (3)
SLC24A2	G:609838	.	.
SLC24A3	G:609839	.	.
SLC24A4	G:609840	.	[Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3)
SLC24A4	G:609840	.	[Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3)
SLC24A5	G:609802	.	[Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3)
SLC24A6	G:609841	.	.
SLC25A1	G:190315	.	.
SLC25A10	G:606794	.	.
SLC25A11	G:604165	.	.
SLC25A12	G:603667	.	Hypomyelination, global cerebral, 612949 (3)
SLC25A13	G:603859	+GR-Bell	Citrullinemia, adult-onset type II, 603471 (3)
SLC25A13	G:603859	+GR-Bell	Citrullinemia, type II, neonatal-onset, 605814 (3)
SLC25A14	G:300242	.	.
SLC25A15	G:603861	Bell>metabolic	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3)
SLC25A16	G:139080	.	.
SLC25A17	G:606795	.	.
SLC25A18	G:609303	.	.
SLC25A19	G:606521	+GR-Bell	Microcephaly, Amish type, 607196 (3)
SLC25A19	G:606521	+GR-Bell	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3)
SLC25A2	G:608157	.	.
SLC25A20	G:613698	.	Carnitine-acylcarnitine translocase deficiency, 212138 (3)
SLC25A21	G:607571	.	.
SLC25A22	G:609302	Bell>neurological	Epileptic encephalopathy, early infantile, 3, 609304 (3)
SLC25A23	G:608746	.	.
SLC25A24	G:608744	.	.
SLC25A25	G:608745	.	.
SLC25A26	G:611037	.	.
SLC25A27	G:613725	.	.
SLC25A28	G:609767	.	.
SLC25A3	G:600370	.	Micochondrial phosphate carrier deficiency, 610773 (3)
SLC25A30	G:610793	.	.
SLC25A31	G:610796	.	.
SLC25A32	G:610815	.	.
SLC25A33	G:610816	.	.
SLC25A34	G:610817	.	.
SLC25A35	G:610818	.	.
SLC25A37	G:610387	.	.
SLC25A38	G:610819	.	Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive, 205950 (3)
SLC25A39	G:610820	.	.
SLC25A4	G:103220	.	Cardiomyopathy, familial hypertrophic, 192600 (3)
SLC25A4	G:103220	.	Progressive external ophthalmoplegia with mitochondrial DNA deletions 3, 609283 (3)
SLC25A40	G:610821	.	.
SLC25A41	G:610822	.	.
SLC25A42	G:610823	.	.
SLC25A43	G:300641	.	.
SLC25A44	G:610824	.	.
SLC25A45	G:610825	.	.
SLC25A46	G:610826	.	.
SLC25A47	G:609911	.	.
SLC25A5	G:300150	.	.
SLC25A6	G:300151	.	.
SLC25A6	G:403000	.	.
SLC26A1	G:610130	.	.
SLC26A11	G:610117	.	.
SLC26A2	G:606718	Bell>developmental	Achondrogenesis Ib, 600972 (3)
SLC26A2	G:606718	Bell>developmental	Achondrogenesis Ib, 600972 (3)
SLC26A2	G:606718	Bell>developmental	Atelosteogenesis II, 256050 (3)
SLC26A2	G:606718	Bell>developmental	Atelosteogenesis II, 256050 (3)
SLC26A2	G:606718	Bell>developmental	De la Chapelle dysplasia, 256050 (3)
SLC26A2	G:606718	Bell>developmental	De la Chapelle dysplasia, 256050 (3)
SLC26A2	G:606718	Bell>developmental	Diastrophic dysplasia, 222600 (3)
SLC26A2	G:606718	Bell>developmental	Diastrophic dysplasia, 222600 (3)
SLC26A2	G:606718	Bell>developmental	Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3)
SLC26A2	G:606718	Bell>developmental	Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3)
SLC26A2	G:606718	Bell>developmental	Epiphyseal dysplasia, multiple, 4, 226900 (3)
SLC26A2	G:606718	Bell>developmental	Epiphyseal dysplasia, multiple, 4, 226900 (3)
SLC26A2	G:606718	Bell>skeletal	Achondrogenesis Ib, 600972 (3)
SLC26A2	G:606718	Bell>skeletal	Atelosteogenesis II, 256050 (3)
SLC26A2	G:606718	Bell>skeletal	De la Chapelle dysplasia, 256050 (3)
SLC26A2	G:606718	Bell>skeletal	Diastrophic dysplasia, 222600 (3)
SLC26A2	G:606718	Bell>skeletal	Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3)
SLC26A2	G:606718	Bell>skeletal	Epiphyseal dysplasia, multiple, 4, 226900 (3)
SLC26A3	G:126650	.	Chloride diarrhea, congenital, Finnish type, 214700 (3)
SLC26A4	G:605646	Bell>endocrine	Enlarged vestibular aqueduct, 600791 (3)
SLC26A4	G:605646	Bell>endocrine	Pendred syndrome, 274600 (3)
SLC26A5	G:604943	.	Deafness, autosomal recessive 61, 613865 (3)
SLC26A6	G:610068	.	.
SLC26A7	G:608479	.	.
SLC26A8	G:608480	.	.
SLC26A9	G:608481	.	.
SLC27A1	G:600691	.	.
SLC27A2	G:603247	.	.
SLC27A3	G:604193	.	.
SLC27A4	G:604194	.	Ichthyosis prematurity syndrome, 608649 (3)
SLC27A5	G:603314	.	.
SLC27A6	G:604196	.	.
SLC28A1	G:606207	.	.
SLC28A2	G:606208	.	.
SLC28A3	G:608269	.	.
SLC29A1	G:602193	.	.
SLC29A2	G:602110	.	.
SLC29A3	G:612373	.	Hyperpigmentation, cutaneous, with hypertrichosis, hepatosplenomegaly, heart anomalies, hearing loss, and hypogonadism, 612391 (3)
SLC29A3	G:612373	.	Pigmented hypertrophic dermatosis with insulin-dependent diabetes, 612391 (3)
SLC29A4	G:609149	.	.
SLC2A1	G:138140	+GR-Bell	GLUT1 deficiency syndrome 1, 606777 (3)
SLC2A1	G:138140	+GR-Bell	GLUT1 deficiency syndrome 2, 612126 (3)
SLC2A10	G:606145	.	Arterial tortuosity syndrome, 208050 (3)
SLC2A11	G:610367	.	.
SLC2A12	G:610372	.	.
SLC2A13	G:611036	.	.
SLC2A14	G:611039	.	.
SLC2A2	G:138160	.	Fanconi-Bickel syndrome, 227810 (3)
SLC2A2	G:138160	.	{Diabetes mellitus, noninsulin-dependent} (3)
SLC2A3	G:138170	.	.
SLC2A4	G:138190	.	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
SLC2A4RG	G:609493	.	.
SLC2A5	G:138230	.	.
SLC2A6	G:606813	.	.
SLC2A7	G:610371	.	.
SLC2A8	G:605245	.	.
SLC2A9	G:606142	.	Hypouricemia, renal, 2, 612076 (3)
SLC2A9	G:606142	.	{Uric acid concentration, serum, QTL 2}, 612076 (3)
SLC30A1	G:609521	.	.
SLC30A10	G:611146	.	.
SLC30A2	G:609617	.	.
SLC30A3	G:602878	.	.
SLC30A4	G:602095	.	.
SLC30A5	G:607819	.	.
SLC30A6	G:611148	.	.
SLC30A7	G:611149	.	.
SLC30A8	G:611145	.	{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)
SLC30A9	G:604604	.	.
SLC31A1	G:603085	.	.
SLC31A2	G:603088	.	.
SLC33A1	G:603690	.	Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)
SLC33A1	G:603690	.	Spastic paraplegia-42, 612539 (3)
SLC34A1	G:182309	.	Fanconi renotubular syndrome 2, 613388 (3)
SLC34A1	G:182309	.	Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3)
SLC34A2	G:604217	Bell>respiratory	?Testicular microlithiasis, 610441 (3)
SLC34A2	G:604217	Bell>respiratory	Pulmonary alveolar microlithiasis, 265100 (3)
SLC34A3	G:609826	.	Hypophosphatemic rickets with hypercalciuria, 241530 (3)
SLC35A1	G:605634	Bell>metabolic	Congenital disorder of glycosylation, type IIf, 603585 (3)
SLC35A2	G:314375	.	.
SLC35A3	G:605632	.	.
SLC35B1	G:610790	.	.
SLC35B2	G:610788	.	.
SLC35B3	G:610845	.	.
SLC35B4	G:610923	.	.
SLC35C1	G:605881	Bell>metabolic	Congenital disorder of glycosylation, type IIc, 266265 (3)
SLC35D1	G:610804	Bell>skeletal	Schneckenbecken dysplasia, 269250 (3)
SLC35D2	G:609182	.	.
SLC35D3	G:612519	.	.
SLC36A1	G:606561	.	.
SLC36A2	G:608331	.	Hyperglycinuria, 138500 (3)
SLC36A2	G:608331	.	Iminoglycinuria, digenic, 242600 (3)
SLC36A3	G:608332	.	.
SLC36A4	G:613760	.	.
SLC37A1	G:608094	.	.
SLC37A4	G:602671	Bell>metabolic	Glycogen storage disease Ib, 232220 (3)
SLC37A4	G:602671	Bell>metabolic	Glycogen storage disease Ib, 232220 (3)
SLC37A4	G:602671	Bell>metabolic	Glycogen storage disease Ic, 232240 (3)
SLC37A4	G:602671	Bell>metabolic	Glycogen storage disease Ic, 232240 (3)
SLC38A1	G:608490	.	.
SLC38A2	G:605180	.	.
SLC38A3	G:604437	.	.
SLC38A4	G:608065	.	.
SLC38A5	G:300649	.	.
SLC38A7	G:614236	.	.
SLC39A1	G:604740	.	.
SLC39A10	G:608733	.	.
SLC39A12	G:608734	.	.
SLC39A13	G:608735	.	Spondylocheirodysplasia, Ehlers-Danlos syndrome-like, 612350 (3)
SLC39A14	G:608736	.	.
SLC39A2	G:612166	.	.
SLC39A3	G:612168	.	.
SLC39A4	G:607059	.	Acrodermatitis enteropathica, 201100 (3)
SLC39A5	G:608730	.	.
SLC39A6	G:608731	.	.
SLC39A7	G:601416	.	.
SLC39A8	G:608732	.	.
SLC3A1	G:104614	Bell>renal	Cystinuria, 220100 (3)
SLC3A2	G:158070	.	.
SLC40A1	G:604653	.	Hemochromatosis, type 4, 606069 (3)
SLC41A1	G:610801	.	.
SLC41A2	G:610802	.	.
SLC41A3	G:610803	.	.
SLC43A1	G:603733	.	.
SLC43A2	G:610791	.	.
SLC44A1	G:606105	.	.
SLC44A2	G:606106	.	.
SLC44A4	G:606107	.	.
SLC45A1	G:605763	.	.
SLC45A2	G:606202	+GR-Bell	Oculocutaneous albinism, type IV, 606574 (3)
SLC45A2	G:606202	+GR-Bell	[Skin/hair/eye pigmentation 5, black/nonblack hair], 227240 (3)
SLC45A2	G:606202	+GR-Bell	[Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3)
SLC45A2	G:606202	+GR-Bell	[Skin/hair/eye pigmentation 5, dark/light eyes], 227240 (3)
SLC45A3	G:605097	.	.
SLC46A1	G:611672	+GR-Bell	Folate malabsorption, hereditary, 229050 (3)
SLC46A2	G:608956	.	.
SLC47A1	G:609832	.	.
SLC47A2	G:609833	.	.
SLC48A1	G:612187	.	.
SLC4A1	GP:109270	.	Renal tubular acidosis, distal, AD, 179800 (3)
SLC4A1	GP:109270	.	Renal tubular acidosis, distal, AR, 611590 (3)
SLC4A1	GP:109270	.	Spherocytosis, type 4, 612653 (3)
SLC4A1	GP:109270	.	[Blood group, Diego], 110500 (3)
SLC4A1	GP:109270	.	[Blood group, Froese], 601551 (3)
SLC4A1	GP:109270	.	[Blood group, Swann], 601550 (3)
SLC4A1	GP:109270	.	[Blood group, Waldner], 112010 (3)
SLC4A1	GP:109270	.	[Blood group, Wright], 112050 (3)
SLC4A1	GP:109270	.	[Malaria, resistance to], 611162 (3)
SLC4A10	G:605556	.	.
SLC4A11	G:610206	Bell>ocular	Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)
SLC4A11	G:610206	Bell>ocular	Corneal endothelial dystrophy 2, 217700 (3)
SLC4A11	G:610206	Bell>ocular	Corneal endothelial dystrophy and perceptive deafness, 217400 (3)
SLC4A1AP	G:602655	.	.
SLC4A2	G:109280	.	.
SLC4A3	G:106195	.	.
SLC4A4	G:603345	.	Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)
SLC4A5	G:606757	.	.
SLC4A7	G:603353	.	.
SLC4A8	G:605024	.	.
SLC4A9	G:610207	.	.
SLC50A1	G:613683	.	.
SLC52A1	G:607883	.	.
SLC52A2	G:607882	.	.
SLC52A3	G:613350	.	Brown-Vialetto-Van Laere syndrome, 211530 (3)
SLC52A3	G:613350	.	Fazio-Londe disease, 211500 (3)
SLC5A1	G:182380	.	Glucose/galactose malabsorption, 606824 (3)
SLC5A11	G:610238	.	.
SLC5A12	G:612455	.	.
SLC5A2	G:182381	.	Renal glucosuria, 233100 (3)
SLC5A3	G:600444	.	.
SLC5A5	G:601843	.	Thyroid dyshormonogenesis 1, 274400 (3)
SLC5A6	G:604024	.	.
SLC5A7	G:608761	.	.
SLC5A8	G:608044	.	.
SLC6A1	G:137165	.	.
SLC6A11	G:607952	.	.
SLC6A12	G:603080	.	.
SLC6A14	G:300444	.	{Obesity, susceptibility to, BMIQ11}, 300306 (3)
SLC6A15	G:607971	.	.
SLC6A16	G:607972	.	.
SLC6A17	G:610299	.	.
SLC6A18	G:610300	.	.
SLC6A19	G:608893	.	Hartnup disorder, 234500 (3)
SLC6A19	G:608893	.	Hyperglycinuria, 138500 (3)
SLC6A19	G:608893	.	Iminoglycinuria, digenic, 242600 (3)
SLC6A2	G:163970	.	Orthostatic intolerance, 604715 (3)
SLC6A20	G:605616	.	Hyperglycinuria, 138500 (3)
SLC6A20	G:605616	.	Iminoglycinuria, digenic, 242600 (3)
SLC6A3	G:126455	.	Parkinsonism-dystonia, infantile, 613135 (3)
SLC6A3	G:126455	.	{Major affective disorder}, 125480 (3)
SLC6A3	G:126455	.	{Nicotine dependence, protection against}, 188890 (3)
SLC6A4	G:182138	.	{Anxiety-related personality traits}, 607834 (3)
SLC6A4	G:182138	.	{Obsessive-compulsive disorder}, 164230 (3)
SLC6A5	G:604159	+GR-Bell	Hyperekplexia, 149400 (3)
SLC6A6	G:186854	.	.
SLC6A7	G:606205	.	.
SLC6A8	G:300036	Bell>neurological	Creatine deficiency syndrome, X-linked, 300352 (3)
SLC6A9	G:601019	.	.
SLC7A1	G:104615	.	.
SLC7A10	G:607959	.	.
SLC7A11	G:607933	.	.
SLC7A2	G:601872	.	.
SLC7A3	G:300443	.	.
SLC7A4	G:603752	.	.
SLC7A5	G:600182	.	.
SLC7A6	G:605641	.	.
SLC7A7	G:603593	+GR-Bell	Lysinuric protein intolerance, 222700 (3)
SLC7A8	G:604235	.	.
SLC7A9	G:604144	.	Cystinuria, 220100 (3)
SLC8A1	G:182305	.	.
SLC8A2	G:601901	.	.
SLC8A3	G:607991	.	.
SLC9A1	G:107310	.	.
SLC9A2	G:600530	.	.
SLC9A3	G:182307	.	.
SLC9A3R1	G:604990	.	Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)
SLC9A3R2	G:606553	.	.
SLC9A4	G:600531	.	.
SLC9A5	G:600477	.	.
SLC9A6	G:300231	Bell>neurological	Mental retardation, X-linked syndromic, Christianson type, 300243 (3)
SLC9A7	G:300368	.	.
SLC9A8	G:612730	.	.
SLC9A9	G:608396	.	{Autism susceptibility 16}, 613410 (3)
SLC9B1	G:611527	.	.
SLC9B2	G:611789	.	.
SLC9C1	G:612738	.	.
SLCO1A2	G:602883	.	.
SLCO1B1	G:604843	.	Hyperbilirubinemia, Rotor type, digenic, 237450 (3)
SLCO1B3	G:605495	.	Hyperbilirubinemia, Rotor type, digenic, 237450 (3)
SLCO1C1	G:613389	.	.
SLCO2A1	G:601460	.	Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3)
SLCO2B1	G:604988	.	.
SLCO3A1	G:612435	.	.
SLCO4A1	G:612436	.	.
SLCO4C1	G:609013	.	.
SLCO5A1	G:613543	.	.
SLCO6A1	G:613365	.	.
SLEB1	P:601744	.	.
SLEB2	P:605218	.	.
SLEB3	P:605480	.	.
SLEH1	P:607279	.	.
SLEN1	P:607965	.	.
SLEN2	P:607966	.	.
SLEN3	P:607967	.	.
SLIRP	G:610211	.	.
SLIT1	G:603742	.	.
SLIT2	G:603746	.	.
SLIT3	G:603745	.	.
SLITRK1	G:609678	+GR-Bell	Tourette syndrome, 137580 (3)
SLITRK1	G:609678	+GR-Bell	Trichotillomania, 613229 (3)
SLITRK2	G:300561	.	.
SLITRK3	G:609679	.	.
SLITRK4	G:300562	.	.
SLITRK5	G:609680	.	.
SLITRK6	G:609681	.	.
SLMAP	G:602701	.	.
SLN	G:602203	.	.
SLPI	G:107285	.	.
SLU7	G:605974	.	.
SLURP1	G:606119	.	Meleda disease, 248300 (3)
SLX4	G:613278	.	Fanconi anemia, complementation group P, 613951 (3)
SMAD1	G:601595	.	.
SMAD2	G:601366	.	.
SMAD3	G:603109	+GR-Bell	Loeys-Dietz syndrome, type 1C, 613795 (3)
SMAD4	G:600993	+GR-Bell	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)
SMAD4	G:600993	+GR-Bell	Myhre syndrome, 139210 (3)
SMAD4	G:600993	+GR-Bell	Polyposis, juvenile intestinal, 174900 (3)
SMAD5	G:603110	.	.
SMAD6	G:602931	.	.
SMAD7	G:602932	.	{Colorectal cancer, susceptibility to, 3}, 612229 (3)
SMAD9	G:603295	.	Pulmonary hypertension, primary, 178600 (3)
SMAP1	G:611372	.	.
SMARCA1	G:300012	.	.
SMARCA2	G:600014	.	.
SMARCA4	G:603254	.	Rhabdoid tumor predisposition syndrome 2, 613325 (3)
SMARCA5	G:603375	.	.
SMARCAD1	G:612761	.	Adermatoglyphia, 136000 (3)
SMARCAL1	G:606622	+GR-Bell	Schimke immunoosseous dysplasia, 242900 (3)
SMARCB1	G:601607	.	Rhabdoid predisposition syndrome 1, 609322 (3)
SMARCB1	G:601607	.	Rhabdoid tumors, somatic, 609322 (3)
SMARCC1	G:601732	.	.
SMARCC2	G:601734	.	.
SMARCD1	G:601735	.	.
SMARCD2	G:601736	.	.
SMARCD3	G:601737	.	.
SMARCE1	G:603111	.	.
SMC1A	G:300040	.	Cornelia de Lange syndrome 2, 300590 (3)
SMC1B	G:608685	.	.
SMC2	G:605576	.	.
SMC3	G:606062	+GR-Bell	Cornelia de Lange syndrome 3, 610759 (3)
SMC4	G:605575	.	.
SMC5	G:609386	.	.
SMC6	G:609387	.	.
SMCP	G:601148	.	.
SMEK1	G:610351	.	.
SMEK2	G:610352	.	.
SMG1	G:607032	.	.
SMG5	G:610962	.	.
SMG6	G:610963	.	.
SMG7	G:610964	.	.
SMG8	G:613175	.	.
SMG9	G:613176	.	.
SMN1	G:600354	Bell>neurological	Spinal muscular atrophy-1, 253300 (3)
SMN1	G:600354	Bell>neurological	Spinal muscular atrophy-1, 253300 (3)
SMN1	G:600354	Bell>neurological	Spinal muscular atrophy-1, 253300 (3)
SMN1	G:600354	Bell>neurological	Spinal muscular atrophy-2, 253550 (3)
SMN1	G:600354	Bell>neurological	Spinal muscular atrophy-2, 253550 (3)
SMN1	G:600354	Bell>neurological	Spinal muscular atrophy-2, 253550 (3)
SMN1	G:600354	Bell>neurological	Spinal muscular atrophy-3, 253400 (3)
SMN1	G:600354	Bell>neurological	Spinal muscular atrophy-3, 253400 (3)
SMN1	G:600354	Bell>neurological	Spinal muscular atrophy-3, 253400 (3)
SMN1	G:600354	Bell>neurological	Spinal muscular atrophy-4, 271150 (3)
SMN1	G:600354	Bell>neurological	Spinal muscular atrophy-4, 271150 (3)
SMN1	G:600354	Bell>neurological	Spinal muscular atrophy-4, 271150 (3)
SMN2	G:601627	+GR-Bell	{Spinal muscular atrophy, type III, modifier of}, 253400 (3)
SMNDC1	G:603519	.	.
SMO	G:601500	.	Basal cell carcinoma, somatic (3)
SMOC1	G:608488	.	Microphthalmia with limb anomalies, 206920 (3)
SMOC2	G:607223	.	Dentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3)
SMPD1	G:607608	Bell>metabolic	Niemann-Pick disease, type A, 257200 (3)
SMPD1	G:607608	Bell>metabolic	Niemann-Pick disease, type A, 257200 (3)
SMPD1	G:607608	Bell>metabolic	Niemann-Pick disease, type B, 607616 (3)
SMPD1	G:607608	Bell>metabolic	Niemann-Pick disease, type B, 607616 (3)
SMPD2	G:603498	.	.
SMPD3	G:605777	.	.
SMPD4	G:610457	.	.
SMPDL3A	G:610728	.	.
SMPX	G:300226	.	Deafness, X-linked 4, 300066 (3)
SMR3B	G:611593	.	.
SMS	G:300105	.	Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)
SMTN	G:602127	.	.
SMTNL1	G:613664	.	.
SMUG1	G:607753	.	.
SMURF1	G:605568	.	.
SMURF2	G:605532	.	.
SMYD1	G:606846	.	.
SMYD2	G:610663	.	.
SMYD3	G:608783	.	.
SNAI1	G:604238	.	.
SNAI2	G:602150	.	Piebaldism, 172800 (3)
SNAI2	G:602150	.	Waardenburg syndrome, type 2D, 608890 (3)
SNAI3	G:612741	.	.
SNAP23	G:602534	.	.
SNAP25	G:600322	.	.
SNAP29	G:604202	Bell>neurological	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3)
SNAP91	G:607923	.	.
SNAPC1	G:600591	.	.
SNAPC2	G:605076	.	.
SNAPC3	G:602348	.	.
SNAPC4	G:602777	.	.
SNAPC5	G:605979	.	.
SNAPIN	G:607007	.	.
SNAX1	P:608984	.	.
SNCA	G:163890	.	Dementia, Lewy body, 127750 (3)
SNCA	G:163890	.	Parkinson disease 1, 168601 (3)
SNCA	G:163890	.	Parkinson disease 4, 605543 (3)
SNCAIP	G:603779	.	.
SNCB	G:602569	.	Dementia, Lewy body, 127750 (3)
SNCG	G:602998	.	.
SND1	G:602181	.	.
SNF8	G:610904	.	.
SNHG1	G:603222	.	.
SNHG3	G:603238	.	.
SNHG5	G:613263	.	.
SNHG6	G:612215	.	.
SNIP1	G:608241	.	Psychomotor retardation, epilepsy, and craniofacial dysmorphism, 614501 (3)
SNN	G:603032	.	.
SNORA11	G:300662	.	.
SNORA12	G:611330	.	.
SNORA45	G:611333	.	.
SNORA5C	G:611335	.	.
SNORA62	G:180646	.	.
SNORA63	G:180647	.	.
SNORA73A	G:180645	.	.
SNORA73B	G:603239	.	.
SNORA74B	G:611331	.	.
SNORA81	G:611334	.	.
SNORD112	G:613649	.	.
SNORD113-1	G:613650	.	.
SNORD114-1	G:613651	.	.
SNORD115-1	G:609837	.	.
SNORD116-1	G:605436	.	.
SNORD15A	G:600455	.	.
SNORD20	G:604012	.	.
SNORD21	G:603635	.	.
SNORD22	G:603223	.	.
SNORD25	G:603224	.	.
SNORD26	G:603225	.	.
SNORD27	G:603226	.	.
SNORD28	G:603227	.	.
SNORD29	G:603228	.	.
SNORD30	G:603229	.	.
SNORD31	G:603230	.	.
SNORD3A	G:180710	.	.
SNORD43	G:611068	.	.
SNORD50A	G:613117	.	.
SNORD50B	G:613264	.	.
SNORD73A	G:603568	.	.
SNORD82	G:611133	.	.
SNORD83A	G:611070	.	.
SNORD83B	G:611071	.	.
SNORD87	G:612216	.	.
SNPH	G:604942	.	.
SNRK	G:612760	.	.
SNRNP200	G:601664	+GR-Bell	Retinitis pigmentosa 33, 610359 (3)
SNRNP40	G:607797	.	.
SNRNP70	G:180740	.	.
SNRPA	G:182285	.	.
SNRPA1	G:603521	.	.
SNRPB	G:182282	.	.
SNRPB2	G:603520	.	.
SNRPC	G:603522	.	.
SNRPD1	G:601063	.	.
SNRPD2	G:601061	.	.
SNRPD3	G:601062	.	.
SNRPE	G:128260	.	.
SNRPF	G:603541	.	.
SNRPG	G:603542	.	.
SNRPN	G:182279	.	Prader-Willi syndrome, 176270 (3)
SNTA1	G:601017	+GR-Bell	Long QT syndrome 12, 612955 (3)
SNTB1	G:600026	.	.
SNTB2	G:600027	.	.
SNTG1	G:608714	.	.
SNTG2	G:608715	.	.
SNUPN	G:607902	.	.
SNW1	G:603055	.	.
SNX1	G:601272	.	.
SNX13	G:606589	.	.
SNX15	G:605964	.	.
SNX17	G:605963	.	.
SNX2	G:605929	.	.
SNX20	G:613281	.	.
SNX27	G:611541	.	.
SNX3	G:605930	.	.
SNX4	G:605931	.	.
SNX5	G:605937	.	.
SNX6	G:606098	.	.
SNX9	G:605952	.	.
SOAT1	G:102642	.	.
SOAT2	G:601311	.	.
SOBP	G:613667	.	Mental retardation, anterior maxillary protrusion, and strabismus, 613671 (3)
SOCS1	G:603597	.	.
SOCS2	G:605117	.	.
SOCS3	G:604176	.	.
SOCS5	G:607094	.	.
SOCS6	G:605118	.	.
SOCS7	G:608788	.	.
SOD1	G:147450	+GR-Bell	Amyotrophic lateral sclerosis, due to SOD1 deficiency, 105400 (3)
SOD2	G:147460	.	{Microvascular complications of diabetes 6}, 612634 (3)
SOD3	G:185490	.	[Superoxide dismutase, elevated extracellular] (3)
SOHLH1	G:610224	.	.
SOLH	G:603267	.	.
SON	G:182465	.	.
SORBS1	G:605264	.	.
SORBS3	G:610795	.	.
SORCS1	G:606283	.	.
SORCS2	G:606284	.	.
SORCS3	G:606285	.	.
SORD	G:182500	.	.
SORL1	G:602005	.	{Alzheimer disease, pathogenesis, association with}, 104300 (3)
SORT1	G:602458	.	[Low density lipoprotein cholesterol level QTL6], 613589 (3)
SOS1	G:182530	+GR-Bell	Fibromatosis, gingival, 135300 (3)
SOS1	G:182530	+GR-Bell	Noonan syndrome 4, 610733 (3)
SOS2	G:601247	.	.
SOST	G:605740	.	Sclerosteosis, 269500 (3)
SOST	G:605740	.	Van Buchem disease, 239100 (3)
SOSTDC1	G:609675	.	.
SOX1	G:602148	.	.
SOX10	G:602229	Bell>cutaneous	PCWH syndrome, 609136 (3)
SOX10	G:602229	Bell>cutaneous	PCWH syndrome, 609136 (3)
SOX10	G:602229	Bell>cutaneous	Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3)
SOX10	G:602229	Bell>cutaneous	Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3)
SOX10	G:602229	Bell>cutaneous	Waardenburg syndrome, type 4C, 613266 (3)
SOX10	G:602229	Bell>cutaneous	Waardenburg syndrome, type 4C, 613266 (3)
SOX11	G:600898	.	.
SOX12	G:601947	.	.
SOX13	G:604748	.	.
SOX14	G:604747	.	.
SOX15	G:601297	.	.
SOX17	G:610928	.	Vesicoureteral reflux 3, 613674 (3)
SOX18	G:601618	.	Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3)
SOX2	G:184429	+GR-Bell	Microphthalmia, syndromic 3, 206900 (3)
SOX2	G:184429	+GR-Bell	Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3)
SOX21	G:604974	.	.
SOX3	G:313430	.	Mental retardation, X-linked, with isolated growth hormone deficiency, 300123 (3)
SOX3	G:313430	.	Panhypopituitarism, X-linked, 312000 (3)
SOX30	G:606698	.	.
SOX4	G:184430	.	.
SOX5	G:604975	.	.
SOX6	G:607257	.	.
SOX7	G:612202	.	.
SOX8	G:605923	.	.
SOX9	G:608160	+GR-Bell	Acampomelic campomelic dysplasia, 114290 (3)
SOX9	G:608160	+GR-Bell	Campomelic dysplasia with autosomal sex reversal, 114290 (3)
SOX9	G:608160	+GR-Bell	Campomelic dysplasia, 114290 (3)
SP1	G:189906	.	.
SP100	G:604585	.	.
SP110	G:604457	Bell>immunodeficiency	Hepatic venoocclusive disease with immunodeficiency, 235550 (3)
SP110	G:604457	Bell>immunodeficiency	{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)
SP140	G:608602	.	.
SP2	G:601801	.	.
SP3	G:601804	.	.
SP4	G:600540	.	.
SP5	G:609391	.	.
SP6	G:608613	.	.
SP7	G:606633	.	Osteogenesis imperfecta, type XII, 613849 (3)
SP8	G:608306	.	.
SPA17	G:608621	.	.
SPACA1	G:612739	.	.
SPACA3	G:612749	.	.
SPACA4	G:609932	.	.
SPACA5	G:300593	.	.
SPAG1	G:603395	.	.
SPAG11B	G:606560	.	.
SPAG16	G:612173	.	.
SPAG4	G:603038	.	.
SPAG6	G:605730	.	.
SPAG7	G:610056	.	.
SPAG8	G:605731	.	.
SPAG9	G:605430	.	.
SPAM1	G:600930	.	.
SPANXA1	G:300305	.	.
SPANXA2	G:300493	.	.
SPANXB1	G:300669	.	.
SPANXC	G:300330	.	.
SPANXD	G:300670	.	.
SPANXE	G:300671	.	.
SPANXN1	G:300664	.	.
SPANXN2	G:300665	.	.
SPANXN3	G:300666	.	.
SPANXN4	G:300667	.	.
SPANXN5	G:300668	.	.
SPARC	G:182120	.	.
SPARCL1	G:606041	.	.
SPAST	G:604277	+GR-Bell	Spastic paraplegia-4, 182601 (3)
SPATA12	G:609869	.	.
SPATA13	G:613324	.	.
SPATA16	G:609856	.	Spermatogenic failure 6, 102530 (3)
SPATA17	G:611032	.	.
SPATA18	G:612814	.	.
SPATA19	G:609805	.	.
SPATA2	G:607662	.	.
SPATA20	G:613939	.	.
SPATA4	G:609879	.	.
SPATA5	G:613940	.	.
SPATA6	G:613947	.	.
SPATA7	G:609868	+GR-Bell	Leber congenital amaurosis 3, 604232 (3)
SPATA7	G:609868	+GR-Bell	Retinitis pigmentosa, juvenile, autosomal recessive, 268000 (3)
SPATA8	G:613948	.	.
SPATA9	G:608039	.	.
SPATC1	G:610874	.	.
SPATS2	G:611667	.	.
SPATS2L	G:613817	.	.
SPC24	G:609394	.	.
SPC25	G:609395	.	.
SPCS1	G:610358	.	.
SPDEF	G:608144	.	.
SPDYA	G:614029	.	.
SPDYC	G:614030	.	.
SPECC1	G:608793	.	.
SPECC1L	G:614140	.	Facial clefting, oblique, 1, 600251 (3)
SPEF1	G:610674	.	.
SPEF2	G:610172	.	.
SPEN	G:613484	.	.
SPESP1	G:609399	.	.
SPG11	G:610844	+GR-Bell	Spastic paraplegia-11, 604360 (3)
SPG14	P:605229	.	.
SPG16	P:300266	.	.
SPG18	P:611225	.	.
SPG19	P:607152	.	.
SPG20	G:607111	+GR-Bell	Troyer syndrome, 275900 (3)
SPG21	G:608181	.	Mast syndrome, 248900 (3)
SPG23	P:270750	.	.
SPG24	P:607584	.	.
SPG25	P:608220	.	.
SPG26	P:609195	.	.
SPG27	P:609041	.	.
SPG28	P:609340	.	.
SPG29	P:609727	.	.
SPG32	P:611252	.	.
SPG34	P:300750	.	.
SPG36	P:613096	.	.
SPG37	P:611945	.	.
SPG38	P:612335	.	.
SPG41	P:613364	.	.
SPG45	P:613162	.	.
SPG46	P:614409	.	.
SPG5B	P:600146	.	.
SPG7	G:602783	+GR-Bell	Spastic paraplegia-7, 607259 (3)
SPG9	P:601162	.	.
SPHK1	G:603730	.	.
SPHK2	G:607092	.	.
SPHKAP	G:611646	.	.
SPI1	G:165170	.	.
SPIB	G:606802	.	.
SPIC	G:612568	.	.
SPICE1	G:613447	.	.
SPIN1	G:609936	.	.
SPIN2A	G:300621	.	.
SPIN2B	G:300517	.	.
SPINK1	G:167790	.	Pancreatitis, hereditary, 167800 (3)
SPINK1	G:167790	.	Tropical calcific pancreatitis, 608189 (3)
SPINK1	G:167790	.	{Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3)
SPINK2	G:605753	.	.
SPINK4	G:613929	.	.
SPINK5	G:605010	.	Atopy, 147050 (3)
SPINK5	G:605010	.	Netherton syndrome, 256500 (3)
SPINK9	G:613511	.	.
SPINLW1	G:609031	.	.
SPINT1	G:605123	.	.
SPINT2	G:605124	.	Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3)
SPINT3	G:613941	.	.
SPIRE1	G:609216	.	.
SPIRE2	G:609217	.	.
SPN	G:182160	.	.
SPNS1	G:612583	.	.
SPNS2	G:612584	.	.
SPNS3	G:611701	.	.
SPO11	G:605114	.	.
SPOCK1	G:602264	.	.
SPOCK2	G:607988	.	.
SPOCK3	G:607989	.	.
SPON1	G:604989	.	.
SPON2	G:605918	.	.
SPOP	G:602650	.	.
SPP1	G:166490	.	.
SPP2	G:602637	.	.
SPPL2A	G:608238	.	.
SPPL2B	G:608239	.	.
SPPL2C	G:608284	.	.
SPPL3	G:608240	.	.
SPR	G:182125	.	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency, 612716 (3)
SPRED1	G:609291	+GR-Bell	Legius syndrome, 611431 (3)
SPRED2	G:609292	.	.
SPRED3	G:609293	.	.
SPRN	G:610447	.	.
SPRR1A	G:182265	.	.
SPRR1B	G:182266	.	.
SPRR2A	G:182267	.	.
SPRR2B	G:182268	.	.
SPRR2C	P:182269	.	.
SPRR3	G:182271	.	.
SPRY1	G:602465	.	.
SPRY2	G:602466	.	.
SPRY3	G:300531	.	.
SPRY4	G:607984	.	.
SPRYD7	G:607866	.	.
SPSB1	G:611657	.	.
SPSB2	G:611658	.	.
SPSB3	G:611659	.	.
SPSB4	G:611660	.	.
SPTA1	G:182860	.	Elliptocytosis-2, 130600 (3)
SPTA1	G:182860	.	Pyropoikilocytosis, 266140 (3)
SPTA1	G:182860	.	Spherocytosis, type 3, 270970 (3)
SPTAN1	G:182810	.	Epileptic encephalopathy, early infantile, 5, 613477 (3)
SPTB	GP:182870	.	Anemia, neonatal hemolytic, fatal and near-fatal (3)
SPTB	GP:182870	.	Spherocytosis, type 2 (3)
SPTBN1	G:182790	.	.
SPTBN2	G:604985	.	Spinocerebellar ataxia 5, 600224 (3)
SPTBN4	G:606214	.	.
SPTBN5	G:605916	.	.
SPTLC1	G:605712	+GR-Bell	Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)
SPTLC2	G:605713	.	Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)
SPTLC3	G:611120	.	.
SPTSSA	G:613540	.	.
SPTSSB	G:610412	.	.
SQLE	G:602019	.	.
SQSTM1	G:601530	.	Paget disease of bone, 602080 (3)
SRA1	G:603819	.	.
SRC	G:190090	.	Colon cancer, advanced (3)
SRCAP	G:611421	.	Floating-Harbor syndrome, 136140 (3)
SRCIN1	G:610786	.	.
SRCRB4D	G:607639	.	.
SRD5A1	G:184753	.	.
SRD5A2	GP:607306	.	Pseudovaginal perineoscrotal hypospadias, 264600 (3)
SRD5A3	G:611715	+GR-Bell	Congenital disorder of glycosylation, type Iq, 612379 (3)
SRD5A3	G:611715	+GR-Bell	Kahrizi syndrome, 612713 (3)
SREBF1	G:184756	.	.
SREBF2	G:600481	.	.
SREK1	G:609268	.	.
SRF	G:600589	.	.
SRFBP1	G:610479	.	.
SRGAP1	G:606523	.	.
SRGAP2	G:606524	.	.
SRGAP3	G:606525	.	.
SRGN	G:177040	.	.
SRI	G:182520	.	.
SRL	G:604992	.	.
SRM	G:182891	.	.
SRP14	G:600708	.	.
SRP19	G:182175	.	.
SRP54	G:604857	.	.
SRP68	G:604858	.	.
SRP72	G:602122	.	.
SRP9	G:600707	.	.
SRPK1	G:601939	.	.
SRPK2	G:602980	.	.
SRPR	G:182180	.	.
SRPX	G:300187	.	.
SRPX2	G:300642	.	Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643 (3)
SRR	G:606477	.	.
SRRD	G:602254	.	.
SRRM1	G:605975	.	.
SRRM2	G:606032	.	.
SRRM4	G:613103	.	.
SRRT	G:614469	.	.
SRSF1	G:600812	.	.
SRSF10	G:605221	.	.
SRSF11	G:602010	.	.
SRSF2	G:600813	.	.
SRSF3	G:603364	.	.
SRSF4	G:601940	.	.
SRSF5	G:600914	.	.
SRSF6	G:601944	.	.
SRSF7	G:600572	.	.
SRSF8	G:603269	.	.
SRSF9	G:601943	.	.
SRY	G:480000	.	46XX sex reversal 1, 400045 (3)
SRY	G:480000	.	46XY sex reversal 1, 400044 (3)
SS18	G:600192	.	.
SS18L1	G:606472	.	.
SS18L2	G:606473	.	.
SSB	G:109090	.	.
SSBP1	G:600439	.	.
SSBP2	G:607389	.	.
SSBP3	G:607390	.	.
SSBP4	G:607391	.	.
SSFA2	G:118990	.	.
SSH1	G:606778	.	.
SSH2	G:606779	.	.
SSH3	G:606780	.	.
SSNA1	G:610882	.	.
SSPN	G:601599	.	.
SSR1	G:600868	.	.
SSR2	G:600867	.	.
SSR3	G:606213	.	.
SSR4	G:300090	.	.
SSRP1	G:604328	.	.
SSSCA1	G:606044	.	.
SST	G:182450	.	.
SSTR1	G:182451	.	.
SSTR2	G:182452	.	.
SSTR3	G:182453	.	.
SSTR4	G:182454	.	.
SSTR5	G:182455	.	Somatostatin analog, resistance to, 102200 (3)
SSX1	G:312820	.	.
SSX2	G:300192	.	Sarcoma, synovial (3)
SSX2IP	G:608690	.	.
SSX3	G:300325	.	.
SSX4	G:300326	.	.
SSX5	G:300327	.	.
SSX6	G:300541	.	.
SSX7	G:300542	.	.
SSX8	G:300543	.	.
SSX9	G:300544	.	.
ST11	G:602011	.	.
ST13	G:606796	.	.
ST14	G:606797	.	Ichthyosis with hypotrichosis, 610765 (3)
ST2	G:185440	.	.
ST3	P:191181	.	.
ST3GAL1	G:607187	.	.
ST3GAL2	G:607188	.	.
ST3GAL3	G:606494	.	Mental retardation, autosomal recessive 12, 611090 (3)
ST3GAL4	G:104240	.	.
ST3GAL5	G:604402	Bell>neurological	Amish infantile epilepsy syndrome, 609056 (3)
ST3GAL6	G:607156	.	.
ST5	G:140750	.	.
ST6GAL1	G:109675	.	.
ST6GAL2	G:608472	.	.
ST6GALNAC1	G:610138	.	.
ST6GALNAC2	G:610137	.	.
ST6GALNAC3	G:610133	.	.
ST6GALNAC4	G:606378	.	.
ST6GALNAC5	G:610134	.	.
ST6GALNAC6	G:610135	.	.
ST7	G:600833	.	.
ST8	P:167000	.	.
ST8SIA1	G:601123	.	.
ST8SIA2	G:602546	.	.
ST8SIA3	G:609478	.	.
ST8SIA4	G:602547	.	.
ST8SIA5	G:607162	.	.
ST8SIA6	G:610139	.	.
STAB1	G:608560	.	.
STAB2	G:608561	.	.
STAC	G:602317	.	.
STAG1	G:604358	.	.
STAG2	G:300826	.	.
STAG3	G:608489	.	.
STAM	G:601899	.	.
STAM2	G:606244	.	.
STAMBP	G:606247	.	.
STAMBPL1	G:612352	.	.
STAP1	G:604298	.	.
STAP2	G:607881	.	.
STAR	G:600617	Bell>endocrine	Lipoid adrenal hyperplasia, 201710 (3)
STARD13	G:609866	.	.
STARD3	G:607048	.	.
STARD3NL	G:611759	.	.
STARD4	G:607049	.	.
STARD5	G:607050	.	.
STARD6	G:607051	.	.
STARD8	G:300689	.	.
STAT1	G:600555	.	Candidiasis, familial, 7, 614162 (3)
STAT1	G:600555	.	Mycobacterial and viral infections, susceptibility to, autosomal recessive, 613796 (3)
STAT1	G:600555	.	Mycobacterial infection, atypical, familial disseminated, 209950 (3)
STAT2	G:600556	.	.
STAT3	G:102582	+GR-Bell	Hyper-IgE recurrent infection syndrome, 147060 (3)
STAT4	G:600558	.	.
STAT5A	G:601511	.	.
STAT5B	G:604260	.	Growth hormone insensitivity with immunodeficiency, 245590 (3)
STAT5B	G:604260	.	Leukemia, acute promyelocytic, STAT5B/RARA type (3)
STAT6	G:601512	.	.
STATH	G:184470	.	.
STAU1	G:601716	.	.
STAU2	G:605920	.	.
STBD1	G:607406	.	.
STC1	G:601185	.	.
STC2	G:603665	.	.
STEAP1	G:604415	.	.
STEAP2	G:605094	.	.
STEAP3	G:609671	.	.
STEAP4	G:611098	.	.
STH	G:607067	.	.
STIL	G:181590	+GR-Bell	Microcephaly, primary autosomal recessive, 7, 612703 (3)
STIM1	G:605921	.	Immune dysfunction, with T-cell inactivation due to calcium entry defect 2, 612783 (3)
STIM2	G:610841	.	.
STIP1	G:605063	.	.
STK10	G:603919	.	.
STK11	G:602216	.	Melanoma, malignant sporadic (3)
STK11	G:602216	.	Pancreatic cancer, sporadic (3)
STK11	G:602216	.	Peutz-Jeghers syndrome, 175200 (3)
STK11	G:602216	.	Testicular tumor, sporadic, 273300 (3)
STK11IP	G:607172	.	.
STK16	G:604719	.	.
STK17A	G:604726	.	.
STK17B	G:604727	.	.
STK19	G:604977	.	.
STK24	G:604984	.	.
STK25	G:602255	.	.
STK3	G:605030	.	.
STK31	G:605790	.	.
STK33	G:607670	.	.
STK35	G:609370	.	.
STK36	G:607652	.	.
STK38	G:606964	.	.
STK39	G:607648	.	.
STK4	G:604965	.	.
STK40	G:609437	.	.
STMN1	G:151442	.	.
STMN2	G:600621	.	.
STMN3	G:608362	.	.
STOM	G:133090	.	.
STOML1	G:608326	.	.
STOML2	G:608292	.	.
STOML3	G:608327	.	.
STON1	G:605357	.	.
STON2	G:608467	.	.
STOX1	G:609397	.	Preeclampsia/eclampsia 4, 609404 (3)
STRA6	G:610745	Bell>developmental	Microphthalmia, syndromic 9, 601186 (3)
STRA8	G:609987	.	.
STRADA	G:608626	.	Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3)
STRADB	G:607333	.	.
STRAP	G:605986	.	.
STRBP	G:611138	.	.
STRC	G:606440	.	Deafness, autosomal recessive 16, 603720 (3)
STS	G:300747	.	Ichthyosis, X-linked, 308100 (3)
STT3A	G:601134	.	.
STT3B	G:608605	.	.
STUB1	G:607207	.	.
STX10	G:603765	.	.
STX11	G:605014	+GR-Bell	Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)
STX12	G:606892	.	.
STX16	G:603666	.	Pseudohypoparathyroidism, type IB, 603233 (3)
STX17	G:604204	.	.
STX18	G:606046	.	.
STX1A	G:186590	.	.
STX1B	G:601485	.	.
STX2	G:132350	.	.
STX3	G:600876	.	.
STX4	G:186591	.	.
STX5	G:603189	.	.
STX6	G:603944	.	.
STX7	G:603217	.	.
STX8	G:604203	.	.
STXBP1	G:602926	.	.
STXBP2	G:601717	+GR-Bell	Hemophagocytic lymphohistiocytosis, familial, 5 (3)
STXBP3	G:608339	.	.
STXBP4	G:610415	.	.
STXBP5	G:604586	.	.
STXBP5L	G:609381	.	.
STXBP6	G:607958	.	.
STYK1	G:611433	.	.
SUB1	G:600503	.	.
SUCLA2	G:603921	+GR-Bell	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with methylmalonic aciduria), 612073 (3)
SUCLG1	G:611224	Bell>metabolic	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3)
SUCLG2	G:603922	.	.
SUCNR1	G:606381	.	.
SUDS3	G:608250	.	.
SUFU	G:607035	.	Medulloblastoma, desmoplastic, 155255 (3)
SUGP1	G:607992	.	.
SUGP2	G:607993	.	.
SUGT1	G:604098	.	.
SULF1	G:610012	.	.
SULF2	G:610013	.	.
SULT1A1	G:171150	.	.
SULT1A2	G:601292	.	.
SULT1A3	G:600641	.	.
SULT1B1	G:608436	.	.
SULT1C2	G:602385	.	.
SULT1C4	G:608357	.	.
SULT1E1	G:600043	.	.
SULT2A1	G:125263	.	.
SULT2B1	G:604125	.	.
SULT4A1	G:608359	.	.
SUMF1	G:607939	.	Multiple sulfatase deficiency, 272200 (3)
SUMF2	G:607940	.	.
SUMO1	G:601912	.	Orofacial cleft 10, 613705 (3)
SUMO2	G:603042	.	.
SUMO3	G:602231	.	.
SUMO4	G:608829	.	{Diabetes mellitus, insulin-dependent, 5}, 600320 (3)
SUN1	G:607723	.	.
SUN2	G:613569	.	.
SUN5	G:613942	.	.
SUOX	G:606887	Bell>metabolic	Sulfite oxidase deficiency, 272300 (3)
SUPT16H	G:605012	.	.
SUPT3H	G:602947	.	.
SUPT4H1	G:603555	.	.
SUPT5H	G:602102	.	.
SUPT6H	G:601333	.	.
SUPT7L	G:612762	.	.
SUPV3L1	G:605122	.	.
SURF1	G:185620	.	Leigh syndrome, due to COX deficiency, 256000 (3)
SURF2	G:185630	.	.
SURF4	G:185660	.	.
SURF6	G:185642	.	.
SUV39H1	G:300254	.	.
SUV39H2	G:606503	.	.
SUV420H1	G:610881	.	.
SUV420H2	G:613198	.	.
SUZ12	G:606245	.	.
SV2A	G:185860	.	.
SV2B	G:185861	.	.
SV2C	G:610291	.	.
SVEP1	G:611691	.	.
SVIL	G:604126	.	.
SVOP	G:611699	.	.
SVOPL	G:611700	.	.
SWAP70	G:604762	.	.
SWSAP1	G:614536	.	.
SYBU	G:611568	.	.
SYCE1	G:611486	.	.
SYCE2	G:611487	.	.
SYCP1	G:602162	.	.
SYCP2	G:604105	.	.
SYCP3	G:604759	.	Spermatogenic failure 4, 270960 (3)
SYCP3	G:604759	.	{Pregnancy loss, susceptibility to} (3)
SYF2	G:607090	.	.
SYK	G:600085	.	.
SYMPK	G:602388	.	.
SYN1	G:313440	.	Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)
SYN2	G:600755	.	{Schizophrenia, susceptibility to}, 181500 (3)
SYN3	G:602705	.	.
SYNC	G:611750	.	.
SYNDIG1	G:614311	.	.
SYNDIG1L	G:609999	.	.
SYNE1	G:608441	+GR-Bell	Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)
SYNE1	G:608441	+GR-Bell	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
SYNE2	G:608442	.	Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)
SYNGAP1	G:603384	.	Mental retardation, autosomal dominant 5, 612621 (3)
SYNGR1	G:603925	.	.
SYNGR2	G:603926	.	.
SYNGR3	G:603927	.	.
SYNGR4	G:608373	.	.
SYNJ1	G:604297	.	.
SYNJ2	G:609410	.	.
SYNJ2BP	G:609411	.	.
SYNM	G:606087	.	.
SYNPO	G:608155	.	.
SYNRG	G:607291	.	.
SYP	G:313475	.	Mental retardation, X-linked 96, 300802 (3)
SYS1	G:612979	.	.
SYT1	G:185605	.	.
SYT11	G:608741	.	.
SYT12	G:606436	.	.
SYT13	G:607716	.	.
SYT14	G:610949	.	Spinocerebellar ataxia, autosomal recessive 11, 614229 (3)
SYT14L	G:610892	.	.
SYT15	G:608081	.	.
SYT16	G:610950	.	.
SYT2	G:600104	.	.
SYT3	G:600327	.	.
SYT4	G:600103	.	.
SYT5	G:600782	.	.
SYT6	G:607718	.	.
SYT7	G:604146	.	.
SYT8	G:607719	.	.
SYT9	G:613528	.	.
SYTL1	G:608042	.	.
SYTL2	G:612880	.	.
SYTL4	G:300723	.	.
SYVN1	G:608046	.	.
TAAR1	G:609333	.	.
TAAR2	G:604849	.	.
TAAR5	G:607405	.	.
TAAR6	G:608923	.	.
TAAR8	G:606927	.	.
TAAR9	G:608282	.	.
TAB1	G:602615	.	.
TAB2	G:605101	.	Congenital heart disease, nonsyndromic, 2, 612863 (3)
TAB3	G:300480	.	.
TAC1	G:162320	.	.
TAC3	G:162330	.	Hypogonadotropic hypogonadism, 146110 (3)
TAC4	G:607833	.	.
TACC1	G:605301	.	.
TACC2	G:605302	.	.
TACC3	G:605303	.	.
TACO1	G:612958	.	.
TACR1	G:162323	.	.
TACR2	G:162321	.	.
TACR3	G:162332	+GR-Bell	Hypogonadotropic hypogonadism, 146110 (3)
TACSTD2	G:137290	.	Corneal dystrophy, gelatinous drop-like, 204870 (3)
TADA1	G:612763	.	.
TADA2A	G:602276	.	.
TADA2B	G:608790	.	.
TADA3	G:602945	.	.
TAF1	G:313650	+GR-Bell	Dystonia-Parkinsonism, X-linked, 314250 (3)
TAF10	G:600475	.	.
TAF11	G:600772	.	.
TAF12	G:600773	.	.
TAF13	G:600774	.	.
TAF15	G:601574	.	.
TAF1A	G:604903	.	.
TAF1B	G:604904	.	.
TAF1C	G:604905	.	.
TAF1D	G:612823	.	.
TAF1L	G:607798	.	.
TAF2	G:604912	.	.
TAF3	G:606576	.	.
TAF4	G:601796	.	.
TAF4B	G:601689	.	.
TAF5	G:601787	.	.
TAF6	G:602955	.	.
TAF6L	G:602946	.	.
TAF7	G:600573	.	.
TAF7L	G:300314	.	.
TAF8	G:609514	.	.
TAF9	G:600822	.	.
TAF9B	G:300754	.	.
TAGAP	G:609667	.	.
TAGLN	G:600818	.	.
TAGLN2	G:604634	.	.
TAGLN3	G:607953	.	.
TAL1	G:187040	.	Leukemia-1, T-cell acute lymphocytic (3)
TAL2	G:186855	.	Leukemia-2, T-cell acute lymphoblastic (3)
TALDO1	G:602063	.	Transaldolase deficiency, 606003 (3)
TANC1	G:611397	.	.
TANK	G:603893	.	.
TAOK1	G:610266	.	.
TAOK2	G:613199	.	.
TAP1	G:170260	.	Bare lymphocyte syndrome, type I, 604571 (3)
TAP2	G:170261	.	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3)
TAPBP	G:601962	.	Bare lymphocyte syndrome, type I, 604571 (3)
TAPBPL	G:607081	.	.
TAPT1	G:612758	.	.
TAPVR1	P:106700	.	.
TARBP1	G:605052	.	.
TARBP2	G:605053	.	.
TARDBP	G:605078	.	Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3)
TARDBP	G:605078	.	Frontotemporal lobar degeneration, TARDBP-related, 612069 (3)
TARS	G:187790	.	.
TARS2	G:612805	.	.
TAS1R1	G:606225	.	.
TAS1R2	G:606226	.	.
TAS1R3	G:605865	.	.
TAS2R1	G:604796	.	.
TAS2R10	G:604791	.	.
TAS2R13	G:604792	.	.
TAS2R14	G:604790	.	.
TAS2R16	GP:604867	.	{Alcohol dependence}, 103780 (3)
TAS2R19	G:613961	.	.
TAS2R20	G:613962	.	.
TAS2R3	G:604868	.	.
TAS2R30	G:613963	.	.
TAS2R31	G:612669	.	.
TAS2R38	G:607751	.	[Phenylthiocarbamide tasting], 171200 (3)
TAS2R4	G:604869	.	.
TAS2R40	G:613964	.	.
TAS2R41	G:613965	.	.
TAS2R42	G:613966	.	.
TAS2R43	G:612668	.	.
TAS2R45	G:613967	.	.
TAS2R46	G:612774	.	.
TAS2R5	G:605062	.	.
TAS2R50	G:609627	.	.
TAS2R60	G:613968	.	.
TAS2R7	G:604793	.	.
TAS2R8	G:604794	.	.
TAS2R9	G:604795	.	.
TASP1	G:608270	.	.
TAT	G:613018	.	Tyrosinemia, type II, 276600 (3)
TAX1BP1	G:605326	.	.
TAZ	G:300394	Bell>cardiac	Barth syndrome, 302060 (3)
TAZ	G:300394	Bell>cardiac	Barth syndrome, 302060 (3)
TAZ	G:300394	Bell>cardiac	Cardiomyopathy, dilated, 3A, 300069 (3)
TAZ	G:300394	Bell>cardiac	Cardiomyopathy, dilated, 3A, 300069 (3)
TAZ	G:300394	Bell>cardiac	Left ventricular noncompaction, X-linked, 300183 (3)
TAZ	G:300394	Bell>cardiac	Left ventricular noncompaction, X-linked, 300183 (3)
TBC1D1	G:609850	.	.
TBC1D10A	G:610020	.	.
TBC1D10B	G:613620	.	.
TBC1D10C	G:610831	.	.
TBC1D15	G:612662	.	.
TBC1D2	G:609871	.	.
TBC1D20	G:611663	.	.
TBC1D24	G:613577	.	Myoclonic epilepsy, infantile, familial, 605021 (3)
TBC1D25	G:311240	.	.
TBC1D3	G:607741	.	.
TBC1D3B	G:610144	.	.
TBC1D3C	G:610806	.	.
TBC1D3F	G:610809	.	.
TBC1D3G	G:610810	.	.
TBC1D3H	G:610811	.	.
TBC1D4	G:612465	.	.
TBC1D7	G:612655	.	.
TBCA	G:610058	.	.
TBCB	G:601303	.	.
TBCC	G:602971	.	.
TBCD	G:604649	.	.
TBCE	G:604934	Bell>endocrine	Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)
TBCE	G:604934	Bell>endocrine	Kenny-Caffey syndrome-1, 244460 (3)
TBCE	G:604934	Bell>neurological	Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)
TBCE	G:604934	Bell>neurological	Kenny-Caffey syndrome-1, 244460 (3)
TBCEL	G:610451	.	.
TBK1	G:604834	.	.
TBKBP1	G:608476	.	.
TBL1X	G:300196	.	.
TBL1XR1	G:608628	.	.
TBL1Y	G:400033	.	.
TBL2	G:605842	.	.
TBL3	G:605915	.	.
TBP	G:600075	.	Spinocerebellar ataxia 17, 607136 (3)
TBP	G:600075	.	{Parkinson disease, susceptibility to}, 168600 (3)
TBPL1	G:605521	.	.
TBPL2	G:608964	.	.
TBR1	G:604616	.	.
TBRG1	G:610614	.	.
TBRG4	G:611325	.	.
TBX1	G:602054	+GR-Bell	Conotruncal anomaly face syndrome, 217095 (3)
TBX1	G:602054	+GR-Bell	DiGeorge syndrome, 188400 (3)
TBX1	G:602054	+GR-Bell	Velocardiofacial syndrome, 192430 (3)
TBX10	G:604648	.	.
TBX15	G:604127	.	Cousin syndrome, 260660 (3)
TBX18	G:604613	.	.
TBX19	G:604614	.	Adrenocorticotropic hormone deficiency, 201400 (3)
TBX2	G:600747	.	.
TBX20	G:606061	.	Atrial septal defect 4, 611363 (3)
TBX21	G:604895	.	Asthma and nasal polyps, 208550 (3)
TBX21	G:604895	.	{Asthma, aspirin-induced, susceptibility to}, 208550 (3)
TBX22	G:300307	.	Cleft palate with ankyloglossia, 303400 (3)
TBX3	G:601621	.	Ulnar-mammary syndrome, 181450 (3)
TBX4	G:601719	.	Small patella syndrome, 147891 (3)
TBX5	G:601620	+GR-Bell	Holt-Oram syndrome, 142900 (3)
TBX6	G:602427	.	.
TBXA2R	G:188070	.	{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3)
TBXAS1	G:274180	.	Ghosal hematodiaphyseal syndrome, 231095 (3)
TCAM1P	G:612756	.	.
TCAP	G:604488	.	Cardiomyopathy, dilated, 1N, 607487 (3)
TCAP	G:604488	.	Muscular dystrophy, limb-girdle, type 2G, 601954 (3)
TCEA1	G:601425	.	.
TCEA2	G:604784	.	.
TCEA3	G:604128	.	.
TCEAL1	G:300237	.	.
TCEAL7	G:300771	.	.
TCEB1	G:600788	.	.
TCEB2	G:600787	.	.
TCEB3	G:600786	.	.
TCEB3B	G:609522	.	.
TCERG1	G:605409	.	.
TCF12	G:600480	.	.
TCF15	G:601010	.	.
TCF19	G:600912	.	.
TCF20	G:603107	.	.
TCF21	G:603306	.	.
TCF23	G:609635	.	.
TCF25	G:612326	.	.
TCF3	G:147141	.	.
TCF4	G:602272	.	Pitt-Hopkins syndrome, 610954 (3)
TCF7	G:189908	.	.
TCF7L1	G:604652	.	.
TCF7L2	G:602228	.	{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)
TCFL5	G:604745	.	.
TCHH	G:190370	.	.
TCHP	G:612654	.	.
TCIRG1	G:604592	Bell>skeletal	Osteopetrosis, autosomal recessive 1, 259700 (3)
TCL1A	G:186960	.	.
TCL1B	G:603769	.	.
TCL4	G:186860	.	.
TCL6	G:604412	.	.
TCN1	G:189905	.	.
TCN2	G:613441	.	Transcobalamin II deficiency, 275350 (3)
TCOF1	G:606847	+GR-Bell	Treacher Collins syndrome 1, 154500 (3)
TCP1	G:186980	.	.
TCP10	G:187020	.	.
TCP10L	G:608365	.	.
TCP11	G:186982	.	.
TCTA	G:600690	.	.
TCTE1	G:186975	.	.
TCTE3	G:186977	.	.
TCTEX1D4	G:611713	.	.
TCTN1	G:609863	+GR-Bell	Joubert syndrome 13, 614173 (3)
TCTN2	G:613846	+GR-Bell	Meckel syndrome, type 8, 613885 (3)
TCTN3	G:613847	.	.
TDD	309150	.	.
TDG	G:601423	.	.
TDGF1	GP:187395	.	.
TDO2	G:191070	.	.
TDP1	G:607198	+GR-Bell	Spinocerebellar ataxia, autosomal recessive with axonal neuropathy, 607250 (3)
TDP2	G:605764	.	.
TDRD1	G:605796	.	.
TDRD3	G:614392	.	.
TDRD6	G:611200	.	.
TDRD7	G:611258	.	Cataract, autosomal recessive congenital 4, 613887 (3)
TDRKH	G:609501	.	.
TEAD1	G:189967	.	Sveinsson choreoretinal atrophy, 108985 (3)
TEAD2	G:601729	.	.
TEAD3	G:603170	.	.
TEAD4	G:601714	.	.
TEC	G:600583	.	.
TECR	G:610057	.	Mental retardation, autosomal recessive 14, 614020 (3)
TECTA	G:602574	.	Deafness, autosomal dominant 8/12, 601543 (3)
TECTA	G:602574	.	Deafness, autosomal recessive 21, 603629 (3)
TECTB	G:602653	.	.
TEF	G:188595	.	.
TEK	G:600221	+GR-Bell	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
TEKT1	G:609002	.	.
TEKT2	G:608953	.	.
TEKT3	G:612683	.	.
TELAB1	P:187260	.	.
TELO2	G:611140	.	.
TEN1	G:613130	.	.
TENC1	G:607717	.	.
TEP1	G:601686	.	.
TEPP	G:610264	.	.
TERC	G:602322	.	Aplastic anemia, 609135 (3)
TERC	G:602322	.	Dyskeratosis congenita, autosomal dominant 1, 127550 (3)
TERC	G:602322	.	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)
TERF1	G:600951	.	.
TERF2	G:602027	.	.
TERF2IP	G:605061	.	.
TERT	GP:187270	+GR-Bell	Dyskeratosis congenita, autosomal dominant 2, 613989 (3)
TERT	GP:187270	+GR-Bell	Dyskeratosis congenita, autosomal recessive 4, 613989 (3)
TERT	GP:187270	+GR-Bell	{Aplastic anemia, susceptibility to}, 609135 (3)
TERT	GP:187270	+GR-Bell	{Coronary artery disease, susceptiblity to} (3)
TERT	GP:187270	+GR-Bell	{Pulmonary fibrosis,idiopathic, susceptibility to}, 178500 (3)
TES	G:606085	.	.
TESC	G:611585	.	.
TESK1	G:601782	.	.
TESK2	G:604746	.	.
TET1	G:607790	.	.
TET2	G:612839	.	Myelodysplastic syndrome, somatic, 614286 (3)
TET3	G:613555	.	.
TEX101	G:612665	.	.
TEX11	G:300311	.	.
TEX12	G:605791	.	.
TEX13A	G:300312	.	.
TEX13B	G:300313	.	.
TEX14	G:605792	.	.
TEX15	G:605795	.	.
TEX28	G:300092	.	.
TFAM	G:600438	.	.
TFAP2A	G:107580	+GR-Bell	Branchiooculofacial syndrome, 113620 (3)
TFAP2B	G:601601	.	Char syndrome, 169100 (3)
TFAP2C	G:601602	.	.
TFAP2D	G:610161	.	.
TFAP2E	G:614428	.	.
TFAP4	G:600743	.	.
TFB1M	G:607033	.	.
TFB2M	G:607055	.	.
TFCP2	G:189889	.	.
TFCP2L1	G:609785	.	.
TFDP1	G:189902	.	.
TFDP2	G:602160	.	.
TFDP3	G:300772	.	.
TFE3	G:314310	.	Renal cell carcinoma, papillary, 1, 300854 (3)
TFEB	G:600744	.	.
TFEC	G:604732	.	.
TFF1	G:113710	.	.
TFF2	G:182590	.	.
TFF3	G:600633	.	.
TFG	G:602498	.	.
TFIP11	G:612747	.	.
TFPI	G:152310	.	.
TFPI2	G:600033	.	.
TFPT	G:609519	.	.
TFR2	G:604720	Bell>hematologic	Hemochromatosis, type 3, 604250 (3)
TFRC	G:190010	.	.
TGCT1	P:300228	.	.
TGFA	G:190170	.	.
TGFB1	G:190180	+GR-Bell	Camurati-Engelmann disease, 131300 (3)
TGFB1	G:190180	+GR-Bell	{Cystic fibrosis lung disease, modifier of}, 219700 (3)
TGFB1I1	G:602353	.	.
TGFB2	G:190220	.	.
TGFB3	G:190230	+GR-Bell	Arrhythmogenic right ventricular dysplasia 1, 107970 (3)
TGFBI	G:601692	.	Corneal dystrophy, Avellino type, 607541 (3)
TGFBI	G:601692	.	Corneal dystrophy, Groenouw type I, 121900 (3)
TGFBI	G:601692	.	Corneal dystrophy, Reis-Bucklers type, 608470 (3)
TGFBI	G:601692	.	Corneal dystrophy, Thiel-Behnke type, 602082 (3)
TGFBI	G:601692	.	Corneal dystrophy, epithelial basement membrane, 121820 (3)
TGFBI	G:601692	.	Corneal dystrophy, lattice type I, 122200 (3)
TGFBI	G:601692	.	Corneal dystrophy, lattice type IIIA, 608471 (3)
TGFBR1	G:190181	+GR-Bell	Loeys-Dietz syndrome, type 1A, 609192 (3)
TGFBR1	G:190181	+GR-Bell	Loeys-Dietz syndrome, type 2A, 608967 (3)
TGFBR1	G:190181	+GR-Bell	{Multiple self-healing squamous epithelioma, susceptiblity to}, 132800 (3)
TGFBR2	G:190182	+GR-Bell	Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3)
TGFBR2	G:190182	+GR-Bell	Esophageal cancer, somatic, 133239 (3)
TGFBR2	G:190182	+GR-Bell	Loeys-Dietz syndrome, type 1B, 610168 (3)
TGFBR2	G:190182	+GR-Bell	Loeys-Dietz syndrome, type 2B, 610380 (3)
TGFBR3	G:600742	.	.
TGFBRAP1	G:606237	.	.
TGIF1	G:602630	.	Holoprosencephaly-4, 142946 (3)
TGIF2	G:607294	.	.
TGIF2LX	G:300411	.	.
TGIF2LY	G:400025	.	.
TGM1	G:190195	Bell>cutaneous	Ichthyosiform erythroderma, congenital, 242100 (3)
TGM1	G:190195	Bell>cutaneous	Ichthyosis, lamellar, autosomal recessive, 242300 (3)
TGM1	G:190195	Bell>cutaneous	Self-healing collodion baby, 242300 (3)
TGM2	G:190196	.	.
TGM3	G:600238	.	.
TGM4	G:600585	.	.
TGM5	G:603805	.	Peeling skin syndrome, acral type, 609796 (3)
TGM6	G:613900	.	Spinocerebellar ataxia 35, 613908 (3)
TGM7	G:606776	.	.
TGOLN2	G:603062	.	.
TGS1	G:606461	.	.
TH1L	G:605297	.	.
THADA	G:611800	.	.
THAP1	G:609520	.	Dystonia 6, torsion, 602629 (3)
THAP10	G:612538	.	.
THAP11	G:609119	.	.
THAP2	G:612531	.	.
THAP3	G:612532	.	.
THAP4	G:612533	.	.
THAP5	G:612534	.	.
THAP6	G:612535	.	.
THAP7	G:609518	.	.
THAP8	G:612536	.	.
THAP9	G:612537	.	.
THAS	P:313850	.	.
THBD	G:188040	.	Thrombophilia due to thrombomodulin defect, 614486 (3)
THBD	G:188040	.	{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)
THBS1	G:188060	.	.
THBS2	G:188061	.	{Lumbar disc herniation, susceptibility to}, 603932 (3)
THBS3	G:188062	.	.
THBS4	G:600715	.	.
THEG	G:609503	.	.
THEM4	G:606388	.	.
THEMIS	G:613607	.	.
THM	P:274230	.	.
THNSL1	G:611260	.	.
THNSL2	G:611261	.	.
THOC1	G:606930	.	.
THOC2	G:300395	.	.
THOC3	G:606929	.	.
THOC5	G:612733	.	.
THOC7	G:611965	.	.
THOP1	G:601117	.	.
THPO	G:600044	.	Thrombocythemia 1, 187950 (3)
THRA	G:190120	.	Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)
THRAP3	G:603809	.	.
THRB	G:190160	.	Thyroid hormone resistance, 188570 (3)
THRB	G:190160	.	Thyroid hormone resistance, autosomal recessive, 274300 (3)
THRB	G:190160	.	Thyroid hormone resistance, selective pituitary, 145650 (3)
THRSP	G:601926	.	.
THSD4	G:614476	.	.
THSD7A	G:612249	.	.
THTPA	G:611612	.	.
THUMPD2	G:611751	.	.
THY1	G:188230	.	.
THYN1	G:613739	.	.
TIA1	G:603518	.	.
TIAF1	G:609517	.	.
TIAL1	G:603413	.	.
TIAM1	G:600687	.	.
TIAM2	G:604709	.	.
TICAM1	G:607601	.	.
TICAM2	G:608321	.	.
TIE1	G:600222	.	.
TIFA	G:609028	.	.
TIFAB	G:612663	.	.
TIGD1	G:612972	.	.
TIGD2	G:612973	.	.
TIGD7	G:612969	.	.
TIGIT	G:612859	.	.
TIMD4	G:610096	.	.
TIMELESS	G:603887	.	.
TIMM10	G:602251	.	.
TIMM13	G:607383	.	.
TIMM17A	G:605057	.	.
TIMM17B	G:300249	.	.
TIMM22	G:607251	.	.
TIMM23	G:605034	.	.
TIMM44	G:605058	.	.
TIMM50	G:607381	.	.
TIMM8A	G:300356	Bell>developmental	Deafness, X-linked 1, progressive (3)
TIMM8A	G:300356	Bell>developmental	Jensen syndrome, 311150 (3)
TIMM8A	G:300356	Bell>developmental	Mohr-Tranebjaerg syndrome, 304700 (3)
TIMM8B	G:606659	.	.
TIMM9	G:607384	.	.
TIMP1	G:305370	.	.
TIMP2	G:188825	.	.
TIMP3	G:188826	.	Sorsby fundus dystrophy, 136900 (3)
TIMP4	G:601915	.	.
TINAG	G:606749	.	.
TINF2	G:604319	+GR-Bell	Dyskeratosis congenita, autosomal dominant 3, 613990 (3)
TINF2	G:604319	+GR-Bell	Revesz syndrome, 268130 (3)
TIPARP	G:612480	.	.
TIPIN	G:610716	.	.
TIPRL	G:611807	.	.
TIRAP	G:606252	.	{Bacteremia, protection against}, 614382 (3)
TIRAP	G:606252	.	{Malaria, protection against}, 611162 (3)
TIRAP	G:606252	.	{Pneumococcal disease, invasive, protection against}, 610799 (3)
TIRAP	G:606252	.	{Tuberculosis, protection against}, 607948 (3)
TJAP1	G:612658	.	.
TJP1	G:601009	.	.
TJP2	G:607709	.	Hypercholanemia, familial, 607748 (3)
TJP3	G:612689	.	.
TK1	G:188300	.	.
TK2	G:188250	Bell>neurological	Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3)
TKCR	P:314300	.	.
TKT	G:606781	.	.
TKTL1	G:300044	.	.
TLE1	G:600189	.	.
TLE2	G:601041	.	.
TLE3	G:600190	.	.
TLE4	G:605132	.	.
TLE6	G:612399	.	.
TLK1	G:608438	.	.
TLK2	G:608439	.	.
TLL1	G:606742	.	Atrial septal defect 6, 613087 (3)
TLL2	G:606743	.	.
TLN1	G:186745	.	.
TLN2	G:607349	.	.
TLR1	G:601194	.	{Leprosy, protection against}, 613223 (3)
TLR1	G:601194	.	{Leprosy, susceptibility to, 5}, 613223 (3)
TLR10	G:606270	.	.
TLR2	G:603028	.	{Colorectal cancer, susceptibility to}, 114500 (3)
TLR2	G:603028	.	{Leprosy, susceptibility to}, 246300 (3)
TLR3	G:603029	.	Herpes simplex encephalitis, susceptibility to, 2, 613002 (3)
TLR4	GP:603030	.	{Colorectal cancer, susceptibility to}, 114500 (3)
TLR4	GP:603030	.	{Macular degeneration, age-related, 10}, 611488 (3)
TLR5	G:603031	.	{Legionaire disease, susceptibility to}, 608556 (3)
TLR5	G:603031	.	{Systemic lupus erythematosus, resistance to}, 601744 (3)
TLR6	G:605403	.	.
TLR7	G:300365	.	.
TLR8	G:300366	.	.
TLR9	G:605474	.	.
TLX1	G:186770	.	.
TLX1NB	G:612734	.	.
TLX2	G:604240	.	.
TLX3	G:604640	.	.
TM2D1	G:610080	.	.
TM2D2	G:610081	.	.
TM2D3	G:610014	.	.
TM4SF1	G:191155	.	.
TM4SF4	G:606567	.	.
TM4SF5	G:604657	.	.
TM6SF1	G:606562	.	.
TM6SF2	G:606563	.	.
TM7SF2	G:603414	.	.
TM7SF3	G:605181	.	.
TM9SF2	G:604678	.	.
TMBIM1	G:610364	.	.
TMBIM6	G:600748	.	.
TMC1	G:606706	.	Deafness, autosomal dominant 36, 606705 (3)
TMC1	G:606706	.	Deafness, autosomal recessive 7, 600974 (3)
TMC2	G:606707	.	.
TMC6	G:605828	.	Epidermodysplasia verruciformis, 226400 (3)
TMC8	G:605829	.	Epidermodysplasia verruciformis, 226400 (3)
TMCO1	G:614123	.	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome, 614132 (3)
TMED1	G:605395	.	.
TMED10	G:605406	.	.
TMED4	G:612038	.	.
TMEFF1	G:603421	.	.
TMEFF2	G:605734	.	.
TMEM102	G:613936	.	.
TMEM106B	G:613413	.	.
TMEM114	G:611579	.	.
TMEM115	G:607069	.	.
TMEM123	G:606356	.	.
TMEM126A	G:612988	.	Optic atrophy-7, 612989 (3)
TMEM127	G:613403	.	{Pheochromocytoma, susceptibility to}, 171300 (3)
TMEM132D	G:611257	.	.
TMEM138	G:614459	.	Joubert syndrome 16, 614465 (3)
TMEM147	G:613585	.	.
TMEM159	G:611304	.	.
TMEM173	G:612374	.	.
TMEM176A	G:610334	.	.
TMEM176B	G:610385	.	.
TMEM18	G:613220	.	.
TMEM181	G:613209	.	.
TMEM183B	G:611365	.	.
TMEM184C	G:613937	.	.
TMEM185A	G:300031	.	.
TMEM187	G:300059	.	.
TMEM189	G:610994	.	.
TMEM2	G:605835	.	.
TMEM204	G:611002	.	.
TMEM205	G:613771	.	.
TMEM216	G:613277	.	Joubert syndrome 2, 608091 (3)
TMEM216	G:613277	.	Meckel syndrome, type 2, 603194 (3)
TMEM237	G:614423	.	Joubert syndrome 14, 614424 (3)
TMEM25	G:613934	.	.
TMEM27	G:300631	.	.
TMEM30A	G:611028	.	.
TMEM30B	G:611029	.	.
TMEM30C	G:611030	.	.
TMEM38A	G:611235	.	.
TMEM38B	G:611236	.	.
TMEM43	G:612048	+GR-Bell	Arrhythmogenic right ventricular dysplasia 5, 604400 (3)
TMEM47	G:300698	.	.
TMEM48	G:610115	.	.
TMEM5	G:605862	.	.
TMEM50A	G:605348	.	.
TMEM55A	G:609864	.	.
TMEM55B	G:609865	.	.
TMEM57	G:610301	.	.
TMEM67	G:609884	Bell>neurological	COACH syndrome, 216360 (3)
TMEM67	G:609884	Bell>neurological	Joubert syndrome 6, 610688 (3)
TMEM67	G:609884	Bell>neurological	Meckel syndrome, type 3, 607361 (3)
TMEM67	G:609884	Bell>neurological	Nephronophthisis 11, 613550 (3)
TMEM67	G:609884	Bell>neurological	{Bardet-Biedl syndrome 14, modifier of}, 209900 (3)
TMEM70	G:612418	.	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3)
TMEM74	G:613935	.	.
TMEM97	G:612912	.	.
TMF1	G:601126	.	.
TMIE	G:607237	.	Deafness, autosomal recessive 6, 600971 (3)
TMLHE	G:300777	.	.
TMOD1	G:190930	.	.
TMOD2	G:602928	.	.
TMOD3	G:605112	.	.
TMOD4	G:605834	.	.
TMPO	G:188380	+GR-Bell	Cardiomyopathy, dilated, 1T, 613740 (3)
TMPRSS11A	G:611704	.	.
TMPRSS11D	G:605369	.	.
TMPRSS11E	G:610399	.	.
TMPRSS13	G:610050	.	.
TMPRSS15	G:606635	.	Enterokinase deficiency, 226200 (3)
TMPRSS2	G:602060	.	.
TMPRSS3	G:605511	.	Deafness, autosomal recessive 10, congenital, 605316 (3)
TMPRSS3	G:605511	.	Deafness, autosomal recessive 8, childhood onset, 601072 (3)
TMPRSS4	G:606565	.	.
TMPRSS5	G:606751	.	.
TMPRSS6	G:609862	.	Iron-refractory iron deficiency anemia, 206200 (3)
TMPRSS9	G:610477	.	.
TMSB10	G:188399	.	.
TMSB15A	G:601587	.	.
TMSB4X	G:300159	.	.
TMSB4Y	G:400017	.	.
TMX1	G:610527	.	.
TNC	G:187380	.	.
TNF	G:191160	.	{Asthma, susceptibility to}, 600807 (3)
TNF	G:191160	.	{Dementia, vascular, susceptibility to} (3)
TNF	G:191160	.	{Malaria, cerebral, susceptibility to}, 611162 (3)
TNF	G:191160	.	{Migraine without aura, susceptibility to}, 157300 (3)
TNF	G:191160	.	{Septic shock, susceptibility to} (3)
TNFAIP1	G:191161	.	.
TNFAIP2	G:603300	.	.
TNFAIP3	G:191163	.	.
TNFAIP6	G:600410	.	.
TNFAIP8	G:612111	.	.
TNFAIP8L2	G:612112	.	.
TNFRSF10A	G:603611	.	.
TNFRSF10B	G:603612	.	Squamous cell carcinoma, head and neck, 275355 (3)
TNFRSF10C	G:603613	.	.
TNFRSF10D	G:603614	.	.
TNFRSF11A	G:603499	.	Osteolysis, familial expansile, 174810 (3)
TNFRSF11A	G:603499	.	Osteopetrosis, autosomal recessive 7, 612301 (3)
TNFRSF11A	G:603499	.	Paget disease of bone, 602080 (3)
TNFRSF11B	G:602643	Bell>skeletal	Paget disease, juvenile, 239000 (3)
TNFRSF12A	G:605914	.	.
TNFRSF13B	G:604907	+GR-Bell	Immunodeficiency, common variable, 2, 240500 (3)
TNFRSF13B	G:604907	+GR-Bell	Immunoglobulin A deficiency 2, 609529 (3)
TNFRSF13C	G:606269	+GR-Bell	Immunodeficiency, common variable, 4, 613494 (3)
TNFRSF14	G:602746	.	.
TNFRSF17	G:109545	.	.
TNFRSF18	G:603905	.	.
TNFRSF19	G:606122	.	.
TNFRSF1A	G:191190	.	Periodic fever, familial, 142680 (3)
TNFRSF1B	G:191191	.	.
TNFRSF21	G:605732	.	.
TNFRSF25	G:603366	.	.
TNFRSF4	G:600315	.	.
TNFRSF6B	G:603361	.	.
TNFRSF8	G:153243	.	.
TNFRSF9	G:602250	.	.
TNFSF10	G:603598	.	.
TNFSF11	G:602642	.	Osteopetrosis, autosomal recessive 2, 259710 (3)
TNFSF12	G:602695	.	.
TNFSF13	G:604472	.	.
TNFSF13B	G:603969	.	.
TNFSF14	G:604520	.	.
TNFSF15	G:604052	.	.
TNFSF18	G:603898	.	.
TNFSF4	G:603594	.	{Myocardial infarction, susceptibility to}, 608446 (3)
TNFSF8	G:603875	.	.
TNFSF9	G:606182	.	.
TNIK	G:610005	.	.
TNIP1	G:607714	.	.
TNIP2	G:610669	.	.
TNIP3	G:608019	.	.
TNK1	G:608076	.	.
TNK2	G:606994	.	.
TNKS	G:603303	.	.
TNKS1BP1	G:607104	.	.
TNKS2	G:607128	.	.
TNMD	G:300459	.	.
TNNC1	G:191040	.	Cardiomyopathy, dilated, 1Z, 611879 (3)
TNNC1	G:191040	.	Cardiomyopathy, familial hypertrophic, 13, 613243 (3)
TNNC2	G:191039	.	.
TNNI1	G:191042	.	.
TNNI2	G:191043	.	Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)
TNNI3	G:191044	+GR-Bell	Cardiomyopathy, dilated, 1FF, 613286 (3)
TNNI3	G:191044	+GR-Bell	Cardiomyopathy, dilated, 2A, 611880 (3)
TNNI3	G:191044	+GR-Bell	Cardiomyopathy, familial hypertrophic, 7, 613690 (3)
TNNI3	G:191044	+GR-Bell	Cardiomyopathy, familial restrictive, 115210 (3)
TNNI3K	G:613932	.	.
TNNT1	G:191041	Bell>neurological	Nemaline myopathy, Amish type, 605355 (3)
TNNT2	G:191045	+GR-Bell	Cardiomyopathy, dilated, 1D, 601494 (3)
TNNT2	G:191045	+GR-Bell	Cardiomyopathy, familial hypertrophic, 2, 115195 (3)
TNNT2	G:191045	+GR-Bell	Cardiomyopathy, familial restrictive, 3, 612422 (3)
TNNT2	G:191045	+GR-Bell	Left ventricular noncompaction 6, 601494 (3)
TNNT3	G:600692	.	Arthyrgryposis, distal, type 2B, 601680 (3)
TNP1	G:190231	.	.
TNP2	G:190232	.	.
TNPO1	G:602901	.	.
TNPO2	G:603002	.	.
TNPO3	G:610032	.	.
TNR	G:601995	.	.
TNRC6A	G:610739	.	.
TNRC6B	G:610740	.	.
TNRC6C	G:610741	.	.
TNS1	G:600076	.	.
TNS3	G:606825	.	.
TNS4	G:608385	.	.
TNXB	G:600985	+GR-Bell	Ehlers-Danlos syndrome, autosomal dominant, hypermobility type, 130020 (3)
TNXB	G:600985	+GR-Bell	Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X deficiency, 606408 (3)
TOB1	G:605523	.	.
TOB2	G:607396	.	.
TOC	P:148500	.	.
TOE1	G:613931	.	.
TOLLIP	G:606277	.	.
TOM1	G:604700	.	.
TOM1L1	G:604701	.	.
TOMM20	G:601848	.	.
TOMM22	G:607046	.	.
TOMM40	G:608061	.	.
TOMM7	G:607980	.	.
TOMM70A	G:606081	.	.
TONSL	G:604546	.	.
TOP1	G:126420	.	DNA topoisomerase I, camptothecin-resistant (3)
TOP1MT	G:606387	.	.
TOP2A	G:126430	.	DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)
TOP2B	G:126431	.	.
TOP3A	G:601243	.	.
TOP3B	G:603582	.	.
TOPBP1	G:607760	.	.
TOPORS	G:609507	+GR-Bell	Retinitis pigmentosa 31, 609923 (3)
TOR1A	G:605204	+GR-Bell	Dystonia, early-onset atypical, with myoclonic features (3)
TOR1A	G:605204	+GR-Bell	Dystonia-1, torsion, 128100 (3)
TOR1A	G:605204	+GR-Bell	{Dystonia-1, modifier of} (3)
TOR1AIP1	G:614512	.	.
TOR1AIP2	G:614513	.	.
TOR1B	G:608050	.	.
TOR2A	G:608052	.	.
TOR3A	G:607555	.	.
TOX	G:606863	.	.
TOX2	G:611163	.	.
TOX3	G:611416	.	.
TOX4	G:614032	.	.
TP53	G:191170	+GR-Bell	Adrenal cortical carcinoma, 202300 (3)
TP53	G:191170	+GR-Bell	Breast cancer, 114480 (3)
TP53	G:191170	+GR-Bell	Choroid plexus papilloma, 260500 (3)
TP53	G:191170	+GR-Bell	Colorectal cancer, 114500 (3)
TP53	G:191170	+GR-Bell	Hepatocellular carcinoma, 114550 (3)
TP53	G:191170	+GR-Bell	Li-Fraumeni syndrome, 151623 (3)
TP53	G:191170	+GR-Bell	Li-Fraumeni-like syndrome, 151623 (3)
TP53	G:191170	+GR-Bell	Nasopharyngeal carcinoma, 607107 (3)
TP53	G:191170	+GR-Bell	Osteosarcoma, 259500 (3)
TP53	G:191170	+GR-Bell	Pancreatic cancer, 260350 (3)
TP53AIP1	G:605426	.	.
TP53BP1	G:605230	.	.
TP53BP2	G:602143	.	.
TP53I3	G:605171	.	.
TP53INP1	G:606185	.	.
TP53RK	G:608679	.	.
TP63	G:603273	+GR-Bell	ADULT syndrome, 103285 (3)
TP63	G:603273	+GR-Bell	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3)
TP63	G:603273	+GR-Bell	Hay-Wells syndrome, 106260 (3)
TP63	G:603273	+GR-Bell	Limb-mammary syndrome, 603543 (3)
TP63	G:603273	+GR-Bell	Orofacial cleft 8, 129400 (3)
TP63	G:603273	+GR-Bell	Rapp-Hodgkin syndrome, 129400 (3)
TP63	G:603273	+GR-Bell	Split-hand/foot malformation 4, 605289 (3)
TP73	G:601990	.	.
TPBG	G:190920	.	.
TPCN1	G:609666	.	.
TPCN2	G:612163	.	[Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)
TPD52	G:604068	.	.
TPD52L1	G:604069	.	.
TPD52L2	G:603747	.	.
TPH1	G:191060	.	.
TPH2	G:607478	.	{Attention deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3)
TPH2	G:607478	.	{Unipolar depression, susceptibility to}, 608516 (3)
TPI1	GP:190450	.	.
TPK1	G:606370	.	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), 614458 (3)
TPM1	G:191010	.	Cardiomyopathy, dilated, 1Y, 611878 (3)
TPM1	G:191010	.	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
TPM2	G:190990	+GR-Bell	Arthrogryposis multiplex congenita, distal, type 1, 108120 (3)
TPM2	G:190990	+GR-Bell	Arthrogryposis, distal, type 2B, 601680 (3)
TPM2	G:190990	+GR-Bell	Nemaline myopathy, 609285 (3)
TPM3	G:191030	+GR-Bell	CAP myopathy, 609284 (3)
TPM3	G:191030	+GR-Bell	Myopathy, congenital, with fiber-type disproportion, 255310 (3)
TPM3	G:191030	+GR-Bell	Nemaline myopathy 1, autosomal dominant, 609284 (3)
TPM4	G:600317	.	.
TPMT	G:187680	.	6-mercaptopurine sensitivity, 610460 (3)
TPO	G:606765	.	Thyroid dyshormonogenesis 2A, 274500 (3)
TPP1	G:607998	Bell>neurological	Ceroid lipofuscinosis, neuronal, 2, 204500 (3)
TPP2	G:190470	.	.
TPPP	G:608773	.	.
TPR	G:189940	.	.
TPRA1	G:608336	.	.
TPRG1L	G:611460	.	.
TPRKB	G:608680	.	.
TPRN	G:613354	.	Deafness, autosomal recessive 79, 613307 (3)
TPRX1	G:611166	.	.
TPRXL	G:611167	.	.
TPSAB1	G:191080	.	.
TPSB2	G:191081	.	.
TPSD1	G:609272	.	.
TPSG1	G:609341	.	.
TPST1	G:603125	.	.
TPST2	G:603126	.	.
TPT1	G:600763	.	.
TPTE	G:604336	.	.
TPTE2	G:606791	.	.
TPX2	G:605917	.	.
TRA2A	G:602718	.	.
TRA2B	G:602719	.	.
TRA@	G:186880	.	Leukemia/lymphoma, T-cell (3)
TRADD	G:603500	.	.
TRAF1	G:601711	.	.
TRAF2	G:601895	.	.
TRAF3	G:601896	.	.
TRAF3IP1	G:607380	.	.
TRAF3IP2	G:607043	.	{Psoriasis susceptibility 13}, 614070 (3)
TRAF3IP3	G:608255	.	.
TRAF4	G:602464	.	.
TRAF5	G:602356	.	.
TRAF6	G:602355	.	.
TRAF7	G:606692	.	.
TRAFD1	G:613197	.	.
TRAIP	G:605958	.	.
TRAK1	G:608112	.	.
TRAK2	G:607334	.	.
TRAM1	G:605190	.	.
TRAM2	G:608485	.	.
TRAP1	G:606219	.	.
TRAPPC1	G:610969	.	.
TRAPPC10	G:602103	.	.
TRAPPC11	G:614138	.	.
TRAPPC12	G:614139	.	.
TRAPPC2	G:300202	.	Spondyloepiphyseal dysplasia tarda, 313400 (3)
TRAPPC2L	G:610970	.	.
TRAPPC3	G:610955	.	.
TRAPPC4	G:610971	.	.
TRAPPC6A	G:610396	.	.
TRAPPC6B	G:610397	.	.
TRAPPC8	G:614136	.	.
TRAPPC9	G:611966	.	Mental retardation, autosomal recessive 13, 613192 (3)
TRAT1	G:604962	.	.
TRB@	G:186930	.	.
TRD@	G:186810	.	.
TRDMT1	G:602478	.	.
TRDN	G:603283	.	.
TREH	G:275360	.	.
TREM1	G:605085	.	.
TREM2	G:605086	+GR-Bell	Nasu-Hakola disease, 221770 (3)
TREML1	G:609714	.	.
TREML2	G:609715	.	.
TREML3	G:609716	.	.
TRERF1	G:610322	.	.
TREX1	G:606609	Bell>neurological	Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3)
TREX1	G:606609	Bell>neurological	Chilblain lupus, 610448 (3)
TREX1	G:606609	Bell>neurological	Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3)
TREX1	G:606609	Bell>neurological	{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
TREX2	G:300370	.	.
TRG@	G:186970	.	.
TRH	G:613879	.	.
TRHDE	G:606950	.	.
TRHR	GP:188545	.	Thyrotropin-releasing hormone resistance, generalized (3)
TRIB1	G:609461	.	.
TRIB2	G:609462	.	.
TRIB3	G:607898	.	.
TRICY1	P:609649	.	.
TRIL	G:613356	.	.
TRIM10	G:605701	.	.
TRIM11	G:607868	.	.
TRIM13	G:605661	.	.
TRIM14	G:606556	.	.
TRIM16	G:609505	.	.
TRIM17	G:606123	.	.
TRIM2	G:614141	.	.
TRIM21	G:109092	.	.
TRIM22	G:606559	.	.
TRIM23	G:601747	.	.
TRIM24	G:603406	.	Thyroid carcinoma, papillary, 188550 (3)
TRIM25	G:600453	.	.
TRIM26	G:600830	.	.
TRIM27	G:602165	.	.
TRIM28	G:601742	.	.
TRIM29	G:610658	.	.
TRIM3	G:605493	.	.
TRIM31	G:609316	.	.
TRIM32	G:602290	+GR-Bell	Bardet-Biedl syndrome 11, 209900 (3)
TRIM32	G:602290	+GR-Bell	Muscular dystrophy, limb-girdle, type 2H, 254110 (3)
TRIM33	G:605769	.	Thyroid carcinoma, papillary, 188550 (3)
TRIM34	G:605684	.	.
TRIM36	G:609317	.	.
TRIM37	G:605073	Bell>developmental	Mulibrey nanism, 253250 (3)
TRIM39	G:605700	.	.
TRIM41	G:610530	.	.
TRIM44	G:612298	.	.
TRIM45	G:609318	.	.
TRIM46	G:600986	.	.
TRIM47	G:611041	.	.
TRIM49	G:606124	.	.
TRIM5	G:608487	.	.
TRIM50	G:612548	.	.
TRIM54	G:606474	.	.
TRIM55	G:606469	.	.
TRIM6	G:607564	.	.
TRIM63	G:606131	.	.
TRIM66	G:612000	.	.
TRIM67	G:610584	.	.
TRIM68	G:613184	.	.
TRIM7	G:609315	.	.
TRIM72	G:613288	.	.
TRIM73	G:612549	.	.
TRIM74	G:612550	.	.
TRIM8	G:606125	.	.
TRIM9	G:606555	.	.
TRIO	G:601893	.	.
TRIOBP	G:609761	.	Deafness, autosomal recessive 28, 609823 (3)
TRIP10	G:604504	.	.
TRIP11	G:604505	.	Achondrogenesis, type IA, 200600 (3)
TRIP12	G:604506	.	.
TRIP13	G:604507	.	.
TRIP4	G:604501	.	.
TRIP6	G:602933	.	.
TRMT1	G:611669	.	.
TRMT12	G:611244	.	.
TRMT1L	G:611673	.	.
TRMT2A	G:611151	.	.
TRMT5	G:611023	.	.
TRMU	G:610230	.	Liver failure, transient infantile, 613070 (3)
TRMU	G:610230	.	{Deafness, mitochondrial, modifier of}, 580000 (3)
TRNAA1	G:601431	.	.
TRNAE1	G:180640	.	.
TRNAG2	G:610407	.	.
TRNAK1	G:189918	.	.
TRNAK2	G:612996	.	.
TRNAL1	G:189932	.	.
TRNAL2	G:189920	.	.
TRNAM1	G:180621	.	.
TRNAM2	G:180620	.	.
TRNAN1	G:189880	.	.
TRNAP1	G:189930	.	.
TRNAP2	G:189931	.	.
TRNAP3	G:189912	.	.
TRNAQ1	G:189919	.	.
TRNAQ2	G:189923	.	.
TRNAR1	G:610406	.	.
TRNAR3	G:601432	.	.
TRNAS1	G:606171	.	.
TRNAS2	G:189910	.	.
TRNAS3	G:606172	.	.
TRNAT1	G:189913	.	.
TRNAT2	G:189933	.	.
TRNAU1	G:165060	.	.
TRNAV1	G:189921	.	.
TRNAV2	G:612995	.	.
TRNT1	G:612907	.	.
TRO	G:300132	.	.
TROAP	G:603872	.	.
TROVE2	G:600063	.	.
TRPA1	G:604775	.	.
TRPC1	G:602343	.	.
TRPC3	G:602345	.	.
TRPC4	G:603651	.	.
TRPC4AP	G:608430	.	.
TRPC5	G:300334	.	.
TRPC6	G:603652	.	Glomerulosclerosis, focal segmental, 2, 603965 (3)
TRPM1	G:603576	.	Night blindness, congenital stationary, type 1C, 613216 (3)
TRPM2	G:603749	.	.
TRPM3	G:608961	.	.
TRPM4	G:606936	.	Progressive familial heart block, type IB, 604559 (3)
TRPM5	G:604600	.	.
TRPM6	G:607009	.	Hypomagnesemia 1, intestinal, 602014 (3)
TRPM7	G:605692	.	{Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1, susceptibility to}, 105500 (3)
TRPM8	G:606678	.	.
TRPS1	G:604386	.	Trichorhinophalangeal syndrome, type I, 190350 (3)
TRPS1	G:604386	.	Trichorhinophalangeal syndrome, type III, 190351 (3)
TRPT1	G:610470	.	.
TRPV1	G:602076	.	.
TRPV2	G:606676	.	.
TRPV3	G:607066	.	.
TRPV4	G:605427	+GR-Bell	Brachyolmia type 3, 113500 (3)
TRPV4	G:605427	+GR-Bell	Hereditary motor and sensory neuropathy, type IIc, 606071 (3)
TRPV4	G:605427	+GR-Bell	Metatropic dysplasia, 156530 (3)
TRPV4	G:605427	+GR-Bell	Parastremmatic dwarfism, 168400 (3)
TRPV4	G:605427	+GR-Bell	SED, Maroteaux type, 184095 (3)
TRPV4	G:605427	+GR-Bell	Scapuloperoneal spinal muscular atrophy, 181405 (3)
TRPV4	G:605427	+GR-Bell	Spinal muscular atrophy, distal, congenital nonprogressive, 600175 (3)
TRPV4	G:605427	+GR-Bell	Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3)
TRPV4	G:605427	+GR-Bell	[Sodium serum level QTL 1], 613508 (3)
TRPV5	G:606679	.	.
TRPV6	G:606680	.	.
TRRAP	G:603015	.	.
TRUB1	G:610726	.	.
TRUB2	G:610727	.	.
TSC1	G:605284	+GR-Bell	Focal cortical dysplasia, Taylor balloon cell type, 607341 (3)
TSC1	G:605284	+GR-Bell	Lymphangioleiomyomatosis, 606690 (3)
TSC1	G:605284	+GR-Bell	Tuberous sclerosis-1, 191100 (3)
TSC2	G:191092	+GR-Bell	Lymphangioleiomyomatosis, somatic, 606690 (3)
TSC2	G:191092	+GR-Bell	Tuberous sclerosis-2, 191100 (3)
TSC22D1	G:607715	.	.
TSC22D3	G:300506	.	.
TSC22D4	G:611914	.	.
TSEN15	G:608756	.	.
TSEN2	G:608753	+GR-Bell	Pontocerebellar hypoplasia type 2B, 612389 (3)
TSEN34	G:608754	+GR-Bell	Pontocerebellar hypoplasia type 2C, 612390 (3)
TSEN54	G:608755	Bell>neurological	Pontocerebellar hypoplasia type 2A, 277470 (3)
TSEN54	G:608755	Bell>neurological	Pontocerebellar hypoplasia type 2A, 277470 (3)
TSEN54	G:608755	Bell>neurological	Pontocerebellar hypoplasia type 4, 225753 (3)
TSEN54	G:608755	Bell>neurological	Pontocerebellar hypoplasia type 4, 225753 (3)
TSFM	G:604723	Bell>metabolic	Combined oxidative phosphorylation deficiency 3, 610505 (3)
TSG101	G:601387	.	Breast cancer, somatic, 114480 (3)
TSGA10	G:607166	.	.
TSHB	G:188540	Bell>endocrine	Hypothryoidism, congenital, nongoitrous 4, 275100 (3)
TSHR	GP:603372	.	Hyperthyroidism, familial gestational, 603373 (3)
TSHR	GP:603372	.	Hyperthyroidism, nonautoimmune, 609152 (3)
TSHR	GP:603372	.	Hypothyroidism, congenital, nongoitrous, 1 275200 (3)
TSHR	GP:603372	.	Thyroid adenoma, hyperfunctioning, somatic (3)
TSHZ1	G:614427	.	Aural atresia, congenital, 607842 (3)
TSHZ2	G:614118	.	.
TSHZ3	G:614119	.	.
TSIX	G:300181	.	.
TSKS	G:608253	.	.
TSKU	G:608015	.	.
TSLP	G:607003	.	.
TSN	G:600575	.	.
TSNAX	G:602964	.	.
TSNAXIP1	G:607720	.	.
TSPAN1	G:613170	.	.
TSPAN12	G:613138	.	Exudative vitreoretinopathy 5, 613310 (3)
TSPAN13	G:613139	.	.
TSPAN15	G:613140	.	.
TSPAN2	G:613133	.	.
TSPAN3	G:613134	.	.
TSPAN31	G:181035	.	.
TSPAN32	G:603853	.	.
TSPAN33	G:610120	.	.
TSPAN4	G:602644	.	.
TSPAN5	G:613136	.	.
TSPAN6	G:300191	.	.
TSPAN7	G:300096	.	Mental retardation, X-linked 58, 300210 (3)
TSPAN8	G:600769	.	.
TSPAN9	G:613137	.	.
TSPEAR	G:612920	.	.
TSPO	G:109610	.	.
TSPY1	G:480100	.	.
TSPYL1	G:604714	Bell>respiratory	Sudden infant death with dysgenesis of the testes syndrome, 608800 (3)
TSPYL2	G:300564	.	.
TSR1	G:611214	.	.
TSSC1	G:608998	.	.
TSSC2	G:608999	.	.
TSSC4	G:603852	.	.
TSSK1B	G:610709	.	.
TSSK2	G:610710	.	.
TSSK3	G:607660	.	.
TSSK4	G:610711	.	.
TSSK6	G:610712	.	.
TST	G:180370	.	.
TSTA3	G:137020	.	.
TTBK2	G:611695	+GR-Bell	Spinocerebellar ataxia 11, 604432 (3)
TTC1	G:601963	.	.
TTC12	G:610732	.	.
TTC19	G:613814	.	Mitochondrial complex III deficiency, 124000 (3)
TTC21A	G:611430	.	.
TTC21B	G:612014	.	Asphyxiating thoracic dystrophy 4, 613819 (3)
TTC21B	G:612014	.	Nephronophthisis 12, 613820 (3)
TTC3	G:602259	.	.
TTC35	G:607722	.	.
TTC39B	G:613574	.	.
TTC4	G:606753	.	.
TTC7A	G:609332	.	.
TTC8	G:608132	+GR-Bell	Bardet-Biedl syndrome 8, 209900 (3)
TTC8	G:608132	+GR-Bell	Retinitis pigmentosa 51, 613464 (3)
TTC9	G:610488	.	.
TTF1	G:600777	.	.
TTF2	G:604718	.	.
TTI1	G:614425	.	.
TTI2	G:614426	.	.
TTIM1	G:147830	.	.
TTK	G:604092	.	.
TTL	G:608291	.	.
TTLL1	G:608955	.	.
TTLL5	G:612268	.	.
TTLL6	G:610849	.	.
TTN	G:188840	Bell>cardiac	Cardiomyopathy, dilated, 1G, 604145 (3)
TTN	G:188840	Bell>cardiac	Cardiomyopathy, familial hypertrophic, 9, 613765 (3)
TTN	G:188840	Bell>cardiac	Muscular dystrophy, limb-girdle, type 2J, 608807 (3)
TTN	G:188840	Bell>cardiac	Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)
TTN	G:188840	Bell>cardiac	Myopathy, proximal, with early respiratory muscle involvement, 603689 (3)
TTN	G:188840	Bell>cardiac	Tibial muscular dystrophy, tardive, 600334 (3)
TTPA	G:600415	Bell>neurological	Ataxia with isolated vitamin E deficiency, 277460 (3)
TTR	G:176300	+GR-Bell	Amyloidosis, hereditary, transthyretin-related, 105210 (3)
TTR	G:176300	+GR-Bell	Carpal tunnel syndrome, familial, 115430 (3)
TTR	G:176300	+GR-Bell	[Dystransthyretinemic hyperthyroxinemia], 145680 (3)
TTTY17A	G:400040	.	.
TTTY3	G:400036	.	.
TTTY4	G:400037	.	.
TTTY5	G:400038	.	.
TTTY6	G:400039	.	.
TTYH1	G:605784	.	.
TTYH2	G:608855	.	.
TTYH3	G:608919	.	.
TUB	G:601197	.	.
TUBA1A	G:602529	.	Lissencephaly 3, 611603 (3)
TUBA1B	G:602530	.	.
TUBA3C	G:602528	.	.
TUBA4A	G:191110	.	.
TUBA8	G:605742	.	Polymicrogyria with optic nerve hypoplasia, 613180 (3)
TUBB	G:191130	.	.
TUBB1	G:612901	.	Macrothrombocytopenia, autosomal dominant, TUBB1-related, 613112 (3)
TUBB2B	G:612850	.	Polymicrogyria, asymmetric, 610031 (3)
TUBB3	G:602661	.	Cortical dysplasia, complex, with other brain malformations, 614039 (3)
TUBB3	G:602661	.	Fibrosis of extraocular muscles, congenital, 3A, 600638 (3)
TUBB4A	G:602662	.	.
TUBB4B	G:602660	.	.
TUBD1	G:607344	.	.
TUBE1	G:607345	.	.
TUBG1	G:191135	.	.
TUBG2	G:605785	.	.
TUBGCP4	G:609610	.	.
TUBGCP5	G:608147	.	.
TUBGCP6	G:610053	.	.
TUFM	G:602389	.	Combined oxidative phosphorylation deficiency 4, 610678 (3)
TUFT1	G:600087	.	.
TULP1	G:602280	+GR-Bell	Leber congenital amaurosis 15, 613843 (3)
TULP1	G:602280	+GR-Bell	Retinitis pigmentosa 14, 600132 (3)
TULP2	G:602309	.	.
TULP3	G:604730	.	.
TUSC1	G:610529	.	.
TUSC2	G:607052	.	.
TUSC3	G:601385	.	Mental retardation, autosomal recessive 7, 611093 (3)
TUSC5	G:612211	.	.
TUT1	G:610641	.	.
TWF1	G:610932	.	.
TWF2	G:607433	.	.
TWIST1	G:601622	.	Craniosynostosis, type 1, 123100 (3)
TWIST1	G:601622	.	Saethre-Chotzen syndrome with eyelid anomalies, 101400 (3)
TWIST1	G:601622	.	Saethre-Chotzen syndrome, 101400 (3)
TWIST2	G:607556	.	.
TWISTNB	G:608312	.	.
TWSG1	G:605049	.	.
TXK	G:600058	.	.
TXLNA	G:608676	.	.
TXLNB	G:611438	.	.
TXLNG	G:300677	.	.
TXLNG2P	G:400031	.	.
TXN	G:187700	.	.
TXN2	G:609063	.	.
TXNDC12	G:609448	.	.
TXNDC3	G:607421	+GR-Bell	Ciliary dyskinesia, primary, 6, 610852 (3)
TXNDC9	G:612564	.	.
TXNIP	G:606599	.	.
TXNL1	G:603049	.	.
TXNL4A	G:611595	.	.
TXNRD1	G:601112	.	.
TXNRD2	G:606448	.	.
TXNRD3	G:606235	.	.
TYK2	G:176941	.	Tyrosine kinase 2 deficiency, 611521 (3)
TYMP	G:131222	+GR-Bell	Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)
TYMS	G:188350	.	.
TYR	G:606933	+GR-Bell	Albinism, oculocutaneous, type IA, 203100 (3)
TYR	G:606933	+GR-Bell	Albinism, oculocutaneous, type IB, 606952 (3)
TYR	G:606933	+GR-Bell	Waardenburg syndrome/albinism, digenic, 103470 (3)
TYR	G:606933	+GR-Bell	[Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3)
TYR	G:606933	+GR-Bell	[Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800 (3)
TYR	G:606933	+GR-Bell	{Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3)
TYRL	P:191270	.	.
TYRO3	G:600341	.	.
TYROBP	G:604142	+GR-Bell	Nasu-Hakola disease, 221770 (3)
TYRP1	G:115501	.	Albinism, oculocutaneous, type III, 203290 (3)
TYS	P:181600	.	.
TYSND1	G:611017	.	.
TYW1	G:611243	.	.
TYW3	G:611245	.	.
U2AF1	G:191317	.	.
U2AF1L4	G:601080	.	.
U2AF2	G:191318	.	.
UACA	G:612516	.	.
UAP1	G:602862	.	.
UBA1	G:314370	Bell>neurological	Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)
UBA2	G:613295	.	.
UBA3	G:603172	.	.
UBA5	G:610552	.	.
UBA52	G:191321	.	.
UBA6	G:611361	.	.
UBA7	G:191325	.	.
UBAC1	G:608129	.	.
UBAP1	G:609787	.	.
UBASH3A	G:605736	.	.
UBASH3B	G:609201	.	.
UBB	G:191339	.	.
UBC	G:191340	.	.
UBD	G:606050	.	.
UBE2A	G:312180	.	Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)
UBE2B	G:179095	.	.
UBE2C	G:605574	.	.
UBE2D1	G:602961	.	.
UBE2D2	G:602962	.	.
UBE2D3	G:602963	.	.
UBE2E1	G:602916	.	.
UBE2E2	G:602163	.	.
UBE2E3	G:604151	.	.
UBE2G1	G:601569	.	.
UBE2G2	G:603124	.	.
UBE2H	G:601082	.	.
UBE2I	G:601661	.	.
UBE2K	G:602846	.	.
UBE2L1	G:600012	.	.
UBE2L3	G:603721	.	.
UBE2L6	G:603890	.	.
UBE2M	G:603173	.	.
UBE2N	G:603679	.	.
UBE2Q2	G:612501	.	.
UBE2R2	G:612506	.	.
UBE2S	G:610309	.	.
UBE2T	G:610538	.	.
UBE2V1	G:602995	.	.
UBE2V2	G:603001	.	.
UBE2W	G:614277	.	.
UBE2Z	G:611362	.	.
UBE3A	G:601623	.	Angelman syndrome, 105830 (3)
UBE3B	G:608047	.	.
UBE3C	G:614454	.	.
UBE3D	G:612495	.	.
UBE4A	G:603753	.	.
UBE4B	G:613565	.	.
UBIAD1	G:611632	.	Corneal dystrophy, crystalline, of Schnyder, 121800 (3)
UBL3	G:604711	.	.
UBL4A	G:312070	.	.
UBL4B	G:611127	.	.
UBL5	G:606849	.	.
UBL7	G:609748	.	.
UBLCP1	G:609867	.	.
UBN1	G:609771	.	.
UBN2	G:613841	.	.
UBP1	G:609784	.	.
UBQLN1	G:605046	.	.
UBQLN2	G:300264	.	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3)
UBQLN3	G:605473	.	.
UBQLN4	G:605440	.	.
UBR1	G:605981	Bell>developmental	Johanson-Blizzard syndrome, 243800 (3)
UBR2	G:609134	.	.
UBR3	G:613831	.	.
UBR4	G:609890	.	.
UBR5	G:608413	.	.
UBR7	G:613816	.	.
UBTD2	G:610174	.	.
UBTF	G:600673	.	.
UBTFL1	G:613696	.	.
UBXN11	G:609151	.	.
UBXN2B	G:610686	.	.
UBXN4	G:611216	.	.
UBXN6	G:611946	.	.
UBXN8	G:602155	.	.
UCHL1	G:191342	+GR-Bell	{Parkinson disease 5, susceptibility to}, 613643 (3)
UCHL3	G:603090	.	.
UCHL5	G:610667	.	.
UCK1	G:609328	.	.
UCK2	G:609329	.	.
UCKL1	G:610866	.	.
UCN	G:600945	.	.
UCN2	G:605902	.	.
UCN3	G:605901	.	.
UCP1	G:113730	.	{Obesity, susceptibility to}, 601665 (3)
UCP2	G:601693	.	{Obesity, susceptibility to, BMIQ4}, 607447 (3)
UCP3	G:602044	.	{Obesity, severe, and type II diabetes}, 601665 (3)
UEVLD	G:610985	.	.
UFC1	G:610554	.	.
UFD1L	G:601754	.	.
UFL1	G:613372	.	.
UFM1	G:610553	.	.
UFSP1	G:611481	.	.
UFSP2	G:611482	.	.
UGCG	G:602874	.	.
UGDH	G:603370	.	.
UGGT1	G:605897	.	.
UGGT2	G:605898	.	.
UGP1	G:191750	.	.
UGP2	G:191760	.	.
UGT1A1	G:191740	.	Crigler-Najjar syndrome, type I, 218800 (3)
UGT1A1	G:191740	.	Crigler-Najjar syndrome, type II, 606785 (3)
UGT1A1	G:191740	.	Hyperbilirubinemia, familial transcient neonatal, 237900 (3)
UGT1A1	G:191740	.	[Bilirubin, serum level of, QTL1], 601816 (3)
UGT1A1	G:191740	.	[Gilbert syndrome], 143500 (3)
UGT1A10	G:606435	.	.
UGT1A3	G:606428	.	.
UGT1A4	G:606429	.	.
UGT1A5	G:606430	.	.
UGT1A6	G:606431	.	.
UGT1A7	G:606432	.	.
UGT1A8	G:606433	.	.
UGT1A9	G:606434	.	.
UGT2A1	G:604716	.	.
UGT2B10	G:600070	.	.
UGT2B11	G:603064	.	.
UGT2B15	G:600069	.	.
UGT2B17	G:601903	.	.
UGT2B28	G:606497	.	.
UGT2B4	G:600067	.	.
UGT2B7	G:600068	.	.
UGT8	G:601291	.	.
UHMK1	G:608849	.	.
UHRF1	G:607990	.	.
UIMC1	G:609433	.	.
ULBP1	G:605697	.	.
ULBP2	G:605698	.	.
ULBP3	G:605699	.	.
ULK1	G:603168	.	.
ULK2	G:608650	.	.
ULK3	G:613472	.	.
UMOD	G:191845	+GR-Bell	Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)
UMOD	G:191845	+GR-Bell	Hyperuricemic nephropathy, familial juvenile 1, 162000 (3)
UMOD	G:191845	+GR-Bell	Medullary cystic kidney disease 2, 603860 (3)
UMODL1	G:613859	.	.
UMPS	G:613891	.	Orotic aciduria, 258900 (3)
UNC119	GP:604011	.	.
UNC13A	G:609894	.	.
UNC13B	G:605836	.	.
UNC13D	G:608897	+GR-Bell	Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)
UNC45A	G:611219	.	.
UNC45B	G:611220	.	.
UNC5A	G:607869	.	.
UNC5B	G:607870	.	.
UNC5C	G:603610	.	.
UNC80	G:612636	.	.
UNC93A	G:607995	.	.
UNC93B1	G:608204	.	Herpes simplex encephalitis, susceptibility to, 1, 610551 (3)
UNG	G:191525	.	Immunodeficiency with hyper IgM, type 4, 608106 (3)
UOX	P:191540	.	.
UPB1	G:606673	.	Beta-ureidopropionase deficiency, 613161 (3)
UPF1	G:601430	.	.
UPF2	G:605529	.	.
UPF3A	G:605530	.	.
UPF3B	G:300298	.	Mental retardation, X-linked, syndromic 14, 300676 (3)
UPK1A	G:611557	.	.
UPK1B	G:602380	.	.
UPK2	G:611558	.	.
UPK3A	G:611559	.	Renal adysplasia, 191830 (3)
UPK3A	G:611559	.	Urogenital adysplasia, 191830 (3)
UPK3B	G:611887	.	.
UPP1	G:191730	.	.
UPRT	G:300656	.	.
UQCC	G:611797	.	.
UQCR10	G:610843	.	.
UQCR11	G:609711	.	.
UQCRB	G:191330	Bell>metabolic	Mitochondrial complex III deficiency, 124000 (3)
UQCRC1	G:191328	.	.
UQCRC2	G:191329	.	.
UQCRFS1	G:191327	.	.
UQCRH	G:613844	.	.
UQCRQ	G:612080	Bell>metabolic	Mitochondrial complex III deficiency, 124000 (3)
URB1	G:608865	.	.
URGCP	G:610337	.	.
URI1	G:603494	.	.
URM1	G:612693	.	.
UROC1	G:613012	.	Urocanase deficiency, 276880 (3)
UROD	G:613521	.	Porphyria cutanea tarda, 176100 (3)
UROD	G:613521	.	Porphyria, hepatoerythropoietic, 176100 (3)
UROS	G:606938	Bell>cutaneous	Porphyria, congenital erythropoietic, 263700 (3)
USE1	G:610675	.	.
USF1	G:191523	.	{Hyperlipidemia, familial combined, susceptibility to}, 602491 (3)
USF2	G:600390	.	.
USH1A	P:276900	.	.
USH1C	G:605242	Bell>ocular	Deafness, autosomal recessive 18, 602092 (3)
USH1C	G:605242	Bell>ocular	Usher syndrome, type 1C, 276904 (3)
USH1E	P:602097	.	.
USH1G	G:607696	Bell>ocular	Usher syndrome, type 1G, 606943 (3)
USH1H	P:612632	.	.
USH2A	G:608400	Bell>ocular	Retinitis pigmentosa 39, 613809 (3)
USH2A	G:608400	Bell>ocular	Usher syndrome, type 2A, 276901 (3)
USHBP1	G:611810	.	.
USO1	G:603344	.	.
USP1	G:603478	.	.
USP10	G:609818	.	.
USP11	G:300050	.	.
USP12P1	G:603091	.	.
USP13	G:603591	.	.
USP14	G:607274	.	.
USP15	G:604731	.	.
USP16	G:604735	.	.
USP17	G:607011	.	.
USP17L2	G:610186	.	.
USP18	G:607057	.	.
USP19	G:614471	.	.
USP2	G:604725	.	.
USP21	G:604729	.	.
USP22	G:612116	.	.
USP24	G:610569	.	.
USP25	G:604736	.	.
USP26	G:300309	.	.
USP28	G:610748	.	.
USP29	G:609546	.	.
USP3	G:604728	.	.
USP30	G:612492	.	.
USP32	G:607740	.	.
USP36	G:612543	.	.
USP39	G:611594	.	.
USP4	G:603486	.	.
USP40	G:610570	.	.
USP44	G:610993	.	.
USP46	G:612849	.	.
USP47	G:614460	.	.
USP5	G:601447	.	.
USP6	G:604334	.	.
USP6NL	G:605405	.	.
USP7	G:602519	.	.
USP8	G:603158	.	.
USP9X	G:300072	.	.
USP9Y	G:400005	.	Spermatogenic failure, Y-linked, 2, 415000 (3)
UST	G:610752	.	.
UTF1	G:604130	.	.
UTP11L	G:609440	.	.
UTP14A	G:300508	.	.
UTP14C	G:608969	.	.
UTP18	G:612816	.	.
UTP20	G:612822	.	.
UTP3	G:611614	.	.
UTRN	G:128240	.	.
UTS2	G:604097	.	.
UTS2R	G:600896	.	.
UTY	G:400009	.	.
UVRAG	G:602493	.	.
UXS1	G:609749	.	.
UXT	G:300234	.	.
VAC14	G:604632	.	.
VAMP1	G:185880	.	.
VAMP2	G:185881	.	.
VAMP3	G:603657	.	.
VAMP4	G:606909	.	.
VAMP5	G:607029	.	.
VAMP7	G:300053	.	.
VAMP8	G:603177	.	.
VANGL1	G:610132	.	Caudal regression syndrome, 600145 (3)
VANGL1	G:610132	.	Neural tube defects, 182940 (3)
VANGL2	G:600533	.	.
VAPA	G:605703	.	.
VAPB	G:605704	+GR-Bell	Amyotrophic lateral sclerosis 8, 608627 (3)
VAPB	G:605704	+GR-Bell	Spinal muscular atrophy, late-onset, Finkel type, 182980 (3)
VARS	G:192150	.	.
VARS2	G:612802	.	.
VASH1	G:609011	.	.
VASH2	G:610471	.	.
VASN	G:608843	.	.
VASP	G:601703	.	.
VAT1	G:604631	.	.
VAV1	G:164875	.	.
VAV2	G:600428	.	.
VAV3	G:605541	.	.
VAX1	G:604294	.	.
VAX2	G:604295	.	.
VBP1	G:300133	.	.
VCAM1	G:192225	.	.
VCAN	G:118661	+GR-Bell	Wagner syndrome 1, 143200 (3)
VCL	G:193065	+GR-Bell	Cardiomyopathy, dilated, 1W, 611407 (3)
VCL	G:193065	+GR-Bell	Cardiomyopathy, familial hypertrophic, 15, 613255 (3)
VCP	G:601023	.	Amyotrophic lateral sclerosis 14 with or without frontotemporal dementia, 613954 (3)
VCP	G:601023	.	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
VCPIP1	G:611745	.	.
VCX	G:300229	.	.
VCX2	G:300532	.	.
VCX3A	G:300533	.	.
VCY	G:400012	.	.
VDAC1	G:604492	.	.
VDAC1P4	G:610030	.	.
VDAC2	G:193245	.	.
VDAC3	G:610029	.	.
VDI	P:125260	.	.
VDR	G:601769	Bell>skeletal	Rickets, vitamin D-resistant, type IIA, 277440 (3)
VEGFA	GP:192240	.	{Microvascular complications of diabetes 1}, 603933 (3)
VEGFB	G:601398	.	.
VEGFC	G:601528	.	.
VENTX	G:607158	.	.
VEPH1	G:609594	.	.
VEZF1	G:606747	.	.
VGF	G:602186	.	.
VGLL1	G:300583	.	.
VGLL2	G:609979	.	.
VGLL3	G:609980	.	.
VHL	G:608537	+GR-Bell	Erythrocytosis, familial, 2, 263400 (3)
VHL	G:608537	+GR-Bell	Hemangioblastoma, cerebellar, somatic (3)
VHL	G:608537	+GR-Bell	Pheochromocytoma, 171300 (3)
VHL	G:608537	+GR-Bell	Renal cell carcinoma, somatic, 144700 (3)
VHL	G:608537	+GR-Bell	von Hippel-Lindau syndrome, 193300 (3)
VIL1	G:193040	.	.
VIM	GP:193060	.	Cataract, pulverulent, autosomal dominant (3)
VIP	G:192320	.	.
VIPR1	G:192321	.	.
VIPR2	G:601970	.	.
VIS1	G:164755	.	.
VKORC1	G:608547	.	Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3)
VKORC1	G:608547	.	Warfarin resistance, 122700 (3)
VKORC1L1	G:608838	.	.
VLDLR	G:192977	Bell>neurological	Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1, 224050 (3)
VMA21	P:310440	.	.
VMD1	P:153840	.	.
VMP1	G:611753	.	.
VN1R1	G:605234	.	.
VNN1	GP:603570	.	.
VNN2	G:603571	.	.
VNN3	G:606592	.	.
VOPP1	G:611915	.	.
VPREB1	G:605141	.	.
VPREB3	G:605017	.	.
VPS11	G:608549	.	.
VPS13A	G:605978	+GR-Bell	Choreoacanthocytosis, 200150 (3)
VPS13B	G:607817	Bell>neurological	Cohen syndrome, 216550 (3)
VPS13C	G:608879	.	.
VPS13D	G:608877	.	.
VPS16	G:608550	.	.
VPS18	G:608551	.	.
VPS25	G:610907	.	.
VPS26A	G:605506	.	.
VPS26B	G:610027	.	.
VPS28	G:611952	.	.
VPS29	G:606932	.	.
VPS33A	G:610034	.	.
VPS33B	G:608552	Bell>developmental	Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3)
VPS35	G:601501	.	Parkinson disease 17, 614203 (3)
VPS36	G:610903	.	.
VPS37A	G:609927	.	.
VPS37B	G:610037	.	.
VPS37C	G:610038	.	.
VPS37D	G:610039	.	.
VPS39	G:612188	.	.
VPS41	G:605485	.	.
VPS45	G:610035	.	.
VPS4A	G:609982	.	.
VPS4B	G:609983	.	.
VPS52	G:603443	.	.
VPS72	G:600607	.	.
VRK1	G:602168	.	Pontocerebellar hypoplasia type 1, 607596 (3)
VRK2	G:602169	.	.
VRNI	P:193235	.	.
VSIG1	G:300620	.	.
VSIG2	G:606011	.	.
VSIG4	G:300353	.	.
VSNL1	G:600817	.	.
VSX1	G:605020	.	Corneal dystrophy, hereditary polymorphous posterior, 122000 (3)
VSX1	G:605020	.	Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)
VSX1	G:605020	.	Keratoconus 1, 148300 (3)
VSX2	G:142993	+GR-Bell	Microphthalmia with coloboma 3, 610092 (3)
VSX2	G:142993	+GR-Bell	Microphthalmia, isolated 2, 610093 (3)
VTA1	G:610902	.	.
VTCN1	G:608162	.	.
VTI1A	G:614316	.	.
VTI1B	G:603207	.	.
VTN	G:193190	.	.
VTRNA1-1	G:612695	.	.
VTRNA1-2	G:612696	.	.
VTRNA1-3	G:612697	.	.
VWA1	G:611901	.	.
VWA5A	G:602929	.	.
VWA7	G:609693	.	.
VWC2	G:611108	.	.
VWCE	G:611115	.	.
VWF	G:613160	+GR-Bell	von Willebrand disease, type 1, 193400 (3)
VWF	G:613160	+GR-Bell	von Willebrand disease, type 2A, 2B, 2M, and 2N, 613554 (3)
VWF	G:613160	+GR-Bell	von Willibrand disease, type 3, 277480 (3)
WAPAL	G:610754	.	.
WARS	G:191050	.	.
WARS2	G:604733	.	.
WAS	G:300392	Bell>immunodeficiency	Neutropenia, severe congenital, X-linked, 300299 (3)
WAS	G:300392	Bell>immunodeficiency	Thrombocytopenia, X-linked, 313900 (3)
WAS	G:300392	Bell>immunodeficiency	Thrombocytopenia, X-linked, intermittent, 313900 (3)
WAS	G:300392	Bell>immunodeficiency	Wiskott-Aldrich syndrome, 301000 (3)
WASF1	G:605035	.	.
WASF2	G:605875	.	.
WASF3	G:605068	.	.
WASH1	G:613632	.	.
WASL	G:605056	.	.
WBP1	G:606961	.	.
WBP2	G:606962	.	.
WBP2NL	G:610981	.	.
WBP4	G:604981	.	.
WBSCR27	G:612546	.	.
WBSCR28	G:612547	.	.
WDFY2	G:610418	.	.
WDFY4	G:613316	.	.
WDHD1	G:608126	.	.
WDPCP	G:613580	.	Bardet-Biedl syndrome 15, 209900 (3)
WDR1	G:604734	.	.
WDR11	G:606417	.	.
WDR13	G:300512	.	.
WDR16	G:609804	.	.
WDR17	G:609005	.	.
WDR19	G:608151	.	Asphyxiating thoracic dystrophy 5, 614376 (3)
WDR19	G:608151	.	Cranioectodermal dysplasia 4, 614378 (3)
WDR19	G:608151	.	Nephronophthisis 13, 614377 (3)
WDR3	G:604737	.	.
WDR34	G:613363	.	.
WDR35	G:613602	.	Cranioectodermal dysplasia 2, 613610 (3)
WDR35	G:613602	.	Short rib-polydactyly syndrome, type V, 614091 (3)
WDR36	G:609669	.	Glaucoma 1, open angle, G, 609887 (3)
WDR4	G:605924	.	.
WDR45	G:300526	.	.
WDR45L	G:609226	.	.
WDR46	G:611440	.	.
WDR48	G:612167	.	.
WDR5	G:609012	.	.
WDR6	G:606031	.	.
WDR61	G:609540	.	.
WDR62	G:613583	+GR-Bell	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3)
WDR65	G:614259	.	van der Woude syndrome 2, 606713 (3)
WDR7	G:613473	.	.
WDR72	G:613214	.	Amelogenesis imperfecta, hypomaturation type, IIA3, 613211 (3)
WDR77	G:611734	.	.
WDR82	G:611059	.	.
WDR85	G:613210	.	.
WDR92	G:610729	.	.
WEE1	G:193525	.	.
WEE2	G:614084	.	.
WFDC1	G:605322	.	.
WFDC12	G:609872	.	.
WFDC5	G:605161	.	.
WFIKKN1	G:608021	.	.
WFIKKN2	G:610895	.	.
WFS1	G:606201	+GR-Bell	Deafness, autosomal dominant 6/14/38, 600965 (3)
WFS1	G:606201	+GR-Bell	Wolfram syndrome, 222300 (3)
WFS1	G:606201	+GR-Bell	Wolfram-like syndrome, autosomal dominant, 614296 (3)
WFS1	G:606201	+GR-Bell	{Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)
WHAMM	G:612393	.	.
WHCR	P:194190	.	.
WHSC1	G:602952	.	.
WHSC1L1	G:607083	.	Leukemia, acute myeloid, 601626 (3)
WHSC2	G:606026	.	.
WIF1	G:605186	.	.
WIPF1	G:602357	.	Wiskott-Aldrich syndrome 2, 614493 (3)
WIPF2	G:609692	.	.
WIPF3	G:612432	.	.
WIPI1	G:609224	.	.
WIPI2	G:609225	.	.
WISP1	G:603398	.	.
WISP2	G:603399	.	.
WISP3	G:603400	.	Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3)
WISP3	G:603400	.	Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3)
WLS	G:611514	.	.
WNK1	G:605232	+GR-Bell	Neuropathy, hereditary sensory and autonomic, type II, 201300 (3)
WNK1	G:605232	+GR-Bell	Pseudohypoaldosteronism, type IIC, 614492 (3)
WNK2	G:606249	.	.
WNK3	G:300358	.	.
WNK4	G:601844	+GR-Bell	Pseudohypoaldosteronism, type IIB, 614491 (3)
WNT1	G:164820	.	.
WNT10A	G:606268	Bell>cutaneous	Odontoonychodermal dysplasia, 257980 (3)
WNT10A	G:606268	Bell>cutaneous	Schopf-Schulz-Passarge syndrome, 224750 (3)
WNT10A	G:606268	Bell>cutaneous	Tooth agenesis, selective, 4, 150400 (3)
WNT10B	G:601906	.	Split-hand/foot malformation 6, 225300 (3)
WNT11	G:603699	.	.
WNT16	G:606267	.	.
WNT2	G:147870	.	.
WNT2B	G:601968	.	.
WNT3	G:165330	Bell>developmental	Tetra-amelia, autosomal recessive, 273395 (3)
WNT3A	G:606359	.	.
WNT4	G:603490	+GR-Bell	Mullerian aplasia and hyperandrogenism, 158330 (3)
WNT4	G:603490	+GR-Bell	SERKAL syndrome, 611812 (3)
WNT5A	G:164975	.	Robinow syndrome, autosomal dominant, 180700 (3)
WNT5B	G:606361	.	.
WNT6	G:604663	.	.
WNT7A	G:601570	Bell>skeletal	Fuhrmann syndrome, 228930 (3)
WNT7A	G:601570	Bell>skeletal	Fuhrmann syndrome, 228930 (3)
WNT7A	G:601570	Bell>skeletal	Ulna and fibula, absence of, with sever limb deficiency, 276820 (3)
WNT7A	G:601570	Bell>skeletal	Ulna and fibula, absence of, with sever limb deficiency, 276820 (3)
WNT7B	G:601967	.	.
WNT8A	G:606360	.	.
WNT8B	G:601396	.	.
WNT9A	G:602863	.	.
WNT9B	G:602864	.	.
WRAP53	G:612661	.	Dyskeratosis congenita, autosomal recessive 3, 613988 (3)
WRAP73	G:606040	.	.
WRB	G:602915	.	.
WRN	G:604611	+GR-Bell	Werner syndrome, 277700 (3)
WRNIP1	G:608196	.	.
WS2B	P:600193	.	.
WSB1	G:610091	.	.
WSN	P:311510	.	.
WT1	G:607102	Bell>renal	Denys-Drash syndrome, 194080 (3)
WT1	G:607102	Bell>renal	Frasier syndrome, 136680 (3)
WT1	G:607102	Bell>renal	Meacham syndrome, 608978 (3)
WT1	G:607102	Bell>renal	Mesothelioma, somatic, 156240 (3)
WT1	G:607102	Bell>renal	Nephrotic syndrome, type 4, 256370 (3)
WT1	G:607102	Bell>renal	Wilms tumor, type 1, 194070 (3)
WT1-AS	G:607899	.	.
WT2	P:194071	.	.
WTAP	G:605442	.	.
WTS	P:309585	.	.
WWC1	GP:610533	.	[Memory, enhanced, association with] (3)
WWOX	G:605131	.	Esophageal squamous cell carcinoma, 133239 (3)
WWP1	G:602307	.	.
WWP2	G:602308	.	.
WWS	P:314580	.	.
WWTR1	G:607392	.	.
XAB2	G:610850	.	.
XAF1	G:606717	.	.
XAGE1A	G:300742	.	.
XAGE1B	G:300743	.	.
XAGE1C	G:300744	.	.
XAGE1D	G:300289	.	.
XAGE1E	G:300745	.	.
XAGE2	G:300416	.	.
XAGE3	G:300740	.	.
XBP1	G:194355	.	{Major affective disorder-7, susceptibility to}, 612371 (3)
XCE	G:300074	.	.
XCL1	G:600250	.	.
XCL2	G:604828	.	.
XCR1	G:600552	.	.
XDH	G:607633	.	Xanthinuria, type I, 278300 (3)
XGR	G:489500	.	.
XGR	P:314705	.	.
XIAP	G:300079	+GR-Bell	Lymphoproliferative syndrome, X-linked, 2, 300635 (3)
XIRP1	G:609777	.	.
XIRP2	G:609778	.	.
XIST	G:314670	.	X-inactivation, familial skewed, 300087 (3)
XKR3	G:611674	.	.
XKRX	G:300684	.	.
XKRY	G:400015	.	.
XPA	G:611153	Bell>cutaneous	Xeroderma pigmentosum, group A, 278700 (3)
XPA	G:611153	Bell>cutaneous	Xeroderma pigmentosum, group A, 278700 (3)
XPC	G:613208	+GR-Bell	Xeroderma pigmentosum, group C, 278720 (3)
XPNPEP1	G:602443	.	.
XPNPEP2	GP:300145	.	{Angioedema induced by ACE inhibitors, susceptibility to} (3)
XPNPEP3	G:613553	.	Nephronophthisis-like nephropathy 1, 613159 (3)
XPO1	G:602559	.	.
XPO4	G:611449	.	.
XPO5	G:607845	.	.
XPO6	G:608411	.	.
XPO7	G:606140	.	.
XPOT	G:603180	.	.
XPR1	G:605237	.	.
XRCC1	G:194360	.	.
XRCC2	G:600375	.	.
XRCC3	G:600675	.	{Breast cancer, susceptibility to}, 114480 (3)
XRCC3	G:600675	.	{Melanoma, cutaneous malignant, 6}, 613972 (3)
XRCC4	G:194363	.	.
XRCC5	G:194364	.	.
XRCC6	G:152690	.	.
XRN1	G:607994	.	.
XRN2	G:608851	.	.
XRRA1	G:609788	.	.
XXYLT1	G:614552	.	.
XYLB	G:604049	.	.
XYLT1	G:608124	.	{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)
XYLT2	G:608125	.	{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)
YAF2	G:607534	.	.
YAP1	G:606608	.	.
YARS	G:603623	.	Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)
YARS2	G:610957	.	Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)
YBX1	G:154030	.	.
YBX2	G:611447	.	.
YEATS2	G:613373	.	.
YEATS4	G:602116	.	.
YES1	G:164880	.	.
YIF1A	G:611484	.	.
YIPF3	G:609775	.	.
YIPF5	G:611483	.	.
YKT6	G:606209	.	.
YME1L1	G:607472	.	.
YOD1	G:612023	.	.
YPEL1	G:608082	.	.
YPEL2	G:609723	.	.
YPEL3	G:609724	.	.
YPEL4	G:609725	.	.
YPEL5	G:609726	.	.
YRDC	G:612276	.	.
YTHDF2	G:610640	.	.
YWHAB	G:601289	.	.
YWHAE	G:605066	.	.
YWHAG	G:605356	.	.
YWHAH	G:113508	.	.
YWHAQ	G:609009	.	.
YWHAZ	G:601288	.	.
YY1	G:600013	.	.
YY1AP1	G:607860	.	.
YY2	G:300570	.	.
ZACN	G:610935	.	.
ZAN	G:602372	.	.
ZAP70	GP:176947	.	.
ZAR1	G:607520	.	.
ZBED1	G:300178	.	.
ZBED4	G:612552	.	.
ZBED6	G:613512	.	.
ZBP1	G:606750	.	.
ZBTB16	G:176797	.	Leukemia, acute promyelocytic, PL2F/RARA type (3)
ZBTB16	G:176797	.	Skeletal defects, genital hypoplasia, and mental retardation, 612447 (3)
ZBTB17	G:604084	.	.
ZBTB20	G:606025	.	.
ZBTB22	G:611439	.	.
ZBTB24	G:614064	.	Immunodeficiency-centromeric instability-facial anomalies syndrome-2, 614069 (3)
ZBTB25	G:194541	.	.
ZBTB32	G:605859	.	.
ZBTB33	G:300329	.	.
ZBTB34	G:611692	.	.
ZBTB38	G:612218	.	.
ZBTB4	G:612308	.	.
ZBTB40	G:612106	.	.
ZBTB42	G:613915	.	.
ZBTB48	G:165270	.	.
ZBTB6	G:605976	.	.
ZBTB7A	G:605878	.	.
ZBTB7B	G:607646	.	.
ZC3H11A	G:613513	.	.
ZC3H12A	G:610562	.	.
ZC3H12D	G:611106	.	.
ZC3H14	G:613279	.	.
ZC3HAV1	G:607312	.	.
ZCCHC11	G:613692	.	.
ZCCHC12	G:300701	.	.
ZCCHC4	G:611792	.	.
ZCRB1	G:610750	.	.
ZDHHC13	G:612815	.	.
ZDHHC15	G:300576	.	Mental retardation, X-linked 91, 300577 (3)
ZDHHC17	G:607799	.	.
ZDHHC8	G:608784	.	.
ZDHHC9	G:300646	.	Mental retardation, X-linked syndromic, Raymond type, 300799 (3)
ZEB1	G:189909	.	Corneal dystrophy, Fuchs endothelial, 6, 613270 (3)
ZEB1	G:189909	.	Corneal dystrophy, posterior polymorphous, 3, 609141 (3)
ZEB2	G:605802	+GR-Bell	Mowat-Wilson syndrome, 235730 (3)
ZFAND2A	G:610699	.	.
ZFAND2B	G:613474	.	.
ZFAND3	G:607455	.	.
ZFAND5	G:604761	.	.
ZFAND6	G:610183	.	.
ZFAT	G:610931	.	{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)
ZFHX3	G:104155	.	{Prostate cancer, susceptibility to}, 176807 (3)
ZFHX4	G:606940	.	.
ZFP161	G:602126	.	.
ZFP3	G:194480	.	.
ZFP36	G:190700	.	.
ZFP36L1	G:601064	.	.
ZFP36L2	G:612053	.	.
ZFP37	G:602951	.	.
ZFP57	G:612192	+GR-Bell	Diabetes mellitus, transient neonatal, 1, 601410 (3)
ZFP62	G:610281	.	.
ZFP90	G:609451	.	.
ZFPM1	G:601950	.	.
ZFPM2	G:603693	.	Diaphragmatic hernia 3, 610187 (3)
ZFPM2	G:603693	.	Tetralogy of Fallot, 187500 (3)
ZFX	G:314980	.	.
ZFY	G:490000	.	.
ZFYVE1	G:605471	.	.
ZFYVE16	G:608880	.	.
ZFYVE20	G:609511	.	.
ZFYVE21	G:613504	.	.
ZFYVE26	G:612012	.	Spastic paraplegia 15, 270700 (3)
ZFYVE27	G:610243	.	Spastic paraplegia 33, 610244 (3)
ZFYVE28	G:614176	.	.
ZFYVE9	G:603755	.	.
ZGLP1	G:611639	.	.
ZHX1	G:604764	.	.
ZHX2	G:609185	.	.
ZHX3	G:609598	.	.
ZIC1	G:600470	.	.
ZIC2	G:603073	.	Holoprosencephaly-5, 609637 (3)
ZIC3	G:300265	Bell>developmental	Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3)
ZIC3	G:300265	Bell>developmental	Heterotaxy, visceral, 1, X-linked 306955 (3)
ZIC4	G:608948	.	.
ZKSCAN1	G:601260	.	.
ZKSCAN3	G:612791	.	.
ZKSCAN4	G:611643	.	.
ZKSCAN5	G:611272	.	.
ZMAT3	G:606452	.	.
ZMIZ1	G:607159	.	.
ZMIZ2	G:611196	.	.
ZMPSTE24	G:606480	Bell>cutaneous	Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3)
ZMPSTE24	G:606480	Bell>cutaneous	Restrictive dermopathy, lethal, 275210 (3)
ZMPSTE24	G:606480	Bell>developmental	Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3)
ZMPSTE24	G:606480	Bell>developmental	Restrictive dermopathy, lethal, 275210 (3)
ZMYM2	G:602221	.	.
ZMYM3	G:300061	.	.
ZMYM4	G:613568	.	.
ZMYM6	G:613567	.	.
ZMYND10	G:607070	.	.
ZMYND11	G:608668	.	.
ZMYND15	G:614312	.	.
ZMYND19	G:611424	.	.
ZNF10	G:194538	.	.
ZNF100	G:603982	.	.
ZNF101	G:603983	.	.
ZNF107	G:603989	.	.
ZNF114	G:603996	.	.
ZNF117	G:194624	.	.
ZNF12	G:194536	.	.
ZNF121	G:194628	.	.
ZNF123P	G:194630	.	.
ZNF124	G:194631	.	.
ZNF131	G:604073	.	.
ZNF132	G:604074	.	.
ZNF133	G:604075	.	.
ZNF134	G:604076	.	.
ZNF135	G:604077	.	.
ZNF136	G:604078	.	.
ZNF137P	G:604079	.	.
ZNF138	G:604080	.	.
ZNF14	G:194556	.	.
ZNF140	G:604082	.	.
ZNF141	G:194648	.	.
ZNF142	G:604083	.	.
ZNF143	G:603433	.	.
ZNF146	G:601505	.	.
ZNF148	G:601897	.	.
ZNF154	G:604085	.	.
ZNF155	G:604086	.	.
ZNF157	G:300024	.	.
ZNF16	G:601262	.	.
ZNF160	G:600398	.	.
ZNF165	G:600834	.	.
ZNF169	G:603404	.	.
ZNF174	G:603900	.	.
ZNF175	G:601139	.	.
ZNF177	G:601276	.	.
ZNF18	G:194524	.	.
ZNF180	G:606740	.	.
ZNF181	G:606741	.	.
ZNF182	G:314993	.	.
ZNF184	G:602277	.	.
ZNF185	G:300381	.	.
ZNF189	G:603132	.	.
ZNF19	G:194525	.	.
ZNF192	G:602240	.	.
ZNF193	G:602246	.	.
ZNF195	G:602187	.	.
ZNF2	G:194500	.	.
ZNF20	G:194557	.	.
ZNF200	G:603231	.	.
ZNF202	G:603430	.	.
ZNF204P	P:603282	.	.
ZNF205	G:603436	.	.
ZNF207	G:603428	.	.
ZNF208	G:603977	.	.
ZNF211	G:601856	.	.
ZNF212	G:602386	.	.
ZNF213	G:608387	.	.
ZNF214	G:605015	.	.
ZNF215	G:605016	.	.
ZNF217	G:602967	.	.
ZNF219	G:605036	.	.
ZNF22	G:194529	.	.
ZNF224	G:194555	.	.
ZNF23	G:194527	.	.
ZNF234	G:604750	.	.
ZNF235	G:604749	.	.
ZNF236	G:604760	.	.
ZNF238	G:608433	.	.
ZNF239	G:601069	.	.
ZNF24	G:194534	.	.
ZNF25	G:194528	.	.
ZNF253	G:606954	.	.
ZNF254	G:604768	.	.
ZNF256	G:606956	.	.
ZNF257	G:606957	.	.
ZNF259	G:603901	.	.
ZNF26	G:194537	.	.
ZNF260	G:613749	.	.
ZNF263	G:604191	.	.
ZNF264	G:604668	.	.
ZNF266	G:604751	.	.
ZNF267	G:604752	.	.
ZNF268	G:604753	.	.
ZNF271	G:604754	.	.
ZNF273	G:604756	.	.
ZNF274	G:605467	.	.
ZNF276	G:608460	.	.
ZNF277	G:605465	.	.
ZNF282	G:603397	.	.
ZNF296	G:613226	.	.
ZNF29P	G:194535	.	.
ZNF3	G:194510	.	.
ZNF300	G:612429	.	.
ZNF304	G:613840	.	.
ZNF317	G:613864	.	.
ZNF32	G:194539	.	.
ZNF320	G:606427	.	.
ZNF322	G:610847	.	.
ZNF323	G:610794	.	.
ZNF330	G:609550	.	.
ZNF331	G:606043	.	.
ZNF333	G:611811	.	.
ZNF335	G:610827	.	.
ZNF33A	G:194521	.	.
ZNF33B	G:194522	.	.
ZNF34	G:194526	.	.
ZNF346	G:605308	.	.
ZNF35	G:194533	.	.
ZNF350	G:605422	.	.
ZNF354A	G:602444	.	.
ZNF365	G:607818	.	{Nephrolithiasis, uric acid, susceptibility to}, 605990 (3)
ZNF366	G:610159	.	.
ZNF367	G:610160	.	.
ZNF382	G:609516	.	.
ZNF384	G:609951	.	.
ZNF385A	G:609124	.	.
ZNF385B	G:612344	.	.
ZNF395	G:609494	.	.
ZNF396	G:609600	.	.
ZNF397	G:609601	.	.
ZNF41	G:314995	.	Mental retardation, X-linked 89, 300848 (3)
ZNF423	G:604557	.	.
ZNF43	G:603972	.	.
ZNF436	G:611703	.	.
ZNF44	G:194542	.	.
ZNF443	G:606697	.	.
ZNF444	G:607874	.	.
ZNF449	G:300627	.	.
ZNF45	G:194554	.	.
ZNF460	G:604755	.	.
ZNF461	G:608640	.	.
ZNF467	G:614040	.	.
ZNF469	G:612078	Bell>cutaneous	Brittle cornea syndrome, 229200 (3)
ZNF480	G:613910	.	.
ZNF496	G:613911	.	.
ZNF503	G:613902	.	.
ZNF513	G:613598	+GR-Bell	Retinitis pigmentosa 58, 613617 (3)
ZNF521	G:610974	.	.
ZNF526	G:614387	.	.
ZNF540	G:613903	.	.
ZNF565	G:614275	.	.
ZNF569	G:613904	.	.
ZNF592	G:613624	.	Spinocerebellar ataxia, autosomal recessive 5, 606937 (3)
ZNF606	G:613905	.	.
ZNF622	G:608694	.	.
ZNF627	G:612248	.	.
ZNF628	G:610671	.	.
ZNF630	G:300819	.	.
ZNF638	G:614349	.	.
ZNF641	G:613906	.	.
ZNF644	G:614159	.	Myopia 21, autosomal dominant, 614167 (3)
ZNF649	G:611903	.	.
ZNF652	G:613907	.	.
ZNF653	G:611371	.	.
ZNF667	G:611024	.	.
ZNF673	G:300585	.	.
ZNF674	G:300573	.	Mental retardation, X-linked 92, 300851 (3)
ZNF687	G:610568	.	.
ZNF69	G:194543	.	.
ZNF699	G:609571	.	.
ZNF7	G:194531	.	.
ZNF70	G:194544	.	.
ZNF71	G:194545	.	.
ZNF711	G:314990	.	Mental retardation, X-linked 97, 300803 (3)
ZNF72P	G:194546	.	.
ZNF73	G:194547	.	.
ZNF737	G:603984	.	.
ZNF74	G:194548	.	.
ZNF746	G:613914	.	.
ZNF750	G:610226	.	Seborrhea-like dermatitis with psoriasiform elements, 610227 (3)
ZNF75A	G:601473	.	.
ZNF75D	G:314997	.	.
ZNF76	G:194549	.	.
ZNF77	G:194551	.	.
ZNF79	G:194552	.	.
ZNF8	G:194532	.	.
ZNF80	G:194553	.	.
ZNF804A	G:612282	.	.
ZNF81	G:314998	.	Mental retardation, X-linked 45, 300498 (3)
ZNF83	G:194558	.	.
ZNF85	G:603899	.	.
ZNF90	G:603973	.	.
ZNF91	G:603971	.	.
ZNF92	G:603974	.	.
ZNF93	G:603975	.	.
ZNF98	G:603980	.	.
ZNF99	G:603981	.	.
ZNHIT2	G:604575	.	.
ZNHIT3	G:604500	.	.
ZNRD1	G:607525	.	.
ZNRF1	G:612060	.	.
ZNRF2	G:612061	.	.
ZNRF3	G:612062	.	.
ZNRF4	G:612063	.	.
ZP1	G:195000	.	.
ZP2	G:182888	.	.
ZP3	G:182889	.	.
ZP4	G:613514	.	.
ZPBP	G:608498	.	.
ZPBP2	G:608499	.	.
ZRANB1	G:611749	.	.
ZRANB2	G:604347	.	.
ZRSR1	G:601079	.	.
ZRSR2	G:300028	.	.
ZSCAN12	G:603978	.	.
ZSCAN20	G:611315	.	.
ZSCAN21	G:601261	.	.
ZSCAN22	G:165260	.	.
ZSCAN4	G:613419	.	.
ZSWIM7	G:614535	.	.
ZW10	G:603954	.	.
ZWILCH	G:609984	.	.
ZWINT	G:609177	.	.
ZXDA	G:300235	.	.
ZXDB	G:300236	.	.
ZYX	G:602002	.	.